Citrus Sinensis ID: 021855
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 306 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.983 | 0.668 | 0.757 | 1e-142 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.964 | 0.710 | 0.698 | 1e-128 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | yes | no | 0.964 | 0.709 | 0.701 | 1e-128 | |
| Q7T2E3 | 403 | Casein kinase I isoform d | yes | no | 0.964 | 0.732 | 0.701 | 1e-128 | |
| Q6P647 | 415 | Casein kinase I isoform d | no | no | 0.964 | 0.710 | 0.698 | 1e-128 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | yes | no | 0.964 | 0.709 | 0.698 | 1e-128 | |
| P49674 | 416 | Casein kinase I isoform e | yes | no | 0.964 | 0.709 | 0.698 | 1e-127 | |
| Q6P3K7 | 409 | Casein kinase I isoform d | no | no | 0.964 | 0.721 | 0.698 | 1e-127 | |
| Q06486 | 415 | Casein kinase I isoform d | no | no | 0.964 | 0.710 | 0.694 | 1e-127 | |
| Q9DC28 | 415 | Casein kinase I isoform d | no | no | 0.964 | 0.710 | 0.694 | 1e-127 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 504 bits (1299), Expect = e-142, Method: Compositional matrix adjust.
Identities = 228/301 (75%), Positives = 272/301 (90%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE +A+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KW+GV+G+ NVLV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+E+ H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR+ANQVYIIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
C+ +P+EFASYFHYC+SL FD +PDY +LKR+F DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 T 301
T
Sbjct: 301 T 301
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1176), Expect = e-128, Method: Compositional matrix adjust.
Identities = 206/295 (69%), Positives = 257/295 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + +E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-128, Method: Compositional matrix adjust.
Identities = 207/295 (70%), Positives = 258/295 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ T E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T2E3|KC1DA_DANRE Casein kinase I isoform delta-A OS=Danio rerio GN=csnk1da PE=2 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1174), Expect = e-128, Method: Compositional matrix adjust.
Identities = 207/295 (70%), Positives = 257/295 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + T E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDITTGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1173), Expect = e-128, Method: Compositional matrix adjust.
Identities = 206/295 (69%), Positives = 256/295 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 456 bits (1173), Expect = e-128, Method: Compositional matrix adjust.
Identities = 206/295 (69%), Positives = 258/295 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ + E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49674|KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1172), Expect = e-127, Method: Compositional matrix adjust.
Identities = 206/295 (69%), Positives = 258/295 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ + E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P3K7|KC1DB_DANRE Casein kinase I isoform delta-B OS=Danio rerio GN=csnk1db PE=2 SV=1 | Back alignment and function description |
|---|
Score = 455 bits (1171), Expect = e-127, Method: Compositional matrix adjust.
Identities = 206/295 (69%), Positives = 256/295 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDISVGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 455 bits (1171), Expect = e-127, Method: Compositional matrix adjust.
Identities = 205/295 (69%), Positives = 256/295 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 455 bits (1171), Expect = e-127, Method: Compositional matrix adjust.
Identities = 205/295 (69%), Positives = 256/295 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 306 | ||||||
| 359484562 | 433 | PREDICTED: casein kinase I isoform delta | 0.993 | 0.702 | 0.898 | 1e-165 | |
| 356513159 | 430 | PREDICTED: casein kinase I isoform delta | 0.983 | 0.7 | 0.910 | 1e-165 | |
| 356523722 | 430 | PREDICTED: casein kinase I isoform delta | 0.983 | 0.7 | 0.910 | 1e-164 | |
| 388495184 | 431 | unknown [Lotus japonicus] | 0.993 | 0.705 | 0.898 | 1e-164 | |
| 356531301 | 426 | PREDICTED: casein kinase I isoform delta | 0.993 | 0.713 | 0.898 | 1e-163 | |
| 224142173 | 424 | predicted protein [Populus trichocarpa] | 0.993 | 0.716 | 0.901 | 1e-163 | |
| 356495220 | 662 | PREDICTED: casein kinase I isoform delta | 0.993 | 0.459 | 0.894 | 1e-163 | |
| 449530861 | 433 | PREDICTED: casein kinase I isoform delta | 0.993 | 0.702 | 0.888 | 1e-162 | |
| 357500563 | 424 | Casein kinase I isoform delta-like prote | 0.993 | 0.716 | 0.878 | 1e-161 | |
| 224092300 | 431 | predicted protein [Populus trichocarpa] | 0.993 | 0.705 | 0.884 | 1e-161 |
| >gi|359484562|ref|XP_002284044.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297738784|emb|CBI28029.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1515), Expect = e-165, Method: Compositional matrix adjust.
Identities = 273/304 (89%), Positives = 292/304 (96%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+HVDT EIVAVKIENS TKHPQLLYEAK+Y +LQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHVDTFEIVAVKIENSKTKHPQLLYEAKLYNLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP I+W G+DG+DN+LVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPGIRWSGIDGDDNILVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGY+FD++FDWTILKYQQTQK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREGYEFDYIFDWTILKYQQTQK 300
Query: 301 TKSQ 304
+++Q
Sbjct: 301 SRTQ 304
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513159|ref|XP_003525281.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1509), Expect = e-165, Method: Compositional matrix adjust.
Identities = 274/301 (91%), Positives = 289/301 (96%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW G+DGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPNIKWSGIDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+R+GYDFD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFARDGYDFDYVFDWTILKYQQSQK 300
Query: 301 T 301
Sbjct: 301 N 301
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523722|ref|XP_003530484.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1507), Expect = e-164, Method: Compositional matrix adjust.
Identities = 274/301 (91%), Positives = 289/301 (96%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW G+DGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVL+LADQMI RIEYVH
Sbjct: 61 GGSGIPNIKWSGIDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLLLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGYDFD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGYDFDYVFDWTILKYQQSQK 300
Query: 301 T 301
Sbjct: 301 N 301
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388495184|gb|AFK35658.1| unknown [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1500), Expect = e-164, Method: Compositional matrix adjust.
Identities = 273/304 (89%), Positives = 287/304 (94%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP +W GVDGEDNVLVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEY H
Sbjct: 61 GGSGIPGTRWSGVDGEDNVLVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYAH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD +TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSSTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGYDFD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGYDFDYVFDWTILKYQQSQK 300
Query: 301 TKSQ 304
Q
Sbjct: 301 NAVQ 304
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531301|ref|XP_003534216.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1496), Expect = e-163, Method: Compositional matrix adjust.
Identities = 273/304 (89%), Positives = 288/304 (94%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIEN TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIIGAKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP+IKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLK+VLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPSIKWCGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKSVLMLADQMMTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGY+FD+VFDWTILKY+Q QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREGYEFDYVFDWTILKYKQAQK 300
Query: 301 TKSQ 304
+ Q
Sbjct: 301 NRVQ 304
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142173|ref|XP_002324433.1| predicted protein [Populus trichocarpa] gi|222865867|gb|EEF02998.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1496), Expect = e-163, Method: Compositional matrix adjust.
Identities = 274/304 (90%), Positives = 287/304 (94%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEI+LA+H+DT EIVA+KIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIIGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAIKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP+IKW GVDGEDN LVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPSIKWSGVDGEDNALVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDATTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASY HYC SLTFDQRPDYGFLKRLF DLFS GY+FD+VFDWTI+KYQQ QK
Sbjct: 241 CKSHPVEFASYMHYCHSLTFDQRPDYGFLKRLFRDLFSHGGYEFDYVFDWTIIKYQQAQK 300
Query: 301 TKSQ 304
+SQ
Sbjct: 301 NRSQ 304
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495220|ref|XP_003516477.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1492), Expect = e-163, Method: Compositional matrix adjust.
Identities = 272/304 (89%), Positives = 287/304 (94%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERII KYKLGRKIGSGSFGEI+LA+++DT EIVAVKIEN TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIICAKYKLGRKIGSGSFGEIYLATNIDTFEIVAVKIENGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLK+VLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPNIKWCGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKSVLMLADQMMTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD +TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSSTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGY+FD+VFDWTILKYQQ QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGYEFDYVFDWTILKYQQAQK 300
Query: 301 TKSQ 304
+ Q
Sbjct: 301 NRVQ 304
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449530861|ref|XP_004172410.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1489), Expect = e-162, Method: Compositional matrix adjust.
Identities = 270/304 (88%), Positives = 289/304 (95%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MER+IG KYKLGRKIGSGSFGEI+LA+H++T EIVAVKIEN+ TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERVIGGKYKLGRKIGSGSFGEIYLATHIETFEIVAVKIENNKTKHPQLLYEAKLYSILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP KW G+DGE+NVLVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPATKWSGIDGEENVLVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDATTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+RE Y+FD+VFDWTI+KYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREEYEFDYVFDWTIIKYQQSQK 300
Query: 301 TKSQ 304
++Q
Sbjct: 301 NRTQ 304
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357500563|ref|XP_003620570.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|357500745|ref|XP_003620661.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355495585|gb|AES76788.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355495676|gb|AES76879.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1477), Expect = e-161, Method: Compositional matrix adjust.
Identities = 267/304 (87%), Positives = 288/304 (94%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+RIIG K+KLGRKIGSGSFGEI+LA+H+DT EIVAVKIE TKHPQLLYEAK+Y ILQ
Sbjct: 1 MDRIIGDKFKLGRKIGSGSFGEIYLATHIDTFEIVAVKIETGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP+I+W GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPSIRWSGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKTVLMLADQMMTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKAN VY+IDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANLVYVIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFL+RLF +LF+REGY FD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLRRLFRELFAREGYKFDYVFDWTILKYQQSQK 300
Query: 301 TKSQ 304
+++Q
Sbjct: 301 SRAQ 304
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224092300|ref|XP_002309549.1| predicted protein [Populus trichocarpa] gi|222855525|gb|EEE93072.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1476), Expect = e-161, Method: Compositional matrix adjust.
Identities = 269/304 (88%), Positives = 288/304 (94%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEIFLA+H+ + EIVAVKIEN TKHPQLLYEAK+YKIL
Sbjct: 1 MERIIGEKYKLGRKIGSGSFGEIFLATHIHSGEIVAVKIENRSTKHPQLLYEAKLYKILG 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGI NIKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQMIARIEY+H
Sbjct: 61 GGSGIANIKWCGVDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLMLADQMIARIEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+GFLHRDIKPDNFLMGLGRKA+QVY+IDFGLAK+YRDPTT++HI YRENKNLTGTARYA
Sbjct: 121 VKGFLHRDIKPDNFLMGLGRKASQVYVIDFGLAKRYRDPTTHQHITYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLES+GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESIGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REG++FDFVFDWTILKY+QTQ+
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREGFEFDFVFDWTILKYKQTQR 300
Query: 301 TKSQ 304
K Q
Sbjct: 301 PKPQ 304
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 306 | ||||||
| TAIR|locus:2117778 | 415 | ckl3 "casein kinase I-like 3" | 0.993 | 0.732 | 0.865 | 3.1e-147 | |
| TAIR|locus:2117843 | 414 | ckl4 "casein kinase I-like 4" | 0.993 | 0.734 | 0.861 | 3.9e-147 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.983 | 0.691 | 0.770 | 2.4e-131 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.983 | 0.668 | 0.757 | 7.3e-130 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.970 | 0.623 | 0.771 | 5.2e-129 | |
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.973 | 0.640 | 0.765 | 8.4e-129 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.970 | 0.630 | 0.767 | 1.7e-128 | |
| TAIR|locus:2050409 | 433 | ckl5 "casein kinase I-like 5" | 0.993 | 0.702 | 0.740 | 5.9e-128 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.973 | 0.674 | 0.761 | 1.2e-127 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.973 | 0.622 | 0.765 | 2e-127 |
| TAIR|locus:2117778 ckl3 "casein kinase I-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1438 (511.3 bits), Expect = 3.1e-147, P = 3.1e-147
Identities = 263/304 (86%), Positives = 286/304 (94%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIG GSFGEIFLA+HVDT EIVAVKIENS TKHPQLLYEAK+Y+IL+
Sbjct: 1 MERIIGGKYKLGRKIGGGSFGEIFLATHVDTFEIVAVKIENSKTKHPQLLYEAKLYRILE 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP IKW+GVDG +N LV+DLLGPSLEDLFVYC RKFS KTVLMLADQM+ RIE+VH
Sbjct: 61 GGSGIPRIKWFGVDGTENALVMDLLGPSLEDLFVYCGRKFSPKTVLMLADQMLTRIEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+G+LHRDIKPDNFLMGLGRKANQVY+IDFGLAK+YRD TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGYLHRDIKPDNFLMGLGRKANQVYLIDFGLAKRYRDANTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA KKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAVDKKQKYDKICEKKISTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CK+HP EFASYFHYC +LTFDQRPDYGFLKRLF DLFSREGY+FD++FDWTI+KYQQ QK
Sbjct: 241 CKNHPVEFASYFHYCHTLTFDQRPDYGFLKRLFRDLFSREGYEFDYIFDWTIIKYQQAQK 300
Query: 301 TKSQ 304
+++Q
Sbjct: 301 SRNQ 304
|
|
| TAIR|locus:2117843 ckl4 "casein kinase I-like 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1437 (510.9 bits), Expect = 3.9e-147, P = 3.9e-147
Identities = 262/304 (86%), Positives = 285/304 (93%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIG GSFGEIFLA+H+DT EIVAVKIENS TKHPQLLYEAK+Y+ L+
Sbjct: 1 MERIIGGKYKLGRKIGGGSFGEIFLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYRTLE 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP I+W+GVDG +N LV+DLLGPSLEDLFVYC RKFS KTVLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPRIRWFGVDGTENALVMDLLGPSLEDLFVYCGRKFSPKTVLMLADQMLTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+G+LHRDIKPDNFLMGLGRKANQVY+IDFGLAK+YRD TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGYLHRDIKPDNFLMGLGRKANQVYLIDFGLAKRYRDANTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQ RRDDLESLGYVLLYFLRGSLPWQGLKA KKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQGRRDDLESLGYVLLYFLRGSLPWQGLKAVDKKQKYDKICEKKISTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
CKSHP EFASYFHYC +LTFDQRPDYGFLKRLF DLFSREGY+FD+++DWTI+KYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHTLTFDQRPDYGFLKRLFRDLFSREGYEFDYIYDWTIIKYQQSQK 300
Query: 301 TKSQ 304
T+SQ
Sbjct: 301 TRSQ 304
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1288 (458.5 bits), Expect = 2.4e-131, P = 2.4e-131
Identities = 232/301 (77%), Positives = 272/301 (90%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFGEI+L +H+ TNE VA+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTHIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PNIKW+GV+G+ N LV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+EY H
Sbjct: 61 GGTGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR+ANQV+IIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
C+ +P+EFASYFHYC+SL FD +PDYG+LKR+F DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 T 301
T
Sbjct: 301 T 301
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1274 (453.5 bits), Expect = 7.3e-130, P = 7.3e-130
Identities = 228/301 (75%), Positives = 272/301 (90%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE +A+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KW+GV+G+ NVLV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+E+ H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR+ANQVYIIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
C+ +P+EFASYFHYC+SL FD +PDY +LKR+F DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 T 301
T
Sbjct: 301 T 301
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1266 (450.7 bits), Expect = 5.2e-129, P = 5.2e-129
Identities = 229/297 (77%), Positives = 266/297 (89%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLG+KIGSGSFGE++L +V T E VAVK+EN TKHPQL YE+K+Y +LQ
Sbjct: 1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW+GV+G+ +V+V+DLLGPSLEDLF YC RK +LKTVLMLADQ++ R+E++H
Sbjct: 61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL KKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLESLGYVL+YFL+GSLPWQGLKA TKKQKYD+I EKKVSTPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQ 297
CK+ P+EF SYFHYC+SL FD +PDY +LKRLF DLF REGY FD+VFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQ 297
|
|
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1264 (450.0 bits), Expect = 8.4e-129, P = 8.4e-129
Identities = 229/299 (76%), Positives = 268/299 (89%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIG GSFGEI+L +++ TNE VA+K+EN TKHPQLLYE+K+YK+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGGGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKVLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KWYGV+G+ NVLV+DLLGPSLEDLF +C RK SLKTVLMLADQMI RIE+VH
Sbjct: 61 GGTGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+ FLHRDIKPDNFLMGLGR+ANQVY+IDFGLAKKYRD + ++HIPYRENKNLTGTARYA
Sbjct: 121 QKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRD-SNHQHIPYRENKNLTGTARYA 179
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLG+VL+YFL+GSLPWQGLKA KKQKY+KI EKKVST IE L
Sbjct: 180 SMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEAL 239
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
C+ +P+EFASYFHYC+SL FD +PDY +LKRLF DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 240 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
Identities = 228/297 (76%), Positives = 265/297 (89%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLGRKIGSGSFGE++L +V T E VAVK+E+ TKHPQL YE+K+Y +LQ
Sbjct: 1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KWYGV+G+ NV+V+DLLGPSLEDLF YC RK SLKTVLMLADQ+I R+E++H
Sbjct: 61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL KKYRD T+RHIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLE+LGYVL+YFL+GSLPWQGLKA TKKQKYD+I EKKV+TPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQ 297
CK+ P+EF SYF YC+SL FD +PDY +LKRLF DLF REGY FD+VFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQ 297
|
|
| TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1256 (447.2 bits), Expect = 5.9e-128, P = 5.9e-128
Identities = 225/304 (74%), Positives = 267/304 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L + V TNE VA+K+E+ T HPQL YE+++Y++LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTDVQTNEEVAIKLESVKTAHPQLSYESRIYRVLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+GIPN+KWYGV+G+ NVLV+DLLGPSLEDLF YC+R+FSLKTVLMLADQMI R+E++H
Sbjct: 61 GGTGIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ +LHRDIKPDNFLMGLGR+ANQVYIID+GLAKKYRD +T+RHIPYRENK+L GT RYA
Sbjct: 121 SKSYLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDD+ESLGY+L+YFL+GSLPWQGLKA KKQKYDKI EKKVST IE L
Sbjct: 181 SLNTHLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIETL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
C+ HP EFASYFHYC+SL FD +PDY +LKRLF +LF REG+ FDFVFDWT+ KYQQ+Q
Sbjct: 241 CRGHPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQS 300
Query: 301 TKSQ 304
Q
Sbjct: 301 GNPQ 304
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
Identities = 227/298 (76%), Positives = 264/298 (88%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLGRKIGSGSFGE+++ +V T E VA+K+E TKHPQL YE+KVY +LQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+P+IKW+GV+G N + +DLLGPSLEDLF YC R FSLKTVLMLADQ+I R+EY+H
Sbjct: 61 GGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRKANQVYIID+GLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF+RGSLPWQGLKA TKKQKY+KI EKK+ TP+EVL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQT 298
CKS+P+EF SYFHYC+SL F+ +PDY +LKRLF DLF REGY FD+VFDWTILKY Q+
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQS 298
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
Identities = 228/298 (76%), Positives = 262/298 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLGRKIG GSFGE+FLA + T E AVK+E + TKHPQL YE+K+Y +LQ
Sbjct: 5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP++KW+GV G+ N +V+DLLGPSLEDLF YC R+ +LK VLMLADQ+I+R+EY+H
Sbjct: 65 GGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMH 124
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD T+RHIPYRENKNLTGTARYA
Sbjct: 125 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYA 184
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKYD+I EKKVSTPIEVL
Sbjct: 185 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 244
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQT 298
CKS+P EF SYF YC+SL F+ +PDY +LKRLF DLF REGY FD+VFDWT LK+ Q+
Sbjct: 245 CKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.6428 | 0.9607 | 0.6901 | yes | no |
| P49674 | KC1E_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6983 | 0.9640 | 0.7091 | yes | no |
| P67829 | KC1A_SHEEP | 2, ., 7, ., 1, 1, ., 1 | 0.6788 | 0.9869 | 0.9292 | N/A | no |
| Q6QNM1 | KC1_TOXGO | 2, ., 7, ., 1, 1, ., 1 | 0.6854 | 0.9869 | 0.9320 | N/A | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6949 | 0.9640 | 0.7108 | yes | no |
| P67963 | KC1A_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.6788 | 0.9869 | 0.8961 | N/A | no |
| Q7T2E3 | KC1DA_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.7016 | 0.9640 | 0.7320 | yes | no |
| P42168 | KC1A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.6589 | 0.9869 | 0.8856 | yes | no |
| Q7RBX5 | KC1_PLAYO | 2, ., 7, ., 1, 1, ., 1 | 0.6523 | 0.9869 | 0.9349 | N/A | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6881 | 0.9640 | 0.7108 | yes | no |
| P29295 | HRR25_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6209 | 1.0 | 0.6194 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.6979 | 0.9411 | 0.7890 | yes | no |
| O15726 | KC1_PLAF4 | 2, ., 7, ., 1, 1, ., 1 | 0.6423 | 0.9869 | 0.9320 | N/A | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.6779 | 0.9640 | 0.6704 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.6523 | 0.9869 | 0.9349 | yes | no |
| Q5ZLL1 | KC1E_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7016 | 0.9640 | 0.7091 | yes | no |
| Q6QNL9 | KC1_EIMTE | 2, ., 7, ., 1, 1, ., 1 | 0.6996 | 0.9575 | 0.8746 | N/A | no |
| Q9JMK2 | KC1E_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6983 | 0.9640 | 0.7091 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00016697001 | SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (433 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 306 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-36 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-22 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-22 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-16 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-12 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-05 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-05 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 6e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 1e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 6e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.001 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.001 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.001 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.001 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.002 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.002 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.002 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.002 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.002 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.003 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.003 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.004 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.004 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 7e-48
Identities = 77/266 (28%), Positives = 110/266 (41%), Gaps = 27/266 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
Y+L RK+GSGSFG ++ A H T +IVAVKI K E ++ + L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH--- 57
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
PNI + + + LV++ DLF Y R S +A Q++ +EY+
Sbjct: 58 -PNIVRLIDAFEDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS G +HRD+KP+N L+ + V I DFGLAKK GT Y
Sbjct: 115 HSNGIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWY 164
Query: 180 ASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
+ L G + D+ SLG +L L G P+ G + Q +I +
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEP 224
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRP 264
S E C + +RP
Sbjct: 225 KWS-SGSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 6e-36
Identities = 77/241 (31%), Positives = 121/241 (50%), Gaps = 17/241 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
Y++ RK+G GSFGE++LA ++VA+K+ E+ + + L E ++ L
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
I + + D LV++ + G SLEDL R S L + Q+++ +EY+
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS+G +HRDIKP+N L L R V +IDFGLAK DP + IP + ++ GT Y
Sbjct: 118 HSKGIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGY 174
Query: 180 ASCNTHLGIEQ---SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
+ LG+ S D+ SLG L L G P++G K ++ + KI + +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 237 I 237
+
Sbjct: 235 L 235
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-34
Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-KW 70
+G G FG ++LA T + VA+KI E+S + +LL E ++ K L PNI K
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH----PNIVKL 56
Query: 71 YGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
YGV D LV++ G SL+DL K S +L + Q++ +EY+HS G +HR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP+N L L +V + DFGL+K K + GT Y + LG
Sbjct: 117 DLKPENIL--LDSDNGKVKLADFGLSKLLTSDK-------SLLKTIVGTPAYMAPEVLLG 167
Query: 188 I-EQSRRDDLESLGYVLLYF 206
S + D+ SLG +L
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-31
Identities = 73/246 (29%), Positives = 115/246 (46%), Gaps = 27/246 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y++ K+G GSFG+++LA T ++VA+K+ + ++L E K+ K L+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH---- 56
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
PNI + Y V D + LV++ G L DL R + S Q+++ +EY+HS
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHS 115
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+G +HRD+KP+N L+ + V + DFGLA++ GT Y +
Sbjct: 116 KGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEK--------LTTFVGTPEYMA 164
Query: 182 CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
LG + D+ SLG V+LY L G P+ G + + KI + K P
Sbjct: 165 PEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPPFPPPEW 221
Query: 241 CKSHPA 246
S A
Sbjct: 222 DISPEA 227
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-24
Identities = 68/221 (30%), Positives = 112/221 (50%), Gaps = 24/221 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTK-HPQLLYEAKVYKILQGGS 63
+++ G KIG G+FG+++ A ++DT E++AVK I+++ K ++ E KV ++L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58
Query: 64 GIPNI-KWYGVDGEDN-VLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN+ K+YGV+ V + G +LE+L + R + + Q++ + Y+
Sbjct: 59 --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN-KNLTGTAR 178
HS G +HRDIKP N + + + DFG A K ++ TT E ++L GT
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTPA 168
Query: 179 YASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQGL 216
Y + G + R D+ SLG V+L G PW L
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGS 63
+YK+ +IG G+ G +F A +T E VA+K Q L E K + Q
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-- 58
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P + K V G VLV++ + L ++ R V ++ + Y+H
Sbjct: 59 --PYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP------YRENKNLT 174
+ G +HRD+KP N L+ + I DFGLA+ + + + YR + L
Sbjct: 117 ANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 210
G +Y G+ DL ++G + L GS
Sbjct: 174 GARKYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 3e-22
Identities = 67/233 (28%), Positives = 101/233 (43%), Gaps = 37/233 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
+K G+ IG GSF + LA +TN+ A+KI E K + E +V L
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK---KVKYVKIEKEVLTRLN 59
Query: 61 GGSGIPNIKWYGV--DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
G GI IK Y D E+N+ VL+ G L+ ++ K A +++
Sbjct: 60 GHPGI--IKLYYTFQD-EENLYFVLEYAPNGELLQ--YIRKYGSLDEKCTRFYAAEILLA 114
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-------------TN 162
+EY+HS+G +HRD+KP+N L+ K + I DFG AK + +
Sbjct: 115 LEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
R + GTA Y S + DL +LG ++ L G P++G
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-22
Identities = 85/304 (27%), Positives = 141/304 (46%), Gaps = 53/304 (17%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL 59
I G ++K+ + IG G FG ++ H N+ VA KIEN ++ ++ E VY +
Sbjct: 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVA-KIEN--LENETIVMETLVYNNI 65
Query: 60 QGGSGIPNIKWYGVDGEDNV--------------------LVLDLLGPSLEDLF--VYCR 97
I W + D++ ++L+ L + +++F + C+
Sbjct: 66 YDIDKIAL--WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCK 123
Query: 98 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
K +K ++ M+ +EY+H G H DIKP+N +M G N+ YIID+G+A +
Sbjct: 124 NKKLIKNIMK---DMLTTLEYIHEHGISHGDIKPEN-IMVDGN--NRGYIIDYGIASHF- 176
Query: 158 DPTTNRHIPY-RENKNL-TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+HI Y +E K+L GT YA + H G +RR DLESLGY +L + LPW+G
Sbjct: 177 -IIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235
Query: 216 LKA------ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269
A K ++ E K+ K+ + L+++++PDY L
Sbjct: 236 FGHNGNLIHAAKCDFIKRLHEGKIKI------KNANKFIYDFIECVTKLSYEEKPDYDAL 289
Query: 270 KRLF 273
++F
Sbjct: 290 IKIF 293
|
Length = 294 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKH-PQLLYEAKVYKILQGGS 63
++ G +G GSFG ++LA DT E++AVK + + L E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58
Query: 64 GIPNI-KWYGVDGEDNVLVLDLL-----GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
PNI ++YG + ++ L++ G SL L + K + Q++ +
Sbjct: 59 --PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSL-LKKFGKLPEPVIRKYTRQILEGLA 115
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+HS G +HRDIK N L+ V + DFG AK+ D T ++ GT
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDG---VVKLADFGCAKRLGDIETG-----EGTGSVRGTP 167
Query: 178 RYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ + G E R D+ SLG ++ G PW
Sbjct: 168 YWMAPEVIR---GEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 4e-19
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 33/173 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTK---HPQLLYEAKVYKILQ 60
+Y+ G+K+G G++ ++ A +T IVA+K E K + L E K+ + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 61 GGSGIPNI----KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD----- 110
PNI +G N+ LV + + LE + + K VL AD
Sbjct: 61 H----PNIIGLLDVFGHK--SNINLVFEFMETDLEKVI---KDK---SIVLTPADIKSYM 108
Query: 111 QMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
M R +EY+HS LHRD+KP+N L+ + + DFGLA+ + P
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGSPNRK 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
+++ KIG G FGE++ A H T + VA+K+ S K +++ E ++ K +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH---- 56
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
PNI K+YG + ++ +V++ G SL+DL + + + + +++ +EY+HS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
G +HRDIK N L+ +V +IDFGL+ + D + + GT + +
Sbjct: 117 NGIIHRDIKAANILL--TSDG-EVKLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
G + D+ SLG + G P
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 6e-18
Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSG--IPNIKW 70
+G GSFG++ L DT ++ A+K+ K ++ + IL + I + +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 71 YGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
E LVL+ G +LF + + +FS + A +++ +EY+HS G ++
Sbjct: 61 AFQTEEKLYLVLEYAPGG----ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCNT 184
RD+KP+N L L + + + DFGLAK+ TN GT Y +
Sbjct: 117 RDLKPENIL--LDADGH-IKLTDFGLAKELSSEGSRTN---------TFCGTPEYLAPEV 164
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP-------- 236
LG + D SLG +L L G P+ A +K+ Y+KI + + P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFY---AEDRKEIYEKILKDPLRFPEFLSPEAR 221
Query: 237 --IEVLCKSHPAE 247
I L + P +
Sbjct: 222 DLISGLLQKDPTK 234
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLY-EAKVYKILQGG 62
LG+K+G G+FGE++ VAVK E++ + + EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
PN+ K GV + E +V++ + G L R K SL +L A Q IAR +E
Sbjct: 61 ---PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQ-IARGME 116
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
Y+ S+ F+HRD+ N L+G + V I DFGL++ D +P R
Sbjct: 117 YLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 61/271 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAK------- 54
+Y + R IG G GE++LA + VA+K EN + L EAK
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP-LLKKRFLREAKIAADLIH 61
Query: 55 -----VYKILQGGSGI----PNIKWYGVDG-EDNVLVLDLLGPSLEDLFVYCRRKFSLKT 104
VY I G + P I+ Y + +V + L L + K S+
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE-------KTSVGA 114
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK---------- 154
L + ++ A IEYVHS+G LHRD+KPDN L+GL +V I+D+G A
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLL 171
Query: 155 --KYRDPTTNRH---IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 209
+ IP + + GT Y + LG+ S D+ +LG +L L
Sbjct: 172 DIDVDERNICYSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227
Query: 210 SLPWQGLKAATKKQKYDKICEK-KVSTPIEV 239
S P+ +++K KI + + +PIEV
Sbjct: 228 SFPY-------RRKKGRKISYRDVILSPIEV 251
|
Length = 932 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 7e-16
Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 7/153 (4%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
YK+ +++G G+FG ++LA + +T E+VA+K + + K L+ + PNI
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 69 -KWYGVDGEDNVL--VLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
K V E++ L V + + +L L + FS + + Q++ + ++H GF
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
HRD+KP+N L+ V I DFGLA++ R
Sbjct: 121 FHRDLKPENLLV---SGPEVVKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 53/157 (33%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
+LG+K+G G+FGE++ T VAVK G + L EA + K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH- 60
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
PNI + GV GE +V + + G L D K +LK +L +A Q IA+ +E
Sbjct: 61 ---PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ-IAKGME 116
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ S+ F+HRD+ N L + V I DFGL++
Sbjct: 117 YLESKNFVHRDLAARNCL--VTEN-LVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 5e-15
Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGSG 64
Y+ K+G G++G ++ A T EIVA+K ++N P L E + K L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH--- 57
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEY 118
PNI K V + LV + DL Y S + + Q++ + Y
Sbjct: 58 -PNIVKLLDVIHTERKLYLVFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
HS LHRD+KP N L+ + + + DFGLA+ + P
Sbjct: 114 CHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIP 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 5e-15
Identities = 56/176 (31%), Positives = 84/176 (47%), Gaps = 25/176 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLY-EAKVYKILQGG 62
LG+K+G G+FGE++ VAVK E++ + + EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKF-SLKTVLMLADQMIAR-I 116
PNI K GV + E ++V++ + G L D R K SL +L A Q IAR +
Sbjct: 61 ---PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ-IARGM 116
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
EY+ S+ F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 117 EYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 8e-15
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK---ILQGGSG- 64
++L R IG G+FG++ + DT ++ A+K N K + V ILQ +
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 65 -IPNIKWYGV-DGEDNVLVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVH 120
+ N+ WY D E+ LV+DLL DL + + KFS + V +++ +EY+H
Sbjct: 61 FLVNL-WYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-GTARY 179
S+G +HRDIKPDN L+ + V+I DF +A + T GT Y
Sbjct: 118 SKGIIHRDIKPDNILLD---EQGHVHITDFNIA---------TKVTPDTLTTSTSGTPGY 165
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+ S D SLG LRG P++G
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (178), Expect = 1e-14
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 20/161 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKH-PQLLYEAKVYKILQGGS 63
KY++ ++IG GSFG+++L ++ +K + N K L E K+ K L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-- 58
Query: 64 GIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLF---VYCRRKFSLKTVLMLADQMIARI 116
PNI K+Y E L V++ G L + F + +L Q+ +
Sbjct: 59 --PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKY 156
+Y+HSR LHRDIKP N FL V + DFG++K
Sbjct: 117 KYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVL 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGSG 64
Y+ KIG G++G ++ A T EIVA+K S L E K+ K L
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH--- 57
Query: 65 IPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
PNI K V D LV + + L L +R + Q++ + + HS
Sbjct: 58 -PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
G LHRD+KP+N L+ + + DFGLA+ + P
Sbjct: 117 HGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 30/246 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYK-ILQGGSGIPNIK-WY 71
I G++G +FLA T +I A+K+ + + + + IL +K +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 72 GVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM----IARI----EYVHS 121
G+ N+ LV++ L G L L L+ V L + + IA I EY+HS
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASL---------LENVGSLDEDVARIYIAEIVLALEYLHS 111
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYA 180
G +HRD+KPDN L+ + + DFGL+K N + +E+K + GT Y
Sbjct: 112 NGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
+ LG S+ D SLG +L FL G P+ G T ++ + I K+ E +
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNGKIE-WPEDV 224
Query: 241 CKSHPA 246
S A
Sbjct: 225 EVSDEA 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 7e-14
Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 36/237 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSG 64
Y+ +IG G++G+++ A + T E+VA+K +EN P + E K+ + L+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---- 56
Query: 65 IPNI-KWYGV---DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI + + G+ ++ +V + + L L KF+ + Q++ ++Y+
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY----RDPTTNRHIP--YRENKNL 173
HS G LHRDIK N L + + + DFGLA+ Y TNR I YR + L
Sbjct: 117 HSNGILHRDIKGSNIL--INNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
G RY + D+ S+G +L G +QG +T+ ++ +KI E
Sbjct: 174 LGATRYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEKIFE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 30/206 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGS 63
K+ + +IG G++G+++ A DT E+VA V+++N P + E K+ + L +
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 64 GIPNIKWYGVDGEDNV----------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
I N+K D +D + LV + + L L FS + Q++
Sbjct: 68 -IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY----RDPTTNRHIP--Y 167
+ Y H + FLHRDIK N L+ Q+ + DFGLA+ Y P TN+ I Y
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 168 RENKNLTGTARYA------SCNTHLG 187
R + L G RY SC LG
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILG 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 52/247 (21%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL--------QGGSG 64
+ I G+FG ++LA T + A+K+ K ++ + +V + QG S
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKV----LKKSDMIAKNQVTNVKAERAIMMIQGES- 56
Query: 65 IPNIK--WYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR----- 115
P + +Y +D + LV++ L G L +KT+ L + +
Sbjct: 57 -PYVAKLYYSFQSKDYLYLVMEYLNGGDCASL---------IKTLGGLPEDWAKQYIAEV 106
Query: 116 ---IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
+E +H RG +HRDIKP+N L+ + + + DFGL++ ENK
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKK 152
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
GT Y + T LG+ + D SLG V+ FL G P+ A T +D I ++
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRR 209
Query: 233 VSTPIEV 239
++ P EV
Sbjct: 210 INWPEEV 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 44/226 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP----QLLYEAKVYKILQ 60
+++ G +GSGSFG ++ ++D + AVK + + G QL E + LQ
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 61 GGSGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKF-SLKTVL--MLADQMI 113
PNI ++ G + E++ L L+L+ G SL L +K+ S + + Q++
Sbjct: 61 H----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQIL 112
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+EY+H R +HRDIK N L+ V + DFG+AK+ + + K+
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQV--------VEFSFAKSF 161
Query: 174 TGTARY------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
G+ + A + D+ SLG +L G PW
Sbjct: 162 KGSPYWMAPEVIAQQGGY-----GLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 40/242 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP--------QLLYEAKVYKILQ 60
++ + +G+GSFG + L H + + A+KI + K +L E ++ + ++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS---KAKIVKLKQVEHVLNEKRILQSIR 59
Query: 61 GGSGIPNI-KWYGVDGEDNVL--VLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIAR 115
P + YG +D+ L V++ + +LF + R+ +F A Q++
Sbjct: 60 H----PFLVNLYGSFQDDSNLYLVMEYVPGG--ELFSHLRKSGRFPEPVARFYAAQVVLA 113
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
+EY+HS ++RD+KP+N L+ + I DFG AK+ + T L G
Sbjct: 114 LEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRT----------YTLCG 160
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVS 234
T Y + L + D +LG +L+Y L G P+ Q Y+KI E KV
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALG-ILIYEMLAGYPPF---FDDNPIQIYEKILEGKVR 216
Query: 235 TP 236
P
Sbjct: 217 FP 218
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 50/164 (30%), Positives = 73/164 (44%), Gaps = 38/164 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSGIP 66
YK KIG G+ GE++ A+ T + VA+K ++ +L+ E + K + P
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH----P 75
Query: 67 NIKWYGVDGEDNVLVLDLL--------GPSLEDLFVYCRRKFSLKTVLMLADQMIARI-- 116
NI VD D+ LV D L G SL D+ + + + IA +
Sbjct: 76 NI----VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR--------MNEPQIAYVCR 123
Query: 117 ------EYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153
EY+HS+ +HRDIK DN L+ G V + DFG A
Sbjct: 124 EVLQGLEYLHSQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-13
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 45/282 (15%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IE---NSGTKHPQLLY--------EAK 54
K+ G IG G++G ++LA +V T E++AVK +E +H E +
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 55 VYKILQGGSGIPNIKWY-GVDGEDNVLVLDL---LGPSLEDLFVYCRR--KFSLKTVLML 108
K L NI Y G + + L + L G S+ R +F + V
Sbjct: 61 TLKDLDH----LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFF 113
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+Q++ + Y+HS+G LHRD+K DN L+ I DFG++KK D N
Sbjct: 114 TEQVLEGLAYLHSKGILHRDLKADNLLVDADGICK---ISDFGISKKSDDIYDN-----D 165
Query: 169 ENKNLTGT----ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224
+N ++ G+ A + G S + D+ SLG V+L G PW +A
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AA 220
Query: 225 YDKICEKKVSTPI--EVLCKSHPAEFASYFHYCQSLTFDQRP 264
K+ K+ + PI +V P + + C ++ D RP
Sbjct: 221 MFKLGNKRSAPPIPPDVSMNLSPVA-LDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 8e-13
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNI-K 69
+G GS G ++ H T +I A+K + QLL E K + S P + K
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKT--LRSCES--PYVVK 63
Query: 70 WYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFL 125
YG + +VL+ + G SL DL K + +A Q++ ++Y+H+ R +
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
HRDIKP N L+ +V I DFG++K + + GT Y S
Sbjct: 123 HRDIKPSNLLIN---SKGEVKIADFGISKVLENTLDQCN-------TFVGTVTYMSPERI 172
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
G S D+ SLG LL G P+ + + IC
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 51/180 (28%), Positives = 77/180 (42%), Gaps = 25/180 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y+L IG G+ ++ A + NE VA+K E T +L E +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH---- 58
Query: 66 PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK-----FSLKTVLMLADQMIARI 116
PN+ K+Y + L V+ L G SL D+ + + TVL +++ +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLKGL 115
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
EY+HS G +HRDIK N L+G + V I DFG++ D + K GT
Sbjct: 116 EYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 26/170 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGS 63
Y+LG IG G+FG ++ +++T + VA+K I K ++ E + K L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58
Query: 64 GIPNI-KWYGVDGEDNVL--VLDL-LGPSLEDLFVYCRRKF-----SLKTVLMLADQMIA 114
PNI K+ G + L +L+ SL + +KF SL V + Q++
Sbjct: 59 --PNIVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVY--QVLQ 110
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ Y+H +G +HRDIK N L K V + DFG+A K D + +
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDA 157
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 9e-12
Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 19/185 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGSG 64
Y++ K+G G+FGE++ A + T +VA+K I K L E K+ K L+ +
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 65 IPNIKWYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
+P I + + +V + L L K + + Q++ I
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+H LHRDIK N L+ + I DFGLA+ Y P P + GT
Sbjct: 130 YLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNPKGGGGGGTR 181
Query: 178 RYASC 182
+Y +
Sbjct: 182 KYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 1e-11
Identities = 71/245 (28%), Positives = 103/245 (42%), Gaps = 53/245 (21%)
Query: 13 RKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGIP 66
+K+G G+FGE++ VAVK + L EA+V K L G P
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL----GHP 56
Query: 67 NI-KWYGV--DGEDNVLVL------DLLG---PSLEDLFVYCRRKFSLKTVLMLADQMIA 114
N+ + GV + E LVL DLL S + SLK +L A Q IA
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ-IA 115
Query: 115 R-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP-----TTNRHIPYR 168
+ +EY+ S+ F+HRD+ N L+G + V I DFGL++ D T +P R
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 169 ----ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKK 222
E + + + +S D+ S G VLL+ F G+ P+ GL
Sbjct: 173 WMAPE------SLKDGIFTS-----KS---DVWSFG-VLLWEIFTLGATPYPGLSNEEVL 217
Query: 223 QKYDK 227
+ K
Sbjct: 218 EYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 30/175 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGS 63
KY++ +G G++G + + T EIVA+K E+ L E KV + L+
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-- 59
Query: 64 GIPNI-----------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
NI + Y LV + + +L +L V Q+
Sbjct: 60 --ENIVNLKEAFRRKGRLY--------LVFEYVERTLLELLEASPGGLPPDAVRSYIWQL 109
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
+ I Y HS +HRDIKP+N L+ ++ + + DFG A+ R + Y
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDY 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGSGIPNIK 69
+I G++G ++ A T EIVA +K+E P L E + LQ + I +K
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN-IVTVK 70
Query: 70 WYGV-DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
V D + +V++ + L+ L ++ F V L Q+++ + ++H LHR
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR 130
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
D+K N L+ + I DFGLA++Y P
Sbjct: 131 DLKTSNLLL---NNRGILKICDFGLAREYGSPLKP 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 38/278 (13%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
KL RK+G+G FGE+++ + T + VAVK GT P+ L EA++ K L+
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH----DKL 63
Query: 68 IKWYGV--DGEDNVLVLDLLGP-SLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVH 120
++ Y V + E +V + + SL D + + +K L ++ +A Q+ + Y+
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLD---FLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARY 179
SR ++HRD+ N L+G I DFGLA+ D + + K + TA
Sbjct: 121 SRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED---DEYTAREGAKFPIKWTAPE 174
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
A+ I + D+ S G +LL G +P+ G+ T ++ +++ E+ P
Sbjct: 175 AANYGRFTI----KSDVWSFG-ILLTEIVTYGRVPYPGM---TNREVLEQV-ERGYRMPR 225
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
C P E C ++RP + +L+ D
Sbjct: 226 PPNC---PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 72/269 (26%), Positives = 110/269 (40%), Gaps = 61/269 (22%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+IGSG+ G ++ H T + A+K+ + T Q+ E + IL+ + PN+
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE---ILRDVNH-PNV 134
Query: 69 ----KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ +GE VL+ + G SLE + + + +A Q+++ I Y+H R
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHRRHI 189
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAK---KYRDPTTNRHIPYRENKNLTGTARYAS 181
+HRDIKP N L+ + V I DFG+++ + DP + GT Y S
Sbjct: 190 VHRDIKPSNLLINSAK---NVKIADFGVSRILAQTMDPCNSS----------VGTIAYMS 236
Query: 182 ---CNTHLGIEQSRRD----DLESLGYVLLYFLRGSLP--------WQGLKAATKKQKYD 226
NT L D D+ SLG +L F G P W L A
Sbjct: 237 PERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------- 287
Query: 227 KICEKKVSTPIEVLCKSHPAEFASYFHYC 255
IC +S P E + EF + C
Sbjct: 288 -IC---MSQPPEAPATASR-EFRHFISCC 311
|
Length = 353 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-GTKHPQLLYEAKVYKILQGGSG 64
++L IG G++G+++ A H T ++VA+KI + + ++ E Y IL+ S
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE---YNILRKYSN 61
Query: 65 IPNI-KWYGV-------DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
PNI +YG +D + LV++L G S+ DL K K L ++ IA
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIA 116
Query: 115 RI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
I Y+H +HRDIK N L+ K +V ++DFG++
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 26/274 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQ-LLYEAKVYKILQGGS 63
+++ +KIG G F E++ A+ + + VA+K E K Q + E + K L +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEYVH 120
I + + D E N+++ L + Y +++ L +TV Q+ + +E++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 121 SRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
SR +HRDIKP N F+ G V + D GL + + TT H +L GT Y
Sbjct: 124 SRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPYY 172
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
S + + D+ SLG +L P+ G K +C+K
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLFSLCQKIEQCDYPP 227
Query: 240 LCKSHPAE-FASYFHYCQSLTFDQRPDYGFLKRL 272
L H +E C DQRPD G++ ++
Sbjct: 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 49/151 (32%), Positives = 79/151 (52%), Gaps = 14/151 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
+L RK+G+G FGE++ +T VAVK GT P+ L EA++ K L+ P
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRH----PKL 63
Query: 68 IKWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I+ Y V E +V +L+ G LE L R L ++ +A Q+ + + Y+ ++
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
++HRD+ N L+G + N + DFGLA+
Sbjct: 124 YIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-------QLLYEAKVYKIL 59
++ G+ +G G+FG ++L VDT +AVK P L E ++ K L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 60 QGGSGIPNI-KWYGVDGEDNVLVL---DLLGPSLED-LFVY------CRRKFSLKTVLML 108
Q I ++YG +D L + + G S++D L Y RK++
Sbjct: 62 QH----ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------ 111
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
Q++ +EY+HS +HRDIK N L A V + DFG +K R T
Sbjct: 112 --QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASK--RLQTICSSGTGM 164
Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 165 --KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 21/174 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP-QLLYEAKVYKILQGGS 63
KY+ KIG G+FGE+F A H T +IVA+K +EN P L E K+ ++L+ +
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 64 GIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
+ I Y LV + L L KF+L + + ++ +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-------TNR 163
Y+H LHRD+K N L+ K + + DFGLA+ + TNR
Sbjct: 133 YYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-11
Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 24/164 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYK 57
KY+ KIG G++G +F A + +T+EIVA+K + +S + LL E K
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 58 ILQGGSGIPNIKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
I ++ Y V D LV + L+ F C + V Q++
Sbjct: 61 I---------VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKG 111
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
+ + HS LHRD+KP N L+ K ++ + DFGLA+ + P
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIP 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 9e-11
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 37/164 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-- 65
Y+L ++IGSG++G+++ A + T E+VA+K+ L ++I+Q +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--------LEPGDDFEIIQQEISMLK 55
Query: 66 ----PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI- 116
PNI ++G + L V++ G SL+D++ R L++ IA +
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--------LSELQIAYVC 107
Query: 117 -------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
Y+H G +HRDIK N L+ + V + DFG++
Sbjct: 108 RETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 33/116 (28%), Positives = 47/116 (40%), Gaps = 26/116 (22%)
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD------------- 158
++ ++ VH GF+HRDIKPDN L + + + + DFGL KK
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNIL--IDADGH-IKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 159 --PTTNRHIPYRENKNLT-------GTARYASCNTHLGIEQSRRDDLESLGYVLLY 205
N + R++K GT Y + G D SLG V+LY
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILY 221
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGS 63
KY+ R +G G+FG + L ++V +K +E E +V K+L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-- 58
Query: 64 GIPN-IKWYGVDGEDNVLVLDLL---GPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEY 118
PN I++Y ED L++ + G +L + C T+L Q++ + +
Sbjct: 59 --PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GT 176
VH++ LHRD+K N L+ + V I DFG++K I ++K T GT
Sbjct: 117 VHTKLILHRDLKTQNILL--DKHKMVVKIGDFGISK----------ILSSKSKAYTVVGT 164
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVL 203
Y S G +++ D+ +LG VL
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 30/231 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIEN-------SGTKHPQLLYEAKVYKILQGGSGIPN 67
+G+G+FG + L + A+K+ +H E +V K + I
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH--NEKRVLKEVSH-PFIIR 65
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ W D ++++ + P E LF Y R +FS T L A +++ +EY+HS+ +
Sbjct: 66 LFWTEHDQRFLYMLMEYV-PGGE-LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV 123
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
+RD+KP+N L+ K + + DFG AKK RD T L GT Y +
Sbjct: 124 YRDLKPENILLD---KEGHIKLTDFGFAKKLRDRTW----------TLCGTPEYLAPEVI 170
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
++ D +LG ++ L G P+ Y+KI K+ P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKLEFP 218
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSGIPNI 68
R +G G+FGE L + + +V K N S + L E + +LQ PNI
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH----PNI 61
Query: 69 -KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRG 123
+Y +DN L++++ G +L D V + + F + VL Q+++ + Y+H G
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
LHRDIK N + KA + + DFG++K Y + + GT Y S
Sbjct: 122 ILHRDIKTLNIFL---TKAGLIKLGDFGISKILGS-------EYSMAETVVGTPYYMSPE 171
Query: 184 THLGIEQSRRDDLESLGYVL 203
G++ + + D+ +LG VL
Sbjct: 172 LCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 1e-10
Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 56/177 (31%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL----LYEAKVYKILQGG 62
+Y+L + IGSG++G + A T VA+K I N L E K+ + L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLR-- 57
Query: 63 SGIPNIKWYGVDGEDNVL-VLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--------- 110
+N++ +LD+L P + F VY + T LM D
Sbjct: 58 -------------HENIIGLLDILRPPSPEDFNDVY------IVTELMETDLHKVIKSPQ 98
Query: 111 ------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS +HRD+KP N L+ +N + I DFGLA+
Sbjct: 99 PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
++G+G+ G + H T +I+AVK +E + Q+L E + P I
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH----KCNSPYIV 62
Query: 69 KWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGF 124
+YG +G+ ++ + + G SL+ + + + + + +A ++ + Y+H
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRD+KP N L+ Q+ + DFG++ + + K GT+ Y +
Sbjct: 123 IHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPER 170
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
G + S + D+ SLG L+ G P+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 40/242 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+++G +G+GSFG + +A H T E A+K K ++L +V + Q S + +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKC----LKKREILKMKQVQHVAQEKSILMEL 75
Query: 69 K-------WYGVDGEDNVLVLDLLGPSLE-----DLFVYCRR--KFSLKTVLMLADQMIA 114
E+ V L LE +LF + R+ +F +++
Sbjct: 76 SHPFIVNMMCSFQDENRVYFL------LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL 129
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
EY+HS+ ++RD+KP+N L L K + V + DFG AKK D T L
Sbjct: 130 AFEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTF----------TLC 176
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
GT Y + + D ++G +L F+ G P+ T + Y+KI ++
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAGRLK 233
Query: 235 TP 236
P
Sbjct: 234 FP 235
|
Length = 329 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 25/190 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGS 63
+Y+ KIG G++G ++ A TNE +A+K +E P + E + K +Q G
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG- 61
Query: 64 GIPNI-KWYGVDGEDNVL-----VLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
NI + V + L LDL L ++ + + +KT L Q++ I
Sbjct: 62 ---NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY---QILRGI 115
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENK 171
Y HS LHRD+KP N L + R+ N + + DFGLA+ + P T H + YR +
Sbjct: 116 AYCHSHRVLHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPE 173
Query: 172 NLTGTARYAS 181
L G+ Y++
Sbjct: 174 ILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLL----YEAKVYKILQ 60
G IGSGSFG ++L + + E++AVK +S + +L E + K LQ
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 61 GGSGIPNIKWY---GVDGEDNVLVLDLL-GPSLEDLF-VYCRRKFSLKTVLMLADQMIAR 115
NI Y +D + + L+ + G S+ L Y F V Q++
Sbjct: 65 H----ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKG 118
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR----DPTTNRHIPYRENK 171
+ Y+H+RG +HRDIK N L+ + I DFG++KK TN P
Sbjct: 119 LNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP----- 170
Query: 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+L G+ + + +R+ D+ SLG +++ L G P+
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP---QLLYEAKVYKIL 59
+G +YK IGSG++G + A + + VA+K I ++ + L E K+ +
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 60 QGGSGIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
+ NI + G D +D +V+DL+ L + ++ + + + + Q+
Sbjct: 62 KH----DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHI-IHSDQPLTEEHIRYFLYQL 116
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ---VYIIDFGLAK 154
+ ++Y+HS +HRD+KP N L+ N+ + I DFG+A+
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+ +
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 64
Query: 69 KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V E+ + ++ G L+ L + L ++ +A Q+ + + YV ++
Sbjct: 65 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 126 HRDIKPDNFLMGLGRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
HRD++ N L+G N V + DFGLA+ D N + + K + TA A+
Sbjct: 125 HRDLRAANILVG----ENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALY 177
Query: 184 THLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
I + D+ S G +L +G +P+ G+ ++ D++ E+ P C
Sbjct: 178 GRFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC- 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
P C ++RP + +L+ D F+
Sbjct: 229 --PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 6e-10
Identities = 39/144 (27%), Positives = 73/144 (50%), Gaps = 11/144 (7%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI-KWYG 72
K+G GS+G ++ A H +T ++VA+K+ +++ E + K P I K+YG
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS----PYIVKYYG 65
Query: 73 VDGEDNVL--VLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
++ L V++ G S+ D+ + + + + + Q + +EY+HS +HRDI
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 130 KPDNFLMGLGRKANQVYIIDFGLA 153
K N L+ + Q + DFG++
Sbjct: 126 KAGNILLN---EEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 42/276 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+ L RK+GSG FGE++ + VA+KI + K E + K L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKH--- 63
Query: 67 NIKWYGV--DGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVH 120
I + V GE ++ +L+ L + R + + +++ +A Q+ + Y+
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKG--SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP---TTNRHIPYRENKNLTGTA 177
+ +HRD+ N L+G + DFGLA+ ++ ++++ IPY+ TA
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTA 172
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEK-KVS 234
A+ + S + D+ S G +LLY F G +P+ G + YD+I ++
Sbjct: 173 PEAASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPG---MNNHEVYDQITAGYRMP 224
Query: 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270
P + C P E C + + RP + L+
Sbjct: 225 CPAK--C---PQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 62/260 (23%), Positives = 97/260 (37%), Gaps = 50/260 (19%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+G G FG + L N A+K +E +H E ++ + P
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS--EKEILEECNH----PF 54
Query: 68 I-KWYG--VDGEDNVLVLDL-LGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHS 121
I K Y D + ++++ LG +L+ R F T ++ EY+H+
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLG---GELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARY 179
RG ++RD+KP+N L+ V ++DFG AKK K T GT Y
Sbjct: 112 RGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKL----------KSGQKTWTFCGTPEY 158
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA-----------ATKKQKYDK 227
+ L D SLG +LLY L G P+ K ++
Sbjct: 159 VAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217
Query: 228 ICEKKVSTPIEVLCKSHPAE 247
+K I+ L + +P E
Sbjct: 218 YIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
+ L IG GSFGE++ A TN++VA+K+ E + + + E + +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR---- 57
Query: 65 IPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P I K+YG + G ++++ G S DL K + + +++ +EY+H
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH 115
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
G +HRDIK N L+ + V + DFG++ + + R+
Sbjct: 116 EEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRN 156
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQ-LLYEAKVYKILQGGS 63
+K+ +KIG G F ++ A + +VA+K E K Q L E + K L
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-- 61
Query: 64 GIPN-IKWYGVDGEDNVLVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQMIARI 116
PN IK+ E+N L + L DL F +R +T+ Q+ + +
Sbjct: 62 --PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
E++HS+ +HRDIKP N + A V + D GL + + TT H +L G
Sbjct: 120 EHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH-------SLVG 168
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY 205
T Y S + + D+ SLG LLY
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLG-CLLY 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 37/165 (22%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIPN 67
+++ ++G G +G++FLA DT EIVA+K LL++ +V +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKK-----SLLFKLNEVRHVLTERDILTT 57
Query: 68 IK--WYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF----SLKTVL----MLAD------- 110
K W ++ LL +D ++Y ++ +T+L +L++
Sbjct: 58 TKSEW----------LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM 107
Query: 111 -QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+M ++ +H G++HRD+KP+NFL+ + + + DFGL+K
Sbjct: 108 AEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 37/171 (21%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGSG 64
Y+ +IG G++G ++ A ++T VA+K + S P L E + K L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES-FE 59
Query: 65 IPNIKWYGVDGEDNVLVLD-LLGPSLE--------------DLFVYCRR----KFSLKTV 105
PNI V +LD GP + DL Y + +T+
Sbjct: 60 HPNI----------VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI 109
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
L Q++ ++++HS +HRD+KP N L+ QV I DFGLA+ Y
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG---QVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 33/162 (20%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQ----LLYEA------KV 55
+ IG G+FGE+ L VDTN + A+K + + H + +L EA K+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
Y Q + + Y + G D + +L LG EDL +F + L A
Sbjct: 67 YYSFQDKDNLYFVMDY-IPGGDMMSLLIRLGIFEEDL-----ARFYIAE-LTCA------ 113
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
IE VH GF+HRDIKPDN L+ + + + DFGL +R
Sbjct: 114 IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 28/173 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL--LYEAKVYKILQGGSGI 65
YK+ KIG G+F E+ A T + A+K ++ Q+ L E + + L S
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL---SPH 57
Query: 66 PNIKWYGVDGEDNV---------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
PNI + + + LV +L+ +L +L +R K V Q++ +
Sbjct: 58 PNI----LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
+++H G HRDIKP+N L+ K + + + DFG + PY E
Sbjct: 114 DHMHRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIYSKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 5e-09
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSG 64
KY KIG G+ G +F A V T + VA+K N K P+ ++ E V K L+ +
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELIINEILVMKELKNPNI 78
Query: 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ + + V E V++ L G SL D+ C + + V + + +E++H+
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQ 135
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
+HRDIK DN L+G+ V + DFG + + R + GT + +
Sbjct: 136 VIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPE 185
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAV-KIENSGT----KHPQLLYEAKVYKILQGGSGIPN- 67
+IG GSFG ++ A++ TNE+VAV K+ SG K ++ E K + L+ PN
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH----PNT 83
Query: 68 IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
I++ G +++ LV++ S DL ++ + + + + Y+HS +
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
HRDIK N L+ + QV + DFG A K + PY
Sbjct: 144 HRDIKAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 37/169 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGSGI 65
KL R IG G++G ++ A + EIVA V+++N P L E + L+
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH---- 65
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFV---YCR-----------RKFSLKTVLMLAD 110
PNI V + +++ G L+ +F+ YC FS V L
Sbjct: 66 PNI----------VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
Q++ ++Y+H +HRD+K N L+ + I DFGLA+ Y P
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLP 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 70/273 (25%), Positives = 124/273 (45%), Gaps = 29/273 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T + VA+K GT P+ L EA++ K L+ +P
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP-- 65
Query: 69 KWYGVDGEDNV-LVLDLLGP-SLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGFL 125
Y V E+ + +V + +G SL D K+ L ++ +A Q+ + Y+ ++
Sbjct: 66 -LYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
HRD++ N L+G N V I DFGLA+ D N + + K + TA A+
Sbjct: 125 HRDLRAANILVG----DNLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALY 177
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
I + D+ S G +L + +G +P+ G+ ++ +++ E+ P C
Sbjct: 178 GRFTI----KSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQV-ERGYRMPCPQGC- 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
P C D+RP + +++ D
Sbjct: 229 --PESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 73/275 (26%), Positives = 111/275 (40%), Gaps = 34/275 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQGGS 63
+++ +KIG G F E++ A+ + VA+K + E + K L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-- 61
Query: 64 GIPN-IKWYGVDGEDNVLVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQMIARI 116
PN IK+Y EDN L + L DL F +R KTV Q+ + +
Sbjct: 62 --PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
E++HSR +HRDIKP N F+ G V + D GL + + TT H +L G
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVG 168
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
T Y S + + D+ SLG +L P+ G K +C+K
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLYSLCKKIEQC 223
Query: 236 PIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFL 269
L H E + C + ++RPD ++
Sbjct: 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-09
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 7/147 (4%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA+K N K ++ E V + + + +
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V E V++ L G SL D+ + + + + +E++HS +
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVI 137
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGL 152
HRDIK DN L+G+ V + DFG
Sbjct: 138 HRDIKSDNILLGMD---GSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 12/168 (7%)
Query: 10 KLGRKIGSGSFGEIFL----ASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
K R +G G FG++ L ++ T E+VAVK K IL+
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 66 PNIKWYGV--DGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSR 122
+K+ G + L L + L L Y + K +L +L+ A Q+ + Y+HS+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
++HRD+ N L+ V I DFGLAK P + + RE+
Sbjct: 127 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAV--PEGHEYYRVRED 169
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 15/149 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGSGIPN 67
R+IG GSFG ++ A V TNE+VA+K + S K ++ E K + ++ PN
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH----PN 86
Query: 68 -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I++ G ++ LV++ S DL ++ + + + + Y+HS
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRDIK N L+ + QV + DFG A
Sbjct: 147 IHRDIKAGNILL---TEPGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 27/272 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L +K+G+G FGE+++ + + N VAVK GT P+ L EA++ K L+ +
Sbjct: 9 QLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDK---LV 64
Query: 69 KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V E+ + ++ G L+ L R L ++ +A Q+ A + Y+ ++
Sbjct: 65 QLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
HRD++ N L+G G I DFGLA+ D N + + K + TA A+
Sbjct: 125 HRDLRSANILVGDGLVCK---IADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 178
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
I + D+ S G +L + +G +P+ G+ ++ +++ E+ P C
Sbjct: 179 RFTI----KSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQV-ERGYRMPCPQDC-- 228
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
P C ++RP + +L+ D
Sbjct: 229 -PISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 43/135 (31%), Positives = 62/135 (45%), Gaps = 39/135 (28%)
Query: 77 DNVL-VLDLLGPSLEDLFVYCRRKFSLKTVLMLAD---------------------QMIA 114
DNVL LD+L P D F + + T LM +D Q++
Sbjct: 59 DNVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIP------- 166
++Y+HS G LHRDIKP N L+ +N + I DFGLA+ +P ++H+
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFGLARV-EEPDESKHMTQEVVTQY 169
Query: 167 YRENKNLTGTARYAS 181
YR + L G+ Y S
Sbjct: 170 YRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-------- 59
+Y+ +GSG++G + A + VAVK L++ + Y+ L
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMKH 73
Query: 60 QGGSGIPNIKWYGVDGED---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
+ G+ ++ E+ LV +L+G L ++ V C+ K S + V L Q++ +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNI-VKCQ-KLSDEHVQFLIYQLLRGL 131
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
+Y+HS G +HRD+KP N + + ++ I+DFGLA++ D T
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 49/227 (21%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGGSGI 65
IG G++G ++ HV T +VA+KI N T + LL + + S
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ-------SQP 61
Query: 66 PNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM---LADQMIARI----- 116
PNI K+YG L GP L + Y S++T++ +A++ I+ I
Sbjct: 62 PNITKYYGS---------YLKGPRLWIIMEYAEGG-SVRTLMKAGPIAEKYISVIIREVL 111
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+Y+H G +HRDIK N L+ V + DFG+A ++ R
Sbjct: 112 VALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSSKR-------STF 161
Query: 174 TGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219
GT + + G + D+ SLG + G+ P+ + A
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 69/272 (25%), Positives = 112/272 (41%), Gaps = 47/272 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGGSGIPNI- 68
+IG G+FGE+F N VAVK T P L L EA++ K PNI
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK-SCRETLPPDLKAKFLQEARILKQYSH----PNIV 56
Query: 69 KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHSRG 123
+ GV + +V++L+ D + R + +K ++ + + A +EY+ S+
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN-----RHIPYR-ENKNLTGTA 177
+HRD+ N L+ + N + I DFG++++ D + IP +
Sbjct: 115 CIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
RY+S D+ S G +LL+ F G++P+ A Q+ + E+ V
Sbjct: 172 RYSS-----------ESDVWSFG-ILLWEAFSLGAVPY----ANLSNQQTREAIEQGVRL 215
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267
P LC P C QRP +
Sbjct: 216 PCPELC---PDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK- 69
+ +G G+FGE+ LA VDT+ + A+K + Q+ + IL +K
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 70 WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHR 127
+Y +DN+ V+D + P + + + R + F ++ IE VH GF+HR
Sbjct: 67 YYSFQDKDNLYFVMDYI-PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
DIKPDN L+ L + + DFGL +R
Sbjct: 126 DIKPDNILIDLD---GHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
KIG GS G + +A + VAVK+ + + +LL+ E + + Q + + K Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 72 GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
V E VL+ L G +L D+ R + + + + + ++ + Y+HS+G +HRDIK
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 132 DNFLMGL-GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 190
D+ L+ L GR V + DFG + ++ +P R K+L GT + +
Sbjct: 146 DSILLTLDGR----VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPY 194
Query: 191 SRRDDLESLGYVLLYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 25/167 (14%)
Query: 9 YKLGRKIGSGSFGEIF-LASHVDTNEIVAVKIENSGTKHPQLLYEAK-----VYKILQGG 62
Y + +GSG+FG ++ + + ++A+K N +P + + + I+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEIN--VHNPAFGKDKRERDKSIGDIVSEV 59
Query: 63 SGI------PNIKWYG---VDGEDNVLVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLA 109
+ I PNI Y ++ + +V+DL+ G L + F + K F+ + + +
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 110 DQMIARIEYVHSRGFL-HRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
QM+ + Y+H + HRD+ P+N ++G + ++V I DFGLAK+
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 5e-08
Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGS 63
Y++ IG GSFG + +I+ K + G + QL+ E + + L+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH-- 58
Query: 64 GIPNI-KWYG--VDGEDNVLVLDL---LGPSLEDLFVYCRRKFSL---KTVLMLADQMIA 114
PNI ++Y +D + L + + G L L C+++ + + + Q++
Sbjct: 59 --PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 115 RIEYVHSRG-----FLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+ H+R LHRD+KP N FL N V + DFGLAK ++
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSS------- 165
Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228
K GT Y S + + D+ SLG ++ S P+ A + Q KI
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKI 222
Query: 229 CEKKVS 234
E K
Sbjct: 223 KEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG- 72
+IG GSFGE+F T ++VA+KI + ++ + +L K+YG
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 73 -VDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
+ G ++++ L G +L+ L +F + T+L +++ ++Y+HS +HRDI
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRDI 127
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 189
K N L+ + V + DFG+A + D R GT + + I+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKR-------NTFVGTPFWMAPEV---IQ 174
Query: 190 QSRRD---DLESLGYVLLYFLRGSLP 212
QS D D+ SLG + +G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 56/277 (20%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-----PN 67
KIG G+FG+++ + N VAVK T L + K K LQ + PN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK-----TCRSTLPPDLKR-KFLQEAEILKQYDHPN 53
Query: 68 I-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHS 121
I K GV + +V++L+ L + R+K ++K +L ++ A +EY+ S
Sbjct: 54 IVKLIGVCVQKQPIYIVMELV--PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTTNRHIPYR----ENKN 172
+ +HRD+ N L+G N + I DFG++++ Y + IP + E N
Sbjct: 112 KNCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICE 230
RY S D+ S G +LL+ F G P+ G+ + +Q ++I E
Sbjct: 169 ---YGRYTS-----------ESDVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI-E 209
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267
P LC P E C + + RP +
Sbjct: 210 SGYRMPAPQLC---PEEIYRLMLQCWAYDPENRPSFS 243
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 6e-08
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV 73
KIG GSFGE+F T ++VA+KI + ++ + +L K+YG
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 74 DGEDNVL-----------VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+D L LDLL P D + + T+L +++ ++Y+HS
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHSE 120
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
+HRDIK N L+ + +V + DFG+A + D R+ GT + +
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170
Query: 183 NTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 212
I+QS D D+ SLG + +G P
Sbjct: 171 EV---IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 25/152 (16%)
Query: 73 VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132
V+G D +L +G L V R + +TVL L EY+H+ G +HRD+KPD
Sbjct: 83 VEGGDCATLLKNIGA----LPVDMARMYFAETVLAL--------EYLHNYGIVHRDLKPD 130
Query: 133 NFLM-GLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRE-------NKNLTGTARYASCN 183
N L+ +G + + DFGL+K TTN + + E +K + GT Y +
Sbjct: 131 NLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
L + D ++G +L FL G +P+ G
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA++ N K ++ E V + + + +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ Y V E V++ L G SL D+ C + + V + + +E++HS
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRDIK DN L+G+ V + DFG + + R + GT + +
Sbjct: 138 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSG-----IPN 67
IG G+FG+++ DT I A+K+ + ++ + IL I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFL 125
+K+ D LV D + S +LF + ++ +FS +++ +E++H +
Sbjct: 61 LKFSFQTDSDLYLVTDYM--SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCN 183
+RD+KP+N L+ + + DFGL+K + TTN GT Y +
Sbjct: 119 YRDLKPENILLD---ATGHIALCDFGLSKANLTDNKTTN---------TFCGTTEYLAPE 166
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
L + ++ D SLG ++ G W A +Q Y I KV P VL
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFPKNVL 221
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 33/191 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQ--LLYEAKVYKILQGGS 63
KY+ +G GS+G + H +T +IVA+K +E+ K + + E ++ K L+ +
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 64 GIPNI-------KWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIAR 115
+ I + Y LV + + + L+DL Y V Q++
Sbjct: 62 LVNLIEVFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRG 112
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-------YRDPTTNRHIPYR 168
IE+ HS +HRDIKP+N L+ ++ V + DFG A+ Y D R YR
Sbjct: 113 IEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRW--YR 167
Query: 169 ENKNLTGTARY 179
+ L G +Y
Sbjct: 168 APELLVGDTKY 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGSGIPN 67
R+IG GSFG ++ A V +E+VA+K + S K ++ E + + L+ PN
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH----PN 76
Query: 68 -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I++ G ++ LV++ S DL ++ + + + + Y+HS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRD+K N L+ + V + DFG A
Sbjct: 137 IHRDVKAGNILL---SEPGLVKLGDFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 20/159 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
YKLG IG+GSFG ++ A +DT+E VA+K + PQ Y+ + I++ + I I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIK---KVLQDPQ--YKNRELLIMKNLNHINII 122
Query: 69 ---KWYGVD----GEDNV---LVLDLLGPSLEDLF-VYCRRKFSLKTVL--MLADQMIAR 115
+Y + E N+ +V++ + ++ Y R +L L + + Q+
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Y+HS+ HRD+KP N L + + + + DFG AK
Sbjct: 183 LAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 70/237 (29%), Positives = 101/237 (42%), Gaps = 22/237 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIP 66
+Y++ +KIG GSFG+I+LA +E +K E TK P EA K IL P
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIK-EIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 67 NI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHS 121
NI ++ E+ L + + DL R+ FS +L Q+ ++++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 122 RGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
R LHRDIK N FL G A + DFG+A++ D GT Y
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQLNDSM-------ELAYTCVGTPYYL 169
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
S + + D+ SLG VL P++G Q KIC+ + PI
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG---NNLHQLVLKICQGYFA-PI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK- 69
+ +G G+FGE+ LA VDT + A+K + Q+ + IL ++
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 70 WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHR 127
+Y +DN+ V+D + P + + + R F ++ +E VH GF+HR
Sbjct: 67 YYSFQDKDNLYFVMDYI-PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
DIKPDN L+ + + + DFGL +R
Sbjct: 126 DIKPDNILID---RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK-WY 71
IG G+FGE+ L DT I A+KI + + Q+ + IL G +K +Y
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 72 GVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEYVHSRGFLHR 127
+ N+ L+++ L D+ +K +L T +A+ ++A I+ +H GF+HR
Sbjct: 69 SFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYIAETVLA-IDAIHQLGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGL 152
DIKPDN L+ V + DFGL
Sbjct: 126 DIKPDNLLLD---AKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 51/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT--------KHPQLLYEAKVYK 57
++L R +G+G++G++FL V D ++ A+K+ T +H + E +V +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT--ERQVLE 59
Query: 58 ILQGGSGIPNIKW-YGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMIA 114
++ + + + + D + + L+LD + +LF +Y R F+ V + +++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLH-LILDYVNGG--ELFTHLYQREHFTESEVRVYIAEIVL 116
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++++H G ++RDIK +N L+ V + DFGL+K++ R +
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEFLAEEEERAYSF------C 167
Query: 175 GTARYASCNTHLGIEQSRRD--DLESLGYVLLYFLRGSLPW 213
GT Y + G D SLG + L G+ P+
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-07
Identities = 24/146 (16%), Positives = 57/146 (39%), Gaps = 12/146 (8%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWY 71
+ + G ++L +E +KI S K E + ++L +P +
Sbjct: 4 KLLKGGLTNRVYLLG--TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 72 GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
G + L+++ + G +L+++ + + + +++A++ + H D+
Sbjct: 62 GESDGWSYLLMEWIEGETLDEV-----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH 116
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKY 156
P N L+ + IID+ A
Sbjct: 117 PGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 48/164 (29%), Positives = 68/164 (41%), Gaps = 45/164 (27%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSGIPNI- 68
KIG G++G ++ A T EIVA+K +E P + E + K L PNI
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH----PNIV 61
Query: 69 KWYGVDGEDNVLVL-------DL-----------LGPSLEDLFVYCRRKFSLKTVLMLAD 110
+ V +N L L DL L P L ++Y
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY--------------- 106
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Q++ I Y HS LHRD+KP N L+ + + + DFGLA+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-07
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A + T + VA+K N K ++ E V + + + +
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ Y V E V++ L G SL D+ C + + V + + ++++HS
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDFLHSNQV 136
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRDIK DN L+G+ V + DFG + + R + GT + +
Sbjct: 137 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 186
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 13 RKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
R +G G FG++ L + +T E VAVK + + K +IL+ +
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 69 KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
K+ G+ ED L+++ L SL++ + K +LK L A Q+ ++Y+ SR
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
++HRD+ N L+ +QV I DFGL K
Sbjct: 130 YVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 20/158 (12%)
Query: 10 KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K +++G G FG++ L + +T E VAVK N + E ++ + L
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH- 65
Query: 63 SGIPNI-KWYGV---DGEDNV-LVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARI 116
NI K+ GV G ++ L+++ L SL D R + +LK +L+ + Q+ +
Sbjct: 66 ---ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+Y+ S+ ++HRD+ N L+ + V I DFGLAK
Sbjct: 123 DYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 39/149 (26%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL +K+G+G FGE+++ + + + VA+K G+ P+ L EA + K LQ +
Sbjct: 9 KLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPR---LV 64
Query: 69 KWYGVDGEDNVLVLD--LLGPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V ++ + ++ + SL D L K ++ ++ +A Q+ + ++ + ++
Sbjct: 65 RLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
HRD++ N L+ + I DFGLA+
Sbjct: 125 HRDLRAANILVS---ETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 22/169 (13%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLY-EAKVYKILQGGSGIPNI--- 68
KIG GS G + +A+ T VAVK + + +LL+ E + + Q PNI
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH----PNIVEM 81
Query: 69 -KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
Y V E V++ L G +L D+ + R + + + + ++ + ++H++G +HR
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
DIK D+ L+ +V + DFG + ++ +P R K+L GT
Sbjct: 140 DIKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 21/153 (13%)
Query: 15 IGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+G G+FG + L + +T E+VAVK +++S +H + E ++ K LQ NI
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH----DNI 67
Query: 69 -KWYGV---DGEDNV-LVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
K+ GV G N+ LV++ L P SL D R + + +L+ A Q+ +EY+ S
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ ++HRD+ N L+ N+V I DFGL K
Sbjct: 127 KRYVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
KLG IG G FG++ L + + VAVK +++ T L EA V L+ PN
Sbjct: 9 KLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH----PNL 62
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRG 123
++ GV + N L + + L Y R + +L L A + +EY+ +
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
F+HRD+ N L+ + + DFGLAK+
Sbjct: 123 FVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 27/232 (11%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK-- 69
+G GSFG++FL + D ++ A+K+ T + K+ + + P I
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 70 WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLH 126
Y E + L+LD L DLF ++ F+ + V ++ ++++HS G ++
Sbjct: 64 HYAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK--NLTGTARYASCNT 184
RD+KP+N L+ + + + DFGL+K+ D E K + GT Y +
Sbjct: 122 RDLKPENILLD---EEGHIKLTDFGLSKESID---------HEKKAYSFCGTVEYMAPEV 169
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
++ D S G ++ L GSLP+QG +K+ I + K+ P
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQG---KDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPN 67
+ +G GSFG++FLA TN+ A+K + E +V + + +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ E+ V++ L DL + + KF L A ++I ++++HS+G +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGG--DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCN 183
+RD+K DN L+ + I DFG+ K+ D T GT Y +
Sbjct: 119 YRDLKLDNILLD---TDGHIKIADFGMCKENMLGDAKTC---------TFCGTPDYIAPE 166
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
LG + + D S G +L L G P+ G
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPN 67
R+IG GSFG ++ A V TNE+VA+K + K ++ E + + L+ PN
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH----PN 76
Query: 68 -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I++ G ++ LV++ S D+ ++ + + + + Y+HS
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRDIK N L+ + V + DFG A
Sbjct: 137 IHRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 35/157 (22%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
IG G+FGE+ L DT +I A+K +++ K QL + K + + S P W
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESDSP---W-- 62
Query: 73 VDGEDNVLVLDLLGPSLEDLFVYCRRKF----SLKTVLMLAD------------QMIARI 116
V+ L + ++Y +F L T+L+ D + + I
Sbjct: 63 --------VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAI 114
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
E VH GF+HRDIKPDN L+ + + + DFGL+
Sbjct: 115 EAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSGIPNI-- 68
IG G FGE++ DT ++ A+K ++ K Q L ++ L P I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 69 KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFL 125
Y D + +LDL+ DL + + FS + A ++I +E++H+R +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT- 184
+RD+KP N L+ + V I D GLA + ++ P+ GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDF-----SKKKPHAS----VGTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
G+ D SLG +L LRG P++ K K
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-07
Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 38/274 (13%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY----KILQGG 62
+ ++ G+ +G G+FG ++L VDT +A K + P+ E ++L+
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 63 SGIPNIKWYGV---DGEDNVLVLD--LLGPSLED-------LFVYCRRKFSLKTVLMLAD 110
+++YG E + + + G S++D L RK++
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT--------R 113
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q++ + Y+HS +HRDIK N L A V + DFG +K+ + +
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTICMSG----TGI 166
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
+++TGT + S G R+ D+ SLG ++ L PW +A KI
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AIFKIAT 223
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ + + SH +E A F C + RP
Sbjct: 224 QPTNPQL----PSHISEHARDFLGCIFVEARHRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-07
Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
KIG GS G + +A+ T + VAVK ++ + +LL+ E + + + + Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 72 GVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
V E V++ L G +L D+ + R + + TV + ++ + Y+H++G +HRDIK
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL---SVLRALSYLHNQGVIHRDIK 145
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 190
D+ L+ ++ + DFG + ++ +P R K+L GT + + +
Sbjct: 146 SDSILL---TSDGRIKLSDFGFCAQ-----VSKEVPKR--KSLVGTPYWMAPEVISRLPY 195
Query: 191 SRRDDLESLGYVLLYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDP 159
Q++ + Y+HS LHRD+KP N +MG G + V I D GLA+ + P
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-07
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 16/214 (7%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGSG 64
+ G+++G+G+F + A V T ++AVK + N+ ++ +++ + L
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 65 IPNI-KWYGVDGED---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P+I + G ED N+ V + G S+ L + F ++ +Q++ + Y+H
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHL-LSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 121 SRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
+HRD+K N L+ G++ + I DFG A + T L GT +
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EFQGQLLGTIAF 174
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ G + R D+ S+G V++ PW
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 48/176 (27%), Positives = 71/176 (40%), Gaps = 58/176 (32%)
Query: 8 KY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGG 62
KY KL KIG GS+G +F + +T +IVA+K P + L E ++ K L+
Sbjct: 2 KYEKLS-KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH- 59
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD------------ 110
PN LV +L ++F RRK L V D
Sbjct: 60 ---PN------------LV------NLIEVF---RRKRKLHLVFEYCDHTVLNELEKNPR 95
Query: 111 ------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Q + + + H +HRD+KP+N L+ K Q+ + DFG A+
Sbjct: 96 GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 67/287 (23%), Positives = 113/287 (39%), Gaps = 64/287 (22%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNI-KW 70
IG G+FG + H + I+AVK + +LL + V S P I K+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM---RSSDCPYIVKF 68
Query: 71 YGV---DGEDNVLVLDLLGPSLEDL--FVYCRRKFSLKTVLMLADQMIARIEYVHSRGF- 124
YG +G D + ++L+ SL+ +VY K ++ ++++ +I +
Sbjct: 69 YGALFREG-DCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALN 121
Query: 125 --------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+HRD+KP N L L R N + + DFG++ + D
Sbjct: 122 YLKEELKIIHRDVKPSNIL--LDRNGN-IKLCDFGISGQLVDSIAK-------------- 164
Query: 177 ARYASCNTHLG---IEQSRRD------DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
R A C ++ I+ S RD D+ SLG L G P+ + +D+
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQ 219
Query: 228 ICEKKVSTPIEVLCKSHPAEFA----SYFHYCQSLTFDQRPDYGFLK 270
+ + V +L S EF+ ++ + C +RP Y L
Sbjct: 220 LTQ-VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 8e-07
Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
+ G+ + + R + GS G +F +SH D + V VK + ++EA++ + L +
Sbjct: 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVK----AGWYASSVHEARLLRRLSHPA 221
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLE-DLFVYCRRK---FSLKTVLMLADQMIARIEYV 119
+ + V G LVL P DL+ Y + L V +A Q+++ I+Y+
Sbjct: 222 VLALLDVRVVGGL-TCLVL----PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI 276
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
H G +HRDIK +N L+ + + DFG A
Sbjct: 277 HGEGIIHRDIKTENVLVN---GPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 8e-07
Identities = 70/288 (24%), Positives = 123/288 (42%), Gaps = 48/288 (16%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
+ +Y+ +GSG++G + + DT + V ++ +++ + Y+ L+
Sbjct: 15 VPERYQNLSPVGSGAYGSV--CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL--- 69
Query: 65 IPNIKWYGVDG--------------EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD 110
+ ++K V G D LV L+G L ++ V C+ K + V L
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIY 127
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q++ ++Y+HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT--------- 175
Query: 171 KNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
T Y + L + ++ D+ S+G ++ L G + G T K+
Sbjct: 176 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLI 230
Query: 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
+ V TP L K +E A +Y QSLT Q P K F ++F
Sbjct: 231 LRLVGTPGAELLKKISSESAR--NYIQSLT--QMP-----KMNFANVF 269
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
KIG GS G + +A+ + ++VAVK ++ + +LL+ E + + Q + + Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 72 GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
V E V++ L G +L D+ + R + LA ++ + +H++G +HRDIK
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLKALSVLHAQGVIHRDIKS 144
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
D+ L+ +V + DFG + ++ +P R K+L GT + + +
Sbjct: 145 DSILL---THDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPELISRLPYG 194
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-07
Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 23/154 (14%)
Query: 11 LGRKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIP 66
+++GSG FG + L +D VA+K+ G + EAKV L P
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID----VAIKMIREGAMSEDDFIEEAKVMMKLSH----P 59
Query: 67 N-IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVH 120
N ++ YGV + +V + + + L Y R K + +L + + +EY+
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYM--ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S GF+HRD+ N L+G + N V + DFGLA+
Sbjct: 118 SNGFIHRDLAARNCLVG---EDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-07
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 28/159 (17%)
Query: 11 LGRKIGSGSFGEIFLASHVD-TNEIVAV-----KIENSGTKHPQLLYEAKVYKILQGGSG 64
LGR IG G FG+++ ++ NE +AV K S + + L EA + +
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH--- 66
Query: 65 IPNI-KWYGVDGEDNV-LVLDL-----LGPSLEDLFVYCRRKFSLK--TVLMLADQMIAR 115
P+I K GV E+ V +V++L L L+ K+SL ++++ + Q+
Sbjct: 67 -PHIVKLIGVITENPVWIVMELAPLGELRSYLQ------VNKYSLDLASLILYSYQLSTA 119
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Y+ S+ F+HRDI N L+ + V + DFGL++
Sbjct: 120 LAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 25/225 (11%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKIL 59
V ++LG+ +G G+FGE++L DT +AVK + + + L E ++ K L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 60 QGGSGIPNIKWYGV--DGED---NVLVLDLLGPSLED-LFVYCRRKFSLKTVLMLADQMI 113
+ +++YG D E+ ++ V + G S++D L Y + Q++
Sbjct: 62 RHDR---IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQIL 116
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ Y+HS +HRDIK N L A V + DFG +K+ + + K++
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQ----TICMSGTGIKSV 169
Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
TGT + S G R+ D+ S+ ++ L PW +A
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 39/167 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK---------- 57
KY++ +K+G G++G ++ A T E+VA+K K++
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALK---------------KIFDAFRNATDAQR 52
Query: 58 ------ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-DLFVYCRRKFSLKTVLM-- 107
LQ PNI K V +N + L+ +E DL R L+ V
Sbjct: 53 TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRY 111
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Q++ ++Y+HS +HRD+KP N L L V + DFGLA+
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNIL--LNSDCR-VKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 45/163 (27%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74
IG G+FGE+ L DT I A+K + ++L + +V V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKK----LRKSEMLEKEQVAH---------------VR 49
Query: 75 GEDNVL-------VLDLLGPSLEDLFVYCRRKF----SLKTVLMLAD------------Q 111
E ++L V+ L ++ ++Y ++ + T+LM D +
Sbjct: 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
I I+ +H G++HRDIKPDN L+ + + DFGL
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
+G G FGE+ + T +I A+K+ K LL + V IL + IP
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKV----MKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+++ D ++ LV++ G L L +F +++ I VH G++
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPTTNRHIP 166
HRDIKP+N L+ + + + DFG A + + N +P
Sbjct: 125 HRDIKPENVLID---RTGHIKLADFGSAARLTANKMVNSKLP 163
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 22/229 (9%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIK 69
IG GSFG++ LA AVK+ T + ++ E V + +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 70 WYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHR 127
+ E VLD + +LF + +R+ F A ++ + I Y+HS ++R
Sbjct: 63 YSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP+N L+ V + DFGL K+ +P GT Y +
Sbjct: 121 DLKPENILLD---SQGHVVLTDFGLCKEGVEPEET-------TSTFCGTPEYLAPEVLRK 170
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
R D LG VL L G P+ + Q YD I K + P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 13 RKIGSGSFGEIFLASHVDTN-EIVAVK-IENSGT-KHPQLLYEAKVYKILQGGSGIPNIK 69
R +G+GSFG + LA++ + + VA+K E S K Q+ + KIL + +
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 70 WYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
YG +++ L L L + F + RR +F A Q++ EY+ S ++R
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP+N L+ K + + DFG AK + L GT Y + L
Sbjct: 156 DLKPENLLLD---KDGFIKMTDFGFAK----------VVDTRTYTLCGTPEYIAPEILLN 202
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPW 213
+ + D +LG + L G P+
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKV-------YKILQGGS 63
+IG GSFGE++ T E+VA+KI E + + + E V Y GS
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 64 GIPNIK-WYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ K W ++ LDLL P LE+ ++ T+L +++ ++Y+HS
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI--------ATILR---EILKGLDYLHS 119
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+HRDIK N L+ + V + DFG+A + D R+ GT + +
Sbjct: 120 ERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 169
Query: 182 CNTHLGIEQSRRD---DLESLGYVLLYFLRGSLPWQGL 216
I+QS D D+ SLG + +G P L
Sbjct: 170 PEV---IKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL +K+G+G FGE+++A++ + + VAVK G+ + L EA V K LQ +
Sbjct: 9 KLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK---LV 64
Query: 69 KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
K + V ++ + ++ G L+ L K L ++ + Q+ + ++ R ++
Sbjct: 65 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
HRD++ N L+ + I DFGLA+ D
Sbjct: 125 HRDLRAANILVS---ASLVCKIADFGLARVIED 154
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1 MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKI 58
MER I +K+KLG G +GE++ + VAVK ++ + + L EA V K
Sbjct: 3 MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 58
Query: 59 LQGGSGIPN-IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLML--ADQMI 113
++ PN ++ GV + + + +L Y R + + V++L A Q+
Sbjct: 59 IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ +EY+ + F+HRD+ N L+G + + V + DFGL++ T H
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY----KILQGGSG 64
++LG+ +G G+FG ++L DT +AVK + P+ E ++L+
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 65 IPNIKWYGV--DGEDNVLVL---DLLGPSLED-LFVYCRRKFSLKTVLMLADQMIARIEY 118
+++YG D + L + + G S++D L Y + Q++ + Y
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSY 121
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+HS +HRDIK N L V + DFG +K+ + + K++TGT
Sbjct: 122 LHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGMKSVTGTPY 174
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
+ S G R+ D+ S+G ++ L PW +A
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 55/235 (23%), Positives = 88/235 (37%), Gaps = 73/235 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-----------------IENS----GTKHPQLL--- 50
+G GSFG++ LA TNE A+K +E +HP L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 51 --YEAK-----VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLK 103
++ K V + L GG + +I+ G +F
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSG--------------------------RFDEA 96
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTT 161
A ++I ++++H +G ++RD+K DN L+ K + I DFG+ K+ +
Sbjct: 97 RARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNGEGKA 153
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 215
+ GT Y + G + + D S G VLLY L G P+ G
Sbjct: 154 S---------TFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 13/106 (12%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-PYRE 169
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA R TN + PY
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA---RTACTNFMMTPY-- 182
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
T Y + LG+ D+ S+G ++ ++GS+ +QG
Sbjct: 183 ----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 34/273 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+++ IG G++G++F + AVKI + + + EA+ Y IL+ S PN+
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI-EAE-YNILKALSDHPNV 77
Query: 69 -KWYG-------VDGEDNVLVLDLL-GPSLEDL---FVYCRRKFSLKTVLMLADQMIARI 116
K+YG +G+ LVL+L G S+ DL F+ + + + + + +
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+++H +HRD+K +N L+ V ++DFG++ + T+ R R N ++ GT
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQL---TSTRL---RRNTSV-GT 187
Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
+ +C L R D+ SLG + G P L K +
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247
Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ P + EF + C + +++RP
Sbjct: 248 TLHQP-----ELWSNEFNDFIRKCLTKDYEKRP 275
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 17/151 (11%)
Query: 14 KIGSGSFGEIFLA-SHVDTNEI--VAVKIENSG--TKHPQ-LLYEAKVYKILQGGSGIPN 67
K+G GSFG + ++ VAVK S + L EA + L N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH----EN 57
Query: 68 -IKWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I+ YGV + +V +L LG L+ L F + T+ A Q+ + Y+ S+
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HRD+ N L+ K V I DFGL +
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIK-WY 71
IG G+FGE+ L DT + A+KI + Q+ + IL + +K +Y
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 72 GVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEYVHSRGFLHR 127
+ N+ L+++ L D+ +K +L +T +A+ ++A I+ +H GF+HR
Sbjct: 69 SFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETVLA-IDSIHQLGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGL 152
DIKPDN L+ V + DFGL
Sbjct: 126 DIKPDNLLLD---SKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNI- 68
++G G+ G + +T I A+K + Q+L E ++ K + P I
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS----PYIV 62
Query: 69 KWYGV-----DGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVH 120
K+YG + + G SL+ ++ +++ K + +A+ ++ + Y+H
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
SR +HRDIKP N L+ + QV + DFG++ + + TGT+ Y
Sbjct: 123 SRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA---------GTFTGTSFYM 170
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
+ G S D+ SLG LL + P
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 8/107 (7%)
Query: 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139
LV + L L+ C S+ V + Q++ + Y H R LHRD+KP N L+
Sbjct: 80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-- 137
Query: 140 RKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
+ ++ + DFGLA+ PT +N + YR L G+ Y++
Sbjct: 138 -EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 12/176 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
K+G G++ +F T +VA+K +E+ + E + K L+ + +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 71 YGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
D + LV + L L+ C S+ V + Q++ + Y H R LHRD+K
Sbjct: 73 VHTD-KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
P N L+ + ++ + DFGLA+ PT +N + YR L G++ Y++
Sbjct: 132 PQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 30/238 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIP 66
+++ + IG G+FGE+ + + +++ A+KI N K + + +L G
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-- 60
Query: 67 NIKW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
+W Y E+N+ LV+D +G L L + +M+ I+ V
Sbjct: 61 --QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H ++HRDIKPDN LM + + + DFG K + T ++ GT Y
Sbjct: 119 HQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGT------VQSSVAVGTPDY 169
Query: 180 ASCNTHLGIEQSR-----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
S +E + D SLG + L G P+ A + + Y KI K
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 29/185 (15%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSGIPNIK 69
KIG G++G ++ + T +IVA+K +E+ P + E + K LQ PNI
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH----PNI- 61
Query: 70 WYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEYVH 120
V +D + L+ + L L+ + + L+ + Q++ I + H
Sbjct: 62 ---VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTG 175
SR LHRD+KP N L+ + + DFGLA+ + P T+ + YR + L G
Sbjct: 119 SRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 176 TARYA 180
+ RY+
Sbjct: 176 SPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 52/178 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKH---PQLLYEAKVYKILQ 60
+ KY + IG G++G + A + +TNE VA+K I N+ + L E K+ + L
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL- 61
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD-------- 110
D E+ + + D++ P + F VY + LM D
Sbjct: 62 -------------DHENVIAIKDIMPPPHREAFNDVY------IVYELMDTDLHQIIRSS 102
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS LHRD+KP N L+ AN + I DFGLA+
Sbjct: 103 QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
Y+ KIG G++G+++ A +T ++VA+K ++ G P L E + ++L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP-PTALREISLLQMLSES 60
Query: 63 SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCRRKFS----LKTVLMLADQ 111
I ++ V+ + LV + L L+ R KT+ Q
Sbjct: 61 IYI--VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
++ + + H G +HRD+KP N L + ++ + I D GL + + P
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIP 164
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 40/151 (26%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
Y+L +++GSG++G+++ A ++ T E+ AVKI L + +++ + + NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC--NI 68
Query: 69 -KWYG--VDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
++G + E + ++ G SL+D++ + S + + + + + Y+HS+G
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HRDIK N L+ V + DFG+A K
Sbjct: 128 MHRDIKGANILL---TDNGDVKLADFGVAAK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 19/152 (12%)
Query: 13 RKIGSGSFGEIFLASHVDTN--EI-VAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+++G G+FG + ++ + E+ VAVK E+ + L EA V L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56
Query: 67 NI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + GV GE +LV++L LGP L+ ++ RR+ + + LA Q+ + Y+ S+
Sbjct: 57 CIVRLIGVCKGEPLMLVMELAPLGPLLK--YLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HRD+ N L+ +Q I DFG+++
Sbjct: 115 HFVHRDLAARNVLL---VNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-06
Identities = 37/151 (24%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
++L ++IGSG++G+++ A +V+T E+ A+K+ + + ++ I+ NI
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI--IMMKDCKHSNI 68
Query: 69 -KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
++G + L + + G SL+D++ + S + ++ + + + Y+HS+G
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIY-HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HRDIK N L+ V + DFG++ +
Sbjct: 128 MHRDIKGANILL---TDNGHVKLADFGVSAQ 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 24/198 (12%)
Query: 1 MERIIGVKYK-LGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQL---- 49
M I +Y G +G G++G++ A T +IVA+K I N TK QL
Sbjct: 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC 61
Query: 50 ------LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLK 103
L E K+ ++ + + + Y V+G+ LV+D++ L+ + + + +
Sbjct: 62 GIHFTTLRELKIMNEIKHENIMGLVDVY-VEGDFINLVMDIMASDLKKVV-DRKIRLTES 119
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163
V + Q++ + +H F+HRD+ P N + I DFGLA++Y P +
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKGICKIADFGLARRYGYPPYSD 176
Query: 164 HIPYRENKNLTGTARYAS 181
+++ + S
Sbjct: 177 --TLSKDETMQRREEMTS 192
|
Length = 335 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 9/146 (6%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNI 68
+ +G G+FG + A T + VA+K P + E K+ K L+ + I
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 69 KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
+ ED V +LLG L L R + + Q++ ++YVHS G +HRD
Sbjct: 76 DIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAK 154
+KP N L+ + + I DFGLA+
Sbjct: 134 LKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 36/157 (22%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
R+ Y++ + IG G+FGE+ L H T ++ A+K+ E +E +
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 59 LQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
+ + + D +V++ + P + + + K +++ ++
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYM-PGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 157
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HS GF+HRD+KPDN L+ K+ + + DFG K
Sbjct: 158 IHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 57/262 (21%), Positives = 108/262 (41%), Gaps = 27/262 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+Y + R +G GSFG L HV++++ A+K E K + +++ +L PN
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK-EIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 68 IKWY--GVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + + + ++ +V++ G ++ + + + F T+L QM ++++H +
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
LHRDIK N + + +V + DFG A+ P GT Y
Sbjct: 120 RVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYAC-------TYVGTPYYVPP 169
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
+ + + D+ SLG +L P+Q A + K K+C+ P+
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQ---ANSWKNLILKVCQGSYK-PL----- 220
Query: 243 SHPAEFASYFHYCQSLTFDQRP 264
P+ ++ F + P
Sbjct: 221 --PSHYSYELRSLIKQMFKRNP 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 47/272 (17%)
Query: 14 KIGSGSFGEIF--LASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPN 67
++GSG+FG + + + + VAVKI + P +LL EA V + L P
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN----PY 57
Query: 68 I-KWYGV-DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
I + G+ + E +LV++L + F+ + + K + L Q+ ++Y+ F+
Sbjct: 58 IVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 126 HRDIKPDNFLMGLGRKANQVY--IIDFGLAK------KYRDPTTNRHIPYRENKNLTGTA 177
HRD+ N L+ Q Y I DFGL+K Y T+ P +
Sbjct: 118 HRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK--------- 163
Query: 178 RYA-SCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVS 234
YA C + S + D+ S G VL++ F G P++G+K Q + +++
Sbjct: 164 WYAPECMNYYKF--SSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES--GERME 218
Query: 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
P + P E C + D+RP +
Sbjct: 219 CP-----QRCPPEMYDLMKLCWTYGVDERPGF 245
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 28/227 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
IG GSFG++ LA H + AVK+ K L + + + + + + N+K
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
+ D + VLD + +LF + +R+ F A ++ + + Y+HS
Sbjct: 60 GLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
++RD+KP+N L+ + + DFGL K+ + GT Y +
Sbjct: 118 VYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNGT-------TSTFCGTPEYLAPEV 167
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
R D LG VL L G P+ A + YD I K
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 52/169 (30%), Positives = 74/169 (43%), Gaps = 29/169 (17%)
Query: 11 LGRKIGSGSFGEIF--LASHVDTNEI---VAVKI---ENSGTKHPQLLYEAKVYKILQGG 62
L R +G G+FGE++ L D + + VAVK S L EA ++
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA----LIMSK 65
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLL-GPSLEDLFVYCR----RKFSL--KTVLMLADQM 112
NI + GV E ++L+L+ G L+ R R SL K +L A +
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKK-YR 157
+Y+ F+HRDI N L+ G GR A I DFG+A+ YR
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 58/252 (23%), Positives = 91/252 (36%), Gaps = 64/252 (25%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
+ +G GSFG++ LA T+E+ AVK+ ILQ +++
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV-------------ILQDD----DVECTM 43
Query: 73 VDGEDNVLVLDLLGPSLEDLFV-------------YCR-----------RKFSLKTVLML 108
E VL L P L L Y +F
Sbjct: 44 T--EKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY 101
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHI 165
A +++ ++++H RG ++RD+K DN L+ + I DFG+ K+ T
Sbjct: 102 AAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILGGVTT----- 153
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK 224
GT Y + D +LG VLLY L G P++G + +
Sbjct: 154 -----STFCGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSPFEG---DDEDEL 204
Query: 225 YDKICEKKVSTP 236
+ I E +V P
Sbjct: 205 FQSILEDEVRYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 49/221 (22%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT--------KHPQLLYEAKVYK 57
++L + +G+G++G++FL V D+ ++ A+K+ T +H + E +V +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT--ERQVLE 59
Query: 58 ILQGGSGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIA 114
++ + + Y + + L+LD + +LF + R +F + V + + +++
Sbjct: 60 HIRQSPFLVTLH-YAFQTDTKLHLILDYINGG--ELFTHLSQRERFKEQEVQIYSGEIVL 116
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
+E++H G ++RDIK +N L+ V + DFGL+K++ + R +
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFHEDEVERAY------SFC 167
Query: 175 GTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPW 213
GT Y + + G + + D S+G ++ L G+ P+
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 40/171 (23%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQ 60
+G +Y+ IG G++G + A+H T VA+K + S +H L E K+ + +
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-KISPFEHQTFCQRTLREIKILRRFK 61
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDL----FVYCRRKFSLKTVL---MLAD-- 110
E+ + +LD++ P S E V + L ++ L++
Sbjct: 62 H--------------ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH 107
Query: 111 ------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS LHRD+KP N L+ N + I DFGLA+
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 24/219 (10%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSGIPNI-- 68
IG G FGE++ DT ++ A+K ++ K Q L ++ L P I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 69 KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFL 125
Y D + +LDL+ DL + + FS K + A ++I +E++H+R +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT- 184
+RD+KP N L+ + V I D GLA + + + GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
G D SLG +L LRG P++ K K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGS 63
+Y+ +IG G++G ++ A + VA V+++ + P + E + K L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 64 GIPNI-KWYGV------DGEDNV-LVLDLLGPSLEDLFVYCRR----KFSLKTVLMLADQ 111
PNI + V D E V LV + + +DL Y + +T+ L Q
Sbjct: 61 H-PNIVRLMDVCATSRTDRETKVTLVFEHVD---QDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
+ ++++H+ +HRD+KP+N L+ G QV + DFGLA+ Y
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 19/112 (16%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP- 166
Q++ + Y+H R LHRD+KP N L+ ++ + DFGLA+ P+ +N +
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTL 167
Query: 167 -YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217
YR L G+ Y++C D+ +G + + ++G + G+K
Sbjct: 168 WYRPPDVLLGSTEYSTCL-----------DMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLL------YEAKVYKIL 59
L R++G G+FG++FLA S +VAVK K P L EA++ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNL 64
Query: 60 QGGSGIPNIKWYGV--DGEDNVLVLDLL------------GPSLEDLF----VYCRRKFS 101
Q +K+YGV DG+ ++V + + GP L + +
Sbjct: 65 QHEH---IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
L +L +A Q+ + + Y+ S+ F+HRD+ N L+G V I DFG++ RD +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYS 175
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPW 213
+ YR + R+ + + + + D+ S G +L F G PW
Sbjct: 176 TDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 14/155 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
KY +KIG GSFG+ L + + +K N P+ E++ + PN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 68 IKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVH 120
I Y E+N +V+D DL+ + F +L Q+ +++VH
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 121 SRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAK 154
R LHRDIK N FL K + + DFG+A+
Sbjct: 119 DRKILHRDIKSQNIFLT----KDGTIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
K+++ +G G++G + H +T EIVA+K EN K L E K+ + L+
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTL-RELKMLRTLKQE 60
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ + + + G+ LV + + ++ +L + V Q+I I + H
Sbjct: 61 NIVELKEAFRRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+HRDIKP+N L+ N V + DFG A+ + + + Y T Y S
Sbjct: 120 DIVHRDIKPENLLI----SHNDVLKLCDFGFARNLSEGSNANYTEY------VATRWYRS 169
Query: 182 CNTHLGIEQSRRDDLESLGYVL 203
LG + D+ S+G +L
Sbjct: 170 PELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 1e-05
Identities = 50/221 (22%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYKILQGGSGIPN 67
++L +G+G++G+++ HV T ++ A+K+ + +G + ++ E + K I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 68 IKWYGV------DGEDNV--LVLDLLGP-SLEDLFVYCRRKFSLKT--VLMLADQMIARI 116
+YG G D+ LV++ G S+ DL + + +LK + + +++ +
Sbjct: 68 --YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL-IKNTKGNTLKEEWIAYICREILRGL 124
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
++H +HRDIK N L+ + +V ++DFG++ + D T R GT
Sbjct: 125 SHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL-DRTVGRR------NTFIGT 174
Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
+ +C+ + + DL SLG + G+ P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
++G+G+ G +F SH + I+A K I N + Q+L+E I
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 65
Query: 65 IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ +YG DGE ++ + + G SL+ + LK + +Q++ ++
Sbjct: 66 ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 113
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
+G +HRD+KP N L+ ++ + DFG++ + D N +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMAN---------S 161
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
GT Y S G S + D+ S+G L+ G P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 81/278 (29%)
Query: 13 RKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT---------------------KHP- 47
+ +G G +G++F V DT +I A+K+ T KHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 48 --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-- 99
L+Y K+Y IL+ SG GE LF++ R+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSG----------GE---------------LFMHLEREGI 96
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F T ++ +E++H +G ++RD+KP+N L+ V + DFGL K+
Sbjct: 97 FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHE 153
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219
T H GT Y + + + D SLG ++ L G+ P+ A
Sbjct: 154 GTVTH-------TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT---AE 203
Query: 220 TKKQKYDKICEKKVSTP----------IEVLCKSHPAE 247
+K+ DKI + K++ P ++ L K +P+
Sbjct: 204 NRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSS 241
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 32/229 (13%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
IG GSFG++ LA H + AVK+ K E K + + + + N+K
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQK-HIMAERNVLLKNVKHPFLV 59
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
Y D + VLD + +LF + +R+ F A ++ + + Y+HS
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP--TTNRHIPYRENKNLTGTARYASC 182
++RD+KP+N L+ V + DFGL K+ + TT+ GT Y +
Sbjct: 118 IYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSKTTS---------TFCGTPEYLAP 165
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
R D LG VL L G P+ A + YD I K
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 35/169 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
+K K+G G++ ++ + T EIVA+K + GT + E + K L+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKH--- 57
Query: 65 IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYC-------------RRKFSLKTVLMLAD 110
NI + + V +N L+L +F Y R TV
Sbjct: 58 -ENIVRLHDVIHTENKLML---------VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY 107
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
Q++ I + H LHRD+KP N L+ K ++ + DFGLA+ + P
Sbjct: 108 QLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAFGIP 153
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 36/238 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIPN 67
+K+ +K+G GS+G ++ + N+ A+K + G+ + +A +IL + PN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PN 60
Query: 68 IKWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI-------- 116
I Y +DG N L + + DL ++ + ++ +Q I RI
Sbjct: 61 IISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKKRK--LIPEQEIWRIFIQLLRGL 116
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYII-DFGLAKKYRDPTTNRHIPYRENKNLTG 175
+ +H + LHRD+K N L AN + I D G++K + I G
Sbjct: 117 QALHEQKILHRDLKSANIL----LVANDLVKIGDLGISKVLKKNMAKTQI---------G 163
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG-----LKAATKKQKYDKI 228
T Y + G S + D+ SLG +L + P++ L+ ++ KY I
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 44/171 (25%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGS 63
+YK+ IG GS+G + A T E VA+K N +H ++L E K+ ++L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRH-- 58
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPS----LEDLFVYCRRKFS-LKTVLMLAD-------- 110
P+I V + ++ P +D++V S L V+ D
Sbjct: 59 --PDI----------VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQ 106
Query: 111 ----QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN---QVYIIDFGLAK 154
Q++ ++Y+H+ HRD+KP N L AN ++ I DFGLA+
Sbjct: 107 FFLYQLLRALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 5/79 (6%)
Query: 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 136
D LV+ +G L L + K S + L QM+ ++Y+H+ G +HRD+KP N +
Sbjct: 94 DFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV 151
Query: 137 GLGRKANQVYIIDFGLAKK 155
+ ++ I+DFGLA++
Sbjct: 152 N---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 49/182 (26%), Positives = 72/182 (39%), Gaps = 53/182 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGG 62
+G +Y R +G GS G +F A D ++ VAVK + L E K+ + L
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-- 60
Query: 63 SGIPNIKWYGVDGEDNVL-VLDLLGPSLEDLFVYCRRKFSLKTV-----LMLAD------ 110
DN++ V ++LGPS DL L +V M D
Sbjct: 61 -------------HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE 107
Query: 111 --------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ----VYIIDFGL 152
Q++ ++Y+HS LHRD+KP N + N + I DFGL
Sbjct: 108 QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFGL 161
Query: 153 AK 154
A+
Sbjct: 162 AR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 27/154 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK----- 69
I G+FG+++L + +++ AVK+ K ++ + V+++ + K
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKV----VKKADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 70 --WYGVDGEDNV-LVLD-LLG---PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+Y + +NV LV++ L+G SL ++ Y + ++K + ++ ++Y+H
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYI----SEVALALDYLHRH 123
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYI--IDFGLAK 154
G +HRD+KPDN L+ +N+ +I DFGL+K
Sbjct: 124 GIIHRDLKPDNMLI-----SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 18/75 (24%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA+
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 156 YRDPTTNRHIPYREN 170
YR P + Y+EN
Sbjct: 183 YRAPEVILGMGYKEN 197
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 21/56 (37%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 99 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S V L QM+ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 113 PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 56/179 (31%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLY-EAKVYKILQ 60
+Y+ +GSG++G++ A T VA+K ++ H + Y E ++ K +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMD 72
Query: 61 GGSGIPNIKWYGVDGEDNVL-VLDLLGP--SLEDLFVYCRRKFSLKTVLMLAD------- 110
+NV+ +LD+ P SLED + L T LM AD
Sbjct: 73 ---------------HENVIGLLDVFTPASSLEDF-----QDVYLVTHLMGADLNNIVKC 112
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKK 155
Q++ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSN----IAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 28/165 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTN--EIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGI 65
Y+L +++G G++G + A + +T+ E VA+K I N +K + K+L+ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 66 PNIKWYGVDGEDNVLVLDLLGPS-LEDLFVY-----CRRKFSLKTVLMLAD--------Q 111
NI D +D++ P +L++Y +++ L D Q
Sbjct: 62 KNITCL-YD-------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQ 113
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
++ ++Y+HS LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 8/107 (7%)
Query: 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139
LV + L L+ C ++ V + Q++ + Y H R LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-- 138
Query: 140 RKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
+ ++ + DFGLA+ PT +N + YR L G+ Y++
Sbjct: 139 -ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL +K+G+G FGE+++ + ++ + VAVK GT Q L EA + K LQ +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDK---LV 64
Query: 69 KWYGV-DGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ Y V E+ + ++ G L+ L K L ++ + Q+ + Y+ + +
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+HRD++ N L+ ++ I DFGLA+ D
Sbjct: 125 IHRDLRAANVLVS---ESLMCKIADFGLARVIED 155
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 32/154 (20%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKV------YKILQGGSGIPNI 68
IG G+FGE+ + +T ++ A+KI N ++L A+ +L G +
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKW----EMLKRAETACFREERDVLVNG----DR 60
Query: 69 KW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLAD----QMIARIE 117
+W Y E+N+ LV+D +G L L KF + +A +M+ I+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLL----SKFEDRLPEDMARFYLAEMVLAID 116
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
VH G++HRDIKPDN L+ K + + DFG
Sbjct: 117 SVHQLGYVHRDIKPDNVLLD---KNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL---------YEAKVYKILQGGSGI 65
+G GSFG++ LA E AVK K +L E +V + +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVK----ALKKDVVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRG 123
++ E V++ L DL + + K F L A +++ ++++HS+G
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGG--DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARYAS 181
++RD+K DN ++ + + I DFG+ K+ + +N+ T GT Y +
Sbjct: 117 IIYRDLKLDNVMLD---RDGHIKIADFGMCKEN---------VFGDNRASTFCGTPDYIA 164
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
G++ + D S G +L L G P+ G
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 17/219 (7%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNI--KWY 71
+G G FGE+ T ++ A K ++ K + A K + I Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 72 GVDGEDNV-LVLDLL-GPSLE-DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
+ +D++ LV+ L+ G L+ ++ F + A Q+I +E++H R ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
+KP+N L+ V I D GLA + + K GT Y + G
Sbjct: 121 LKPENVLLD---DHGNVRISDLGLAVELKGGKK--------IKGRAGTPGYMAPEVLQGE 169
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
D +LG L + G P++ K +K++ +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
IG GSFG++ DT I A+K + S H L E V + +P
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT--LAERTVLAQVNCPFIVP- 57
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFL 125
+K+ E LVL + +LF + +R +F L +++ +E +H +
Sbjct: 58 LKFSFQSPEKLYLVLAFINGG--ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAK--KYRDPTTNRHIPYRENKNLTGTARYASCN 183
+RD+KP+N L+ + + DFGL K D TN GT Y +
Sbjct: 116 YRDLKPENILLDY---QGHIALCDFGLCKLNMKDDDKTN---------TFCGTPEYLAPE 163
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLP 212
LG ++ D +LG VLLY + LP
Sbjct: 164 LLLGHGYTKAVDWWTLG-VLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYKILQGGS 63
KIG G++G ++ A + T E+VA+K + ++ + LL E
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-------- 58
Query: 64 GIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
PNI K V +N LV + L L+ F+ + L+ + Q++ + +
Sbjct: 59 --PNIVKLLDVIHTENKLYLVFEFLHQDLKK-FMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNL 173
HS LHRD+KP N L+ + + DFGLA+ + P T H + YR + L
Sbjct: 116 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 174 TGTARYAS 181
G Y++
Sbjct: 173 LGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 20/67 (29%), Positives = 34/67 (50%), Gaps = 5/67 (7%)
Query: 91 DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
DLF Y R L+ + + +++ + Y+H RG +HRD+K +N + + +
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLG 227
Query: 149 DFGLAKK 155
DFG A K
Sbjct: 228 DFGAACK 234
|
Length = 392 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK 69
L ++IGSG FG ++L ++ ++ I + EA+V L S ++
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL---SHPKLVQ 63
Query: 70 WYGVDGEDN--VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
YGV E + LV + + L D R KFS +T+L + + + Y+ S +H
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 127 RDIKPDNFLMGLGRKANQVY-IIDFGLAK 154
RD+ N L+G NQV + DFG+ +
Sbjct: 124 RDLAARNCLVG----ENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 11 LGRKIGSGSFGEIFLASHVD-----TNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
L R++G G+FG++FLA + +VAVK + S EA++ LQ
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR---------------RKFSLKTVLML 108
+K+YGV E + L++ DL + R + + +L +
Sbjct: 69 ---IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
A Q+ A + Y+ S+ F+HRD+ N L+G + V I DFG++ RD + + YR
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RDVYSTDY--YR 177
Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGL 216
+ R+ + + + + D+ SLG VL F G PW L
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 52/221 (23%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
++L +G+G++G+++ HV T ++ A+K+ + T+ + + ++ +L+ S NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEI-NMLKKYSHHRNI 75
Query: 69 -KWYGV------DGEDNV--LVLDLLGP-SLEDLFVYCRRKFSLKT--VLMLADQMIARI 116
+YG G D+ LV++ G S+ DL V + +LK + + +++ +
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL-VKNTKGNALKEDWIAYICREILRGL 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
++H+ +HRDIK N L+ + +V ++DFG++ + D T R GT
Sbjct: 135 AHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL-DRTVGRR------NTFIGT 184
Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
+ +C+ + R D+ SLG + G+ P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 36/146 (24%), Positives = 75/146 (51%), Gaps = 9/146 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKV-YKILQGGSGIPNIKWYG 72
++G G+FG+++ A + +T + A K+ TK + L + V +IL + +K G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 73 V---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
DG+ +++ G +++ + + R + + ++ QM+ ++Y+HS +HRD+
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK 155
K N L+ L + + DFG++ K
Sbjct: 137 KAGNVLLTLD---GDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 47/242 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
+ LG+ +G G FG++ +A + ++ VAVK +++ T L+ E ++ K
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72
Query: 58 ILQGGSGIPNIKW-------------YGVDGEDNVLVLDLLGPSLEDLFVYCR---RKFS 101
++ I N+ Y G + P ++ F C+ + +
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KY 156
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+ Y
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDY 189
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQ 214
TTN +P K + A + TH + D+ S G VLL+ F G P+
Sbjct: 190 YKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLLWEIFTLGGSPYP 238
Query: 215 GL 216
G+
Sbjct: 239 GI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 51/241 (21%)
Query: 11 LGRKIGSGSFGEIFLASHV-----DTNEI--VAVKIENSGTKH---PQLLYEAKVYKILQ 60
LG+ +G G FG++ +A + N + VAVK+ S L+ E ++ K++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FSL 102
I N+ G +D L + + S +L Y R + S
Sbjct: 82 KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+ Y
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 196
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
TTN +P K + A + TH + D+ S G VLL+ F G P+ G
Sbjct: 197 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 245
Query: 216 L 216
+
Sbjct: 246 V 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 41/170 (24%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----EN------------SGTKHPQL--LYEAKV 55
+G G+FG+++ A H +T A KI E S KHP + LYEA
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
Y+ N W ++++ G +L+ + + R + + + QM+
Sbjct: 73 YE---------NKLW---------ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ ++HS +HRD+K N L+ L V + DFG++ K + R
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRD 161
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 51/227 (22%), Positives = 84/227 (37%), Gaps = 32/227 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTK-HPQLLYEAKVYKILQGGSG 64
+++ KIG GSFG +F + A+K + + + + EA+V L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + + G+ N+++ L L + R V Q++ + ++HS+
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK----------------YRDPTTNRHIPY 167
LHRDIK N + + V I D G+AK Y P PY
Sbjct: 122 ILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 168 RENKNL--TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
E ++ G Y C D + G ++L +RG P
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIRGVFP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 50/189 (26%), Positives = 77/189 (40%), Gaps = 37/189 (19%)
Query: 8 KYKLGRKIGSGSFGEIF--LASHVDTNEI---VAVKIEN---SGTKHPQLLYEAKVYKIL 59
K L R++G GSFG ++ LA V E VA+K N S + + L EA V K
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF 66
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCR------RKFSLKTVLMLAD 110
++ + GV G+ ++V++L+ DL Y R L
Sbjct: 67 N----CHHVVRLLGVVSTGQPTLVVMELMA--KGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 111 --QMIARI----EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYRDP 159
QM A I Y+ ++ F+HRD+ N ++ + V I DFG+ + Y
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYRK 177
Query: 160 TTNRHIPYR 168
+P R
Sbjct: 178 GGKGLLPVR 186
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 42/192 (21%), Positives = 72/192 (37%), Gaps = 38/192 (19%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
+++ G+ ++L VA+K+ + L EAK+ +IL G P + +Y
Sbjct: 28 KELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY- 84
Query: 73 VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV--LMLADQMIARIEYVHSRGFLHRDI- 129
GED + + + G L L + RK L+ + D++ G H ++
Sbjct: 85 --GEDFIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRL----------GIEHGELS 132
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 189
+P ++ VYIIDF A + P +N+T L E
Sbjct: 133 RPWKNVLV---NDRDVYIIDFDSATFKKKP-----------RNVTQALSL------LFRE 172
Query: 190 QSRRDDLESLGY 201
R + GY
Sbjct: 173 GLRIEKTILRGY 184
|
Length = 201 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYK-------I 58
++L + +G+G++G++FL V DT ++ A+K+ + L+ +AK + +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKV----LQKAALVQKAKTVEHTRTERNV 57
Query: 59 LQGGSGIPNIK--WYGVDGEDNV-LVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
L+ P + Y E + L+LD + S ++F +Y R FS V + ++I
Sbjct: 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYV--SGGEMFTHLYQRDNFSEDEVRFYSGEII 115
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+E++H G ++RDIK +N L+ V + DFGL+K++ R +
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEFLSEEKERTYSF------ 166
Query: 174 TGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPW 213
GT Y + G + D SLG ++ L G+ P+
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 40/223 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
KY + R +GSG+ G + A V E AVK+ +N L +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92
Query: 58 ILQGGSGIPNIKWYGVDGEDNV----LVLDLLGPSLEDLFVYCR------RKFSLKTVLM 107
I++ + +NV LVLD DL + R F +
Sbjct: 93 IVKCHE---DFAKKDPRNPENVLMIALVLDYANAG--DLRQEIKSRAKTNRTFREHEAGL 147
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKKYRDPTTNRH 164
L Q++ + +VHS+ +HRDIK N L+ GL V + DFG +K Y ++
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSD-- 199
Query: 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
+ GT Y + S++ D+ SLG VLLY L
Sbjct: 200 ---DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
+++ + IG G+FGE+ + T I A+KI N ++L A+ + + + N
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW----EMLKRAETACFREERNVLVNG 58
Query: 68 -IKW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
+W Y E+ + LV+D +G L L + +M+ I +
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
H ++HRDIKPDN L+ + + + DFG K T
Sbjct: 119 HQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGT 157
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
+L Q++ ++ VHSR +HRD+K N FLM G + + DFG +K+Y D +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDS-----V 223
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+ GT Y + S++ D+ SLG +L L P++G
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
Y + + + GS G +F+A+ + V +KI GT L EA + + + S I +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT----LIEAMLLQNVNHPSVI-RM 122
Query: 69 KWYGVDGEDNVLVLDLLGPSLE-DLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGF 124
K V G +VL P DL+ Y R + L++ Q++ + Y+H++
Sbjct: 123 KDTLVSGAITCMVL----PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+HRD+K +N + +QV I D G A+
Sbjct: 179 IHRDVKTENIFI---NDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 14 KIGSGSFGEIFLA--SHVDTNE---IVAVKIENSGTKHPQLLY--EAKVYKILQGGSGIP 66
++G G+FG++FLA ++ + +VAVK ++ + + EA++ +LQ
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH--- 68
Query: 67 NIKWYGV--DGEDNVLVLDLL------------GPS---LEDLFVYCRRKFSLKTVLMLA 109
+++YGV +G ++V + + GP L + +L +L +A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q+ + + Y+ S F+HRD+ N L+G G V I DFG++ RD + + YR
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YRV 180
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGL 216
R+ + L + + D+ S G VL F G PW L
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 47/204 (23%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK---- 69
++G G+FG+++ A + +T + A K+ + TK + L + V + PNI
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 70 --WYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+Y E+N+ +L G +++ + + R + + ++ Q + + Y+H +
Sbjct: 70 AFYY----ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---- 181
HRD+K N L L + + DFG++ K R I R+ + GT + +
Sbjct: 126 HRDLKAGNILFTLD---GDIKLADFGVSAK-----NTRTIQRRD--SFIGTPYWMAPEVV 175
Query: 182 -CNTHLGIEQSRRDDLESLGYVLL 204
C T + D+ SLG L+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLI 199
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 18/78 (23%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA+
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 156 YRDPTTNRHIPYRENKNL 173
YR P + Y+EN ++
Sbjct: 191 YRAPEVILGMGYKENVDI 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 31/211 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGGSG 64
+Y L +++G GSFG ++L +K+ G +P +A L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 65 IPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIE 117
P I K++ ++ + ++ + G L+ + + S V Q++ +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR---DPTTNRHIPYRENKNLT 174
Y+H R LHRD+K N + K N + I DFG+++ D T T
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT----------TFT 166
Query: 175 GTARYASCN--THLGIEQSRRDDLESLGYVL 203
GT Y S H G + + D+ SLG +L
Sbjct: 167 GTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 45/174 (25%), Positives = 68/174 (39%), Gaps = 40/174 (22%)
Query: 12 GRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGT--------------KHPQLLYEAK 54
G K+G G++G ++ A D E +IE +G KHP ++ K
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 55 VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
V+ S W L+ D L + + R + K + L M+
Sbjct: 66 VFL-----SHSDRKVW---------LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111
Query: 115 R--------IEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
I Y+H+ LHRD+KP N L MG G + +V I D G A+ + P
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 64/203 (31%)
Query: 11 LGRKIGSGSFGEIFLASHVDTNE-----IVAVKI--ENSGTKH-PQLLYEAKVYKILQGG 62
LG+ +G G+FG++ A V + VAVK+ +++ K L+ E ++ K++
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI--- 72
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLED--LFV---YCRR------------------- 98
G+ + +++LLG ++ L+V Y
Sbjct: 73 ------------GK-HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119
Query: 99 --------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150
+ K ++ A Q+ +E++ S+ +HRD+ N L+ + + I DF
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKIADF 176
Query: 151 GLAK-----KYRDPTTNRHIPYR 168
GLA+ Y TTN +P +
Sbjct: 177 GLARDIHHIDYYRKTTNGRLPVK 199
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 21/107 (19%)
Query: 49 LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLM 107
LL EA+ +G+P Y VD E+ +V++ + G L+D+ ++
Sbjct: 389 LLSEAR-------RAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG------NPELVR 435
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+++A++ H G +H D+ NF++ + +++Y+IDFGL K
Sbjct: 436 KVGEIVAKL---HKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 31/178 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEA-KVYKILQGGSGIPNI-KWY 71
+G G++G ++ A + T +A+K I +++ Q L+E ++ L+ NI ++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR----NIVQYL 71
Query: 72 GVDGEDN---VLVLDLLGPSLEDLFVYCRRKFS-LK----TVLMLADQMIARIEYVHSRG 123
G D E+ + + + G SL L R K+ LK T++ Q++ ++Y+H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHIPYRENKNLTGTARY 179
+HRDIK DN L + + V I DFG +K+ +P T + TGT +Y
Sbjct: 129 IVHRDIKGDNVL--VNTYSGVVKISDFGTSKRLAGINPCT---------ETFTGTLQY 175
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
Q++ I Y+H+ LHRD+KP N L MG G + +V I D G A+ + P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 30/113 (26%), Positives = 56/113 (49%), Gaps = 21/113 (18%)
Query: 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
+D LV++L+ +L + + + + + L QM+ I+++HS G +HRD+KP N +
Sbjct: 95 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 136 MGLGRKANQVYIIDFGLAKK---------------YRDPTTNRHIPYRENKNL 173
+ + + I+DFGLA+ YR P + Y+EN ++
Sbjct: 152 V---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNIKWY 71
+G G+ G ++ A H+ T I+AVK+ + + Q++ E +IL I +Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE---LEILYKCDSPYIIGFY 65
Query: 72 G---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
G V+ ++ + G SL+ VY RK + +A ++ + Y+ S LHRD
Sbjct: 66 GAFFVENRISICTEFMDGGSLD---VY--RKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
+KP N L+ QV + DFG++ + + K GT Y + G
Sbjct: 121 VKPSNMLVN---TRGQVKLCDFGVSTQLVNSIA---------KTYVGTNAYMAPERISGE 168
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + G P+
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 48/220 (21%), Positives = 88/220 (40%), Gaps = 51/220 (23%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
++G+G+ G + H + I+A K I N + Q+L+E I
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 65
Query: 65 IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ +YG DGE ++ + + G SL+ + +R + ++++ ++
Sbjct: 66 ---VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---------IPEEILGKVSIAVL 113
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
RG +HRD+KP N L+ ++ + DFG++ + D N +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMAN---------S 161
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
GT Y S G S + D+ S+G L+ G P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 53/242 (21%)
Query: 11 LGRKIGSGSFGEIFLA-------SHVDTNEIVAVKI--ENSGTKH-PQLLYEAKVYKILQ 60
LG+ +G G FG++ A S D VAVK+ +N+ K L+ E ++ K++
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75
Query: 61 GGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRR----------------KFS 101
I N+ GV +G V+V +L + F+ RR + S
Sbjct: 76 KHKNIINL--LGVCTQEGPLYVIVEYAAKGNLRE-FLRARRPPGPDYTFDITKVPEEQLS 132
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KY 156
K ++ A Q+ +EY+ SR +HRD+ N L+ + N + I DFGLA+ Y
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDY 189
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQ 214
T+N +P K + A + TH + D+ S G +L++ F G P+
Sbjct: 190 YKKTSNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-ILMWEIFTLGGSPYP 238
Query: 215 GL 216
G+
Sbjct: 239 GI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 21/152 (13%)
Query: 14 KIGSGSFGEI------FLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
++GSG+FG + +D I +K EN + +++ EA++ L P
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNENEKSVRDEMMREAEIMHQLDN----PY 56
Query: 68 I-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I + GV + E +LV+++ G L + + ++ V+ L Q+ ++Y+ + F
Sbjct: 57 IVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 125 LHRDIKPDNFLMGLGRKANQVY--IIDFGLAK 154
+HRD+ N L+ NQ Y I DFGL+K
Sbjct: 117 VHRDLAARNVLL-----VNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 44/225 (19%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI------ 65
G +G G++G ++ + +++AVK T + L E K Y+ LQ +
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSN-VLAAE-KEYEKLQEEVDLLKSLKH 61
Query: 66 PNIKWY-GVDGEDNVL--------------VLDLLGPSLEDLFVYCRRKFSLKTVLMLAD 110
NI Y G +DN + +L+ GP E V+C+
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE--PVFCK----------YTK 109
Query: 111 QMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q++ + Y+H+ +HRDIK +N LM G + +IDFG A++ H +
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRL--AWVGLHGTHSN 163
Query: 170 N-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
K++ GT + + R+ D+ S+G + G P
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 10/83 (12%)
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDFGLAKKYRDPTTNR 163
V + Q++ + Y+H + LHRD+KP N L+ LG ++ + DFGLA+ P+
Sbjct: 105 VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG----ELKLADFGLARAKSIPSQTY 160
Query: 164 H-----IPYRENKNLTGTARYAS 181
+ YR L G Y+S
Sbjct: 161 SSEVVTLWYRPPDVLLGATDYSS 183
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 41/285 (14%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGG 62
G+ +G+G+FG++ A S D VAVK+ ++ L+ E K+ L
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEY 118
I N+ G +++ + DL + RRK +L+ +L + Q+ + +
Sbjct: 99 ENIVNLLGACTIGGPILVITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ S+ +HRD+ N L+ G+ I DFGLA R I N + G AR
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVK---ICDFGLA---------RDIMNDSNYVVKGNAR 204
Query: 179 ----YASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEK- 231
+ + + + D+ S G +LL+ F GS P+ G+ +K Y I E
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYG-ILLWEIFSLGSNPYPGMPVDSK--FYKLIKEGY 261
Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
+++ P PAE C +RP + + +L
Sbjct: 262 RMAQPEHA-----PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVKI--ENSGTKH-PQLLYEAKVYK 57
K LG+ +G G FG++ +A + ++ VAVK+ +++ K L+ E ++ K
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 75
Query: 58 ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------ 99
++ I N+ G +D L + + S +L Y R +
Sbjct: 76 MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
+ K ++ Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNI 190
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
Y TTN +P K + A + TH + D+ S G VL++ F G P
Sbjct: 191 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 239
Query: 213 WQGL 216
+ G+
Sbjct: 240 YPGI 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 32/129 (24%), Positives = 57/129 (44%), Gaps = 13/129 (10%)
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F + L A +++ +E +H ++RD+KP+N L+ + I D GLA K
Sbjct: 99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVK---- 151
Query: 160 TTNRHIPYREN-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
IP E+ + GT Y + + D LG ++ + G P++G K
Sbjct: 152 -----IPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
Query: 219 ATKKQKYDK 227
K+++ D+
Sbjct: 207 KVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
Q++ + +H G +HRDIKP+N L+ + QV IIDFG A
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 14/126 (11%)
Query: 91 DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
+LF + R+ F+ + ++++ +EY+HSR ++RDIK +N ++ K + I
Sbjct: 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKIT 137
Query: 149 DFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
DFGL K+ D T + GT Y + + R D LG V+ +
Sbjct: 138 DFGLCKEGISDGATMK--------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 208 RGSLPW 213
G LP+
Sbjct: 190 CGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 27/158 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI-KWYGV 73
IG G++G+++ ++ + AVKI + + + + EA+ Y ILQ PN+ K+YG+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI-EAE-YNILQSLPNHPNVVKFYGM 87
Query: 74 -------DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY------- 118
G LVL+L G S+ +L K L L + MI+ I Y
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 119 -VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+H+ +HRD+K +N L+ V ++DFG++ +
Sbjct: 143 HLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQ 177
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 46/163 (28%), Positives = 68/163 (41%), Gaps = 29/163 (17%)
Query: 15 IGSGSFGEIFLASHVD-----TNEI-VAVKIENSGT---KHPQLLYEAKVYKILQGGSGI 65
+GSG+FGE++ + D + I VAVK G + + L EA L
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAH----LMSNFNH 58
Query: 66 PNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRK---------FSLKTVLMLADQMI 113
PNI K GV E ++++L+ DL Y R +LK +L + +
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGG--DLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGL--GRKANQVYIIDFGLAK 154
Y+ F+HRD+ N L+ V I DFGLA+
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 6e-04
Identities = 27/110 (24%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 52 EAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLA 109
EA++ + + G +P + Y VD E+ ++V++ + G L+DL +
Sbjct: 49 EARIMSRARKAGVNVPAV--YFVDPENFIIVMEYIEGEPLKDLIN--SNGMEELELSREI 104
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
+++ ++ HS G +H D+ N ++ ++Y+IDFGLA+ +D
Sbjct: 105 GRLVGKL---HSAGIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKDL 147
|
Length = 211 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 17/46 (36%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
Q++ ++++HS +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 58/232 (25%), Positives = 91/232 (39%), Gaps = 34/232 (14%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
IG GSFG++ LA + AVK+ K L + + + + + + N+K
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQ---KKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGF 124
Y + + VLD + +LF + + R F A ++ + + Y+HS
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKNLTGTARYAS 181
++RD+KP+N L+ V + DFGL K+ D TT GT Y +
Sbjct: 118 VYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSDTTT----------TFCGTPEYLA 164
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
D LG VL L G P+ A + YD I K +
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNILHKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 36/128 (28%), Positives = 58/128 (45%), Gaps = 13/128 (10%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q+I+ +E++H R ++RD+KP+N L+ V I D GLA + +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL--RGSLPWQGLKAATKKQKYDKI 228
K GT + + G E D +LG L + RG +G K K+ K +I
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRI 213
Query: 229 CEKKVSTP 236
V+ P
Sbjct: 214 LNDSVTYP 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIFLASHV---DTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
+ + +GSG+FG ++ + + +I VA+K+ E + K + +L EA V
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV----MAS 65
Query: 63 SGIPNI-KWYGVD-GEDNVLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIE 117
P++ + G+ L+ L+ L L Y R + +L Q+ +
Sbjct: 66 VDHPHVVRLLGICLSSQVQLITQLM--PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ + +HRD+ N L+ + V I DFGLAK
Sbjct: 124 YLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 45/273 (16%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPNI- 68
+G G+FGE+F + D VAVK PQ L EA++ K PNI
Sbjct: 3 LGKGNFGEVFKGTLKDKTP-VAVK--TCKEDLPQELKIKFLSEARILKQYDH----PNIV 55
Query: 69 KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFL 125
K GV + + + + D + R+K K ++ A A + Y+ S+ +
Sbjct: 56 KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN----RHIPYR-ENKNLTGTARYA 180
HRD+ N L+G + N + I DFG++++ D + + IP + RY+
Sbjct: 116 HRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
S D+ S G +LL+ F G P+ G+ +++ +K ++S P
Sbjct: 173 S-----------ESDVWSYG-ILLWETFSLGVCPYPGMTNQQAREQVEK--GYRMSCP-- 216
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271
+ P + C + RP + L++
Sbjct: 217 ---QKCPDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 24/71 (33%), Positives = 41/71 (57%), Gaps = 7/71 (9%)
Query: 90 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149
EDL ++ +L+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I D
Sbjct: 169 EDL---YKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICD 222
Query: 150 FGLAKK-YRDP 159
FGLA+ Y+DP
Sbjct: 223 FGLARDIYKDP 233
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 8e-04
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
K LG IG G FG + + T + VAVK L E V L + +
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL 64
Query: 68 IKWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGF 124
+ GV + + +V++L+ F+ R + S+ +L + + +EY+ S+
Sbjct: 65 L---GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+HRD+ N L+ + + DFGLA+ N +P +
Sbjct: 122 VHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK 162
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGG 62
L R++G G+FG++FL + E+VAVK EA++ Q
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH- 67
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL------------GPSLEDLFVYCRRKFSLKTVLM 107
NI K+YGV +G+ ++V + + GP L L +
Sbjct: 68 ---ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 108 L--ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
L A Q+ + + Y+ S+ F+HRD+ N L+G V I DFG++ RD T
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMS---RDVYTT 175
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 12/48 (25%), Positives = 25/48 (52%), Gaps = 7/48 (14%)
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
++ ++ H G +H D+ N ++ +++Y+IDFGL K +
Sbjct: 102 LVGKL---HKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYSDEI 142
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 29/169 (17%)
Query: 9 YKLGRKIGSGSFG---EIFLASHVDTNEIVAVKIE----NSGTKHPQLLYEAKVYKILQG 61
+ LGR +G G FG E L S + + VAVK+ S + + L EA K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 62 GSGIPNI-KWYGVD----GEDNVLVLDLLGPSLE--DL--FVYCRR------KFSLKTVL 106
PN+ K GV + + + ++ P ++ DL F+ R L+T++
Sbjct: 61 ----PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+ + +EY+ S+ F+HRD+ N ++ + V + DFGL+KK
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 45/152 (29%), Positives = 60/152 (39%), Gaps = 33/152 (21%)
Query: 11 LGRKIGSGSFGE--IFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
L IG + LA H TN +VAVK N S L E + LQ
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH--- 58
Query: 65 IPNIKWYG---VDGEDNVLVLDLLG-PSLEDLFVYCRRKFSLKTVLM--LADQMIARI-- 116
PNI Y + + +V L+ S EDL LKT L + IA I
Sbjct: 59 -PNILPYVTSFIVDSELYVVSPLMAYGSCEDL---------LKTHFPEGLPELAIAFILK 108
Query: 117 ------EYVHSRGFLHRDIKPDNFLMGLGRKA 142
+Y+HS+GF+HR +K + L+ K
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGKV 140
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 33/151 (21%), Positives = 65/151 (43%), Gaps = 8/151 (5%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
Y + + IG G+FGE+ L H + ++ A+K+ E +E +
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ + D + +V++ + P + + + K +++ ++ +HS G
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYM-PGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HRD+KPDN L+ K + + DFG K
Sbjct: 164 IHRDVKPDNMLLD---KHGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 17/147 (11%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN-IKWYG 72
K+ G FG++ + H T ++ KI + K+ + E V+++++ PN IK Y
Sbjct: 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKA--KNFNAI-EPMVHQLMKDN---PNFIKLYY 76
Query: 73 VDG--EDNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
+ +VL++D + DLF + K S V + Q++ + +H +H
Sbjct: 77 SVTTLKGHVLIMDYIKDG---DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHN 133
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAK 154
DIK +N L R +++Y+ D+GL K
Sbjct: 134 DIKLENVL--YDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 30/177 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKH---PQLLYEAKVYKILQGGS 63
+Y++ +KIG+G FGE+FL H T E K I G K QL+ E V + L+ +
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKN 73
Query: 64 GIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEY 118
+ I + + +L L C + F ++ + Q++ + Y
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133
Query: 119 VHS-------RGFLHRDIKPDNFLMGLG--------RKANQV------YIIDFGLAK 154
H+ LHRD+KP N + G +AN + I DFGL+K
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
|
Length = 1021 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 18/50 (36%), Positives = 29/50 (58%), Gaps = 3/50 (6%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Q++ + Y H R LHRD+KP N L+ + ++ + DFGLA+ P+
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKSVPS 157
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 28/210 (13%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
+G G+FG++ L + + A+KI K ++ + +V L + N +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKI----LKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
Y +D + V++ + +LF + R+ FS ++++ ++Y+HS
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGG--ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCN 183
++RD+K +N ++ K + I DFGL K+ D T K GT Y +
Sbjct: 117 VYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAAT--------MKTFCGTPEYLAPE 165
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ R D LG V+ + G LP+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 42/180 (23%), Positives = 69/180 (38%), Gaps = 60/180 (33%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IEN----------------SGTKHPQLL- 50
+G G FG++ LA + T E+ A+K I + +HP L+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 51 ------YEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT 104
E V +++ +G G DL+ D+F R F
Sbjct: 67 LFACFQTEDHVCFVMEYAAG----------G-------DLMMHIHTDVFSEPRAVFYAAC 109
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTT 161
V++ ++Y+H ++RD+K DN L+ V I DFGL K+ + D T+
Sbjct: 110 VVL-------GLQYLHENKIVYRDLKLDNLLLDT---EGFVKIADFGLCKEGMGFGDRTS 159
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 16/36 (44%), Positives = 25/36 (69%), Gaps = 3/36 (8%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
++ +HS GF+HRD+KPDN L+ K+ + + DFG
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 42/152 (27%), Positives = 62/152 (40%), Gaps = 30/152 (19%)
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFG---LAKKYRDP 159
LML Q++ + H++G +HRD+KP N ++ G+ A ++DFG L RD
Sbjct: 84 LML--QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK---VLDFGIGTLLPGVRDA 138
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLYFLRGSLPW 213
LT T T+ EQ R DL + G + L L G
Sbjct: 139 DVAT---------LTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
Query: 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245
QG A+ + Y ++ VS P + HP
Sbjct: 190 QG--ASVAEILYQQLSPVDVSLPPWI--AGHP 217
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.002
Identities = 19/75 (25%), Positives = 39/75 (52%), Gaps = 7/75 (9%)
Query: 91 DLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
+LF +R+ S + A +++ +EY+H G ++RD+KP+N L+ ++ +
Sbjct: 87 ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIM 143
Query: 147 IIDFGLAKKYRDPTT 161
+ DF L+K+
Sbjct: 144 LSDFDLSKQSDVEPP 158
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 39/150 (26%), Positives = 79/150 (52%), Gaps = 14/150 (9%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-IENS--GTKHPQLLYEAKVYKILQGGSGIPNIK 69
++G G++G + HV T I+AVK I + + +LL + + ++ +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDIS--MRSVDCPYTVT 64
Query: 70 WYG-VDGEDNVLV-LDLLGPSLEDLF--VYCRRKFSLKTVL-MLADQMIARIEYVHSR-G 123
+YG + E +V + ++++ SL+ + VY + + +L +A ++ +EY+HS+
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRD+KP N L+ + QV + DFG++
Sbjct: 125 VIHRDVKPSNVLIN---RNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 10/69 (14%)
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YRDP 159
L +A Q+ A +EY+ S F+HRD+ N L+G G V I DFGL++ YR
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL---TVKISDFGLSRDIYSADYYRVQ 183
Query: 160 TTNRHIPYR 168
+ +P R
Sbjct: 184 -SKSLLPVR 191
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 20/57 (35%), Positives = 33/57 (57%), Gaps = 3/57 (5%)
Query: 99 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
K L+T+L + +EY+ +R F+HRD+ N ++ R+ V + DFGL+KK
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 23/159 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASH-VDTNEIVAVKI--ENSGTKHPQLL-YEAKVYKILQGGSG 64
Y R +G GS+GE+ L H D + V K+ N+ + + EA++ L+
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH--- 58
Query: 65 IPNIKWY--GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI-------AR 115
PNI Y +GED +L + + DL+ + K L+ +Q++
Sbjct: 59 -PNIVAYRESWEGEDGLLYIVMGFCEGGDLY---HKLKEQKGKLLPENQVVEWFVQIAMA 114
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
++Y+H + LHRD+K N + + N + + D G+A+
Sbjct: 115 LQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
KL + IG G FG++ L + VAVK I+N T L EA V L+ + +
Sbjct: 9 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQ-AFLAEASVMTQLRHSN---LV 62
Query: 69 KWYGVDGEDN---VLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ GV E+ +V + + G ++ L R +L + + +EY+ +
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
F+HRD+ N L+ + N + DFGL K+
Sbjct: 123 FVHRDLAARNVLVS---EDNVAKVSDFGLTKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 21/76 (27%), Positives = 37/76 (48%), Gaps = 5/76 (6%)
Query: 91 DLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
DL+ Y +R ++ +L + ++ I+Y+H +HRDIK +N + V +
Sbjct: 168 DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLG 224
Query: 149 DFGLAKKYRDPTTNRH 164
DFG A D N++
Sbjct: 225 DFGAACFPVDINANKY 240
|
Length = 391 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 306 | |||
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.31 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.7 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.57 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.44 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.95 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.95 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.81 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.8 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.78 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.75 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.71 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.57 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.45 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.43 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.43 | |
| PLN02236 | 344 | choline kinase | 97.38 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.35 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.35 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.35 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.19 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.03 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.02 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.02 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.91 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.69 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.43 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.41 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.26 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.96 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.9 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.81 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.5 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.45 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.42 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.1 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.87 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.61 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.9 |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-52 Score=360.70 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=225.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
..+|.+++.||.|+|++|++|+.+.++++||||++.+. ....-...|..+|.+|.+|+.+..+...+.++...|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 46799999999999999999999999999999987643 3334456688899999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
|+||+ +|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ |.+++++|+|||.++.+...
T Consensus 152 vLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChh
Confidence 99999 9999999987 4679999999999999999999999999999999999999 79999999999999877644
Q ss_pred CCCccc------cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 160 TTNRHI------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 160 ~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
...... .......++||+.|.+||++.....++.+|+|+|||++|.|+.|.+||.+.++ ...++++..-.+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~~l~y 304 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQALDY 304 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHHHhcc
Confidence 332111 11112568999999999999999999999999999999999999999988544 577788877777
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
..+ +..++.+.+||.++|..||++|+|+++|.+ +.++
T Consensus 305 ~fp-----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~--HpFF 341 (604)
T KOG0592|consen 305 EFP-----EGFPEDARDLIKKLLVRDPSDRLTSQQIKA--HPFF 341 (604)
T ss_pred cCC-----CCCCHHHHHHHHHHHccCccccccHHHHhh--Cccc
Confidence 777 778999999999999999999999999977 6666
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-52 Score=349.65 Aligned_cols=260 Identities=26% Similarity=0.335 Sum_probs=219.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---------chhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
.+.+.|.+.+.||+|+||.|-+|..+.|++.||+|+++.... .....+|++++++|+| |++..+..++..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H-P~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH-PNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC-CCEEEEeeeeec
Confidence 367889999999999999999999999999999998874321 1124689999999987 778888888888
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
....|+|+||+ ||+|.+.+.. ++.+.+.....++.||+.|+.|||++||+||||||+|||++..+++..+||+|||+|
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred CCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 88899999999 8999998876 456888899999999999999999999999999999999986667899999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ---SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
+...+.. ...+.+||+.|.|||++.++.+ ..++|+||+||++|-+++|.+||++... .....+++..
T Consensus 327 K~~g~~s--------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~eQI~~ 396 (475)
T KOG0615|consen 327 KVSGEGS--------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKEQILK 396 (475)
T ss_pred hccccce--------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHHHHhc
Confidence 8765322 2348899999999999987653 3488999999999999999999987432 2335667777
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+++....+ .+..++++..+||..||..||+.|||++|.++ +.+++
T Consensus 397 G~y~f~p~-~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~--hpW~~ 441 (475)
T KOG0615|consen 397 GRYAFGPL-QWDRISEEALDLINWMLVVDPENRPSADEALN--HPWFK 441 (475)
T ss_pred CcccccCh-hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc--Chhhh
Confidence 77766533 34778999999999999999999999999987 55654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=355.41 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=226.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.+|+..+.||+|||+.+|.+++..+|+.||+|++.. ........+|+++.++|.| ++|..+..++.+..+.|++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~H-pnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKH-PNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCC-CcEEeeeeEeecCCceEEE
Confidence 579999999999999999999999999999998764 3445668899999999987 7777888888999999999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|+| .++|..++.. .+.+++.+++.+++||+.||.|||+.+|+|||||..|+|+ +++..+||+|||+|..+..+.
T Consensus 97 LELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence 9999 8888888884 6789999999999999999999999999999999999999 589999999999999887665
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. ..+.+||+.|.|||++.....+..+||||+||++|-|+.|++||...+- ...+.++.......|
T Consensus 173 Er-------k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v---kety~~Ik~~~Y~~P---- 238 (592)
T KOG0575|consen 173 ER-------KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV---KETYNKIKLNEYSMP---- 238 (592)
T ss_pred cc-------cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH---HHHHHHHHhcCcccc----
Confidence 43 2478999999999999988899999999999999999999999987433 456667777777777
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCC
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFD 285 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~ 285 (306)
..++.++++||.++|++||.+|||+++|+. +.++.+...+..
T Consensus 239 -~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 239 -SHLSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFFKSGFTPAR 280 (592)
T ss_pred -cccCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhhhCCCcCCC
Confidence 577999999999999999999999999987 888854444433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=341.73 Aligned_cols=258 Identities=23% Similarity=0.314 Sum_probs=215.8
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeeceeCc-eeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-~~~lv~ 82 (306)
.+.+.+..||+|..|+||+++|+.|++.+|+|++... ....+..+|+++++...+ ++++..+..+.... ...|+|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~s-pyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQS-PYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC-CCeeeEeEEEEeCCceEEeeh
Confidence 4677899999999999999999999999999988433 224567889999999854 66666666666666 599999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||| +|+|.+++... +.+++.....++.++++||.|||+ .+|+||||||+|||+ +..|.+||+|||.+..+.++.
T Consensus 158 EYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS~ 233 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNSI 233 (364)
T ss_pred hhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhhh
Confidence 999 88999998863 579999999999999999999996 899999999999999 689999999999998876553
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--hhhhhHHHHHHHhhcccccchH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL--KAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
. .+++||..|||||.+.+..|+.++||||||+.+.|+++|+.||... ........+..++....+....
T Consensus 234 a---------~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~ 304 (364)
T KOG0581|consen 234 A---------NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE 304 (364)
T ss_pred c---------ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc
Confidence 2 2789999999999999999999999999999999999999999874 2233445566666654443322
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
..+|++++++|..||++||.+|||+++|++ +.++.+....
T Consensus 305 ---~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--Hpfi~~~~~~ 344 (364)
T KOG0581|consen 305 ---GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ--HPFIKKFEDP 344 (364)
T ss_pred ---ccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CHHHhhcccc
Confidence 147999999999999999999999999988 7777644443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-51 Score=338.29 Aligned_cols=248 Identities=26% Similarity=0.357 Sum_probs=211.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
-...|++.+.||+|+||.||.++.+.|++.+|+|++++. ........|..++..+.| |.+..+...+++.+..|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~h-PFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKH-PFIVKLIYSFQTEEKLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCC-CcEeeeEEecccCCeEE
Confidence 357899999999999999999999999999999988754 233457789999999766 66667777788899999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+|+||+ ||.|...+.+ .+.+++..+..++.+|+.||.|||+.||+||||||+|||+ |..|+++|+|||+|+....
T Consensus 102 lVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhccc
Confidence 999999 8899988886 5679999999999999999999999999999999999999 7999999999999986544
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.+. ....++||+.|||||++.+..|+.++|+||||+++|+|++|..||.+.+.. ..++++...+...+.
T Consensus 178 ~~~-------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~---~~~~~I~~~k~~~~p- 246 (357)
T KOG0598|consen 178 DGD-------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK---KMYDKILKGKLPLPP- 246 (357)
T ss_pred CCC-------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH---HHHHHHhcCcCCCCC-
Confidence 433 224789999999999999999999999999999999999999999986544 555566655533331
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCC----ChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRP----DYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rp----s~~~l~~ 271 (306)
..++.+.+++++++|+.||++|. ++.+|.+
T Consensus 247 ---~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 247 ---GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ---ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 33688999999999999999995 5666654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-51 Score=330.03 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=215.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch----hhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|+...++|+|+||.||+++++.||+.||||.+....+.+ -+++|++++++|.|.+ ++.+...+......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~N-LVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHEN-LVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccch-HHHHHHHHHhcceeEEEe
Confidence 46899999999999999999999999999999988766644 3788999999998854 555555556677899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|||..++.+.+.....+++.+.+..+++|++.|+.|+|+++++||||||+|||++ ..|.+||+|||.|+.+..++..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCCcch
Confidence 9999999988887677899999999999999999999999999999999999996 8999999999999988765543
Q ss_pred ccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc-----
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP----- 236 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 236 (306)
...++.|.+|+|||.+.| -+|++++||||+||++.||++|...|++.++.++.-.+.+..+..++.-
T Consensus 158 -------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 158 -------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred -------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 236688999999999998 5699999999999999999999999999888877766666555443322
Q ss_pred ------------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 237 ------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 237 ------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
++.-.+..+.-+.+++..||+.||++|++-++++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11112344566889999999999999999999876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=336.35 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=210.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
-++|.+.+.||+|+|+.||+|+++.++..||||.+.... ....+..|+.+++.+.| +++..+..+....+..|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H-~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKH-PNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCC-cceeeEEEEEecCCeEEEE
Confidence 367999999999999999999999999999999887664 23457889999999996 6666677777778899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC-c--ceEEEEeeccccccC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-A--NQVYIIDFGLAKKYR 157 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~-~--~~~kl~Dfg~~~~~~ 157 (306)
|||| ||+|.+++.. .+.++++.+..++.||+.||++||+++|+||||||+|||++.... + -.+||+|||+|+.+.
T Consensus 88 MEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999 7999999987 447999999999999999999999999999999999999975422 2 689999999999887
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... .+.+|++.|||||+++.+.|+.|+|+||+|+++|+|++|+.||...+..+... .+.......
T Consensus 167 ~~~~a--------~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~---~~~k~~~~~-- 233 (429)
T KOG0595|consen 167 PGSMA--------ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL---YIKKGNEIV-- 233 (429)
T ss_pred chhHH--------HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH---HHhcccccc--
Confidence 54432 47799999999999999999999999999999999999999998765543333 222222111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+......+....+++...++.+|.+|.++.+... +.++.
T Consensus 234 ~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~--~~~l~ 272 (429)
T KOG0595|consen 234 PVLPAELSNPLRELLISLLQRNPKDRISFEDFFD--HPFLA 272 (429)
T ss_pred CchhhhccCchhhhhhHHHhcCccccCchHHhhh--hhhcc
Confidence 2222455777889999999999999998777643 45543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=341.84 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=220.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-h--hhHHHHHHHHHHhCCCCCCcceeeceeCc-eeE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-P--QLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNV 79 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~--~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-~~~ 79 (306)
++-++|.+.++||.|.||.||+|+.++++..||||.++..... + .-++|++.+++|..|+++..+.....+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4668999999999999999999999999999999988865432 2 25789999999996677767654444444 899
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|||||..+|.+++...++.+++..+..|+.||+.||+|+|++|+.||||||+|||++ ....+||+|||+|+...+.
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccccccC
Confidence 9999999999999998888899999999999999999999999999999999999994 5899999999999876543
Q ss_pred CCCccccccCCccccccccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc---
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST--- 235 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--- 235 (306)
. ||+ .++.|.+|+|||++. ...|+.+.||||+||+++|+.+-+..|+|.++.++..++..+++.....
T Consensus 164 p-----PYT---eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 164 P-----PYT---EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred C-----Ccc---hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 2 333 678899999999886 5568999999999999999999999999988877766666555444221
Q ss_pred -------------------chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 236 -------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 236 -------------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
++..+.++++++..++|.+|+.+||.+||||.+.++ ..++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~--~pff 294 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ--HPFF 294 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc--Cccc
Confidence 134455668999999999999999999999999988 4444
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=325.26 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=205.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcce-eeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIK-WYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~-~~~~~~~~~~lv~ 82 (306)
.|+|++.||.|.||+||++.+..+|..+|.|.+.-+ ...+....|+.+|++|+|+|++.... .+..+....+|+|
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 589999999999999999999999999999976632 33456788999999999976665554 3334445589999
Q ss_pred ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--cC--ccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 83 DLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHS--RG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 83 e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~--~~--i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
|+| .|+|...+... .+.++++.+|+++.|++.||.++|+ .+ |.||||||.||++ +..|.+||+|||+++
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLGR 176 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccchhHh
Confidence 999 89999887643 3459999999999999999999999 45 9999999999999 499999999999999
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
.+++..+. ....+||+.|||||++.+..|+++|||||+||++|||+.-..||.+.+- .+.-.++.....+
T Consensus 177 ~l~s~~tf-------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 177 FLSSKTTF-------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSLCKKIEQGDYP 246 (375)
T ss_pred HhcchhHH-------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHHHHHHHcCCCC
Confidence 88776553 2377999999999999999999999999999999999999999998632 2333344444333
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
. ++. ..+|.++.+||..|+.+||+.||+.-.++..+
T Consensus 247 ~-~p~--~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 247 P-LPD--EHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred C-CcH--HHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 2 222 66789999999999999999999854444433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=334.37 Aligned_cols=263 Identities=25% Similarity=0.336 Sum_probs=221.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch----hhHHHHHHHHHHhCCCCCCcceeecee-CceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVD-GEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~~ 79 (306)
....|+.+++||+|.||.||+|++..||+.||+|.+..+...+ -..+|+.+|++|.|++++......... ...+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3467889999999999999999999999999999776554333 368899999999986655544443333 57899
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|+|||..+|..++...+-.|++.++..++.||+.||.|||++||+|||||.+|||+ |.+|.+||+|||+|+.+...
T Consensus 195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeeccCC
Confidence 999999999999998755679999999999999999999999999999999999999 79999999999999977655
Q ss_pred CCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc--
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP-- 236 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 236 (306)
.... + ...+.|.+|+|||++.|.. |+.++|+||+||||.||++|++.|++-.+.++...+.+.|+..-...
T Consensus 272 ~~~~---~---T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 272 GSAP---Y---TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCcc---c---ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 4432 2 2567899999999999875 99999999999999999999999999888888888888877652211
Q ss_pred -------------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 237 -------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 237 -------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+...+..+++...+|+..+|..||.+|.||.+.+. .+++.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--seyF~ 404 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--SEYFT 404 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--Ccccc
Confidence 22224566888999999999999999999999877 66663
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=304.98 Aligned_cols=260 Identities=20% Similarity=0.265 Sum_probs=220.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.+|...+.+|+|.||.||+|++.+||+.||||.+..... .-..++|++.++.+.|. ++..+...+...+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~-nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHP-NIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCc-chhhhhhhccCCCceEEEE
Confidence 579999999999999999999999999999998875533 34689999999999874 4545555555667899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
||+..+|...+......++...+..++.++++||+|||++.|.||||||.|+|++ ++|.+||+|||+++.+.++...
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCCCcc
Confidence 9999999999998777799999999999999999999999999999999999995 9999999999999988765543
Q ss_pred ccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST------ 235 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~------ 235 (306)
. ...+.|.+|+|||.+.|.. |+..+||||.|||+.||+.|.+-|++.++.++...+.+..+.....
T Consensus 158 ~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 158 Q-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred c-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 2 1226799999999999875 9999999999999999999999999988887777776665544221
Q ss_pred --------------chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 236 --------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 236 --------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+...+.+.+++++.+|+.+||..||.+|+++.|.++ +.++.+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~ 286 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKS 286 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhc
Confidence 122244566788999999999999999999999987 777764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=309.96 Aligned_cols=236 Identities=23% Similarity=0.334 Sum_probs=212.2
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
-.+|++.+.||.|+||.|.+++++.+|..+|+|+++...- .+...+|..+++.+.| |.+..+...+.+....++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~-PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH-PFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC-ceeEEEEEeeccCCeEEE
Confidence 3579999999999999999999999999999999886532 2346778899998885 666667777788899999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|||. ||.|.+++.. .+.++++.++.++.||+.||.|||+++|++|||||+|||+ |..|.+||+|||.|+.....
T Consensus 122 vmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc
Confidence 99999 8899999887 5579999999999999999999999999999999999999 79999999999999987664
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
. .+.+||+.|+|||++....++.++|+||||+++|||+.|..||...++ ...+++++......|
T Consensus 198 T----------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~fP--- 261 (355)
T KOG0616|consen 198 T----------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVKFP--- 261 (355)
T ss_pred E----------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcccCC---
Confidence 3 277999999999999999999999999999999999999999998655 688999999999998
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCC
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRP 264 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rp 264 (306)
+.+++++++||.++|++|-++|.
T Consensus 262 --~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 262 --SYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred --cccCHHHHHHHHHHHhhhhHhhh
Confidence 77799999999999999999994
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=329.11 Aligned_cols=255 Identities=27% Similarity=0.361 Sum_probs=217.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----C---CchhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----T---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
...++|++++.||+|+||.|+.|++..+++.||+|+++.. . ......+|+.+++++.+|+++..+........
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567999999999999999999999999999999987764 1 23345679999999997788888877777777
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc-ceEEEEeecccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDFGLAK 154 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~-~~~kl~Dfg~~~ 154 (306)
..++||||+ +|+|.+.+.. .+.+++..+..+++|++.|++|||++||+||||||+|||+ +.+ +.+||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccc
Confidence 899999999 7799999998 6789999999999999999999999999999999999999 466 999999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-Q-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
....... .....+|++.|+|||++.+.. | +.++||||+|++||.|++|..||...+. ...+.++....
T Consensus 170 ~~~~~~~-------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~~ki~~~~ 239 (370)
T KOG0583|consen 170 ISPGEDG-------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLYRKIRKGE 239 (370)
T ss_pred ccCCCCC-------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHHHHHhcCC
Confidence 7631111 224779999999999999987 8 4899999999999999999999987433 34555566666
Q ss_pred cccchHHHhhcC-chHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 233 VSTPIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 233 ~~~~~~~~~~~~-~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
...+ ..+ +++++.|+.+||..||.+|+|+.+++ ...+++.
T Consensus 240 ~~~p-----~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~~ 280 (370)
T KOG0583|consen 240 FKIP-----SYLLSPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQK 280 (370)
T ss_pred ccCC-----CCcCCHHHHHHHHHHcCCCcccCCCHHHHh--hChhhcc
Confidence 6666 555 89999999999999999999999998 4777775
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=323.33 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=206.0
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCce-EEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCc-eeE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEI-VAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNV 79 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~-vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-~~~ 79 (306)
.....+.+.+|.|+||+||+|.+. |.. ||+|++..... ...+.+|+.++.+++|++++. +........ ..+
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~-f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQ-FYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeee-EEEEEcCCCCceE
Confidence 344566778999999999999986 445 99998886532 236899999999998865555 433333333 689
Q ss_pred EEEecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccCCCCCceeeccCCCcc-eEEEEeeccccc
Q 021855 80 LVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRG-FLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKK 155 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~-i~H~dlkp~Nilv~~~~~~~-~~kl~Dfg~~~~ 155 (306)
+||||+ +|+|..++.. ....++...+..++.||+.|+.|||+++ |+||||||+|||+ +.++ .+||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcccee
Confidence 999999 9999999987 3667999999999999999999999999 9999999999999 5776 999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL--GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
...... ......||..|||||++. ...|+.++||||||+++|||+||..||.+.... ......+....
T Consensus 194 ~~~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~v~~~~~ 263 (362)
T KOG0192|consen 194 KVISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASAVVVGGL 263 (362)
T ss_pred eccccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcCC
Confidence 544321 112468899999999999 568999999999999999999999999987652 33333333333
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+.+.+ ..+++.+..+|.+||+.||++||++.+++..|+.+..
T Consensus 264 Rp~~p---~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 264 RPPIP---KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCC---ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 33322 4478999999999999999999999999999999976
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=312.66 Aligned_cols=272 Identities=21% Similarity=0.228 Sum_probs=218.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeece----eCc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----~~~ 76 (306)
+..+|...+.||.|+||.|+.|.+..||+.||+|.+... .......+|+++++.++|.+.+.....+.. .-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 455677789999999999999999999999999976643 334567899999999997555544443333 345
Q ss_pred eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
..|+|+|+|+.+|..++.. +..++.+.+..++.||++||.|+|+.+|+||||||.|+++ +.+..+|++|||+|+..
T Consensus 100 DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence 6899999999999999886 4459999999999999999999999999999999999999 68999999999999987
Q ss_pred CCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH-------
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI------- 228 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~------- 228 (306)
....... .....+.|.+|.|||++... .|+.+.||||+|||+.||++|+..|.+.+...+...+...
T Consensus 176 ~~~~~~~-----~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 176 DKFFEDG-----FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred cccCccc-----chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 6541111 11366789999999988654 5999999999999999999999999986544433222221
Q ss_pred ----------------hhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCcc
Q 021855 229 ----------------CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFV 287 (306)
Q Consensus 229 ----------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~ 287 (306)
.....+.+.....++.++.+.+|+++||..||.+|+|++|.+. +.+++......+.|
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~--hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA--HPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc--ChhhhhhcCCccCC
Confidence 2222333445566788999999999999999999999999988 88888777776666
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=332.31 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=214.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+-|++++.||.|+.|.|-+|++.+||+.+|||++..... .....+|+.+++-+.|++.+ .++..+....+.|++
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl-~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVL-RLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCee-eeeeeeccCceEEEE
Confidence 348999999999999999999999999999998875422 23467899999988885554 444445567789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
.||+ +|.|.+++.. .+++++.++.++++||+.|+.|+|..+|+||||||+|+|+ |..+.|||+|||+|..-....
T Consensus 91 lEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCc
Confidence 9999 9999999987 5679999999999999999999999999999999999999 688889999999997644333
Q ss_pred CCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
- -.+.+|+++|++||++.|.+| +.++||||+|+|||.|+||+.||.+. +....+.+...+.+.+|
T Consensus 167 l--------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV~~G~f~MP--- 232 (786)
T KOG0588|consen 167 L--------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKVQRGVFEMP--- 232 (786)
T ss_pred c--------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHHHcCcccCC---
Confidence 2 237789999999999999998 78999999999999999999999853 45677788888888888
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.++|+++.+||++||.+||++|.|+++|++ +.++
T Consensus 233 --s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k--HP~l 266 (786)
T KOG0588|consen 233 --SNISSEAQDLLRRMLDVDPSTRITTEEILK--HPFL 266 (786)
T ss_pred --CcCCHHHHHHHHHHhccCccccccHHHHhh--Cchh
Confidence 888999999999999999999999999988 5555
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=331.68 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=216.4
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-hhhHHHHHHHHHHhC-----CCCCCcceeeceeCc
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQG-----GSGIPNIKWYGVDGE 76 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~-----~~~~~~~~~~~~~~~ 76 (306)
..++.+|+|.+.||+|.||.|.+|.+..|++.||||++++.... .+...|+.+|..|+. ..++.+...++...+
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 45667999999999999999999999999999999999876553 456779999999982 234556678888999
Q ss_pred eeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
+.|||+|.+.-+|.++++..+ .+++...+..++.||+.||.+||+.||+|+||||+|||+-.. ....+||+|||+|+.
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEecccccc
Confidence 999999999999999998643 459999999999999999999999999999999999999532 355999999999987
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
...... ....+..|+|||++.|.+|+.+.||||||||++||++|.+.|++.+..++...+....+...+.
T Consensus 341 ~~q~vy----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 341 ESQRVY----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cCCcce----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 554332 5677899999999999999999999999999999999999999987776655544443322111
Q ss_pred c------------------------------------------------------hHHHhh-cCchHHHHHHHhhhcCCC
Q 021855 236 P------------------------------------------------------IEVLCK-SHPAEFASYFHYCQSLTF 260 (306)
Q Consensus 236 ~------------------------------------------------------~~~~~~-~~~~~~~~li~~cl~~dP 260 (306)
. ...... .-...+.++|.+||.+||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 0 000000 112348999999999999
Q ss_pred CCCCChHHHHHHHHHhHhhcCCC
Q 021855 261 DQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 261 ~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
.+|+|+.+.++ +.++......
T Consensus 491 ~~R~tp~qal~--Hpfl~~~~~~ 511 (586)
T KOG0667|consen 491 AERITPAQALN--HPFLTGTSLE 511 (586)
T ss_pred hhcCCHHHHhc--Cccccccccc
Confidence 99999999987 7776644444
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=311.72 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=214.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+-.+.|++...||.|..+.||+|+...+++.||||+++.+..+ ..+.+|+..+..+.| ||+......|..+...++
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H-PNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH-PNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC-CCcceEEEEEEecceeEE
Confidence 3467899999999999999999999999999999998865443 457889988887766 666667777778889999
Q ss_pred EEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 81 VLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
||.+| +|++.+++... ..++++..+..+++++++||.|||.+|-+|||+|+.|||+ +++|.+||+|||.+..+..
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence 99999 99999998753 3459999999999999999999999999999999999999 6999999999999877766
Q ss_pred CCCCccccccCCccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
.+..... +. ..+.+++.|||||+++.. -|+.|+||||||++..||.+|..||..+.+. +.+...+...++.+
T Consensus 179 ~G~R~~~--rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---kvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 179 SGDRQVT--RF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---KVLLLTLQNDPPTL 252 (516)
T ss_pred cCceeeE--ee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---HHHHHHhcCCCCCc
Confidence 5533222 11 467899999999996644 3899999999999999999999999887654 44444444444322
Q ss_pred -----hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 237 -----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 237 -----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.......++..++++|..||++||.+|||+.++++ ..+++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk--h~FFk 297 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK--HAFFK 297 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc--cHHHh
Confidence 12222455778999999999999999999999988 55554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=316.09 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=202.5
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceee-ceeCc-eeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWY-GVDGE-DNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~-~~~~~-~~~lv~ 82 (306)
.++...+.||+|+||.||++.+.++|...|+|....... ...+.+|+.++.+|.| ++|...... ...+. .++++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~-p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNH-PNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCC-CCEEeeCCccccccCeeeEeee
Confidence 457889999999999999999998899999997665421 3447889999999995 444444333 33333 689999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC-cceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~-~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +|+|.+++...+..+++..+..+.+||++||.|||++|++||||||+|||+. . ++.+||+|||++.......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCcccccccccc
Confidence 999 8999999997655799999999999999999999999999999999999994 6 6999999999998765411
Q ss_pred CCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ........||+.|||||++..+ ...+++|||||||++.||+||+.||... ......+..+..... .+.
T Consensus 173 ~~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~---~P~ 243 (313)
T KOG0198|consen 173 TK----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDS---LPE 243 (313)
T ss_pred cc----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCC---CCC
Confidence 11 1122356899999999999953 3456999999999999999999999873 112233333333331 123
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+...+|+++++++.+|++.||++||||.++++ +.++.
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~--hpf~~ 280 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE--HPFLK 280 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhh--Chhhh
Confidence 44668999999999999999999999999987 55554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=323.77 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=210.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|-+.+.||+|.||.||+|+.+.|.+.||+|.+.+.... ....+|+.+++.++|++.+. ...++....+.++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~-m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVE-MLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhh-HHHhhcccceEEEEe
Confidence 4688999999999999999999999999999988765443 34788999999999855544 444455667899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
||+.|+|.+++.. ...++++.+..++.++..||.|||+++|.|||+||+|||+ +..|.+|++|||+++-.......
T Consensus 81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCcee
Confidence 9998899999987 5679999999999999999999999999999999999999 69999999999999876553321
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....||+.|||||++.+.+|+..+|+|||||++||+++|++||...+ ....+..+.......| .
T Consensus 157 -------ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~I~~d~v~~p-----~ 221 (808)
T KOG0597|consen 157 -------LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKSILKDPVKPP-----S 221 (808)
T ss_pred -------eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHHHhcCCCCCc-----c
Confidence 236679999999999999999999999999999999999999998633 3355566666666665 5
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.+++.+..++..+|.+||.+|.|..+++.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 77899999999999999999999999876
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=304.60 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=215.9
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch----hhHHHHHHHHHHhCCCCCCcce--eeceeCceeEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIK--WYGVDGEDNVL 80 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~~~--~~~~~~~~~~l 80 (306)
++|+.+..|++|.||.||+|++++|++.||+|.++.+.... ..++|+.++.+++| ++|..+. ..+..-+..|+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H-~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARH-PNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCC-CCeeeeEEEEeccccceeee
Confidence 46889999999999999999999999999999888665433 46899999999985 6777764 34555667999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||||..+|.+++..-..++...++..++.|++.||.|||++.|+||||||+|+|++ ..|.+|++|||+|+.+.++.
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhhhcCCc
Confidence 999999999999998777899999999999999999999999999999999999994 89999999999999887763
Q ss_pred CCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc-----
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS----- 234 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~----- 234 (306)
. ++ ...+.|.+|+|||++.|.. |+.+.||||+|||+.||+++++.|++.+..++...+.+..+..-.
T Consensus 232 k----~~---T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 232 K----PY---TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred c----cC---cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 3 12 2567899999999999876 899999999999999999999999998877776666655443211
Q ss_pred --------------cchHHHh---h--cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 235 --------------TPIEVLC---K--SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 235 --------------~~~~~~~---~--~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.+...+. + .+++.-.+|++.+|.+||.+|.||.+-++ +.++..
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e 366 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRE 366 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--cccccc
Confidence 0011111 1 13477889999999999999999999988 666654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=320.12 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=210.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+--+.|++++.||+|+||.||+|+.+.||..+|+|++.+..- -.....|-.+|.. ...+.++.+...+.+.++.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCee
Confidence 345789999999999999999999999999999998875432 2335567778877 5568888888888999999
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
||+|||+ ||++-+++.. .+.+++..+..++.+++.|+..+|+.|++||||||+|+|+ |..|++||+|||+|..+.
T Consensus 217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhh
Confidence 9999999 9999999887 5679999999999999999999999999999999999999 799999999999986432
Q ss_pred CCC--------------CCc----ccc-----c-----------------cCCccccccccccCcccccCCCCCchhhHH
Q 021855 158 DPT--------------TNR----HIP-----Y-----------------RENKNLTGTARYASCNTHLGIEQSRRDDLE 197 (306)
Q Consensus 158 ~~~--------------~~~----~~~-----~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiw 197 (306)
... ... ..+ . ...-..+||+.|+|||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 100 000 000 0 001135799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCC---ChHHHHHHHH
Q 021855 198 SLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP---DYGFLKRLFH 274 (306)
Q Consensus 198 slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp---s~~~l~~~l~ 274 (306)
|||||+|||+.|.+||.+.++......+... ...+..|.. ...++++++||.+||. ||++|. +++||.+ +
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw-r~~l~fP~~---~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~--H 445 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNW-RETLKFPEE---VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK--H 445 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hhhccCCCc---CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc--C
Confidence 9999999999999999997776555544432 222344433 3457899999999999 999997 4777766 4
Q ss_pred HhH
Q 021855 275 DLF 277 (306)
Q Consensus 275 ~~~ 277 (306)
.++
T Consensus 446 PfF 448 (550)
T KOG0605|consen 446 PFF 448 (550)
T ss_pred Ccc
Confidence 444
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=328.89 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=214.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+--++|++.++||+|.||.|+++..+.+++.+|||+++++. .-.....|..++.....||.+..+...+...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 44578999999999999999999999999999999888653 3345778889998888889999999999999999
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|+||||+ ||++..+.. .+.+++..+..+++.|+.||.|||++||+|||||.+|||+ |.+|.+||+|||+++...
T Consensus 445 ~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccC
Confidence 9999999 666333222 3569999999999999999999999999999999999999 799999999999998644
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
-.+. ..++++||+.|+|||++.+..|+.++|+||||+++|||+.|..||.+.++. ..+..+.......|
T Consensus 520 ~~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---e~FdsI~~d~~~yP- 588 (694)
T KOG0694|consen 520 GQGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---EVFDSIVNDEVRYP- 588 (694)
T ss_pred CCCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHhcCCCCCC-
Confidence 2222 335889999999999999999999999999999999999999999986554 66777777777776
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCC-C----hHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRP-D----YGFLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rp-s----~~~l~~ 271 (306)
..+|.+..+||+++|+++|++|. + +++|..
T Consensus 589 ----~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~ 623 (694)
T KOG0694|consen 589 ----RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK 623 (694)
T ss_pred ----CcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence 77799999999999999999998 4 566655
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=322.83 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=210.9
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
.+.+.+.||+|.||.||.|++..+ ..||+|.+..... .+.+.+|+.++++|+| +++..++.....+...+|||||+
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H-~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRH-EKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcc-cCeEEEEEEEecCCceEEEEEecc
Confidence 456789999999999999999653 3689998887544 4678999999999998 45555555555656799999999
Q ss_pred CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 ~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
.|+|.+++.. .+..++......++.||++|++||+++++|||||..+|||| +++..+||+|||+|+....+....
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~~- 360 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYTA- 360 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCceee-
Confidence 9999999986 44568999999999999999999999999999999999999 589999999999999544433321
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
....--..-|+|||.+....++.+|||||||++|+||+| |+.||.+++..+.. ..++...+.+.+ ..
T Consensus 361 -----~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~----~~le~GyRlp~P---~~ 428 (468)
T KOG0197|consen 361 -----SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL----ELLERGYRLPRP---EG 428 (468)
T ss_pred -----cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH----HHHhccCcCCCC---CC
Confidence 112223456999999999999999999999999999999 99999998765333 344555556555 56
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
+|+.+.++|..||..+|++|||++.+...|+++....
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 6999999999999999999999999999999987643
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=302.30 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=217.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
.+.+.|++-+.||+|.|+.|+++.+..||+.+++|+++.. ...+.+.+|+.+-..|+| |+|..+......+...|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH-P~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC-CcEeehhhhhcccceeE
Confidence 5778999999999999999999999999999999987743 345667889999888877 66666666666777899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+|+|++ |++|..-+... --+++..+..+++||++||.|+|.+||+|||+||.|+++.+++...-+||+|||++.....
T Consensus 87 lvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999 77887666542 3478999999999999999999999999999999999998888889999999999988762
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
+. .+....||++|+|||++...+|+..+||||.|++||-|+.|.+||++.+. ...++++..+....+.+
T Consensus 166 -g~-------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye~I~~g~yd~~~~ 234 (355)
T KOG0033|consen 166 -GE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYEQIKAGAYDYPSP 234 (355)
T ss_pred -cc-------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHHhccccCCCCc
Confidence 22 34578999999999999999999999999999999999999999998544 36677777777776643
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
. .++++++.++||++||..||.+|.|+.|.++
T Consensus 235 ~-w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 235 E-WDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred c-cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 3 3788999999999999999999999998766
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=324.13 Aligned_cols=251 Identities=22% Similarity=0.379 Sum_probs=210.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
..|....+||+|+.|.||.|+...+++.||+|.++..+ ...-..+|+.+++..+|.+.+..+..|... +..++||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEee
Confidence 46888899999999999999999999999999887543 345588999999999886666666655544 689999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +|+|.++... ..+++.++..++.+++.||.|||.+||+|||||.+|||++ .+|.+||+|||+|..+.....
T Consensus 352 m~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred cCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeeeeccccccC--
Confidence 9 8898888874 3499999999999999999999999999999999999995 899999999999988766554
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
.....+||++|||||++....|++++||||||++..||+-|.+||-.+++-.....+.......+..+ +.
T Consensus 425 -----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~-----~k 494 (550)
T KOG0578|consen 425 -----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNP-----EK 494 (550)
T ss_pred -----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCc-----cc
Confidence 23578999999999999999999999999999999999999999987554322222222222222222 77
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
+|+.+++++.+||+.||.+|+|+.+|++ +.++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~--HpFl 526 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLE--HPFL 526 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhc--Chhh
Confidence 8999999999999999999999999988 5555
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=317.36 Aligned_cols=263 Identities=19% Similarity=0.320 Sum_probs=201.9
Q ss_pred cccCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCccee-ece
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKW-YGV 73 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~-~~~ 73 (306)
++-.++|++.+.||+|+||.||+|.+. .+++.||+|++..... ...+.+|+.++..+.+|+++..+.. +..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 456789999999999999999999752 3456799998875432 2357789999999965566665544 333
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhc-------------------------------------------------------
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCR------------------------------------------------------- 97 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~------------------------------------------------------- 97 (306)
.....+++|||+ +|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 455688999999 889998876421
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCc
Q 021855 98 ------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171 (306)
Q Consensus 98 ------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 171 (306)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++......... ....
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~-----~~~~ 234 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKG 234 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcch-----hccc
Confidence 236778889999999999999999999999999999999 47899999999999764332211 0112
Q ss_pred cccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHH
Q 021855 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFAS 250 (306)
Q Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (306)
...++..|+|||++.+..++.++|||||||++|+|++ |..||.+..... .+........... ....+++.+.+
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~l~~ 308 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFCQRLKDGTRMR---APENATPEIYR 308 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHhcCCCCC---CCCCCCHHHHH
Confidence 3345678999999999899999999999999999997 999998744321 1112222111111 12456888999
Q ss_pred HHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 251 YFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 251 li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+|.+||+.||.+|||+.+|++.|++++..
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=308.32 Aligned_cols=254 Identities=21% Similarity=0.266 Sum_probs=200.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||.|+||.||+|++..+++.||+|.+.... ....+.+|+.+++.+.| +++..+..++..+...++++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH-ANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEEe
Confidence 56999999999999999999999999999999876432 23456789999999977 555556556666778999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
++.++|.+.+......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.........
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~~- 159 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKT- 159 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCcc-
Confidence 99889999887655568899999999999999999999999999999999999 57899999999998754332211
Q ss_pred cccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc--------
Q 021855 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-------- 234 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 234 (306)
.....++..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+.+.......
T Consensus 160 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 160 ------YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred ------ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 124467889999999876 45899999999999999999999999875544333222222111100
Q ss_pred --------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 235 --------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 235 --------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.+.....+..++++.++|.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0011112346788999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=300.07 Aligned_cols=259 Identities=19% Similarity=0.254 Sum_probs=209.6
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCc------e
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE------D 77 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~------~ 77 (306)
.|+..+.||.|+||.||+|+.+.+|+.||+|.+..+.. -....+|+.+++.++|.+++..+........ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 47778889999999999999999999999998765433 3457899999999999776666655444444 7
Q ss_pred eEEEEeccCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 78 NVLVLDLLGPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
.++++||...+|..++.... .+++...+..+++||+.||+|||+.||+||||||+|||++ +.|.+||+|||+|+
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEeeeccchHH
Confidence 89999999999999998765 3688899999999999999999999999999999999994 79999999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
....+.. ......+|.+|+|||++.|. .|+...||||+||+++||++++..|.+.++.++...+.+..+...
T Consensus 169 a~~ip~~-------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 169 AFSIPMR-------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred HhcCCcc-------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 6554332 22356789999999999988 589999999999999999999999999887666555555544331
Q ss_pred ccc----------------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 234 STP----------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 234 ~~~----------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
... .....+..+++..+++.+||+.+|.+|.|++..+. +.++.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~--h~yf~ 306 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT--HPYFS 306 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc--Chhhc
Confidence 100 11111233457999999999999999999999887 44443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=311.01 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=199.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+.....+....+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH-PFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCC-CcHhhhHhhhccCCeEEEE
Confidence 47999999999999999999999999999999876432 22346779999999987 5555555556677789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+||+ +++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCCc
Confidence 9999 7899988876 4568999999999999999999999999999999999999 578999999999987654321
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+
T Consensus 156 ----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~---- 218 (291)
T cd05612 156 ----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEKILAGKLEFP---- 218 (291)
T ss_pred ----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCcCCC----
Confidence 1346889999999999988999999999999999999999999875443 33334444433333
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
...++.+.++|++||+.||.+||+ ++++++
T Consensus 219 -~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 219 -RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 455788999999999999999995 777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=306.31 Aligned_cols=255 Identities=20% Similarity=0.251 Sum_probs=198.7
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+|+.++..+.|+ ++..+...+......++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE-NIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCc-cccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999998765422 34567899999999874 4545555556677899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
||+.+++.+.+......+++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||.+.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc
Confidence 999777766666545569999999999999999999999999999999999999 58899999999999765432211
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc---------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV--------- 233 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------- 233 (306)
......++..|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+........
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 157 ------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 11244678999999999998899999999999999999999999987654332222221111000
Q ss_pred -------ccc--------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 234 -------STP--------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 234 -------~~~--------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..+ .......+|+.+.++|.+||++||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00111235778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=307.97 Aligned_cols=261 Identities=20% Similarity=0.244 Sum_probs=200.6
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.++|++.+.||.|+||.||+|++..+++.||+|++..... .....+|+.+++.+.| +++..+..++......++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCC-CCcCeEEEEEecCCeEEEEE
Confidence 4689999999999999999999998999999998764322 2346789999999977 55556666666777899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
||+.+++.+.+......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++........
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc-
Confidence 999999998887655678999999999999999999999999999999999999 5789999999999865432221
Q ss_pred ccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh-HHHHHHHhhccc-------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKV------- 233 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~------- 233 (306)
......++..|+|||++.+. .++.++|||||||++|+|++|..||.+...... ............
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred ------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence 11244678899999998764 588999999999999999999999987533211 111111110000
Q ss_pred ---------------ccchHH--HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 234 ---------------STPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 234 ---------------~~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+..... .....++.+.+++.+||+.||.+|||++++++ +.++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~--h~~f~~ 293 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS--HEYFSD 293 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc--Cccccc
Confidence 000000 00123567899999999999999999999987 666643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=314.94 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=201.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
.-++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.++..+.| +++..+...+......+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH-PFIVNMMCSFQDENRVY 94 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEcCCEEE
Confidence 346899999999999999999999999999999987643 223457789999999976 55556656666778899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++||+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCC
Confidence 999998 7899888876 4568999999999999999999999999999999999999 5889999999999976543
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
... ...|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+
T Consensus 171 ~~~----------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~p-- 235 (329)
T PTZ00263 171 RTF----------TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIYEKILAGRLKFP-- 235 (329)
T ss_pred Ccc----------eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHHHHHhcCCcCCC--
Confidence 221 446899999999999999999999999999999999999999875443 33344444443333
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
..+++.+.++|.+||+.||.+||+ ++++++
T Consensus 236 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 236 ---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 456888999999999999999996 577665
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=280.50 Aligned_cols=295 Identities=68% Similarity=1.189 Sum_probs=283.3
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
-+++++|+++++||+|+||.+|+|....+|..||||+..+...++.+..|..+...|++...+|.+..++.+....++||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
+..|.+|.+++..+.+.++.++++.++-||+.-+.|+|..+++||||||+|+|++.......+.|+|||+|+.+.+..+.
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99999999999999999999999999999999999999999999999999999987778889999999999999999999
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.++|++......||+.|+|-....+...+..-|+=|+|.++.++.-|..||++..+.++.++++++.+.....+.+.+|.
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 99999999999999999998888888888899999999999999999999999999999999999999999999999999
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceecchhh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQ 297 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 297 (306)
.+|.++.-.+.-|-..--++-|+..-|...|+-++...+...+.-|||+.++++.
T Consensus 251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~ 305 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKS 305 (341)
T ss_pred CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHh
Confidence 9999999999999999999999999999999999999999999999999998554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=303.22 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=208.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeecee-C---ceeEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD-G---EDNVL 80 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~---~~~~l 80 (306)
..-.|+-.+.+|.|.||.||.|...++++.||||....+.... .+|+.++..+.|+|.+..+..|... + -...+
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3456888999999999999999999999999999777655533 3689999988775555444444332 2 24568
Q ss_pred EEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 81 VLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 81 v~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|+||+..+|...+.. .+..++.-.+.-+.+||.+||.|||+.||+||||||+|+|+. .+.|.+||+|||+|+.+.
T Consensus 100 VleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 100 VLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeec
Confidence 999999999998874 245688888999999999999999999999999999999994 456999999999999876
Q ss_pred CCCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
..... ....+|..|+|||.+.|.. |+.+.||||.||++.||+.|++.|.+.+..++...+-+..+..-...
T Consensus 178 ~~epn--------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 178 KGEPN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred cCCCc--------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 55432 3778999999999999875 99999999999999999999999999887766665555443331111
Q ss_pred ---------------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 237 ---------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 237 ---------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+....++++.+++.++|+++|.+|.++.+++. +.++.
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~--h~fFd 310 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA--HPFFD 310 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc--chhhH
Confidence 01133456889999999999999999999998865 44443
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=311.18 Aligned_cols=240 Identities=22% Similarity=0.303 Sum_probs=197.6
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+|++.+.||+|+||.||+|++..+++.||+|++... .....+..|..++..+.+++++..+..++......+++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999987643 222346678888888888887877777777788899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCC
Confidence 999 7899888765 4568999999999999999999999999999999999999 5789999999999864322111
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
......|+..|+|||++.+..++.++||||+||++|+|++|..||.+.+.. ..+..+.......+
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~~~----- 221 (324)
T cd05587 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIMEHNVSYP----- 221 (324)
T ss_pred -------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC-----
Confidence 112456899999999999999999999999999999999999999875543 33333333333333
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCCh
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDY 266 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~ 266 (306)
..+++.+.+++.+||+.||.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 4568899999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=311.25 Aligned_cols=262 Identities=20% Similarity=0.259 Sum_probs=199.2
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeece----eCceeE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNV 79 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----~~~~~~ 79 (306)
+|++.+.||+|++|.||+|++..+++.||+|.+... .....+.+|+.+++.+.|++.+.....+.. .....+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999987642 222347789999999987554443332221 123579
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+++||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccccc
Confidence 9999999999988875 4468999999999999999999999999999999999999 58899999999998754322
Q ss_pred CCCccccccCCccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH----------
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK---------- 227 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~---------- 227 (306)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 157 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 157 TPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 2111 01124568999999999876 5789999999999999999999999976543221111111
Q ss_pred -------------HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 228 -------------ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 228 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
......+.+.....+..++.+.++|.+||+.||++|||++++++ +.++..
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~--hp~f~~ 295 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA--DPYFKG 295 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc--Cchhhh
Confidence 11111112222223456788999999999999999999999987 666653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=314.51 Aligned_cols=250 Identities=22% Similarity=0.273 Sum_probs=212.8
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.++|++++++|.|+||.+++++++..+..+++|.+.... ......+|+.+++++.|++.+.+...+..++...+|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999999999999999999876432 2346788999999988866666556666666669999
Q ss_pred Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
|+|| ||++.+.+...+ ..++++.+..++.||+.|+.|||+++|+|||||+.|||++ .++.|+|.|||+|+...+.
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCCc
Confidence 9999 899999988765 4599999999999999999999999999999999999996 7788899999999988766
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. .....+||+.|++||++.+.+|+.|+|||||||++|||++-+.+|...+.. ..+.++.......
T Consensus 160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~~~~~P---- 225 (426)
T KOG0589|consen 160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINRGLYSP---- 225 (426)
T ss_pred hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhhccCCC----
Confidence 42 234789999999999999999999999999999999999999999886554 4445555444222
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
+...++.+++.+|..||+.+|..||++.+|+..
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 226678999999999999999999999999886
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=313.36 Aligned_cols=263 Identities=17% Similarity=0.179 Sum_probs=201.7
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
...+|++.+.||+|+||.||+|++..+++.||+|.... ..+.+|+.+++.+.| +++..+..++......++++|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----GGTATEAHILRAINH-PSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----hhhHHHHHHHHhCCC-CCCCCEeEEEEECCeeEEEEec
Confidence 34689999999999999999999999999999996542 346789999999987 5565666666677789999999
Q ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+.++|...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++.........
T Consensus 165 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~-- 238 (391)
T PHA03212 165 YKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINAN-- 238 (391)
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccccc--
Confidence 99999888765 4568999999999999999999999999999999999999 57899999999998653222111
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh----hHHHHHHHhhcc--------
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT----KKQKYDKICEKK-------- 232 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~----~~~~~~~~~~~~-------- 232 (306)
......||+.|+|||++.+..+++++|||||||++|+|++|..||....... ....+..++...
T Consensus 239 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 239 ----KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ----ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1124578999999999999999999999999999999999998875422100 000111111000
Q ss_pred ------------------cc----cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCC
Q 021855 233 ------------------VS----TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284 (306)
Q Consensus 233 ------------------~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~ 284 (306)
.. .+........+.++.++|.+||+.||.+|||+.++++ +.++.....+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~--hp~f~~~~~~~ 386 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD--FAAFQDIPDPY 386 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc--ChhhccCCCCC
Confidence 00 0000011234678999999999999999999999987 77776544333
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=312.07 Aligned_cols=250 Identities=21% Similarity=0.312 Sum_probs=201.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+...+......+++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS-EWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC-CCCccEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999876431 22346778899998875 6666666666778889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTYA 155 (333)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccccc
Confidence 9999 8899998875 4568999999999999999999999999999999999999 588999999999987654311
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch-HH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI-EV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (306)
....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... .....+. ..
T Consensus 156 ----------~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 224 (333)
T cd05600 156 ----------NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-ETLQRPVYDD 224 (333)
T ss_pred ----------CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-ccccCCCCCc
Confidence 24568999999999999999999999999999999999999998755433222222111 1111111 10
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
....+++++.++|.+||+.+|.+||+++++++.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 112558899999999999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=299.76 Aligned_cols=260 Identities=21% Similarity=0.340 Sum_probs=211.6
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.+|++++.||.|.-|.||+++...++..+|+|++++... -.+...|.+||..+.| |.++.++..+......|++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH-PFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH-PFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC-CccchhhheeeccceeEEE
Confidence 568899999999999999999999999999999886432 2345568888988876 7788888888888889999
Q ss_pred Eecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 82 LDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
|||| ||+|..+.+.+.. .+++..+..++.+++.||.|||-+|||+|||||+|||| .++|+|.|+||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999 8899988876543 49999999999999999999999999999999999999 49999999999886532110
Q ss_pred CC--------------------------------Cc--------------c--ccc-cCCccccccccccCcccccCCCC
Q 021855 160 TT--------------------------------NR--------------H--IPY-RENKNLTGTARYASCNTHLGIEQ 190 (306)
Q Consensus 160 ~~--------------------------------~~--------------~--~~~-~~~~~~~~~~~y~aPE~~~~~~~ 190 (306)
.+ .. . .|- ...-.++||..|.|||++.|.--
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 00 0 000 11124579999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCC----h
Q 021855 191 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD----Y 266 (306)
Q Consensus 191 ~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps----~ 266 (306)
+.++|+|+||+++|||+.|..||.+.+.. +.+..++......+.. +..+..+++||+++|.+||.+|.. +
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~---~Tl~NIv~~~l~Fp~~---~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK---ETLRNIVGQPLKFPEE---PEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCch---hhHHHHhcCCCcCCCC---CcchhHHHHHHHHHhccChhhhhccccch
Confidence 99999999999999999999999986554 5666677666666643 356788999999999999999997 8
Q ss_pred HHHHHHHHHhHh
Q 021855 267 GFLKRLFHDLFS 278 (306)
Q Consensus 267 ~~l~~~l~~~~~ 278 (306)
.||.+ +.+++
T Consensus 387 ~eIK~--HpFF~ 396 (459)
T KOG0610|consen 387 AEIKR--HPFFE 396 (459)
T ss_pred HHhhc--Ccccc
Confidence 88876 55553
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=303.09 Aligned_cols=248 Identities=19% Similarity=0.268 Sum_probs=195.5
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.++..+.|+ ++..+...+......++++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~-~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCC-cEEEEEEEEccCCeEEEEE
Confidence 3889999999999999999999999999999876432 123467799999998774 4444444455667899999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+.+.... ..+++..+..++.|++.||.|||++||+||||||+|||+ ++++.++|+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 999 778887765433 358999999999999999999999999999999999999 578999999999987643322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+...... .....
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05631 157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE----DQEEY 224 (285)
T ss_pred e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc----ccccC
Confidence 1 11446899999999999999999999999999999999999999875443222222222211 11112
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
...+++++.+||++||+.||.+||+ ++++++
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 2567889999999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=316.97 Aligned_cols=261 Identities=21% Similarity=0.250 Sum_probs=197.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeece-------eCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-------DGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-------~~~ 76 (306)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.+.|.+.+.....+.. ...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45678999999999999999999999999999999875432 234579999999987555544333221 112
Q ss_pred eeEEEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 77 DNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
..+++|||+++++.+++.. ....+++..++.++.||+.||.|||+.||+||||||+|||+. ...+.+||+|||++
T Consensus 141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla 218 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccc
Confidence 4678999999998877653 245689999999999999999999999999999999999994 23457999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
+........ ....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.+.....
T Consensus 219 ~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 219 KNLLAGQRS--------VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred hhccCCCCc--------ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 865432211 144678999999998765 58999999999999999999999998765443332222221110
Q ss_pred c----------------c----c-chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 233 V----------------S----T-PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 233 ~----------------~----~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
. + . ....+....|+++.+||.+||++||.+|||+.+++. +.++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~--hp~f~ 355 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA--DPFFD 355 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC--ChhHH
Confidence 0 0 0 011122346788999999999999999999999986 45543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=300.63 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=195.3
Q ss_pred CceeEeeeecccCccEEEEEEEcC-CCceEEEEEccCCCC----chhhHHHHHHHHHHh--CCCCCCcceeece-----e
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTK----HPQLLYEAKVYKILQ--GGSGIPNIKWYGV-----D 74 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~--~~~~~~~~~~~~~-----~ 74 (306)
.+|++.+.||+|+||.||+|++.. +++.||+|.+..... .....+|+.+++.+. .|+++..+...+. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 467899998764322 234667888887775 2455555543321 3
Q ss_pred CceeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
....++++|++.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccce
Confidence 45689999999999998887533 348999999999999999999999999999999999999 47899999999998
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc--
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK-- 231 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-- 231 (306)
........ .....++..|+|||++.+..++.++|||||||++|+|++|..||.+.........+......
T Consensus 158 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 158 RIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred EeccCCcc--------cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 76543211 12456889999999999889999999999999999999999999876544333322221110
Q ss_pred -----------------ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 232 -----------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 232 -----------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....+.....+.+++.+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0111122333457788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=310.04 Aligned_cols=239 Identities=22% Similarity=0.306 Sum_probs=194.0
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+...+......+++|||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999876432 22346678889988876 55666666667778899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++........
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~----- 150 (323)
T cd05571 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCC-----
Confidence 788888765 4578999999999999999999999999999999999999 5889999999999875322211
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+.......+ ..+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~~~~~~~~~p-----~~~~~ 220 (323)
T cd05571 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRFP-----RTLSP 220 (323)
T ss_pred --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCCCH
Confidence 112456899999999999999999999999999999999999999764432 23333333333333 56788
Q ss_pred HHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 247 EFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
++.++|.+||+.||++|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 999999999999999999 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=307.63 Aligned_cols=240 Identities=21% Similarity=0.305 Sum_probs=197.3
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+|++.+.||+|+||.||+|++..+++.||+|++..... ......|..++..+.+++++..+..++......+++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999998774321 1234557777777777788887777777788899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCC
Confidence 999 7899888765 4568999999999999999999999999999999999999 5889999999999875432221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~~~~~~~p----- 221 (323)
T cd05616 157 -------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIMEHNVAYP----- 221 (323)
T ss_pred -------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----
Confidence 112456899999999999999999999999999999999999999875543 33344444444333
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCCh
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDY 266 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~ 266 (306)
..+++++.+++.+||+.||++|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 4568899999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=302.49 Aligned_cols=262 Identities=19% Similarity=0.277 Sum_probs=197.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcC----------------CCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----------------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSG 64 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~----------------~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~ 64 (306)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+|+.++.++.| ++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKD-PN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCC-CC
Confidence 456899999999999999999997632 344799998875432 2357789999999977 55
Q ss_pred CCcceeeceeCceeEEEEecc-CCCHHHHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 021855 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------------------RKFSLKTVLMLADQMIARIEYVHSRGFL 125 (306)
Q Consensus 65 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~ 125 (306)
+..+..++......++++||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 555655666677899999999 789998876421 1357788899999999999999999999
Q ss_pred ccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHH
Q 021855 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 205 (306)
Q Consensus 126 H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 205 (306)
||||||+|||+ +.++.+||+|||.+......... .......++..|+|||++.+..++.++|||||||++|+
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYY-----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCcee-----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 99999999999 47899999999998765332211 01123345678999999998899999999999999999
Q ss_pred HHh--CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 206 FLR--GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 206 l~t--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
|++ +..||...+........................+.+++.+.++|.+||+.||.+|||+++|.+.|+
T Consensus 233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 987 667887755433222222211111111111112456788999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=308.24 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=208.7
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
....|+..+.||+|.||.||+|.+..|++.||+|+++.+... .+..+|+.++..+.+ +++...+..+..+...+++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-PNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-chHHhhhhheeecccHHHH
Confidence 345688889999999999999999999999999998876544 357789999999887 5554455555677788999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||| +|++.+++.. +..+++..+..++++++.||.|||+.+.+|||||+.||+++ ..|.+||+|||.+.......
T Consensus 90 Mey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechh
Confidence 9999 8899998875 33458888889999999999999999999999999999995 67999999999998766544
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. ...++||+.|||||++.+..|+.++||||||++.+||++|.+|+....+. ..+. ++... ..+.+
T Consensus 166 ~r-------r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---rvlf-lIpk~---~PP~L 231 (467)
T KOG0201|consen 166 KR-------RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---RVLF-LIPKS---APPRL 231 (467)
T ss_pred hc-------cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---eEEE-eccCC---CCCcc
Confidence 32 13789999999999999888999999999999999999999999987652 1111 12222 22233
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+++.++++|..||.+||+.||||.+|++ +++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK--h~FIk 267 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK--HKFIK 267 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhh--hHHHH
Confidence 3577999999999999999999999999988 55554
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=319.50 Aligned_cols=262 Identities=20% Similarity=0.254 Sum_probs=195.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCC-----CCcceeec-eeCce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSG-----IPNIKWYG-VDGED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~-----~~~~~~~~-~~~~~ 77 (306)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .......|+.++..+.+.+. +..+..++ ....+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 3578999999999999999999999999999999986432 22345668888888876432 33333333 34467
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCC-------------Ccc
Q 021855 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR-------------KAN 143 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~-------------~~~ 143 (306)
.++++++++++|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||||+|||+...+ +.+
T Consensus 207 ~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 899999999999998876 4569999999999999999999998 5999999999999995211 123
Q ss_pred eEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHH
Q 021855 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223 (306)
Q Consensus 144 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 223 (306)
.+||+|||.+....... ....+|..|+|||++.+..++.++|||||||++|||++|+.||.+.+......
T Consensus 286 ~vkl~DfG~~~~~~~~~----------~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 286 RVRICDLGGCCDERHSR----------TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred eEEECCCCccccCcccc----------ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 59999999875422211 24578999999999999999999999999999999999999998755433333
Q ss_pred HHHHHhhcccc-------------------------cch---------HHHhhcCchHHHHHHHhhhcCCCCCCCChHHH
Q 021855 224 KYDKICEKKVS-------------------------TPI---------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (306)
Q Consensus 224 ~~~~~~~~~~~-------------------------~~~---------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l 269 (306)
.+.+....... .+. .......++.+.+||.+||++||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 22222111000 000 00000114567899999999999999999999
Q ss_pred HHHHHHhHhh
Q 021855 270 KRLFHDLFSR 279 (306)
Q Consensus 270 ~~~l~~~~~~ 279 (306)
++ +.++.+
T Consensus 436 L~--Hp~~~~ 443 (467)
T PTZ00284 436 TT--HPYVLK 443 (467)
T ss_pred hc--Cccccc
Confidence 88 666643
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=283.18 Aligned_cols=267 Identities=19% Similarity=0.211 Sum_probs=208.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeec----eeCce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYG----VDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~----~~~~~ 77 (306)
|-+++|++.+.||.|||+-||++++..++..+|+|.+.... ......+|++..+.+++++.+..+...- .....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 56889999999999999999999999999999999877654 3455888999999999866555543221 12335
Q ss_pred eEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeccCCCcceEEEEeec
Q 021855 78 NVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~Nilv~~~~~~~~~kl~Dfg 151 (306)
.|++++|. .|+|.+.+... +.-+++..++.++.++.+||.+||+.. .+||||||.||+++ +++.++|.|||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~G 174 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLG 174 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEecc
Confidence 78999998 89999988754 234899999999999999999999998 99999999999995 68999999999
Q ss_pred cccccCCCCCCc--cccccCCccccccccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH
Q 021855 152 LAKKYRDPTTNR--HIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (306)
Q Consensus 152 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 226 (306)
++.......... ......+....+|..|+|||.+.-+ ..+.++|||||||++|.|+.|..||..... ...+...
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaL 253 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLAL 253 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEE
Confidence 987644222211 1122233355689999999998744 468899999999999999999999975332 1112222
Q ss_pred HHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.+....+..|.. +.+|+.+.++|+.||++||.+||++.+|+..++.++
T Consensus 254 Av~n~q~s~P~~---~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 AVQNAQISIPNS---SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeeccccccCCC---CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 333334444433 457999999999999999999999999999887654
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=308.07 Aligned_cols=245 Identities=24% Similarity=0.319 Sum_probs=200.4
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCC-ceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~-~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+.-++|++.+.||+|+||.||+|.+..++ ..||+|.+... .....+.+|+.++..+.| +++..+..++..+..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNLYGSFKDESY 105 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCCcceEEEEEeCCE
Confidence 34567999999999999999999876554 68999987532 223456789999999876 566666666677788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeec
Confidence 99999999 7899988876 4568999999999999999999999999999999999999 58899999999999765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+
T Consensus 182 ~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~p 248 (340)
T PTZ00426 182 DTRT----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQKILEGIIYFP 248 (340)
T ss_pred CCCc----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHHHHhcCCCCCC
Confidence 3321 1456899999999999988999999999999999999999999875443 33344444433333
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
...++.+.++|++||+.||.+|+ +++++++
T Consensus 249 -----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 249 -----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred -----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 55688899999999999999995 7888766
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=306.83 Aligned_cols=273 Identities=25% Similarity=0.357 Sum_probs=228.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
+...|++.+.||.|.||.||.++.+.||+.+|+|.+..... .....+|+.+++.+.+|+++..+...+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45689999999999999999999999999999998875533 2467889999999997788888888888888999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC-cceEEEEeeccccccC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYR 157 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~-~~~~kl~Dfg~~~~~~ 157 (306)
+|||++ ||.|.+.+... .+++..+..++.|++.++.|||+.|++||||||+|+|+...+. .+.++++|||++....
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 999999 89999988875 3999999999999999999999999999999999999975543 5689999999998876
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
.... ....+||+.|+|||++....|+..+||||+|+++|.|+.|..||.+.... .....+....+....
T Consensus 191 ~~~~--------~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~---~~~~~i~~~~~~f~~ 259 (382)
T KOG0032|consen 191 PGER--------LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF---EIFLAILRGDFDFTS 259 (382)
T ss_pred CCce--------EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh---HHHHHHHcCCCCCCC
Confidence 5221 23678999999999999999999999999999999999999999986544 344456666654443
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceec
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 293 (306)
+ .+..++..++++|++||..||..|+|+.++++ +.++...+.....+.+-.+.
T Consensus 260 ~-~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~--HpWi~~~~~~~~~~~~~~~~ 312 (382)
T KOG0032|consen 260 E-PWDDISESAKDFIRKLLEFDPRKRLTAAQALQ--HPWIKSIGEATNIPLDISVL 312 (382)
T ss_pred C-CccccCHHHHHHHHHhcccCcccCCCHHHHhc--CccccCCcccccccccchhh
Confidence 3 34777999999999999999999999999999 57776554444444444443
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=300.24 Aligned_cols=261 Identities=21% Similarity=0.277 Sum_probs=203.8
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.+|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+.+|+.+++.+.| +++..+..++..+...++++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCC-CCcceEEEEEeeCCeEEEEEe
Confidence 57999999999999999999999999999999876432 22356789999999977 555556566667778999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
|+.+++.+.+......++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.........
T Consensus 85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCccc-
Confidence 99889998887655568999999999999999999999999999999999999 57899999999998754332211
Q ss_pred cccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc--------
Q 021855 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-------- 234 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 234 (306)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+.......
T Consensus 161 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 161 ------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred ------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 123456889999999875 45889999999999999999999999875543333222222111100
Q ss_pred --------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 235 --------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 235 --------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.+.....+.+++++.++|.+||+.||.+|||+.++++ +.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~ 292 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK--HAYFRSL 292 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc--Chhhhhc
Confidence 0001122356788999999999999999999999987 6666543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=304.37 Aligned_cols=240 Identities=22% Similarity=0.310 Sum_probs=198.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.|++.+.||+|+||.||+|++..+++.||+|++... .....+..|..++..+.|++++..+..++......+++|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478899999999999999999999999999987643 122346678888888888888887877777778899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCc
Confidence 999 7899888765 4569999999999999999999999999999999999999 5889999999999875432221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
......|+..|+|||++.+..++.++||||+||++|+|++|..||.+.... .....+.......+
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~~p----- 221 (323)
T cd05615 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIMEHNVSYP----- 221 (323)
T ss_pred -------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----
Confidence 112456899999999999989999999999999999999999999875443 33344444443333
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCCh
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDY 266 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~ 266 (306)
..+++++.+++.+||+.||.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 4568899999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=279.09 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=217.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
.--++|++++.||+|.||.||+|+.++++-.||+|++..+ .-..++.+|+++...|+| ++|...+.++.+....
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~h-pnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRH-PNILRLYGYFHDSKRI 97 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCC-ccHHhhhhheecccee
Confidence 3446799999999999999999999999999999987643 334568889999999987 6666777888899999
Q ss_pred EEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 79 VLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
|+++||. .|++...+... ...+++...+.++.|+|.||.|+|.++++||||||+|+|++ ..+.+|++|||.+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeec
Confidence 9999999 88888877743 34599999999999999999999999999999999999994 8999999999999765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
... ...+.+||..|.+||+..+...+..+|+|++|++.||++.|..||...+ ....+.++.+.....|
T Consensus 175 p~~---------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~p 242 (281)
T KOG0580|consen 175 PSN---------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKFP 242 (281)
T ss_pred CCC---------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccCC
Confidence 422 2347899999999999999999999999999999999999999998765 3466667777777777
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..++.++.++|.+|+.++|.+|.+..++.+ ..++.
T Consensus 243 -----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~--hpwI~ 277 (281)
T KOG0580|consen 243 -----STISGGAADLISRLLVKNPIERLALTEVMD--HPWIV 277 (281)
T ss_pred -----cccChhHHHHHHHHhccCccccccHHHHhh--hHHHH
Confidence 777999999999999999999999999977 44443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=294.90 Aligned_cols=256 Identities=15% Similarity=0.241 Sum_probs=201.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc---CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+-..+|++.+.||+|+||.||+|.+. ..+..||+|.+...... ..+.+|+..+..+.| +++..+..++.....
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH-SNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEecCCC
Confidence 45678999999999999999999765 45678999988765332 346788999988866 566666666667778
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.+++|||+ +++|.+++......+++..++.++.||+.||.|||++|++||||||+||++ +.++.++++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 99999999 678888887645568999999999999999999999999999999999999 47899999999987543
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
...... ......++..|+|||++.+..++.++|||||||++|++++ |..||...+..... ..+ ......
T Consensus 158 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~---~~~-~~~~~~ 227 (266)
T cd05064 158 KSEAIY------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI---KAV-EDGFRL 227 (266)
T ss_pred cccchh------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HHH-HCCCCC
Confidence 221110 0112234568999999999999999999999999999875 99999876543222 222 222222
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
+. ...++..+.+++.+||+.+|.+|||+++|.+.|+++
T Consensus 228 ~~---~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 PA---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 21 256788999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=309.71 Aligned_cols=258 Identities=20% Similarity=0.330 Sum_probs=201.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcCC-----CceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
.++|++.+.||+|+||.||+|++..+ +..||+|.+...... ..+.+|+.+++.+..|+++..+...+.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 45799999999999999999986443 357999988754332 3467899999999555777777666777778
Q ss_pred eEEEEecc-CCCHHHHHHHhc-----------------------------------------------------------
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR----------------------------------------------------------- 97 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~----------------------------------------------------------- 97 (306)
.+++|||+ +++|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999 889998875421
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccc
Q 021855 98 ----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (306)
Q Consensus 98 ----------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (306)
.++++..++.++.||+.||.|||++|++||||||+|||+ ++++.++|+|||++..........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~---- 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYV---- 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCccee----
Confidence 136778899999999999999999999999999999999 478899999999987654332110
Q ss_pred cCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .+............+ ...++
T Consensus 270 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~~~~---~~~~~ 342 (374)
T cd05106 270 -VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQMSRP---DFAPP 342 (374)
T ss_pred -eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCccCC---CCCCH
Confidence 1112334567999999998899999999999999999997 999998754321 222222222222211 34578
Q ss_pred HHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
++.++|.+||+.||.+|||+.+|++.|++++
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.64 Aligned_cols=261 Identities=19% Similarity=0.297 Sum_probs=203.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+..++|++.+.||+|++|.||++++..++..+|+|.+..... ...+.+|+.+++.+.| +++..+..++......++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEE
Confidence 456899999999999999999999999999999998775432 2457889999999987 555555555666778999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+|||+ +++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCcccccccc
Confidence 99999 7799988876 44689999999999999999999986 69999999999999 4789999999999876543
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh---------
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC--------- 229 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~--------- 229 (306)
... ....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+....
T Consensus 157 ~~~---------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 157 SMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred ccc---------ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence 221 24468899999999999899999999999999999999999997644322111111000
Q ss_pred ------------------------------hcccccchHH-HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 230 ------------------------------EKKVSTPIEV-LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 230 ------------------------------~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
........+. ....+++++.++|.+||+.||++|||+++|++ +.++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~--h~~~~ 305 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN--HTFIK 305 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc--ChHHh
Confidence 0000000000 01245788999999999999999999999987 66665
Q ss_pred hc
Q 021855 279 RE 280 (306)
Q Consensus 279 ~~ 280 (306)
..
T Consensus 306 ~~ 307 (331)
T cd06649 306 RS 307 (331)
T ss_pred hc
Confidence 43
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=303.83 Aligned_cols=235 Identities=18% Similarity=0.289 Sum_probs=191.8
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|+++.+++.||+|++... .....+..|..++..+.+|+++..+..++......+++|||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999987642 222345677788877766788877777777888899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+|||+ +.++.++|+|||++........
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~----- 151 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK----- 151 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC-----
Confidence 788887765 4569999999999999999999999999999999999999 5889999999999875322211
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~ 221 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILNDEVVYP-----TWLSQ 221 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCCH
Confidence 112456899999999999989999999999999999999999999875443 33333433333332 45688
Q ss_pred HHHHHHHhhhcCCCCCCCCh
Q 021855 247 EFASYFHYCQSLTFDQRPDY 266 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rps~ 266 (306)
++.++|.+||+.||.+||++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=302.14 Aligned_cols=272 Identities=21% Similarity=0.296 Sum_probs=209.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+..++|++.+.||.|+||.||++.+..++..+++|.+..... ...+.+|+.++..+.| +++..+..++......++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CcccceeEEEEECCEEEE
Confidence 467899999999999999999999999999999998765432 2457789999999976 556666666667788999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++||+ +++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+|||+ +.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhh
Confidence 99999 7899998876 44688999999999999999999985 79999999999999 4788999999999875533
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH-----------
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK----------- 227 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~----------- 227 (306)
... ....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+..
T Consensus 157 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (333)
T cd06650 157 SMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227 (333)
T ss_pred hcc---------ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence 221 134678899999999988899999999999999999999999976433211111100
Q ss_pred --------------------------HhhcccccchHHH-hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 228 --------------------------ICEKKVSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 228 --------------------------~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
..........+.. ...+++++.++|.+||+.||++|||+.+++. +.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~--h~~~~~~ 305 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV--HAFIKRS 305 (333)
T ss_pred CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh--CHHHhcC
Confidence 0000000000000 0135678999999999999999999999976 7888766
Q ss_pred CCCCCccccce
Q 021855 281 GYDFDFVFDWT 291 (306)
Q Consensus 281 ~~~~~~~~~~~ 291 (306)
.......+.|.
T Consensus 306 ~~~~~~~~~~~ 316 (333)
T cd06650 306 EAEEVDFAGWL 316 (333)
T ss_pred ccccccHHHHH
Confidence 55554455664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.27 Aligned_cols=240 Identities=22% Similarity=0.323 Sum_probs=192.1
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|++..+++.||+|++.... .......|..++....+|+++..+...+......+++|||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999876431 22334556667766666778877777777778899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~----- 151 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEG----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCC-----
Confidence 899888765 4568999999999999999999999999999999999999 5889999999999875432221
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+ ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~ 221 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDSILNDRPHFP-----RWISK 221 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCCCH
Confidence 112456899999999999989999999999999999999999999875543 22333333222222 45688
Q ss_pred HHHHHHHhhhcCCCCCCCChH-HHHH
Q 021855 247 EFASYFHYCQSLTFDQRPDYG-FLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rps~~-~l~~ 271 (306)
++.++|.+||+.||.+||++. ++++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 899999999999999999864 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=295.14 Aligned_cols=253 Identities=19% Similarity=0.240 Sum_probs=194.6
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHh--CCCCCCcceeece-----eCc
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQ--GGSGIPNIKWYGV-----DGE 76 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~--~~~~~~~~~~~~~-----~~~ 76 (306)
+|++.+.||+|++|.||+|++..+++.||+|.+..... .....+|+.+++.+. .|+++..+..++. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999998764322 234567888888775 2455554433322 234
Q ss_pred eeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++|++.++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||.+..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcccc
Confidence 578999999889988887533 348999999999999999999999999999999999999 4889999999999876
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc---
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--- 232 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--- 232 (306)
....... ....++..|+|||++.+..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 158 ~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 158 YSCQMAL--------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccCcccC--------CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 5432211 13457889999999999899999999999999999999999997754433322222211100
Q ss_pred ----------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 ----------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ----------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...+.....+.+++.+.++|.+||+.||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 011112233456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=304.28 Aligned_cols=240 Identities=20% Similarity=0.290 Sum_probs=195.7
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|++..+++.||+|++... .....+..|..++..+.+|+++..+...+......+++|||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999987643 122345678888887777788888877777888899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.........
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~---- 152 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVT---- 152 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCcc----
Confidence 788877765 4568999999999999999999999999999999999999 58899999999998754322211
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~~~ 221 (321)
T cd05591 153 ---TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFESILHDDVLYP-----VWLSK 221 (321)
T ss_pred ---ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCCCH
Confidence 12456899999999999989999999999999999999999999876543 33334433333332 45688
Q ss_pred HHHHHHHhhhcCCCCCCC-------ChHHHHH
Q 021855 247 EFASYFHYCQSLTFDQRP-------DYGFLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rp-------s~~~l~~ 271 (306)
++.++|.+||+.||++|| +++++++
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 999999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=304.28 Aligned_cols=237 Identities=24% Similarity=0.327 Sum_probs=190.7
Q ss_pred ecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 15 IGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
||+|+||.||+|++..+++.||+|++... .....+.+|+.++..+.| +++..+...+......++++||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC-PFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 69999999999999999999999987642 222346778899999876 55555555566777899999999 889
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccccc
Q 021855 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (306)
Q Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (306)
|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence 9888875 4568999999999999999999999999999999999999 5889999999999875322211
Q ss_pred CCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHH
Q 021855 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (306)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (306)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+ ..+++.+
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~-----~~~~~~~ 220 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMYRKILQEPLRFP-----DGFDRDA 220 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCCCCCC-----CcCCHHH
Confidence 112456899999999999999999999999999999999999999875432 33344444333333 5678899
Q ss_pred HHHHHhhhcCCCCCCCC---hHHHHH
Q 021855 249 ASYFHYCQSLTFDQRPD---YGFLKR 271 (306)
Q Consensus 249 ~~li~~cl~~dP~~Rps---~~~l~~ 271 (306)
.++|.+||+.||.+||+ +.+++.
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 99999999999999985 455544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.19 Aligned_cols=240 Identities=21% Similarity=0.320 Sum_probs=192.2
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|++..+++.||+|++... ........|..++....+++++..+...+......+++|||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999987643 222345667777776666788877777777788999999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC-----
Confidence 788888765 4568999999999999999999999999999999999999 5788999999999864322111
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+ ..+++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~~~~~~~-----~~~~~ 221 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRVDTPHYP-----RWITK 221 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----CCCCH
Confidence 112456899999999999999999999999999999999999999875443 22333222222222 45688
Q ss_pred HHHHHHHhhhcCCCCCCCCh-HHHHH
Q 021855 247 EFASYFHYCQSLTFDQRPDY-GFLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rps~-~~l~~ 271 (306)
++.++|.+||+.||++||++ +++++
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 99999999999999999987 46653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=308.02 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=200.6
Q ss_pred CCceeEeeeecccCccEEEEEEE-----cCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~-----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
.++|++.+.||+|+||.||+|++ ..++..||+|++..... ...+.+|+.++..+.+|+++..+..++.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999974 34567899998875432 23577899999999666777777777777888
Q ss_pred eEEEEecc-CCCHHHHHHHhc-----------------------------------------------------------
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR----------------------------------------------------------- 97 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~----------------------------------------------------------- 97 (306)
.+++|||+ +|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999 889988875421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 98 ---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 98 ---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
..+++..+..++.||+.||.|||+.|++||||||+|||+ +.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcccc
Confidence 136778889999999999999999999999999999999 47889999999998765432211
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .+.+..........+
T Consensus 271 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~~~~--- 339 (375)
T cd05104 271 V-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMIKEGYRMLSP--- 339 (375)
T ss_pred c-----ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHHHhCccCCCC---
Confidence 0 1112334567999999999999999999999999999998 899997654321 222222222222111
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
...+.++.++|.+||+.||++|||+.+|++.|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 34578899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.72 Aligned_cols=239 Identities=22% Similarity=0.318 Sum_probs=192.5
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||++++..+|+.||+|++.... ....+.+|+.+++.+.| +++..+...+......+++|||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCEEEEEEeCCCC
Confidence 46899999999999999999999999876431 22345678889988876 55666666666777899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~---- 151 (323)
T cd05595 80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGAT---- 151 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCc----
Confidence 788777765 4568999999999999999999999999999999999999 58899999999998653222211
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+.......+ ..+++
T Consensus 152 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~~~~~~~~p-----~~~~~ 220 (323)
T cd05595 152 ---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEEIRFP-----RTLSP 220 (323)
T ss_pred ---cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCCH
Confidence 12456899999999999999999999999999999999999999765433 22333333333333 55688
Q ss_pred HHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 247 EFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
++.++|.+||+.||.+|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 999999999999999998 7887765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=305.97 Aligned_cols=259 Identities=22% Similarity=0.256 Sum_probs=195.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeecee-----
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVD----- 74 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~----- 74 (306)
.+.++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+|+.+++.+.|++.+..+..+...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35678999999999999999999999999999999886432 234567899999999875554444333222
Q ss_pred CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
....++++||+++++...+. ..++...+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCcc
Confidence 13579999999888877764 348889999999999999999999999999999999999 588999999999987
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh----
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE---- 230 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~---- 230 (306)
....... .....++..|+|||++.+..++.++|||||||++|+|++|..||.+.+.............
T Consensus 172 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 172 TACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred ccccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 5432211 1244678899999999999999999999999999999999999987554322211111110
Q ss_pred ---------------cccccc---hHH------------HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 231 ---------------KKVSTP---IEV------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 231 ---------------~~~~~~---~~~------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.....+ ... .....++.+.++|.+||+.||++|||++++++ +.++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~ 319 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR--HPYIT 319 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc--Cchhh
Confidence 000000 000 00123567899999999999999999999987 44443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.72 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=197.4
Q ss_pred ceeEeeeecccCccEEEEEEEc---CCCceEEEEEccCC------CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+|++.+.||+|+||.||++++. .+++.||+|++... .....+..|+.++..+.+++++..+...+......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47899999987632 12234667889999998888888887777778889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+++|||+ +++|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 9999999 7799888765 4568999999999999999999999999999999999999 578999999999987643
Q ss_pred CCCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHH-HHHhhccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKVST 235 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~ 235 (306)
..... ......|+..|+|||++.+.. ++.++|||||||++|+|++|..||...........+ ..+.......
T Consensus 157 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd05614 157 SEEKE------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230 (332)
T ss_pred ccCCC------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 32211 112456899999999998754 788999999999999999999999754332222222 2222222222
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
+ ..+++.+.++|.+||+.||++|| +++++++
T Consensus 231 ~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 231 P-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred C-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 2 45688999999999999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=301.64 Aligned_cols=243 Identities=22% Similarity=0.316 Sum_probs=192.7
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHh--CCCCCCcceeeceeCceeEEE
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~~lv 81 (306)
|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+|..++..+. .|+++..+..++......+++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999876431 2234556666654443 246666666677778889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|...+. ...+++..+..++.||+.||.|||++|++||||||+||++ +.++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999 778877665 3469999999999999999999999999999999999999 588999999999986432221
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+
T Consensus 156 ~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~~~~~p---- 221 (324)
T cd05589 156 D-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFDSIVNDEVRYP---- 221 (324)
T ss_pred C-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC----
Confidence 1 112456899999999999999999999999999999999999999875443 23333333333333
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
..+++.+.++|.+||+.||.+|| ++.++++
T Consensus 222 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 222 -RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 45688999999999999999999 4556554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=303.69 Aligned_cols=239 Identities=22% Similarity=0.327 Sum_probs=192.8
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||++++..+++.||+|++.... ....+.+|+.+++.+.| +++..+...+......+++|||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999876432 22346778888888876 56666666667778899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc-----
Confidence 788877765 4568999999999999999999999999999999999999 5889999999999875322211
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+.......+ ..+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~~p-----~~~~~ 220 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEDIKFP-----RTLSA 220 (328)
T ss_pred --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHhccCCccCC-----CCCCH
Confidence 112456899999999999989999999999999999999999999865432 22223322222222 55688
Q ss_pred HHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 247 EFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
++.++|++||+.||.+|+ ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 999999999999999997 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=300.47 Aligned_cols=240 Identities=22% Similarity=0.304 Sum_probs=194.8
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|++..+++.||+|++... .....+..|..++..+.+|+++..+...+......+++|||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999987643 222345678888888877788888877777788899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|...+.. ...+++..+..++.||+.||.|||++|++||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV----- 151 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC-----
Confidence 888887765 4569999999999999999999999999999999999999 5889999999999865322211
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
......++..|+|||++.+..++.++|+|||||++|+|++|..||.+.+.. .....+.......+ ..+++
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~ 221 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQSILEDEVRYP-----RWLSK 221 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCCCC-----CcCCH
Confidence 112446889999999999999999999999999999999999999865432 22333333333322 45688
Q ss_pred HHHHHHHhhhcCCCCCCCCh-----HHHHH
Q 021855 247 EFASYFHYCQSLTFDQRPDY-----GFLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rps~-----~~l~~ 271 (306)
.+.++|.+||+.||.+|||+ .++++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 99999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=299.72 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=192.0
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|++..+++.||+|++... ........|..++....+|+++..+...+......+++|||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999987643 222345567777776666777777777777788899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||+ +.++.++|+|||++........
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDA----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCC-----
Confidence 899888875 4568999999999999999999999999999999999999 5789999999999865322111
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
......|+..|+|||++.+..++.++||||+||++|+|++|..||.+.+.. .....+.......+ ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~ 221 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIRMDNPCYP-----RWLTR 221 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----ccCCH
Confidence 112456889999999999989999999999999999999999999875443 22222222222222 45678
Q ss_pred HHHHHHHhhhcCCCCCCCChH-HHHH
Q 021855 247 EFASYFHYCQSLTFDQRPDYG-FLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rps~~-~l~~ 271 (306)
++.++|.+||+.||.+||++. ++..
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 899999999999999999986 6644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=295.73 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=209.2
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch-----hhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
..+|++.+.||+|.||.|-+|+....|+.||||.+..+.... ...+|+.++..|+| ++|..++..+.+.+..+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNH-PhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNH-PHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCC-CceeehhhhhcCCceEEE
Confidence 457999999999999999999988899999999877654332 36789999999988 556566666777788999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
||||. +|.|.+++.. .+.+++.++..+++||..|+.|+|+++++|||||.+|||+ |.++++||+|||++..+...
T Consensus 131 vMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhccc
Confidence 99999 9999999998 4579999999999999999999999999999999999999 79999999999999776554
Q ss_pred CCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.. ..+++|++-|.+||++.|.+| ++.+|-||||++||.|..|..||.+.+.. ..+.++-.+-+..|
T Consensus 207 kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQIs~GaYrEP-- 273 (668)
T KOG0611|consen 207 KF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQISRGAYREP-- 273 (668)
T ss_pred cH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHhhcccccCC--
Confidence 32 247899999999999999997 79999999999999999999999986543 44455544444443
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
.-|.+..-||+-||.+||++|.|+.+|...
T Consensus 274 ----~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 ----ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ----CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 336778999999999999999999998763
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=288.98 Aligned_cols=257 Identities=20% Similarity=0.328 Sum_probs=203.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+...+|.+.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+|+.++..+.|. ++..+...+......++++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP-NLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCC-ChhheEEEEcCCCCcEEEE
Confidence 345679999999999999999999998999999998775432 34578899999998874 4545555555667789999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||++ ++++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccce
Confidence 998 789999886533 348899999999999999999999999999999999999 488999999999987654432
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
... ......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.... ... ........
T Consensus 159 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~-~~~~~~~~--- 225 (263)
T cd05052 159 YTA------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YEL-LEKGYRME--- 225 (263)
T ss_pred eec------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH-HHCCCCCC---
Confidence 211 112233567999999999899999999999999999998 9999987543322 222 22222221
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
....+|+.+.++|.+||+.||++|||+.++++.|+.++
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 22556889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=318.29 Aligned_cols=269 Identities=19% Similarity=0.221 Sum_probs=213.1
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCccee-e-ce----e-Cc
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKW-Y-GV----D-GE 76 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~-~-~~----~-~~ 76 (306)
.-+++|.+.|.+|||+.||+|++...+..||+|++...... ....+|+.+++.|.+|++|+.+.. . .. . ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45678999999999999999999888799999987765322 346789999999998887766543 1 11 1 24
Q ss_pred eeEEEEecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 77 DNVLVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
+..|.|||| +|+|.+++.. ....|++.++++|+.|+++|+.+||... |+|||||-+|||+ ..+|.+||||||+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcccc
Confidence 578999999 5899999873 3455999999999999999999999987 9999999999999 4899999999999
Q ss_pred ccccC-CCCCCcccc-ccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 021855 153 AKKYR-DPTTNRHIP-YRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 153 ~~~~~-~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (306)
+.--. .+....... ....-....|+.|+|||++. +.+.+.|+|||+|||+||.||....||.... -.+
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------~la 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------KLA 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------cee
Confidence 86422 221111110 01111335789999999875 6778999999999999999999999998632 225
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCcc
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFV 287 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~ 287 (306)
|+...+..|.. ++++..+++||+.||+.||.+||++-+++..+-++........+..
T Consensus 266 Ilng~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 266 ILNGNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred EEeccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 66777776643 6788999999999999999999999999999998887655555554
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=301.42 Aligned_cols=238 Identities=20% Similarity=0.306 Sum_probs=191.0
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|++..+++.||+|++.... ....+..|..++..+.+|+++..+...+......+++|||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999887432 12336678888888877788888877777888899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||+ +.++.++|+|||++........
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC-----
Confidence 788877765 4579999999999999999999999999999999999999 5789999999999864322211
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhh------hhHHHHHHHhhcccccchHHH
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 240 (306)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||...... ........+.......+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p---- 225 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP---- 225 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----
Confidence 112457899999999999999999999999999999999999999632111 11122233333333333
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCCh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDY 266 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~ 266 (306)
..++..+.++|.+||+.||.+|+|+
T Consensus 226 -~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 226 -RSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred -CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 5568889999999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=300.23 Aligned_cols=262 Identities=21% Similarity=0.322 Sum_probs=201.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcce-eecee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIK-WYGVD 74 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~-~~~~~ 74 (306)
+.+++|++.+.||.|+||.||+|++. .+++.||+|++...... ..+.+|+.++.++.+|+++..+. .+...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 45679999999999999999999753 34578999988754332 34667999999996556655554 44445
Q ss_pred CceeEEEEecc-CCCHHHHHHHhc--------------------------------------------------------
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCR-------------------------------------------------------- 97 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~-------------------------------------------------------- 97 (306)
+...++++||+ +++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 56788999999 789988875321
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccc
Q 021855 98 ----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173 (306)
Q Consensus 98 ----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (306)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++......... ......
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~ 235 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKGDA 235 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcch-----hhccCC
Confidence 257888999999999999999999999999999999999 57889999999999765332211 011233
Q ss_pred cccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHH
Q 021855 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYF 252 (306)
Q Consensus 174 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (306)
.++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+ .............. ....++++.+++
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~l~ 309 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKEGTRMRA---PEYATPEIYSIM 309 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhccCCCCC---CccCCHHHHHHH
Confidence 45678999999999999999999999999999998 999997643221 11122222211111 134578899999
Q ss_pred HhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 253 HYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 253 ~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.+||+.+|++||++.+|++.|++++..
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=292.74 Aligned_cols=247 Identities=20% Similarity=0.194 Sum_probs=195.0
Q ss_pred ceeEe--eeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhCCCCCCcceeecee----Cc
Q 021855 8 KYKLG--RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVD----GE 76 (306)
Q Consensus 8 ~y~i~--~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~ 76 (306)
+++.. ..++.|+++.||+|.+ +|+.||+|.+...... ..+.+|+.++.++.|+ ++..+..++.+ ..
T Consensus 19 ~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 19 DIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDLP 95 (283)
T ss_pred HcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCC-CEEEEeeeEEecccCCC
Confidence 34444 6789999999999987 6889999988754322 3456899999999886 44444443333 34
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
..++++||+ +|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||++ ++++.+||+|||++.
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEK 171 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHh
Confidence 678999999 7899999876 45688999999999999999999985 99999999999999 578999999999987
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
....... ...++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.. .....+....
T Consensus 172 ~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~i~~~~ 238 (283)
T PHA02988 172 ILSSPPF----------KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDLIINKN 238 (283)
T ss_pred hhccccc----------cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcC
Confidence 6543221 3356889999999976 67899999999999999999999999875433 2233333222
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
...+.+ ..+++.+.++|.+||+.||++|||++++++.|+.+-
T Consensus 239 ~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 NSLKLP---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCC---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 222211 356889999999999999999999999999998764
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=302.88 Aligned_cols=257 Identities=19% Similarity=0.239 Sum_probs=195.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeece-----eC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~ 75 (306)
+.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.+.|.+.+.....+.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999999999999999887532 22456788999999887555544433322 22
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...+++|||+.+++...+.. .++...+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccc
Confidence 45799999999888887743 47889999999999999999999999999999999999 4789999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc---
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--- 232 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--- 232 (306)
....... ....++..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 176 ~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 176 AGTSFMM--------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred cCCCCcc--------cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 4332211 24467899999999999999999999999999999999999998755433222221111100
Q ss_pred ----------------cccc---hH------------HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 233 ----------------VSTP---IE------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 233 ----------------~~~~---~~------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.... .. ......++.+.++|.+||+.||.+|||++++++ +.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~--hp~~ 321 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--HPYI 321 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc--Cccc
Confidence 0000 00 000112456899999999999999999999987 4444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=294.41 Aligned_cols=261 Identities=20% Similarity=0.256 Sum_probs=202.9
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||.|++|.||+|++..+++.||+|.+.... ....+.+|+.+++.+.| +++..+...+......++++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCC-CCcceEEEEEecCCeEEEEEe
Confidence 57999999999999999999999999999999876432 22356789999999987 555556566667778999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
|+.++|.+.+......+++..+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||.+.....+...
T Consensus 85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCCCc-
Confidence 99989998887656678999999999999999999999999999999999999 57899999999998754332211
Q ss_pred cccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc--------
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-------- 234 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 234 (306)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.........
T Consensus 161 ------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 161 ------YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred ------ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 1234568889999998764 4788999999999999999999999875543322222221111000
Q ss_pred --------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 235 --------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 235 --------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.........+++.+.++|.+||+.||.+|||++++++ +.++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~--h~~f~~~ 292 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK--HPYFHCL 292 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc--Ccccccc
Confidence 0011222456888999999999999999999999977 5555433
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=306.84 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=200.7
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|++|.||+|++..+++.||+|++... .....+.+|+.++..+.| +++..+...+.+....+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCC-CCccchhhheecCCeEEEE
Confidence 4799999999999999999999999999999987643 223356778888988876 5555565566677889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccC
Confidence 9999 78999988763 579999999999999999999999999999999999999 588999999999987654432
Q ss_pred CCc----------------------cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchh
Q 021855 161 TNR----------------------HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (306)
Q Consensus 161 ~~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~ 218 (306)
... ...........|++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 000 0000112245689999999999999999999999999999999999999987554
Q ss_pred hhhHHHHHHHhh--cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCC-hHHHHH
Q 021855 219 ATKKQKYDKICE--KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKR 271 (306)
Q Consensus 219 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~l~~ 271 (306)
. ....++.. .....+.. ..+++++.++|.+||+ ||.+||+ ++++++
T Consensus 236 ~---~~~~~i~~~~~~~~~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 236 Q---ETYNKIINWKESLRFPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred H---HHHHHHhccCCcccCCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 3 22223322 12222211 2368899999999998 9999998 999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=302.04 Aligned_cols=259 Identities=21% Similarity=0.321 Sum_probs=198.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeece-----eC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~ 75 (306)
+.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.+.|.+.+..+..+.. ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 56789999999999999999999999999999998765422 2346679999999987554443332221 12
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++++++++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++..
T Consensus 93 ~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcccee
Confidence 3568999999999988775 3469999999999999999999999999999999999999 4889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc-
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV- 233 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~- 233 (306)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 168 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 168 ADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred cCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 54322 14467899999999877 4689999999999999999999999976443222222111111000
Q ss_pred ----------------------ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 234 ----------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 234 ----------------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...........++.+.++|.+||+.||.+|||+.++++ +.++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~--hp~~~~~ 304 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA--HPYFSQY 304 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc--Ccchhcc
Confidence 00011112345667899999999999999999999987 6666543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=300.43 Aligned_cols=238 Identities=21% Similarity=0.315 Sum_probs=189.8
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|++..+++.||+|++.... ....+..|..++..+.+|+++..+..++......++++||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999877532 11235667888887767788888877777888999999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~----- 151 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC-----
Confidence 788777765 4569999999999999999999999999999999999999 5889999999999865322211
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhh------hhHHHHHHHhhcccccchHHH
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 240 (306)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... ........+.......+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---- 225 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---- 225 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----
Confidence 112456899999999999999999999999999999999999999532111 11112233333333333
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCCh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDY 266 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~ 266 (306)
...+..+.++|.+||+.||.+||++
T Consensus 226 -~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 -RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 5568889999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=303.48 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=203.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-CCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
+-+..|++.++||+||.+.||++..... +.+|+|..... .+. ..+.+|+..|.+|.++..+..+..|...++..|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 4578899999999999999999986543 45566644332 222 358899999999999988888899999999999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|||+=..+|..++......++.-.+..+..||+.|+.+.|..||||.||||.|+|+ -.|.+||+|||.|.-....
T Consensus 437 mvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 437 MVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcc
Confidence 999999999999998755545545788899999999999999999999999999999 7899999999999887776
Q ss_pred CCCccccccCCccccccccccCcccccCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-----------QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 228 (306)
.+... ...-+||+.|||||.++... .+.+|||||||||||+|+.|+.||.... +....+..+
T Consensus 513 TTsI~-----kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI 585 (677)
T KOG0596|consen 513 TTSIV-----KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI 585 (677)
T ss_pred cccee-----eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh
Confidence 66431 22558999999999986432 4678999999999999999999998643 234555555
Q ss_pred hhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.......+.+...+ ..++.++++.||++||.+|||..+|+.
T Consensus 586 ~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 55444333333222 123999999999999999999999977
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=312.94 Aligned_cols=254 Identities=24% Similarity=0.245 Sum_probs=196.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeecee-----
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVD----- 74 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~----- 74 (306)
..+++|.+.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.++..+.|.+.+.....+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 4578999999999999999999999999999999988654332 2356677777777664443322222111
Q ss_pred --CceeEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEE
Q 021855 75 --GEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (306)
Q Consensus 75 --~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~ 148 (306)
....++++||+ +++|.+.+... ...+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEE
Confidence 11367999999 78999888642 2458899999999999999999999999999999999999 478999999
Q ss_pred eeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 021855 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (306)
Q Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 228 (306)
|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+...
T Consensus 186 DFGls~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDD-----VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHKT 257 (496)
T ss_pred ecccCeecccccccc-----ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH
Confidence 999987654322111 112457899999999999999999999999999999999999999875432 223333
Q ss_pred hhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
....... ....+++++.+++.+||+.||.+||++.++++.
T Consensus 258 ~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRYDP----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCCCC----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 3222211 225678899999999999999999999998764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=306.19 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=206.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
|..+...+...||+|.||+||+|+|- -.||||+++-.... +.|.+|+.+++.-+|.| |..+..+...... .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N-IlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN-ILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh-heeeehhhcCCce-e
Confidence 45566788999999999999999994 35999998865443 45888999999988855 4444444444444 9
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
|++.+| |.+|..++......++......|++||+.|+.|||.++|+|+|||..|||+ ++++.|||+|||++..-.-
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeee
Confidence 999999 668888887666679999999999999999999999999999999999999 5779999999999854322
Q ss_pred CCCCccccccCCccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
..... ......+...|||||++.. .+|++.||||||||++|||++|..||.... ..+.+.....+....
T Consensus 541 w~g~~-----q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~---~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 541 WSGEQ-----QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN---RDQIIFMVGRGYLMP 612 (678)
T ss_pred ecccc-----ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC---hhheEEEecccccCc
Confidence 21111 2235678889999999863 468999999999999999999999998432 234444444443334
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.......+++.++++|+..||..+|++||.+.+|+..|++++..
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 44445577888999999999999999999999999999988864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=300.23 Aligned_cols=253 Identities=20% Similarity=0.231 Sum_probs=193.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeece-----eC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~ 75 (306)
+.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.+.|.+.+..+..+.. ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 46789999999999999999999998999999998875432 2346678999999887555544433322 22
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++||+.+++.+.+.. .++...+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++..
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCccccc
Confidence 35799999998888877643 48889999999999999999999999999999999999 5789999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc----
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK---- 231 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---- 231 (306)
...... .....++..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..............
T Consensus 169 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 169 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred CCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 433221 12456789999999999989999999999999999999999999875432221111111100
Q ss_pred ---------------cccc-----c----------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 232 ---------------KVST-----P----------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 232 ---------------~~~~-----~----------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.... + ........+..+.++|.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000 0 00001123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=305.36 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=197.9
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+...+......+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN-PWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999999999999999886431 22345678999998875 6666666677778899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence 9999 7889888875 4569999999999999999999999999999999999999 589999999999987543221
Q ss_pred CCccc-----------------cc--------------cCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhC
Q 021855 161 TNRHI-----------------PY--------------RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 209 (306)
Q Consensus 161 ~~~~~-----------------~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg 209 (306)
..... +. .......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 10000 00 000124689999999999998999999999999999999999
Q ss_pred CCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCC---hHHHHH
Q 021855 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKR 271 (306)
Q Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~l~~ 271 (306)
..||...+... ....+.........+. ...+++.+.++|.+||. +|.+|++ +++++.
T Consensus 236 ~~Pf~~~~~~~---~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQE---TYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHH---HHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99998755432 2222222211111111 12457899999999997 9999998 888866
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=299.69 Aligned_cols=236 Identities=23% Similarity=0.320 Sum_probs=185.9
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHH-HHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~-l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+.||+|+||.||+|++..+++.||+|++.... .......|... ++.+.| +++..+...+......++++||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH-PFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCC-CCCCceeEEEEcCCeEEEEEeCCC
Confidence 46899999999999999999999999876431 11233344443 444544 66666766677778899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC----
Confidence 7788888765 4568889999999999999999999999999999999999 5789999999999875332211
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCc
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (306)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.. ..+..+.......+ +.++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~ 220 (325)
T cd05602 152 ---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNKPLQLK-----PNIT 220 (325)
T ss_pred ---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHHHhCCcCCC-----CCCC
Confidence 112456899999999999999999999999999999999999999875443 22333333322222 5678
Q ss_pred hHHHHHHHhhhcCCCCCCCChHH
Q 021855 246 AEFASYFHYCQSLTFDQRPDYGF 268 (306)
Q Consensus 246 ~~~~~li~~cl~~dP~~Rps~~~ 268 (306)
+.+.++|.+||+.||.+||++.+
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCC
Confidence 89999999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=304.01 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=199.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
-.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+...+..+...+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h-~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS-EWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCEEE
Confidence 356899999999999999999999999999999987532 122345678888888876 55666666667778899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||.+.....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccC
Confidence 999999 8899988764 358899999999999999999999999999999999999 5899999999999876543
Q ss_pred CCCCccccccCCccccccccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
.... ......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.. ..+..+......
T Consensus 195 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~ 265 (370)
T cd05596 195 NGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMDHKNS 265 (370)
T ss_pred CCcc------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCCCc
Confidence 2211 11245689999999998754 3788999999999999999999999875543 233343332211
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCC--CCChHHHHH
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 271 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~ 271 (306)
...+. ...+|.++.++|.+||+.+|.+ |+|++++++
T Consensus 266 ~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 266 LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 11111 1356889999999999999987 999999977
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=302.60 Aligned_cols=258 Identities=20% Similarity=0.267 Sum_probs=196.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCc-----ee
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-----DN 78 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-----~~ 78 (306)
+|++.+.||+|+||.||+|++..+++.||+|.+..... ...+.+|+.+++.+.|.+.+..+.. ..... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI-LQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhhe-ecCCCccccceE
Confidence 47899999999999999999999999999998764322 2356789999999987554444433 33333 68
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++++||+.++|.+.+.. ...+++..+..++.||+.||.|||+.|++||||||+|||+ +.++.+||+|||++.....
T Consensus 80 ~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeeccc
Confidence 99999999898888764 4568999999999999999999999999999999999999 5889999999999876433
Q ss_pred CCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc------
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK------ 231 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~------ 231 (306)
.... ......++..|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 156 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 156 DESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred Cccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 2211 111345688999999998754 789999999999999999999999876544333222221110
Q ss_pred --------------ccccc-hH---HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 232 --------------KVSTP-IE---VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 232 --------------~~~~~-~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
....+ .. ......++++.++|.+||+.||.+|||+.++++ +.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~ 292 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA--HPYLD 292 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc--CHhhC
Confidence 00000 00 112345778999999999999999999999977 44443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.72 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=200.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCC-----ceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~-----~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
.-.+|++.+.||.|++|.||+|.+...+ ..|++|.+..... ...+.+|+.++..+.| +++..+..+.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH-PNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCC-cccceEEEEEcCCC
Confidence 3457999999999999999999876544 6799998765432 2346789999998876 45555555555667
Q ss_pred eeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~ 140 (306)
..++++||+ +++|.+++.... ..++...++.++.|++.||.|||++|++|+||||+||++ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence 789999999 789998887531 347888999999999999999999999999999999999 4
Q ss_pred CcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhh
Q 021855 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAA 219 (306)
Q Consensus 141 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~ 219 (306)
+++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYY-----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233 (283)
T ss_pred CCCcEEECCCcceeeccccccc-----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 7889999999998754332211 01123355788999999998899999999999999999998 99999876543
Q ss_pred hhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 220 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
. ....+.... ..+ ....+|+.+.+|+.+||+.||.+||++.+|++.|+++
T Consensus 234 ~---~~~~i~~~~-~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 E---VIEMIRSRQ-LLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H---HHHHHHcCC-cCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2 222222222 111 1256789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=286.04 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=198.6
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
..+|++.+.||+|++|.||++.. .+..+++|..........+.+|+.+++++.|.+.+.....+.......++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35799999999999999999976 4778999988766666678899999999987555554444444556789999999
Q ss_pred -CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 86 -GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 86 -~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||++ ++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~-- 157 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccCC--
Confidence 6799998875433 37899999999999999999999999999999999999 4889999999999875433221
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
....+..|+|||++.+..++.++|||||||++|+|++ |+.||........ . ..+....... ...
T Consensus 158 --------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~-~~~~~~~~~~---~~~ 222 (256)
T cd05082 158 --------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V-PRVEKGYKMD---APD 222 (256)
T ss_pred --------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---H-HHHhcCCCCC---CCC
Confidence 2234567999999998889999999999999999998 9999976443221 1 1122222211 124
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
.+++.+.++|.+||+.+|++|||+.++++.|+++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 5688999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=287.70 Aligned_cols=262 Identities=21% Similarity=0.279 Sum_probs=201.5
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCc----eEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
|+-+...+|++.+.||+|+||.||+|++..++. .||+|++..... ...+.+|..++..+.| +++..+..++.
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~ 79 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVCRLLGICL 79 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCC-CCCceEEEEEc
Confidence 566778899999999999999999999876665 478998765433 2346678888888776 44444444333
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
. ...+++++++ +++|.+++......+++..+..++.||+.||.|||++|++||||||+||+++ +++.++|+|||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~ 155 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGL 155 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCc
Confidence 3 3467889888 7899988876455689999999999999999999999999999999999994 788899999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhc
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
++.......... .....++..|+|||...+..++.++|||||||++|||++ |..||......... .....
T Consensus 156 ~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----~~~~~ 226 (279)
T cd05109 156 ARLLDIDETEYH-----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP----DLLEK 226 (279)
T ss_pred eeecccccceee-----cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHC
Confidence 986643322110 012234567999999998889999999999999999998 99999765432222 22222
Q ss_pred ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
....+.+ ..++.++.+++.+||+.||++||++.++++.|+++...
T Consensus 227 ~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 227 GERLPQP---PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCcCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 2222211 45678999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=301.16 Aligned_cols=239 Identities=22% Similarity=0.318 Sum_probs=191.5
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||++++..+++.||+|++.... ....+.+|+.++..+.| +++..+...+......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999876431 12345667888887766 56666666667778899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
++|...+.. ...+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~--- 152 (325)
T cd05594 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGAT--- 152 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcc---
Confidence 788777765 4568999999999999999999997 799999999999999 58899999999998653322111
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCc
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (306)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+ ..++
T Consensus 153 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~~ 220 (325)
T cd05594 153 ----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRFP-----RTLS 220 (325)
T ss_pred ----cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCC
Confidence 12456899999999999999999999999999999999999999775432 22333333333332 4568
Q ss_pred hHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 246 AEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 246 ~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
+++.++|.+||+.||.+|+ ++.++++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 8999999999999999997 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=291.37 Aligned_cols=248 Identities=19% Similarity=0.254 Sum_probs=195.6
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ....+.+|+.+++.+.| +++..+...+......+++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCC-CCEeeeeeeecCCCeEEEEE
Confidence 4899999999999999999998899999999876432 12345679999999976 44544555555667899999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+.+.... ..+++..+..++.|++.||.|||+.|++||||||+||++ ++++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999 788887775433 358999999999999999999999999999999999999 578999999999987643222
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. ....++..|+|||++.+..++.++||||+||++|+|++|..||.+.........+........ ...
T Consensus 157 ~~--------~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~ 224 (285)
T cd05605 157 TI--------RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----EEY 224 (285)
T ss_pred cc--------ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----ccc
Confidence 11 134678999999999988899999999999999999999999987554333222222222111 112
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
...+++.+.++|.+||+.||.+|| +++++++
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 245688999999999999999999 7777755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=297.69 Aligned_cols=235 Identities=24% Similarity=0.334 Sum_probs=185.7
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHH-HHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~-l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+.||+|+||.||+|++..+++.||+|++.... ....+..|... ++.+.| +++..+...+......+++|||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCC-CCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46899999999999999999999999876431 11233444443 444554 66666666666778899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCC----
Confidence 7788887765 4568999999999999999999999999999999999999 5889999999999865322111
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCc
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (306)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+.......+ +..+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~ 220 (323)
T cd05575 152 ---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNILNKPLRLK-----PNIS 220 (323)
T ss_pred ---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCCC
Confidence 112456899999999999999999999999999999999999999875432 33333333333222 5568
Q ss_pred hHHHHHHHhhhcCCCCCCCChH
Q 021855 246 AEFASYFHYCQSLTFDQRPDYG 267 (306)
Q Consensus 246 ~~~~~li~~cl~~dP~~Rps~~ 267 (306)
+.+.++|.+||+.||.+||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCC
Confidence 8999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=289.57 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=198.5
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
.+...++|++.+.||+|++|.||+|++..+++.|++|+...... ...+.+|+.++..+.|++ +..+...+......+
T Consensus 4 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~-ii~~~~~~~~~~~~~ 82 (267)
T cd06646 4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN-IVAYFGSYLSREKLW 82 (267)
T ss_pred ccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCC-eeeeeEEEEeCCEEE
Confidence 45567889999999999999999999988999999998765432 234667889998887754 444545556677889
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++||+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||++ +.++.++|+|||++.....
T Consensus 83 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecc
Confidence 999999 6788888765 4568999999999999999999999999999999999999 4788999999999976543
Q ss_pred CCCCccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
.... .....++..|+|||.+. ...++.++|+||+||++|+|++|..||......... ..........
T Consensus 159 ~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~ 228 (267)
T cd06646 159 TIAK-------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FLMSKSNFQP 228 (267)
T ss_pred cccc-------cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---eeeecCCCCC
Confidence 2211 12446788999999885 344788999999999999999999999764432111 1111112221
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
+.......++..+.++|.+||+.||++|||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1111124567899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.97 Aligned_cols=239 Identities=20% Similarity=0.296 Sum_probs=192.0
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|++..+++.||+|++..... ...+.+|..++.++.+++++..+..++......+++|||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999998875321 2346678888888887788888877777888899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGD----- 151 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCC-----
Confidence 888877765 4569999999999999999999999999999999999999 5889999999999875322211
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhh----hhHHHHHHHhhcccccchHHHhh
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ........+.......+ .
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p-----~ 224 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP-----R 224 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC-----C
Confidence 112456899999999999999999999999999999999999999643211 11122333333333332 4
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYG 267 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~ 267 (306)
.++..+.++|.+||+.||.+|+++.
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 5688899999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=302.46 Aligned_cols=260 Identities=18% Similarity=0.222 Sum_probs=200.4
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc--CCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++..+|++.+.||.|++|.||++... .++..|++|.+... ....+|+.+++.+.| +++..+...+......+++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISH-RAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCC-CCccceeeeEeeCCEEEEE
Confidence 45678999999999999999999754 45678999987653 235679999999987 4455555555667789999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
+|++.++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++........
T Consensus 165 ~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCcccc
Confidence 99999999988843 5579999999999999999999999999999999999999 5889999999999876544322
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc-------
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS------- 234 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------- 234 (306)
.. ......||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+..+......
T Consensus 241 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 241 TP-----QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cc-----cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 11 112457899999999999999999999999999999999999999765432222222221111000
Q ss_pred --------------------cchH--HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 --------------------TPIE--VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 --------------------~~~~--~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+ .....++.++.++|.+||+.||.+|||+.+++. ..++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~--~p~f~ 379 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS--LPLFT 379 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh--Cchhh
Confidence 0000 011234667899999999999999999999977 56664
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=292.65 Aligned_cols=259 Identities=21% Similarity=0.285 Sum_probs=201.1
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCce----EEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~----vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
.+-..+|++.+.||+|+||.||+|.+..++.. ||+|.+..... ...+.+|+.+++.+.|.+.+. +..++..
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~g~~~~- 80 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR-LLGICLT- 80 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCe-EEEEEcC-
Confidence 45567899999999999999999998665553 89998764322 345777888999887755444 4433333
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...+++++++ +|+|.+++......++...++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||.+.
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~ 157 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccc
Confidence 3467888888 889999888655568899999999999999999999999999999999999 478899999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
......... .......+..|++||++.+..++.++|||||||++|+|++ |..||.+..... +........
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~~~~~~ 228 (316)
T cd05108 158 LLGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGE 228 (316)
T ss_pred cccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhCCC
Confidence 655432211 0012234567999999999999999999999999999998 999998754332 222333332
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+.+ ..++.++.+++.+||+.||++|||+.+++..|..+..
T Consensus 229 ~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 RLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 22222 4457889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=309.42 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=204.8
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccC--CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCCH
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENS--GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSL 89 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l 89 (306)
-+||+|.||+||-|++..|....|||-+.. +...+.+..|+.+.+.|.|.+++.++.. ...++.+-|+||.. ||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs-~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGS-VSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhc-cCCCCeEEEEeecCCCCcH
Confidence 369999999999999999999999996543 2334568889999999999776666655 44556788999988 9999
Q ss_pred HHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC--CCCCCccc
Q 021855 90 EDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHI 165 (306)
Q Consensus 90 ~~~~~~~~~~~--~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~~ 165 (306)
.+++....+++ ++..+-.+..||++||.|||++.|||||||.+|+||. .-.|.+||+|||.++++. ++.+
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~T---- 733 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCT---- 733 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccc----
Confidence 99999877787 7889999999999999999999999999999999994 358999999999998764 2332
Q ss_pred cccCCccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 166 PYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
.++.||.+|||||++..++ |++++|||||||++.||.||++||..+.. ......+...-...++.+ ..
T Consensus 734 -----ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs--pqAAMFkVGmyKvHP~iP---ee 803 (1226)
T KOG4279|consen 734 -----ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS--PQAAMFKVGMYKVHPPIP---EE 803 (1226)
T ss_pred -----cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC--hhHhhhhhcceecCCCCc---HH
Confidence 3789999999999998776 88999999999999999999999976543 223333332222223322 55
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
++.+.+.+|.+|+.+||.+||++.+|+. ..++..++.+
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~--DpFlq~~~kk 841 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ--DPFLQHNNKK 841 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc--CcccccCCCC
Confidence 5889999999999999999999999987 6777655443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=294.78 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=205.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----------------chhhHHHHHHHHHHhCCCCCCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------HPQLLYEAKVYKILQGGSGIPN 67 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~~~~ 67 (306)
..-++|++.+.||+|.||.|-+|++..+++.||+|++.+... .+...+|+.+++++.|.+.+..
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345689999999999999999999999999999998764321 1246789999999998554444
Q ss_pred ceeece-eCceeEEEEecc-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce
Q 021855 68 IKWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (306)
Q Consensus 68 ~~~~~~-~~~~~~lv~e~~-~~~l~~~~~~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~ 144 (306)
+..... .....|+|+||| .|.+... .. ... +++.+++.++.++..||.|||..||+||||||+|+|++ ++|.
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-PP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---SDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-CC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---CCCc
Confidence 444433 456789999999 5554322 11 234 88999999999999999999999999999999999994 8899
Q ss_pred EEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCchhhh
Q 021855 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (306)
Q Consensus 145 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 220 (306)
+||+|||.+..+.......... ......||+.|+|||...++. .+.+.||||+|++||-|+.|+.||.+..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~--~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--- 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDD--QLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--- 323 (576)
T ss_pred EEeeccceeeecccCCccccHH--HHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence 9999999998764432221111 122478999999999988743 3678999999999999999999998754
Q ss_pred hHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
....+.+++...+..+.. +.+.+.+++||.+||.+||++|.+..+|.. +.++.
T Consensus 324 ~~~l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~--Hpwvt 376 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIKL--HPWVT 376 (576)
T ss_pred HHHHHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhhee--cceec
Confidence 346777887777776643 345788999999999999999999999955 55554
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=288.74 Aligned_cols=253 Identities=21% Similarity=0.258 Sum_probs=194.3
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|++.+.||+|++|.||+|++..+|+.+++|.+..... ...+.+|+.+++++.|+ ++..+...+.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK-NIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCC-CeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999998764322 23467899999999774 45555555567778999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
|++++|.+.+......+++..++.++.||+.||.|||++|++||||+|+||++ +.++.++|+|||.+.........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCCC-
Confidence 99989988887655679999999999999999999999999999999999999 47899999999998765432211
Q ss_pred cccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCch-hhhhHHHHHHHhhccc--------
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLK-AATKKQKYDKICEKKV-------- 233 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~-~~~~~~~~~~~~~~~~-------- 233 (306)
.....++..|+|||++.+.. ++.++|||||||++|+|++|..||.... .......+.+......
T Consensus 156 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 156 ------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred ------cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh
Confidence 12345678899999987754 7899999999999999999998864322 2111111111110000
Q ss_pred ---c-----c-----chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 234 ---S-----T-----PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 234 ---~-----~-----~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
. . ......+.+++++.++|.+||+.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 0 001122356788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=300.57 Aligned_cols=259 Identities=19% Similarity=0.258 Sum_probs=202.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCC-----CceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
.++|++++.||+|+||.||+|.+... +..||+|++..... ...+.+|+.++..+..|++++.+..++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 56788999999999999999987433 34699998865433 24578899999999756778777777777888
Q ss_pred eEEEEecc-CCCHHHHHHHhc-----------------------------------------------------------
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR----------------------------------------------------------- 97 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~----------------------------------------------------------- 97 (306)
.+++|||+ +|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999 889988775421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC
Q 021855 98 ------------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 98 ------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~ 141 (306)
..+++..+..++.||+.||.|||+++|+|+||||+|||+ +.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---AQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---eC
Confidence 136777888999999999999999999999999999999 47
Q ss_pred cceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhh
Q 021855 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (306)
Q Consensus 142 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~ 220 (306)
++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 889999999998765332211 11123446678999999999899999999999999999997 999997643221
Q ss_pred hHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.....+......+. ...+++.+.++|.+||+.||++|||+.+|.+.|+.++.
T Consensus 348 ---~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 ---TFYNKIKSGYRMAK---PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHHHHhcCCCCCC---CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11122222222221 14568899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=296.10 Aligned_cols=240 Identities=23% Similarity=0.326 Sum_probs=191.4
Q ss_pred eeeecccCccEEEEEEEc---CCCceEEEEEccCC------CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 12 GRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.+.||+|+||.||++++. .+++.||+|++... .....+.+|+.+++.+.| +++..+...+..+...+++|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH-PFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCC-CchhceeeEEecCCeEEEEE
Confidence 367999999999999863 57889999987642 122345678999999987 55555555566677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 999 7789888765 4568889999999999999999999999999999999999 5889999999999865332221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+.......+
T Consensus 156 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~~~~~~~~~~----- 220 (323)
T cd05584 156 V-------THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKILKGKLNLP----- 220 (323)
T ss_pred c-------ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----
Confidence 1 12446899999999999988999999999999999999999999875443 33344443333333
Q ss_pred hcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
..+++.+.++|.+||+.||++|| +++++++
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 55688999999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=301.51 Aligned_cols=250 Identities=21% Similarity=0.305 Sum_probs=197.5
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+...+......+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~-~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS-PWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCeEEEE
Confidence 47999999999999999999999999999999877432 22335667777776655 6666666666677789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9999 889999988755679999999999999999999999999999999999999 588999999999997654432
Q ss_pred CCccccccCCccccccccccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHL------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
.. ......+++.|+|||++. +..++.++|||||||++|+|++|..||....... .+..+......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~~~~~~ 227 (330)
T cd05601 157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---TYNNIMNFQRF 227 (330)
T ss_pred ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---HHHHHHcCCCc
Confidence 21 112346789999999987 4567899999999999999999999998754432 22232222111
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...+ ....+++.+.++|..||+ +|.+|||+++++.
T Consensus 228 ~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1101 113568889999999998 9999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=289.71 Aligned_cols=258 Identities=18% Similarity=0.235 Sum_probs=202.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCc--eEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~--~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||+|....++. .+++|.+..... ...+.+|+.++.++.+|+++..+..++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999876664 467887663222 245778999999997667777777777777788999
Q ss_pred Eecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceE
Q 021855 82 LDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~ 145 (306)
+||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeE
Confidence 9998 789999886422 247888999999999999999999999999999999999 478899
Q ss_pred EEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHH
Q 021855 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK 224 (306)
Q Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~ 224 (306)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||....... .
T Consensus 159 kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~ 227 (297)
T cd05089 159 KIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L 227 (297)
T ss_pred EECCcCCCccccceec--------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 9999999864322111 011223457999999998889999999999999999997 999998754432 2
Q ss_pred HHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
...... ...... ...+++.+.+++.+||+.+|.+|||+++++..|+.++.....
T Consensus 228 ~~~~~~-~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 228 YEKLPQ-GYRMEK---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHHHhc-CCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 222222 211111 145688999999999999999999999999999999875544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=299.73 Aligned_cols=254 Identities=21% Similarity=0.327 Sum_probs=194.6
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+...+.+....+++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~-~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS-LWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCeEEEE
Confidence 47999999999999999999999999999999876421 22346678888888876 5555665666677889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccc
Confidence 9999 7899988876 4579999999999999999999999999999999999999 578999999999987543211
Q ss_pred CCc-------ccc---------------------ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 021855 161 TNR-------HIP---------------------YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212 (306)
Q Consensus 161 ~~~-------~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p 212 (306)
... ..+ ........||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 100 000 0001234789999999999999999999999999999999999999
Q ss_pred CCCchhhhhHHHHHHHhhc--ccccchHHHhhcCchHHHHHHHhhhcCCCC---CCCChHHHHHH
Q 021855 213 WQGLKAATKKQKYDKICEK--KVSTPIEVLCKSHPAEFASYFHYCQSLTFD---QRPDYGFLKRL 272 (306)
Q Consensus 213 f~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~dP~---~Rps~~~l~~~ 272 (306)
|.+.... ..+.++... ....+.. ..+++++.++|.+++. +|. .||++++|++.
T Consensus 236 f~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQ---ETYKKVMNWKETLIFPPE---VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHH---HHHHHHHcCcCcccCCCc---CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 9875543 223333321 1111111 2357889999998664 444 45899999773
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=283.47 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=199.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|++|.||+|++..++ .|++|.+..... ...+.+|+.++..+.| +++..+.... .+...++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~-~~~~~~lv~ 79 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQLYAVV-SEEPIYIVT 79 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCC-CCcceEEEEE-CCCCcEEEE
Confidence 45688999999999999999999887654 599998875433 3457889999999876 4444444333 345578999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccccc
Confidence 999 67999888753 2347899999999999999999999999999999999999 478899999999987654322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......++..|+|||+..+..++.++|+|||||++|+|++ |..||.+..... ....+.. ....+.
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~~~~-~~~~~~-- 224 (262)
T cd05071 157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVER-GYRMPC-- 224 (262)
T ss_pred cc------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHHHhc-CCCCCC--
Confidence 11 1113345678999999988889999999999999999999 888997754332 2222211 111111
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
...++..+.++|.+||+.||++|||++++.+.|++++
T Consensus 225 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1456888999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=295.95 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=196.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||++++..+++.||+|++... .....+.+|..++..+.| +++..+...+..+...+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR-RWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCceEEEEecCCeEEEE
Confidence 4799999999999999999999999999999987632 122346678888877655 6677776777778889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 9998 889999987656679999999999999999999999999999999999999 588999999999987654332
Q ss_pred CCccccccCCccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
.. ......|++.|+|||++.. ..++.++|||||||++|+|++|..||...+... .+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~---~~~~i~~~~~~~ 227 (331)
T cd05597 157 TV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNHKEHF 227 (331)
T ss_pred Cc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH---HHHHHHcCCCcc
Confidence 21 1113468999999999863 357889999999999999999999998754332 222332222111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCC--CCChHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 271 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~ 271 (306)
..+.....+++.+.++|++||..++++ |++++++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 222222446889999999988764443 779988877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=287.78 Aligned_cols=267 Identities=25% Similarity=0.431 Sum_probs=186.2
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCC---CceEEEEEccCCCCch--hh--------HHHHHHHHHHh--CCCCCC
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKHP--QL--------LYEAKVYKILQ--GGSGIP 66 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~--~~--------~~e~~~l~~l~--~~~~~~ 66 (306)
..+.+++|++.+.||+|+||.||+|.+..+ +..+++|+........ +. ..++..+..+. .+.+++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 467889999999999999999999998776 6677888644332211 00 01111122221 224444
Q ss_pred cceeeceeC----ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc
Q 021855 67 NIKWYGVDG----EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (306)
Q Consensus 67 ~~~~~~~~~----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~ 142 (306)
.+...+... ...+++++++..++.+.+.. ....++..+..++.|++.||.|||+.+++||||||+|||+ +.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~ 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGN 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCC
Confidence 443333222 23477888888888877765 3346788899999999999999999999999999999999 578
Q ss_pred ceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhH
Q 021855 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222 (306)
Q Consensus 143 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~ 222 (306)
+.++|+|||+++....................||+.|+|||+..+..++.++|||||||++|+|++|..||.+.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 89999999999765432211110001112346899999999999999999999999999999999999999876322111
Q ss_pred H-HHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 223 Q-KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 223 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
. ........+.... ......+++.+.+++..||+.+|++||++++|.+.|
T Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEG-KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhh-hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 1110011111111 111245678899999999999999999999998865
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=274.66 Aligned_cols=291 Identities=58% Similarity=1.011 Sum_probs=279.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|-+|+|+++||.|.||.++.|.+.-+++.||||........+++.-|....+.|.+.++||.++.|+..+.+..+|+|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 78999999999999999999999999999999999988888889999999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC--CCcceEEEEeeccccccCCCCC
Q 021855 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~--~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
.+|.+|.+++..+++.++.+.+..++.||+.-+.++|+..+++|||||+|+|++.. .+...|.++|||+++....+.+
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 99999999999999999999999999999999999999999999999999999643 3466889999999999999999
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
..++||+.....+||+.|||=....|...+..-|+=|||-++.+++-|..||.+....+....++++.+.....+...+|
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc 264 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC 264 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceecc
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 294 (306)
.++|.++...++-.-..+-.+-|+.+-+...|..++...+...|..+||.-++
T Consensus 265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 99999999999999999999999999999999999999999999999999887
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=307.68 Aligned_cols=250 Identities=20% Similarity=0.216 Sum_probs=199.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCC-CceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~-~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
...|.+.+.||.|++|.||+|....+ ++.|++|.+...... ..+.+|+.+++.+.| ++++.+...+......+++|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDH-FGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEEECCEEEEEE
Confidence 34599999999999999999998777 788888976543322 345679999998876 56666666667778999999
Q ss_pred ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 83 DLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 83 e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
||+ +++|.+.+... ..++++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCC
Confidence 999 88998877532 3458899999999999999999999999999999999999 5889999999999986543
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......
T Consensus 222 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~--- 290 (478)
T PTZ00267 222 SVSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQVLYGKYDP--- 290 (478)
T ss_pred cccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCC---
Confidence 3211 0123556899999999999999999999999999999999999999875432 2333333322221
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....+++++.++|.+||+.||++||++.+++.
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11456789999999999999999999999864
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=286.40 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=195.4
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|++.+.||+|++|.||+|++..++..|++|.+..... ...+.+|+.++..+.| +++..+......+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH-PNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCC-CCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999998764322 2456789999999986 556566556667788999999
Q ss_pred ccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+.++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++.....+..
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcc
Confidence 99889988876533 458999999999999999999999999999999999999 5889999999999875433221
Q ss_pred CccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--------
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-------- 232 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------- 232 (306)
. .....++..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.................
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 157 V-------YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred c-------ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 1 1133567889999988765 47889999999999999999999998654322211111111000
Q ss_pred -------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 -------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 -------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...........+++++.++|++||+.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000111122346888999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=291.27 Aligned_cols=257 Identities=19% Similarity=0.234 Sum_probs=200.6
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCce--EEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~--vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
-++|++.+.||+|+||.||+|+++.++.. +++|.+..... ...+.+|+.++.++.+|+++..+..++......++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 35799999999999999999998877754 46776553222 23467799999999666888777777777788999
Q ss_pred EEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce
Q 021855 81 VLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~ 144 (306)
++||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||+ +.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCCc
Confidence 99999 789999886432 247889999999999999999999999999999999999 57889
Q ss_pred EEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHH
Q 021855 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (306)
Q Consensus 145 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~ 223 (306)
++|+|||++........ ......+..|+|||++.+..++.++|||||||++|+|+| |..||...+...
T Consensus 163 ~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 231 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--- 231 (303)
T ss_pred EEeCccccCcccchhhh--------cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---
Confidence 99999999863221110 012233567999999988889999999999999999998 999997654432
Q ss_pred HHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
..... ....... .....++.+.++|.+||+.+|++|||+++++..|+.++...
T Consensus 232 ~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 232 LYEKL-PQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHH-hcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 22222 1211111 11345788999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=287.23 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=199.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcC-----CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
.++|.+.+.||.|++|.||+|.+.. +++.||+|.+...... ..+.+|+.+++.+.| +++..+..++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH-ENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCC-CCchheeeEEecCCC
Confidence 4679999999999999999998743 4578999988765433 467889999999987 455556555666678
Q ss_pred eEEEEecc-CCCHHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR-------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~ 143 (306)
.++++||+ +++|.+++...+ ..+++..+..++.|++.||.+||++|++||||||+||++ +.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCCC
Confidence 99999999 889999886532 237788899999999999999999999999999999999 4789
Q ss_pred eEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhH
Q 021855 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKK 222 (306)
Q Consensus 144 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 222 (306)
.++|+|||.+......... .......++..|+|||++.+..+++++|||||||++|+|++ |..||...+....
T Consensus 160 ~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~- 233 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV- 233 (280)
T ss_pred eEEECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-
Confidence 9999999998754322211 01123345678999999999999999999999999999998 9999987554322
Q ss_pred HHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
...+.......+ ...++..+.+++.+||+.||++|||++++++.|+
T Consensus 234 --~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 --IECITQGRLLQR----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --HHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 222222222211 1456889999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=284.22 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=200.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+-.++|++.+.||+|++|.||+|.+. ++..|++|.+.... ....+.+|+.+++.+.|. ++..+..........++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD-KLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCC-CeeeEEEEEcCCCCcEEEE
Confidence 34578999999999999999999865 45679999876533 235678899999999874 4444555555667789999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|++ +++|.+++... ...++...+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCc
Confidence 998 78999988653 3458889999999999999999999999999999999999 588999999999997654322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+ . .....+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~-~~~~~~~-- 225 (261)
T cd05072 158 YTA------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL---Q-RGYRMPR-- 225 (261)
T ss_pred eec------cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH---H-cCCCCCC--
Confidence 110 112334667999999998889999999999999999998 99999875443222222 1 1112211
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
...++.++.+++.+||+.+|++|||++++.+.|+++
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 -MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 145678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=287.91 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=204.7
Q ss_pred cCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
-..+|.+.+.||.|++|.||++.+. .++..+++|.+..... ...+.+|+.++..+.| +++..+..++.....
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 81 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEGDP 81 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCc
Confidence 4568999999999999999999752 3456689998765432 3457889999999976 566666666677788
Q ss_pred eEEEEecc-CCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~ 144 (306)
.++++||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||++ ++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCCc
Confidence 99999999 789998887432 238999999999999999999999999999999999999 58899
Q ss_pred EEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHH
Q 021855 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (306)
Q Consensus 145 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~ 223 (306)
++|+|||.+......... .......++..|+|||++.+..++.++|+|||||++|+|++ |..||.......
T Consensus 159 ~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--- 230 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--- 230 (288)
T ss_pred EEeccCCccccccCCcee-----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999998754332211 01113345678999999999899999999999999999998 999997754432
Q ss_pred HHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
....+....... .....++.+.+++.+||+.||.+|||++++.+.|+.+....
T Consensus 231 ~~~~i~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 231 VIECITQGRVLQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HHHHHHcCCcCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 233333222211 12456788999999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.40 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=196.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.+|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.++..+.| +++..+...+......+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCEEEEE
Confidence 3699999999999999999999999999999987642 223456789999999877 5555555666677889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..+....
T Consensus 80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccc
Confidence 9999 8899998876 4468899999999999999999999999999999999999 588999999999975332100
Q ss_pred CCcc------------------------------------ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHH
Q 021855 161 TNRH------------------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL 204 (306)
Q Consensus 161 ~~~~------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~ 204 (306)
.... ..........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0000 0000112346899999999999999999999999999999
Q ss_pred HHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCC---ChHHHHH
Q 021855 205 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP---DYGFLKR 271 (306)
Q Consensus 205 ~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp---s~~~l~~ 271 (306)
+|++|..||.+........ .+.........+ ....+++.+.++|.+|+ .+|.+|+ ++.++++
T Consensus 236 ell~G~~Pf~~~~~~~~~~---~i~~~~~~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 236 EMLVGQPPFLADTPAETQL---KVINWETTLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred ehhhCCCCCCCCCHHHHHH---HHhccCccccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999998765432222 221111111111 11356888999999977 5999999 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=288.34 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=190.1
Q ss_pred ecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
||+|+||.||++.+..+++.||+|.+..... ...+..|+.+++.+.| +++..+...+......+++|||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC-CcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 6899999999999999999999998764321 2345678889998865 55656655566677899999999 788
Q ss_pred HHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 89 LEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 89 l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||.+.........
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~--- 153 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSK--- 153 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCcc---
Confidence 8877643 23458999999999999999999999999999999999999 57899999999998765433221
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHH-HHHHhhcccccchHHHhhcC
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK-YDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 244 (306)
.....++..|+|||++.+..++.++|+|||||++|+|++|..||........... ...+...... ....+
T Consensus 154 ----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 224 (280)
T cd05608 154 ----TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT-----YPDKF 224 (280)
T ss_pred ----ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC-----CcccC
Confidence 1244678999999999999999999999999999999999999976433222111 2222222111 22457
Q ss_pred chHHHHHHHhhhcCCCCCCC-----ChHHHHHHHHHhH
Q 021855 245 PAEFASYFHYCQSLTFDQRP-----DYGFLKRLFHDLF 277 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~l~~~~ 277 (306)
++.+.+++.+||+.||++|| +++++++ +.++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~--h~~~ 260 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT--HPLF 260 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc--Chhh
Confidence 88999999999999999999 5667766 4444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.27 Aligned_cols=261 Identities=20% Similarity=0.306 Sum_probs=202.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcC-------CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
..++|.+.+.||+|+||.||+|++.. +...+|+|.+...... ..+.+|+.++..+..|+++..+...+..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 45789999999999999999998643 2346999988754322 3467789999999656777777666677
Q ss_pred CceeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~ 138 (306)
....++++||+ +++|.+++.... ..++...+..++.|++.||.|||++|++||||||+||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill-- 173 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-- 173 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE--
Confidence 77899999999 779999987532 247888999999999999999999999999999999999
Q ss_pred CCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 021855 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (306)
Q Consensus 139 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~ 217 (306)
+.++.++|+|||.+.......... ......++..|+|||++.+..++.++|+|||||++|+|++ |..||....
T Consensus 174 -~~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 -TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred -cCCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 478899999999987553221110 0112223467999999998889999999999999999998 889997643
Q ss_pred hhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.. .+...+....... .....+.++.+++.+||+.+|++|||++++++.|++++...
T Consensus 248 ~~----~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 248 VE----ELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HH----HHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 32 2222222222211 12456789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=296.08 Aligned_cols=254 Identities=20% Similarity=0.260 Sum_probs=193.4
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
..+|++.+.||+|++|.||+|++..+++.||+|+.... ....|+.+++.+.| +++..+..++......+++++++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNH-PSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCC-CCCcChhheEEeCCeeEEEEEcc
Confidence 45799999999999999999999999999999975432 34568999999987 55556655666777889999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +..+.++|+|||.+........
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~---- 212 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPA---- 212 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCcc----
Confidence 999999887656679999999999999999999999999999999999999 5889999999999864322111
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCchhh------hhHHHHHHHhhcccc----
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW-QGLKAA------TKKQKYDKICEKKVS---- 234 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf-~~~~~~------~~~~~~~~~~~~~~~---- 234 (306)
.....++..|+|||++.+..++.++|||||||++|+|+++..|+ ...... .....+.........
T Consensus 213 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 213 ----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred ----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 12456889999999999999999999999999999999865544 331111 000111111110000
Q ss_pred cc-------------------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 235 TP-------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 235 ~~-------------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.+ .......++.++.++|.+||+.||.+|||++++++ +.++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~--hp~f 354 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN--YPMF 354 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc--Cchh
Confidence 00 00001244667888999999999999999999987 4444
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.61 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=196.2
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+...+.+....+++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCC-CCeeeeEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999886432 12346778899998876 56666666667778899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 81 DYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCcccccccc
Confidence 999 7899888875 4568999999999999999999999999999999999999 5789999999998754321100
Q ss_pred Ccc----------------------------------------ccccCCccccccccccCcccccCCCCCchhhHHHHHH
Q 021855 162 NRH----------------------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY 201 (306)
Q Consensus 162 ~~~----------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 201 (306)
... ..........||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000012346899999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCchhhhhHHHHHHHhh--cccccchHHHhhcCchHHHHHHHhhh--cCCCCCCCChHHHHHHHHHhH
Q 021855 202 VLLYFLRGSLPWQGLKAATKKQKYDKICE--KKVSTPIEVLCKSHPAEFASYFHYCQ--SLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 202 il~~l~tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl--~~dP~~Rps~~~l~~~l~~~~ 277 (306)
++|+|++|..||...+..... ..+.. .....+. ...+++++.++|.+|+ ..+|..||+++++++ +.++
T Consensus 237 il~elltG~~Pf~~~~~~~~~---~~i~~~~~~~~~~~---~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~--hp~f 308 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQ---LKVINWENTLHIPP---QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA--HPFF 308 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHH---HHHHccccccCCCC---CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc--Cccc
Confidence 999999999999875443222 12221 1111111 1346889999999954 556666999999987 4444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=289.45 Aligned_cols=256 Identities=19% Similarity=0.214 Sum_probs=188.6
Q ss_pred eeeecccCccEEEEEEEc--CCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeec-eeCceeEEEEeccCCC
Q 021855 12 GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVLDLLGPS 88 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~~~lv~e~~~~~ 88 (306)
...||+|+||.||+|+++ .+++.+|+|.+..........+|+.+++.+.|++.+.....+. ......++++|+++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 568999999999999965 4678899999887666667889999999998865555444333 2345688999999999
Q ss_pred HHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC-CCcceEEEEeeccccccCCC
Q 021855 89 LEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 89 l~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~-~~~~~~kl~Dfg~~~~~~~~ 159 (306)
|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||++......
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 988876421 248899999999999999999999999999999999999432 35679999999999765433
Q ss_pred CCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh------HHHHHHHhhcc
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK------KQKYDKICEKK 232 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~------~~~~~~~~~~~ 232 (306)
... ........+|+.|+|||++.+. .++.++||||+||++|+|++|..||........ ...+..+....
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred Ccc----ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 211 1112245778999999999875 589999999999999999999999965322100 01111111000
Q ss_pred ccc---------------------------------chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 VST---------------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ~~~---------------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
... .........++.+.++|.+||++||.+|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000001123456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=298.06 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=192.8
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.+|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++......++++|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH-PNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCC-CCcceeeeEeccCCeEEEEEe
Confidence 568899999999999999999999999999998865433 2457789999999987 555555555667778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|... ...++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 153 ~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 153 FMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred cCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccccc-
Confidence 99 6666432 235677888999999999999999999999999999999 5889999999999876543221
Q ss_pred ccccccCCccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
......|+..|+|||++.. ...+.++|||||||++|+|++|+.||..............+.....
T Consensus 224 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 293 (353)
T PLN00034 224 ------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP---- 293 (353)
T ss_pred ------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC----
Confidence 1124568999999998743 2346789999999999999999999974332221222222211111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
......+++++.++|.+||+.||++|||+.++++ +.++...
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~--hp~~~~~ 334 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ--HPFILRA 334 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--CcccccC
Confidence 1112456889999999999999999999999987 5666543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=281.01 Aligned_cols=246 Identities=21% Similarity=0.332 Sum_probs=192.7
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
+.||+|++|.||+|.+..+++.+++|....... ...+.+|+.+++.+.| +++..+...+......++++||+ +++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 468999999999999998999999998764322 2457889999999876 55555655666677899999998 779
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccccc
Q 021855 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (306)
Q Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (306)
|.+++......+++..++.++.|++.||.|||++|++||||+|+||++ +.++.++|+|||.+..........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~----- 151 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS----- 151 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc-----
Confidence 998887645568999999999999999999999999999999999999 478899999999987543221110
Q ss_pred CCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchH
Q 021855 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (306)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (306)
.......+..|+|||.+.+..++.++|+|||||++|+|++ |..||............ ......+. ....+..
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~----~~~~~~~~---~~~~~~~ 224 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI----EQGVRLPC---PELCPDA 224 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH----HcCCCCCC---cccCCHH
Confidence 0011123456999999999899999999999999999998 99999765543222222 12222221 2456789
Q ss_pred HHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 248 FASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 248 ~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
+.+++.+||+.||++|||+.++.+.|.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=294.53 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=215.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+++-|.+.+.||+|.|+.|-+|+|.-||..||||++++.+-. ..+.+|+..++-.+| ++++.++..-......|+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQH-pNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQH-PNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcC-cCeeeeeehhcccceEEE
Confidence 567799999999999999999999999999999998865433 357889999987776 556666555555667999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
++|.- +|+|.+++.....+++++.+..++.||+.|+.|+|+..+|||||||+|+.+- +.-|.+||.|||++..+...
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCCCc
Confidence 99998 7899999988888899999999999999999999999999999999999876 67899999999999776554
Q ss_pred CCCccccccCCccccccccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.. ....+|+..|.|||++.|..|+ +++||||||+|||-|..|+.||+..+.. +.+-.+..-.+..|
T Consensus 173 ~k--------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---ETLTmImDCKYtvP-- 239 (864)
T KOG4717|consen 173 KK--------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---ETLTMIMDCKYTVP-- 239 (864)
T ss_pred ch--------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---hhhhhhhcccccCc--
Confidence 33 2377899999999999999985 7899999999999999999999876554 34445556666666
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
..++.+-++||..||+.||.+|.|.++|.. ..++
T Consensus 240 ---shvS~eCrdLI~sMLvRdPkkRAslEeI~s--~~Wl 273 (864)
T KOG4717|consen 240 ---SHVSKECRDLIQSMLVRDPKKRASLEEIVS--TSWL 273 (864)
T ss_pred ---hhhhHHHHHHHHHHHhcCchhhccHHHHhc--cccc
Confidence 667889999999999999999999999976 4444
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=281.96 Aligned_cols=256 Identities=17% Similarity=0.284 Sum_probs=201.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcCC---CceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
.++|++.+.||+|+||.||+|++..+ ...|++|.+...... ..+.+|+.++..+.| +++..+..........+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH-PNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCcceEeEEEecCCceE
Confidence 46799999999999999999998643 457899987654332 346779999999876 55555655556677789
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++|++ +++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||++ ++++.++|+|||.+.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcccc
Confidence 999999 779999987655578999999999999999999999999999999999999 4789999999999987642
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...+ ......+.
T Consensus 159 ~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~-~~~~~~~~ 229 (266)
T cd05033 159 SEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAV-EDGYRLPP 229 (266)
T ss_pred cccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHH-HcCCCCCC
Confidence 22111 0012234567999999998889999999999999999998 9999976543322 2222 22111121
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
+ ..+++.+.+++.+||+.+|++||++.++++.|++++
T Consensus 230 ~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 230 P---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred C---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1 456889999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=287.07 Aligned_cols=241 Identities=20% Similarity=0.255 Sum_probs=187.5
Q ss_pred ecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
||+|+||.||++++..+|+.||+|.+.... .......|+.++..+.| +++..+...+......+++|||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCC-CcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 689999999999999999999999876321 22335568899999976 55555555556677899999999 788
Q ss_pred HHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccc
Q 021855 89 LEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (306)
Q Consensus 89 l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (306)
|.+++.... .++++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++.........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~----- 151 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTI----- 151 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCcee-----
Confidence 988775433 358899999999999999999999999999999999999 57889999999998765432211
Q ss_pred cCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh-hHHHHHHHhhcccccchHHHhhcCch
Q 021855 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
....++..|+|||++.+..++.++|+|||||++|+|++|..||....... ............... ....+++
T Consensus 152 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 224 (277)
T cd05607 152 ---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF----EHQNFTE 224 (277)
T ss_pred ---eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc----ccccCCH
Confidence 13467889999999999889999999999999999999999997643221 112222222211111 1145688
Q ss_pred HHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 247 EFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
++.++|.+||+.||.+||++.++.+
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchh
Confidence 9999999999999999999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.66 Aligned_cols=259 Identities=21% Similarity=0.307 Sum_probs=202.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEE-----cCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~-----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+..++|.+.+.||+|+||.||+|.+ ..++..+|+|.+..... ...+.+|+.+++++.+|+++..+...+...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 4456899999999999999999975 23456799998765432 234778999999996557777776666777
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
...++++||+ +++|.+++..... .+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||.+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence 7899999998 7899998875332 38999999999999999999999999999999999999 47889999999998
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
.......... ......++..|+|||++.+..++.++||||+||++|+|++ |..||...... ..+.+.....
T Consensus 189 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~---~~~~~~~~~~ 260 (302)
T cd05055 189 RDIMNDSNYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD---SKFYKLIKEG 260 (302)
T ss_pred ccccCCCcee-----ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch---HHHHHHHHcC
Confidence 7654322110 1113345678999999999899999999999999999998 99999765432 1222222222
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
.... .....++.+.+++.+||+.+|++|||+.++++.|++.
T Consensus 261 ~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 YRMA---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CcCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 2211 1134578899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.29 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=194.6
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+...+.+....+++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS-PWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCeeEEE
Confidence 47999999999999999999999999999999875421 12346678889988876 5666666667778889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccc
Confidence 9999 8899988875 4568999999999999999999999999999999999999 488999999999986332110
Q ss_pred CC-----------cccc------------------------cc-----CCccccccccccCcccccCCCCCchhhHHHHH
Q 021855 161 TN-----------RHIP------------------------YR-----ENKNLTGTARYASCNTHLGIEQSRRDDLESLG 200 (306)
Q Consensus 161 ~~-----------~~~~------------------------~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG 200 (306)
.. ...+ +. ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 0000 00 00124689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCC---CChHHHHH
Q 021855 201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR---PDYGFLKR 271 (306)
Q Consensus 201 ~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---ps~~~l~~ 271 (306)
|++|+|++|..||...+... .+..+.........+. ...+++++.++|.+||+ +|.+| +|+.+++.
T Consensus 236 vil~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHE---TYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHH---HHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 99999999999998755432 2222222111111111 12467889999999998 77776 58888876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=284.09 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=198.6
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||.|++|.||+|++..+++.||+|.+.... ....+.+|+.+++.+.|+ ++..+..++......+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP-NVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCc-ceeeeeeeEEECCeEEEE
Confidence 57999999999999999999999999999999765321 123467899999999774 454555455566788999
Q ss_pred Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+||+ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 9999 67898887532 3347899999999999999999999999999999999999 478899999999987654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ....... +......+.
T Consensus 158 ~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~ 228 (267)
T cd08228 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQK-IEQCDYPPL 228 (267)
T ss_pred chhHH-------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHH-HhcCCCCCC
Confidence 32211 11345778899999999888999999999999999999999999764321 1122222 222111111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
.....+..+.++|.+||+.+|++|||+.++++.|+.+
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1134578899999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.95 Aligned_cols=258 Identities=20% Similarity=0.295 Sum_probs=198.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcC-----CCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+-+++|.+.+.||+|++|.||+|.+.. ++..|++|....... ...+.+|+.+++.+.| +++..+..++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH-QNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccC
Confidence 456789999999999999999999876 678899998764432 2357889999999877 4555555555556
Q ss_pred ceeEEEEecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEE
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~ 148 (306)
...++++||+ +++|.+++.... ..+++..+..++.||+.||.|||+++++|+||||+||+++.......++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 6789999999 889999887643 247889999999999999999999999999999999999532234579999
Q ss_pred eeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHH
Q 021855 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~ 227 (306)
|||++.......... .......+..|+|||++.+..++.++|||||||++|+|++ |..||...+.... ...
T Consensus 162 dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~~ 233 (277)
T cd05036 162 DFGMARDIYRASYYR-----KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---MEF 233 (277)
T ss_pred cCccccccCCcccee-----cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence 999997653221110 1112233567999999998899999999999999999997 9999987544322 222
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
+ ....... ....++..+.+++.+||+.+|++|||+++|++.|.
T Consensus 234 ~-~~~~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 V-TGGGRLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H-HcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2 1111111 12556889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=290.95 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=213.8
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-hhhHHHHHHHHHHhCCC-----CCCcceeeceeC
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGS-----GIPNIKWYGVDG 75 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~-----~~~~~~~~~~~~ 75 (306)
++++..+|.+.+.+|+|.||.|-.+.+.+++..||+|++.+.... +...-|+.++.++..+. .+.....++...
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 567889999999999999999999999999999999998876544 44556999999996432 233335667788
Q ss_pred ceeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC--------------
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-------------- 140 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~-------------- 140 (306)
++.||++|.+|.|+.+++...+ .+++...+..+++|+++++.+||+++++|.||||+||++.+++
T Consensus 164 ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 164 GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 8999999999999999998633 4589999999999999999999999999999999999996322
Q ss_pred ---CcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 021855 141 ---KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (306)
Q Consensus 141 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~ 217 (306)
....|+++|||+|........ ..+.|.+|+|||++.+..|+.++||||+||||+|+.||...|+.-+
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~hs----------~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHHS----------TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccCCCcceEEEecCCcceeccCcc----------eeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 255789999999976544332 5678999999999999999999999999999999999999999877
Q ss_pred hhhhHHHHHHHhhcccccchHHH-----------------------------------hh---cCchHHHHHHHhhhcCC
Q 021855 218 AATKKQKYDKICEKKVSTPIEVL-----------------------------------CK---SHPAEFASYFHYCQSLT 259 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------~~---~~~~~~~~li~~cl~~d 259 (306)
+.+.....+++++..+.....-. .. ....++.+||++||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 66666666666553222111000 00 01124889999999999
Q ss_pred CCCCCChHHHHHHHHHhHhh
Q 021855 260 FDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 260 P~~Rps~~~l~~~l~~~~~~ 279 (306)
|.+|+|+.|.+. +.++..
T Consensus 394 P~~RiTl~EAL~--HpFF~~ 411 (415)
T KOG0671|consen 394 PARRITLREALS--HPFFAR 411 (415)
T ss_pred ccccccHHHHhc--CHHhhc
Confidence 999999999976 666653
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=283.26 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=199.2
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchh----hHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
|++.+.||+|++|.||++++..+++.+|+|++........ ..+|+.+++.+.| +++..+..+.......++++|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRH-PNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTB-TTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccc-cccccccccccccccccccccc
Confidence 8999999999999999999999999999999887654433 2448899999965 6666676777778889999999
Q ss_pred cCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 LGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+.+ +|.+++.. ...++...+..++.||++||.+||+.|++|+||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~-- 153 (260)
T PF00069_consen 80 CPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNE-- 153 (260)
T ss_dssp ETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTS--
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc--
Confidence 955 99988883 5578999999999999999999999999999999999999 5899999999999975411111
Q ss_pred cccccCCccccccccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 164 HIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
......++..|+|||++. +..++.++|+||||+++++|++|..||.............+............ ..
T Consensus 154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 227 (260)
T PF00069_consen 154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ-SR 227 (260)
T ss_dssp -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS-HT
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc-cc
Confidence 112456788999999998 77899999999999999999999999987633333333333322221111100 01
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..++.+.++|.+||+.||++|||+.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12378999999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.12 Aligned_cols=262 Identities=27% Similarity=0.376 Sum_probs=202.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.| +++..+...+.+....+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~H-PNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-PGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCC-cCcCeEEEEEeeCCEEEEE
Confidence 689999999999999999999999999999998765322 2357789999999987 5555555666677789999
Q ss_pred Eecc-CCCHHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEee
Q 021855 82 LDLL-GPSLEDLFVYC----------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Df 150 (306)
|||+ +++|.+++... ...++...+..++.||+.||.|||+.||+||||||+||++ +.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9999 88999887642 1234566788899999999999999999999999999999 58899999999
Q ss_pred ccccccCCCCCCc-----------cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhh
Q 021855 151 GLAKKYRDPTTNR-----------HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (306)
Q Consensus 151 g~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~ 219 (306)
|++.......... ...........||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9997652111000 00011122456899999999999999999999999999999999999999764322
Q ss_pred hhHHHHHHHhhcccccchHH-HhhcCchHHHHHHHhhhcCCCCCCC-ChHHHHHHHHHhHh
Q 021855 220 TKKQKYDKICEKKVSTPIEV-LCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFS 278 (306)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~~ 278 (306)
.. .... ....+... ....+|+.+.+++.+||+.||++|| +++++.+.|+.++.
T Consensus 238 ki--~~~~----~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KI--SYRD----VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh--hhhh----hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1111 11111111 1145688899999999999999997 78889999998875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=300.58 Aligned_cols=258 Identities=21% Similarity=0.293 Sum_probs=199.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
...++|++.+.||+|+||.||+|++..+++.+|+|++... .....+.+|+.+++.+.| +++..+...+..+...
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEE
Confidence 3457899999999999999999999999999999987532 122346678888887766 5566666666778889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+++|||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecc
Confidence 9999999 7899998864 358999999999999999999999999999999999999 588999999999997654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.. ..+.++.....
T Consensus 194 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---~~~~~i~~~~~ 264 (370)
T cd05621 194 ETGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---GTYSKIMDHKN 264 (370)
T ss_pred cCCce------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCc
Confidence 32211 112456899999999997643 788999999999999999999999875543 23333333221
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCC--CCChHHHHHHHHHhHhh
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~l~~~~~~ 279 (306)
....+. ...+++.+.++|..||+.+|.+ |+++.++++ +.++..
T Consensus 265 ~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~--hp~~~~ 309 (370)
T cd05621 265 SLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ--HPFFKN 309 (370)
T ss_pred ccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhc--CcccCC
Confidence 111111 1345788999999999865543 889999988 555543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=303.13 Aligned_cols=255 Identities=22% Similarity=0.249 Sum_probs=195.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
..+.+|.+.+.||+|+||.||+|.+..+++.||+|... .....+|+.+++++.| +++..+..++......+++++
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~H-pnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSH-PAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEEE
Confidence 34678999999999999999999999999999999533 2346789999999987 555556566667778899999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
++.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++.........
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccccccc
Confidence 99999998887655579999999999999999999999999999999999999 478899999999987654322110
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh----hHHHHHHHhhc-ccc---c
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT----KKQKYDKICEK-KVS---T 235 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~----~~~~~~~~~~~-~~~---~ 235 (306)
......||..|+|||++.+..++.++|||||||++|||++|..|+....... ....+.+++.. ... .
T Consensus 318 -----~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 318 -----FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred -----cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 1124568999999999999999999999999999999999876654322110 01111111111 000 0
Q ss_pred c------------------------hHHH--hhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 236 P------------------------IEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 236 ~------------------------~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
+ ...+ ....+.++.+||.+||+.||.+|||+.|+++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 0000 0134567899999999999999999999987
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=297.32 Aligned_cols=236 Identities=24% Similarity=0.366 Sum_probs=189.8
Q ss_pred eeecccCccEEEEEEEc---CCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 13 RKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
+.||+|+||.||++++. .+++.+|+|++.... ......+|+.++.++.| +++..+...+......++++||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH-PFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCC-CCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999863 578999999876432 22345678889999876 55666666667778899999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+++|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~--- 153 (318)
T cd05582 81 RGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK--- 153 (318)
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCC---
Confidence 7899888765 4568999999999999999999999999999999999999 5789999999999875433211
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.......+ ..+
T Consensus 154 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~i~~~~~~~p-----~~~ 221 (318)
T cd05582 154 ----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTMILKAKLGMP-----QFL 221 (318)
T ss_pred ----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCC
Confidence 112456889999999999888999999999999999999999999875432 23333333333332 456
Q ss_pred chHHHHHHHhhhcCCCCCCCChHH
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGF 268 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~ 268 (306)
++.+.++|++||+.||.+||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 889999999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=282.88 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=201.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
.++|++.+.||+|++|.||+|.+..+++.+++|.+........+.+|+.+++.+.| +++..+...+......++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS-PYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCC-CcEeeeeeeeecCCcEEEEEecC
Confidence 46899999999999999999999888999999988765556678889999999966 55555555556667899999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~~-- 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAK-- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCccc--
Confidence 679988887656678999999999999999999999999999999999999 47889999999998765443211
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
.....++..|+|||++.+..++.++||||||+++|+|++|..||............. . ..... ......+
T Consensus 156 -----~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~-~~~~~-~~~~~~~ 225 (256)
T cd06612 156 -----RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---N-KPPPT-LSDPEKW 225 (256)
T ss_pred -----cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---c-CCCCC-CCchhhc
Confidence 123456888999999998889999999999999999999999998754432211111 1 11111 1111345
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
+..+.++|.+||+.||++|||+.+++.
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 788999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=279.76 Aligned_cols=249 Identities=19% Similarity=0.266 Sum_probs=196.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
.+|++.+.||+|+||.||+|.+.. +..+++|.+.... ....+.+|+.+++.+.| +++..+..++......++++||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSH-PKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCC-CCceeEEEEEccCCCEEEEEEcC
Confidence 578999999999999999998754 4578999876543 33567889999999987 55555555566677889999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~~- 157 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYTS- 157 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCceec-
Confidence 789998887544568999999999999999999999999999999999999 578999999999887543322211
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
.....++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+.... ...+.... ....+ ..
T Consensus 158 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~~~~-~~~~~---~~ 225 (256)
T cd05114 158 -----SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMISRGF-RLYRP---KL 225 (256)
T ss_pred -----cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCCC-CCCCC---CC
Confidence 112234567999999998889999999999999999999 9999987554322 22222221 11111 33
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
.+..+.+++.+||+.||.+|||++++++.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 467899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=279.71 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=201.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|++|.||+|.+.. ++.||+|.+.... ....+.+|+.+++++.| +++..+..++......++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRH-PKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCC-CCccceeEEEecCCCeeeee
Confidence 445789999999999999999998654 5679999876543 33467889999999986 55556666666777889999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|++ +++|.+++.... ..+++..+..++.|++.||.+||++|++||||||+||++ ++++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCCc
Confidence 999 899999987533 358999999999999999999999999999999999999 478999999999998765322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
... ......+..|+|||++.+..++.++|+||||+++|+|++ |+.||.+..... ....+ ......+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~-~~~~~~~~-- 225 (261)
T cd05068 158 YEA------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQV-DQGYRMPC-- 225 (261)
T ss_pred ccc------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-HcCCCCCC--
Confidence 211 011223457999999998889999999999999999999 999998754332 22222 22222221
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
....+..+.+++.+||+.+|.+||++++|...|+++
T Consensus 226 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 226 -PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 145678999999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=295.97 Aligned_cols=236 Identities=24% Similarity=0.294 Sum_probs=184.9
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHH-HHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~-l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+.||+|+||.||+|++..+++.+|+|++.... ....+..|..+ ++.+.| +++..+...+......+++|||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-p~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCC-CCCccEEEEEecCCEEEEEEcCCC
Confidence 46899999999999999999999999876431 12234445444 444444 66666666667778899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC----
Confidence 7788777765 5578999999999999999999999999999999999999 5889999999999864322111
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCc
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (306)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...+.. ..+..+........ +..+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~~~~~~~~~~-----~~~~ 220 (325)
T cd05604 152 ---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNILHKPLVLR-----PGAS 220 (325)
T ss_pred ---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHHHHHcCCccCC-----CCCC
Confidence 112456899999999999999999999999999999999999999875432 23333333322222 4567
Q ss_pred hHHHHHHHhhhcCCCCCCCChHH
Q 021855 246 AEFASYFHYCQSLTFDQRPDYGF 268 (306)
Q Consensus 246 ~~~~~li~~cl~~dP~~Rps~~~ 268 (306)
..+.++|.+||+.||.+||++.+
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCC
Confidence 88999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=281.28 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=200.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.++|++.+.||.|++|.||+|.+..+++.+++|++.... ....+.+|+.+++.+.| +++..+......+...++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH-PNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCC-CChhceEEEEEeCCEEEEEEe
Confidence 468999999999999999999998889999999877543 23457889999999877 555556566667788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
++ +++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhhc
Confidence 99 668888887654679999999999999999999999999999999999999 58899999999998765432211
Q ss_pred ccccccCCccccccccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+....... ........+...
T Consensus 158 -------~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~ 227 (262)
T cd06613 158 -------RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL---ISKSNFPPPKLK 227 (262)
T ss_pred -------cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhccCCCcccc
Confidence 1234678889999999877 788999999999999999999999987554322222 222211211111
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....++.++.++|++||+.+|..|||+.+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22445778999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=281.29 Aligned_cols=251 Identities=17% Similarity=0.270 Sum_probs=197.7
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
.++|++.+.||+|++|.||+|.+.. +..+|+|.+..... ...+.+|+.++..+.| +++..+..++......++++||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSH-EKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCC-CCeeeEEEEEccCCCcEEEEEc
Confidence 4679999999999999999998754 44599998775432 3567889999999876 5666666666666678999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +++|.+++......+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.+||+|||.+.....+...
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCcee-
Confidence 9 778999887645568999999999999999999999999999999999999 47889999999998765433211
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
......++..|++||++.+..++.++|+|||||++|+|++ |..||....... ....+.... ....+ .
T Consensus 157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~-~~~~~---~ 224 (256)
T cd05113 157 -----SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQGL-RLYRP---H 224 (256)
T ss_pred -----ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhcCC-CCCCC---C
Confidence 1112335567999999998889999999999999999998 999997654432 222222221 11111 3
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
..++.+.+++.+||+.||.+|||+.+|++.|+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 45789999999999999999999999988663
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=283.54 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=201.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
..+|++.+.||.|++|.||+|.+.. +..+++|.+..... ...+..|+.+++.+.| +++..+..++......++++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRH-KHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCC-cchhheeeeEecCCCeEEEEe
Confidence 4579999999999999999999877 88899998775543 4567788999999876 555555556667778999999
Q ss_pred cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.|++|+||+|+||++ ++++.++|+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCccc
Confidence 99 77999998753 3358999999999999999999999999999999999999 4889999999999876543221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
. .....++..|++||++.+..++.++|+||||+++|+|++ |..||...+.. ..+..... ....+.
T Consensus 160 ~-------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~-~~~~~~--- 225 (261)
T cd05148 160 L-------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQITA-GYRMPC--- 225 (261)
T ss_pred c-------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHHh-CCcCCC---
Confidence 1 112334667999999988889999999999999999998 89999875533 22222222 212221
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
...+++.+.++|.+||+.||.+|||+.+|++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 145688999999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=300.63 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=194.0
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+...+.+....+++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h-~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCC-CcCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999999999999999876432 22346778899998876 55666666667778899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 81 DYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCcccccccc
Confidence 999 7799888875 3468999999999999999999999999999999999999 5889999999999753321000
Q ss_pred Ccc----------------------------------------ccccCCccccccccccCcccccCCCCCchhhHHHHHH
Q 021855 162 NRH----------------------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY 201 (306)
Q Consensus 162 ~~~----------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 201 (306)
... ..........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000 0000011346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCC---hHHHHH
Q 021855 202 VLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKR 271 (306)
Q Consensus 202 il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~l~~ 271 (306)
++|+|++|..||.+.+.... ...+.........+ ....+++++.++|.+|+ .+|.+|++ ++++++
T Consensus 237 il~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET---QMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH---HHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999999987544322 22222211111111 11456888999999976 59999987 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=281.34 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=197.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|++|.||+|.+. .+..+++|.+..... ...+.+|+.+++++.|.+.+... .+. .....++++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~-~~~-~~~~~~lv~ 79 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLY-AVV-SEEPIYIVT 79 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEE-eEE-CCCCcEEEE
Confidence 56678999999999999999999865 456789998775433 34678899999999875544443 333 345678999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|++ +++|.+++... ...+++..++.++.|++.||.|||++|++|+||+|+||++ ++++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeeccCcc
Confidence 999 77999988653 2348999999999999999999999999999999999999 478899999999997654322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+...... .+ ......+.
T Consensus 157 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~-~~~~~~~~-- 224 (260)
T cd05070 157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE---QV-ERGYRMPC-- 224 (260)
T ss_pred cc------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HH-HcCCCCCC--
Confidence 11 1112234567999999988889999999999999999999 899998755432222 22 22222221
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
....+..+.+++.+||+.||.+|||++++.+.|+.
T Consensus 225 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 -PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 14567889999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=291.89 Aligned_cols=261 Identities=21% Similarity=0.319 Sum_probs=199.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCccee-eceeC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKW-YGVDG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~-~~~~~ 75 (306)
-.++|++.+.||+|+||.||+|.+. .+++.||+|++...... ..+.+|+.++..+.+|+++..+.. +...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3578999999999999999999853 45788999988754332 346789999999977666665543 44455
Q ss_pred ceeEEEEecc-CCCHHHHHHHhc---------------------------------------------------------
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCR--------------------------------------------------------- 97 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~--------------------------------------------------------- 97 (306)
...++++||+ +++|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5678999999 889988876421
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccccc
Q 021855 98 ---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (306)
Q Consensus 98 ---------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (306)
..++...+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~-----~ 236 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----V 236 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcch-----h
Confidence 125677788899999999999999999999999999999 47889999999998764322111 1
Q ss_pred CCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchH
Q 021855 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (306)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (306)
......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ..............+ ...++.
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~ 310 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLKEGTRMRAP---DYTTPE 310 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHHHHHhccCCCCCC---CCCCHH
Confidence 1112344567999999998889999999999999999997 999997643221 111222222111111 335778
Q ss_pred HHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 248 FASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 248 ~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+.+++.+||+.||.+|||+.+|++.|+.+++.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=295.70 Aligned_cols=252 Identities=22% Similarity=0.257 Sum_probs=196.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||++++..+++.||+|++.... ....+.+|..++..+.| +++..+..++......+++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC-QWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999876421 12235567777766655 6676777777778889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9999 889999988655678999999999999999999999999999999999999 588999999999987654332
Q ss_pred CCccccccCCccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.. ..+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~ 227 (331)
T cd05624 157 TV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHEERF 227 (331)
T ss_pred ce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---HHHHHHHcCCCcc
Confidence 21 1123468999999999875 46788999999999999999999999875443 2233333222222
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCC--CCChHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 271 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~ 271 (306)
+.+.....+++.+.++|.+||..++.+ |++++++++
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 222222456889999999999976644 357777765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.34 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=196.5
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCce-----
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED----- 77 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~----- 77 (306)
++|++.+.||.|++|.||+|.+..+++.||+|...... ....+.+|+.++..+.+++++..+...+.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999999999999999866432 224577899999999887777776655544333
Q ss_pred eEEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 78 NVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
.++++||+.+++.+++.... ..+++..++.++.||+.||.|||++|++||||+|+||+++ +.++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~ 158 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG 158 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence 79999999889988876532 3479999999999999999999999999999999999994 23889999999998
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
......... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+.......+.......
T Consensus 159 ~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 159 RAFSIPVKS-------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred eecCCCccc-------cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 765332211 1123457789999988754 47899999999999999999999998754433222221111100
Q ss_pred --------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 --------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 --------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.+.......+..++.+.++|.+||++||.+|||+++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001111122456888999999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=286.46 Aligned_cols=252 Identities=17% Similarity=0.278 Sum_probs=196.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
..++.|++.+.||.|++|.||+|++..+++.+++|.+..... ...+.+|+.+++.+.| +++..+...+......+++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH-PYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CcEeeeEEEEEeCCeEEEE
Confidence 356779999999999999999999999999999998765432 2346778888998886 4555555555566789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ ++++..++......+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccccc
Confidence 9999 667777766555678999999999999999999999999999999999999 478999999999886533221
Q ss_pred CCccccccCCccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
. ......++..|+|||++. ...++.++|+|||||++|+|++|..||...+.. ....+......+
T Consensus 165 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~- 233 (292)
T cd06644 165 Q-------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSEPP- 233 (292)
T ss_pred c-------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHHHHHhcCCCc-
Confidence 1 112445788899999985 334688999999999999999999999765432 222222211111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.......++.++.++|.+||+.||++||+++++++
T Consensus 234 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 -TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11112456788999999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=286.61 Aligned_cols=261 Identities=18% Similarity=0.282 Sum_probs=195.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCC--------------ceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN--------------EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPN 67 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~--------------~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~ 67 (306)
-.++|++.+.||+|+||.||++++..++ ..||+|.+..... ...+.+|+.+++++.| +++..
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKN-PNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCcCe
Confidence 3468999999999999999999875432 3589998775432 2347789999999987 45555
Q ss_pred ceeeceeCceeEEEEecc-CCCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcee
Q 021855 68 IKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135 (306)
Q Consensus 68 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nil 135 (306)
+..++......++++||+ +++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 555556677889999999 789998875421 13678889999999999999999999999999999999
Q ss_pred eccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 021855 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPW 213 (306)
Q Consensus 136 v~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t--g~~pf 213 (306)
+ ++++.+||+|||++......... .......++..|+|||++.+..++.++|+|||||++|+|++ |..||
T Consensus 162 l---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 162 V---GNHYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred E---cCCCcEEecccccccccccCcce-----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 9 47889999999998764332211 01123344678999999998889999999999999999998 67888
Q ss_pred CCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
...+........................+..|+.+.+++.+||+.||++|||+++|++.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 234 SLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 7654432222221111111111111112446789999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=284.15 Aligned_cols=248 Identities=22% Similarity=0.305 Sum_probs=194.6
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.|++.+.||+|+||.||+|.+..+++.+|+|.+..... ...+.+|+.++..+.|+ ++..+...+..+...++++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~-~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCc-CceeEEEEEecCCEEEEEE
Confidence 47889999999999999999999999999998764321 23467799999998774 4444555556677899999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+.+.... .++++..+..++.|++.||.|||+.||+||||||+||++ ++++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 999 678887776433 358999999999999999999999999999999999999 478899999999986543221
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
. .....++..|+|||++.+..++.++|+|||||++|+|++|..||.................... ...
T Consensus 157 ~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----~~~ 224 (285)
T cd05632 157 S--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----EVY 224 (285)
T ss_pred c--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----ccc
Confidence 1 1134678999999999988899999999999999999999999987544332222222221111 112
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
...+++.+.+++.+||+.||.+||+ +.+++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 2556788999999999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.55 Aligned_cols=255 Identities=20% Similarity=0.297 Sum_probs=196.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcC-----CCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+.+++|++.+.||+|++|.||+|.+.. ++..||+|.+..... ...+.+|+.+++.+.| +++..+.......
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC
Confidence 567899999999999999999998642 356799998764322 2346788899988876 4555555556667
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceE
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRR---------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~ 145 (306)
...++++||+ +++|.+++..... .++...+..++.|++.||.|||+.|++|+||||+||++ ++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCCE
Confidence 7889999998 7899988865321 25677888999999999999999999999999999999 478999
Q ss_pred EEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHH
Q 021855 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK 224 (306)
Q Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~ 224 (306)
+|+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QV 230 (277)
T ss_pred EECCCCCccccCCcceee-----cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence 999999987543322210 1112344678999999998899999999999999999999 78999875443 22
Q ss_pred HHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
........... .....++.+.+++.+||+.||++|||+.++++.|+
T Consensus 231 ~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 22222222111 12456788999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=292.90 Aligned_cols=235 Identities=26% Similarity=0.343 Sum_probs=184.7
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHH-HHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAK-VYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+.||+|+||.||+|++..+++.||+|++.... ....+..|.. +++.+.| +++..+...+......+++|||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH-PFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCEEEEEEcCCC
Confidence 46899999999999999999999999876431 1223444444 4555555 66666666667778899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+++|...+.. ...+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++........
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCC----
Confidence 7788777765 4568999999999999999999999999999999999999 5889999999999865322211
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCc
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (306)
......++..|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+.......+ ...+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~ 220 (321)
T cd05603 152 ---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILHKPLQLP-----GGKT 220 (321)
T ss_pred ---ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCC
Confidence 112456889999999999988999999999999999999999999875432 23333333333332 4567
Q ss_pred hHHHHHHHhhhcCCCCCCCChH
Q 021855 246 AEFASYFHYCQSLTFDQRPDYG 267 (306)
Q Consensus 246 ~~~~~li~~cl~~dP~~Rps~~ 267 (306)
..+.++|.+||+.||.+||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCC
Confidence 8899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=285.61 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=198.4
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
..+|++.+.||+|++|.||+|.+..+++.+++|.+..... ...+.+|+.+++.+.| +++..+...+......++++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCC-CCEeeEEEEEEeCCEEEEeec
Confidence 4689999999999999999999988999999998765432 3457788899988876 455555555556778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||.+.........
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhccccccc
Confidence 99 7899988763 457899999999999999999999999999999999999 47889999999998754332211
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... ........ .. ....
T Consensus 173 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~---~~~~~~~~-~~-~~~~ 240 (296)
T cd06654 173 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATNGTP-EL-QNPE 240 (296)
T ss_pred -------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH---HHhcCCCC-CC-CCcc
Confidence 113467889999999998889999999999999999999999997654322111 11111111 10 1114
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.+++.+.++|.+||..||.+||++.++++ ..++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~--~~~~ 273 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFL 273 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh--Chhh
Confidence 56788999999999999999999999987 4444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=285.34 Aligned_cols=260 Identities=18% Similarity=0.302 Sum_probs=203.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc-------CCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~-------~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
+..++|.+.+.||+|+||.||+|++. .++..|++|....... ...+.+|+.++..+..|+++..+...+.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45678999999999999999999753 2345789998765322 2457789999999966677777776667
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeec
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~ 137 (306)
.....++++||+ +++|.+++.... ..++...+..++.||+.||.|||++|++||||||+||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili- 170 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV- 170 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence 777889999999 779999887532 236778889999999999999999999999999999999
Q ss_pred cCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 021855 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (306)
Q Consensus 138 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~ 216 (306)
+.++.++|+|||.+.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 171 --~~~~~~kl~D~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 171 --TENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred --cCCCcEEECCCccceecccccccc-----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 478999999999987654322211 1112234567999999998889999999999999999998 88999765
Q ss_pred hhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+... .... +........ ...++..+.+++.+||+.+|.+|||+.++++.|++++.
T Consensus 244 ~~~~---~~~~-~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 244 PVEE---LFKL-LKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred CHHH---HHHH-HHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 4332 2222 222222111 14568899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=282.55 Aligned_cols=258 Identities=17% Similarity=0.215 Sum_probs=196.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCc----eEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+-.++|++.+.||.|++|.||+|.+..+++ .+++|.+...... ..+..|+..+..+.|+ ++..+..+.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~-~iv~~~~~~~-~~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA-YIVRLLGICP-GA 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCC-CcceEEEEEC-CC
Confidence 345789999999999999999999877776 4677776543322 2344555566777664 4444444433 34
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++|++ +++|.+++......+++..+..++.||+.||.|||++|++|+||||+||++ +.++.+||+|||.+..
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADL 158 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCcccee
Confidence 567888888 799999987656678999999999999999999999999999999999999 5889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
........ ......++..|++||++.+..++.++|||||||++||+++ |..||.+..... ..........
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~~~~~ 229 (279)
T cd05111 159 LYPDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLLEKGER 229 (279)
T ss_pred ccCCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHCCCc
Confidence 53322111 1113345678999999998899999999999999999998 999998754432 2222222222
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.+.+ ..++.++.+++.+||..||++|||+.++.+.|..+.+
T Consensus 230 ~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 LAQP---QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 2211 3356789999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=282.71 Aligned_cols=251 Identities=19% Similarity=0.312 Sum_probs=195.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeecee------Cce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVD------GED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~------~~~ 77 (306)
.++.|++.+.||.|+||.||+|.+..+++.+|+|.+.... ....+.+|+.++.++.+|+++..+...+.. ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 4678999999999999999999999999999999876543 334577899999998666666665444332 245
Q ss_pred eEEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
.++++||+ +++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||+|+||++ +.++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCcee
Confidence 78999999 679988887533 458999999999999999999999999999999999999 5788999999999876
Q ss_pred cCCCCCCccccccCCccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
...... ......++..|+|||++. +..++.++|+||+||++|+|++|..||.......... ....
T Consensus 161 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~---~~~~ 230 (272)
T cd06637 161 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---LIPR 230 (272)
T ss_pred cccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH---HHhc
Confidence 533221 112456788999999986 3357889999999999999999999997654332221 1111
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...... ....++..+.++|.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111111 11346788999999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=274.25 Aligned_cols=253 Identities=22% Similarity=0.238 Sum_probs=211.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----------chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
.+|+=.+.+|.|..+.|-.+.++.|+.++|+|++..... .....+|+.+++++.+||+|..+........
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 456778899999999999999999999999998762211 1235778999999999999988877777777
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
-.++|+|.| .|.|.+++... -.+|++....++.|+.+|+.|||.++||||||||+|||+ |++.+++|+|||.++.
T Consensus 97 F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceeec
Confidence 789999999 89999998863 359999999999999999999999999999999999999 7999999999999988
Q ss_pred cCCCCCCccccccCCccccccccccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 229 (306)
+..... .+..+||+.|+|||.+.. ..|+..+|+||+|+++|.++.|..||..- .+...+..+.
T Consensus 173 l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQmlMLR~Im 241 (411)
T KOG0599|consen 173 LEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQMLMLRMIM 241 (411)
T ss_pred cCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHHHHHHHH
Confidence 765443 247789999999998853 23788999999999999999999999863 2334455566
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.+.+....+. +.+++...++||.+||+.||++|.|++|.+. +.++
T Consensus 242 eGkyqF~spe-Wadis~~~KdLIsrlLqVdp~~Ritake~La--Hpff 286 (411)
T KOG0599|consen 242 EGKYQFRSPE-WADISATVKDLISRLLQVDPTKRITAKEALA--HPFF 286 (411)
T ss_pred hcccccCCcc-hhhccccHHHHHHHHHeeCchhcccHHHHhc--ChHH
Confidence 6666655443 3778899999999999999999999999877 4444
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=294.18 Aligned_cols=253 Identities=22% Similarity=0.275 Sum_probs=196.7
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||++++..+++.+|+|++... .....+.+|..++..+.| +++..+...+......+++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-QWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCEEEEE
Confidence 4799999999999999999999999999999987531 112235667777777655 5666666666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 9998 889999988655678999999999999999999999999999999999999 588999999999987643322
Q ss_pred CCccccccCCccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
.. ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+.. ..+.++.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~ 227 (332)
T cd05623 157 TV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKERF 227 (332)
T ss_pred cc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCccc
Confidence 21 112346899999999986 345789999999999999999999999875443 2333333332222
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCC--CCChHHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKRL 272 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~ 272 (306)
..+.....+++++.++|.+||..+|.+ |++++++++.
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 222223456889999999999765544 6788888763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=285.56 Aligned_cols=268 Identities=18% Similarity=0.195 Sum_probs=205.4
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeece-eCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-DGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~~l 80 (306)
..+|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+|+.++..+.|.+.+.....+.. .....++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4679999999999999999999999999999998764322 2235679999999988554443333322 2356899
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
++|++.++|.+++......+++..++.++.||+.||.|||+.|++||||+|+||++ +.++.++|+|||.+.......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCCcc
Confidence 99999989998887655678999999999999999999999999999999999999 478999999999997654432
Q ss_pred CCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc-----
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS----- 234 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~----- 234 (306)
.. .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.........
T Consensus 163 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 163 KP-------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CC-------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 11 112345778999999876 45789999999999999999999999876554433333322111100
Q ss_pred -----------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCC
Q 021855 235 -----------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFD 285 (306)
Q Consensus 235 -----------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~ 285 (306)
..........++.+.++|.+||+.||++|||+++++. +.++....+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~--h~~f~~~~~~~~ 301 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE--SSYFKEKPLPCE 301 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhccCCCCCC
Confidence 0001111235788999999999999999999999987 788887776644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=297.08 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=195.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+..++|++.+.||+|+||.||+|++..+++.+|+|++... .....+.+|..+++.+.| +++..+...+......
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~ 118 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYL 118 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEE
Confidence 4467999999999999999999999999999999987532 122335677888877765 5666666666677889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+++|||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcC
Confidence 9999999 7899888864 358899999999999999999999999999999999999 478999999999997654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.. ..+..+.....
T Consensus 194 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~ 264 (371)
T cd05622 194 KEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKN 264 (371)
T ss_pred cCCcc------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCC
Confidence 32211 112456899999999987543 788999999999999999999999875443 23333333221
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCC---CCChHHHHH
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQ---RPDYGFLKR 271 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~---Rps~~~l~~ 271 (306)
....+. ...+++.+.++|..||+ +|.. |++++++++
T Consensus 265 ~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 265 SLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKR 303 (371)
T ss_pred cccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhc
Confidence 111111 14578899999999998 5444 678888876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=280.51 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=196.8
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
..+|++.+.||+|++|.||+|.+. ++..+++|++.... ....+.+|+.+++.+.| +++..+..++......++++|+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH-PNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCceEEEEec
Confidence 457899999999999999999876 46678999876543 33467889999999876 4555555556666788999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +++|.+++......+++..+..++.||+.||.|||+.|++||||||+||++ ++++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecccccccc
Confidence 9 789999887645568999999999999999999999999999999999999 578999999999987543322110
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....++..|+|||.+.+..++.++|+||||+++|++++ |..||.......... .. ........ ..
T Consensus 158 ------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~~-~~~~~~~~---~~ 224 (256)
T cd05059 158 ------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE---SV-SAGYRLYR---PK 224 (256)
T ss_pred ------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH---HH-HcCCcCCC---CC
Confidence 012223457999999999899999999999999999999 899997654432222 21 11211111 14
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
.+++.+.+++.+||+.+|++|||+.++++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 5688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=281.48 Aligned_cols=251 Identities=22% Similarity=0.243 Sum_probs=194.1
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeC--ceeEEEEe
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLVLD 83 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--~~~~lv~e 83 (306)
|++.+.||+|++|.||+|.+..+++.+|+|.+..... .....+|+.++.++..|+++..+..++.+. +..++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999998765322 223456888888887667777676555555 77899999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
|+.+++.+.+......+++..++.++.|++.||.|||+.|++||||+|+||+++ . +.++|+|||.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCCCc-
Confidence 998899988876555689999999999999999999999999999999999994 5 99999999999765432221
Q ss_pred cccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc--------
Q 021855 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-------- 234 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 234 (306)
....++..|+|||++.. ..++.++|+|||||++|+|++|..||.+.+.................
T Consensus 156 -------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 156 -------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred -------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 13356788999997654 45788999999999999999999999875543322222111110000
Q ss_pred -------c------chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 235 -------T------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 235 -------~------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
. .........+..+.++|.+||++||++||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 011122456789999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=281.37 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=197.2
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ....+.+|+.++..+.| +++..+...+......++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH-PNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEee
Confidence 5899999999999999999999999999999875432 23456778888888876 5555666666777889999999
Q ss_pred c-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 85 L-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
+ ++++.+.+... ...+++..+..++.|++.||.+||++|++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccccc
Confidence 9 77898887643 3348899999999999999999999999999999999999 57899999999998765432211
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||...+... ........... +. ..
T Consensus 157 -------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-~~---~~ 222 (255)
T cd08219 157 -------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LILKVCQGSYK-PL---PS 222 (255)
T ss_pred -------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HHHHHhcCCCC-CC---Cc
Confidence 124467888999999998889999999999999999999999998654322 22222222221 11 14
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.++..+.++|.+||+.||.+|||+.+++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 46788999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=278.77 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=196.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|++|.||+|.+..+ ..+++|....... ...+.+|+.+++.+.|++.++....+ .....+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~v~ 79 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV--SEEPIYIVT 79 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCCcEEEE
Confidence 3457899999999999999999987654 4589998765433 34578899999999886655543333 344578999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCc
Confidence 999 679999886533 347899999999999999999999999999999999999 588999999999997653322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......++..|+|||+..+..++.++|+||||+++|+|++ |..||.+....... ... ......+.
T Consensus 157 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~-~~~~~~~~-- 224 (260)
T cd05069 157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQV-ERGYRMPC-- 224 (260)
T ss_pred cc------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH-HcCCCCCC--
Confidence 11 1112345677999999998889999999999999999999 99999875543222 222 12222211
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
....+..+.+++.+||+.||.+||+++++++.|++
T Consensus 225 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 -PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 14567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=279.86 Aligned_cols=246 Identities=25% Similarity=0.304 Sum_probs=197.9
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|.+.+.||+|++|.||+|.+..+++.|++|.+... .....+.+|+.+++.+.| +++..+...+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS-SYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCC-CCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999987643 223457778899999876 445555555556678999999
Q ss_pred cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+ +++|.+++... ...++...++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccc
Confidence 98 78999988764 3568999999999999999999999999999999999999 4789999999999876544322
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. .....++..|+|||+..+..++.++|+|||||++++|++|..||...+.. ...........+. ..
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~----~~ 222 (256)
T cd08529 157 F-------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIRGVFPP----VS 222 (256)
T ss_pred h-------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCC----Cc
Confidence 1 12446788899999999988999999999999999999999999875532 2222222222211 11
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..+++++.++|.+||+.+|++||++.+++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 356789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=285.05 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=201.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCC-----CceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+-.++|++.+.||+|++|.||++.+... ...+++|.+...... ..+.+|+.++.++..|+++..+...+...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3457899999999999999999987643 367899987754332 34677999999985556666666666667
Q ss_pred ceeEEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~ 139 (306)
...++++||+ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~--- 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--- 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence 7899999998 78999888642 2357889999999999999999999999999999999999
Q ss_pred CCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchh
Q 021855 140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA 218 (306)
Q Consensus 140 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~ 218 (306)
+.++.++|+|||.+.......... ......++..|+|||++.+..++.++|||||||++|++++ |..||.....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYR-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred cCCCeEEeCcccccccccccccee-----ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 478999999999997654332211 0112233567999999988889999999999999999998 9999987543
Q ss_pred hhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.... .......... .....+..+.+++.+||+.||++|||++++++.|+.++
T Consensus 241 ~~~~----~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 EELF----KLLKEGYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHH----HHHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2211 1222221111 11455788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=279.31 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=189.9
Q ss_pred eecccCccEEEEEEE--cCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 14 KIGSGSFGEIFLASH--VDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 14 ~lg~g~~~~v~~~~~--~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
.||+|+||.||+|.+ ..++..+|+|++...... ..+..|+.+++.+.| +++..+..+. .....++++|++ +
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~-~~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN-PYIVRMIGIC-EAESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCC-CCcceEEEEE-cCCCcEEEEecCCC
Confidence 689999999999965 466788999988755432 346778889998876 4454444433 345678999999 6
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|.+++.. ...+++..+..++.|++.||.|||++|++||||||.||++ +.++.++|+|||.+..........
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~--- 152 (257)
T cd05116 80 GPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYY--- 152 (257)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCee---
Confidence 789888865 4568999999999999999999999999999999999999 478899999999987654332210
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCc
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (306)
.......++..|+|||.+....++.++|+|||||++|+|++ |..||........ ...+. .....+ ....++
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~i~-~~~~~~---~~~~~~ 224 (257)
T cd05116 153 -KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQMIE-SGERME---CPQRCP 224 (257)
T ss_pred -eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH-CCCCCC---CCCCCC
Confidence 00112233578999999988889999999999999999998 9999987544322 22222 211111 125578
Q ss_pred hHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 246 AEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 246 ~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
+++.++|.+||+.||++||++++|...|+++
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=282.20 Aligned_cols=261 Identities=21% Similarity=0.312 Sum_probs=202.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcC----CCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+-+++|++.+.||+|+||.||+|.+.. ++..|++|.+..... ...+.+|..+++.+.|.+.+..+........
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 557899999999999999999999875 357889998764432 2346778889999977555554444444456
Q ss_pred eeEEEEecc-CCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEE
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR-------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~ 148 (306)
..+++++++ +++|.+++.... ..+++..++.++.|++.||.|||+++++|+||+|+||+++ +++.++|+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEEC
Confidence 788999998 689988876532 3488999999999999999999999999999999999994 78999999
Q ss_pred eeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHH
Q 021855 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~ 227 (306)
|||+++......... ......++..|+|||++.+..++.++|||||||++|++++ |+.||...+..... .
T Consensus 160 d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~ 230 (280)
T cd05043 160 DNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA----A 230 (280)
T ss_pred CCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH----H
Confidence 999997654322111 0012345667999999998889999999999999999999 99999875443221 1
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.......... ...+++++.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 231 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 231 YLKDGYRLAQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHcCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1222222111 144678999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=284.46 Aligned_cols=257 Identities=21% Similarity=0.337 Sum_probs=197.7
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||+|+||.||+|++..+++.||+|.+..... ......|.....+..+++++..+..++......++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999998775432 23355566665555566777666666667778999999
Q ss_pred ccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 84 LLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 84 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
|+.++|.+++... ...+++..++.++.||+.||.|||++ +++||||||+||++ +.++.+||+|||.+......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 9999998887642 33589999999999999999999997 99999999999999 58899999999998765332
Q ss_pred CCCccccccCCccccccccccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLG----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
... ....++..|+|||++.+ ..++.++|+|||||++|+|++|..||..... ...............
T Consensus 158 ~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 227 (283)
T cd06617 158 VAK--------TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSPQ 227 (283)
T ss_pred ccc--------ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCCC
Confidence 211 12456788999998865 4468899999999999999999999975322 112222222221111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
. + ...+|+++.++|.+||..+|.+|||++++++ ..++....
T Consensus 228 ~-~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~ 268 (283)
T cd06617 228 L-P--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ--HPFFELHL 268 (283)
T ss_pred C-C--ccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhhhcc
Confidence 1 1 1346889999999999999999999999987 66665444
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=289.51 Aligned_cols=281 Identities=20% Similarity=0.238 Sum_probs=204.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeece----eCce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----~~~~ 77 (306)
++++|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+.+|+.+++.+.|.+.+.....+.. ....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 5789999999999999999999999999999999876422 22346779999999987554443322211 2235
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
.++++|++++++...+. ...+++..++.++.|++.||.+||+.|++||||||+||++ +.++.++|+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeecc
Confidence 79999999989888775 3468999999999999999999999999999999999999 588999999999987654
Q ss_pred CCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh------
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------ 230 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~------ 230 (306)
....... ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 158 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccC----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 3222110 1123467889999998765 4688999999999999999999999976433221111111110
Q ss_pred -----------------cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH--HHHhHhhcC--CC-CCccc
Q 021855 231 -----------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL--FHDLFSREG--YD-FDFVF 288 (306)
Q Consensus 231 -----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~~~~~--~~-~~~~~ 288 (306)
.....+.....+..++.+.++|.+||+.||++|||+.++++. |+.+..... .. .+-+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 313 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPF 313 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCCh
Confidence 001111122234567889999999999999999999999884 444432211 11 23456
Q ss_pred cceecc
Q 021855 289 DWTILK 294 (306)
Q Consensus 289 ~~~~~~ 294 (306)
|.+..+
T Consensus 314 ~~~~~~ 319 (336)
T cd07849 314 DFELFD 319 (336)
T ss_pred hhcccc
Confidence 665553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=285.12 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=203.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
-.++|.+.+.||.|++|.||+|.+. .++..+++|.+...... ..+.+|+.+++++.| +++..+..++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 81 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-EHIVKFYGVCGDGDP 81 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCc
Confidence 4567999999999999999999854 34566888987654432 457789999999876 556666666667778
Q ss_pred eEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~ 141 (306)
.++++||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||++ +.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---cc
Confidence 99999999 889999886532 237889999999999999999999999999999999999 58
Q ss_pred cceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhh
Q 021855 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (306)
Q Consensus 142 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~ 220 (306)
++.++|+|||.+.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+...
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYR-----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred CCcEEECCCCcccccCCCceee-----cCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 8999999999987543322110 1123445778999999999899999999999999999999 999997755432
Q ss_pred hHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
............ .....|..+.+++.+||+.||++|||++++++.|+++.+
T Consensus 234 ---~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 ---VIECITQGRVLE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HHHHHhCCCCCC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 222222222111 114457889999999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=280.25 Aligned_cols=258 Identities=18% Similarity=0.282 Sum_probs=201.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCC---ceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~---~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
-.++|++.+.||+|+||.||+|.+..++ ..+++|.+..... ...+.+|+.++..+.| +++..+..++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCcc
Confidence 3578999999999999999999886444 3689998765432 2357778899998876 5666666666677788
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++||+ +++|.+++......++...+..++.|++.||.+||+.|++|+||||+||++ +.++.++|+|||.+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 9999999 779999987655568999999999999999999999999999999999999 478899999999997654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
....... ......++..|++||++.+..++.++|+|||||++|++++ |..||........ ...+.. ....+
T Consensus 158 ~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~-~~~~~ 229 (267)
T cd05066 158 DDPEAAY----TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEE-GYRLP 229 (267)
T ss_pred cccceee----ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhC-CCcCC
Confidence 3322110 0011223467999999998889999999999999999887 9999987554322 222221 11222
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
. ....++.+.+++.+||+.+|.+||++.++++.|.+++
T Consensus 230 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 230 A---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred C---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 1 1446788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=280.76 Aligned_cols=261 Identities=19% Similarity=0.278 Sum_probs=203.8
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCc----eEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
|..+..++|++.+.||+|+||.||+|.++.++. .+++|........ ..+.+|+.+++++.|.+.+..+ .++.
T Consensus 1 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-~~~~ 79 (279)
T cd05057 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL-GICL 79 (279)
T ss_pred CcccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEE-EEEe
Confidence 456678899999999999999999999876654 5888987655432 3567899999999775444444 3333
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
. ...++++||+ +++|.+++......+++..+..++.||+.||.|||++|++|+||+|+||++ ++++.++|+|||.
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~ 155 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGL 155 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcc
Confidence 3 6788999998 889999887755669999999999999999999999999999999999999 4788999999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhc
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
++......... ......++..|+|||.+....++.++|+||||+++|++++ |..||.......... ....
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~ 226 (279)
T cd05057 156 AKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD----LLEK 226 (279)
T ss_pred cccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHhC
Confidence 97654322210 0011223567999999988889999999999999999998 999998755432222 2222
Q ss_pred ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
....+.+ ...+..+.+++.+||..||++||++.++++.|+++.+
T Consensus 227 ~~~~~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 GERLPQP---PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2222211 3457789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=278.48 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=200.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||.|++|.||+|.+..+++.|++|.+... .....+.+|+.+++++.| +++..+...+......+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~-~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-PNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCeeeeeeeeecCCeEEEE
Confidence 5899999999999999999999989999999976531 123457789999999876 4454554455566788999
Q ss_pred Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+||+ +++|.+++... ...+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 9999 77999887642 2348899999999999999999999999999999999999 478999999999987654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ............ ..+.
T Consensus 158 ~~~~~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~ 228 (267)
T cd08224 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKCD-YPPL 228 (267)
T ss_pred CCCcc-------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhcCC-CCCC
Confidence 33221 11345778899999999888999999999999999999999999654321 111122211111 1111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
+ ...++..+.++|.+||..+|++|||+.+|++.|+.+
T Consensus 229 ~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 P--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 135578899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=282.70 Aligned_cols=248 Identities=25% Similarity=0.432 Sum_probs=190.8
Q ss_pred eEeeeecccCccEEEEEEEc----CCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 10 KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 10 ~i~~~lg~g~~~~v~~~~~~----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.+.+.||.|.||.||+|.+. ..+..|++|.+..... ...+.+|+..+.+++| +++..+..+.......++++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRH-PNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSB-TTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccc-cccccccccccccccccccc
Confidence 57899999999999999987 4467899999965433 3468889999999955 66666666666667799999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+++... ...++...++.++.||+.||.|||+++++|++|+++||++ ++++.+||+|||.+.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 999 68999999875 4569999999999999999999999999999999999999 478999999999997652221
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ...........|+|||.+.+..++.++||||||+++||+++ |+.||...+... ....... ....+
T Consensus 158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~~~-~~~~~--- 225 (259)
T PF07714_consen 158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKLKQ-GQRLP--- 225 (259)
T ss_dssp SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHHHT-TEETT---
T ss_pred cc-----cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc-cccce---
Confidence 11 01123446778999999998889999999999999999999 789998764432 2222222 21211
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
....++..+.++|.+||..||.+|||+.+|++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1256789999999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=283.30 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=200.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
.+|++.+.||.|++|.||+|.+..+++.|++|.+.... ....+.+|+.+++.+.|+ ++..+...+......++++||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNP-NIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCC-ceeeeeeeEecCceEEEEEEe
Confidence 57999999999999999999999999999999876432 234567889999988774 455555555667789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +++|..++.. ..+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+.........
T Consensus 98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 98 LAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred cCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccccccc-
Confidence 9 7788887764 358999999999999999999999999999999999999 47899999999998764432211
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+........ ....... ......
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~~~~~~~--~~~~~~ 240 (296)
T cd06655 172 ------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPE--LQNPEK 240 (296)
T ss_pred ------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCcc--cCCccc
Confidence 11345788899999999888999999999999999999999999875443222211 1111111 111245
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+++.+.++|.+||..||.+|||+.+++. ..++.
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~--~~~~~ 273 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLK 273 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhh
Confidence 6788999999999999999999999987 67765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=282.12 Aligned_cols=255 Identities=20% Similarity=0.290 Sum_probs=198.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCC-----CceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+..++|++.+.||+|++|.||+|.+... +..|++|....... ...+.+|+.+++.+.| +++..+..++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~ 81 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSTG 81 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEcCC
Confidence 5567899999999999999999987643 47899998765432 2346778888888876 5555566666667
Q ss_pred ceeEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceE
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~ 145 (306)
...++++||+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++ +.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence 7899999999 789999886422 236778899999999999999999999999999999999 488999
Q ss_pred EEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHH
Q 021855 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK 224 (306)
Q Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~ 224 (306)
+|+|||.+......... .......++..|+|||.+.+..++.++|||||||++|++++ |..||...+.....
T Consensus 159 kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-- 231 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL-- 231 (277)
T ss_pred EECCcccchhhccCccc-----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH--
Confidence 99999998754332211 01123345778999999988889999999999999999998 99999765443222
Q ss_pred HHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
.... ...... ....++..+.++|.+||+.+|++|||+.++++.|+
T Consensus 232 -~~~~-~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 -KFVI-DGGHLD---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -HHHh-cCCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 2222 111111 11445889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=287.54 Aligned_cols=280 Identities=22% Similarity=0.257 Sum_probs=211.9
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
++++|++.+.||.|++|.||+|.+..+++.|++|.+... .....+.+|+.++..+.|++.+.....+.......++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 578899999999999999999999999999999976532 2234567899999999875544444444444567899
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
++|+++++|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 88 v~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 88 VTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred EeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCCCc
Confidence 99999999988776 3457888899999999999999999999999999999999 578999999999987543221
Q ss_pred CCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh----------
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC---------- 229 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~---------- 229 (306)
....++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+.+..
T Consensus 163 ----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 163 ----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 13356788999998766 568999999999999999999999997654432222211111
Q ss_pred -------------hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC-----CCccccce
Q 021855 230 -------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD-----FDFVFDWT 291 (306)
Q Consensus 230 -------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~-----~~~~~~~~ 291 (306)
......+.....+.+++.+.++|.+||+.+|++|||+++++. ..+++...-+ +-..|+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~--~~~~~~~~~~~~~~~~~~~~~~~ 310 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA--HPYLAPYHDPTDEPVAEEKFDWS 310 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CCccccccCCccccCchhhcCCc
Confidence 111112223333557789999999999999999999999977 5555422222 33468888
Q ss_pred ecchhhhHHh
Q 021855 292 ILKYQQTQKT 301 (306)
Q Consensus 292 ~~~~~~~~~~ 301 (306)
.-+.+.+..+
T Consensus 311 ~~~~~~~~~~ 320 (328)
T cd07856 311 FNDADLPVDT 320 (328)
T ss_pred hhcccCCHHH
Confidence 8777665543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=282.43 Aligned_cols=253 Identities=19% Similarity=0.285 Sum_probs=195.5
Q ss_pred CceeEeeeecccCccEEEEEEEc----CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
..|++.+.||+|+||.||+|.+. .++..+++|.+...... ..+.+|+.+++.+.| +++..+..+.......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH-PNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCCceE
Confidence 46899999999999999999853 45678999987643322 347789999999976 55555555556677889
Q ss_pred EEEecc-CCCHHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc
Q 021855 80 LVLDLL-GPSLEDLFVYCR----------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~ 142 (306)
+++||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||++ +.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cCC
Confidence 999999 679988875321 236788899999999999999999999999999999999 478
Q ss_pred ceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhh
Q 021855 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 221 (306)
Q Consensus 143 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~ 221 (306)
+.++|+|||++.......... ......++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~- 234 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYR-----VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE- 234 (283)
T ss_pred CcEEeccccccccccCCccee-----cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 899999999997654322111 1123345667999999998889999999999999999998 999997754321
Q ss_pred HHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
..... ......+ ....+++.+.+++.+||+.||++||++++|.+.|..
T Consensus 235 --~~~~~-~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 --VIEMV-RKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHH-HcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 12221 2221111 125568899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=281.37 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=195.6
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++.+.||+|++|.||+|++..+++.|++|.+..... ...+.+|+.+++.+.| +++..+...+......++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH-PNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCC-CCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999998999999998754322 2346789999999887 45555555566677889999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
||+.+.+.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCccc
Confidence 999665555444334568999999999999999999999999999999999999 47889999999999765443211
Q ss_pred ccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc-------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS------- 234 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------- 234 (306)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+..+..............
T Consensus 157 -------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 157 -------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred -------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 113456788999999876 45789999999999999999999999876544333222221111000
Q ss_pred ----------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 235 ----------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 235 ----------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.+.....+.++..+.++|.+||+.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0111222456788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=278.89 Aligned_cols=254 Identities=21% Similarity=0.359 Sum_probs=199.0
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++..+.|++.+.||+|++|.||+|... +++.||+|.+..... ...+.+|+.+++.+.|. ++..+..+. .....+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~-~~~~~~~v 78 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP-RLVRLYAVV-TQEPIYII 78 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCc-CeeeEEEEE-ccCCcEEE
Confidence 466789999999999999999999854 567899998775443 34678899999999774 444444433 34568999
Q ss_pred Eecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|++ +++|.+++... ...++...+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCC
Confidence 9999 78999887643 3358899999999999999999999999999999999999 47899999999998765422
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
... ......++..|+|||++.+..++.++||||||+++|++++ |+.||.+.+........ ......+.
T Consensus 156 ~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~~- 224 (260)
T cd05067 156 EYT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL----ERGYRMPR- 224 (260)
T ss_pred Ccc------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH----HcCCCCCC-
Confidence 211 1113345678999999998889999999999999999999 99999875543222222 22222221
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
....+.++.++|.+||+.+|++|||++++++.|+.
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 --PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 14567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=282.47 Aligned_cols=258 Identities=24% Similarity=0.299 Sum_probs=193.4
Q ss_pred Cce-eEeeeecccCccEEEEEEE----cCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeece--eCc
Q 021855 7 VKY-KLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV--DGE 76 (306)
Q Consensus 7 ~~y-~i~~~lg~g~~~~v~~~~~----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~ 76 (306)
++| ++.+.||+|+||.||++.. ..++..||+|.+..... ...+.+|+.+++.+.|. ++..+..++. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE-NIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCC-CEeeEEEEEecCCCc
Confidence 455 9999999999999988653 35678899998875432 34577899999999764 4444443332 234
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++||+ +++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKA 156 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccccc
Confidence 578999999 7889888864 358999999999999999999999999999999999999 4788999999999876
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhH-----------HH
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-----------QK 224 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~-----------~~ 224 (306)
......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||......... ..
T Consensus 157 ~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 157 VPEGHEYYR----VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cCCcchhhc----cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 543222110 111223456799999998888999999999999999999999998653221100 00
Q ss_pred HHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
...........+ ....++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 233 ~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 011111111111 12456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=279.38 Aligned_cols=259 Identities=18% Similarity=0.271 Sum_probs=200.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCc---eEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+...+|+..+.||+|++|.||+|++..++. .+++|.+..... ...+..|+.++..+.|+ ++..+..++.....
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH-NIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCC-CeeEEEEEEccCCC
Confidence 456789999999999999999999875554 689998765422 24577788888888764 55555566666778
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++|++ +++|.+++......+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 89999999 678988887655668999999999999999999999999999999999999 47889999999998765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
........ .......+..|++||++.+..++.++|||||||++|++++ |..||...+... ....+ ......
T Consensus 158 ~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i-~~~~~~ 229 (268)
T cd05063 158 EDDPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAI-NDGFRL 229 (268)
T ss_pred ccccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH-hcCCCC
Confidence 43222110 0011223457999999988889999999999999999998 999997654432 22222 222222
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
+.. ..++..+.+++.+||+.+|++||+++++++.|++++
T Consensus 230 ~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 PAP---MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 211 346788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=282.90 Aligned_cols=252 Identities=19% Similarity=0.273 Sum_probs=196.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
..++|++.+.||+|++|.||+|++..+++.|++|++..... ...+.+|+.+++.+.| +++..+...+......++++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h-~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH-SNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCEEEEEE
Confidence 34689999999999999999999999999999998765432 2346678888888866 55555555556677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+++.. .+.+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||.+........
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCccc
Confidence 999 6789888765 4568999999999999999999999999999999999999 4788999999999876543221
Q ss_pred CccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
......++..|+|||++. ...++.++|+|||||++|+|++|..||........ ...........+..
T Consensus 162 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~ 231 (267)
T cd06645 162 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMTKSNFQPPKL 231 (267)
T ss_pred -------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhhhccCCCCCcc
Confidence 112446788999999874 44588899999999999999999999976443211 11111222222111
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....++..+.++|.+||+.||++|||+++|++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111346788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=278.29 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=196.9
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-------chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
++|++.+.||.|++|.||.|.+..+++.+++|.+..... ...+.+|+.+++++.| +++..+..++......+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH-ERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEccCCeEE
Confidence 579999999999999999999988999999998654321 1346778889999876 55555555556667899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++|++ +++|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+.....
T Consensus 81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccc
Confidence 999999 7789888875 4468899999999999999999999999999999999999 4789999999999875433
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
...... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...... .............
T Consensus 157 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~--- 226 (263)
T cd06625 157 ICSSGT----GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTNP--- 226 (263)
T ss_pred cccccc----cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHHHhccCCCC---
Confidence 211100 001345678899999999988999999999999999999999999764332 2222222221111
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....+++.+.++|.+||..+|.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 122566889999999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=278.15 Aligned_cols=247 Identities=19% Similarity=0.246 Sum_probs=195.3
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|++.+.||.|++|.||++.+..+++.+++|.+..... ...+.+|+.+++++.|.+.+.....+.......++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58999999999999999999998899999998764322 23467788889988775544433333334456789999
Q ss_pred cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
++ +++|.+.+... ...+++..+..++.|++.||.+||++|++||||+|+||++ +.++.++|+|||.+........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCC
Confidence 99 67898887653 3458999999999999999999999999999999999999 4889999999999876543222
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
......+++.|+|||++.+..++.++|+|||||+++++++|+.||...+.. ...........+. ..
T Consensus 158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~----~~ 223 (257)
T cd08223 158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVYRIIEGKLPP----MP 223 (257)
T ss_pred -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCCC----Cc
Confidence 112446788999999999999999999999999999999999999764432 2222222222211 22
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...++.+.+++.+||+.||++|||+.+++.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 456889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=281.50 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=200.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|++|.||+|++..++..+++|.+.... ....+.+|+.+++.+.| +++..+..++......+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccC-CchhhhhheeEeCCeEEEE
Confidence 46899999999999999999998899999999765321 12356789999999876 5555555555667788999
Q ss_pred Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+|++ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 9999 67998887642 3348899999999999999999999999999999999999 578899999999987654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... ............. .+.
T Consensus 158 ~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~ 228 (267)
T cd08229 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDY-PPL 228 (267)
T ss_pred cCCcc-------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhcCCC-CCC
Confidence 32221 11345788899999998888999999999999999999999999764321 1111122111111 111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.....++.+.++|.+||+.||.+|||+++|.+.++++.
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11346788999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=293.74 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=200.5
Q ss_pred cCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
-.++|.+.+.||+|+||.||+|++. .++..||+|++...... ..+.+|+.++.++..|+++..+...+....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3457888999999999999999864 34568999998755332 357789999999985577777766666777
Q ss_pred eeEEEEecc-CCCHHHHHHHhc----------------------------------------------------------
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR---------------------------------------------------------- 97 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~---------------------------------------------------------- 97 (306)
..++++||+ +|+|.+++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 899999999 889998886421
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc
Q 021855 98 ---------------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (306)
Q Consensus 98 ---------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~ 138 (306)
..+++..+..++.||+.||.|||+++++||||||+|||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl-- 272 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI-- 272 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE--
Confidence 125666788899999999999999999999999999999
Q ss_pred CCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 021855 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (306)
Q Consensus 139 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~ 217 (306)
++.+.++|+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 273 -~~~~~~kL~DfGla~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 273 -CEGKLVKICDFGLARDIMRDSNYI-----SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred -eCCCEEEEEecCcceecccccccc-----cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 478899999999987643222110 1123346778999999998889999999999999999998 899997643
Q ss_pred hhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
... ............. ....++.++.+++.+||..+|.+||++.+|++.|+.++
T Consensus 347 ~~~---~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNE---QFYNAIKRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chH---HHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 221 1112122221111 11456789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=282.80 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=194.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+|+.+++++.| +++..+...+......++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEECCEEEEEEe
Confidence 368899999999999999999999999999998765422 2346789999988876 555555555566678899999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|... ..+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~~- 150 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSIA- 150 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccccc-
Confidence 99 5565432 247888999999999999999999999999999999999 4889999999999876543221
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhH----HHHHHHhhcccccchH
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK----QKYDKICEKKVSTPIE 238 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~ 238 (306)
....++..|+|||++.+..++.++|+|||||++|+|++|+.||......... .......... ....
T Consensus 151 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~- 220 (279)
T cd06619 151 --------KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPVL- 220 (279)
T ss_pred --------cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-CCCC-
Confidence 1446788999999999989999999999999999999999999753322111 1111111111 1111
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
.....++++.++|.+||+.||.+||+++++++ ..++.+.+
T Consensus 221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~--~~~~~~~~ 260 (279)
T cd06619 221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMD--HPFIVQYN 260 (279)
T ss_pred -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc--Cccccccc
Confidence 11345788999999999999999999999987 55554443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=285.22 Aligned_cols=260 Identities=18% Similarity=0.288 Sum_probs=196.7
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCC----------------ceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCC
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTN----------------EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIP 66 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~----------------~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~ 66 (306)
.++|++.+.||+|+||.||+|.+..++ ..|++|.+..... ...+.+|+.++.++.| +++.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD-PNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCC-CCEe
Confidence 468999999999999999999876543 4578998775432 2456779999999977 4555
Q ss_pred cceeeceeCceeEEEEecc-CCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcee
Q 021855 67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135 (306)
Q Consensus 67 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nil 135 (306)
.+..++..+...++++|++ +++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 5555556667899999998 789998886533 25889999999999999999999999999999999999
Q ss_pred eccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 021855 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPW 213 (306)
Q Consensus 136 v~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t--g~~pf 213 (306)
+ +.++.++|+|||.+.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 163 i---~~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 163 V---GKNYTIKIADFGMSRNLYSSDYYR-----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred e---cCCCceEEccccceeecccCccee-----ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 9 477999999999987643332111 1123345678999999988889999999999999999998 77888
Q ss_pred CCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
...+..........................+|.++.+++.+||+.||.+|||+.+|++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 7654332222221111111111101112445788999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=285.61 Aligned_cols=254 Identities=18% Similarity=0.232 Sum_probs=195.7
Q ss_pred CceeEeeeecccCccEEEEEEEcC-----CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
..|++.+.||.|++|.||+|.+.. +++.||+|++...... ..+.+|..++..+.| +++..+..........
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH-PNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEcCCCce
Confidence 468889999999999999998754 3578999998755432 346678888888876 4555555555666678
Q ss_pred EEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc
Q 021855 79 VLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~ 142 (306)
++++||+ +++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||++ +++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cCC
Confidence 9999998 67888887531 1247788899999999999999999999999999999999 478
Q ss_pred ceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhh
Q 021855 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 221 (306)
Q Consensus 143 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~ 221 (306)
+.+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 233 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYK-----LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-- 233 (283)
T ss_pred CceEecccccccccccchhee-----eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 889999999987653322110 1123345678999999988889999999999999999998 88899775443
Q ss_pred HHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
.....+...... + ....+++.+.+++..||+.+|.+||++++|+..|+++
T Consensus 234 -~~~~~i~~~~~~-~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 234 -DVIEMIRNRQVL-P---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred -HHHHHHHcCCcC-C---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 223332222211 1 1256788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=285.48 Aligned_cols=268 Identities=20% Similarity=0.300 Sum_probs=203.7
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||+|+||.||++.+..++..+++|.+..... ...+.+|+.++.++.| +++..+...+......++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS-PYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCEEEEEee
Confidence 469999999999999999999999999999998765432 2346789999999976 556566556667788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+ +++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccccc
Confidence 99 7799988876 3568999999999999999999997 599999999999999 4788999999999865433221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc---------
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------- 232 (306)
....++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.......
T Consensus 156 ---------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 156 ---------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ---------ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 14467889999999988889999999999999999999999997543222111111000000
Q ss_pred --------------------cccchHHH-hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccc
Q 021855 233 --------------------VSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290 (306)
Q Consensus 233 --------------------~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 290 (306)
.....+.. ...++.++.++|.+||+.||++|||+.+++. ..++.+.......-..|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~~~~~~~~~~~~~~~~~ 303 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK--HPFIKRAELEEVDFAGW 303 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhhhcccccchhhhh
Confidence 00000000 0125678999999999999999999999987 67766544443333444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=277.96 Aligned_cols=248 Identities=19% Similarity=0.298 Sum_probs=190.6
Q ss_pred eecccCccEEEEEEEc--CCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CC
Q 021855 14 KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP 87 (306)
Q Consensus 14 ~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~ 87 (306)
.||+|+||.||+|.+. .++..||+|+...... ...+.+|+.+++++.|.+.+..+.. . .....++++||+ ++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~-~-~~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGV-C-EAEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEE-E-cCCCeEEEEEeCCCC
Confidence 4899999999999775 4456799998875433 2447789999999977554444433 3 234678999999 78
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccc
Q 021855 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (306)
Q Consensus 88 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (306)
+|.+++......+++..++.++.|++.||.|||++|++||||||+||++ +.++.++|+|||.+...........
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~--- 153 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYK--- 153 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCcccee---
Confidence 9998887655678999999999999999999999999999999999999 4788999999999875433221110
Q ss_pred cCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
......++..|+|||.+.+..++.++|||||||++|++++ |..||...........+ ........ ....++
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~~---~~~~~~ 225 (257)
T cd05115 154 -ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI----EQGKRLDC---PAECPP 225 (257)
T ss_pred -ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----HCCCCCCC---CCCCCH
Confidence 0011223567999999988889999999999999999996 99999876544322222 22222121 145688
Q ss_pred HHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
++.++|.+||+.||++||++.+|.+.|++++
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=283.41 Aligned_cols=248 Identities=20% Similarity=0.268 Sum_probs=193.5
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.|++.+.||+|+||.||++.+..+++.||+|.+..... ...+.+|+.+++.+.|++.+ .+...+......++++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~-~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVV-SLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCee-eeeEEEecCCEEEEEE
Confidence 37889999999999999999999999999998764321 12356789999998775444 4444445667899999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+.+.... ..+++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 998 788988775432 358999999999999999999999999999999999999 578899999999986543222
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. ....++..|+|||++.+..++.++|+||+||++|+|++|..||................... ....
T Consensus 157 ~~--------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~ 224 (285)
T cd05630 157 TI--------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----QEEY 224 (285)
T ss_pred cc--------cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----hhhc
Confidence 11 13467899999999999899999999999999999999999998643321111222211111 1112
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
...+++++.+++.+||+.||.+||| ++++++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 2456888999999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=282.09 Aligned_cols=253 Identities=20% Similarity=0.289 Sum_probs=194.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeec-----eeCcee
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYG-----VDGEDN 78 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 78 (306)
..++|++.+.||+|++|.||+|.+..+++.+++|+...... ...+.+|+.++..+..|+++..+..++ ..+...
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 45789999999999999999999999999999998765332 345777999999996556666554433 234568
Q ss_pred EEEEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 79 VLVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
++++||+ +++|.+++.. ....+++..+..++.|++.||.|||+.+++||||||+||+++ .++.++|+|||.+.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~ 172 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEEccCCcee
Confidence 9999999 7889887653 234588899999999999999999999999999999999994 78889999999987
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 229 (306)
........ .....++..|+|||++.. ..++.++||||+||++|+|++|..||......... ....
T Consensus 173 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~---~~~~ 242 (286)
T cd06638 173 QLTSTRLR-------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---FKIP 242 (286)
T ss_pred ecccCCCc-------cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH---hhcc
Confidence 65432211 123467889999998853 34788999999999999999999999875432221 1111
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
... .+.......++.++.++|.+||+.||++|||+.++++.
T Consensus 243 ~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 RNP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccC--CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 111 11111113457789999999999999999999999873
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=280.95 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=196.5
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeecee------Cce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVD------GED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~------~~~ 77 (306)
..++|++.+.||.|++|.||+|.+..+++.+++|++..... ...+.+|+.+++++..|+++..+..++.. ...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 35899999999999999999999988899999998775433 35578899999999656776666555433 345
Q ss_pred eEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
.++++||+ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccc
Confidence 79999999 67888887653 3568999999999999999999999999999999999999 47899999999998
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 228 (306)
......... .....++..|+|||++... .++.++|||||||++|+|++|..||...... .....+
T Consensus 161 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~ 230 (275)
T cd06608 161 AQLDSTLGR-------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFKI 230 (275)
T ss_pred eecccchhh-------hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHHh
Confidence 764432221 1244578899999987542 4678899999999999999999999764432 222222
Q ss_pred hhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
......... ....+++.+.++|.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 222211111 11346788999999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=284.72 Aligned_cols=254 Identities=19% Similarity=0.315 Sum_probs=200.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.++|++.+.||.|++|.||+|.+..++..+++|.+..... ...+..|+.+++.+.| +++..+...+......++++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH-PNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEecCCeEEEEee
Confidence 4679999999999999999999988899999998764432 2357789999999985 566666666667778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhcccccc
Confidence 99 778888887656679999999999999999999999999999999999999 57899999999988654332211
Q ss_pred ccccccCCccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 163 RHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
.....++..|++||++. +..++.++|+|||||++|+|++|..||...+... ..........+..
T Consensus 160 -------~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~- 228 (280)
T cd06611 160 -------RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLKILKSEPPTL- 228 (280)
T ss_pred -------cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHHHhcCCCCCc-
Confidence 12445788899999975 3446789999999999999999999998754432 2222222111111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.....++..+.++|.+||+.+|.+|||++++++ +.++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~ 265 (280)
T cd06611 229 -DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK--HPFV 265 (280)
T ss_pred -CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc--Chhh
Confidence 111456789999999999999999999999977 4444
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.52 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=199.9
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|++.+.||.|++|.||+|.+..+++.|++|++..... ...+.+|+.+++++.| +++..+...+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-PYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCC-CCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999998999999998765432 3457889999999985 566666666667788999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+++++|.+++......+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~- 155 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPR- 155 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCCC-
Confidence 99999999987656679999999999999999999999999999999999999 47899999999998766543211
Q ss_pred cccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc----------
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---------- 232 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------- 232 (306)
......++..|+|||++.+.. ++.++||||+||++|+|++|..||.+.................
T Consensus 156 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 156 -----LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -----ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 112346788999999987654 6899999999999999999988887654332222211111100
Q ss_pred ------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 ------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...+.....++.+..+.++|.+||+.||++|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000112223456788999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=278.34 Aligned_cols=258 Identities=18% Similarity=0.305 Sum_probs=199.2
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCc---eEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
...|++.+.||+|++|.||+|.+..++. .|++|.+..... ...+..|+.+++.+.| +++..+..++......+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-cCcceEEEEECCCCceE
Confidence 3569999999999999999999876654 599998875432 2357789999998876 55556666666777889
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++||+ +++|.+++....+.+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence 999999 678988887655568999999999999999999999999999999999999 5788999999999875543
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
...... +........+..|+|||++.+..++.++|||||||++||+++ |..||...+.... ...+ ......+.
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i-~~~~~~~~ 232 (269)
T cd05065 159 DTSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAI-EQDYRLPP 232 (269)
T ss_pred Cccccc--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHH-HcCCcCCC
Confidence 222110 000001112457999999998899999999999999999887 9999987554322 2222 12222221
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
+ ..++..+.+++.+||+.+|++||++++++..|+.+
T Consensus 233 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 P---MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred c---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 45678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=283.69 Aligned_cols=261 Identities=19% Similarity=0.285 Sum_probs=195.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEcC----------------CCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVD----------------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGI 65 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~----------------~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~ 65 (306)
..++|++.+.||+|+||.||++++.. ++..+|+|.+..... ...+.+|+.+++.+.| +++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKD-PNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCc
Confidence 45689999999999999999986532 344689998875432 2457789999999976 555
Q ss_pred CcceeeceeCceeEEEEecc-CCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCce
Q 021855 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 134 (306)
Q Consensus 66 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Ni 134 (306)
..+..++......++++||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 56666666777889999999 789998886532 1366778999999999999999999999999999999
Q ss_pred eeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCC
Q 021855 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLP 212 (306)
Q Consensus 135 lv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t--g~~p 212 (306)
+++ .++.++|+|||.+.......... .......+..|++||+..+..++.++|+|||||++|+|++ |..|
T Consensus 162 li~---~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 162 LVG---KNYTIKIADFGMSRNLYSGDYYR-----IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred EEc---CCCCEEeccCcccccccCCccee-----ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 994 78899999999987653322110 1112334567999999888889999999999999999998 7789
Q ss_pred CCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
|...+..........................+++.+.+++.+||+.||.+|||+.+|.+.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 97654332221111111111000000011446788999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=278.74 Aligned_cols=253 Identities=19% Similarity=0.317 Sum_probs=191.4
Q ss_pred eeEeeeecccCccEEEEEEEcCCCc--eEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeece-----eCce
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGED 77 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~--~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~ 77 (306)
|.+.+.||+|+||.||+|.+..++. .+|+|.+..... ...+.+|..+++.+.|.+.+..+..+.. ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578999999999999999876665 589998765422 2346778899999977554444433221 1224
Q ss_pred eEEEEecc-CCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeec
Q 021855 78 NVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg 151 (306)
.++++||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCC
Confidence 68999999 78998877532 1237899999999999999999999999999999999999 478999999999
Q ss_pred cccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhh
Q 021855 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 230 (306)
.+......... .......++..|++||++.+..++.++|||||||++|+|++ |..||.+..... .......
T Consensus 158 ~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDYY-----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYLRQ 229 (272)
T ss_pred cccccCcccce-----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHc
Confidence 98765432211 01123345677999999999899999999999999999999 899998754332 2222222
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
.. ..+ ....++..+.++|.+||+.||++|||+++|++.|+++
T Consensus 230 ~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GN-RLK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC-CCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 111 1245678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=282.81 Aligned_cols=248 Identities=17% Similarity=0.303 Sum_probs=193.7
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
.|++.+.||.|++|.||+|.+..++..+++|.+..... ...+.+|+.+++.+.| +++..+...+......++++||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCC-CCeeeEEEEEeeCCEEEEEEEec
Confidence 46889999999999999999999999999998765432 2356778899999876 45555555556677899999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+++|..++.....++++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+........
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccccccc---
Confidence 677777766545679999999999999999999999999999999999999 4788999999999865432211
Q ss_pred ccccCCccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 165 IPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
......++..|+|||++. +..++.++|+||+||++|+|++|..||...+.. .............. .
T Consensus 159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~--~ 229 (282)
T cd06643 159 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSEPPTL--A 229 (282)
T ss_pred ----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHHHHhhcCCCCC--C
Confidence 112446788999999984 345788999999999999999999999875432 22222222211111 1
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....++..+.++|.+||+.||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11456789999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=285.60 Aligned_cols=264 Identities=19% Similarity=0.311 Sum_probs=203.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCC-------CceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~-------~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
+...+|++.+.||+|+||.||+|++... +..|++|....... ...+.+|+.+++++..|+++..+...+.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 4456899999999999999999986432 23689998775432 2457789999999965677777766666
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeec
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~ 137 (306)
.....++++||+ +++|.+++.... ..++...+..++.|++.||.|||++|++||||||+||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill- 167 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV- 167 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE-
Confidence 777889999999 779998886422 236778889999999999999999999999999999999
Q ss_pred cCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 021855 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (306)
Q Consensus 138 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~ 216 (306)
+.++.++|+|||.++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 168 --TEDNVMKIADFGLARDVHNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred --cCCCcEEECCcccceecccccccc-----cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 478899999999987654322110 0112233567999999999899999999999999999998 88999775
Q ss_pred hhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
+... .. ..+........ ...++.++.+++.+||+.+|++|||+.++++.|++++.....
T Consensus 241 ~~~~---~~-~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 241 PVEE---LF-KLLKEGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred CHHH---HH-HHHHcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 4322 22 22222222111 145578899999999999999999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=279.91 Aligned_cols=254 Identities=21% Similarity=0.358 Sum_probs=192.8
Q ss_pred eeEeeeecccCccEEEEEEEcC---CCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeC-----c
Q 021855 9 YKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG-----E 76 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-----~ 76 (306)
|.+.+.||+|+||.||.|.+.. ++..||+|.+...... ..+.+|+..++.+.|++.+..+..+.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5788999999999999998754 3478999988754332 34677889999887754443333222211 2
Q ss_pred eeEEEEecc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEee
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Df 150 (306)
..++++||+ +++|..++.... ..+++..+..++.|++.||.|||++|++||||||+||++ ++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECCc
Confidence 368999998 789988875421 248899999999999999999999999999999999999 57899999999
Q ss_pred ccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHh
Q 021855 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~ 229 (306)
|.+.......... .......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.... .......
T Consensus 158 g~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYR-----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLR 229 (273)
T ss_pred cceeecccccccc-----ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH
Confidence 9987654332210 1112234567999999988889999999999999999999 88999765433 2222222
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
... ... ....+++.+.+++.+||+.||.+|||+.++++.|++++
T Consensus 230 ~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 230 HGN-RLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred cCC-CCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 221 111 12566889999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=297.54 Aligned_cols=237 Identities=22% Similarity=0.324 Sum_probs=197.1
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCCHH
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLE 90 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~ 90 (306)
++.||+|+.|.||+|+. .++.||||..+. .-..+++.|+.|.|.+ |..+...+...-.+||+|||| .|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e-----lkETdIKHLRkLkH~N-II~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE-----LKETDIKHLRKLKHPN-IITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhh-----hhhhhHHHHHhccCcc-eeeEeeeecCCceeEEeeeccccccHH
Confidence 67899999999999986 578899996553 2234788899998855 445555666777899999999 99999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCC
Q 021855 91 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170 (306)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 170 (306)
.++.. +..+.......|..+||.|+.|||...|+|||||..|||++ .+..+||+|||.++....-.+.
T Consensus 201 ~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STk-------- 268 (904)
T KOG4721|consen 201 EVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTK-------- 268 (904)
T ss_pred HHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhh--------
Confidence 99986 66789999999999999999999999999999999999996 7889999999999887665442
Q ss_pred ccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHH
Q 021855 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFAS 250 (306)
Q Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (306)
-.+.||..|||||++...+.+.|+||||||++|+||+||..||...+.. ..+--.....+..+++ ..+|+.++-
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~LpvP---stcP~Gfkl 342 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHLPVP---STCPDGFKL 342 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccccCc---ccCchHHHH
Confidence 2678999999999999999999999999999999999999999875433 2222222223333434 566999999
Q ss_pred HHHhhhcCCCCCCCChHHHHHHHH
Q 021855 251 YFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 251 li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
||++||+-.|..|||+.+++..|+
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHh
Confidence 999999999999999999998876
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=282.09 Aligned_cols=261 Identities=21% Similarity=0.280 Sum_probs=200.4
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-------hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+|++.+.||.|++|.||+|.+..+++.|++|.+...... ..+..|+.+++.+.| +++..+..++......++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH-PNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCC-CCChhhhheeecCCEEEE
Confidence 589999999999999999999989999999987654322 335678899999886 455555555556778999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
++||++++|.+++......+++..+..++.||++||.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCCC
Confidence 99999999999887643368999999999999999999999999999999999999 478999999999997654432
Q ss_pred CCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc-------
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK------- 232 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~------- 232 (306)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.................
T Consensus 157 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 157 RK-------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred cc-------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 21 113345778999998865 457899999999999999999988887655432222221111000
Q ss_pred -------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 233 -------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 233 -------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
...+........+..+.++|.+||++||.+|||+++++. ..++.+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~~ 289 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSNDP 289 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccCCC
Confidence 001112222445778999999999999999999999988 77776443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=299.72 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=207.8
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.|.-++.||.|+||.||-|++..+.+.||||.+.-. ..+.+.++|+..+.++.|++ ..-+..++..+...++||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPn-tieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPN-TIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCC-cccccceeeccchHHHHH
Confidence 456678999999999999999999999999988743 33567899999999999854 445556666777789999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|||-|+..+++.-...++.+..+..|+.+.+.||.|||+.+.+|||||..|||++ +.|.+||+|||++.......
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~PAn-- 180 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAPAN-- 180 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCchh--
Confidence 9999999999988788899999999999999999999999999999999999995 99999999999997644322
Q ss_pred ccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 163 RHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.++||++|||||++. .+.|+-++||||||++..||...++|+.+++...... .+.... ++.+.
T Consensus 181 ---------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY---HIAQNe-sPtLq- 246 (948)
T KOG0577|consen 181 ---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNE-SPTLQ- 246 (948)
T ss_pred ---------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH---HHHhcC-CCCCC-
Confidence 679999999999986 4578899999999999999999999999887753333 332222 22222
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...++..++.++..||++-|.+|||.++++. +.++.
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~--H~fv~ 282 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLK--HRFVL 282 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHhh--cchhc
Confidence 2677899999999999999999999999877 44443
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=295.86 Aligned_cols=255 Identities=21% Similarity=0.304 Sum_probs=193.9
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||+|++..+++.||+|++... .....+..|..++..+.| +++..+...+......+++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 4699999999999999999999999999999987632 222346678888888876 5555555556677889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccc
Confidence 9999 7899988875 4568999999999999999999999999999999999999 588999999999986543211
Q ss_pred CCcc----------------------------ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 021855 161 TNRH----------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212 (306)
Q Consensus 161 ~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p 212 (306)
.... ..........||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 1000 000001134689999999999999999999999999999999999999
Q ss_pred CCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCC---hHHHHH
Q 021855 213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKR 271 (306)
Q Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~l~~ 271 (306)
|....... .+..+.........+. ....++.+.++|.+|+. ||.+|++ ++++++
T Consensus 236 f~~~~~~~---~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 236 FCSETPQE---TYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCHHH---HHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 98755432 2222222111111110 02357889999999874 9999985 566655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=283.21 Aligned_cols=262 Identities=20% Similarity=0.312 Sum_probs=202.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcC-------CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
+..++|.+.+.||+|++|.||+|++.. ....+++|.+...... ..+.+|+.+++.+..|+++..+..++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 345789999999999999999998632 3456899987754332 346778899998865677777766666
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeec
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~ 137 (306)
.....++++||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 167 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV- 167 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE-
Confidence 677789999999 789999886532 247888899999999999999999999999999999999
Q ss_pred cCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 021855 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (306)
Q Consensus 138 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~ 216 (306)
+.++.++|+|||.++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred --cCCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 478899999999997654322110 0112233457999999998889999999999999999999 89999775
Q ss_pred hhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.... .+..+.. ..... ....++.++.+++.+||+.||++|||++++++.|.++....
T Consensus 241 ~~~~---~~~~~~~-~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 241 PVEE---LFKLLRE-GHRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CHHH---HHHHHHc-CCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 4322 2222221 11111 12456788999999999999999999999999999997644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=275.54 Aligned_cols=272 Identities=18% Similarity=0.179 Sum_probs=219.3
Q ss_pred cCCceeE-eeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceee----ceeCceeE
Q 021855 5 IGVKYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWY----GVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i-~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~----~~~~~~~~ 79 (306)
+.++|.+ .++||-|-.|.|-.+.++.|++.+|+|++.. .+...+|+++.=+...+++++.+... +.+.....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 4566766 5789999999999999999999999998764 34466788877777777887776433 23445678
Q ss_pred EEEecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 80 LVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+|||++ ||.|.+-+...+. .+++.++..|+.||..|+.|||+.+|+||||||+|+|.+....+..+||+|||.++...
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 999999 8999998887544 49999999999999999999999999999999999999877789999999999998765
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhH-HHHHHHhhcccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDKICEKKVSTP 236 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 236 (306)
.+... .+.+.|+.|.|||++-...|+...|+||+|+++|-|+.|.+||+.......- ....++..+.+.+|
T Consensus 216 ~~~~L--------~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 216 EPGDL--------MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred CCccc--------cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 43332 2556799999999999999999999999999999999999999875543222 23345555556666
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccc
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 290 (306)
.+. +..+|+..+++|+.+|..+|++|.|++++.+ +.++.+...-+..|...
T Consensus 288 ~pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~--hpwi~~~~~vp~tpl~t 338 (400)
T KOG0604|consen 288 EPE-WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD--HPWINQYEAVPQTPLST 338 (400)
T ss_pred Chh-HhHHHHHHHHHHHHHhcCCchhheeHHHhhc--CchhcccccCCCCCchh
Confidence 444 3678999999999999999999999999987 77776655555555443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=288.13 Aligned_cols=280 Identities=19% Similarity=0.219 Sum_probs=205.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeecee----Cc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~ 76 (306)
++++|.+.+.||.|++|.||+|++..+++.|++|.+... .....+.+|+.+++.+.|.+.+.....+... ..
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 567899999999999999999999999999999987643 1223466789999998775444433322211 13
Q ss_pred eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
..++++||++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++...
T Consensus 83 ~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTT 158 (337)
T ss_pred cEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccccc
Confidence 5799999999999888765 4569999999999999999999999999999999999999 47899999999998765
Q ss_pred CCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc----
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK---- 231 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---- 231 (306)
...... .....++..|+|||.+.. ..++.++|+|||||++|+|++|..||.+.+.......+......
T Consensus 159 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 159 SEKGDF-------MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred CCCccc-------ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 433211 123456888999998865 45889999999999999999999999765432222211111110
Q ss_pred -------------------ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH--HHHhHh-hcCCCCCcccc
Q 021855 232 -------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL--FHDLFS-REGYDFDFVFD 289 (306)
Q Consensus 232 -------------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~~-~~~~~~~~~~~ 289 (306)
..........+.+++.+.++|++||+.||++|||++++++. |+.+.. ........+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~ 311 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFS 311 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccc
Confidence 01111122235678889999999999999999999999884 443321 12222344555
Q ss_pred ceecch
Q 021855 290 WTILKY 295 (306)
Q Consensus 290 ~~~~~~ 295 (306)
.++...
T Consensus 312 ~~~~~~ 317 (337)
T cd07858 312 FDFEED 317 (337)
T ss_pred hhhhhh
Confidence 555443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=293.59 Aligned_cols=239 Identities=23% Similarity=0.293 Sum_probs=186.1
Q ss_pred ecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHh--CCCCCCcceeeceeCceeEEEEecc-C
Q 021855 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
||+|+||.||+|++..+++.||+|++.... .......|..++.... +++++..+...+......+++|||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999999999999999876421 1122344556665554 5677777777777788899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~----- 151 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNK----- 151 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCC-----
Confidence 788888765 4569999999999999999999999999999999999999 5789999999999865322211
Q ss_pred ccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCc
Q 021855 167 YRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (306)
......|+..|+|||++.+.. ++.++|||||||++|+|++|..||...... ..+..+.......+. ..++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~----~~~~ 222 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMYRNIAFGKVRFPK----NVLS 222 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHHHHHHcCCCCCCC----ccCC
Confidence 112456899999999987654 789999999999999999999999875432 233333333322221 3457
Q ss_pred hHHHHHHHhhhcCCCCCCCC----hHHHHH
Q 021855 246 AEFASYFHYCQSLTFDQRPD----YGFLKR 271 (306)
Q Consensus 246 ~~~~~li~~cl~~dP~~Rps----~~~l~~ 271 (306)
+++.++|.+||+.||.+||+ +.++++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 88999999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=289.73 Aligned_cols=259 Identities=21% Similarity=0.262 Sum_probs=196.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeece-----e
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----D 74 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~ 74 (306)
.+.++|++.+.||+|++|.||+|++..+++.||+|.+.... ....+.+|+.+++++.|.+.+..+..+.. .
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35788999999999999999999999999999999876432 22346679999999987555444433322 2
Q ss_pred CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
....++++|++.++|.+.+.. .++...+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||.+.
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccce
Confidence 235799999999999887754 28899999999999999999999999999999999999 588999999999997
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-- 232 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-- 232 (306)
....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 167 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 167 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred eCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 6543221 113456888999999999999999999999999999999999998654332222111111100
Q ss_pred -----------------ccc---chHHH-------------hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 233 -----------------VST---PIEVL-------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 233 -----------------~~~---~~~~~-------------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
... +.... ....++.+.++|.+||+.||++|||+.+++. ..++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~--~~~~~ 315 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ--HPYIN 315 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc--ChhHh
Confidence 000 00000 1123567899999999999999999999987 55554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=275.23 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=199.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+-.++|++.+.||.|++|.||+|.. .++.|++|.+..... ...+.+|+.++..+.|.+ +..+..+...+...++++
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPN-LVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcc-eeeeEEEEcCCCCeEEEE
Confidence 3467899999999999999999986 478899998876644 456788999999998744 444444455577889999
Q ss_pred ecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|++ +++|.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccccc
Confidence 999 6799998875432 58999999999999999999999999999999999999 588999999999997653322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
. ....+..|+|||++.+..++.++|+||||+++|++++ |..||........ . ..........
T Consensus 157 ~----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~-~~~~~~~~~~--- 219 (256)
T cd05039 157 D----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V-PHVEKGYRME--- 219 (256)
T ss_pred c----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---H-HHHhcCCCCC---
Confidence 1 2233567999999988889999999999999999997 9999976543322 1 2222221211
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
.....++.+.++|.+||..+|.+|||+.++++.|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1145688999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=276.90 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=197.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----------hhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+|.+...||+|++|.||+|.+..+++.+++|.+...... ..+.+|+.+++.+.| +++..+..++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH-ENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCC
Confidence 478899999999999999999888999999977643221 246678889999976 55656666667778
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++||+ +++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||++ ++++.++|+|||.+..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK 155 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcc
Confidence 899999999 7789888875 4568999999999999999999999999999999999999 5889999999999876
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
.......... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ..+........
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~-- 229 (267)
T cd06628 156 LEANSLSTKT-NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKIGENAS-- 229 (267)
T ss_pred cccccccCCc-cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHHHhccCC--
Confidence 6532211100 01112345788899999999888999999999999999999999999875432 22222212111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
+.....++..+.++|++||+.||.+||++.++++
T Consensus 230 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 --PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1122456889999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=280.45 Aligned_cols=256 Identities=18% Similarity=0.299 Sum_probs=197.7
Q ss_pred ceeEeeeecccCccEEEEEEEcC-----CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
+|++.+.||+|+||.||+|.+.. ....+++|.+...... ..+.+|+.+++.+.| +++..+...+......+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH-PHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCCcE
Confidence 47899999999999999998743 2356888877654332 357789999999877 45545555555667789
Q ss_pred EEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcee
Q 021855 80 LVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nil 135 (306)
+++||+ +++|.+++.... ..++...++.++.|++.||.|||+.|++||||||+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999 789988876421 23778889999999999999999999999999999999
Q ss_pred eccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 021855 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 214 (306)
Q Consensus 136 v~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~ 214 (306)
+ ++++.++|+|||.+.......... ......++..|+|||.+.+..++.++||||||+++++|++ |..||.
T Consensus 160 l---~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 160 V---AEGRKMKISDFGLSRDVYEEDSYV-----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred E---cCCCcEEeccccccccccCccchh-----cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9 478899999999987643322110 1112344668999999988889999999999999999998 999998
Q ss_pred CchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 215 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+..... +..........+. ...++.++.+++.+||+.+|.+||++.++++.|++++.+
T Consensus 232 ~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 232 GIAPER----LFNLLKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCHHH----HHHHHhCCCCCCC---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 754332 2222222222221 145678999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.69 Aligned_cols=261 Identities=23% Similarity=0.252 Sum_probs=194.7
Q ss_pred CCceeEeeeecccCccEEEEEEE----cCCCceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCcceeec-eeCcee
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDN 78 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~----~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~~ 78 (306)
..+|++.+.||+|+||.||++.. ..++..|++|.+...... ..+.+|+.++..+.|.+.+.....+. ......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46899999999999999999974 457889999987654332 35678999999998754443333222 234467
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++||+ +++|.+++......+++..++.++.|++.||.|||++|++||||||+||++ +.++.++|+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCccccccc
Confidence 8999999 789999987655568999999999999999999999999999999999999 478999999999998654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh------------HHHH
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK------------KQKY 225 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~------------~~~~ 225 (306)
....... ......++..|+|||++.+..++.++||||||+++|+|++|..|+........ ....
T Consensus 160 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEYYK----VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCccee----ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 3322100 00112234569999999988899999999999999999998877644221100 0001
Q ss_pred HHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
..........+ ....+++.+.++|.+||+.+|++|||+++|++.|+.+
T Consensus 236 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111111 1145678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=280.13 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=197.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+...+|.+.+.||+|+||.||++... .++..+++|.+..... ...+.+|+.++..+.| +++..+..++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 80 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH-QHIVRFYGVCTEGR 80 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCC-CCCceEEEEEecCC
Confidence 45678999999999999999999642 3466788897664332 2457889999999976 55555655666677
Q ss_pred eeEEEEecc-CCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR--------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~--------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~ 141 (306)
..++++||+ +++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+|||+ ++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence 789999999 789998887532 247889999999999999999999999999999999999 47
Q ss_pred cceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhh
Q 021855 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (306)
Q Consensus 142 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~ 220 (306)
++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 232 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232 (280)
T ss_pred CCCEEECCCCceeEcCCCcee-----ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH
Confidence 899999999998654322110 11123345678999999999999999999999999999998 999997654432
Q ss_pred hHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
. ........ ... ....+|+.+.++|.+||+.||.+||++++|++.|+
T Consensus 233 ~---~~~~~~~~-~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 A---IECITQGR-ELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H---HHHHHcCc-cCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 2 22222211 111 11456889999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=281.50 Aligned_cols=251 Identities=18% Similarity=0.322 Sum_probs=195.5
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeece------eCce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGV------DGED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~------~~~~ 77 (306)
..+.|++.+.||.|+||.||+|++..+++.+++|+..... ....+..|+.++.++.+|+++..+..++. ....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 4578999999999999999999999999999999876543 33456778888988876677766544442 2456
Q ss_pred eEEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||+|+||++ ++++.++|+|||.+..
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhh
Confidence 79999999 668988887533 348888899999999999999999999999999999999 4788999999999875
Q ss_pred cCCCCCCccccccCCccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
...... ......++..|+|||++. ...++.++|+|||||++|+|++|..||.......... ....
T Consensus 171 ~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---~~~~ 240 (282)
T cd06636 171 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---LIPR 240 (282)
T ss_pred hhcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---hHhh
Confidence 433221 112456788999999886 3457889999999999999999999997654322111 1111
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.. +.......+++.+.++|.+||+.||.+|||+.+|++
T Consensus 241 ~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 NP---PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CC---CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11 111112456889999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=276.62 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=194.8
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
-++|++.+.||+|++|.||.+.. +++.+++|..........+.+|+.++..+.|++.+..... +.. ...++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-~~~-~~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV-ILH-NGLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEE-EcC-CCcEEEEECC
Confidence 36799999999999999999864 6788999988766556678889999999987555544433 333 3478999999
Q ss_pred -CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 86 -GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 86 -~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+++|.+++..... .+++..++.++.|++.||.|||++|++||||+|+||++ +.++.++|+|||.+........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceeccccCC--
Confidence 7899999875432 47899999999999999999999999999999999999 4789999999999875432211
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
....+..|+|||.+.+..++.++|+|||||++|+|++ |..||........... ......... ..
T Consensus 156 --------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~~~~---~~ 220 (254)
T cd05083 156 --------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC----VEKGYRMEP---PE 220 (254)
T ss_pred --------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH----HhCCCCCCC---CC
Confidence 2233567999999998899999999999999999998 9999987554322222 222222211 24
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
.+++.+.+++.+||+.+|.+||++++|+..|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 568899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=311.26 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=196.0
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeec-eeCce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG-VDGED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~ 77 (306)
...-++|++.+.||+|+||.||+|++..++..+++|.+..... ...+..|+.++..|.|++.+..+..+. .....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3455789999999999999999999999999999998764322 245778999999998865555444433 33456
Q ss_pred eEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHc-------CccccCCCCCceeeccC-------
Q 021855 78 NVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-------GFLHRDIKPDNFLMGLG------- 139 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-------~i~H~dlkp~Nilv~~~------- 139 (306)
.+++|||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++..
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999 78999888642 24689999999999999999999985 49999999999999521
Q ss_pred -------CCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCC
Q 021855 140 -------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGS 210 (306)
Q Consensus 140 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~ 210 (306)
+..+.+||+|||++......... ....+++.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~--------~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMA--------HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccc--------cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 22456899999999765332211 24468999999999864 45889999999999999999999
Q ss_pred CCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 211 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.||...... ..+...+......+ ....++++.+||..||+.+|.+||++.+++.
T Consensus 241 ~PF~~~~~~---~qli~~lk~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 241 TPFHKANNF---SQLISELKRGPDLP----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCcCCcH---HHHHHHHhcCCCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999764332 12222222222211 1345788999999999999999999999985
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.63 Aligned_cols=254 Identities=21% Similarity=0.267 Sum_probs=194.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||.|++|.||+|.++.+++.|++|.+..... ...+.+|+.+++.+.| +++..+..++......++++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH-ANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCC-cceeeEEEEEecCCeEEEEEe
Confidence 679999999999999999999988899999998764322 2346789999999976 556666666677788999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
|+.++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCCcc-
Confidence 99889999887655678999999999999999999999999999999999999 58899999999998654322111
Q ss_pred cccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhh-hhHHHHHHHhhccc--------
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICEKKV-------- 233 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~-------- 233 (306)
.....++..|+|||++.+. .++.++||||+|+++|+|++|..||...... ..............
T Consensus 160 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 160 ------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred ------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 1123457789999998764 5789999999999999999999999764421 11111111110000
Q ss_pred --------------ccchHHHhhcCc--hHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 234 --------------STPIEVLCKSHP--AEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 234 --------------~~~~~~~~~~~~--~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..+........+ .++.+++.+||+.||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000111112233 77889999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=287.05 Aligned_cols=269 Identities=20% Similarity=0.272 Sum_probs=203.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeec----eeCc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYG----VDGE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~----~~~~ 76 (306)
++.+|++.+.||.|++|.||+|.+..+++.|++|.+.... ....+.+|+.+++.+.| +++..+...+ ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH-DNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCC-CCccCHHHhccccCCCCc
Confidence 4689999999999999999999999999999999876532 22346678999999986 4454443222 2345
Q ss_pred eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
..++++||++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||++ +.++.++|+|||.+...
T Consensus 82 ~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceee
Confidence 6899999998898888765 4458999999999999999999999999999999999999 58899999999998765
Q ss_pred CCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH-------
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI------- 228 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~------- 228 (306)
........ .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 158 SSSPTEHK---YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred cccCcCCC---cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 43322110 01123467889999999866 45889999999999999999999999775433222211111
Q ss_pred ----------------hhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 229 ----------------CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 229 ----------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
.......+.....+..++++.++|.+||+.||.+|||+.+++. ..++++...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~--~~~~~~~~~~ 303 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ--HPFLAQYHDP 303 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh--ChhhhhccCC
Confidence 1111112222333556889999999999999999999999977 6666543333
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.19 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=198.9
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|++|.||++.+..+++.+|+|++... .....+.+|+.+++++.| +++..+...+..+...+++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH-PFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCeEEEE
Confidence 4799999999999999999999999999999987642 223457789999999985 6666666666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+||+ +++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCCC
Confidence 9999 8899998876 3568999999999999999999999999999999999999 578999999999987654431
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+.......+
T Consensus 156 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~---- 218 (290)
T cd05580 156 ----------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKILEGKVRFP---- 218 (290)
T ss_pred ----------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCccCC----
Confidence 1446788999999998888899999999999999999999999765432 23333333333322
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
...++.+.++|.+||+.||.+|+ +++++++
T Consensus 219 -~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 -SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 45588999999999999999999 5666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=279.37 Aligned_cols=259 Identities=21% Similarity=0.305 Sum_probs=198.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcC-----CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+..++|++.+.||+|++|.||+|.++. .+..||+|.+...... ..+.+|+.+++.+.| +++..+...+...
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC-HHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC
Confidence 456899999999999999999997642 3457999987644322 245678888988876 5566666556666
Q ss_pred ceeEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceE
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~ 145 (306)
...++++||+ +++|.+++.... ..++...+..++.|++.||.|||++|++||||||+||++ ++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcE
Confidence 7889999999 789999987532 124567788999999999999999999999999999999 478999
Q ss_pred EEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHH
Q 021855 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK 224 (306)
Q Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~ 224 (306)
+|+|||.+.......... ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+..... .
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-----KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---V 230 (288)
T ss_pred EECcCCcccccccccccc-----ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999987543322110 1112334667999999998899999999999999999998 788997654332 2
Q ss_pred HHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+....... .....++.+.+++.+||+.||.+|||+.++++.|++.+.
T Consensus 231 ~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 231 LKFVMDGGYLD----QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHHHHcCCCCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 22222221111 113457889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=276.23 Aligned_cols=259 Identities=21% Similarity=0.318 Sum_probs=199.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCC---CceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+-..+|.+.+.||.|++|.||+|.+... ...|++|....... ...+.+|+.+++.+.|.+.+. +..+..+ ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~-~~~~~~~-~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK-LIGVITE-NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhc-eeEEEcC-CC
Confidence 3456799999999999999999987543 34688998765432 235778999999998754444 4333333 45
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++|++ +++|.+++......+++..++.++.|++.||.|||+.|++|+||||+||+++ ..+.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeec
Confidence 78999999 7899999876555689999999999999999999999999999999999994 7889999999998765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
...... ......++..|+|||.+.+..++.++||||||+++|++++ |..||...........+.. ......
T Consensus 158 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~--~~~~~~ 229 (270)
T cd05056 158 EDESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN--GERLPM 229 (270)
T ss_pred ccccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--CCcCCC
Confidence 433211 0112234567999999988889999999999999999996 9999987654322222211 111111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...+|+.+.++|.+||..+|.+|||+.++++.|+++...+
T Consensus 230 -----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 230 -----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred -----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 2556889999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=279.59 Aligned_cols=247 Identities=19% Similarity=0.244 Sum_probs=192.7
Q ss_pred eeecccCccEEEEEEEcCCCc--eEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNE--IVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~--~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|++|.||+|++..++. .+++|.+.... ....+.+|+.++.++.+|+++..+...+......++++||+ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999887775 45788776432 22457789999999977777777776777777789999999 7
Q ss_pred CCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeec
Q 021855 87 PSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (306)
Q Consensus 87 ~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg 151 (306)
++|.+++.... ..++++.+..++.|++.||.|||+.|++|+||||+||++ ++++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCC
Confidence 89999886422 237889999999999999999999999999999999999 588999999999
Q ss_pred cccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhh
Q 021855 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 230 (306)
++........ ......+..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+... ..... .
T Consensus 158 l~~~~~~~~~--------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~-~ 225 (270)
T cd05047 158 LSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL-P 225 (270)
T ss_pred Cccccchhhh--------ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH-h
Confidence 9853221110 011223567999999988889999999999999999997 999997654332 22222 2
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
....... ....+.++.+++.+||+.||.+|||+.+++..|+.++
T Consensus 226 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 QGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCC---CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2111111 1345788999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=277.58 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=197.2
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--------CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
+|+.++.||+|++|.||+|.+..+++.+++|++.... ....+.+|+.+++++.|.+ +..+...+......+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH-IIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCc-eehhhceeccCCeEE
Confidence 5889999999999999999999999999999876432 1235678999999998744 444545556677889
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc-ceEEEEeeccccccC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDFGLAKKYR 157 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~-~~~kl~Dfg~~~~~~ 157 (306)
+++||+ +++|.+++.. ..++++..+..++.||+.||.|||++|++|+||+|+||++. .+ ..++|+|||.+....
T Consensus 80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~---~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID---STGQRLRIADFGAAARLA 155 (268)
T ss_pred EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEEcccccccccc
Confidence 999998 7789888875 45689999999999999999999999999999999999994 44 479999999987765
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
........ ......++..|+|||++.+..++.++|+||+||++++|++|..||.............+........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 230 (268)
T cd06630 156 AKGTGAGE---FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP-- 230 (268)
T ss_pred cccccCCc---cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC--
Confidence 43221111 1123467889999999988889999999999999999999999997544332222222222212111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
......++++.+++.+||+.+|++|||+.++++
T Consensus 231 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 -SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 122456788999999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=281.44 Aligned_cols=261 Identities=22% Similarity=0.263 Sum_probs=195.0
Q ss_pred CceeEeeeecccCccEEEEEEE----cCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeecee-Ccee
Q 021855 7 VKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD-GEDN 78 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~ 78 (306)
.-|++.+.||+|++|.||+++. ..++..|++|.+..... ...+.+|+.+++.+.|.+.+.....+... ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3468999999999999999974 45688899998764422 23577899999999875444433333322 3567
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++||+ +++|.+++......+++..+..++.||+.||.|||++|++||||||+||++ +.++.++|+|||.+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccccc
Confidence 8999999 889999887644468999999999999999999999999999999999999 478899999999987654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchh-----------hhhHHHHH
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA-----------ATKKQKYD 226 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~-----------~~~~~~~~ 226 (306)
...... .......++..|+|||++.+..++.++|||||||++|+|+++..|+..... ........
T Consensus 161 ~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 161 TDKEYY----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cCccce----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 332211 011234567789999999888899999999999999999998766532110 00001111
Q ss_pred HHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.........+ ....+++.+.+++.+||+.||.+|||++++++.|++++
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 237 RVLEEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHHHcCccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1111111111 12456889999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=282.91 Aligned_cols=287 Identities=18% Similarity=0.252 Sum_probs=213.3
Q ss_pred ceeEeeeecccCccEEEEEEEcCC--CceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeec----eeCce
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDT--NEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYG----VDGED 77 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~--~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~----~~~~~ 77 (306)
+|++.+.||.|++|.||++++..+ +..||+|.+.... ....+.+|+.++.++.+|+++..+.... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 8899999876432 2345678999999997666666654332 22245
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
.++++++++++|.+.+.. ...+++..+..++.||+.||.|||+.|++||||||+|||+ +.++.++|+|||.+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecc
Confidence 788999999999988865 4568999999999999999999999999999999999999 578999999999997654
Q ss_pred CCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh-------
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC------- 229 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~------- 229 (306)
....... .......++..|+|||++.+ ..++.++|+||+|+++|++++|..||...+............
T Consensus 157 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGENA---GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ccccccc---ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 3322110 01123467889999998766 458999999999999999999999997644221111111100
Q ss_pred ----------------hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh-----cCCCCCccc
Q 021855 230 ----------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR-----EGYDFDFVF 288 (306)
Q Consensus 230 ----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~-----~~~~~~~~~ 288 (306)
........+...+..+..+.+++.+||+.||.+|||+.+++. ..++.+ ++..+..++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~--~~~~~~~~~~~~~~~~~~~~ 311 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE--HPYLAIWHDPDDEPVCQKPF 311 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--ChhhhhhcCccccccccccc
Confidence 011111122233456788999999999999999999999976 666652 333467777
Q ss_pred cceecchhhhHHhhh
Q 021855 289 DWTILKYQQTQKTKS 303 (306)
Q Consensus 289 ~~~~~~~~~~~~~~~ 303 (306)
+.++..++.++..++
T Consensus 312 ~~~~~~~~~~~~~~~ 326 (332)
T cd07857 312 DFSFESEDSMEELRD 326 (332)
T ss_pred cCCccccccHHHHHH
Confidence 788877777766654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=275.23 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=200.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||.|++|.||+|.+. .++.+++|.+.... ....+.+|+.+++.+.| +++..+...+......++++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRH-DKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCC-CCEeeeeeeeecCCceEEEE
Confidence 56789999999999999999999875 45779999877543 33568889999999886 55555555566667789999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|++ +++|.+++.... ..++...+..++.|++.||.|||++|++|+||+|+||++ ++++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceeccchh
Confidence 998 779999887533 458999999999999999999999999999999999999 478999999999987654321
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. .......+..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.... ....... .....+.+
T Consensus 158 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~-~~~~~~~~- 226 (261)
T cd05034 158 YT------AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVE-RGYRMPRP- 226 (261)
T ss_pred hh------hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH-cCCCCCCC-
Confidence 11 0112234567999999998889999999999999999998 99999765433 2222222 22222211
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
...++.+.+++.+||+.+|.+||+++++.+.|+.
T Consensus 227 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 --PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 3447889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=274.80 Aligned_cols=248 Identities=24% Similarity=0.301 Sum_probs=191.5
Q ss_pred eeecccCccEEEEEEEcCCC---ceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~---~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+.||+|++|.||+|.+..++ ..+++|.+..... ...+.+|+.+++.+.|. ++..+..+.. ....++++||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP-CIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCC-CeeeEEEEEc-CCceEEEEEeCC
Confidence 46899999999999876544 7899998875543 34577889999998764 4444443333 44679999998
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||.+.........
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 79 LGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcc---
Confidence 7899998876 3468999999999999999999999999999999999999 48899999999998765432221
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
+.......++..|+|||.+.+..++.++|||||||++|++++ |..||...+.... ...+ ......+ ....+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~-~~~~~~~---~~~~~ 223 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAML-ESGERLP---RPEEC 223 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHH-HcCCcCC---CCCCC
Confidence 111112223467999999998899999999999999999998 9999977544322 2221 2221111 12456
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
++.+.++|.+||+.+|.+|||+.+|++.|+.+.
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=282.37 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=198.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.++|++.+.||+|++|.||+|.+..+++.|++|.+..... ...+.+|+.+++.+.| +++..+...+......++++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCEEEEeec
Confidence 4789999999999999999999989999999998764332 2446778888888866 455555555566778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+|||+ +.++.++|+|||.+.........
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCCccC
Confidence 99 7889888764 458899999999999999999999999999999999999 47899999999998764332211
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....++..|+|||.+.+..++.++|+|||||++|++++|..||...+..... ....... .+......
T Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---~~~~~~~--~~~~~~~~ 239 (297)
T cd06656 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATNG--TPELQNPE 239 (297)
T ss_pred -------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---eeeccCC--CCCCCCcc
Confidence 11345788899999999888999999999999999999999999764432111 1111111 11111124
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.+++.+.+++.+||+.||++|||++++++ +.+++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~ 273 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLK 273 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhc
Confidence 56788999999999999999999999988 55553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=317.01 Aligned_cols=256 Identities=25% Similarity=0.333 Sum_probs=208.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+-...|+|++.||+|+||.|.+++++.|++.||.|+++. .....-|..|-.++.-- ...=+..+.+.+.++.+.
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccce
Confidence 446789999999999999999999999999999998775 22334466677777532 234455567788999999
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|+||||+ ||+|.+++.... .++++.+.++++.|..||.-+|++|+|||||||+|||+ |..|++||+|||.|....
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcC
Confidence 9999999 999999999755 79999999999999999999999999999999999999 799999999999999888
Q ss_pred CCCCCccccccCCccccccccccCccccc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHL----G-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
..+... ....+|||.|.|||++. + +.|++.+|+||+|+++|||+.|..||+.++-...+..+..- +..
T Consensus 227 ~dG~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-k~~ 299 (1317)
T KOG0612|consen 227 ADGTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-KES 299 (1317)
T ss_pred CCCcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-hhh
Confidence 776643 24778999999999995 3 56999999999999999999999999986655444333221 223
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCC---hHHHHHHHHHhH
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKRLFHDLF 277 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~~l~~~l~~~~ 277 (306)
+.+| +. ..+|+++++||.+.+. +|+.|.. ++++.. +.+|
T Consensus 300 l~FP-~~--~~VSeeakdLI~~ll~-~~e~RLgrngiedik~--HpFF 341 (1317)
T KOG0612|consen 300 LSFP-DE--TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN--HPFF 341 (1317)
T ss_pred cCCC-cc--cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh--Cccc
Confidence 4444 22 3479999999999875 6778987 888866 5555
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=276.75 Aligned_cols=253 Identities=19% Similarity=0.238 Sum_probs=194.7
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|++.+.||.|++|.||+|++..+++.|++|.+..... ...+.+|+.+++++.| +++..+..++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCC-CCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999998764322 2357789999999987 455555555567778999999
Q ss_pred ccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+.++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCccc
Confidence 9988888887653 3458999999999999999999999999999999999999 58899999999998755432211
Q ss_pred ccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc---------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------- 232 (306)
.....++..|+|||++.+.. ++.++|+||||+++|+|+||+.||...+...............
T Consensus 157 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 157 -------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred -------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 11334577899999887654 6889999999999999999999997754332221111111100
Q ss_pred ------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 ------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...........+++.+.++|.+||+.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 001111122346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=277.96 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=198.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++.+.||+|++|.||+|.+..+++.|++|.+.... ....+.+|+.+++.+.| +++..+...+......++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-ENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCC-CCeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999876432 23467889999999986 45555555556677899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
||+++++.+.+......+++..++.++.||+.||.|||+.|++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence 999777776665545668999999999999999999999999999999999999 57999999999998765543321
Q ss_pred ccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc--------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-------- 233 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-------- 233 (306)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||.+..................
T Consensus 157 ------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 157 ------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 11244667889999999888 789999999999999999999999986544322222111111000
Q ss_pred ----------cc---c--hH-HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 234 ----------ST---P--IE-VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 234 ----------~~---~--~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.. + .+ .....+++++.++|.+||..+|++|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 0 00 111234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=285.97 Aligned_cols=259 Identities=19% Similarity=0.234 Sum_probs=190.3
Q ss_pred Eeeeeccc--CccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 11 LGRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 11 i~~~lg~g--~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
+.+.||+| +++.||+++++.+|+.||+|.+...... ..+.+|+.+++.+.| +++..+..++......++++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCEEEEEEec
Confidence 56789999 6789999999999999999988754322 235668888888876 5555566666777889999999
Q ss_pred c-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 85 L-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.++++||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccccccc
Confidence 9 78999988653 3458999999999999999999999999999999999999 47889999999876543222111
Q ss_pred ccccccCCccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS------ 234 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------ 234 (306)
............++..|+|||++.+ ..++.++|||||||++|+|++|..||........... . .....+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~-~~~~~~~~~~~~ 234 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--K-LNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH--H-hcCCcccccccc
Confidence 1000001112346778999999976 3589999999999999999999999976443211111 0 000000
Q ss_pred -----------------------------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 -----------------------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 -----------------------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.........+++.+.++|.+||+.||++|||++++++ +.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~--~p~f~ 311 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN--HSFFK 311 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc--Chhhh
Confidence 0000111235678999999999999999999999987 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=274.58 Aligned_cols=253 Identities=19% Similarity=0.274 Sum_probs=189.4
Q ss_pred eeecccCccEEEEEEEcC---CCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+.||+|+||.||+|.+.. .+..+|+|.+..... ...+.+|+.+++.+.|.+.+..+..+...+...++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 345799998754322 2356778888888877555554443444556688999998
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+++|.+++.......+...+..++.|++.||.|||+.+++||||||+||++ +.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~~- 156 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSV- 156 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcceee-
Confidence 789999987644557788888999999999999999999999999999999 4788999999999875433221100
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||...+... ......... ....+ ...
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~---~~~ 227 (262)
T cd05058 157 --HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLLQGR-RLLQP---EYC 227 (262)
T ss_pred --cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhcCC-CCCCC---CcC
Confidence 01113345668999999988889999999999999999999 566776544322 222221111 11111 345
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
|+.+.+++.+||+.+|++||++.++++.|+.++.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 7889999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=274.64 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=196.9
Q ss_pred eeecccCccEEEEEEEcCC---CceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+.||+|++|.||+|.+... +..+++|.+..... ...+.+|+..+..+.| +++..+..+.......++++||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH-PNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCC-CChheeeeeecCCCceEEEEEecc
Confidence 4689999999999998765 88899998876544 3467789999999985 55555555555677899999999
Q ss_pred CCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 86 GPSLEDLFVYC--------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 86 ~~~l~~~~~~~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+++|.+++... ...+++..++.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccc
Confidence 89999998865 3668999999999999999999999999999999999999 478999999999998765
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...... .....
T Consensus 157 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~-~~~~~ 227 (262)
T cd00192 157 DDDYY-----RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---LEYLRK-GYRLP 227 (262)
T ss_pred ccccc-----ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHHc-CCCCC
Confidence 43211 11124456788999999998889999999999999999999 6999987644322 222221 11111
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
....+|+++.+++.+||+.||.+|||+.++++.|+
T Consensus 228 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12455889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=277.58 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=193.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+|+.++..+.| +++..+..++......++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH-ENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCC-cchhhHHHhcccCCeEEEEE
Confidence 479999999999999999999988899999998764332 2346788999998876 55656666666778899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
||+.+.+.+.+......+++..+..++.||+.||.|||+.|++|+||+|+||++ ++++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccc
Confidence 999554444333334458999999999999999999999999999999999999 57899999999998765433221
Q ss_pred ccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc--------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-------- 233 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-------- 233 (306)
.....++..|+|||++.+. .++.++||||||+++|+|++|..||....................
T Consensus 157 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 157 -------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred -------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 1134568889999998764 478899999999999999999999976543222111111100000
Q ss_pred ---------------ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 234 ---------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 234 ---------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..+.....+.++..+.+++.+||+.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00011122456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=274.00 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=197.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|++|.||+|.+. .+..+++|.+..... ...+.+|+.+++.+.|.+.+. +...... ...++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK-LHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcce-EEEEEcC-CCeEEEE
Confidence 56789999999999999999999865 345689998765432 346788999999998754444 4333333 6689999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+++... ...++...+..++.|++.||.|||+.|++|+||+|+||++ +..+.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeeccCCC
Confidence 999 67999998753 3347888899999999999999999999999999999999 488999999999987654322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......++..|+|||++.+..++.++|+|||||++|++++ |..||...+.......+ ......+.
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~~~~~~~-- 224 (260)
T cd05073 157 YT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----ERGYRMPR-- 224 (260)
T ss_pred cc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----hCCCCCCC--
Confidence 11 1112334567999999998889999999999999999999 99999875543222221 22222221
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 -PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 14567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=281.59 Aligned_cols=256 Identities=18% Similarity=0.221 Sum_probs=186.8
Q ss_pred eeeecccCccEEEEEEEc--CCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeec-eeCceeEEEEeccCCC
Q 021855 12 GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVLDLLGPS 88 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~~~lv~e~~~~~ 88 (306)
+..||+|+||.||+|++. .++..||+|.+........+.+|+.+++.+.|++.+.....+. ......++++||++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 468999999999999865 3568899998877666667888999999998855554444332 3455679999999999
Q ss_pred HHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC-CCcceEEEEeeccccccCCC
Q 021855 89 LEDLFVYC--------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 89 l~~~~~~~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~-~~~~~~kl~Dfg~~~~~~~~ 159 (306)
|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+... +..+.+||+|||++......
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 98887532 1247888999999999999999999999999999999999432 35789999999999865443
Q ss_pred CCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh------HHHHHHHhhcc
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK------KQKYDKICEKK 232 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~------~~~~~~~~~~~ 232 (306)
.... .......++..|+|||++.+. .++.++|||||||++|+|+||..||........ .....+.....
T Consensus 166 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 166 LKPL----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cccc----cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 2211 112245678899999998774 489999999999999999999999965322110 00000000000
Q ss_pred c----------------------------ccc-----hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 V----------------------------STP-----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ~----------------------------~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
. ... .+......+..+.++|.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000 00001123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=286.84 Aligned_cols=251 Identities=22% Similarity=0.260 Sum_probs=205.3
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEcc-----CCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
-.+-|+..+.||+||||.||-++.+.||+-+|+|.+. ........++|..++..++.. .++.+...+...+..|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~-FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSP-FIVSLAYAFETKDALC 261 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccC-cEEEEeeeecCCCceE
Confidence 3466889999999999999999999999999998655 334455678899999988774 5555555566677899
Q ss_pred EEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 80 LVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+|+..| ||+|..++.+.+ ..++++.+..++.+|+.||.+||+.+||+|||||+|||+ |+.|+++|+|+|+|..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecC
Confidence 999999 888887766544 359999999999999999999999999999999999999 799999999999998876
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... ...+||..|||||++.++.|+..+|+|||||++|+|+.|+.||...........+.+.+ ....
T Consensus 339 ~g~~~--------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~----~~~~ 406 (591)
T KOG0986|consen 339 EGKPI--------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT----LEDP 406 (591)
T ss_pred CCCcc--------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH----hcch
Confidence 54432 24489999999999999999999999999999999999999998755444443333322 2222
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
..+...+|+++++|.+.+|++||++|.. ++++.+
T Consensus 407 ~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 407 EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 3344778999999999999999999963 556655
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.57 Aligned_cols=257 Identities=17% Similarity=0.250 Sum_probs=199.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||+|++|.||+|++..++..||+|.+..... ...+.+|+.++.++.| +++..+...+......++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCC-CcHHhhhhheecCCeEEEEEe
Confidence 468999999999999999999998999999998764322 2457789999999876 455555455556778999999
Q ss_pred cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 84 LL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 84 ~~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
|+ +++|..++... ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++ .++.++|+|||.+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccCC
Confidence 99 67888777642 2368999999999999999999997 5999999999999994 7899999999998765332
Q ss_pred CCCccccccCCccccccccccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
.. ....++..|+|||++.+. .++.++|+|||||++|+|++|..||..............+.....
T Consensus 157 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 157 LA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred cc---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 22 133567789999998544 357899999999999999999999976443322223333322221
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
. .....+++++.++|.+||+.+|++||+++++++ ..++.....
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~--~~~~~~~~~ 270 (286)
T cd06622 228 P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVKYKN 270 (286)
T ss_pred C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc--ChhhhhccC
Confidence 1 122457889999999999999999999999987 566654443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=281.49 Aligned_cols=257 Identities=20% Similarity=0.297 Sum_probs=197.9
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.+|+..+.||+|++|.||++.+..+++.+|+|.+..... ...+.+|+.++.++..++++..+..+...+...++++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467788999999999999999999999999998765432 23467788889888755666666666666778899999
Q ss_pred ccCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 84 LLGPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 84 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++.++.++... ....+++..+..++.|++.||.|||+. +++||||||+||++ +.++.++|+|||++.....
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhcc
Confidence 998887765432 235689999999999999999999975 99999999999999 4788999999999876543
Q ss_pred CCCCccccccCCccccccccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
.... ....++..|+|||++.+. .++.++|||||||++|+|++|+.||..... ......+......+.
T Consensus 161 ~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 230 (288)
T cd06616 161 SIAK--------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPI 230 (288)
T ss_pred CCcc--------ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCc
Confidence 3221 133568889999999876 588999999999999999999999976431 112222222222111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
........+++++.++|.+||+.||++|||+++|+. ..+++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~--~~~~~ 271 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE--HPFIK 271 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhh
Confidence 111111346889999999999999999999999977 55554
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=284.98 Aligned_cols=268 Identities=21% Similarity=0.222 Sum_probs=199.3
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeecee--------
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVD-------- 74 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-------- 74 (306)
++++|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+|+.+++.+.|.+.+.....+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 46899999999999999999999999999999998765432 34577899999999775544443332222
Q ss_pred -----CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEe
Q 021855 75 -----GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 75 -----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
....++++||++++|.+++. ...+++..++.++.||+.||.|||+.|++||||||+||+++ ..++.++|+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence 23578999999888888775 34689999999999999999999999999999999999995 3567899999
Q ss_pred eccccccCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 021855 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 228 (306)
||.+.......... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 159 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 159 FGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred cccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99987654322110 01113356788999998755 45788999999999999999999999765433222111110
Q ss_pred h----------------------hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 229 C----------------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 229 ~----------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
. ......+.....+..+.++.++|.+||+.||.+|||+.+++. ..+++....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--h~~~~~~~~ 308 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM--HPYMSCYSC 308 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC--CCccccccC
Confidence 0 001111112223456788999999999999999999999977 677764433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=277.81 Aligned_cols=251 Identities=19% Similarity=0.300 Sum_probs=193.7
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeecee-----CceeE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVD-----GEDNV 79 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~~ 79 (306)
.++|.+.+.||+|++|.||+|.+..+++.+++|++..... ...+.+|+.++.++..|+++..+..++.. ....+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 5789999999999999999999999999999998865432 34566788899888655666666544332 24589
Q ss_pred EEEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 80 LVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
+++||+ +++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||.+..
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchh
Confidence 999999 7799888753 23468999999999999999999999999999999999999 4788999999999876
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
....... .....++..|+|||++.... ++.++|+|||||++|+|++|+.||........ +..+..
T Consensus 178 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---~~~~~~ 247 (291)
T cd06639 178 LTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---LFKIPR 247 (291)
T ss_pred ccccccc-------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---HHHHhc
Confidence 5432211 11345788899999986432 67899999999999999999999987544322 222211
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...... ......+..+.++|.+||+.||++||++.++++
T Consensus 248 ~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 248 NPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111110 011345678999999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=279.71 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=200.2
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCc----eEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
+.+-..+|++.+.||+|++|.||+|.+..++. .+++|.+...... ..+.+|+.++..+.| +++..+..+...
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~ 80 (303)
T cd05110 2 RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH-PHLVRLLGVCLS 80 (303)
T ss_pred cccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEcC
Confidence 34567889999999999999999999877776 4688877654332 246778888888876 444444433332
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
...+++++++ +++|.+++......+++..+..++.|++.||.|||++||+|+||||+||++ +.++.+||+|||.+
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~ 156 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLA 156 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccc
Confidence 3467888888 789998887655568999999999999999999999999999999999999 47888999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
.......... ......++..|++||++.+..++.++|||||||++|+|++ |..||.+....... ......
T Consensus 157 ~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~----~~~~~~ 227 (303)
T cd05110 157 RLLEGDEKEY-----NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP----DLLEKG 227 (303)
T ss_pred ccccCccccc-----ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHCC
Confidence 7654322110 1112344678999999998899999999999999999998 99999875433222 222222
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
...+.+ ..++.++.+++.+||..+|++||++.++++.|+++...
T Consensus 228 ~~~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 228 ERLPQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 222211 44577899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=275.42 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=193.6
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.++|++.+.||+|++|.||+|.+..++..|++|.+...... ..+.+|+.++..+.| +++..+..++..+...++++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCC-CCEeEEEEEEecCCeEEEEE
Confidence 36899999999999999999999989999999987644322 246789999999876 55556666666777899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|++++++.+.+......+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||.+.........
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCCC
Confidence 999989888776544567888899999999999999999999999999999999 47899999999998754332211
Q ss_pred ccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc---------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------- 232 (306)
.....++..|+|||++.+. .++.++|+||||+++|+|++|..||...+... ..+.......
T Consensus 160 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 160 -------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred -------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhh
Confidence 1233568889999998764 47889999999999999999999997654321 1111111000
Q ss_pred ----------------cccchHHHhh--cCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 ----------------VSTPIEVLCK--SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ----------------~~~~~~~~~~--~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.+........ ..++.+.+++.+||+.||++|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000001 12567899999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=276.27 Aligned_cols=245 Identities=29% Similarity=0.368 Sum_probs=197.6
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+|++.+.||.|++|.||+|++..++..|++|.+.... ....+.+|+.+++++.| +++..+...+......++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH-PFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCC-CChHHHHHhhcCCCeEEEEE
Confidence 5899999999999999999999899999999876432 23457788999999877 55555555566777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|...+... .++++..+..++.||++||.|||++|++|+||+|+||++ ++++.++|+|||.+........
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCcc
Confidence 999 78998888763 578999999999999999999999999999999999999 5889999999999876544321
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. ....++..|+|||++.+..++.++|+||||+++|+|++|..||...+..................+
T Consensus 156 ~--------~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 222 (258)
T cd05578 156 T--------TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP----- 222 (258)
T ss_pred c--------cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc-----
Confidence 1 134577889999999988899999999999999999999999987654322222222221222222
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCCh--HHHH
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDY--GFLK 270 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~--~~l~ 270 (306)
...++.+.++|.+||+.||.+||++ ++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 5568899999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=276.70 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=207.9
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
--++|+.++.||+|.||.|.+++-+.+++.+|+|+++++-. -...+.|..++....| |.+..+...+......|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H-PFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRH-PFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccC-cHHHHhhhhhccCceEE
Confidence 34578899999999999999999999999999998776522 2235667788887776 44555556667778899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+||||. ||.|..++.+ ...++++....+...|..||.|||+++||+||||.+|.|+ |.+|++||+|||+++.--.
T Consensus 245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccc
Confidence 999999 8888877765 5579999999999999999999999999999999999999 7999999999999986433
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.+. ....++||+.|+|||++....|+.++|+|.+|+++|||+.|+.||+..++ ...++.+....+..|
T Consensus 321 ~g~-------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~kFP-- 388 (516)
T KOG0690|consen 321 YGD-------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDLKFP-- 388 (516)
T ss_pred ccc-------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhccCC--
Confidence 322 23588999999999999999999999999999999999999999998544 466777777777777
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
..++++++.|+.-+|.+||.+|. ++.||.+
T Consensus 389 ---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 389 ---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 77799999999999999999995 4666644
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=280.05 Aligned_cols=259 Identities=23% Similarity=0.275 Sum_probs=194.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeece-------eC
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-------DG 75 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~-------~~ 75 (306)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+|+.+++++.|++.+.....+.. ..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 469999999999999999999999999999998754322 2235678999999987555544433222 12
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++||+++++.+.+......+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 92 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 92 GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARA 168 (310)
T ss_pred ceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCccc
Confidence 3569999999999988887655568999999999999999999999999999999999999 4889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
.......... ......++..|+|||++.+.. ++.++|+||||+++|+|++|..||.+.........+........+
T Consensus 169 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 169 FSLSKNSKPN---RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred ccCCcccCCC---CccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 5443221100 112345678899999887654 788999999999999999999999876544333333333221110
Q ss_pred cc----------------------h-HHH-hhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 235 TP----------------------I-EVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 235 ~~----------------------~-~~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.. . ..+ ....++.+.++|.+||+.||.+|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0 000 0112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=276.40 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=198.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+|+.+++++.| +++..+..++......++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccC-CCEeeEEEEEecCCeEEEEE
Confidence 479999999999999999999998999999998764322 2456789999999976 55666666666778899999
Q ss_pred eccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+++++.+.+..... .+++..++.++.||+.||.|||++|++|+||+|+||+++ +.++.+||+|||.+........
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCcc
Confidence 9998888888764332 367888899999999999999999999999999999994 3456899999999875433211
Q ss_pred CccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--------
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-------- 232 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------- 232 (306)
. .....++..|+|||++.+. .++.++||||||+++|+|++|..||...................
T Consensus 159 ~-------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 159 T-------FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred c-------cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 1 1133567889999988764 57899999999999999999999998654432222211111100
Q ss_pred -------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 233 -------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 233 -------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.........+..++.+.++|.+||+.+|++||++.++++ ..++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~--~~~~~ 288 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE--HEYFK 288 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc--CchHh
Confidence 001111223456788999999999999999999999987 55554
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.63 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=200.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||.|++|.||+|++..+++.+++|.+..... ...+.+|+.+++.+.|. ++..+...+..+...++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSP-YITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCC-CeeeeeEEEEECCeEEEEEE
Confidence 478999999999999999999999999999998765432 23567889999999864 55555555667788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
++ +++|.+++.. ..+++..++.++.|++.||.|||+.+++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeecccccc
Confidence 99 7789888874 278999999999999999999999999999999999999 57899999999999776543221
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....++..|+|||++.+..++.++||||||+++|+|++|..||...+.. .....+.....+ .... .
T Consensus 155 -------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~-~~~~--~ 221 (274)
T cd06609 155 -------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLFLIPKNNPP-SLEG--N 221 (274)
T ss_pred -------cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHHHhhhcCCC-CCcc--c
Confidence 12445778899999999888999999999999999999999999765432 222222221111 1111 2
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.+++.+.+++.+||..||++|||++++++ ..++.
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~--~~~~~ 255 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK--HKFIK 255 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh--Chhhc
Confidence 26888999999999999999999999977 55554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=279.01 Aligned_cols=263 Identities=24% Similarity=0.260 Sum_probs=196.0
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeece-------e
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-------D 74 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-------~ 74 (306)
-++|++.+.||.|++|.||+|.+..+++.+++|.+.... ......+|+.+++.+.|++.+.....+.. .
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999999999999765332 22356789999999987554444332221 2
Q ss_pred CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
....+++++|+.+++...+......+++..+..++.|+++||.|||+.|++|+||||+||++ ++++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccch
Confidence 23579999999888888776545569999999999999999999999999999999999999 588999999999987
Q ss_pred ccCCCCCCccc----cccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh
Q 021855 155 KYRDPTTNRHI----PYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 155 ~~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 229 (306)
........... .........++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 65433221110 00111234567889999988654 47899999999999999999999998755543333322221
Q ss_pred hccc----------------------ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 230 EKKV----------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 230 ~~~~----------------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.... +..........++.+.++|.+||+.||.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1110 00111112344577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=279.81 Aligned_cols=254 Identities=22% Similarity=0.249 Sum_probs=196.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeC--ceeEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVL 80 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--~~~~l 80 (306)
++|++.+.||.|++|.||+|.+..+++.+++|.+...... ..+.+|+.++.++.| +++..+..+.... ...++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCC-CCEEEEEEEEEecCCCcEEE
Confidence 5799999999999999999999989999999987644322 235679999999986 5555554444444 78999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
++||+.++|.+++......+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccCCc
Confidence 99999889999887655568999999999999999999999999999999999999 578999999999987665432
Q ss_pred CCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc-----
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS----- 234 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~----- 234 (306)
.. .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+...+.....
T Consensus 161 ~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 161 KP-------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred cc-------cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 21 12345678899999987654 688999999999999999999999875544332222221111000
Q ss_pred ------------------cchHHHhhc-CchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 235 ------------------TPIEVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 235 ------------------~~~~~~~~~-~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....+... +++.+.++|.+||+.||++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000111111 4778999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=271.45 Aligned_cols=247 Identities=24% Similarity=0.302 Sum_probs=199.8
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|++.+.||.|++|.||.+++..+++.+++|.+.... ....+.+|+.+++++.| +++..+..++......++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-PNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCC-CCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999766432 23457789999999876 556556556667788999999
Q ss_pred cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccc
Confidence 99 78999988754 3458999999999999999999999999999999999999 4788999999999876544332
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. .....++..|+|||++.+..++.++|+||||+++++|++|..||...... .....+........ .
T Consensus 157 ~-------~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~----~ 222 (256)
T cd08221 157 M-------AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQGNYTPV----V 222 (256)
T ss_pred c-------ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC----c
Confidence 1 12446788999999998888999999999999999999999999764332 23333322222221 1
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
..++.++.++|.+||+.+|.+|||+.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 5568899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.52 Aligned_cols=260 Identities=23% Similarity=0.300 Sum_probs=200.2
Q ss_pred CCceeEeeeecccCccEEEEEEEc----CCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeecee--Cc
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GE 76 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~ 76 (306)
.+.|++.+.||+|++|.||+|++. .++..+|+|.+..... ...+.+|+.+++.+.| +++..+..++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~-~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH-ENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCC-CChheEEeeeecCCCC
Confidence 457889999999999999999864 3478899998876544 3467889999999876 455555444443 55
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++||+ +++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccccccc
Confidence 789999999 789999987655568999999999999999999999999999999999999 5789999999999987
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh-----------HHH
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-----------KQK 224 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~-----------~~~ 224 (306)
........ .......++..|++||.+.+..++.++|+|||||++++|++|..||........ ...
T Consensus 159 ~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 159 LPEDKDYY----YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccCCcce----eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 65322211 011122345679999999888899999999999999999999999875432210 111
Q ss_pred HHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
...........+.+ ..++..+.+++.+||+.+|.+|||+.+|++.|+++
T Consensus 235 ~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRP---PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCC---ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22222222222211 34578899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=272.18 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=196.6
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|++.+.||.|++|.||+|.+..+++.+++|.+.... ....+.+|+.+++++.| +++..+...+......++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-PNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCC-CchhheeeeEecCCEEEEEEe
Confidence 5899999999999999999999999999999876542 23457778999999876 455555555566778999999
Q ss_pred cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||++. ++++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCcc
Confidence 99 779999887543 3489999999999999999999999999999999999995 3456789999999976544322
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. ....++..|+|||.+.+..++.++|+||||+++++|++|..||...+.. ............ + ..
T Consensus 158 ~--------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~-~---~~ 222 (256)
T cd08220 158 A--------YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKIMSGTFA-P---IS 222 (256)
T ss_pred c--------cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHHHhcCCC-C---CC
Confidence 1 1345788999999999888899999999999999999999999765432 222222222111 1 12
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..+++++.+++.+||+.||++|||+.+++.
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 456889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=274.47 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=197.2
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
+|++.+.||.|++|.||+|++..++..|++|.+.... ....+.+|+.+++.+.| +++..+..++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC-CCEeeeeeeEeeCCcEEEEEec
Confidence 5899999999999999999999999999999876442 23456789999999976 6666666666777889999999
Q ss_pred cCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 85 LGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 85 ~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
+.++|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||++ ++++.++|+|||.+.........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCccc
Confidence 9889988876543 458999999999999999999999999999999999999 57899999999998754332211
Q ss_pred ccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc-------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS------- 234 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------- 234 (306)
.....++..|++||++.+. .++.++|+||||+++|+|++|..||.+.+.................
T Consensus 157 -------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 157 -------FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred -------cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 1133467889999998764 4688999999999999999999999875543322222111100000
Q ss_pred --------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 235 --------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 235 --------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.......+..++.+.++|.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011122345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=272.67 Aligned_cols=252 Identities=19% Similarity=0.282 Sum_probs=194.2
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--------chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+..... ...+.+|+.+++.+.| +++..+..++......+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH-VNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCC-CCEeeEeeEeecCCeEE
Confidence 488999999999999999986 4788899997764321 1346778889999976 45555555566678899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++||+ +++|.+++.. ..++++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+.....
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence 999999 7799888875 3468899999999999999999999999999999999999 5889999999999876432
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
....... ........++..|+|||++.+..++.++|+||||+++|+|++|..||...+..... ....... ...+
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---~~~~~~~--~~~~ 228 (265)
T cd06631 155 VGLHGTH-SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM---FYIGAHR--GLMP 228 (265)
T ss_pred ccccccc-cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH---HHhhhcc--CCCC
Confidence 2111000 00112446788999999999888999999999999999999999999865433211 1111111 1111
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....++..+.++|++||+.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122557889999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=278.98 Aligned_cols=255 Identities=21% Similarity=0.307 Sum_probs=199.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|++|.||+|.+..+++.+++|.+...... ..+..|+.++..+.| +++..+...+......+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH-PFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCC-CCchhheeeeecCCEEEEE
Confidence 4799999999999999999999989999999988754322 346778889998886 5566666666677789999
Q ss_pred Eecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|++ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence 9998 77999988753 2458999999999999999999999999999999999999 47899999999998754322
Q ss_pred CCCccc----------------------cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 021855 160 TTNRHI----------------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (306)
Q Consensus 160 ~~~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~ 217 (306)
...... +........++..|+|||++.+..++.++||||||+++|+|++|..||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 111000 0001113467888999999998889999999999999999999999998755
Q ss_pred hhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCC----hHHHHH
Q 021855 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD----YGFLKR 271 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps----~~~l~~ 271 (306)
.. ..+..+.......+.. ...++.+.++|.+||+.||++||| ++++++
T Consensus 237 ~~---~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD---ETFSNILKKEVTFPGS---PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH---HHHHHHhcCCccCCCc---cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 43 2233333333222211 225889999999999999999999 777766
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=275.50 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=199.3
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ..+.+|+.+++++.| +++..+..........++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH-PNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcC-CCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999889999999987654332 456778899999985 5666665556667889999999
Q ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+.+++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~-- 154 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP-- 154 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc--
Confidence 9889998887655679999999999999999999999999999999999999 47899999999998766543311
Q ss_pred ccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc-----------
Q 021855 165 IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK----------- 232 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------- 232 (306)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+............
T Consensus 155 -----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 155 -----YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -----ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 1133567789999998877 68999999999999999999999997755433222221111110
Q ss_pred -----------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 -----------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 -----------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.........+.++.++.++|.+||++||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 011112233456889999999999999999999999976
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=279.21 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=198.4
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
....+|++.+.||+|++|.||+|.+..+++.|++|.+..... ...+.+|+.+++.+.| +++..+..++......
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~~~ 90 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH-PNTIEYKGCYLREHTA 90 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEEeCCeE
Confidence 345679999999999999999999988999999998754322 1346788999999876 5555555556667788
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++++||+.+++.+++......+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||++.....
T Consensus 91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCC
Confidence 9999999999988887656679999999999999999999999999999999999999 5789999999999865432
Q ss_pred CCCCccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
.. ...++..|+|||++. ...++.++||||||+++|+|++|..||...+...... .+.....+.
T Consensus 168 ~~-----------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~---~~~~~~~~~ 233 (307)
T cd06607 168 AN-----------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNDSPT 233 (307)
T ss_pred CC-----------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH---HHhcCCCCC
Confidence 21 345677899999884 3458889999999999999999999998754432211 111111111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
. ....++..+.++|.+||+.||++||++.+++. ..++.
T Consensus 234 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~ 271 (307)
T cd06607 234 L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK--HRFVL 271 (307)
T ss_pred C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc--Chhhc
Confidence 1 11345788999999999999999999999987 44443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=271.75 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=191.2
Q ss_pred eeecccCccEEEEEEEcC-CC--ceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSGSFGEIFLASHVD-TN--EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~-~~--~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+.||+|++|.||+|.+.. .+ ..|++|.+..... ...+.+|+.+++++.|.+ +..+...... ...++++|++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN-LIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCC-ccceeEEEcC-CeEEEEEEecC
Confidence 468999999999999865 33 3689998876544 345778999999998754 4444433334 7789999999
Q ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+++|.+.+.... ..+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~-- 153 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH-- 153 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc--
Confidence 789999987644 468999999999999999999999999999999999999 47899999999999876443221
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
+.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+......... ....... ....
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~---~~~~ 225 (257)
T cd05040 154 --YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---KEGERLE---RPEA 225 (257)
T ss_pred --eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCcCC---CCcc
Confidence 111123446678999999998889999999999999999998 999997654432222222 1111111 1134
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
.|..+.+++.+||+.+|++|||++++++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 5789999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=276.68 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=196.7
Q ss_pred cCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
-.++|++.+.||.|+||.||+|++. .++..+++|.+..... ...+.+|+.+++.+.| +++..+..++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH-PNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCC
Confidence 3468999999999999999999874 3678899998775433 2447779999999877 55655655666667
Q ss_pred eeEEEEecc-CCCHHHHHHHhc---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCce
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR---------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 134 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Ni 134 (306)
..++++|++ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||+|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 889999999 679998886421 2367888899999999999999999999999999999
Q ss_pred eeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 021855 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 213 (306)
Q Consensus 135 lv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf 213 (306)
++ +.++.++|+|||.+.......... .......+..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 162 l~---~~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 162 LV---GENMVVKIADFGLSRNIYSADYYK-----ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred Ee---cCCCceEECccccceecccCcccc-----ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99 488999999999987543221110 0112234567999999998899999999999999999998 88899
Q ss_pred CCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
.+..... ....+....... .....+..+.++|.+||+.||.+|||+.++++.|+
T Consensus 234 ~~~~~~~---~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 234 YGMAHEE---VIYYVRDGNVLS----CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCHHH---HHHHHhcCCCCC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 7655432 222222222111 11456788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=269.28 Aligned_cols=244 Identities=20% Similarity=0.310 Sum_probs=190.6
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
+.||+|++|.||+|... ++..+|+|.+...... ..+.+|+.+++.+.| +++..+...+......++++||+ +++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDH-PNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCC-CCcCeEEEEEecCCccEEEEECCCCCc
Confidence 46899999999999854 5788999987754332 346789999998866 55655655566677889999999 789
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccccc
Q 021855 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (306)
Q Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (306)
|.+++......+++..+..++.|++.||.|+|++|++||||+|+||++ +.++.++|+|||.+.........
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~------ 149 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYS------ 149 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccc------
Confidence 988887655568999999999999999999999999999999999999 47889999999998653322111
Q ss_pred CCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchH
Q 021855 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (306)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (306)
......++..|+|||++.+..++.++||||||+++|++++ |..||............ ....... ....++..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~ 222 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV----EKGYRMS---CPQKCPDD 222 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH----HcCCCCC---CCCCCCHH
Confidence 0112233567999999998889999999999999999998 99999875443222222 1121111 12456889
Q ss_pred HHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 248 FASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 248 ~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
+.+++.+||+.+|++|||+.++.+.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=301.10 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=211.7
Q ss_pred CceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
.+.++.+.||+|+||.||+|+.. +....||||.++.... +.+|.+|+.++..|.| ++|+.+......++-.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H-~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH-PNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEccCCee
Confidence 44567899999999999999753 3346799998886544 4679999999999988 6666666667788889
Q ss_pred EEEEecc-CCCHHHHHHHhc---------CC----CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce
Q 021855 79 VLVLDLL-GPSLEDLFVYCR---------RK----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~---------~~----~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~ 144 (306)
++|+||+ .|+|.+++.-.. .. ++..+.+.++.|||.|+.||-+..+|||||-.+|+||+ +...
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---ENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cceE
Confidence 9999999 999999987542 12 77889999999999999999999999999999999995 8999
Q ss_pred EEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHH
Q 021855 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (306)
Q Consensus 145 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~ 223 (306)
|||+|||+++..=+... |+......-..+||+||-++.+.++.+|||||+|++++|+++ |+.||++.++++..
T Consensus 642 VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI- 715 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI- 715 (774)
T ss_pred EEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-
Confidence 99999999975322221 112223344678999999999999999999999999999999 99999998876443
Q ss_pred HHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
+.+..++. .+.+ +++|.++.+||..||+.+|.+|||+.+|...|+.+.+...
T Consensus 716 --e~i~~g~l-L~~P---e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 716 --ECIRAGQL-LSCP---ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred --HHHHcCCc-ccCC---CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 33333333 2222 7789999999999999999999999999999999876443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=278.31 Aligned_cols=270 Identities=21% Similarity=0.327 Sum_probs=206.4
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+.-++|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+|+.++.....++++..+..++......++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 345779999999999999999999998899999998865432 23355677666666656777777777777888999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
++|++++++.+++......+++..+..++.|++.||.|||+ .|++||||+|+||++ ++++.++|+|||.+......
T Consensus 92 v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 92 CMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCC
Confidence 99999888888887656678999999999999999999997 599999999999999 57899999999998765432
Q ss_pred CCCccccccCCccccccccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... ..............
T Consensus 169 ~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 238 (296)
T cd06618 169 KAK--------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEEPPS 238 (296)
T ss_pred Ccc--------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCCCCC
Confidence 221 1234677899999987654 788999999999999999999999753221 12222222222111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccc
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 290 (306)
. + ....+++++.++|.+||+.||.+||++++++. ..++.......+.+-+|
T Consensus 239 ~-~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~~~~~~~~~~ 289 (296)
T cd06618 239 L-P-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ--HPFIRRYETAEVDVAGW 289 (296)
T ss_pred C-C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--ChhhhccchhHHHHHHH
Confidence 1 1 11246788999999999999999999999987 56666555444444433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=297.35 Aligned_cols=249 Identities=17% Similarity=0.306 Sum_probs=206.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
+.++|+..||.|+||.||+|..+.++-..|-|++.... .-.+++-|+.+|....| |++..+...+..++..++..||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdH-P~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDH-PVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCC-hHHHHHHHHHhccCceEEEEee
Confidence 45678889999999999999999998888889877543 34568889999999986 5555555555566788999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
| ||....++...++.+.+.++..+++|++.||.|||+++|+|||||..|||++ -+|.++|+|||.+........
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~t~q-- 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKSTRQ-- 185 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchhHHh--
Confidence 9 7778888888899999999999999999999999999999999999999996 899999999999876543322
Q ss_pred cccccCCccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 164 HIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
....+.||++|||||+++. .+|+.++||||||++|.+|..+.+|-...++. ..+.++.+..++..
T Consensus 186 -----kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---RVllKiaKSePPTL-- 255 (1187)
T KOG0579|consen 186 -----KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSEPPTL-- 255 (1187)
T ss_pred -----hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---HHHHHHhhcCCCcc--
Confidence 2237899999999999863 47999999999999999999999998876654 33344444333322
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..+..++..+.+++.+||..||..||++.+|++
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 223778999999999999999999999999876
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=276.47 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=198.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
..|+..+.||.|++|.||.|.+..++..||+|.+..... ...+.+|+.+++.+.| +++..+...+.+....++++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEEEEe
Confidence 468889999999999999999998999999998764432 2356778888988876 556566566667788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+++.. .++++..+..++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCccc
Confidence 99 7799888763 468899999999999999999999999999999999999 47889999999998765432211
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....++..|+|||++.+..++.++|+|||||++|+|++|..||.......... .+ ..... +....
T Consensus 158 -------~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~-~~~~~---~~~~~ 223 (277)
T cd06640 158 -------RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF---LI-PKNNP---PTLTG 223 (277)
T ss_pred -------cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh---hh-hcCCC---CCCch
Confidence 113456788999999988889999999999999999999999998754332111 11 11111 11224
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.++..+.++|.+||+.+|.+||++++++. ..++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~ 257 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLK--HKFIV 257 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHh--ChHhh
Confidence 55788999999999999999999999977 45544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=277.15 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=196.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.+|++.+.||+|++|.||++.+..+++.|++|.+..... ...+.+|+.+++.+.| +++..+...+......+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN-PFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEecCCEEEEE
Confidence 469999999999999999999999999999998765421 2346678888888876 5555555556667788999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|++ +++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||++ +..+.++|+|||.+.......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCc
Confidence 9999 7799888876 4568999999999999999999999999999999999999 478999999999886422111
Q ss_pred CCcc--------ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 161 TNRH--------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 161 ~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
.... ..........++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcc
Confidence 1000 0000011235677899999998888999999999999999999999999865432 2233333322
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
...+.. ...+++++.++|.+||+.||++||++.++.+.|+
T Consensus 233 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 233 IEWPEG--DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred cCCCCc--cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 222211 1356888999999999999999998655544444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=277.88 Aligned_cols=253 Identities=20% Similarity=0.323 Sum_probs=199.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||.|++|.||+|.+..+++.+++|.+..... ...+.+|+.+++.+.| +++..+...+......++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-PYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCC-CchhhhheeeecCCEEEEEEE
Confidence 468899999999999999999999999999998765432 2457788999998885 555555555556678999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
++ +++|.+++......+++..+..++.|++.||.|||+ .|++|+||+|+||+++ .++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHHHh
Confidence 99 589999887654678999999999999999999999 9999999999999994 788999999999876533221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchh--hhhHHHHHHHhhcccccchHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA--ATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 239 (306)
. ...++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .................. +.
T Consensus 157 ~---------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 226 (265)
T cd06605 157 K---------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL-PS 226 (265)
T ss_pred h---------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC-Ch
Confidence 1 24567889999999998999999999999999999999999976421 111122222222221111 11
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
..+++.+.++|.+||..||.+|||+.+++. ..++
T Consensus 227 --~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~--~~~~ 260 (265)
T cd06605 227 --GKFSPDFQDFVNLCLIKDPRERPSYKELLE--HPFI 260 (265)
T ss_pred --hhcCHHHHHHHHHHcCCCchhCcCHHHHhh--Cchh
Confidence 126888999999999999999999999976 4444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.15 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=199.5
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCc-eeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-~~~lv~e 83 (306)
++|.-...||+|+||.||+|.... +..||||.+..... ..+|.+|+.++.+++| +++..+..|+.+.+ ..++|+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H-~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH-PNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC-cCcccEEEEEecCCceEEEEEE
Confidence 567777899999999999998654 48899998887655 4669999999999995 66667777777666 5999999
Q ss_pred cc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC---ccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG---FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
|+ .|+|.+.+..... .++|..+.+|+.++|.||.|||+.. |+||||||+|||+ |+++.+||+|||+|+....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence 99 7899999886555 7899999999999999999999853 9999999999999 7999999999999965433
Q ss_pred -CCCCccccccCCccc-cccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh--HHHH-HHHhhc-c
Q 021855 159 -PTTNRHIPYRENKNL-TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK--KQKY-DKICEK-K 232 (306)
Q Consensus 159 -~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~--~~~~-~~~~~~-~ 232 (306)
.... ... .||..|++||++..+..+.++||||||+++.|++||+.|.....+... ...+ ...... .
T Consensus 230 ~~~~~--------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 230 GDTSV--------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cccce--------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 2111 122 789999999999999999999999999999999999988864321111 1111 111111 1
Q ss_pred cccchHH-Hh-hcCc-----hHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 233 VSTPIEV-LC-KSHP-----AEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 233 ~~~~~~~-~~-~~~~-----~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.....+. +. ..++ ..+..+..+|++.+|..||++.++++.|+.+..
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 1111110 00 1112 237788999999999999999999999976654
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=278.21 Aligned_cols=250 Identities=18% Similarity=0.308 Sum_probs=196.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
..+|++.+.||+|++|.||++.+..+++.|++|+...... ...+.+|+.++..+.| +++..+...+......++++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS-PYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCC-CCcceEeeeEecCCEEEEEE
Confidence 4689999999999999999999998999999997664322 3457789999999876 55555555566668899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+++.. .+.+++..+..++.+++.||.|||+ .+++|+||+|+||++ ++++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred ecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc
Confidence 999 6788877765 4568999999999999999999997 589999999999999 478999999999986543322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh----h----HHHHHHHhhcc
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT----K----KQKYDKICEKK 232 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~----~----~~~~~~~~~~~ 232 (306)
. ....++..|+|||++.+..++.++|+|||||++|++++|..||....... . ......+....
T Consensus 159 ~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 159 A---------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229 (284)
T ss_pred c---------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence 1 13467889999999988889999999999999999999999998644310 0 11122222111
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
...... ..++..+.+++.+||+.||++|||+.++++.
T Consensus 230 ~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111101 2357789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=274.55 Aligned_cols=240 Identities=25% Similarity=0.328 Sum_probs=182.1
Q ss_pred eecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHh--CCCCCCcceeeceeCceeEEEEecc-
Q 021855 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
.||+|+||.||++.+..+++.+|+|.+...... ..+.++..++..+. +++++..+...+..++..++++||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 479999999999999999999999987643221 22344444444443 3455555555566677899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~~---- 152 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---- 152 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccCc----
Confidence 7888887765 4569999999999999999999999999999999999999 5889999999999865433221
Q ss_pred cccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 166 PYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||......... ........ ... .....+
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~-~~~---~~~~~~ 222 (279)
T cd05633 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT-VNV---ELPDSF 222 (279)
T ss_pred -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhc-CCc---CCcccc
Confidence 13467899999999864 55889999999999999999999999764332221 12111111 111 122456
Q ss_pred chHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 245 PAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
++++.++|.+||+.||.+|| |++++++
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 88999999999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=281.19 Aligned_cols=269 Identities=21% Similarity=0.286 Sum_probs=197.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeece-----eC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~ 75 (306)
+.++|.+.+.||+|++|.||+|.+..+++.||+|.+.... ....+.+|+.+++.+.|.+.+.....+.. ..
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4678999999999999999999999899999999876432 22346789999999977554443333322 12
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...+++++++..++.... +..+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+..
T Consensus 93 ~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 93 QDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLARH 166 (342)
T ss_pred ceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcC
Confidence 356899999987776654 3468999999999999999999999999999999999999 5789999999999875
Q ss_pred cCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh----
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE---- 230 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~---- 230 (306)
..... ....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+............+
T Consensus 167 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 167 ADAEM----------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred CCCCC----------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 43211 13456788999999876 4588999999999999999999999987543222111111100
Q ss_pred ----------------cc---cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH--HHHhHhhcCCCCCcccc
Q 021855 231 ----------------KK---VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL--FHDLFSREGYDFDFVFD 289 (306)
Q Consensus 231 ----------------~~---~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--l~~~~~~~~~~~~~~~~ 289 (306)
.. .........+..++.+.++|.+||+.||.+||++++++.. |+.+-.....+...+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~~~ 316 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYD 316 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCccc
Confidence 00 0011111223567789999999999999999999999863 54443333333333333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=271.33 Aligned_cols=246 Identities=21% Similarity=0.230 Sum_probs=197.9
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|++.+.||+|++|.+|++++..+++.|++|.+.... ....+.+|+.+++.+.| +++..+...+......++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH-PNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCC-CCeeeeEeeecCCCeEEEEEe
Confidence 5899999999999999999999999999999876432 22457789999999987 555556666667778999999
Q ss_pred cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
++ +++|.+.+.... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchh
Confidence 99 779988886532 357899999999999999999999999999999999999 4788999999999876543221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. .....++..|+|||++.+..++.++|+|||||++++|++|..||...... ............. ..
T Consensus 157 ~-------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~----~~ 222 (256)
T cd08218 157 L-------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLVLKIIRGSYPP----VS 222 (256)
T ss_pred h-------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHHHHHhcCCCCC----Cc
Confidence 1 11345678899999999888999999999999999999999999764332 2232332222211 12
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..++.++.++|.+||+.+|++||++.++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 456889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.86 Aligned_cols=252 Identities=21% Similarity=0.240 Sum_probs=194.6
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
|++.+.||.|++|.||+|.+..+|..|++|++..... ...+.+|+.+++.+.| +++..+..++......++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH-PNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCC-CCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999998999999998764432 2357789999999986 4555555555667889999999
Q ss_pred cCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 LGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
++++|.+++.... ..+++..+..++.|++.||.|||+++++||||+|+||++ +.++.++|+|||.+.........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCccc-
Confidence 9889998887533 358999999999999999999999999999999999999 47899999999998754332211
Q ss_pred cccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh------------
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------------ 230 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~------------ 230 (306)
.....++..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.+...
T Consensus 156 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 156 ------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred ------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 1123457889999988765 478899999999999999999999986544322222111100
Q ss_pred ---------cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 231 ---------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 231 ---------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.............+++.+.++|.+||+.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00011112233566788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=281.48 Aligned_cols=270 Identities=20% Similarity=0.276 Sum_probs=202.4
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeece--eC
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DG 75 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~ 75 (306)
+..+.++|++.+.||+|++|.||+|.+..+++.+++|.+... .....+.+|+.++.++.+|+++..+..++. +.
T Consensus 2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred CchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 456788999999999999999999999888999999976532 223346679999999944455555544332 34
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++|++.++|...+.. ..+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.++|+|||.+..
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARS 156 (337)
T ss_pred ceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhc
Confidence 46899999999899888764 268888999999999999999999999999999999999 5899999999999876
Q ss_pred cCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh-----
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC----- 229 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~----- 229 (306)
.......... .......++..|+|||++.+ ..++.++|+||||+++|+|++|+.||.+..............
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 157 LSELEENPEN--PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred cccccccccC--cchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 5433221100 01123467889999998765 457889999999999999999999997654332222111111
Q ss_pred ------------------hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 230 ------------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 230 ------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
......+.....+.++.++.++|.+||+.||++|||+.++++ ..++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~--~~~~~~~ 301 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE--HPYVAQF 301 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh--Chhhhhh
Confidence 111111222233457889999999999999999999999987 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=272.61 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=199.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||.|++|.||+|.+..++..+++|++.... ....+.+|+.+++.+.| +++..+..........++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-PNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCC-CCEEEEEEEEeeCCEEEEEEe
Confidence 47999999999999999999998889999999876443 23457788999988876 455555555567778999999
Q ss_pred cc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 84 LL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
++ +++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||++ ++++.++|+|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence 99 778988887532 358999999999999999999999999999999999999 478899999999987765443
Q ss_pred CCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch-H
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI-E 238 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~ 238 (306)
.... .......++..|++||++... .++.++|+||||+++++|++|..||...+.. ..+.+.......... .
T Consensus 157 ~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (267)
T cd06610 157 DRTR---KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETG 230 (267)
T ss_pred cccc---cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCc
Confidence 2210 011244678899999998877 6889999999999999999999999875443 222222222211111 1
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....+++.+.+++.+||+.||++|||+++|++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111356788999999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=273.23 Aligned_cols=253 Identities=19% Similarity=0.306 Sum_probs=198.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcC-----CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
..+|++.+.||.|+||.||+|+++. +.+.+++|.+...... ..+.+|+.+++++.| +++..+..++.+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCC-cceeeeEEEECCCCc
Confidence 3689999999999999999999753 3467899987755443 457889999999976 555566666666778
Q ss_pred eEEEEecc-CCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEE
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~ 148 (306)
.++++|++ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEEc
Confidence 89999999 689999887533 158999999999999999999999999999999999999 478899999
Q ss_pred eeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHH
Q 021855 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~ 227 (306)
|||.+......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||...... .....
T Consensus 160 ~~~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~ 230 (275)
T cd05046 160 LLSLSKDVYNSEYY------KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNR 230 (275)
T ss_pred ccccccccCccccc------ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHH
Confidence 99998654322111 1123456778999999988889999999999999999999 88999764432 22222
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
........+. ...++..+.+++.+||+.||.+|||+.++++.|.
T Consensus 231 ~~~~~~~~~~---~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPV---PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 2222222211 1456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=283.56 Aligned_cols=264 Identities=20% Similarity=0.293 Sum_probs=200.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeC-----
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~----- 75 (306)
++++|++.+.||+|++|.||+|++..+++.|++|.+..... ...+.+|+.+++.+.|++.+.....+....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 67899999999999999999999999999999998764321 234567899999987754444333222221
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++|+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||+|+||++ +.++.++|+|||.+..
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcccccccc
Confidence 24899999999999988864 468999999999999999999999999999999999999 4789999999999876
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-- 232 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-- 232 (306)
..... ....++..|+|||.+.+. .++.++|||||||++|++++|..||.+.........+.......
T Consensus 168 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 168 TDDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccc----------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 54321 134567889999998653 57889999999999999999999997654432222221111100
Q ss_pred ---------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCC
Q 021855 233 ---------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFD 285 (306)
Q Consensus 233 ---------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~ 285 (306)
...........+++.+.++|.+||+.||.+|||+.+|+. +.++.+...+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~--h~~~~~~~~~~~ 309 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA--HPYLAEYHDPED 309 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc--CCCccccCCCcc
Confidence 000111222345888999999999999999999999977 677765555433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=281.09 Aligned_cols=255 Identities=20% Similarity=0.243 Sum_probs=197.8
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeC-----cee
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----EDN 78 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-----~~~ 78 (306)
+|++.+.||.|++|.||+|++..+++.|++|.+.... ....+.+|+.+++.+.| +++..+....... ...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH-ENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCC-cchhhhhhhhcccCcccccce
Confidence 6899999999999999999998889999999876532 33467889999999986 4444444333333 368
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++++++++++|.+++.. ...+++..++.++.||+.||.+||+.|++||||||+||++ +.++.++|+|||.+.....
T Consensus 80 ~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecc
Confidence 99999998888888765 3479999999999999999999999999999999999999 4789999999999987654
Q ss_pred CCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc-----
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK----- 232 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----- 232 (306)
..... .......++..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.......
T Consensus 156 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 156 DEDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 43110 011234578889999999888 78999999999999999999999998765433222222211110
Q ss_pred ------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 ------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.........+..++.+.++|.+||+.+|.+||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011111222456788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=276.59 Aligned_cols=259 Identities=20% Similarity=0.256 Sum_probs=193.1
Q ss_pred ceeEeeeecccCccEEEEEEEcC--CCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeC--cee
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVD--TNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDN 78 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~--~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--~~~ 78 (306)
+|++.+.||+|++|.||+|.+.. +++.||+|.+... .......+|+.++..+.| +++..+..++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH-ENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCC-CCccceEEEEeCCCCceE
Confidence 58999999999999999999987 8899999988762 333557789999999987 4555554444444 779
Q ss_pred EEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc-CCCcceEEEEeeccc
Q 021855 79 VLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153 (306)
Q Consensus 79 ~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~-~~~~~~~kl~Dfg~~ 153 (306)
++++|++++++.+++.... ..+++..++.++.||+.||.|||+.+++||||||+||+++. .+..+.+||+|||.+
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999999888888775432 25889999999999999999999999999999999999941 112899999999998
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhh------hHHHHH
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------KKQKYD 226 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~------~~~~~~ 226 (306)
.......... .......++..|+|||++.+. .++.++|||||||++|+|++|..||.+..... ....+.
T Consensus 160 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 160 RLFNAPLKPL----ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred cccCCCcccc----cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 7654332210 111234568889999988764 47899999999999999999999997654322 000111
Q ss_pred HHhhc--------------------------ccccc---hHH-Hh--hcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 227 KICEK--------------------------KVSTP---IEV-LC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 227 ~~~~~--------------------------~~~~~---~~~-~~--~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..+.. ....+ ... .. ...++.+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11000 00000 000 00 145678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=268.09 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=195.6
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
..+|++.+.||.|++|.||+|.+. ++..+++|.+..... ...+.+|+.+++.+.| +++..+...+......++++||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSH-PKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCC-CCeeeEEEEEccCCceEEEEEc
Confidence 457999999999999999999875 367899998765433 3568889999999977 4455555555666788999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +++|.+++......++++.++.++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCccc-
Confidence 9 778988887655568999999999999999999999999999999999999 47889999999998754332211
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.......+..|+|||++.+..++.++|+||||+++|+|++ |..||....... ....+ ........+ .
T Consensus 157 -----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~-~~~~~~~~~---~ 224 (256)
T cd05112 157 -----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI-NAGFRLYKP---R 224 (256)
T ss_pred -----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH-hCCCCCCCC---C
Confidence 1112234567999999998889999999999999999998 999997644322 22221 111111111 3
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
..++.+.+++.+||+.+|++|||++++++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 3478899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=268.97 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=192.4
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
+.||.|++|.||+|.+.. ++.|++|.+...... ..+.+|+.+++.+.| +++..+..++......++++|++ +++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH-PNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 468999999999999877 899999987754332 357789999998876 55555556666777899999999 788
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccccc
Q 021855 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (306)
Q Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (306)
|.+++......++...+..++.+++.||.|||++|++||||+|+||++ +.++.++|+|||.+..........
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~----- 150 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV----- 150 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee-----
Confidence 988887655568899999999999999999999999999999999999 588999999999987543221110
Q ss_pred CCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchH
Q 021855 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (306)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (306)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |..||........... .......+. ....+..
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~----~~~~~~~~~---~~~~~~~ 223 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER----IESGYRMPA---PQLCPEE 223 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH----HhcCCCCCC---CccCCHH
Confidence 0012233567999999998899999999999999999999 8899977554322222 222211111 1455789
Q ss_pred HHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 248 FASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 248 ~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
+.+++.+||+.+|.+|||++++++.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=277.83 Aligned_cols=252 Identities=19% Similarity=0.301 Sum_probs=197.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
..|+....||.|+||.||+|.+..+++.|++|.+.... ....+.+|+.++..+.| +++..+...+..+...++++||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-QNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCC-CchhhhhhheeeCCeEEEEEec
Confidence 44666778999999999999998889999999876432 23457778888888876 5555555555667789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +++|..++.. ..+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~- 173 (297)
T cd06659 100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK- 173 (297)
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccccccc-
Confidence 9 6788776653 458999999999999999999999999999999999999 58899999999998654332211
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
.....++..|+|||++.+..++.++|+|||||++|+|++|..||........ ........ .+.......
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~--~~~~~~~~~ 242 (297)
T cd06659 174 ------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRDSP--PPKLKNAHK 242 (297)
T ss_pred ------ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhccC--CCCccccCC
Confidence 1245678899999999988899999999999999999999999976543322 22221111 111111245
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+++.+.++|.+||+.+|.+||++.++++ ..++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~--~~~~~ 275 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD--HPFLL 275 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh--Chhhc
Confidence 6788999999999999999999999988 45554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=267.47 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=212.8
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
.+.||+|+|+.|--+....|+.++|+|++.+...+ ....+|++++...++|++|..+..++.++..+|+|||-+ ||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 57899999999999999999999999999987655 457889999999999999998888999999999999999 899
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC--CCCCCcccc
Q 021855 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHIP 166 (306)
Q Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~~~ 166 (306)
|.+.+.. ...+++.++..+..+|+.||.|||.+||+||||||+|||-...+.-.-+||+||.+..... .+.+-...|
T Consensus 163 lLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 163 LLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred HHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 9998886 4469999999999999999999999999999999999999766667788999998876432 222211112
Q ss_pred ccCCccccccccccCccccc---CC--CCCchhhHHHHHHHHHHHHhCCCCCCCchhh------------hhHHHHHHHh
Q 021855 167 YRENKNLTGTARYASCNTHL---GI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------------TKKQKYDKIC 229 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~---~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~------------~~~~~~~~~~ 229 (306)
..-+.+|++.|||||++. +. .|+.+.|.||||+|+|-|+.|..||.+.=.. =+...++.+.
T Consensus 242 --~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 242 --ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred --cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 223668999999999875 22 3889999999999999999999999773221 1345566777
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
++.+..|... +..+|.+.+++|+.+|..|+.+|.++.++++
T Consensus 320 EGkYeFPdkd-WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 320 EGKYEFPDKD-WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCcCChhh-hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 7777776544 4788999999999999999999999998877
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=278.23 Aligned_cols=252 Identities=19% Similarity=0.309 Sum_probs=195.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
..|.....||.|++|.||++.+..++..|++|.+.... ....+.+|+..+..+.| +++..+...+......++++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH-ENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCC-CcHHHHHHheecCCeEEEEEeC
Confidence 44566788999999999999998899999999875432 23346788888888876 4444444445566788999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +++|.+++. ...+++..+..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||++.........
T Consensus 101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~~- 174 (292)
T cd06658 101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVPK- 174 (292)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhccccccc-
Confidence 9 667877765 3458999999999999999999999999999999999999 47899999999998754332211
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.. ....... ....
T Consensus 175 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~-~~~~ 243 (292)
T cd06658 175 ------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD----NLPPRVK-DSHK 243 (292)
T ss_pred ------CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----cCCCccc-cccc
Confidence 1234678899999999888899999999999999999999999987544322222111 1111111 1134
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.+..+.+++.+||..||.+|||++++++ +.++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~--~~~~~ 276 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLK 276 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh--Chhhh
Confidence 5778999999999999999999999987 56655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.13 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=204.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.+|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+|+..+..+.| +++..+..++......++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES-PYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEccCCeEEEEEE
Confidence 368999999999999999999999999999998776543 4567889999999885 555556555666678999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+ +++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 99 6899998876 3578999999999999999999999 999999999999999 5889999999999876543322
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++|..||..............+....... ..
T Consensus 156 ~~-------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 224 (264)
T cd06623 156 QC-------NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS----LP 224 (264)
T ss_pred cc-------cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC----CC
Confidence 11 13456788999999998889999999999999999999999997764322223333333222211 12
Q ss_pred hc-CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 242 KS-HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 242 ~~-~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.. ++..+.++|.+||..+|++|||+.++++ ..+++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~--~~~~~ 260 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ--HPFIK 260 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh--CHHHH
Confidence 33 6889999999999999999999999987 44443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=271.63 Aligned_cols=252 Identities=21% Similarity=0.260 Sum_probs=193.0
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHh--CCCCCCcceeeceeCce-----
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQ--GGSGIPNIKWYGVDGED----- 77 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~----- 77 (306)
|++.+.||.|++|.||+|+++.+++.+++|.+...... ..+.+|+.++.++. .|+++..+...+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78899999999999999999888999999988643222 24556888887775 24555555544444443
Q ss_pred eEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++|++.++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceec
Confidence 89999999889988877533 358999999999999999999999999999999999999 47799999999998765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh------
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------ 230 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~------ 230 (306)
...... ....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+.....
T Consensus 158 ~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 158 SFEMAL--------TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred cCCccc--------ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 433221 123467889999999998999999999999999999999999987654433222221110
Q ss_pred -------------cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 231 -------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 231 -------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...........+..++.+.++|.+||+.||.+||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00011112222345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=278.21 Aligned_cols=258 Identities=22% Similarity=0.308 Sum_probs=197.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeC-----
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~----- 75 (306)
+.++|++.+.||+|++|.||+|.+..++..||+|.+..... ...+.+|+.+++.+.|.+.+.....+..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 57889999999999999999999999999999998764322 234678999999998755444433333222
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++++++++|.+++. ...+++..++.++.||+.||.|||+.||+||||+|+||++ +.++.++|+|||.+..
T Consensus 93 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccccc
Confidence 2468999999999988876 3468999999999999999999999999999999999999 4789999999999876
Q ss_pred cCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc---
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--- 231 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--- 231 (306)
...... ...++..|++||.+.+ ..++.++|+||||+++|++++|..||...+.........+....
T Consensus 168 ~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 168 TDSEMT----------GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccCcc----------ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 433221 3456788999999876 35889999999999999999999999865433222211111000
Q ss_pred --------------------ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 232 --------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 232 --------------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..........+.+++.+.++|.+||+.||.+|||+.+++. +.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~--~~~~~~ 303 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA--HPYFEE 303 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc--CccHhh
Confidence 0000111223466788999999999999999999999985 555543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=276.48 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=198.8
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeecee----
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD---- 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~---- 74 (306)
.+..++|++.+.||+|++|.||+|.+..+++.|++|.+..... ...+.+|+.+++.+.|.+ +..+..++..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~-i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN-IVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCC-eeeeeheecCcchh
Confidence 3456789999999999999999999998999999998764322 234567889999997754 4444333322
Q ss_pred ------CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEE
Q 021855 75 ------GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (306)
Q Consensus 75 ------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~ 148 (306)
....++++||+.+++.+.+......+++..+..++.|++.||.|||++||+|+||+|+||++ ++++.++|+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~ 158 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLA 158 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeC
Confidence 23789999999888888877544568999999999999999999999999999999999999 588999999
Q ss_pred eeccccccCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 021855 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (306)
|||.+......... ......++..|+|||.+.+. .++.++|||||||++++|++|+.||...........+.+
T Consensus 159 dfg~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 159 DFGLARLYNSEESR------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cccccccccCCccc------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99998765443221 11123457789999988654 478899999999999999999999987655444444444
Q ss_pred Hhhcccccc----------------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 228 ICEKKVSTP----------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 228 ~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.+....+.. .......+|+.+.++|.+||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 333221110 01122346889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.71 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=197.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
....|...+.||+|++|.||+|++..++..+++|.+..... ...+.+|+.+++.+.| +++..+..++......+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH-PNSIEYKGCYLREHTAW 101 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCeEE
Confidence 34558889999999999999999998999999998764322 1346778889998876 45555555556677889
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+++||+.+++.+.+.....++++..+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||.+......
T Consensus 102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPA 178 (317)
T ss_pred EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCCc
Confidence 999999889988877656679999999999999999999999999999999999999 47899999999988643321
Q ss_pred CCCccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
....++..|+|||++. ...++.++|+|||||++|+|++|..||...... .....+........
T Consensus 179 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~ 244 (317)
T cd06635 179 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPTL 244 (317)
T ss_pred -----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhccCCCC
Confidence 1345678899999974 456888999999999999999999999875433 22222222222111
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
....+++.+.++|.+||+.+|.+||++.++++.+-.
T Consensus 245 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 245 ---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 114467889999999999999999999999875443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=274.16 Aligned_cols=240 Identities=18% Similarity=0.243 Sum_probs=180.9
Q ss_pred eeecccCccEEEEEEEcCCCc-------eEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 13 RKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~-------~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+.||+|+||.||+|.+..++. .+++|....... ...+.+|..+++.+.| +++..+...+......+++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH-KHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCC-CChhheeeEEEeCCCcEEEEe
Confidence 468999999999998865443 378887654322 2346778888888776 555556555666678899999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC-----CcceEEEEeeccccccC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-----KANQVYIIDFGLAKKYR 157 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~-----~~~~~kl~Dfg~~~~~~ 157 (306)
|+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++ ..+.++++|||.+....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99 7789888876555689999999999999999999999999999999999995221 12347999999886533
Q ss_pred CCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCC-CCCCCchhhhhHHHHHHHhhccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGS-LPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
.. ....++..|+|||++.+. .++.++||||||+++|+|++|. .||......... .........
T Consensus 160 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~----~~~~~~~~~ 224 (258)
T cd05078 160 PK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL----QFYEDRHQL 224 (258)
T ss_pred Cc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH----HHHHccccC
Confidence 21 134567889999999864 5789999999999999999984 666554332211 112222222
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
+ ...+.++.++|.+||+.||++|||+++|++.|
T Consensus 225 ~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 225 P-----APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred C-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2 33457899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=276.78 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=197.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.+.|+..+.||+|++|.||+|.+..+++.||+|.+..... ...+.+|+.+++++.| +++..+...+......++++
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCC-CccHhhhcccccCCceEEEE
Confidence 3467888999999999999999988899999998764332 2356789999999876 55555555566677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||++ ++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 82 EYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcch
Confidence 999 678888775 3468999999999999999999999999999999999999 4789999999999876543221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. .....++..|+|||++.+..++.++|+|||||++|+|++|..||......... ... ..... +...
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~-~~~~~---~~~~ 222 (277)
T cd06642 157 K-------RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLI-PKNSP---PTLE 222 (277)
T ss_pred h-------hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhh-hcCCC---CCCC
Confidence 1 11345678899999999888999999999999999999999999764432211 111 11111 1122
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..++.++.++|.+||+.+|++|||+.+++. ..++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~ 257 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK--HKFIT 257 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH--hHHHH
Confidence 456788999999999999999999999988 44443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=279.21 Aligned_cols=276 Identities=20% Similarity=0.266 Sum_probs=205.4
Q ss_pred CCcccCCceeE-eeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----------------hhhHHHHHHHHHHhCCC
Q 021855 1 MERIIGVKYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------PQLLYEAKVYKILQGGS 63 (306)
Q Consensus 1 ~~~~~~~~y~i-~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~e~~~l~~l~~~~ 63 (306)
|..-+.++|.. .+.||.|++|.||+|.+..+++.||+|.+...... ..+.+|+.++..+.| +
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ 80 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH-E 80 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC-c
Confidence 34446778875 57799999999999999989999999987543221 136789999999977 4
Q ss_pred CCCcceeeceeCceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc
Q 021855 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (306)
Q Consensus 64 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~ 143 (306)
++..+..++..+...++++|++.++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~ 156 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG 156 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence 55555555667778999999999999988865 4568999999999999999999999999999999999999 5788
Q ss_pred eEEEEeeccccccCCCCCCccc------c-ccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Q 021855 144 QVYIIDFGLAKKYRDPTTNRHI------P-YRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 215 (306)
Q Consensus 144 ~~kl~Dfg~~~~~~~~~~~~~~------~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~ 215 (306)
.++|+|||.+.....+...... . ........++..|+|||++.+.. ++.++|+|||||++|+|++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998765422111000 0 00111234577899999987654 68999999999999999999999987
Q ss_pred chhhhhHHHHHHHhhcccc--------------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 216 LKAATKKQKYDKICEKKVS--------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
.........+......... ..........++.+.++|.+||+.+|++|||+++++. ..
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~--~~ 314 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK--HE 314 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc--Cc
Confidence 6544333222221111110 0111122455788999999999999999999999987 77
Q ss_pred hHhhcCCC
Q 021855 276 LFSREGYD 283 (306)
Q Consensus 276 ~~~~~~~~ 283 (306)
+++.....
T Consensus 315 ~~~~~~~~ 322 (335)
T PTZ00024 315 YFKSDPLP 322 (335)
T ss_pred ccCCCCCC
Confidence 77644333
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=278.72 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=198.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeece-----eC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~ 75 (306)
+.++|.+.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+|+.++.+++|.+.+.....+.. ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 56899999999999999999999988999999998875422 2346778999999987554444333321 12
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++++++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++..
T Consensus 95 ~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEeccccccc
Confidence 34688999999999887763 458999999999999999999999999999999999999 4788999999999875
Q ss_pred cCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh----
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE---- 230 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~---- 230 (306)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 170 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 170 TDDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred ccccc----------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 43221 13456888999999876 4688999999999999999999999976443222111111100
Q ss_pred -------------------cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCC
Q 021855 231 -------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284 (306)
Q Consensus 231 -------------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~ 284 (306)
..............++.+.++|.+||+.||.+||++.+++. +.++.+...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~f~~~~~~~ 310 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHDPD 310 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc--ChhhhhcCCCC
Confidence 00011111112245778999999999999999999999987 67776544443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=303.06 Aligned_cols=259 Identities=20% Similarity=0.283 Sum_probs=210.1
Q ss_pred CCceeEeeeecccCccEEEEEEEcCC-C----ceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDT-N----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~-~----~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
...-++.+.||+|+||.||.|..... + ..||+|.+..... ..+|.+|..+++.+.|+|.+..+..... ...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCC
Confidence 45667899999999999999987532 2 2488888776543 3468999999999999666665655544 778
Q ss_pred eEEEEecc-CCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEee
Q 021855 78 NVLVLDLL-GPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Df 150 (306)
.+|++||| +|+|.+++... ...++......++.|||+|..||+++++|||||..+|+|++ ....+|++||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEccc
Confidence 89999999 99999999986 55689999999999999999999999999999999999994 7799999999
Q ss_pred ccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHh
Q 021855 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~ 229 (306)
|+|+..-.... |+......-...|||||.+..+.++.+|||||||+++||++| |..||.+.+..+....+..
T Consensus 847 GlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~-- 919 (1025)
T KOG1095|consen 847 GLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE-- 919 (1025)
T ss_pred chhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh--
Confidence 99984332222 122222233457999999999999999999999999999999 9999998766543332322
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
++++..| ..+|+.+.++|..||+.+|++||++..|++.++.++...
T Consensus 920 ggRL~~P-----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 920 GGRLDPP-----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CCccCCC-----CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 3355555 777999999999999999999999999999999998643
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=269.89 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=195.5
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeec-eeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~~~lv~ 82 (306)
+|++.+.||.|++|.||+|.+..+++.+++|.+..... ...+..|+.+++.+.|++.+.....+. ......++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999998764322 234667888999988755444333332 2445679999
Q ss_pred ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH-----HcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 83 DLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVH-----SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 83 e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH-----~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
||+ +++|.+++... ...+++..++.++.||+.||.||| +.+++|+||+|+||++ ++++.++|+|||.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccccc
Confidence 999 78999888654 356899999999999999999999 9999999999999999 47899999999998
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
......... .....++..|++||++.+..++.++|+||||+++++|++|..||...+... .... .....
T Consensus 158 ~~~~~~~~~-------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~-~~~~~ 226 (265)
T cd08217 158 KILGHDSSF-------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK-IKEGK 226 (265)
T ss_pred ccccCCccc-------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH-HhcCC
Confidence 865443221 123467889999999998889999999999999999999999998754321 1222 22221
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
. +.....+++.+.+++.+||+.+|++|||+++|++
T Consensus 227 ~---~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 F---RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred C---CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1 1222566889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=269.46 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=190.8
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-------chhhHHHHHHHHHHhCCCCCCcceeece-eCcee
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGV-DGEDN 78 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~ 78 (306)
.+|++.+.||+|++|.||+|.+..++..|++|.+..... ...+.+|+.+++.+.|++.+.....+.. .....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999999999999998754321 1246678899999976444443333322 24567
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++|++ +++|.+.+.. ...+++...+.++.|++.||.|||+++++||||+|+||++ +.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence 8999999 6789888875 3458999999999999999999999999999999999999 578899999999987654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
....... ......++..|+|||++.+..++.++|+||+||++|+|++|..||...... ............
T Consensus 158 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~~~~~~~~~~--- 227 (266)
T cd06651 158 TICMSGT----GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAIFKIATQPTN--- 227 (266)
T ss_pred cccccCC----ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHHHHHhcCCCC---
Confidence 3221110 111345788899999999888999999999999999999999999865332 222222211111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
+.+...+++.+.+++ +||..+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 112244577888888 788899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=268.99 Aligned_cols=247 Identities=21% Similarity=0.249 Sum_probs=189.0
Q ss_pred eEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 10 ~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
.....||+|++|.||+|++..++..|++|.+..... ...+.+|+.+++.++|. ++..+..++..+...++++|++ +
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR-NIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCC-CeeeeeeeeccCCEEEEEEecCCC
Confidence 345689999999999999988899999998765432 23577899999998774 4445555556677899999999 7
Q ss_pred CCHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 87 PSLEDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 87 ~~l~~~~~~~~~~~--~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
++|.+++......+ +...+..++.||+.||.|||++||+||||||+||++. ...+.++|+|||.+.........
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~-- 165 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPC-- 165 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCc--
Confidence 89999887644455 7888899999999999999999999999999999994 23679999999998654322111
Q ss_pred ccccCCccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....++..|+|||++.+.. ++.++|+||||+++|+|++|..||......... ....... . ..+.+..
T Consensus 166 -----~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-~~~~~~~-~---~~~~~~~ 235 (268)
T cd06624 166 -----TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-MFKVGMF-K---IHPEIPE 235 (268)
T ss_pred -----cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-Hhhhhhh-c---cCCCCCc
Confidence 11345788999999987654 788999999999999999999999764322111 1111100 1 1111224
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.+++++.+++.+||+.+|.+|||+.+++.
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 56788999999999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=288.52 Aligned_cols=256 Identities=27% Similarity=0.369 Sum_probs=207.5
Q ss_pred eeEeeeecccCccEEEEEEEcCCC----ceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
-.+.++||+|+||.||+|+.+..+ ..||+|...... ...++.+|..+++.++| +++..++.......-.+
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H-~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH-PNVVRFYGVAVLEEPLM 237 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCccE
Confidence 346799999999999999876432 238999877522 23458889999999877 66767777778888999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++||+| +|+|.+++......++..+...++.+.|.||+|||+++++||||-.+|+|++ .++.+||+|||++..-..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccCCcc
Confidence 999999 8899999998666799999999999999999999999999999999999994 677889999999865331
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
-.... ....-...|+|||.+....|++++||||||+++||+++ |..||.+.... ....++.....+.+.
T Consensus 315 ~~~~~-------~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 315 YVMKK-------FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKIVKNGYRMPI 384 (474)
T ss_pred eeecc-------ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHHHhcCccCCC
Confidence 11100 01134567999999999999999999999999999999 89999997765 333344344545444
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
+ ...|..+..++.+||..||+.||||.++.+.|+.+.....
T Consensus 385 ~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 385 P---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred C---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 4 3558889999999999999999999999999999987544
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=271.62 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=194.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeec--eeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYG--VDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~--~~~~~~~lv 81 (306)
++|+..+.||.|++|.||+|.+..+++.+++|.+..... ...+.+|+.+++++.|. ++..+..++ ......+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSP-YIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCC-CeeeeeeEEEccCCCeEEEE
Confidence 479999999999999999999998999999998775433 24578899999998764 444443333 234468999
Q ss_pred Eecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 82 LDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+||+ +++|.+++.. ....++...+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccc
Confidence 9999 7789887653 23458899999999999999999999999999999999999 578899999999986543
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchh--hhhHHHHHHHhhccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA--ATKKQKYDKICEKKVST 235 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~ 235 (306)
.... ....++..|++||.+.+..++.++|+|||||++|+|++|..||..... .................
T Consensus 157 ~~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd06621 157 NSLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227 (287)
T ss_pred cccc---------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh
Confidence 3221 133467789999999988899999999999999999999999976522 11111122111111111
Q ss_pred chHH--HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 236 PIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 236 ~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.... ....+++.+.++|.+||+.||++|||+.+++. ..++.
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~--~~~~~ 270 (287)
T cd06621 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE--HPWIK 270 (287)
T ss_pred hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh--Ccccc
Confidence 1000 00234678999999999999999999999987 44543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=268.19 Aligned_cols=245 Identities=25% Similarity=0.356 Sum_probs=195.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-------CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+|+..+.||+|++|.||+|.+..++..|++|.+.... ....+.+|+.+++.+.| +++..+..+.......++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCC-CCchheeeeEecCCeEEE
Confidence 5788999999999999999998889999999775432 22457778899999876 555556566667778999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
++||+ +++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.+||+|||.+......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 80 FLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceecccc
Confidence 99999 6789888875 3458899999999999999999999999999999999999 47899999999998765433
Q ss_pred CCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.. .....++..|++||.+.... ++.++|+||||+++|+|++|..||...... .......... ..+
T Consensus 156 ~~--------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~---~~~ 221 (258)
T cd06632 156 SF--------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AAVFKIGRSK---ELP 221 (258)
T ss_pred cc--------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HHHHHHHhcc---cCC
Confidence 21 12445788899999988776 899999999999999999999999765422 2222221111 111
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....+++.+.+++.+||+.+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 222556889999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=276.77 Aligned_cols=251 Identities=19% Similarity=0.308 Sum_probs=207.9
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
.-|.++.+||.|+||.||+|.|+++|..+|||...-+.+-++..+|+.++.+......+.++..|+ .....++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-K~sDLWIVMEYCG 111 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYF-KHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhc-cCCceEeehhhcC
Confidence 347789999999999999999999999999999888888889999999999987744444444444 456799999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
-|+..+++.-.+.++++.++..+++.-+.||.|||...-+|||||..|||+ +.+|..||+|||.+..+...-..
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAK--- 185 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAK--- 185 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHHh---
Confidence 689999998878889999999999999999999999999999999999999 68999999999999765443221
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH--hhc
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL--CKS 243 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 243 (306)
.-...||+.|||||++....|+.++||||||++..||..|++||....+. ..+. .....|.+.+ +..
T Consensus 186 ----RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIF----MIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 186 ----RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIF----MIPTKPPPTFKKPEE 254 (502)
T ss_pred ----hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeE----eccCCCCCCCCChHh
Confidence 12678999999999999999999999999999999999999999875543 1111 1222222221 145
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
++.++.++|++||.+.|++|.|+-+|.+ +.++
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~--H~Fi 286 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCE--HTFI 286 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhh--hhhh
Confidence 6899999999999999999999999876 4444
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=269.44 Aligned_cols=242 Identities=21% Similarity=0.310 Sum_probs=188.3
Q ss_pred CceeEeeee--cccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKI--GSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~l--g~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
++|++.+.+ |+|+||.||++++..+++.+++|......... .|......+.+++++..+...+......++++||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 466776776 99999999999999999999999876542221 1333333344567777777666677789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc-eEEEEeeccccccCCCCCC
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~-~~kl~Dfg~~~~~~~~~~~ 162 (306)
+ +++|.+++... ..++++.+..++.||+.||.|||+.|++||||+|+||++. .++ .++|+|||.+.......
T Consensus 91 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~~-- 164 (267)
T PHA03390 91 IKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTPS-- 164 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCCc--
Confidence 9 78999988763 4799999999999999999999999999999999999994 555 89999999987543221
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh-HHHHHHHhhcccccchHHHh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (306)
...++..|+|||++.+..++.++|+||+|+++|+|++|..||........ ...+......... ..
T Consensus 165 ---------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~ 230 (267)
T PHA03390 165 ---------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP-----FI 230 (267)
T ss_pred ---------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCC-----cc
Confidence 33568889999999998999999999999999999999999985433221 1112221111111 11
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCC-hHHHHH
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPD-YGFLKR 271 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps-~~~l~~ 271 (306)
...++.+.++|.+||+.||.+||+ ++++++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 467899999999999999999995 688875
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.13 Aligned_cols=240 Identities=15% Similarity=0.181 Sum_probs=178.2
Q ss_pred eeecccCccEEEEEEEcC------------CCceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 13 RKIGSGSFGEIFLASHVD------------TNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~------------~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+.||+|++|.||+|.... ....+++|.+...... ..+.+|+.++..+.| +++..+..++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~h-p~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH-KHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCC
Confidence 468999999999997532 2235888887654322 346667788888876 5566666666666778
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC----CcceEEEEeeccc
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR----KANQVYIIDFGLA 153 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~----~~~~~kl~Dfg~~ 153 (306)
++++||+ +++|..++......+++..+..++.||+.||.|||++||+||||||+|||+.... ....++++|||.+
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999 6677777665455689999999999999999999999999999999999994210 1224899999988
Q ss_pred cccCCCCCCccccccCCccccccccccCccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCchhhhhHHHHHHHhhc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~-tg~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
....... ...++..|+|||++. +..++.++|||||||++|+|+ +|..||......... .....
T Consensus 160 ~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~ 224 (262)
T cd05077 160 ITVLSRQ-----------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RFYEG 224 (262)
T ss_pred ccccCcc-----------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HHHhc
Confidence 6543211 334677899999887 456899999999999999998 588998764332111 11111
Q ss_pred ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
..... ...++++.++|.+||+.||.+||++.+|++.+
T Consensus 225 ~~~~~-----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QCMLV-----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CccCC-----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11111 22356799999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.97 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=197.9
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.++|++.+.||+|++|.||++.+..++..|++|.+.... ....+.+|+.+++.+.| +++..+...+......++++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH-PNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCC-CCeeehhheeeeCCcEEEEEe
Confidence 468999999999999999999988889999999876432 23457788888988876 555556555666778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccccccc
Confidence 99 7899888764 357889999999999999999999999999999999999 47889999999988654432221
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....++..|++||.+.+..++.++|+||||+++|++++|..||...+.......... ....... ...
T Consensus 172 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~~~---~~~ 239 (293)
T cd06647 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGTPELQ---NPE 239 (293)
T ss_pred -------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CCCCCCC---Ccc
Confidence 1134577889999999888899999999999999999999999976443211111111 1111111 113
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.++..+.++|++||+.+|++||++.+++. +.++.
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~--h~~~~ 273 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLK 273 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHh
Confidence 45778999999999999999999999987 55654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=267.52 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=195.1
Q ss_pred eeEeeeecccCccEEEEEEEcCCC----ceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+++.+.||.|++|.||++.+..++ ..||+|.+..... ...+.+|+..+..+.| +++..+...+......+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDH-PNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCCeeEEE
Confidence 467899999999999999998766 8899998875543 3467789999999955 5666665555666789999
Q ss_pred Eecc-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|++ +++|.+++...... +++..+..++.|++.||.+||+.|++|+||+|+||++ ++++.++|+|||.+......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecccc
Confidence 9999 78999988754433 8999999999999999999999999999999999999 58889999999998765543
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.... . ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+... ......... ....
T Consensus 157 ~~~~-----~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~~-~~~~- 225 (258)
T smart00219 157 DYYK-----K-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYLKKGY-RLPK- 225 (258)
T ss_pred cccc-----c-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCC-CCCC-
Confidence 2211 0 01225678999999988889999999999999999998 889987644322 222222211 1111
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
....+.++.+++.+||+.||.+|||+.++++.|
T Consensus 226 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 --PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 144688999999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=265.35 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=198.3
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
.|++.+.||+|++|.||++.+..+++.+++|...... ....+.+|+..+..+.| +++..+...+......++++|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH-PNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEEEecC
Confidence 4889999999999999999998889999999887655 44568889999998885 55555555566667889999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+++|.+++......+++..+..++.|++.||.+||++|++||||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc---
Confidence 589988887644578999999999999999999999999999999999999 4789999999999876544321
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
.....++..|++||.+.+..++.++|+||||+++|+|++|..||...+.......... ...+.. .....+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~--~~~~~~ 223 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGL--RNPEKW 223 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCc--Cccccc
Confidence 1245678889999999988899999999999999999999999987543222222111 111111 011224
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
+..+.++|.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 788999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=272.49 Aligned_cols=256 Identities=22% Similarity=0.322 Sum_probs=203.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
..+.|++...||+|++|.||+|.+..++..+++|++..... ...+.+|+..+..+.| +++..+...+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH-PNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCC-CCeeEEEEEEEECCEEEEEEe
Confidence 45679999999999999999999988899999998875543 4567789999999876 556666666667788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+++......++...+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchhh
Confidence 99 589999988644479999999999999999999999999999999999999 47889999999988654432211
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....++..|++||++.+..++.++|+||||+++|+|++|..||...+.... ...+......... ...
T Consensus 173 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~--~~~ 240 (286)
T cd06614 173 -------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---LFLITTKGIPPLK--NPE 240 (286)
T ss_pred -------hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcCCCCCc--chh
Confidence 1133467889999999988899999999999999999999999986544322 1222222211111 113
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.++..+.++|.+||+.+|.+|||+.++++ ..++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~ 274 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ--HPFLK 274 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhh--ChHhh
Confidence 46889999999999999999999999976 55554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=269.37 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=194.4
Q ss_pred ceeEeeeecccCccEEEEEEEcC-CCceEEEEEccCCCC------------chhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTK------------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~------------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
.|++.+.||+|++|.||+|.+.. +++.+++|.+..... ...+.+|+.++.+...|+++..+..++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999887 678899997653211 12355677777654455666666666667
Q ss_pred CceeEEEEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEe
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
....++++||+ +++|.+++.. ....+++..++.++.|++.||.|||+ .|++|+||+|+||++ +.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 78899999999 7789887743 23458999999999999999999996 689999999999999 4889999999
Q ss_pred eccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh
Q 021855 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 229 (306)
||.+........ .....++..|++||.+.+..++.++|+||||+++|+|++|..||....... ......
T Consensus 158 fg~~~~~~~~~~--------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~~~~ 226 (269)
T cd08528 158 FGLAKQKQPESK--------LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LATKIV 226 (269)
T ss_pred ccceeecccccc--------cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHHHHh
Confidence 999976543321 124467888999999998889999999999999999999999997643322 222222
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
....... . ...+++.+.++|.+||+.||++||++.++.++++
T Consensus 227 ~~~~~~~-~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYEPL-P--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCCcC-C--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 2222211 1 1346789999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=270.94 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=194.2
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeC--ceeEEEE
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLVL 82 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--~~~~lv~ 82 (306)
|++.+.||.|++|.||+|.+..+++.+++|.+.... ....+.+|+.+++.+.|.+ +..+....... ...++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPN-IVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCC-eeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999889999999887543 2234678999999998644 44444344444 7899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
||+.++|.+++......+++..++.++.||+.||.|||+.|++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcc
Confidence 999889998887644579999999999999999999999999999999999999 58899999999998766543311
Q ss_pred ccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST------ 235 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~------ 235 (306)
. .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+...+......
T Consensus 157 ~------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 157 D------YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred c------ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 0 1123457789999987654 57899999999999999999999998755433222222211111000
Q ss_pred ----------------chHHHhhc-CchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 236 ----------------PIEVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 236 ----------------~~~~~~~~-~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
........ +++.+.++|++||+.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00111122 3788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=266.75 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=190.4
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-------chhhHHHHHHHHHHhCCCCCCcceeecee-Ccee
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVD-GEDN 78 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~ 78 (306)
.+|++.+.||+|++|.||.|.+..++..|++|.+..... ...+.+|+.++.++.|.+.+.....+... ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999997653221 12456788999999775444433332222 3467
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++||+ +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence 8999999 7799888765 3458899999999999999999999999999999999999 478999999999987653
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
...... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||...... ..+.+........
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~-- 228 (265)
T cd06652 158 TICLSG----TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTNP-- 228 (265)
T ss_pred cccccc----cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHHHHhcCCCCC--
Confidence 221110 0112345788999999999888999999999999999999999999865332 2222222221111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
......+..+.++|.+||. +|.+||++++|+.
T Consensus 229 -~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 229 -VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1124456788999999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.79 Aligned_cols=236 Identities=18% Similarity=0.246 Sum_probs=181.6
Q ss_pred eeecccCccEEEEEEEcCCC----------ceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 13 RKIGSGSFGEIFLASHVDTN----------EIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~----------~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+.||+|+||.||+|.+..++ ..+++|.+..... ...+.+|+.+++.+.|++.+ .+..++.. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLV-KLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchh-heeeEEec-CCcEEE
Confidence 46899999999999987766 3577887665443 46678889999998775444 44333333 567999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc-------eEEEEeeccc
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-------QVYIIDFGLA 153 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~-------~~kl~Dfg~~ 153 (306)
+||+ +++|.+++......++...+..++.||+.||.|||+.||+||||||+||+++ .++ .++|+|||.+
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~---~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA---RYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEe---cCccccCCceeEEeCCCCcc
Confidence 9999 7889888876444689999999999999999999999999999999999994 444 7999999998
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhh
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 230 (306)
....... ...++..|+|||++.+. .++.++||||||+++++|++ |..||...+.......+.
T Consensus 156 ~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 156 ITVLSRE-----------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred ccccccc-----------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 7643311 33456789999999877 78999999999999999999 688887654322222221
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
.....+ ......+.++|.+||..+|.+|||+.++++.|
T Consensus 221 ~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 DQHRLP-----MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred cCCCCC-----CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 111111 11136899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=268.89 Aligned_cols=250 Identities=21% Similarity=0.277 Sum_probs=184.2
Q ss_pred eeecccCccEEEEEEEc--CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|.+. .++..+++|.+...... ..+.+|+.+++++.|++ +..+...+......++++||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSN-LLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCC-EeeEEEEEcCCCCcEEEEECCCC
Confidence 46899999999999864 35567899987654332 35777999999998754 444444555566789999999 6
Q ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 87 PSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 87 ~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
++|.+++.... ...+...+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||.+.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCccee
Confidence 89998886432 235677788899999999999999999999999999999 47889999999998643222111
Q ss_pred ccccccCCccccccccccCcccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI-------EQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
.......++..|+|||++.+. .++.++|+||||+++|+|++ |..||.......... .........
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~--~~~~~~~~~ 229 (269)
T cd05087 157 -----VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT--YTVREQQLK 229 (269)
T ss_pred -----ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH--HHhhcccCC
Confidence 011234567789999998642 35789999999999999996 999997754432221 122222222
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
.+.+......++.+.++|++|| .+|++|||+++|+..|+
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 3323333456778999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=270.74 Aligned_cols=246 Identities=21% Similarity=0.318 Sum_probs=187.3
Q ss_pred eeecccCccEEEEEEEcCCC------ceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 13 RKIGSGSFGEIFLASHVDTN------EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~------~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+.||+|++|.||+|++.... +.+++|.+.... ....+.+|+.+++.+.|+ ++..+..++......++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHP-NIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCC-CeeeEeeeecCCCCeEEEEe
Confidence 36899999999999876443 678999776442 334577899999998774 44445445556667899999
Q ss_pred cc-CCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc-----eEEEEeec
Q 021855 84 LL-GPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-----QVYIIDFG 151 (306)
Q Consensus 84 ~~-~~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~-----~~kl~Dfg 151 (306)
++ +++|.+++... ...+++..+..++.|++.||.|||+++++|+||+|+||+++ .++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVS---EKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEe---cCCCCCCcceEECCcc
Confidence 98 78999888642 12378899999999999999999999999999999999995 444 89999999
Q ss_pred cccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhh
Q 021855 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 230 (306)
++.......... .......+..|+|||++.+..++.++|||||||++|+|++ |..||...+....... + .
T Consensus 157 ~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~---~-~ 227 (269)
T cd05044 157 LARDIYKSDYYR-----KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH---V-T 227 (269)
T ss_pred cccccccccccc-----cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH---H-h
Confidence 987553322111 1123345678999999999899999999999999999998 9999976544322211 1 1
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
...... .....|+.+.++|.+||+.+|.+||+++++.+.|.
T Consensus 228 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGGRLQ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCccC---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111 11456788999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=267.50 Aligned_cols=247 Identities=23% Similarity=0.293 Sum_probs=195.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|.+.+.||.|++|.||+|.+..++..+++|.+... .....+.+|+.+++.+.|. ++..+...+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~-~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP-NIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCC-ChhhhhheeccCCeEEEEEe
Confidence 589999999999999999999999999999987643 2334567899999999874 44445445566778999999
Q ss_pred cc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+ +++|.+.+..... .+++..+..++.|++.||.|||+.+++|+||+|+||+++ ++...++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence 99 7899888865332 478999999999999999999999999999999999995 2335679999999876543322
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. .....++..|+|||+..+..++.++|+||||+++++|++|..||...+.. ............ ...
T Consensus 158 ~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~----~~~ 223 (257)
T cd08225 158 L-------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---QLVLKICQGYFA----PIS 223 (257)
T ss_pred c-------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHhcccCC----CCC
Confidence 1 11345788899999998888999999999999999999999999764332 222222222211 122
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
+..+.++.++|.+||+.+|++|||++++++
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 456788999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=270.14 Aligned_cols=254 Identities=20% Similarity=0.310 Sum_probs=197.6
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHh--CCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.|++.+.||.|++|.||+|.+..+++.+++|.+.... ....+.+|+.+++.+. .++++..+...+..+...++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5888999999999999999999999999999876432 2345677889999987 2455555555556777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCcc
Confidence 999 7788888754 4689999999999999999999999999999999999994 789999999999876654332
Q ss_pred CccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
. .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ .... .........
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~-~~~~~~~~~-- 223 (277)
T cd06917 157 K-------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLI-PKSKPPRLE-- 223 (277)
T ss_pred c-------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhcc-ccCCCCCCC--
Confidence 1 1234678899999988754 478899999999999999999999976543211 1111 111111111
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
...++.++.+++.+||+.||++||++.+++. ..++++..
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~--~~~~~~~~ 262 (277)
T cd06917 224 DNGYSKLLREFVAACLDEEPKERLSAEELLK--SKWIKAHS 262 (277)
T ss_pred cccCCHHHHHHHHHHcCCCcccCcCHHHHhh--ChHhhccc
Confidence 1236789999999999999999999999977 56665433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=270.09 Aligned_cols=253 Identities=28% Similarity=0.397 Sum_probs=202.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|.+.+.||+|++|.||+|.+..+++.|++|++... .....+.+|..++.++..++++..+...+......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999999999999999987653 22345677888998887457777776666777789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|++ +++|.+++.. .+.+++..++.++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcc
Confidence 9999 8999998876 4469999999999999999999999999999999999999 478999999999987654432
Q ss_pred CCccc-------------cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 021855 161 TNRHI-------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 161 ~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (306)
..... .........++..|+|||+..+..++.++|+||||++++++++|..||...... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHH
Confidence 21000 011223445788899999998888999999999999999999999999875432 22333
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCCh----HHHHH
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY----GFLKR 271 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~----~~l~~ 271 (306)
........+ ..+++.+.++|.+||+.||++|||+ +++++
T Consensus 234 ~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 ILKLEYSFP-----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHhcCCCCC-----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 332222222 4558889999999999999999999 77754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=268.51 Aligned_cols=240 Identities=23% Similarity=0.361 Sum_probs=185.7
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||.|++|.||+|.+..+++.||+|++...... .....|..++.....++++..+...+......++++||+ +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999999989999999987643211 123334444444445577777766666777899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~------- 150 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLEN------- 150 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceecccc-------
Confidence 899988875 4568999999999999999999999999999999999999 47889999999988653321
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
....++..|++||.+.+..++.++|+||||+++|+|++|..||...+.. ..+..........+ ......+++
T Consensus 151 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~ 222 (260)
T cd05611 151 ----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFDNILSRRINWP-EEVKEFCSP 222 (260)
T ss_pred ----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcccCCC-CcccccCCH
Confidence 1345678899999998888899999999999999999999999765433 22222222222211 112235688
Q ss_pred HHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 247 EFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.+.++|.+||+.||++||++.++.+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHH
Confidence 9999999999999999997754433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=293.41 Aligned_cols=263 Identities=20% Similarity=0.232 Sum_probs=186.5
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCC-ceEEEE------------------EccC-CCCchhhHHHHHHHHHHhCCCC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVK------------------IENS-GTKHPQLLYEAKVYKILQGGSG 64 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~-~~vaiK------------------~~~~-~~~~~~~~~e~~~l~~l~~~~~ 64 (306)
+.++|++.+.||+|+||.||++..+... ..++.| .... ......+.+|+.++..+.| ++
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H-pn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH-EN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC-CC
Confidence 4578999999999999999998765322 222222 1111 1112346789999999977 55
Q ss_pred CCcceeeceeCceeEEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC
Q 021855 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (306)
Q Consensus 65 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~ 140 (306)
+..+..++......+++++++.+++..++.... .......+..++.||+.||.|||++||+||||||+|||+ +
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl---~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL---N 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---C
Confidence 666666667777889999999888888765321 123456678899999999999999999999999999999 5
Q ss_pred CcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh
Q 021855 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (306)
Q Consensus 141 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 220 (306)
.++.+||+|||++..+...... ......|+..|+|||++.+..++.++|||||||++|+|++|..++.......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 8899999999999766443221 1124568999999999999999999999999999999999875443222111
Q ss_pred hHHHHHHHhhcc------cc-------------------cchHH--HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 221 KKQKYDKICEKK------VS-------------------TPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 221 ~~~~~~~~~~~~------~~-------------------~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
....+.+++... .+ ...+. .....+.++.++|.+||+.||.+|||+.|++.
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~-- 453 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA-- 453 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh--
Confidence 111121111110 00 00000 11235667888999999999999999999987
Q ss_pred HHhHhh
Q 021855 274 HDLFSR 279 (306)
Q Consensus 274 ~~~~~~ 279 (306)
+.++..
T Consensus 454 hp~f~~ 459 (501)
T PHA03210 454 LPLFSA 459 (501)
T ss_pred Chhhhc
Confidence 555543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=268.57 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=194.8
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
|.+.+.||.|++|.||+|....+++.|++|.+..... .....+|+..+.++..|+++..+...+......++++|++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6789999999999999999988899999998765422 1234568888888884566666666666678899999999
Q ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
++++.+.+.... ..+++..+..++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~~-- 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPY-- 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCCc--
Confidence 999998887643 468999999999999999999999999999999999999 57899999999998765432211
Q ss_pred ccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc-----------
Q 021855 165 IPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK----------- 232 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------- 232 (306)
....++..|+|||++.+ ..++.++|+||||+++++|++|..||...................
T Consensus 156 ------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 156 ------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 13456788999998854 447899999999999999999999997654433222222111110
Q ss_pred -----------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 -----------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 -----------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
............++.+.++|++||+.||.+|||+++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001112222334678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=267.66 Aligned_cols=249 Identities=18% Similarity=0.247 Sum_probs=182.2
Q ss_pred eeecccCccEEEEEEEcC--CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~--~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|.... ....+++|.+...... ..+.+|+..++.+.| +++..+...+......++++||+ +
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH-PNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCC-CCcceEEEEECCCCceEEEEEeCCC
Confidence 468999999999996532 3456888876543322 346778888888876 44555555555667899999999 7
Q ss_pred CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 87 PSLEDLFVYCRR----KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 87 ~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
++|.+++..... ..++..+..++.||+.||.|||++||+||||||+||++ ++++.+||+|||.+.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchhe
Confidence 899998875332 24577888999999999999999999999999999999 58899999999998653222110
Q ss_pred ccccccCCccccccccccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
. ......++..|+|||++.. ..++.++|||||||++|+|++ |..||........... ........
T Consensus 157 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~~~~~~~~ 229 (269)
T cd05042 157 I-----TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ--VVREQDIK 229 (269)
T ss_pred e-----ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH--HhhccCcc
Confidence 0 1113345677999998742 356889999999999999999 7889876543322111 12222222
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
.+.+.....+++.+.+++..|| .||++|||+++|++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 230 LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 3333344567888999999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=267.81 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=193.8
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC------------chhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+|.+.+.||.|++|.||+|.+..+++.+|+|.+..... ...+.+|+.+++.+.| +++..+..++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH-LNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCC-CCcceEEEEeccC
Confidence 68899999999999999999988899999997653211 1235668888988876 5555565566667
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...++++||+ +++|.+.+... ..++...+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISK 156 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccc
Confidence 7889999999 88999888763 568999999999999999999999999999999999999 578999999999987
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
......... ......++..|+|||++.... ++.++|+||||++++++++|..||....... .........
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~ 228 (272)
T cd06629 157 KSDDIYDND-----QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---AMFKLGNKR 228 (272)
T ss_pred ccccccccc-----ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH---HHHHhhccc
Confidence 643221110 111345788899999987654 7899999999999999999999997543321 111211111
Q ss_pred ccc-chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 VST-PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
... ........++..+.++|.+||+.||++|||+++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111 112223456889999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=261.26 Aligned_cols=271 Identities=21% Similarity=0.278 Sum_probs=205.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCC----ceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
..|++...||+|.||.||+|....++ +.+|+|.++.+ .......+|+.+++.+.|.+.+.....+-..+...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46899999999999999999655443 36899988876 34467899999999999977766666555557789
Q ss_pred EEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC-CCcceEEEEeeccc
Q 021855 79 VLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLA 153 (306)
Q Consensus 79 ~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~-~~~~~~kl~Dfg~~ 153 (306)
++++||...+|++++...+ ..++...+..+++||+.|+.|||++=|.||||||.||||..+ .+.|.+||+|+|++
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9999999999999998643 348888999999999999999999999999999999999522 34699999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhh------HHHHH
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATK------KQKYD 226 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~------~~~~~ 226 (306)
+.+.++-. |.......+.|.+|+|||.+.|.. |+++.||||+|||+.||+|-.+.|.+...... ...+.
T Consensus 184 R~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 184 RLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred HHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 98876543 222233567899999999999876 99999999999999999999988866321110 11111
Q ss_pred HHhhccccc-----------c-----hHHHh----------------hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 227 KICEKKVST-----------P-----IEVLC----------------KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 227 ~~~~~~~~~-----------~-----~~~~~----------------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
++..-...+ | +..+. ..-++...+|+.++|++||.+|.|+++.++ +
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle--h 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE--H 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc--c
Confidence 211111000 0 00000 112455889999999999999999999877 6
Q ss_pred HhHhhcCCC
Q 021855 275 DLFSREGYD 283 (306)
Q Consensus 275 ~~~~~~~~~ 283 (306)
.++......
T Consensus 338 ~yF~~d~lp 346 (438)
T KOG0666|consen 338 PYFTEDPLP 346 (438)
T ss_pred cccccCCCC
Confidence 666654433
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=271.24 Aligned_cols=244 Identities=24% Similarity=0.344 Sum_probs=193.4
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+.|...+.||+|++|.||+|++..+++.|++|.+...... ..+.+|+.++..+.| +++..+..++......+++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH-PNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEEE
Confidence 3466778899999999999999889999999987643221 346778889999876 5555566666677789999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
+||+.+++.+.+.....++++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCCC--
Confidence 9999989988887656678999999999999999999999999999999999999 47889999999987542211
Q ss_pred CccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
....++..|+|||++. +..++.++|+|||||++|+|++|..||......... ........+..
T Consensus 175 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~-- 240 (313)
T cd06633 175 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNDSPTL-- 240 (313)
T ss_pred ---------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhcCCCCC--
Confidence 1346788899999984 456888999999999999999999999875433222 22222111111
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....++..+.+++.+||+.+|.+||++.+++.
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12445778999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.15 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=195.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|.+.+.||+|++|.||+|.+..+++.|++|.+..... ...+.+|+.+++.+.| +++..+..........++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-PNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCC-CChhheeeeEecCCEEEEEEe
Confidence 68999999999999999999988899999998775533 2457788899999977 455555555566778899999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence 99 7889888875 3458899999999999999999999999999999999999 47899999999998765443221
Q ss_pred ccccccCCccccccccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
... ......++..|+|||++.+.. ++.++||||||++++++++|..||...... ......... ......+.
T Consensus 156 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~~-~~~~~~~~ 229 (264)
T cd06626 156 MGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVGA-GHKPPIPD 229 (264)
T ss_pred ccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHhc-CCCCCCCc
Confidence 100 011345678899999998776 789999999999999999999999765322 111112211 11111111
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....++.+.++|.+||+.+|.+|||+.+++.
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 -SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1234788999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=269.49 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=196.6
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
.|...+.||.|++|.||++.+..+++.+++|.+.... ....+.+|+.++..+.| +++..+..++......++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h-~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH-PNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCC-CChheEEEEEEcCCeEEEEEecc
Confidence 5667789999999999999998889999999875432 22346778888888876 55555555556677889999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+++|.+++.. ..++...+..++.|++.||.+||++|++||||+|+||++ +.++.++|+|||.+.........
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~-- 171 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPR-- 171 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCcc--
Confidence 7899888775 468999999999999999999999999999999999999 47899999999987654332111
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.... ............ .....+
T Consensus 172 -----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~~~~~~~~~--~~~~~~ 241 (285)
T cd06648 172 -----RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRIRDNLPPKL--KNLHKV 241 (285)
T ss_pred -----cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHHhcCCCCC--cccccC
Confidence 1234578899999999988899999999999999999999999976443322 222222211111 111336
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
++.+.++|.+||+.+|++|||+.++++ ..+++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~ 273 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN--HPFLA 273 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc--Ccccc
Confidence 788999999999999999999999986 45554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=269.21 Aligned_cols=240 Identities=23% Similarity=0.291 Sum_probs=186.7
Q ss_pred ecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
||+|+||.||+|.+..+++.|++|.+.... ....+..|+.++..++| +++..+...+......++++||+ +++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC-CCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 689999999999999999999999875422 22345678999999875 55555655556667899999999 689
Q ss_pred HHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccc
Q 021855 89 LEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (306)
Q Consensus 89 l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (306)
|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||.+........
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCc------
Confidence 998887533 258999999999999999999999999999999999999 5889999999999876543211
Q ss_pred cCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH-HhhcccccchHHHhhcCch
Q 021855 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK-ICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 246 (306)
.....++..|++||++.+..++.++|+||||+++|+|++|+.||...........+.. ....... ....+++
T Consensus 151 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 223 (277)
T cd05577 151 --IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVE-----YPDKFSP 223 (277)
T ss_pred --cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccccc-----CCccCCH
Confidence 1234567789999999888899999999999999999999999976543222222211 1111111 2245688
Q ss_pred HHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 247 EFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
.+.++|.+||+.||.+|| ++.+++.
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 999999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=268.46 Aligned_cols=240 Identities=24% Similarity=0.290 Sum_probs=183.0
Q ss_pred eecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHh--CCCCCCcceeeceeCceeEEEEecc-
Q 021855 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
.||+|+||.||+|++..+++.||+|.+...... .....|..++..+. +++++..+...+......++++||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999999989999999987643221 12344444444433 3455555556666777899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+++|..++.. ...+++..+..++.|++.||.|||+.+++||||+|+||++ +.++.++|+|||.+........
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~~---- 152 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---- 152 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccCC----
Confidence 7888877765 4568999999999999999999999999999999999999 4788999999999875433221
Q ss_pred cccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 166 PYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
....++..|+|||++.+. .++.++|+||+|+++|+|++|..||...................... ...+
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 222 (278)
T cd05606 153 -----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL-----PDSF 222 (278)
T ss_pred -----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC-----CCcC
Confidence 134678899999999754 58899999999999999999999998753322222222221111111 2445
Q ss_pred chHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 245 PAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
++++.+++.+||..+|.+|| +++++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 88999999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=270.01 Aligned_cols=239 Identities=17% Similarity=0.232 Sum_probs=179.7
Q ss_pred eecccCccEEEEEEEcCC------------------------CceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCc
Q 021855 14 KIGSGSFGEIFLASHVDT------------------------NEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPN 67 (306)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~------------------------~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~ 67 (306)
.||+|+||.||+|....+ ...|++|++..... ...+.+|+.+++.+.| +++..
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h-~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH-IHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC-CCeee
Confidence 589999999999975321 23578887764322 2346667777877776 66666
Q ss_pred ceeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC----CCc
Q 021855 68 IKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----RKA 142 (306)
Q Consensus 68 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~----~~~ 142 (306)
+..++......+++|||+ +++|..++....+.+++..+..++.||+.||.|||++||+||||||+||+++.. ...
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 666677777889999999 778887776545668999999999999999999999999999999999999521 123
Q ss_pred ceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCchhhh
Q 021855 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAAT 220 (306)
Q Consensus 143 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~-tg~~pf~~~~~~~ 220 (306)
..++++|||.+....... ...++..|+|||.+.+ ..++.++|||||||++|+++ +|..||.......
T Consensus 161 ~~~kl~d~g~~~~~~~~~-----------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 161 PFIKLSDPGVSFTALSRE-----------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ceeeecCCcccccccccc-----------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 358999999875432211 2245678999998875 45899999999999999985 6999998754432
Q ss_pred hHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
.... .......+ ...++.+.++|.+||+.+|++|||++++++.|
T Consensus 230 ~~~~----~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERF----YEKKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHH----HHhccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2221 12222222 22356799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=272.61 Aligned_cols=243 Identities=23% Similarity=0.309 Sum_probs=209.3
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
++-...|.++.+||+|+||.|.+|..+.|.+.+|||+++.+- +-.-...|..+|.-...++.+..+..++..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 455677899999999999999999999999999999887652 223356677777766666777777888888888
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.|+||||+ ||+|-..+.. -+.+.++.+..++.+|+-||-+||++||++||||.+|||+ |.+|.+||+|||+++..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccc
Confidence 99999999 8888877776 4579999999999999999999999999999999999999 79999999999999864
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
-.... ..++++||+.|+|||++...+|+..+|+||+|++||||+.|+.||.++++. ..+..+.+.+...|
T Consensus 501 i~~~~-------TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~aI~ehnvsyP 570 (683)
T KOG0696|consen 501 IFDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQAIMEHNVSYP 570 (683)
T ss_pred ccCCc-------ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHccCcCc
Confidence 33322 335889999999999999999999999999999999999999999996654 66777778887777
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCC
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP 264 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rp 264 (306)
..+|.++.+++...|.+.|.+|.
T Consensus 571 -----KslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 571 -----KSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -----ccccHHHHHHHHHHhhcCCcccc
Confidence 66789999999999999999995
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=268.52 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=196.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
-|++.+.||.|+||.||+|.+..++..+|+|....... ...+.+|+.++.++.| +++..+...+..+...++++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCEeEEEEEEEeCCeEEEEEEe
Confidence 47889999999999999999988899999998764322 2356778889998877 4455555556677789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +++|.+++. ...+++..+..++.|++.|+.+||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 84 ~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06641 84 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchhh-
Confidence 9 678887776 3468999999999999999999999999999999999999 47889999999998665432111
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||....... ....+.... . +.....
T Consensus 158 ------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~-~---~~~~~~ 224 (277)
T cd06641 158 ------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFLIPKNN-P---PTLEGN 224 (277)
T ss_pred ------hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHHHhcCC-C---CCCCcc
Confidence 113456788999999988888999999999999999999999997654321 222211111 1 112245
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
++.++.+++.+||+.+|.+||++.+++. ..++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~--~~~~~ 257 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLK--HKFIV 257 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHh
Confidence 6788999999999999999999999988 44443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=260.33 Aligned_cols=265 Identities=21% Similarity=0.341 Sum_probs=204.6
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchh---hHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
.+.+..||+|..|.|++++.+.+|...|+|.+.+.....+ .+..+.+...-..-+.|+....++......++.||.+
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 4467789999999999999999999999999887655433 4555565554444566666677777888889999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
...+..++....+++++..+-++...+..||.||-++ ||+|||+||+|||+ |+.|++||+|||.+-++..+...
T Consensus 174 s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 174 STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccccc--
Confidence 8888888888788899999999999999999999976 89999999999999 79999999999999876654432
Q ss_pred ccccCCccccccccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 165 IPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
....|-+.|||||.+... .|+.++||||||++++||.||..||.+-+-. -..+-++...- ++.++. .
T Consensus 249 ------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln~e-PP~L~~-~ 318 (391)
T KOG0983|consen 249 ------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLNEE-PPLLPG-H 318 (391)
T ss_pred ------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHhcC-CCCCCc-c
Confidence 244567889999999754 5889999999999999999999999884322 12233333322 222111 1
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccc
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 290 (306)
..+|+.+.+++..||++|+.+||...+|++ +.++..-........+|
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~--h~Fi~~ye~a~~dVa~W 365 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE--HPFIKRYETAEVDVASW 365 (391)
T ss_pred cCcCHHHHHHHHHHhhcCcccCcchHHHhc--CcceeecchhhccHHHH
Confidence 347999999999999999999999999987 44443333333344444
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=273.49 Aligned_cols=247 Identities=20% Similarity=0.289 Sum_probs=193.9
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
....|...+.||.|++|.||+|++..++..+++|.+..... ...+.+|+.+++.+.|++ +..+..+.......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN-TIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCC-cccEEEEEEcCCeeE
Confidence 34568888999999999999999998999999998753211 234667889999987654 444545555667889
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+++||+.+++.+.+......+++..+..++.|++.||.|||+.+++||||+|+||++ +.++.++|+|||.+......
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecCc
Confidence 999999889988876656668999999999999999999999999999999999999 47899999999998654322
Q ss_pred CCCccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
. ...++..|+|||.+. ...++.++|||||||++|+|++|..||.......... .......+..
T Consensus 169 ~-----------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~ 234 (308)
T cd06634 169 N-----------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNESPAL 234 (308)
T ss_pred c-----------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH---HHhhcCCCCc
Confidence 1 345678899999975 3457889999999999999999999997754332221 2221111111
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
....++..+.++|.+||+.+|.+||+++++++.
T Consensus 235 ---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 114567889999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.32 Aligned_cols=264 Identities=17% Similarity=0.275 Sum_probs=218.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCC---ceEEEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~---~~vaiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
|-.....|.++||.|.||+|+.|+.+..+ ..||||.++.. +.+.+|+.|..++.++.| |+|.++........-
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH-PNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIRLEGVVTKSKP 704 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC-CcEEEEEEEEecCce
Confidence 34455679999999999999999987554 46999998854 445679999999999987 566667777777788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
..|++||| .|+|.+++....+.++.-+...+++.|+.|+.||-++|.|||||-.+|||| +.+..+|++|||+++.+
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeec
Confidence 99999999 999999999877789999999999999999999999999999999999999 68999999999999987
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
.+..... |.. ..-.-...|+|||.+....++.+|||||+|++++|.++ |..||..+++++....+ +..++.
T Consensus 782 edd~~~~---ytt-~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI----e~gyRL 853 (996)
T KOG0196|consen 782 EDDPEAA---YTT-LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI----EQGYRL 853 (996)
T ss_pred ccCCCcc---ccc-cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH----HhccCC
Confidence 6544221 111 11112467999999999999999999999999999887 99999999886544443 444455
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
|.+ ..+|..+..||..||++|.++||.+.+|+..|++++++-+.
T Consensus 854 PpP---mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 854 PPP---MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred CCC---CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 544 44589999999999999999999999999999999975443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=264.48 Aligned_cols=240 Identities=21% Similarity=0.280 Sum_probs=189.5
Q ss_pred ecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
||.|++|.||+|++..+++.+++|++.... ....+.+|+.+++.+.| +++..+...+.++...++++||+ +++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNH-PFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCC-CCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 689999999999999889999999876432 22457788999999876 55555555566777899999998 789
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccccc
Q 021855 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (306)
Q Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (306)
|.+++.. ...++...+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~------ 149 (262)
T cd05572 80 LWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKT------ 149 (262)
T ss_pred HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCccccc------
Confidence 9998876 3458999999999999999999999999999999999999 47899999999998765443211
Q ss_pred CCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHH
Q 021855 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (306)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (306)
....++..|++||.+.+..++.++|+||+|+++|+|++|..||..... +.......+.........+ ...++++
T Consensus 150 --~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~ 223 (262)
T cd05572 150 --WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKLEFP---NYIDKAA 223 (262)
T ss_pred --ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCCCCC---cccCHHH
Confidence 134568889999999888899999999999999999999999987542 1222233333111111111 3347899
Q ss_pred HHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 249 ASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 249 ~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
.++|.+||+.||++||+ ++++++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 99999999999999998 677766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=268.84 Aligned_cols=252 Identities=19% Similarity=0.305 Sum_probs=196.8
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CC
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP 87 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~ 87 (306)
-...||+|++|.||++.+..+++.|++|.+.... ....+.+|+.+++.+.| +++..+...+......++++||+ ++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCC-cchhheeeEEEeCCEEEEEEecCCCC
Confidence 3467999999999999999999999999875432 23457789999998876 55556655666778899999999 66
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccc
Q 021855 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (306)
Q Consensus 88 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (306)
+|.+++. ...+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+........
T Consensus 103 ~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~------ 171 (292)
T cd06657 103 ALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP------ 171 (292)
T ss_pred cHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc------
Confidence 7877664 3458999999999999999999999999999999999999 5788999999998865433221
Q ss_pred cCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchH
Q 021855 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (306)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (306)
......++..|++||.+.+..++.++|+||+|+++|+|++|..||.+............ ..+..... ...+++.
T Consensus 172 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~ 245 (292)
T cd06657 172 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD----NLPPKLKN-LHKVSPS 245 (292)
T ss_pred -cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----hCCcccCC-cccCCHH
Confidence 11234578889999999888889999999999999999999999987544322222221 11111111 1456788
Q ss_pred HHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 248 FASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 248 ~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
+.+++.+||+.||.+||++.++++ +.++.....
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~~ 278 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 278 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc--ChHHhccCC
Confidence 999999999999999999999988 777765554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.54 Aligned_cols=252 Identities=21% Similarity=0.242 Sum_probs=196.0
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
|++.+.||+|++|.||+|.+..+++.+++|.+.... ....+..|+.+++.+.| +++..+..+.......++++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCC-CCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999877542 23456778899998875 5555555555566789999999
Q ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
++++|.+++......+++..+..++.|++.||.+||+.|++||||+|+||++ ++++.++|+|||.+.........
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~-- 154 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT-- 154 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc--
Confidence 9889999998754579999999999999999999999999999999999999 47899999999998765433211
Q ss_pred ccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc-----------
Q 021855 165 IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK----------- 232 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------- 232 (306)
......+..|+|||.+.+. .++.++|+|||||+++++++|..||...........+.......
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 155 -----YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -----cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 1133456789999998776 78999999999999999999999997754332222221111100
Q ss_pred ----------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 ----------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ----------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.........+..+..+.++|++||+.||++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 001111222345778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.95 Aligned_cols=252 Identities=16% Similarity=0.181 Sum_probs=183.8
Q ss_pred eeeccc--CccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g--~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
..||.| ++++||+|++..+++.||+|+....... ..+.+|+.+++.+.| +++..+..++..+...++++||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRH-PNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcceEeeeEecCCceEEEEeccc
Confidence 456666 8999999999999999999987754322 345667777777766 66666666677778899999999
Q ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
++++.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++++||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCcccc
Confidence 679988877532 348999999999999999999999999999999999999 4788999999986543322211111
Q ss_pred ccccCCccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc-------
Q 021855 165 IPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST------- 235 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~------- 235 (306)
..+.......++..|+|||++.+. .++.++|||||||++|+|++|..||.......... .........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL---QKLKGPPYSPLDITTF 236 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH---HHhcCCCCCCcccccc
Confidence 111111123346679999999764 47899999999999999999999998754321111 110000000
Q ss_pred -----------------------------------chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 236 -----------------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 236 -----------------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
........+++.+.++|++||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000011335678999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=263.29 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=197.8
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|.+.+.||.|++|.||++.+..++..+++|.+..... ...+.+|+.+++.+.| +++..+..........++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-PNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCC-CChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999998999999998875432 3457778899999986 445455444555678899999
Q ss_pred cc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 84 LL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
++ +++|.+.+.... ..++...+..++.+++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeecccC
Confidence 99 679998887642 568999999999999999999999999999999999999 47899999999998765443
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......++..|+|||...+..++.++|+||+|+++++|++|..||...... ............ +
T Consensus 157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~--- 222 (258)
T cd08215 157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALKILKGQYP-P--- 222 (258)
T ss_pred cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHHHhcCCCC-C---
Confidence 21 112446788899999999888999999999999999999999999765422 222222222211 1
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....++..+.+++.+||..+|++|||+.++++
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 12456789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.95 Aligned_cols=253 Identities=21% Similarity=0.330 Sum_probs=196.2
Q ss_pred ceeEeeeecccCccEEEEEEEc---CCCceEEEEEccCC------CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+|++.+.||+|++|.||++++. .++..|++|++... .....+.+|+.++.++.+++++..+...+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46788999987632 12234678999999998778887776666777788
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++||+ +++|.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 9999999 6788888765 3468899999999999999999999999999999999999 478899999999987654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHH-HHHhhcccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKVS 234 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~-~~~~~~~~~ 234 (306)
..... ......++..|++||.+.+.. .+.++|+||||+++|+|++|..||...........+ .........
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd05583 157 AEEEE------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230 (288)
T ss_pred ccccc------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC
Confidence 33221 112345788999999987665 678999999999999999999999643322111222 222222222
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
.+ ..+++.+.++|.+||+.||++|||+.++.+.|+.
T Consensus 231 ~~-----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 FP-----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CC-----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 22 4467889999999999999999998887665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=264.60 Aligned_cols=251 Identities=20% Similarity=0.344 Sum_probs=188.9
Q ss_pred eeEeeeecccCccEEEEEEEc---CCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeC------
Q 021855 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG------ 75 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~------ 75 (306)
|.+.+.||+|++|.||+|.+. .+++.||+|++...... ..+.+|+.+++.+.|. ++..+..++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHP-NVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCC-CcceEEEEEccCCCCCcc
Confidence 678899999999999999864 35788999988754332 3467789999999774 444443332211
Q ss_pred ceeEEEEecc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEe
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
...+++++|+ +++|.+++.... ..++...+..++.|++.||.|||++||+||||||+||++ +.++.++|+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECc
Confidence 1246788888 788887764321 247888999999999999999999999999999999999 4788999999
Q ss_pred eccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHH
Q 021855 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI 228 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~ 228 (306)
||.+.......... ......++..|++||.+.+..++.++|||||||++|+|++ |..||...+.... ...+
T Consensus 157 fg~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYR-----QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYL 228 (273)
T ss_pred ccccccccCCccee-----cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHH
Confidence 99987654322110 1112334567999999988889999999999999999999 8999987544322 2222
Q ss_pred hhcc-cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 229 CEKK-VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 229 ~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
.... ...+ ...++.+.+++.+||+.+|++|||+.+++..|+.+
T Consensus 229 ~~~~~~~~~-----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGNRLKQP-----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCcCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2111 1111 34578899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=259.48 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=197.4
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|++.+.||+|++|.||++.+..+++.|++|.+..... ...+.+|+.++.++.| +++..+..+.......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-PNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCC-CCccEEEEEEEeCCEEEEEEe
Confidence 58999999999999999999998899999998775542 2457788899999876 455555555566778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
++ +++|.+++... ..+++..++.++.|++.||.+||++|++||||+|+||+++ .++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCccc
Confidence 99 67898888763 5689999999999999999999999999999999999994 6899999999999876543321
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....++..|++||...+..++.++|+||+|+++|+|++|..||......... ........ +....
T Consensus 156 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~----~~~~~ 221 (254)
T cd06627 156 -------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL---FRIVQDDH----PPLPE 221 (254)
T ss_pred -------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHhccCC----CCCCC
Confidence 12446788899999998888899999999999999999999999865432222 12111111 11225
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..++.+.+++.+||+.+|++|||+.+++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 56889999999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=276.84 Aligned_cols=258 Identities=21% Similarity=0.341 Sum_probs=215.7
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
.....+||-|-||.||.|.|++-.-.||+|.++.+.. -.+|++|..+++.+.| ++++.+...+..+--+||++||| .
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikH-pNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcC-ccHHHHhhhhccCCCeEEEEecccC
Confidence 4567899999999999999999889999998886643 4679999999999987 55555555666777899999999 9
Q ss_pred CCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 87 PSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 87 ~~l~~~~~~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
|+|.+++..+.+. ++.-..+.++.||+.|+.||..++++||||-.+|+||+ ++-.+|++|||+++....+....+.
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCceeccc
Confidence 9999999987655 77777889999999999999999999999999999995 8889999999999987766554321
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
...-..-|.|||-+....++.+||||+||++|+|+.| |.-||.+.+-...+ ..++..+++..+ ..+
T Consensus 425 ------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY----~LLEkgyRM~~P---eGC 491 (1157)
T KOG4278|consen 425 ------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----GLLEKGYRMDGP---EGC 491 (1157)
T ss_pred ------CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH----HHHhccccccCC---CCC
Confidence 2223456999999999999999999999999999999 99999996654333 444445554433 677
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
|+.+.+||+.||+++|.+||++.++...|++++..+...
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 999999999999999999999999999999999755544
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=260.03 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=198.0
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeC--ceeEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLV 81 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--~~~~lv 81 (306)
+|.+.+.||+|++|.||+|.+..+++.|++|++..... ...+.+|+..++++.|++ +..+....... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN-IVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCC-EeeEEEEEecCCCCeEEEE
Confidence 58899999999999999999998999999998876543 456788999999998644 44444444444 678999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|++ +++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence 9999 88999888763 3789999999999999999999999999999999999994 68999999999987765543
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
... ......++..|++||.+.+...+.++|+||||+++|+|++|..||..... .............. ...
T Consensus 156 ~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~---~~~ 225 (260)
T cd06606 156 TGE-----GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSGEP---PEI 225 (260)
T ss_pred ccc-----cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccCCC---cCC
Confidence 210 01244678889999999988899999999999999999999999987541 12222222211111 112
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....++.+.++|.+||+.||++||++.+++.
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 2455889999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=265.62 Aligned_cols=249 Identities=20% Similarity=0.345 Sum_probs=193.4
Q ss_pred ceeEeeeecccCccEEEEEEEc---CCCceEEEEEccCCC------CchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+|++.+.||.|++|.||+|++. .+|+.||+|++.... ....+.+|+.++..+.+++++..+...+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999874 478899999876421 2244677899999998888888887777777788
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++||+ +++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 9999999 7799888875 4568899999999999999999999999999999999999 478999999999987654
Q ss_pred CCCCCccccccCCccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh-hcccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC-EKKVS 234 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~ 234 (306)
..... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.... ....+
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 157 EDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230 (290)
T ss_pred ccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC
Confidence 32211 11234578899999998753 46789999999999999999999997532222222222222 22222
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
.+ ..+++.+.+++++||+.||.+|| +++++++
T Consensus 231 ~~-----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 YP-----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CC-----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 21 44678899999999999999997 5566544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=261.35 Aligned_cols=244 Identities=20% Similarity=0.306 Sum_probs=196.3
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ....+.+|+.+++.+.| ++++.+...+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC-CCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999876432 22346778889999885 566666656666688999999
Q ss_pred cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 84 LL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 84 ~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
++ +++|.+++... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++ +++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC
Confidence 99 77898887642 24588999999999999999999999999999999999995 6889999999998765443
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ....++..|++||.+.+..++.++|+||||+++++|++|+.||...+.... .......... +
T Consensus 157 ~~---------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-~--- 220 (256)
T cd08530 157 MA---------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RYKVQRGKYP-P--- 220 (256)
T ss_pred Cc---------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhcCCCC-C---
Confidence 21 134567889999999988899999999999999999999999987543221 1222222211 1
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....++.++.+++.+||+.+|++|||+.+++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11356788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.38 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=192.5
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-------CchhhHHHHHHHHHHhCCCCCCcceeece-eCcee
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGV-DGEDN 78 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~ 78 (306)
.+|++.+.||+|++|.||+|++..++..|++|.+.... ....+.+|+.+++.+.|.+.+.....+.. .....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999764321 11346778999999987554443333322 23467
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++|++ +++|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence 8999999 7789888875 3458899999999999999999999999999999999999 478899999999997654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
....... ......++..|+|||++.+..++.++|+|||||++|++++|+.||...... ..+.+.......
T Consensus 158 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~--- 227 (264)
T cd06653 158 TICMSGT----GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFKIATQPTK--- 227 (264)
T ss_pred cccccCc----cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHHHHcCCCC---
Confidence 3211100 111345788899999999888999999999999999999999999864332 222233222211
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
+.++..+++.+.++|.+||+ +|..||++.+++.
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 22335678899999999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=237.51 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=205.7
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.+|.-.++||+|.||+||+|++..|++.||+|....+.. .....+|+-+++.+.|.+.+ .+...-..+....+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhkniv-rl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV-RLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhccee-ehhhhhccCceeEEeH
Confidence 357788999999999999999999999999997664433 34689999999999985544 4444444556789999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+|.-+|..++...++.++.+.+..++.|+++||.++|+.++.||||||+|.++ +.+|.+||+|||+++-+..+..
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCceE-
Confidence 999999999999888889999999999999999999999999999999999999 6899999999999987655432
Q ss_pred ccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccc----
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP---- 236 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 236 (306)
..+..+.|.+|.+|.++.|.. |+...|+||.||++.|+.. |.+.|++.+..++...+.+..+..-...
T Consensus 157 ------cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred ------eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 234567799999999999876 7889999999999999997 8888888766655555555443321100
Q ss_pred -----------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 237 -----------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 237 -----------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
-..+-++++..=+++++++|.-+|.+|.++++.++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 01112334455679999999999999999998765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=279.56 Aligned_cols=262 Identities=21% Similarity=0.255 Sum_probs=208.5
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
+...|++...+|.|+|+.|-.+.+..+++..++|++.... .+..+|+.++....+|+++........+..+.++|||.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc--cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 4578899999999999999999999999999999988763 34456777888888888888887777888899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ ++-+.+-+.. ..-+. ..+..|+++|+.|+.|||+.|++||||||+|||+. ++.+.++|+|||.++..+....
T Consensus 398 l~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~~-- 471 (612)
T KOG0603|consen 398 LDGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSCD-- 471 (612)
T ss_pred ccccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhhc--
Confidence 9 5555555543 22233 67778999999999999999999999999999994 4899999999999987665421
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
..+-|..|.|||++....|++++||||||++||+|++|..||..-... .....++.... +...
T Consensus 472 --------tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~-------~s~~ 534 (612)
T KOG0603|consen 472 --------TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPK-------FSEC 534 (612)
T ss_pred --------ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCc-------cccc
Confidence 335588999999999888999999999999999999999999874443 22222222111 1166
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceec
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 293 (306)
+|+.+++||+.||+.||.+||+++++.. +.++.+.........+|+.+
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~--h~w~~~~~t~p~~q~~~s~~ 582 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIGA--HPWFLSHPTFPPDQLPWSDL 582 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhcc--CcchhcCCCCCcccCCcccc
Confidence 7999999999999999999999999977 77774343333344566644
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=260.21 Aligned_cols=250 Identities=19% Similarity=0.248 Sum_probs=179.8
Q ss_pred eeecccCccEEEEEEEcCC--CceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 13 RKIGSGSFGEIFLASHVDT--NEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~--~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
+.||+|+||.||+|+.... ...+++|.+.... ....+.+|+.++..+.| +++..+...+......++++||+ +
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH-PNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCC-cchhheEEEecCCCccEEEEecCCC
Confidence 3689999999999975432 2346677655432 23467888888888876 44544544555667789999999 6
Q ss_pred CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 87 PSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 87 ~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
++|.+++.... ...+...+..++.||+.||.|||+.+++||||||+|||+ +.++.++|+|||.+.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~- 155 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI- 155 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh-
Confidence 89998887532 235677788999999999999999999999999999999 57899999999987542211110
Q ss_pred cccccCCccccccccccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
.......++..|+|||++.. ..++.++|||||||++|+|++ |..||............. .......
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~--~~~~~~~ 229 (268)
T cd05086 156 ----ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI--KDQQVKL 229 (268)
T ss_pred ----hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--hhccccc
Confidence 01123456788999998753 235789999999999999997 577887654432222211 1122222
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
+.+.....+++.+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 223333556888999999999 68999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=280.61 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=207.2
Q ss_pred CCce-eEeeeecccCccEEEEEEEcCCCceEEEE------EccCCCCchhhHHHHHHHHHHhCCCCCCcceeece-eCce
Q 021855 6 GVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-DGED 77 (306)
Q Consensus 6 ~~~y-~i~~~lg~g~~~~v~~~~~~~~~~~vaiK------~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~ 77 (306)
+++| +....||+|+|-+||+|.+..+|.+||.- +...+...+.+..|+++|+.|+|.+++..+..|.. ....
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 3444 35788999999999999999999998843 23344445679999999999999666665544433 3345
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
..+++|.+ .|+|..+... .+.++.+.+..|++||++||.|||+. -|+|||||.+||||+ -.-|.+||+|+|+|.
T Consensus 118 in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHH
Confidence 78999999 9999999887 44689999999999999999999987 499999999999996 468999999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
....+... ...||+.|||||+.. ..|+..+||||||+++.||+|+..||..-.. ..+.+.+...+..+
T Consensus 195 l~r~s~ak---------svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 195 LLRKSHAK---------SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKP 262 (632)
T ss_pred Hhhccccc---------eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCH
Confidence 87665543 568999999999988 6899999999999999999999999987543 34566676666655
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
..+... -.++++++|.+||.. .++|||+.||++ ..++...
T Consensus 263 ~sl~kV---~dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~d 302 (632)
T KOG0584|consen 263 AALSKV---KDPEVREFIEKCLAT-KSERLSAKELLK--DPFFDED 302 (632)
T ss_pred HHhhcc---CCHHHHHHHHHHhcC-chhccCHHHHhh--Chhhccc
Confidence 554433 378999999999999 999999999987 6666543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=281.19 Aligned_cols=264 Identities=20% Similarity=0.306 Sum_probs=195.7
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccC---CCCchhhHHHHHHHHHHhCCCCCCcceeece-----eCcee
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDN 78 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 78 (306)
.-+..-+.||+|+||.||++++++||+.||+|.++. ....+...+|++++++|+|.+++..+..-.. .....
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 345567899999999999999999999999998876 4455668889999999996444433322211 23456
Q ss_pred EEEEecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC-CcceEEEEeecccc
Q 021855 79 VLVLDLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLAK 154 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~-~~~~~kl~Dfg~~~ 154 (306)
+++|||| +|+|...+... ..++++.+++.++.++..||.|||++||+||||||.||++.... ..-..||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 8999999 99999998743 34699999999999999999999999999999999999985433 33456999999999
Q ss_pred ccCCCCCCccccccCCccccccccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhh--hhHHHHHHHhhc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA--TKKQKYDKICEK 231 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~--~~~~~~~~~~~~ 231 (306)
.+++... .....||..|++||++. .+.|+..+|.|||||++|+++||..||-..-.. .....+..+.+.
T Consensus 173 el~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 173 ELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred cCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 8876552 23778999999999999 478999999999999999999999999642211 001111111111
Q ss_pred c----------cccc------hHH---HhhcCchHHHHHHHhhhcCCCCCCC--ChHHHHHHHHHhHh
Q 021855 232 K----------VSTP------IEV---LCKSHPAEFASYFHYCQSLTFDQRP--DYGFLKRLFHDLFS 278 (306)
Q Consensus 232 ~----------~~~~------~~~---~~~~~~~~~~~li~~cl~~dP~~Rp--s~~~l~~~l~~~~~ 278 (306)
. .+.| ++. +...+-..+-..+..+|..+|.+|- .+.+.-..+..|+.
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1 0000 010 1111223366788889999999998 77777777777765
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=276.25 Aligned_cols=245 Identities=25% Similarity=0.341 Sum_probs=204.9
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch----hhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
-+.|.+.+.||+|.|+.|.+|++..|+..||+|.++...... .+.+|+.+++.|.| |++..+...-......|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~H-PnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNH-PNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCC-cceeeeeeeeeecceeEEE
Confidence 467999999999999999999999999999999988665433 36889999999988 5555555555566789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +|.+.+++... +.+.+..+..++.|+..|++|||+.+|+|||||++|||+ +.+.++||+|||++..+....
T Consensus 134 ~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeecccc
Confidence 9999 88999998874 456778999999999999999999999999999999999 688999999999998776433
Q ss_pred CCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
. ....+|+++|.|||++.+..| ++.+|+||+|+++|-|+.|.+||.+-+ ....-.+.+.+++..+
T Consensus 210 ~--------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---lk~Lr~rvl~gk~rIp--- 275 (596)
T KOG0586|consen 210 M--------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---LKELRPRVLRGKYRIP--- 275 (596)
T ss_pred c--------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---cccccchheeeeeccc---
Confidence 2 247889999999999999986 689999999999999999999998732 2223334445555555
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
--++.+..++|+++|..+|.+|++.+++.+
T Consensus 276 --~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 276 --FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 333668899999999999999999999866
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=260.98 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=189.4
Q ss_pred ecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
||.|++|.||++++..+++.+++|.+.... ....+.+|+.++.++.| +++..+......+...++++|++ +++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCC-cchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999999889999999876542 23456778888988886 55555555556677899999999 679
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc-cccc
Q 021855 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR-HIPY 167 (306)
Q Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~ 167 (306)
|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++.......... ....
T Consensus 80 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCccccccccc
Confidence 98888763 368999999999999999999999999999999999999 588999999999987543321100 0000
Q ss_pred cCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchH
Q 021855 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (306)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (306)
.......++..|++||......++.++|+||||+++|++++|..||...... .............+.. ...++.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~---~~~~~~ 229 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNILNGKIEWPED---VEVSDE 229 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCcCCCcc---ccCCHH
Confidence 0112345678899999998888999999999999999999999999765433 2233332222222211 124789
Q ss_pred HHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 248 FASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 248 ~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
+.+++.+||+.+|.+|||+..+.+.|
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 99999999999999999995554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=274.52 Aligned_cols=267 Identities=21% Similarity=0.263 Sum_probs=211.5
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---------chhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---------HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
++++++|-++..||+|||+.||+|.+...++.||+|+-..... .....+|..+.+.|.|..++.....+..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 5678999999999999999999999999999999997543322 2346778889999887554444455556
Q ss_pred eCceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CccccCCCCCceeeccCCCcceEEEEeec
Q 021855 74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (306)
Q Consensus 74 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg 151 (306)
+...+|-|+|||.|+..+++......++++++..|++||+.||.||.+. .|+|-||||.|||+......|.+||+|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7788999999997666666665566799999999999999999999976 59999999999999766789999999999
Q ss_pred cccccCCCCCCccccccCCccccccccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 021855 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (306)
+++................+...||.+|++||.+.-+ ..+.++||||+|+|+|.++.|+.||...-..........
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 9999887776655555566778899999999987644 257899999999999999999999976433322222233
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
++....-.+.+ .+.++++..++|++||++.-++|.+..+|..
T Consensus 699 IlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 699 ILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 33322221111 1566889999999999999999999888765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=255.46 Aligned_cols=261 Identities=23% Similarity=0.269 Sum_probs=206.9
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC----CCCchhhHHHHHHHHHHhCCCCCCcceeece-------
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGV------- 73 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~------- 73 (306)
..+.|+-...+|+|.||.||+|+.+.+++.|++|..-- .......++|++++..|.|.+....+..+..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34678888999999999999999999999999885332 2233457899999999998665544432221
Q ss_pred eCceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 74 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
+...+|+|+++|..+|..++......++...+..++.+++.||.|+|++.|+|||+||.|+|+ +.+|.++|+|||++
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeeccccc
Confidence 334589999999999999998766679999999999999999999999999999999999999 48999999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
+.+..+.......| ...+.|.+|++||.+.|.. |+++.|||+.||++.+|+||.+.|++..+......+...++..
T Consensus 172 r~fs~~~n~~kpry---tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRY---TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred cceecccccCCCCc---ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 87765544332222 2556799999999999875 9999999999999999999999999988777666666666554
Q ss_pred cccc------hH---HH-----h--------h-----cCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 VSTP------IE---VL-----C--------K-----SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ~~~~------~~---~~-----~--------~-----~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
-+.. ++ .+ . . .-+++..+|+.++|..||.+|+++++.++
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 2211 00 00 0 0 01346889999999999999999998876
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=260.65 Aligned_cols=245 Identities=21% Similarity=0.267 Sum_probs=188.5
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-------CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+|.+.+.||+|++|.||++++..++..+++|+.... .....+..|+.+++.+.| +++..+..++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH-PAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCC-CcHHHHHHHHhcCCceEE
Confidence 689999999999999999999877766666654421 112235567888888876 555555555566677899
Q ss_pred EEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 81 VLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
++||+ +++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 99999 7788887753 234589999999999999999999999999999999999993 466999999998765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
...... .....++..|+|||...+..++.++|+||||+++++|++|..||..... ............+
T Consensus 156 ~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~~~~~~~~-- 223 (260)
T cd08222 156 MGSCDL-------ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTP-- 223 (260)
T ss_pred CCCccc-------ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHcCCCC--
Confidence 433221 1234567889999999888889999999999999999999999975332 2222222222211
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....++.++.++|.+||+.||++||++.+++.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 122456789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=265.06 Aligned_cols=258 Identities=19% Similarity=0.249 Sum_probs=185.0
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+++.+| +.+.||++++..+++.||+|++.... ....+.+|+.+++.+.|. ++..+...+......++++||+
T Consensus 6 i~~~~~--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~-~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFE--DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP-NILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhc--CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCc-chhhhhheeecCCeEEEEEeccC
Confidence 444444 44556666667789999999876542 224577899999999875 4444544556677889999999
Q ss_pred CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 ~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
++++.+++... ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeecccccccc
Confidence 68888888753 3458899999999999999999999999999999999999 4789999999998876543222111
Q ss_pred ccccCCccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc---------
Q 021855 165 IPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV--------- 233 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------- 233 (306)
..........++..|+|||++.+. .++.++|+||+||++++|++|..||........ ..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchh
Confidence 111112234567789999998763 488999999999999999999999986443211 1111100000
Q ss_pred -------------------ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 234 -------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 234 -------------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..........++.++.++|.+||+.||++|||++++++ ..+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~p~~~ 299 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN--HSFFK 299 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc--CchHh
Confidence 00001111233567899999999999999999999988 66654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=252.50 Aligned_cols=234 Identities=26% Similarity=0.376 Sum_probs=187.6
Q ss_pred ecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
||.|++|.||++.+..+++.+++|.+..... ...+..|+.+++.+.| +++..+...+..+...++++|++ +++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH-PFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCC-CcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6899999999999988899999998765432 2356778889998886 45555555556777899999999 889
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccccc
Q 021855 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (306)
Q Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (306)
|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~------ 149 (250)
T cd05123 80 LFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSR------ 149 (250)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCc------
Confidence 9988876 3468999999999999999999999999999999999999 47889999999998765443211
Q ss_pred CCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHH
Q 021855 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (306)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (306)
.....++..|++||...+...+.++|+||||+++|++++|..||...+. ..............+ ...+..+
T Consensus 150 -~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-----~~~~~~l 220 (250)
T cd05123 150 -TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPLRFP-----EFLSPEA 220 (250)
T ss_pred -ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCCCCC-----CCCCHHH
Confidence 1245678889999999888889999999999999999999999976443 222333333332222 4457889
Q ss_pred HHHHHhhhcCCCCCCCChHH
Q 021855 249 ASYFHYCQSLTFDQRPDYGF 268 (306)
Q Consensus 249 ~~li~~cl~~dP~~Rps~~~ 268 (306)
.++|.+||..||+.||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 99999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=274.25 Aligned_cols=244 Identities=21% Similarity=0.323 Sum_probs=203.8
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccCC
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP 87 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 87 (306)
.+.||+|-||+||-|.++.+|+.||+|++++- +....+.+|+.++..+.| +++.++...+...+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~H-PGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHH-PGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCC-CCeeEEEEeecCCceEEEEehhhcc
Confidence 47899999999999999999999999998753 334567889999999865 8899999888888899999999999
Q ss_pred CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 88 SLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 88 ~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
+..+.+... .+.+++.....++.||+.||.|||-++|+|+||||+|||+.+.+..-.+||+|||.++.+.+..-
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence 888876643 45699999999999999999999999999999999999998767788999999999998765443
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCch
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (306)
.+..+||+.|+|||++..+-|...-||||+|+|+|--++|..||....+. .. ++....+-.| +.-+.++++
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--nd---QIQNAaFMyP-p~PW~eis~ 793 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--ND---QIQNAAFMYP-PNPWSEISP 793 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hH---HhhccccccC-CCchhhcCH
Confidence 24789999999999999999999999999999999999999999864321 11 2211222222 233467789
Q ss_pred HHHHHHHhhhcCCCCCCCChHHHH
Q 021855 247 EFASYFHYCQSLTFDQRPDYGFLK 270 (306)
Q Consensus 247 ~~~~li~~cl~~dP~~Rps~~~l~ 270 (306)
.+.+||+.+|+..=.+|.|.+.-+
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhc
Confidence 999999999999999999877643
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=299.60 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=200.6
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
-++.-.-.||.|.||.||.|.+..||+..|+|.+.-. ...+...+|..++..+.| ++++..+......+..+|+|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnH-pNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNH-PNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccC-ccccccCceeecHHHHHHHH
Confidence 4555677899999999999999999999999966532 333557889999999988 55666666677778899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||| +|+|.+++.. ++..++.....+..|++.|+.|||+.||||||+||.||++ +.+|.+|++|||+|.....+..
T Consensus 1314 EyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCchh
Confidence 999 8999999875 5557777777888999999999999999999999999999 6899999999999988766532
Q ss_pred CccccccCCccccccccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
. +| .......||+.|||||++.+-. -+-+.|||||||+..||+||+.||...+.. .+...+...+..+.
T Consensus 1390 ~--~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh~Pq--- 1461 (1509)
T KOG4645|consen 1390 T--MP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGHKPQ--- 1461 (1509)
T ss_pred c--CC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccCCCC---
Confidence 1 11 1223668999999999998654 345899999999999999999999887643 33333332222222
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
++.+++++-+++|..||..||.+|.++.||++
T Consensus 1462 -~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 -IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 12457899999999999999999999887766
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=252.77 Aligned_cols=243 Identities=20% Similarity=0.305 Sum_probs=206.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+.|+++++||.|+|+.|-+++++.|.+.+|+|+++++ ..-.....|..+..+...+|.+.-+..++..+...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5799999999999999999999999999999986643 33344566888888888888888888899999999999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
.||. ||+|-..+.. +++++++.+..+...|..||.|||+.||++||||.+|+|+ |..|.+||+|+|+++.-..++
T Consensus 330 ieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCC
Confidence 9999 7788777765 5679999999999999999999999999999999999999 799999999999998654443
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-----chhhhhHHHHHHHhhccccc
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG-----LKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~-----~~~~~~~~~~~~~~~~~~~~ 235 (306)
. ..++++||+.|.|||++.|..|+..+|+|+||++++||+.|+.||.- .+..+....++-+.+..++.
T Consensus 406 d-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 406 D-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred c-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 3 33588999999999999999999999999999999999999999953 12222334456667777777
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCC
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 265 (306)
| ..+|-....+++.-|.+||.+|..
T Consensus 479 p-----rslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 479 P-----RSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred c-----ceeehhhHHHHHHhhcCCcHHhcC
Confidence 7 455777889999999999999953
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.85 Aligned_cols=268 Identities=25% Similarity=0.293 Sum_probs=206.7
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHH-HHHHHHHHhCCCCCCcceeeceeC---c
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWYGVDG---E 76 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~-e~~~l~~l~~~~~~~~~~~~~~~~---~ 76 (306)
++|++++...+.+.||+|.||+||+|+| .|+.||||++.+....+.+.+ |+...-.|+|.|++..+..-..+. .
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4788999999999999999999999999 478899999998766555433 555566678877766664322222 3
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCceeeccCCCcceEEE
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYI 147 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~i~H~dlkp~Nilv~~~~~~~~~kl 147 (306)
..+|+++|. .|||.+++.. ..++.+...+++..+|.||+|||.. .|+|||||+.|||| ..++..-|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEE
Confidence 579999998 9999999985 5799999999999999999999953 59999999999999 48999999
Q ss_pred EeeccccccCCCCCCccccccCCccccccccccCcccccCCC------CCchhhHHHHHHHHHHHHhC----------CC
Q 021855 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRG----------SL 211 (306)
Q Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~sDiwslG~il~~l~tg----------~~ 211 (306)
+|+|+|....+.....+++.+ ..+||.+|||||++...- --..+||||||.+++|++-. ..
T Consensus 358 ADLGLAv~h~~~t~~idi~~N---~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPN---PRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred eeceeeEEecccCCcccCCCC---CccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 999999887665544444433 668999999999996532 12468999999999998753 58
Q ss_pred CCCCchhhhh--HHHHHHHhhcccccchHHHhhcCc--hHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 212 PWQGLKAATK--KQKYDKICEKKVSTPIEVLCKSHP--AEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 212 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
||.+..+.++ .+...-.+-.+.++..+......+ ..+.++|+.||..+|.-|.|+-.+.+.|.++.+
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 8877544332 222333444444444443222222 357899999999999999999999999998874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=257.54 Aligned_cols=136 Identities=27% Similarity=0.524 Sum_probs=114.1
Q ss_pred CcccC-CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-hhhHHHHHHHHHHhCCC-------CCCcce---
Q 021855 2 ERIIG-VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGS-------GIPNIK--- 69 (306)
Q Consensus 2 ~~~~~-~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~-------~~~~~~--- 69 (306)
+..+. ++|-+.++||+|.|++||++.+.++.+.||+|+.++.... +..+.|+++|++++... .+..+.
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 44555 9999999999999999999999999999999998876554 44678999999997544 122222
Q ss_pred -eeceeCceeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeec
Q 021855 70 -WYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMG 137 (306)
Q Consensus 70 -~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~ 137 (306)
..+..+.+.|+|+|++|.+|..+|.+.. ++++...+..|++||+.||.|||+ +||+|.||||+|||+.
T Consensus 152 khsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 2245778999999999999999998654 459999999999999999999996 5999999999999995
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=279.98 Aligned_cols=143 Identities=23% Similarity=0.465 Sum_probs=122.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|.+.+.||+|+||.||+|++..+++.||+|++..... ...+..|+.++..+.| +++..+...+......+++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS-PFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCC-CCcCeEEEEEEECCEEEEE
Confidence 679999999999999999999999999999998865322 1346678888887766 5555555666677889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999 8899998875 3468899999999999999999999999999999999999 478999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=248.63 Aligned_cols=221 Identities=17% Similarity=0.171 Sum_probs=171.1
Q ss_pred cCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCCHHHHHHHh
Q 021855 18 GSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC 96 (306)
Q Consensus 18 g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~ 96 (306)
|.++.||++++..+++.+|+|.+..... ..+|...+.... ++++..+..++......++++||+ +++|.+.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---YSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK- 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---hhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence 8899999999999999999998865432 223333333333 356666666666778899999999 7799888865
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCcccccc
Q 021855 97 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176 (306)
Q Consensus 97 ~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (306)
...+++..+..++.|++.||.|||++|++||||||+||++ +.++.++++|||.+........ ...++
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~~----------~~~~~ 145 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSCD----------GEAVE 145 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccccc----------cCCcC
Confidence 3468999999999999999999999999999999999999 5788999999998765433211 23446
Q ss_pred ccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhh
Q 021855 177 ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQ 256 (306)
Q Consensus 177 ~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 256 (306)
..|+|||...+..++.++|+||+|+++|+|++|..||...... ... ..... ....+++.+.++|.+||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~--~~~~~-----~~~~~~~~~~~li~~~l 213 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INT--HTTLN-----IPEWVSEEARSLLQQLL 213 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc--ccccC-----CcccCCHHHHHHHHHHc
Confidence 6799999998888999999999999999999999887642211 000 00011 11456788999999999
Q ss_pred cCCCCCCCChHH
Q 021855 257 SLTFDQRPDYGF 268 (306)
Q Consensus 257 ~~dP~~Rps~~~ 268 (306)
+.||++||++.+
T Consensus 214 ~~dp~~R~~~~~ 225 (237)
T cd05576 214 QFNPTERLGAGV 225 (237)
T ss_pred cCCHHHhcCCCc
Confidence 999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=265.76 Aligned_cols=263 Identities=18% Similarity=0.263 Sum_probs=210.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+.-....+.++||+|-||.|.++.-. .+..||+|.+..... ..+|.+|++++.+|+| |++..+...+...+..++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkh-PNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKH-PNIVELLGVCVQDDPLCM 612 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCC-CCeeEEEeeeecCCchHH
Confidence 44556788999999999999999753 368899998876533 3569999999999976 555555555566678999
Q ss_pred EEecc-CCCHHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~-~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++||+ .|+|.+++.....+. ..+....++.||+.|++||.+.++|||||.+.|+|+ +.++.+|++|||+++.+-+
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCccccccccc
Confidence 99999 899999998765443 556667799999999999999999999999999999 6999999999999986543
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t--g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
... |+..+..+-...|||+|-+.-+.++.+||+|+||+++||+++ ...||..+.................+..
T Consensus 690 g~y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 690 GDY-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV 764 (807)
T ss_pred CCc-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce
Confidence 332 223345566788999999999999999999999999999886 7899998776655444444444444433
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
....+.-+|..+.++|.+||..|-.+|||+++|...|.+.
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 3334466789999999999999999999999998877653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=282.76 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=187.6
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeece----------
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGV---------- 73 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~---------- 73 (306)
.+|+..+.||+||||.||+++++-+|+.||||.+.... ......+|+..+.+|+|++.+.+...+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 45788999999999999999999999999999877543 22346779999999988665322110000
Q ss_pred --------------------------------------------------------------------------------
Q 021855 74 -------------------------------------------------------------------------------- 73 (306)
Q Consensus 74 -------------------------------------------------------------------------------- 73 (306)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred --------------------eC--------ceeEEEEeccCCCHHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCc
Q 021855 74 --------------------DG--------EDNVLVLDLLGPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGF 124 (306)
Q Consensus 74 --------------------~~--------~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~qi~~~L~~LH~~~i 124 (306)
.+ ...||-||||..++...+...+... .....|+++++|++||.|+|++||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 00 1236888999666665544433322 477899999999999999999999
Q ss_pred cccCCCCCceeeccCCCcceEEEEeeccccccC----------CCCCCcc-ccccCCccccccccccCcccccCCC---C
Q 021855 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR----------DPTTNRH-IPYRENKNLTGTARYASCNTHLGIE---Q 190 (306)
Q Consensus 125 ~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~----------~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~---~ 190 (306)
+||||||.|||+ +++..|||+|||++.... .+.+... .........+||.-|+|||++.+.. |
T Consensus 719 IHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 719 IHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred eeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999 699999999999997621 0000000 0111233668999999999998655 9
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHH
Q 021855 191 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (306)
Q Consensus 191 ~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~ 270 (306)
+.|+||||||++|+||+ .||.. ..+....+.......++.+ +++..+.-+.-.++|+.|+++||++||||.||+
T Consensus 796 n~KiDmYSLGIVlFEM~---yPF~T--sMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEML---YPFGT--SMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred cchhhhHHHHHHHHHHh---ccCCc--hHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 99999999999999998 55754 2233444555445555555 333344445678999999999999999999998
Q ss_pred H
Q 021855 271 R 271 (306)
Q Consensus 271 ~ 271 (306)
.
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 7
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=270.46 Aligned_cols=251 Identities=20% Similarity=0.334 Sum_probs=206.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-hhhHHHHHHHHHHhCCCCCCcceeece-----eCceeE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDNV 79 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~~ 79 (306)
.+-|++.+.||.|.+|.||+++++.+++.+|+|+....... .+..-|+.+++.+.+|++++..+.++. .++.++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 56789999999999999999999999999999998876554 445668889999999999888765554 345789
Q ss_pred EEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 80 LVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|||||| +||..++.... +..+.++.+..|++.++.||.+||.+.++|||+|-.|||++ .++.+||.|||.+..+.
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeeeeeeeee
Confidence 999999 88999988754 34599999999999999999999999999999999999996 89999999999998765
Q ss_pred CCCCCccccccCCccccccccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
..... .-+..||+.|||||++... .|+..+|+||||++..||.-|.+|+..+.+. ..+..+..
T Consensus 175 sT~gr-------RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---raLF~IpR-- 242 (953)
T KOG0587|consen 175 STVGR-------RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR-- 242 (953)
T ss_pred ccccc-------ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---hhhccCCC--
Confidence 54332 2367899999999999744 3667899999999999999999999987664 22222211
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
-++|...-+..++.++.++|..||.+|..+||+..++++
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 112222223677899999999999999999999988866
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=265.43 Aligned_cols=207 Identities=23% Similarity=0.306 Sum_probs=176.2
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCC-----CCCcceeecee
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGS-----GIPNIKWYGVD 74 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~-----~~~~~~~~~~~ 74 (306)
++.++..+|.|....|+|-|++|..|++...|+.||||++.... .+..-+.|+.+|+.|.... ++..+.-.|..
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 35678999999999999999999999999889999999987653 3455678999999998532 23333344556
Q ss_pred CceeEEEEeccCCCHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~--~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
..++|+|+|.+..+|.+++...+.+ +...++..++.|+.-||..|-.+||+|.||||+||||. +....+||||||+
T Consensus 506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGS 583 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGS 583 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCcc
Confidence 7899999999999999999865543 78899999999999999999999999999999999995 5678889999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchh
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~ 218 (306)
|......... .+..+..|.|||++.|.+|+...|+||+||+|||+.||+..|++...
T Consensus 584 A~~~~eneit---------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 584 ASFASENEIT---------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cccccccccc---------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 9876655443 34557789999999999999999999999999999999999998544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=262.56 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=201.7
Q ss_pred EeeeecccCccEEEEEEEcC--CC--ceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 11 LGRKIGSGSFGEIFLASHVD--TN--EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~--~~--~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+.+.||.|-||.||.|.... .| --||||+-+.++. .+.|+.|..+++.+.|+.++..+..+. +.-.+||||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~--e~P~WivmE 470 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV--EQPMWIVME 470 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee--ccceeEEEe
Confidence 46789999999999997532 22 3488897776433 456899999999998855554444332 345789999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
.+ .|.|..++......++......++.||..||.|||+.++|||||-.+||||+ +...+||+|||+++.......-
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccccchh
Confidence 99 8999999998777899999999999999999999999999999999999995 8889999999999877654432
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
..+...-..-|||||-+....++.+||||=||++++|++. |..||.+....+....++. +.+.+.|
T Consensus 548 ------kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn--GeRlP~P----- 614 (974)
T KOG4257|consen 548 ------KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN--GERLPCP----- 614 (974)
T ss_pred ------hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC--CCCCCCC-----
Confidence 1111122335999999999999999999999999999998 9999998665433333322 2333344
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
+++|+.+..|+.+||.+||.+||++.+|...|++++..+
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 788999999999999999999999999999999998733
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=271.71 Aligned_cols=266 Identities=21% Similarity=0.214 Sum_probs=171.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCC----CceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCccee----e-ceeC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDT----NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW----Y-GVDG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~----~-~~~~ 75 (306)
..++|++.+.||+|+||.||+|++..+ +..||+|.+...........+. +....+......+.. . ...+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~--l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER--VRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH--HHhhchhhHHHHHHhhhcccccccC
Confidence 356899999999999999999999888 8999999876433222211111 111111111111111 1 1345
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCC-------------------CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCcee
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRK-------------------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~-------------------~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nil 135 (306)
...++++||+ +++|.+++...... .....+..++.||+.||.|||+.||+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 6789999999 77888887642211 123346679999999999999999999999999999
Q ss_pred eccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCC----------------------CCch
Q 021855 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----------------------QSRR 193 (306)
Q Consensus 136 v~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~ 193 (306)
++ ++.+.+||+|||++......... ......+++.|+|||.+.... ++.+
T Consensus 288 l~--~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 288 FS--EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred Ee--CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 94 34689999999999765432221 112457789999999664322 2345
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCchhhhh---------HHHHHHHhhcccccchHH---HhhcCchHHHHHHHhhhcCCCC
Q 021855 194 DDLESLGYVLLYFLRGSLPWQGLKAATK---------KQKYDKICEKKVSTPIEV---LCKSHPAEFASYFHYCQSLTFD 261 (306)
Q Consensus 194 sDiwslG~il~~l~tg~~pf~~~~~~~~---------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~ 261 (306)
+|||||||++|||+++..|+........ ...+.............. .....+....+||.+||+.||.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 6999999999999998776543211000 000001111110000000 0011123456899999999999
Q ss_pred CCCChHHHHHHHHHhHhhcCC
Q 021855 262 QRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 262 ~Rps~~~l~~~l~~~~~~~~~ 282 (306)
+|||+.++++ +.++...+.
T Consensus 440 kR~ta~e~L~--Hpff~~~~~ 458 (566)
T PLN03225 440 QRISAKAALA--HPYFDREGL 458 (566)
T ss_pred cCCCHHHHhC--CcCcCCCCc
Confidence 9999999988 677764443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=263.22 Aligned_cols=246 Identities=20% Similarity=0.268 Sum_probs=200.8
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.+++++..||-||||.|-+++.......+|+|++++. ........|..++.... .+.|..++-.+.+....|+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhh
Confidence 3466788999999999999987655555788876643 22234566777887766 46676777777788889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||-| ||.+++.+.. .+.++...+..++..+++|+.|||+.||++|||||+|.++ +.+|-+||.|||.++.+.+..
T Consensus 499 mEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCC
Confidence 9998 9999999987 5579999999999999999999999999999999999999 699999999999999877654
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. =+++||+.|.|||++...--+.++|.||||+++|||++|.+||++.++...+..+ .++......+
T Consensus 575 KT--------wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I---LkGid~i~~P-- 641 (732)
T KOG0614|consen 575 KT--------WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI---LKGIDKIEFP-- 641 (732)
T ss_pred ce--------eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH---Hhhhhhhhcc--
Confidence 32 2789999999999999988899999999999999999999999997766444444 3333222222
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
..++....+||+++...+|.+|.. +++|.+
T Consensus 642 -r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 642 -RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred -cccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 566888999999999999999975 556655
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=245.30 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=194.2
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
+.+-+..||.|+||+|++..++.+|+..|+|.+..... +.+++.|.+...+-..-++|..++...-.++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34446789999999999999999999999998876544 345666666654444334444444334467789999999
Q ss_pred cCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 85 LGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 85 ~~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
|..|+..+..+. ...+++...-.+......||.||-+. .|+|||+||+|||+ +..|.+||+|||.+..+..+
T Consensus 145 Md~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHH
Confidence 999998876542 34588888888888899999999965 89999999999999 79999999999999765443
Q ss_pred CCCccccccCCccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
... ..-.|-.+|+|||.+... -|+.+||+||||+++||+.||+.||.+.+.. -..+.....+..+...
T Consensus 222 iAk--------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv--feql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 222 IAK--------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV--FEQLCQVVIGDPPILL 291 (361)
T ss_pred HHh--------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH--HHHHHHHHcCCCCeec
Confidence 221 133566789999999744 3889999999999999999999999886652 3344444444444332
Q ss_pred -HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 238 -EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 238 -~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
+..+-+++..+..+|..||.+|-+.||...+|.+
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 3333557889999999999999999999999876
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=284.17 Aligned_cols=249 Identities=13% Similarity=0.185 Sum_probs=185.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-C
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 86 (306)
.|...+.||+|+||.||+|++..++..||+|.+..... ....|+..++++.| +++..+..++......++||||+ +
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~H-pnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQH-PNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCC-CCcceEEEEEEcCCCCEEEEeCCCC
Confidence 45667789999999999999988999999998764433 22356888888866 66666666666777889999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH---SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
++|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||++ +.++..++. ++........
T Consensus 768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-eccccccccC----
Confidence 89998885 3788999999999999999999 6799999999999999 466666654 5544322111
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh-hHHHHHHHh----------hcc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKIC----------EKK 232 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~----------~~~ 232 (306)
....++..|+|||++.+..++.++|||||||++|||++|+.||....... ....+.+.. ...
T Consensus 836 -------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 836 -------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 12356889999999999999999999999999999999999995422111 011111110 000
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.....+ .......++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 909 ~~~~~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 909 IRGDVS-VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred ccCCCC-ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 000000 0011233577899999999999999999999999999763
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=264.88 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=205.3
Q ss_pred CceeEeeeecccCccEEEEEEEc---C----CCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHV---D----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~---~----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
.+..+.+.+|.|+||.|++|.-. . ....||+|....... ...+..|+.+++.+.+|+++..+.......+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34456779999999999999643 1 145799998775544 3568899999999999999988877777788
Q ss_pred eeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~ 140 (306)
..+++.||+ .|+|.+++...+ ..++....+.++.||+.|++||++.+++||||-.+|||++
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~--- 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT--- 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec---
Confidence 899999999 899999998755 2488899999999999999999999999999999999995
Q ss_pred CcceEEEEeeccccccCCCCCCccccccCCcccc--ccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 021855 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (306)
Q Consensus 141 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~ 217 (306)
.+..+|++|||+++........ .. .... -...|||||.+....|+.+|||||+|+++|||++ |..||.+..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y-----~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYY-----RT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred CCCEEEEccccceeccCCCCce-----Ee-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 7789999999999854332211 10 0111 2344999999999899999999999999999999 999998843
Q ss_pred hhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.... .+. .+....+...+ ..+++++.++|+.||+.+|++||++.++.+.|+..+..
T Consensus 527 ~~~~--l~~-~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 527 PTEE--LLE-FLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred cHHH--HHH-HHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 2211 122 33333333333 55689999999999999999999999999999997653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=259.89 Aligned_cols=253 Identities=20% Similarity=0.249 Sum_probs=200.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCC---CceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
-.+..++.+.||+|.||.|+.|.|... ...||||.+..... -.+|++|+.++.+|.|. ++..++....+ .-.
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~-hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHP-HLIRLYGVVLD-QPA 185 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCc-ceeEEeeeecc-chh
Confidence 345567889999999999999999743 34589998876543 36799999999999884 44444433323 567
Q ss_pred EEEEecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 79 VLVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.+|+|.+ .|+|.+-+.. ....+.......++.|||.|+.||.++++|||||-.+|+++. ..-.+||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceecc
Confidence 8999999 8899998876 344577888899999999999999999999999999999995 6789999999999887
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
........+ .....-...|+|||.+....++.+||+|++|++++||++ |..||.+.........+. .....
T Consensus 263 g~ned~Yvm----~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD----~~erL 334 (1039)
T KOG0199|consen 263 GENEDMYVM----APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID----AGERL 334 (1039)
T ss_pred CCCCcceEe----cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc----ccccC
Confidence 665543322 122334557999999999999999999999999999999 899999977654443333 33333
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
+.+ ..+|+++.+++.+||..+|.+|||+..|.+.+
T Consensus 335 pRP---k~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 335 PRP---KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCC---CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 333 56699999999999999999999999997543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=232.63 Aligned_cols=236 Identities=25% Similarity=0.332 Sum_probs=184.9
Q ss_pred CccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccCC-CHHHHHH
Q 021855 19 SFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFV 94 (306)
Q Consensus 19 ~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 94 (306)
++|.||+|.+..+++.+++|++..... ...+.+|+..++++.| +++..+..........++++|++++ +|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKH-PNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCC-CcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 578999999988899999999876554 4578889999998855 5555555555566788999999955 9999887
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCcccc
Q 021855 95 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174 (306)
Q Consensus 95 ~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (306)
... .++...++.++.+++.++.+||+.+++|+||+|+||+++ +++.++|+|||.+......... ....
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~--------~~~~ 147 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGLL--------TTFV 147 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeecccccc--------cccc
Confidence 633 389999999999999999999999999999999999994 7799999999999775543211 1445
Q ss_pred ccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHh
Q 021855 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHY 254 (306)
Q Consensus 175 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (306)
++..|++||...+..++.++|+||||++++++++|..||...... ...... .......... ....++.++.+++.+
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~i~~ 223 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKK-IGKPKPPFPP-PEWKISPEAKDLIRK 223 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHH-HhccCCCCcc-ccccCCHHHHHHHHH
Confidence 677899999999888999999999999999999999999763222 112222 2211111111 001167889999999
Q ss_pred hhcCCCCCCCChHHHHH
Q 021855 255 CQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 255 cl~~dP~~Rps~~~l~~ 271 (306)
||..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=264.07 Aligned_cols=246 Identities=21% Similarity=0.196 Sum_probs=189.1
Q ss_pred eeeecccCcc-EEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccCCCHH
Q 021855 12 GRKIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLE 90 (306)
Q Consensus 12 ~~~lg~g~~~-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~ 90 (306)
.+.+|.|+.| .||+|.. .++.||||.+-.+.. .-+.+|+..+..-..|+++...+....+....||..|.|..+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~-~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~ 590 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFF-DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQ 590 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhHhH-HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHH
Confidence 4677888877 6899977 578999997765433 34678999998888888888877778888899999999999999
Q ss_pred HHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC--CcceEEEEeeccccccCCCCCCccc
Q 021855 91 DLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 91 ~~~~~~~~~---~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~--~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+++...... ......+..+.|++.||++||+.+||||||||+|||++..+ ....++|+|||+|+++.....+
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS--- 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS--- 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch---
Confidence 999863111 11134567889999999999999999999999999997543 3458899999999988765543
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
+.......||-.|+|||++.....+.++||+|+||++|+.++ |.+||...-.. ... +..+..... .+.+..
T Consensus 668 -~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~N---Il~~~~~L~--~L~~~~ 739 (903)
T KOG1027|consen 668 -FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QAN---ILTGNYTLV--HLEPLP 739 (903)
T ss_pred -hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhh---hhcCcccee--eeccCc
Confidence 223457789999999999999888889999999999999999 49999763322 111 222221111 000111
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..++.+||.+|+.+||..||+|.+++.
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 227899999999999999999999975
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=232.99 Aligned_cols=286 Identities=42% Similarity=0.679 Sum_probs=227.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCC-ceEEEEEccCCCC--chhhHHHHHHHHHHhC---CCCCCcceeec-eeCceeEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTK--HPQLLYEAKVYKILQG---GSGIPNIKWYG-VDGEDNVL 80 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~-~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~---~~~~~~~~~~~-~~~~~~~l 80 (306)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+...... ...+..|..++..+.. ..+++.+...+ ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999987664 6789997765432 2267889999999983 45677777777 46778899
Q ss_pred EEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC--CcceEEEEeecccc--c
Q 021855 81 VLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAK--K 155 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~--~~~~~kl~Dfg~~~--~ 155 (306)
||+.+|.+|.++..... +.++..++..++.|++.+|.++|+.|++||||||.|++++..+ ..-.+.|.|||+++ .
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~ 178 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK 178 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence 99999999999986544 6699999999999999999999999999999999999997432 12578999999998 4
Q ss_pred cCCCCCCccccccC-CccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRE-NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
..........+.+. ...+.||..|+|+....+...+.+.|+||++.++.++..|..||...........+.+.......
T Consensus 179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~ 258 (322)
T KOG1164|consen 179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLT 258 (322)
T ss_pred ccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcc
Confidence 32222211112222 23556999999999999999999999999999999999999999876654444444443333322
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceecchh
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQ 296 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 296 (306)
.. .+...+..+.++...+-..+...+|+...+...|...+...+.++..|++|......
T Consensus 259 ~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~~ 317 (322)
T KOG1164|consen 259 DR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLRL 317 (322)
T ss_pred cc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccccccc
Confidence 21 223346778888888888999999999999999999999999999999999986544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=232.68 Aligned_cols=258 Identities=19% Similarity=0.223 Sum_probs=198.4
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeece-----e
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----D 74 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~ 74 (306)
++..+|.=...+|.|.- .|..|.+.-+++.|++|....+. ......+|..++..+.|.+.+.....+.. .
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 34567888889999988 78888888889999999766542 23557889999999999777665544432 3
Q ss_pred CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
..+.|++||++..+|...+.. .++-+.+..++.|++.|++|||++||+||||||+||++ ..++.+|+.|||++.
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLAR 166 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhc
Confidence 346799999999999988873 46788999999999999999999999999999999999 589999999999997
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
.....- .....+.+..|.|||++.+-.+...+||||+||++.||++|...|.+.+..++.-++....+..-.
T Consensus 167 ~e~~~~--------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 167 TEDTDF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred ccCccc--------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 643320 123567889999999999999999999999999999999999999986554432222221111110
Q ss_pred cc---------------------------------hHHHh-hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 TP---------------------------------IEVLC-KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 ~~---------------------------------~~~~~-~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.. ..... +.-+..+++++.+||..||++|.|+++++. +.+++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~--HPY~~ 314 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR--HPYIK 314 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc--CCeee
Confidence 00 00000 011335889999999999999999999987 66654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=254.16 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=207.1
Q ss_pred eeEeeeecccCccEEEEEEEcCCC----ceEEEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.+..++||+|+||+||+|.|.-.+ .+||+|++... ....+++.|..++.++.|.+.+..+...-.. ...|+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHHH
Confidence 345789999999999999885334 46888877644 3356788999999999886555544333222 26789
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
++|+ .|+|.+++...+.++-....+.|+.|||+|+.|||+.+++||||-.+|+||. +...+|+.|||+++.+....
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecchhhccCccc
Confidence 9999 8999999998888899999999999999999999999999999999999995 88999999999999877655
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.....+ ...-..-|+|-|.+....++.+|||||+|++++|++| |..||.+....+....+++ ..+++.|
T Consensus 853 ~ey~~~-----~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~--geRLsqP--- 922 (1177)
T KOG1025|consen 853 KEYSAP-----GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK--GERLSQP--- 922 (1177)
T ss_pred cccccc-----ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc--cccCCCC---
Confidence 443221 1123456999999999999999999999999999999 9999999776544444433 2234444
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
+.++-++.-+|.+||..|+..||+++++...|.++.+.-+-
T Consensus 923 --piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 923 --PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred --CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 66788999999999999999999999999999999874443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=235.62 Aligned_cols=252 Identities=18% Similarity=0.258 Sum_probs=188.5
Q ss_pred eEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeece----eCceeEEE
Q 021855 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNVLV 81 (306)
Q Consensus 10 ~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----~~~~~~lv 81 (306)
+=.+.||.|+||.||.+.+.++|+.|++|.+..-. .-..+.+|++++..++|.|.+..+..... .-.+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999999999999999999765432 22456789999999988776554432211 12346788
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
+|.+..+|..++.. -..++.+.+.-++.||++||.|||+.||.||||||.|.|| +++..+||+|||+++.......
T Consensus 136 TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchhhh
Confidence 99999999888876 4468999999999999999999999999999999999999 6899999999999986554433
Q ss_pred CccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--------
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-------- 232 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------- 232 (306)
... ...+.|.+|+|||+++|.. |+.+.||||+||++.|++..+..|..-++..+.+.+-...+..
T Consensus 212 ~hM------TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 212 LNM------THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred hhh------HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 221 1335688999999999876 8999999999999999999999998766554444333322211
Q ss_pred ------------cccch-HH---Hh--hcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 ------------VSTPI-EV---LC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ------------~~~~~-~~---~~--~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...|. +. +. .....+...++..++..||.+|.+-.+.+.
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 11110 00 00 011234668888999999999998776554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=238.15 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=187.9
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHh-CCCCCCcceeecee----CceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSGIPNIKWYGVD----GEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~----~~~~~lv~ 82 (306)
...+.+.+|+|.||.||+|.. +++.||||++... ..+.+..|..+..-.. .|++|..+...... ...+.||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~-~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ-EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCHH-HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345788999999999999965 6799999987753 3456777777766543 23444433333332 33789999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---------GFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---------~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
+|. .|+|.+++.. ..+++....+++..|++||+|||+. .|+|||||.+|||| .+++...|+|||+
T Consensus 288 ~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccce
Confidence 998 9999999984 4689999999999999999999963 59999999999999 5899999999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccCCC-CC-----chhhHHHHHHHHHHHHhCCC------------CCC
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QS-----RRDDLESLGYVLLYFLRGSL------------PWQ 214 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~sDiwslG~il~~l~tg~~------------pf~ 214 (306)
|..+........ .-.-+||.+|||||++.|.. +. .+.||||+|.+++||++.-. ||.
T Consensus 363 Al~~~p~~~~~d-----~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 363 ALRLEPGKPQGD-----THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eEEecCCCCCcc-----hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 998774433322 22468999999999998753 22 36899999999999998632 232
Q ss_pred Cchh--hhhHHHHHHHhhcccccchHH--HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 215 GLKA--ATKKQKYDKICEKKVSTPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 215 ~~~~--~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.... ........-.+..+.++..+. .......-+++.+..||..||+.|.|+..+.+.+.++....
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1100 001111112222222222222 22233456899999999999999999999999998886533
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=221.63 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=190.9
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeece--eCceeEEEEe
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVLVLD 83 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~~lv~e 83 (306)
.++|++.+++|.|-|++||.|.+..+++.++||+++.... ....+|++++..|.+++++..+..... ......+++|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk-kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK-KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH-HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 4679999999999999999999888999999998876543 457889999999998888777644433 2344578999
Q ss_pred ccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
+... +...+. ..++...+..++.+++.||.|+|++||.|||+||.|+|+. ...-.++|+|+|+|-.......-
T Consensus 116 ~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 116 YVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred hhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCcee
Confidence 9844 444443 3578888999999999999999999999999999999994 34668899999999776544332
Q ss_pred ccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCC-CchhhhhHHHHHHHhhcc--------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ-GLKAATKKQKYDKICEKK-------- 232 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~-~~~~~~~~~~~~~~~~~~-------- 232 (306)
...+.+..|-.||.+..-+ |+..-|+|||||++..|+..+.||. +.+..++...+.+..+..
T Consensus 190 --------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 190 --------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred --------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 2556788899999887654 8889999999999999999999984 434444433333322211
Q ss_pred ----------------cccc----h-HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 ----------------VSTP----I-EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ----------------~~~~----~-~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.+.+ . +....-.++++.+++.++|.+|..+|+|++|..+
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0000 0 0011223688999999999999999999999765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-31 Score=241.56 Aligned_cols=257 Identities=19% Similarity=0.175 Sum_probs=175.2
Q ss_pred cccCCceeEeeeecccCccEEEEEEEc----------------CCCceEEEEEccCCCC----------------chhhH
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHV----------------DTNEIVAVKIENSGTK----------------HPQLL 50 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~----------------~~~~~vaiK~~~~~~~----------------~~~~~ 50 (306)
++-.++|++.+.||+|+||.||+|... ..++.||+|.+..... .+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 456789999999999999999999642 2346799998764321 11233
Q ss_pred HHHHHHHHHhCCCCCC----cceeece--------eCceeEEEEecc-CCCHHHHHHHhc--------------------
Q 021855 51 YEAKVYKILQGGSGIP----NIKWYGV--------DGEDNVLVLDLL-GPSLEDLFVYCR-------------------- 97 (306)
Q Consensus 51 ~e~~~l~~l~~~~~~~----~~~~~~~--------~~~~~~lv~e~~-~~~l~~~~~~~~-------------------- 97 (306)
.|+.++.++.+++... .+..++. .....++|+||+ +++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 4666777777655321 1111111 234579999999 788988875321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCcccc
Q 021855 98 ---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174 (306)
Q Consensus 98 ---~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (306)
..+++..+..++.|++.+|.|||+.+|+||||||+|||+ +.++.++|+|||++.......... .....
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~------~~~g~ 371 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFN------PLYGM 371 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccC------ccccC
Confidence 123566788899999999999999999999999999999 477899999999986543321110 01223
Q ss_pred ccccccCcccccCCCC--------------------C--chhhHHHHHHHHHHHHhCCC-CCCCchhhhhH--------H
Q 021855 175 GTARYASCNTHLGIEQ--------------------S--RRDDLESLGYVLLYFLRGSL-PWQGLKAATKK--------Q 223 (306)
Q Consensus 175 ~~~~y~aPE~~~~~~~--------------------~--~~sDiwslG~il~~l~tg~~-pf~~~~~~~~~--------~ 223 (306)
+++.|+|||++..... + .++|+||+||++|+|++|.. ||......... .
T Consensus 372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~ 451 (507)
T PLN03224 372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN 451 (507)
T ss_pred CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH
Confidence 4789999998864321 1 24699999999999999885 77542211110 1
Q ss_pred HHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCC---CCCCChHHHHH
Q 021855 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTF---DQRPDYGFLKR 271 (306)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~Rps~~~l~~ 271 (306)
.+........... .....++..++++.+||..+| .+|+|++++++
T Consensus 452 ~~r~~~~~~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 452 RWRMYKGQKYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHHhhcccCCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1111111111111 124567889999999999876 68999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-33 Score=221.77 Aligned_cols=253 Identities=19% Similarity=0.290 Sum_probs=193.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCc-ceeeceeCceeEEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPN-IKWYGVDGEDNVLVL 82 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~-~~~~~~~~~~~~lv~ 82 (306)
+.+.|.|.+.+|.|.||.+-+++|+.++..+++|.+..+. ...+|.+|...---|.+|.+|.. ....+...+.+++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 5678999999999999999999999999999999776653 44678888887766776655544 345566666788999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ .|+|.+-+.. .++-+.....++.|++.||.|||++++||||||.+|||+-+. +..++||+|||.+........
T Consensus 102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccccCceeh
Confidence 999 7888877653 458889999999999999999999999999999999999543 456999999999875433211
Q ss_pred CccccccCCccccccccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCchhh-hhHHHHHHHhhccccc
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICEKKVST 235 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~ 235 (306)
.......|.+||+.... ...+.+|+|.||+++|.++||+.||+...-. .....+.+. .++...
T Consensus 179 ----------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-~~rk~~ 247 (378)
T KOG1345|consen 179 ----------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-LKRKNP 247 (378)
T ss_pred ----------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-hcccCc
Confidence 22335568889876533 2467899999999999999999999853322 223444443 334444
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.++..+..+++.+.++.++-|.++|++|=-..+..+
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 556666788999999999999999999943333333
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=212.65 Aligned_cols=212 Identities=20% Similarity=0.278 Sum_probs=160.6
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch---hhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
....+..||+|++|.|-+.++..+|...|+|.+...-..+ ..++|+.+..+-..-+...+++.....+...++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3445678999999999999999999999999877544433 3455555544332222222222222467789999999
Q ss_pred cCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 85 LGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 85 ~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+..||..+... .+..+++..+-+++..+.+||.|||++ .++|||+||+|||+ +.+|.+|++|||.+-.+.++.
T Consensus 127 M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhh
Confidence 99999887653 355699999999999999999999976 89999999999999 699999999999997765543
Q ss_pred CCccccccCCccccccccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
.. ....|-.+|+|||.+..+ .|+.+|||||||+.+.||.+++.||.... +.-..+.+.+...
T Consensus 204 Ak--------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~qLkqvVeep 269 (282)
T KOG0984|consen 204 AK--------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQQLKQVVEEP 269 (282)
T ss_pred HH--------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHHHHHHHhcCC
Confidence 32 123566789999998643 58899999999999999999999997532 3334444554444
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=238.59 Aligned_cols=255 Identities=22% Similarity=0.302 Sum_probs=188.5
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.-|..++.||-|+||+|.+++...|...+|.|.+.+.. .......|-.||..... +-++.++.-+.+.+.+|+|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn-~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCC-cceEEEEEEeccCCceEEE
Confidence 45788999999999999999988999999999765321 11123345666765433 4456667778889999999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC--
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD-- 158 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~-- 158 (306)
|+|. ||++-+++-. .+-+.+..+..++.++.+|+.+.|++|++||||||+|||+ |.+|.|||+|||+|..+.=
T Consensus 708 MdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceecc
Confidence 9999 8999888876 4468999999999999999999999999999999999999 7999999999999865420
Q ss_pred -C-----CCCc---cc----------------cc--------cCCccccccccccCcccccCCCCCchhhHHHHHHHHHH
Q 021855 159 -P-----TTNR---HI----------------PY--------RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 205 (306)
Q Consensus 159 -~-----~~~~---~~----------------~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 205 (306)
. +... .+ .. ...-..+||..|+|||++...-|+.-+|+||.|+||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0 0000 00 00 01113479999999999999999999999999999999
Q ss_pred HHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCC---ChHHHHH
Q 021855 206 FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP---DYGFLKR 271 (306)
Q Consensus 206 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp---s~~~l~~ 271 (306)
|+.|..||-...+......+. .+..-+..+ .+.+++++..++|.++. .++++|. .+++|..
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~-nw~~~l~~~---~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKa 927 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVI-NWRNFLHIP---YQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKA 927 (1034)
T ss_pred HhhCCCCccCCCCCcceeeee-ehhhccccc---cccccCHHHHHHHHHHh-cChhhhhcccchhhhhc
Confidence 999999998765543332221 111111122 23677888888888754 4677886 2444543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=235.28 Aligned_cols=195 Identities=23% Similarity=0.344 Sum_probs=166.9
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----------chhhHHHHHHHHHHhC--CCCCCcceeeceeC
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQG--GSGIPNIKWYGVDG 75 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~~--~~~~~~~~~~~~~~ 75 (306)
.|...+.+|.|+||.|++|.++++..+|++|.+.+++. --..-.|+.++..++. |++|..+..++.+.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 48899999999999999999999999999997665421 1123559999999982 35566666777788
Q ss_pred ceeEEEEecc--CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 76 EDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 76 ~~~~lv~e~~--~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
+.+|+++|-- +-+|.+++.. ...+++..+..++.|++.|+.+||+.||+|||||-+|+.+ |.+|.+||+|||++
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 8999999988 5577788876 5679999999999999999999999999999999999999 79999999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQG 215 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~ 215 (306)
....+..- ..+.||..|.|||++.|.+| +..-|||+||+++|.+.....||++
T Consensus 718 a~~ksgpf---------d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGPF---------DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCCc---------ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 76544322 37899999999999999986 7889999999999999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=208.84 Aligned_cols=208 Identities=29% Similarity=0.429 Sum_probs=177.1
Q ss_pred ecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccC-CCHH
Q 021855 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG-PSLE 90 (306)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 90 (306)
||+|.+|.||++....+++.+++|++...... ..+.+|+..++.+.+ +++..+..+.......++++|+++ ++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 68999999999999888999999998877653 678899999999987 666666666666678999999995 8999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC-cceEEEEeeccccccCCCCCCccccccC
Q 021855 91 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYRDPTTNRHIPYRE 169 (306)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 169 (306)
+++......++...++.++.+++.+|.+||+.|++|+||+|.||++. . .+.++|+|||.+........ .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcc-------h
Confidence 98876434689999999999999999999999999999999999994 5 78999999999976554321 0
Q ss_pred CccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHH
Q 021855 170 NKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (306)
Q Consensus 170 ~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (306)
.....+...|++||..... ..+.++|+|++|++++++ ..+
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~ 190 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL 190 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence 1234567889999999887 788999999999999999 468
Q ss_pred HHHHHhhhcCCCCCCCChHHHHHH
Q 021855 249 ASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 249 ~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
.+++..|++.||++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 899999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=223.20 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=196.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcC---CCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+.+.|.++.+||.|.|+.||++.+.. .++.||+|.+..-..-.....|+.++..+.++.++..+..+...++..++|
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 45678999999999999999998876 788999999887777778999999999999999999998888899999999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC--
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD-- 158 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~-- 158 (306)
+||+ .....+++. .++...+..+++.++.||.++|++||+|||+||.|++.. ...+.-.|.|||++.....
T Consensus 114 lp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred ecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHhhh
Confidence 9999 455656654 467889999999999999999999999999999999996 4567778999999861100
Q ss_pred --------------C--CCC----------c---------cccccCCccccccccccCcccccCCC-CCchhhHHHHHHH
Q 021855 159 --------------P--TTN----------R---------HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYV 202 (306)
Q Consensus 159 --------------~--~~~----------~---------~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~i 202 (306)
+ +.. . ...........||+.|+|||++...+ .++++||||.|++
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 000 0 00011112346999999999998776 6889999999999
Q ss_pred HHHHHhCCCCCCCchhhhh-HHHHH------------H------Hhh-cc-------------------cc-----cchH
Q 021855 203 LLYFLRGSLPWQGLKAATK-KQKYD------------K------ICE-KK-------------------VS-----TPIE 238 (306)
Q Consensus 203 l~~l~tg~~pf~~~~~~~~-~~~~~------------~------~~~-~~-------------------~~-----~~~~ 238 (306)
+.-++++..||........ ...+. . +.. .+ .+ ....
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 9999999999965321110 00000 0 000 00 00 0000
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
......+..+.+++.+||..||.+|.|+++.++
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011223456889999999999999999999876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=204.42 Aligned_cols=167 Identities=17% Similarity=0.184 Sum_probs=128.0
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
|+|.+++...+.++++..++.++.|++.||.|||+.+ ||+|||+ +.++.+++ ||.+......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc-------
Confidence 6888888865667999999999999999999999998 9999999 58888998 9998754331
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH--HHhhcC
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE--VLCKSH 244 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 244 (306)
...+++.|+|||++.+..++.++|||||||++|+|++|..||....... ..+............. ......
T Consensus 63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHH
Confidence 2256899999999999999999999999999999999999997643321 1111111111111000 001122
Q ss_pred ch--HHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 245 PA--EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 245 ~~--~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
++ .+.++|.+||+.||.+||++.++++.+.....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 33 69999999999999999999999998876653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=216.30 Aligned_cols=259 Identities=18% Similarity=0.273 Sum_probs=195.2
Q ss_pred CCceeEeeeecccCccEEEEEEEcCC-----CceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
..++++...+.+|.||.||.|.|++. .+.|.+|..+..... ..++.|.-.+.-+.|.+..+.......+...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 45678888999999999999977643 234556665543332 2245555555555554444444444445555
Q ss_pred eEEEEecc-CCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEe
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR-------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
.+..+.+. -|+|..++..++ +.++..+...++.|++.|+.|||+.|++|.||-.+|.++ |+...+||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEecc
Confidence 67777777 689999887432 235666778899999999999999999999999999999 6889999999
Q ss_pred eccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHH
Q 021855 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI 228 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~ 228 (306)
=.+++.+....... ..........|||||.+....|+.+||+||||++++||+| |+.||...++.+....+.+
T Consensus 440 saLSRDLFP~DYhc-----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd- 513 (563)
T KOG1024|consen 440 SALSRDLFPGDYHC-----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD- 513 (563)
T ss_pred chhccccCcccccc-----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc-
Confidence 99998765443321 1112234667999999999999999999999999999999 9999998777544444332
Q ss_pred hhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+.++..| -++|+++..+|--||..+|++||++++++..|.++-.+
T Consensus 514 -GyRlaQP-----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 514 -GYRLAQP-----FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -cceecCC-----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 2333444 67799999999999999999999999999999988654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=237.04 Aligned_cols=252 Identities=18% Similarity=0.264 Sum_probs=205.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC--CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
-..+|++.+.+|+|.||.||+++++.+++..|+|+++.. .......+|+-+++...|.+.++++..|- .....++.|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl-r~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL-RRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh-hhcCcEEEE
Confidence 356899999999999999999999999999999987754 33455677888888888877666665543 445689999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||| +|+|.++..- .+++++.++...++..+.||.|||+.|-+|||||-.||+++ +.|.+||.|||.+..+.....
T Consensus 92 EycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhhhhh
Confidence 999 6788777654 55799999999999999999999999999999999999995 899999999999877655443
Q ss_pred CccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
+...+.||+.|||||+.. .+.|...+|||++|+...|+..-+.|.....+. ......-+..+..+.-
T Consensus 168 -------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 168 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMTKSGFQPPTL 237 (829)
T ss_pred -------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhhccCCCCCcc
Confidence 234789999999999875 446889999999999999999888887665433 3333344555555544
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....+++.+.++++.||..+|.+||+++-++.
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 445678899999999999999999999988765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=243.52 Aligned_cols=187 Identities=14% Similarity=0.170 Sum_probs=132.1
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc----------------C
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL----------------G 139 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~----------------~ 139 (306)
...+.++|+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. .
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~ 132 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGS 132 (793)
T ss_pred chhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccc
Confidence 456788899999999999765556999999999999999999999999999999999999941 1
Q ss_pred CCcceEEEEeeccccccCCCCCC--------ccccc-cCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCC
Q 021855 140 RKANQVYIIDFGLAKKYRDPTTN--------RHIPY-RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 210 (306)
Q Consensus 140 ~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~ 210 (306)
+.++.+|++|||+++........ ...++ .......+|+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 133 ~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~ 212 (793)
T PLN00181 133 DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPV 212 (793)
T ss_pred cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCC
Confidence 23445556666665432110000 00000 0011235788999999999999999999999999999999998
Q ss_pred CCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 211 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.|+..... .+........+.. . ....+....++..||++||.+||++.++++
T Consensus 213 ~~~~~~~~-----~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 213 SSREEKSR-----TMSSLRHRVLPPQ---I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CchhhHHH-----HHHHHHHhhcChh---h-hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88764221 1111111111110 0 111345678999999999999999999976
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=197.54 Aligned_cols=197 Identities=32% Similarity=0.476 Sum_probs=161.7
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
|.+.+.||.|+++.||++.+..+++.+++|.+.... ....+.+|+..+..+.+ +++..+..+.......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKH-PNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CChhhheeeeecCCceEEEEecc
Confidence 678899999999999999998888999999887654 34567788899998866 45555555555667789999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+++|.+++......+++..++.++.+++.+|.+||+.+++|+|++|.||++ +..+.++|+|||.+.........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~-- 154 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA-- 154 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc--
Confidence 449999887643228899999999999999999999999999999999999 46799999999998876544310
Q ss_pred ccccCCccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 021855 165 IPYRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~tg~~pf~~ 215 (306)
......++..|++||.. ....++.++|+||||+++++|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 01134567789999998 666678899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=211.55 Aligned_cols=260 Identities=20% Similarity=0.235 Sum_probs=184.1
Q ss_pred eEeeeecccCccEEEEEEEcCCCceEEEEEccC----CCCch----hhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 10 ~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~----~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.-...+|.|++|.|+.+.........+.|.+.. ..... ....|.-+-..|.|.+.+..+............
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~- 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS- 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh-
Confidence 357889999999888887665555555553321 11111 123344445556665545444333332222222
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||||.++|..++.. ...+....+-.++.|++.|++|+|+.||.|||+||+|++++ ..|.+|++|||.+..+..+..
T Consensus 400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcceeeccCcc
Confidence 99996688888875 34688888889999999999999999999999999999995 888999999999987766554
Q ss_pred CccccccCCccccccccccCcccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCchhhhhH-HHHHHHhhcccccchHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSR-RDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDKICEKKVSTPIEV 239 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDiwslG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (306)
.... ......|+.+|+|||++.+..|.+ ..||||.|++++.|.+|+.||......... .................
T Consensus 476 ~~~~---~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 476 KNIH---ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hhhh---hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 3211 234678999999999999999875 589999999999999999999764433222 11111112222233333
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+...++...+.+|.+||++||.+|.|+++|++ .++++.
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~--d~W~~~ 590 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILN--DEWIRS 590 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhh--ChHhhh
Confidence 44667888999999999999999999999988 666653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=191.61 Aligned_cols=180 Identities=19% Similarity=0.206 Sum_probs=133.3
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcC-CCceEEEEEccCCC-------CchhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
+.+.++|++.+.||+|+||.||+|++.. +++.+|+|...... ....+.+|+.+++.+.|++.++.+...
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4678899999999999999999999876 67778999765321 123478999999999987777655432
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC-CCCceeeccCCCcceEEEEeecc
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI-KPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl-kp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
...+++|||+ +++|. ... ... ...++.|++++|.|||+.||+|||| ||+|||+ +.++.++|+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~-~~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLH-LAR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHH-HhC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECcc
Confidence 3579999999 56664 221 111 1457889999999999999999999 9999999 4678999999999
Q ss_pred ccccCCCCCCcccc-ccCCccccccccccCcccccCCC------CCchhhHH
Q 021855 153 AKKYRDPTTNRHIP-YRENKNLTGTARYASCNTHLGIE------QSRRDDLE 197 (306)
Q Consensus 153 ~~~~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~------~~~~sDiw 197 (306)
|+.+........+. +.......++..|++||.+.... .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 98776544333221 11113556788899999997543 23446665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-22 Score=176.38 Aligned_cols=257 Identities=30% Similarity=0.425 Sum_probs=187.2
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
|.+.+.||.|+|+.||.+.+. ..+++|.+..... ...+.+|..++..+.+++++..+...+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999886 6788897775433 34578888899999887656555555555555799999
Q ss_pred cc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc-eEEEEeeccccccCCC
Q 021855 84 LL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDP 159 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~-~~kl~Dfg~~~~~~~~ 159 (306)
++ ++++.+++.... ..++......++.|++.++.++|+.+++|||+||+||++. ..+ .++++|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCC
Confidence 99 677776665432 2688999999999999999999999999999999999994 556 7999999999755443
Q ss_pred CCCccccccCCccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCchhh-hhHHHHHHHhhccccc
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICEKKVST 235 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~ 235 (306)
....... .......++..|++||.+.+ ..++...|+||+|++++++++|..||...... ..............+.
T Consensus 156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 3211000 01236688999999999988 57889999999999999999999998765431 0111111111111110
Q ss_pred chHHHhhc----CchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 236 PIEVLCKS----HPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 236 ~~~~~~~~----~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
........ ....+.+++..|+..+|..|.+..+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000011 12468899999999999999987776553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=176.19 Aligned_cols=231 Identities=23% Similarity=0.253 Sum_probs=144.8
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch-----hhHHHHHHHHHHhCC-----------CCCCc----
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-----QLLYEAKVYKILQGG-----------SGIPN---- 67 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~e~~~l~~l~~~-----------~~~~~---- 67 (306)
.+..++.||.|+++.||.+++.+|++.+++|++....... .+.+|.-....+.+. ..++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4567899999999999999999999999999866443221 122222111111110 00110
Q ss_pred c---eeece---eCc-----eeEEEEeccCCCHHHHHHHh---cCC---CCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q 021855 68 I---KWYGV---DGE-----DNVLVLDLLGPSLEDLFVYC---RRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130 (306)
Q Consensus 68 ~---~~~~~---~~~-----~~~lv~e~~~~~l~~~~~~~---~~~---~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlk 130 (306)
+ ..+.. +.. ..++.|+.+.++|.+++.-. ... +.......+..|+.+.+++||+.|++|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 0 01111 111 23678888899998886531 111 2234455667999999999999999999999
Q ss_pred CCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccC--------CCCCchhhHHHHHHH
Q 021855 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--------IEQSRRDDLESLGYV 202 (306)
Q Consensus 131 p~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~i 202 (306)
|+|+++ +.+|.+.|+||+.......... ....+..|.+||.... ..++.+.|.|+||++
T Consensus 173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 173 PENFLL---DQDGGVFLGDFSSLVRAGTRYR----------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp GGGEEE----TTS-EEE--GGGEEETTEEEE----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eeeEEE---cCCCCEEEcChHHHeecCceee----------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999 5899999999988765433211 1233466888887643 246889999999999
Q ss_pred HHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCC
Q 021855 203 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR 263 (306)
Q Consensus 203 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 263 (306)
+|.|++|..||........... .-..|.++|+.++.||..+|++||.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999986543322211 111335678899999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-24 Score=197.35 Aligned_cols=247 Identities=18% Similarity=0.159 Sum_probs=167.4
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc------hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+|...+.||++.|=.|.+|++.+ | .|++|++-+.... .+.+.|++ ....++++.++.... -....-.|++
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-HHhhHHHHHH
Confidence 67789999999999999998754 4 4889988765532 22333444 333344444444433 3334456777
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc--CCC
Q 021855 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY--RDP 159 (306)
Q Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~--~~~ 159 (306)
=+|...+|.+-+.- +.-+...+...|+.|++.||..+|+.||+|||||.+|||++ +=..+.|+||..=+.. ..+
T Consensus 100 RqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence 78888888887763 22366777888999999999999999999999999999996 7778899999875432 111
Q ss_pred CCCccccccCCccccccccccCcccccCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGI----------E-QSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~-~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~ 227 (306)
......-|.. +...-..|.|||.+... + .+++-||||+||++.||++ |.+||.- ..+..
T Consensus 176 NPadf~fFFD--TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFD--TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLA 246 (1431)
T ss_pred CcccceEEEe--cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHh
Confidence 1111111111 11223359999987541 2 5678999999999999999 7888853 22222
Q ss_pred HhhcccccchHH-HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 228 ICEKKVSTPIEV-LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 228 ~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
...+. ....+. +..-.+..++++|..|++.||++|.|+++.++.
T Consensus 247 Yr~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 22221 111111 112235579999999999999999999998876
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=171.41 Aligned_cols=187 Identities=19% Similarity=0.266 Sum_probs=133.9
Q ss_pred eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC-CcceEEEEeeccccc
Q 021855 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~-~~~~~kl~Dfg~~~~ 155 (306)
..|++|..+..+|..++-. ...+.....-++.|+++|+.|||+.||.|||||.+|||+...| .--.+.++|||++--
T Consensus 317 tlylvMkrY~~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA 394 (598)
T KOG4158|consen 317 TLYLVMKRYRQTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA 394 (598)
T ss_pred eEEEehhcchhhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence 3589999999999988764 3467777788999999999999999999999999999996543 345678999999853
Q ss_pred cCCCCCCccccccC-CccccccccccCcccccCCC--C----CchhhHHHHHHHHHHHHhCCCCCCCchhhhhH-HHHHH
Q 021855 156 YRDPTTNRHIPYRE-NKNLTGTARYASCNTHLGIE--Q----SRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDK 227 (306)
Q Consensus 156 ~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~--~----~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~-~~~~~ 227 (306)
-...+ ...||.. .....|+...+|||+....+ . -.++|.|+.|.+.||+++...||+.-...... ..++
T Consensus 395 d~~hG--lqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq- 471 (598)
T KOG4158|consen 395 DDNHG--LQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ- 471 (598)
T ss_pred ccccc--cccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-
Confidence 22211 1122221 22456788899999986432 1 24899999999999999999999872211100 0111
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
+. .++.....+|+.+++++..+|+.||++|+|.+=-.+.|+
T Consensus 472 --e~----qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 472 --ES----QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred --hh----hCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 11 122233677899999999999999999998664444443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=168.32 Aligned_cols=243 Identities=12% Similarity=0.144 Sum_probs=181.5
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
..+..+|.....|+.|+|+|+.+ .++.|+++-. +...+|..|.-.++.+.|++.++.+..+... .+.+++..|
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-pnlv~isq~ 268 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-PNLVIISQY 268 (448)
T ss_pred hhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-CCceEeeee
Confidence 44677889999999999999654 4556766532 3344677888889888888877777665544 578888899
Q ss_pred c-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeccCCCcceEEEE--eeccccccCC
Q 021855 85 L-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYII--DFGLAKKYRD 158 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~Nilv~~~~~~~~~kl~--Dfg~~~~~~~ 158 (306)
+ .++|..++.....- .+..++.+++.+|++|+.|||+.. |..--|...++++ |++...+|+ |-..+. ..
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsf--qe 343 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSF--QE 343 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeee--ec
Confidence 8 88999998763322 677888999999999999999874 5556899999999 566665554 433221 11
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCC---chhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
. ...-.+.|++||.+...+-+ .++|+|||.++++|+.|...||...++.+...++ .....+.
T Consensus 344 ~------------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---aleglrv 408 (448)
T KOG0195|consen 344 V------------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---ALEGLRV 408 (448)
T ss_pred c------------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---hhccccc
Confidence 1 22346789999999876643 4789999999999999999999987765433332 2222222
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.+++..++.+.+||+-|...||.+||.++.++-.|+++.
T Consensus 409 ---~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 ---HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 233777899999999999999999999999999888763
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=167.03 Aligned_cols=171 Identities=16% Similarity=0.236 Sum_probs=126.1
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchh-----------hHHHHHHHHHHhCCCCCCccee
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----------LLYEAKVYKILQGGSGIPNIKW 70 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~e~~~l~~l~~~~~~~~~~~ 70 (306)
..+++++|++.+.+|.|++|.||++.. ++..+|+|++........ +.+|+..+.++.| ++++.+..
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~-~GI~~~~d 102 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS-EGLASLND 102 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH-CCCCcceE
Confidence 467899999999999999999999755 466899999875432221 4678888999966 66766655
Q ss_pred ecee--------CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC
Q 021855 71 YGVD--------GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 71 ~~~~--------~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~ 141 (306)
++.. ....+++|||+ |.+|.++. .+++ ....+++.+|..+|+.|++|||++|.||+++ .
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~ 170 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---K 170 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---C
Confidence 5332 23578999999 45776652 1333 2456999999999999999999999999994 5
Q ss_pred cceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHH
Q 021855 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207 (306)
Q Consensus 142 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~ 207 (306)
++ ++|+|||........... ..++....++.++|+||||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 66 999999988654322110 11334445777999999998877643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=187.51 Aligned_cols=252 Identities=22% Similarity=0.301 Sum_probs=182.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHh--CCCCCCcceeeceeCceeEEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
-+..|.|.+.+|.|+||.||+|.+.. |+.||+|+-.....+.-++- .+++.+|. -.+.+..+.......+..++++
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~-~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC-LQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh-HHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 46789999999999999999999876 99999999887666543221 22333443 1133333444444555678999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC----CCcceEEEEeeccccccC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----RKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~----~~~~~~kl~Dfg~~~~~~ 157 (306)
+|. .|+|.+++.. ...+++..+..+..||+.-+.+||..+|+||||||+|+|+... .+...++|+|||.+....
T Consensus 774 ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 774 EYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999 9999999983 5569999999999999999999999999999999999999642 346688999999996543
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
--... +......+|-.+-.+|+..|.+|+...|.|.|..++|-|+.|+.-= ...+......
T Consensus 853 lfp~~-----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------~~~g~~~~~~ 913 (974)
T KOG1166|consen 853 LFPDG-----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------VKNGSSWMVK 913 (974)
T ss_pred EcCCC-----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------hcCCcceecc
Confidence 21111 1223556777889999999999999999999999999999886221 1111111111
Q ss_pred HHHhhcCchH-HHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 238 EVLCKSHPAE-FASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 238 ~~~~~~~~~~-~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+..-+..+ ..+++..+|..|=..=|...+|+..|+.++.
T Consensus 914 ~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 914 TNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1011111222 4578888888666666889999999988875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=159.36 Aligned_cols=137 Identities=21% Similarity=0.244 Sum_probs=102.3
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----------chh-----------------hHHHHHHHHHHhCCC
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----------HPQ-----------------LLYEAKVYKILQGGS 63 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~-----------------~~~e~~~l~~l~~~~ 63 (306)
...||+|++|.||+|.+. +|+.||+|++..... ... ...|...+..+.+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~- 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA- 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC-
Confidence 468999999999999986 899999998765421 011 12388889998763
Q ss_pred CCCcceeeceeCceeEEEEeccCCC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCceeeccCCC
Q 021855 64 GIPNIKWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 64 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L-H~~~i~H~dlkp~Nilv~~~~~ 141 (306)
+++....... ...+++|||++++ +...... ...++...+..++.|++.+|.++ |+.||+||||||+|||++
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 3222222211 2348999999654 4333222 45689999999999999999999 799999999999999993
Q ss_pred cceEEEEeeccccccC
Q 021855 142 ANQVYIIDFGLAKKYR 157 (306)
Q Consensus 142 ~~~~kl~Dfg~~~~~~ 157 (306)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-22 Score=190.03 Aligned_cols=221 Identities=25% Similarity=0.382 Sum_probs=155.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
....|+.++.+..|+||.||.++|+.+.+.+|.|+ +.+. -+++- +. .+.+ ..+.|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~---------lilRn-----il-----t~a~--npfvv--- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN---------LILRN-----IL-----TFAG--NPFVV--- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccc---------hhhhc-----cc-----cccC--Cccee---
Confidence 34678999999999999999999999999999853 2211 11110 00 0110 11111
Q ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC-CC--
Q 021855 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP-TT-- 161 (306)
Q Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~-~~-- 161 (306)
|+-.+++.. -++++. +++.++.|||+.||+|||+||+|.+++ .-|.+|+.|||+++...-. .+
T Consensus 136 --gDc~tllk~-~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 --GDCATLLKN-IGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred --chhhhhccc-CCCCcc--------hhhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchh
Confidence 333344433 123332 237889999999999999999999996 8999999999998643211 00
Q ss_pred -Cccc----cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 162 -NRHI----PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 162 -~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
...+ .-......++|+.|.|||++.-.-|+..+|+|++|+++|+++.|..||.++.++ +.+...+...+..+
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~visd~i~wp 278 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDDIEWP 278 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhhhhcccc
Confidence 0011 111223568999999999999999999999999999999999999999996554 44444444444444
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCC-ChHHH
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFL 269 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l 269 (306)
..+ ...+++++++|.++|+.+|..|. +..++
T Consensus 279 E~d--ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 279 EED--EALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred ccC--cCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 332 56688999999999999999997 44433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.4e-21 Score=152.61 Aligned_cols=139 Identities=22% Similarity=0.271 Sum_probs=104.1
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----------------------------hhhHHHHHHHHHHhCC
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------------------PQLLYEAKVYKILQGG 62 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~~~e~~~l~~l~~~ 62 (306)
+.+.||+|++|.||+|++. +|+.||+|++...... .....|...+.++.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999987754211 1124577888888764
Q ss_pred CCCCcceeeceeCceeEEEEeccCCC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCC
Q 021855 63 SGIPNIKWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR 140 (306)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~ 140 (306)
++.....+... ..+++|||+++. +...... ...++......++.|++.++.++|+ .||+||||||+||++ +
T Consensus 80 -~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll---~ 152 (190)
T cd05145 80 -GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY---H 152 (190)
T ss_pred -CCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---E
Confidence 33333222222 348999999554 3332222 3457888899999999999999999 999999999999999 3
Q ss_pred CcceEEEEeeccccccCC
Q 021855 141 KANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 141 ~~~~~kl~Dfg~~~~~~~ 158 (306)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 68999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-22 Score=180.46 Aligned_cols=224 Identities=21% Similarity=0.319 Sum_probs=177.1
Q ss_pred eecccCccEEEEEEE---cCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 14 KIGSGSFGEIFLASH---VDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 14 ~lg~g~~~~v~~~~~---~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
.+|.|.+|.|++++. ...+..++.|+.... ........|..++.....++.+..+...+......++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 368999999998753 245667888865532 222245557778888877787777777778888899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
++.+...+.. ...+.+.....+...++-+++++|+.+++|||+|++||++ +.+|.+++.|||.++..-...
T Consensus 81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhh-----
Confidence 6677666554 3457788888889999999999999999999999999999 799999999999998754433
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCc
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (306)
..+||.-|||||++. ....++|.||+|++.++|+||..||.+ .....+.+.....| ..++
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~p-----~~l~ 211 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEMP-----RELS 211 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCCc-----hhhh
Confidence 227899999999997 345689999999999999999999987 23334444455555 5557
Q ss_pred hHHHHHHHhhhcCCCCCCCCh
Q 021855 246 AEFASYFHYCQSLTFDQRPDY 266 (306)
Q Consensus 246 ~~~~~li~~cl~~dP~~Rps~ 266 (306)
..+.+++..++..+|..|.-.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 889999999999999999744
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-21 Score=151.01 Aligned_cols=191 Identities=16% Similarity=0.122 Sum_probs=133.4
Q ss_pred eEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch------hhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 10 ~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.+...|++|+||+|+.+.. .+..++.+.+....... .+.+|+.++++|.++++++.+..+ ...+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678999999999998754 56777777665443322 367899999999888888887654 34689999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC-CCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI-KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl-kp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+ |.+|...... . ...++.|++.+|.++|+.||+|||| ||.|||+ +.++.++|+|||++........
T Consensus 79 yI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcch
Confidence 98 5566433211 1 1346789999999999999999999 7999999 4788999999999985443321
Q ss_pred C------ccccccCCccccccccccCcccccCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCch
Q 021855 162 N------RHIPYRENKNLTGTARYASCNTHLGI-EQS-RRDDLESLGYVLLYFLRGSLPWQGLK 217 (306)
Q Consensus 162 ~------~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~-~~sDiwslG~il~~l~tg~~pf~~~~ 217 (306)
. .++..........++.+++|+.-.-. ..+ ...++++.|+-+|.++|+..++.+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 00000000011134556666644322 233 45677799999999999999987644
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=164.18 Aligned_cols=213 Identities=15% Similarity=0.205 Sum_probs=157.2
Q ss_pred HhCCCCCCcceeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCc-cccCCCCCceee
Q 021855 59 LQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF-LHRDIKPDNFLM 136 (306)
Q Consensus 59 l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i-~H~dlkp~Nilv 136 (306)
+.| .++..+.....++...+++.+|| .|+|.+.+......++.-....++++|+.||.|||+..| .|+.|++.|.++
T Consensus 4 l~h-~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv 82 (484)
T KOG1023|consen 4 LDH-DNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV 82 (484)
T ss_pred cch-hhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee
Confidence 344 44545555555668899999999 899999998766678888899999999999999998866 999999999999
Q ss_pred ccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCC-------CCchhhHHHHHHHHHHHHhC
Q 021855 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-------QSRRDDLESLGYVLLYFLRG 209 (306)
Q Consensus 137 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDiwslG~il~~l~tg 209 (306)
|....+||+|||+.......... ...........|.|||.+.+.. .+.+.|+||+|++++|+++.
T Consensus 83 ---d~~w~lklt~~Gl~~~~~~~~~~-----~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 83 ---DSRWVLKLTDFGLNSLLEETAEP-----EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ---eeeEEEEechhhhcccccccccc-----cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 69999999999998765421000 0011222455699999997641 36779999999999999999
Q ss_pred CCCCCCchhhhh-HHHHHHHhhcccccchHHHh--hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 210 SLPWQGLKAATK-KQKYDKICEKKVSTPIEVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 210 ~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
..||........ ...+..+.+...+...+.+. ...++.+..++.+||..+|..||+++++...++.+....
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 999976433222 22333332212222222211 145667999999999999999999999999998887643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=147.32 Aligned_cols=141 Identities=23% Similarity=0.270 Sum_probs=106.1
Q ss_pred ceeEeeeecccCccEEEEEE-EcCCCceEEEEEccCCCCc--------------------------hhhHHHHHHHHHHh
Q 021855 8 KYKLGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKH--------------------------PQLLYEAKVYKILQ 60 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~-~~~~~~~vaiK~~~~~~~~--------------------------~~~~~e~~~l~~l~ 60 (306)
-|.+.+.||+|++|.||+|. +..+|+.||+|++...... ..+..|...+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 6678999999987643210 12356888999997
Q ss_pred CCCCCCcceeeceeCceeEEEEeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccCCCCCceeecc
Q 021855 61 GGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG-FLHRDIKPDNFLMGL 138 (306)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-i~H~dlkp~Nilv~~ 138 (306)
+ ..+.....+.. ...+++||++++ ++...... ...+....+..++.||+.+|.+||+.| ++||||||+||++
T Consensus 109 ~-~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli-- 182 (237)
T smart00090 109 E-AGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV-- 182 (237)
T ss_pred h-cCCCCCeeeEe--cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE--
Confidence 5 23322222222 235899999955 45444322 334566667889999999999999999 9999999999999
Q ss_pred CCCcceEEEEeecccccc
Q 021855 139 GRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 139 ~~~~~~~kl~Dfg~~~~~ 156 (306)
+ ++.++|+|||.+...
T Consensus 183 -~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 -H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred -E-CCCEEEEEChhhhcc
Confidence 3 788999999998643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-17 Score=134.60 Aligned_cols=136 Identities=17% Similarity=0.191 Sum_probs=99.6
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCC--CCchhhHHHHHHHHHHhC----CCCCCcceeeceeC---ce-eEE
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQG----GSGIPNIKWYGVDG---ED-NVL 80 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~----~~~~~~~~~~~~~~---~~-~~l 80 (306)
-.+.||+|+++.||. +..++.. +||++... .....+.+|+.+++.+.+ +++++.+..+.... +. ..+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999995 7777666 58877643 234568899999999953 45666665444433 23 337
Q ss_pred EEeccC---CCHHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCccccCCCCCceeeccCC-CcceEEEEeeccc
Q 021855 81 VLDLLG---PSLEDLFVYCRRKFSLKTVLMLADQMIARI-EYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLA 153 (306)
Q Consensus 81 v~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L-~~LH~~~i~H~dlkp~Nilv~~~~-~~~~~kl~Dfg~~ 153 (306)
++||++ ++|.+++.. ..+++. ..++.|++.++ .|||+.+|+||||||+|||++..+ .++.++|+|++.+
T Consensus 83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 899964 799999965 346655 35678888888 899999999999999999995322 4458999994443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-18 Score=152.03 Aligned_cols=175 Identities=24% Similarity=0.294 Sum_probs=127.7
Q ss_pred eeEEEEecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
+.+|.|++| ..+|.+++.... ...+......++.|++.|+.| ++.+|+|+||.||++. .+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhhe
Confidence 578999999 789999986422 235677788999999999999 9999999999999995 6668999999998
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
.......+. -.++.....-.||..||+||.+.+..|+.++||||||++++|++. -..+|.. ......+..+.
T Consensus 404 ts~~~~~~~-~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~r~g~ 476 (516)
T KOG1033|consen 404 TSQDKDETV-APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATLTDIRDGI 476 (516)
T ss_pred eecccCCcc-cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhhhcCC
Confidence 765543311 111222335579999999999999999999999999999999997 3344432 12222222222
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHH
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 268 (306)
++. .+..++ +.-..|+..++.+.|.+||++.+
T Consensus 477 ip~---~~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 477 IPP---EFLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred CCh---HHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 221 111222 34568999999999999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=7e-17 Score=132.39 Aligned_cols=131 Identities=25% Similarity=0.410 Sum_probs=102.6
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCCCc----------hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+.||+|++|.||+|++ .+..+++|+....... ..+.+|..++..+.+ ++++....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK-AGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHH-CCCCCCeEEEEeCCCCEEEE
Confidence 5789999999999987 6778999976543221 235678888888876 34444444444566789999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
||+ +++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.|||+ + ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~---~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL---S-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE---E-CCCEEEEECCcccC
Confidence 999 778888876421 2 778899999999999999999999999999999 3 68899999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.7e-17 Score=130.79 Aligned_cols=136 Identities=24% Similarity=0.323 Sum_probs=100.7
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC------------------------chhhHHHHHHHHHHhCCCC
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------------------HPQLLYEAKVYKILQGGSG 64 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~------------------------~~~~~~e~~~l~~l~~~~~ 64 (306)
|.+.+.||.|++|.||++.+. +|+.||+|++..... ......|..++..+.+..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~- 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG- 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC-
Confidence 888999999999999999874 799999997654320 012456777888886642
Q ss_pred CCcceeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc
Q 021855 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (306)
Q Consensus 65 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~ 143 (306)
+....... ....+++|||+ ++++..+.. ......++.+++.++.++|+.|++||||+|.||++ +.++
T Consensus 95 i~v~~~~~--~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~~ 162 (198)
T cd05144 95 FPVPKPID--WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDDE 162 (198)
T ss_pred CCCCceee--cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCCC
Confidence 22221221 23458999999 556654422 13356788999999999999999999999999999 4789
Q ss_pred eEEEEeeccccccCC
Q 021855 144 QVYIIDFGLAKKYRD 158 (306)
Q Consensus 144 ~~kl~Dfg~~~~~~~ 158 (306)
.++|+|||.+.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999865433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-16 Score=129.87 Aligned_cols=127 Identities=24% Similarity=0.404 Sum_probs=97.7
Q ss_pred eecccCccEEEEEEEcCCCceEEEEEccCCCC-c---------hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-H---------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~---------~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.||+|++|.||+|.+ ++..+++|....... . ..+.+|..++..+.+. +++....+.......+++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKA-GVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHC-CCCCCEEEEEECCCCEEEEE
Confidence 379999999999985 567899997553321 1 2355788899888764 33344444455566789999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
++ +++|.+++.... . .++.+++.+|.+||+.|++|||++|.||++ + ++.++++|||.+..
T Consensus 78 ~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcC
Confidence 99 778887765311 1 788999999999999999999999999999 3 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.8e-16 Score=144.46 Aligned_cols=133 Identities=23% Similarity=0.394 Sum_probs=100.4
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC--C--------CchhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--T--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~--~--------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
..|...+.||+|++|.||++.+... .+++|..... . ....+.+|..++..+.+.. ++....+.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG-VPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccC-CCeeEEEEEeCC
Confidence 3455688999999999999987543 3444432111 1 1134678999999998744 444444555556
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..+++|||+ +++|.+++. ....++.+++.+|.+||+.|++||||||+||++ +++.++|+|||++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccccc
Confidence 678999999 778887764 245688999999999999999999999999999 567899999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.3e-15 Score=120.99 Aligned_cols=135 Identities=27% Similarity=0.364 Sum_probs=93.3
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhh----------------------HHHHHHHHHHhCCC-C
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQL----------------------LYEAKVYKILQGGS-G 64 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~----------------------~~e~~~l~~l~~~~-~ 64 (306)
.+.||+|++|.||+|.+. +++.||+|++...... ... ..|...+..+.+.. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999876 7899999987643211 001 23555555554421 1
Q ss_pred CCcceeeceeCceeEEEEeccCC-CHH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCC
Q 021855 65 IPNIKWYGVDGEDNVLVLDLLGP-SLE-DLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 65 ~~~~~~~~~~~~~~~lv~e~~~~-~l~-~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~ 141 (306)
++....+ ...++++||+.+ ++. ..+.... .. ..+..++.+++.++.++|+ .||+|+||+|+||++ +
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E-
Confidence 2222221 246899999954 221 1111111 11 5678899999999999999 999999999999999 3
Q ss_pred cceEEEEeeccccccCC
Q 021855 142 ANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 142 ~~~~kl~Dfg~~~~~~~ 158 (306)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 78999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-17 Score=153.14 Aligned_cols=255 Identities=27% Similarity=0.302 Sum_probs=183.0
Q ss_pred CCceeEeeeecccCccEEEEEEEcC-CCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
...|.+.+.||+|+++.|-...... +...++.|.+..... ......|..+.+.+..|.++.............++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4568899999999999998887643 334455564443321 12233466666666645666666666667778889
Q ss_pred EEecc-CCCHHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCceeeccCCCcc-eEEEEeecccccc
Q 021855 81 VLDLL-GPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKY 156 (306)
Q Consensus 81 v~e~~-~~~l~~~~-~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dlkp~Nilv~~~~~~~-~~kl~Dfg~~~~~ 156 (306)
.+++. ++++.+.+ .......+...+..++.|+..++.|+| ..++.|+|++|+|.+++ ..+ .++++|||++...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhccc
Confidence 99998 77777776 332225677778889999999999999 99999999999999994 666 8999999999876
Q ss_pred CC-CCCCccccccCCccccc-cccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 157 RD-PTTNRHIPYRENKNLTG-TARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 157 ~~-~~~~~~~~~~~~~~~~~-~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
.. .+.... .....| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+........ .+.......
T Consensus 176 ~~~~g~~~~-----~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--~~~~~~~~~- 247 (601)
T KOG0590|consen 176 RNKNGAERS-----LKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--RYSSWKSNK- 247 (601)
T ss_pred cccCCccee-----eecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--cceeecccc-
Confidence 65 333221 123455 99999999999854 57889999999999999999999976544321 111111111
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...........+....+++.+++..+|+.|.+.+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 11111222566788999999999999999999988844
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.2e-14 Score=112.23 Aligned_cols=131 Identities=21% Similarity=0.281 Sum_probs=103.7
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCC-CCCCcceeeceeCceeEEEEeccCC-C
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG-SGIPNIKWYGVDGEDNVLVLDLLGP-S 88 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~~~~~~~~~~~~lv~e~~~~-~ 88 (306)
+.+.++.|.++.||++.... ..+++|..........+.+|...+..+.+. ..++.+..+....+..++++|++.+ .
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 46789999999999998743 678999876654445688899999999876 4555555555555678999999854 3
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
+..+ +......++.+++.+|.++|.. +++|+|++|.||+++ ..+.++++||+.+.
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~ 137 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAG 137 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEeccccc
Confidence 4322 4455667889999999999985 799999999999994 57899999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.5e-14 Score=118.18 Aligned_cols=132 Identities=16% Similarity=0.228 Sum_probs=94.2
Q ss_pred eeec-ccCccEEEEEEEcCCCceEEEEEccCC---------------CCchhhHHHHHHHHHHhCCCC-CCcceeece-e
Q 021855 13 RKIG-SGSFGEIFLASHVDTNEIVAVKIENSG---------------TKHPQLLYEAKVYKILQGGSG-IPNIKWYGV-D 74 (306)
Q Consensus 13 ~~lg-~g~~~~v~~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~e~~~l~~l~~~~~-~~~~~~~~~-~ 74 (306)
..|| .||.|+||.+.. .+..+++|.+... .....+.+|+.++..|.+... ++....+.. .
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 788889999876 3678899876431 112346779999999987432 233322221 1
Q ss_pred Cc---eeEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEe
Q 021855 75 GE---DNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 75 ~~---~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
.. ..++++|++. .+|.+++.. ..++... +.+++.+|.+||++||+|+||||.|||++ .++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence 12 2359999994 478777653 3455443 56899999999999999999999999994 667899999
Q ss_pred eccccc
Q 021855 150 FGLAKK 155 (306)
Q Consensus 150 fg~~~~ 155 (306)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.5e-15 Score=135.67 Aligned_cols=254 Identities=18% Similarity=0.157 Sum_probs=188.5
Q ss_pred cCCceeEeeeecc--cCccEEEEEEE--cCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 5 IGVKYKLGRKIGS--GSFGEIFLASH--VDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~--g~~~~v~~~~~--~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+...+.+...+|. |.+|.+|.++. ..++..+|+|.-+.. .....-.+|......+..+.+.......+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 4456677888999 99999999988 788889999863322 222334556666666666666655455556777
Q ss_pred eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHH----HHHHHHHcCccccCCCCCceeeccCCCc-ceEEEEeec
Q 021855 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA----RIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDFG 151 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~----~L~~LH~~~i~H~dlkp~Nilv~~~~~~-~~~kl~Dfg 151 (306)
..++-+|+++.++.++.......++...++....+... ||.++|+.+++|-|++|.||+.+ .+ ...+++|||
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df~ 268 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDFG 268 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCcc
Confidence 88999999999999988765555888999999999999 99999999999999999999995 55 899999999
Q ss_pred cccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc
Q 021855 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
....+.+......- .......+...|++||...+ .++..+|++|+|.++.+-.++..+...... ..+...-..
T Consensus 269 ~v~~i~~~~~~~~~--~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----~~W~~~r~~ 341 (524)
T KOG0601|consen 269 LVSKISDGNFSSVF--KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN----SSWSQLRQG 341 (524)
T ss_pred eeEEccCCccccce--eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC----CCccccccc
Confidence 98877655433211 01112256778999999765 577899999999999999998776644210 112111111
Q ss_pred ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....++...+..+...+..|++.+|-.|++++.+.+
T Consensus 342 ---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 ---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1223455666778888999999999999999888765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.2e-14 Score=109.42 Aligned_cols=149 Identities=19% Similarity=0.233 Sum_probs=112.1
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEE-ccCCCC---------chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTK---------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~-~~~~~~---------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
....+.+|+-+.|+.+.+ .|+.++||. +.+.-. .....+|...+.++..- .++....++.+.....|
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence 577889999999999977 678888883 222222 23456788888888753 56666667777778899
Q ss_pred EEeccCC--CHHHHHHHhcCCCCHHH-HHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 81 VLDLLGP--SLEDLFVYCRRKFSLKT-VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 81 v~e~~~~--~l~~~~~~~~~~~~~~~-~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+|||..| ++.+++......-+.+. ...++..|-+.+.-||.++++||||+.+||++........+.++|||++....
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~ 167 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR 167 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence 9999977 78888765443333333 37889999999999999999999999999999644455566899999997765
Q ss_pred CCCCC
Q 021855 158 DPTTN 162 (306)
Q Consensus 158 ~~~~~ 162 (306)
.+...
T Consensus 168 ~~EDK 172 (229)
T KOG3087|consen 168 LPEDK 172 (229)
T ss_pred Ccccc
Confidence 54444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=7e-13 Score=105.83 Aligned_cols=136 Identities=16% Similarity=0.190 Sum_probs=96.2
Q ss_pred eeeecccCccEEEEEEEcC------CCceEEEEEccC--------------CC--------C--ch----hhHHHHHHHH
Q 021855 12 GRKIGSGSFGEIFLASHVD------TNEIVAVKIENS--------------GT--------K--HP----QLLYEAKVYK 57 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~------~~~~vaiK~~~~--------------~~--------~--~~----~~~~e~~~l~ 57 (306)
...||.|--+.||.|.... .+..+|+|+... +. . .. ...+|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999997543 247899996431 10 0 01 1347888898
Q ss_pred HHhCC-CCCCcceeeceeCceeEEEEeccCCC-HHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCc
Q 021855 58 ILQGG-SGIPNIKWYGVDGEDNVLVLDLLGPS-LED-LFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDN 133 (306)
Q Consensus 58 ~l~~~-~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~L-H~~~i~H~dlkp~N 133 (306)
++... -.+|....+ ...+++|||.+++ +.. .+. ...++.+....+..+++.+|..| |+.|++||||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 88753 234444332 4678999999654 211 122 22355566677889999999988 89999999999999
Q ss_pred eeeccCCCcceEEEEeeccccccC
Q 021855 134 FLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 134 ilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|++ .++.+.|+|||.+....
T Consensus 156 IL~----~~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLW----HDGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE----ECCcEEEEECCCceeCC
Confidence 999 45789999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.7e-13 Score=114.16 Aligned_cols=198 Identities=12% Similarity=0.122 Sum_probs=130.0
Q ss_pred HHHHhCCCCCCcceeecee-----CceeEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHc--Cc
Q 021855 56 YKILQGGSGIPNIKWYGVD-----GEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR--GF 124 (306)
Q Consensus 56 l~~l~~~~~~~~~~~~~~~-----~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~--~i 124 (306)
+..+-|.+ +...+.|+.+ .....+++||+ .+++..++++. +..+......+|+-||+.||.|||+. -|
T Consensus 121 llqlvHsn-lvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSN-LVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHH-HHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34444544 4444334332 23467889999 88999888743 34578888899999999999999987 49
Q ss_pred cccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHH
Q 021855 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL 204 (306)
Q Consensus 125 ~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~ 204 (306)
+|++++.+.|+++ .+|.+|+.--.-.. .........-...+...+.+.|.+||.-..-..+-++|||++|++..
T Consensus 200 ihgnlTc~tifiq---~ngLIkig~~ap~s---~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQ---HNGLIKIGSVAPDS---THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred ccCCcchhheeec---CCceEEecccCccc---cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 9999999999995 78888774321110 00000000000112334567899999877767778999999999999
Q ss_pred HHHhCCCC-CCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 205 YFLRGSLP-WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 205 ~l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
+|..|..- -.+.+.......+...+...- ..--+.++.+|++..|+.||++..++-
T Consensus 274 emailEiq~tnseS~~~~ee~ia~~i~~le-----------n~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIANVIIGLE-----------NGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhhheeecc-----------CccccCcCcccccCCCCCCcchhhhhc
Confidence 99988754 333333222222222211110 122357899999999999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=8.2e-13 Score=119.24 Aligned_cols=139 Identities=23% Similarity=0.356 Sum_probs=95.0
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCc------------------------------------------hhh
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH------------------------------------------PQL 49 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~------------------------------------------~~~ 49 (306)
.+.||+|+.|+||+|+.. +|+.||||+....-.. -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999864 7899999986532100 023
Q ss_pred HHHHHHHHHHh----CCCCCCcceeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 021855 50 LYEAKVYKILQ----GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA-RIEYVHSRG 123 (306)
Q Consensus 50 ~~e~~~l~~l~----~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~-~L~~LH~~~ 123 (306)
.+|...+.++. +.+.+.....+.......+++|||+ |.++.+.........+. ..++..++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~---~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDR---KALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCH---HHHHHHHHHHHHHHHHhCC
Confidence 44555555554 2333333334444455679999999 67777765432222332 345555555 467899999
Q ss_pred ccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 124 i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++|+|++|.||++ +.++.++++|||++..+.
T Consensus 278 ~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 9999999999999 478999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.5e-12 Score=101.57 Aligned_cols=126 Identities=21% Similarity=0.305 Sum_probs=93.2
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccCC-CH
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP-SL 89 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 89 (306)
.+.++.|..+.||+++. .+..+++|+..... ......+|..++..+.+....+.+..+. ....+++||++.| ++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 46788999999999986 37789999876543 2345678999999887755556554433 3346899999944 44
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----cccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 90 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF-----LHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i-----~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
... ... ....+.+++.+|..||+.++ +|||++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~------~~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE------DFS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAG 135 (170)
T ss_pred ccc------ccc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEeccccc
Confidence 322 011 12356789999999999885 9999999999993 5679999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2e-12 Score=100.06 Aligned_cols=128 Identities=22% Similarity=0.366 Sum_probs=96.6
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCC-CC---------chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TK---------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-~~---------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
..+++|+-+.++.+.+. |..+++|.=.+. -. .....+|..++..+.. ..++....++.+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEcCCCCEEEE
Confidence 45789999999999763 445777742221 11 2245778888888876 47777777888888899999
Q ss_pred eccCCCH-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 83 DLLGPSL-EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 83 e~~~~~l-~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
||.+|.+ .+.+... ...++..+-.-+.-||.+||+||||+++||++ ..+.+.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl----~~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL----SGGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEE----eCCcEEEEECCcccc
Confidence 9996654 4566542 24566778888899999999999999999999 455699999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.8e-13 Score=126.20 Aligned_cols=272 Identities=20% Similarity=0.189 Sum_probs=180.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----C-CchhhHHHHHHHHHHhCCCCCCccee---eceeCc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----T-KHPQLLYEAKVYKILQGGSGIPNIKW---YGVDGE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~-~~~~~~~e~~~l~~l~~~~~~~~~~~---~~~~~~ 76 (306)
--+.+.+.+-+.+|.++.++.++-..++...+.|+.... . +.+....+-.+ ..++..+.... -+....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~----~i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNI----LITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCc----cccCCCCceecccCCCCCCC
Confidence 345667788899999999999876666655555532211 0 01111111111 11122222211 123455
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++++. ++++...+.. .+..+.+.+...+..+..++.+||+..+.|+|++|.|++.. ..+..+++||+....
T Consensus 878 P~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSK 953 (1205)
T ss_pred CcchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccccccc
Confidence 678999998 6677777665 33466667777778899999999999999999999999994 899999999973221
Q ss_pred cC---------------------CCCCCccc---cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 021855 156 YR---------------------DPTTNRHI---PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 211 (306)
Q Consensus 156 ~~---------------------~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~ 211 (306)
.. ........ ..+......+|+.|.+||...+..-+..+|+|++|.++++.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 10 00000000 1123446678999999999999999999999999999999999999
Q ss_pred CCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccce
Q 021855 212 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT 291 (306)
Q Consensus 212 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~ 291 (306)
||....++ +.++.+.....+-+... ...+....+++.+.+..+|.+|..+..-. +..+-+...+-+|+
T Consensus 1034 p~na~tpq---~~f~ni~~~~~~~p~g~--~~~s~~aq~~~~~ll~~~~~qr~~a~~~~-------e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1034 PFNAETPQ---QIFENILNRDIPWPEGP--EEGSYEAQDLINRLLTEEPTQRLGAKGAA-------EVKGHPFFQDVDWE 1101 (1205)
T ss_pred CCCCcchh---hhhhccccCCCCCCCCc--cccChhhhhhhhhhhccCchhccCccccc-------ccccCCccCCCCcc
Confidence 99875543 55555554444433221 44578899999999999999998765211 12344555666777
Q ss_pred ecchh
Q 021855 292 ILKYQ 296 (306)
Q Consensus 292 ~~~~~ 296 (306)
.++.+
T Consensus 1102 ~l~~q 1106 (1205)
T KOG0606|consen 1102 NLALQ 1106 (1205)
T ss_pred ccccc
Confidence 76543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.3e-12 Score=113.97 Aligned_cols=145 Identities=19% Similarity=0.281 Sum_probs=92.5
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---------------------------c--------------
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---------------------------H-------------- 46 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---------------------------~-------------- 46 (306)
.|+. +.||+|++|+||.|+.+.+|+.||||+...... .
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3554 789999999999999888899999998764310 0
Q ss_pred -hhhHHHHHHHHHHh----CCCCCCcceeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 021855 47 -PQLLYEAKVYKILQ----GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120 (306)
Q Consensus 47 -~~~~~e~~~l~~l~----~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH 120 (306)
-++.+|.....++. +.+.+.....+.......+++|||+ |+.+.++-.-...+.+........ +..-+..+.
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~--v~~~~~Qif 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG--VEVFFTQVF 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH--HHHHHHHHH
Confidence 12344555555554 2222322334444566789999999 667766432112233322221111 111133445
Q ss_pred HcCccccCCCCCceeeccCCCcc----eEEEEeeccccccCC
Q 021855 121 SRGFLHRDIKPDNFLMGLGRKAN----QVYIIDFGLAKKYRD 158 (306)
Q Consensus 121 ~~~i~H~dlkp~Nilv~~~~~~~----~~kl~Dfg~~~~~~~ 158 (306)
..|++|+|++|.||+++ .++ .+++.|||++..++.
T Consensus 278 ~~GffHaDpHPGNIlv~---~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVS---YDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEe---cCCCCCCeEEEEecceEEECCH
Confidence 68999999999999995 555 999999999876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-12 Score=116.36 Aligned_cols=244 Identities=18% Similarity=0.111 Sum_probs=166.8
Q ss_pred CCceeEeeeecccCccEEEEEEEc-CCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
..+|-.+..||.|.++.|+....+ .++..+++|-...... +.....|+.+...+..+.+.+....-+......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 456788999999999999987655 6788888886554322 22345677777777655555443333334445678
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
-.||| ++++.... .....+++...+.+..|++.++.++|++.++|+|++|+||++. ..++..++.||++...+...
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~--~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILIS--NDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeec--cchhhhhcccccccccccee
Confidence 89999 55555444 3344688889999999999999999999999999999999995 22388899999998753322
Q ss_pred CCCccccccCCcccccccccc--CcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 160 TTNRHIPYRENKNLTGTARYA--SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
.. .......+. ++.......+..++|++|||..+.+..++...-... ..+..+..+.....
T Consensus 421 ~~----------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------~~~~~i~~~~~p~~- 483 (524)
T KOG0601|consen 421 SG----------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG------VQSLTIRSGDTPNL- 483 (524)
T ss_pred cc----------cccccccccccchhhccccccccccccccccccccccccCcccCccc------ccceeeecccccCC-
Confidence 21 222333334 444444556788999999999999999886433221 11222222222222
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
...+..+..+...+...++..||.+.++....
T Consensus 484 ----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 484 ----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred ----CchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 22246788899999999999999998875543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.4e-10 Score=105.48 Aligned_cols=181 Identities=15% Similarity=0.136 Sum_probs=124.1
Q ss_pred eeEeeeecccCccEEE-EEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 9 YKLGRKIGSGSFGEIF-LASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~-~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
|++ ....-++.+ +| .|..+.++.+|.+...+.... .....+.++-++.++|++++.++..+. .+...|+++|.+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-~~~~~ylvTErV 91 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-EEGTLYLVTERV 91 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-ccCceEEEeecc
Confidence 444 333334333 34 456677888898888776555 344667788899999977776666554 444899999988
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
.. |...+... ........+.||+.||.||| +++++|++|.-+.|+| +..|..||++|..+..........
T Consensus 92 ~P-l~~~lk~l----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~- 162 (690)
T KOG1243|consen 92 RP-LETVLKEL----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPA- 162 (690)
T ss_pred cc-HHHHHHHh----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCccc-
Confidence 32 33344432 25556667899999999997 6789999999999999 599999999999886544322100
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhC
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 209 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg 209 (306)
....---.|..|+.+.... ...|.|.|||++++++.|
T Consensus 163 ------~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 163 ------KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ------ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 0111122355665543222 356999999999999999
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.4e-11 Score=101.57 Aligned_cols=254 Identities=13% Similarity=0.193 Sum_probs=159.3
Q ss_pred eEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCc-c-----eeeceeCce-eEEEE
Q 021855 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN-I-----KWYGVDGED-NVLVL 82 (306)
Q Consensus 10 ~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~-~-----~~~~~~~~~-~~lv~ 82 (306)
...+.||+|+.+.+|-.- +-+..| -|++....-.... +....+.....++.... + ..++-+++. .-+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~V-AKIYh~Pppa~~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQV-AKIYHAPPPAAQA-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecc--hhhchh-heeecCCCchHHH-HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 457889999999999652 222334 4877755432221 12222322222232222 1 233434443 55677
Q ss_pred eccCC--CHHHHHHH--hc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 83 DLLGP--SLEDLFVY--CR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 83 e~~~~--~l~~~~~~--~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
....+ ....++.- .. ...+++...+.++.++.+..-||..|.+-||++++|+||+ +++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcccceee
Confidence 76633 33333321 01 1266888999999999999999999999999999999995 889999988543222
Q ss_pred cCCCCCCccccccCCccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhC-CCCCCCchhhhh----HH-H
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATK----KQ-K 224 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg-~~pf~~~~~~~~----~~-~ 224 (306)
- ..++ ...+.+|...|++||...- ...+...|.|.||+++++++.| .+||++...... .+ .
T Consensus 167 ~-~ng~-------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 167 N-ANGT-------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred c-cCCc-------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 1 1111 1236688999999998763 3346789999999999999885 999987321110 00 0
Q ss_pred --------HHHHhhcccccchHHHhhcCchHHHHHHHhhhcCC--CCCCCChHHHHHHHHHhHh
Q 021855 225 --------YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLT--FDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 225 --------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d--P~~Rps~~~l~~~l~~~~~ 278 (306)
..+...+..+.|...-..-+++++..+..+|+... +.-|||++..+..|..+-.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 01111111222222222445788999999999754 5789999998888877754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.6e-12 Score=114.26 Aligned_cols=155 Identities=14% Similarity=0.197 Sum_probs=109.7
Q ss_pred HHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCc--cccccccccCccccc
Q 021855 110 DQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK--NLTGTARYASCNTHL 186 (306)
Q Consensus 110 ~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~--~~~~~~~y~aPE~~~ 186 (306)
.+++.|+.++|. .++||++|.|++|.+ +..+..||+.|+.+.....+..-...+|...- .......|.|||++.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 455699999995 589999999999999 68999999999998765543332111121111 223455699999999
Q ss_pred CCCCCchhhHHHHHHHHHHHH-hCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCC
Q 021855 187 GIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (306)
Q Consensus 187 ~~~~~~~sDiwslG~il~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 265 (306)
+...++++|++|+|+.+|.+. .|+..+......... ...... ..........++|+++++=+.+++..++..||+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~---~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNL---LNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcc---cccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 988899999999999999999 466666543322211 111111 111111122677899999999999999999998
Q ss_pred hHHHHH
Q 021855 266 YGFLKR 271 (306)
Q Consensus 266 ~~~l~~ 271 (306)
+..+..
T Consensus 259 ~~~l~~ 264 (700)
T KOG2137|consen 259 LDLLLS 264 (700)
T ss_pred hhhhhc
Confidence 877755
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.5e-09 Score=88.60 Aligned_cols=131 Identities=19% Similarity=0.212 Sum_probs=91.0
Q ss_pred cEEEEEEEcCCCceEEEEEccCCCC-----------ch--hhHHHHHHHHHHhCCCCCCcc--eeecee-----CceeEE
Q 021855 21 GEIFLASHVDTNEIVAVKIENSGTK-----------HP--QLLYEAKVYKILQGGSGIPNI--KWYGVD-----GEDNVL 80 (306)
Q Consensus 21 ~~v~~~~~~~~~~~vaiK~~~~~~~-----------~~--~~~~e~~~l~~l~~~~~~~~~--~~~~~~-----~~~~~l 80 (306)
..|..+.. .|+.+.+|....... .+ .+.+|...+.++... +++.. ..++.. ....++
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~-GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEV-GVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHc-CCCCCCeeEEEEecCCCccceeEE
Confidence 34555544 467788896543221 11 367888888888642 23332 233322 235789
Q ss_pred EEeccCC--CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc----CCCcceEEEEeeccc
Q 021855 81 VLDLLGP--SLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL----GRKANQVYIIDFGLA 153 (306)
Q Consensus 81 v~e~~~~--~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~----~~~~~~~kl~Dfg~~ 153 (306)
++|++++ +|.+++... ....+......++.+++..+..||+.||+|+||++.|||+.. .++.+.+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9999965 687887542 234566777889999999999999999999999999999952 123578999999987
Q ss_pred c
Q 021855 154 K 154 (306)
Q Consensus 154 ~ 154 (306)
.
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 4
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.7e-09 Score=87.86 Aligned_cols=136 Identities=21% Similarity=0.325 Sum_probs=94.0
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCC-CCCcceeeceeC---ceeEEEEecc
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGS-GIPNIKWYGVDG---EDNVLVLDLL 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~-~~~~~~~~~~~~---~~~~lv~e~~ 85 (306)
+.++.|..+.+|++.... |+.+++|...... ....+.+|..++..+.+.. .++.+..+.... +..++++|++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 578899999999998643 5789999876543 2456788999999998742 245444444332 2568999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 021855 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------------------------------- 121 (306)
Q Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~------------------------------------------- 121 (306)
+.++.+.+.. ..++.+....++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 4445443321 235555555666666666666663
Q ss_pred -------------cCccccCCCCCceeeccCCC--cceEEEEeecccc
Q 021855 122 -------------RGFLHRDIKPDNFLMGLGRK--ANQVYIIDFGLAK 154 (306)
Q Consensus 122 -------------~~i~H~dlkp~Nilv~~~~~--~~~~kl~Dfg~~~ 154 (306)
..++|+|+.|.||+++ . .+.+.++||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFH---PDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEc---CCCCcEEEEEeccccc
Confidence 2469999999999995 4 5678899999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.3e-09 Score=84.47 Aligned_cols=125 Identities=27% Similarity=0.362 Sum_probs=77.1
Q ss_pred EEEEEEEcCCCceEEEEEccCC---------------C--------C-----chhhHHHHHHHHHHhCCC-CCCcceeec
Q 021855 22 EIFLASHVDTNEIVAVKIENSG---------------T--------K-----HPQLLYEAKVYKILQGGS-GIPNIKWYG 72 (306)
Q Consensus 22 ~v~~~~~~~~~~~vaiK~~~~~---------------~--------~-----~~~~~~e~~~l~~l~~~~-~~~~~~~~~ 72 (306)
.||.|... .|..+|+|+.... . . .....+|...|.++.... .+|.+..+
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 48888753 4678999964311 0 0 113567888898887642 34544333
Q ss_pred eeCceeEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCccccCCCCCceeeccCCCcceEEEEe
Q 021855 73 VDGEDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY-VHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 73 ~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~-LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
...+++|||.+ |.....+... .++.+....++.+++..+.. +|+.||+||||++.||++ .++.+.++|
T Consensus 79 ---~~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv----~~~~~~iID 149 (188)
T PF01163_consen 79 ---NRNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILV----DDGKVYIID 149 (188)
T ss_dssp ---ETTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEE----ETTCEEE--
T ss_pred ---eCCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEe----ecceEEEEe
Confidence 24679999997 6444444331 12234455677788885554 679999999999999999 345999999
Q ss_pred eccccccC
Q 021855 150 FGLAKKYR 157 (306)
Q Consensus 150 fg~~~~~~ 157 (306)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.5e-08 Score=78.09 Aligned_cols=136 Identities=13% Similarity=0.132 Sum_probs=98.3
Q ss_pred ecccCccEEEEEEEcCCCceEEEEEcc--------CCCCchhhHHHHHHHHHHhCCCC-CCcceeece----eCceeEEE
Q 021855 15 IGSGSFGEIFLASHVDTNEIVAVKIEN--------SGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGV----DGEDNVLV 81 (306)
Q Consensus 15 lg~g~~~~v~~~~~~~~~~~vaiK~~~--------~~~~~~~~~~e~~~l~~l~~~~~-~~~~~~~~~----~~~~~~lv 81 (306)
-+.||.|-|+..... |+.+-+|.-. .+...+.+.+|...+..|..... ++....... .....+||
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 356888999987653 3457778433 14466789999999999975322 333332221 12346899
Q ss_pred EeccC--CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce--EEEEeeccccc
Q 021855 82 LDLLG--PSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKK 155 (306)
Q Consensus 82 ~e~~~--~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~--~kl~Dfg~~~~ 155 (306)
+|.++ .+|.+++.... .+.+......++.+++.++.-||+.|+.|+|+.+.||++. ..+. +.++||..++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~---~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVK---TEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeec---CCCCeeEEEEEhhccch
Confidence 99886 68888875422 2457777788999999999999999999999999999993 3444 99999988754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.5e-07 Score=79.08 Aligned_cols=213 Identities=17% Similarity=0.206 Sum_probs=143.1
Q ss_pred CccEEEEEEEcCCCceEEEEEccCCCCch--hhHHHHHHHHHHhCCCCCCcceeec---eeCceeEEEEecc--CCCHHH
Q 021855 19 SFGEIFLASHVDTNEIVAVKIENSGTKHP--QLLYEAKVYKILQGGSGIPNIKWYG---VDGEDNVLVLDLL--GPSLED 91 (306)
Q Consensus 19 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~e~~~l~~l~~~~~~~~~~~~~---~~~~~~~lv~e~~--~~~l~~ 91 (306)
...+.|++....+|..|++|++...+... .-..-++.++++.|.+.++.-..+- -.....++|++|. .++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44588999999999999999884332211 1233467788888877776543332 2345679999998 456766
Q ss_pred HHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 92 LFVYC--------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 92 ~~~~~--------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+.-.. +.+.++..+|.++.|+..||.++|+.|+.=+-|.|.+|+++ .+.+++|+..|..-...
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeeec
Confidence 64321 12467899999999999999999999999999999999994 66688887766654332
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
...+ +-+.+ -.+-|.=.||.++..|.||..-=...+. .......
T Consensus 445 ~d~~---------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-~~~s~~~----------- 488 (655)
T KOG3741|consen 445 EDPT---------------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDS-TQSSHLT----------- 488 (655)
T ss_pred CCCC---------------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccc-hHHHHHH-----------
Confidence 2211 11111 1356888999999999999643211111 1111111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
.+...++.+++++|......++++ -++++++.+
T Consensus 489 -~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 489 -RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 122556788999999999999986 366666554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.3e-08 Score=78.90 Aligned_cols=109 Identities=23% Similarity=0.345 Sum_probs=79.9
Q ss_pred CchhhHHHHHHHHHHhCCCCCCc--ceeecee----CceeEEEEeccCC--CHHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 021855 45 KHPQLLYEAKVYKILQGGSGIPN--IKWYGVD----GEDNVLVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARI 116 (306)
Q Consensus 45 ~~~~~~~e~~~l~~l~~~~~~~~--~~~~~~~----~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~qi~~~L 116 (306)
..+...+|...+..|.. .+++. ...+... ....++++|++.+ +|.+++.... ..+......++.+++..+
T Consensus 54 ~~~ra~~E~~~~~~L~~-~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLRE-AGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLI 131 (206)
T ss_pred cchHHHHHHHHHHHHHH-cCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHH
Confidence 44567888888888865 33333 3333332 1345899999844 6788877533 266777888999999999
Q ss_pred HHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 117 ~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
.-||++||+|+|+++.|||+...+....+.|+||+.+..
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999995333345899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.5e-08 Score=79.04 Aligned_cols=133 Identities=20% Similarity=0.295 Sum_probs=94.5
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEcc----------C------CC--------CchhhHHHHHHHHHHhCC-C
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----------S------GT--------KHPQLLYEAKVYKILQGG-S 63 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~----------~------~~--------~~~~~~~e~~~l~~l~~~-~ 63 (306)
+.++..||-|--|.||.|.+. .|.++|+|.-. . .. ......+|..+|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 357899999999999999865 58889999421 0 00 012357788999988754 3
Q ss_pred CCCcceeeceeCceeEEEEeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc
Q 021855 64 GIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (306)
Q Consensus 64 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~ 142 (306)
.+|.... .+..+++||+..| .|... +++.+....++..|++-+.-+-..|++|||+++-||+++ ++
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~d 238 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---ED 238 (304)
T ss_pred CCCCccc----cccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---cC
Confidence 3443322 2357899999955 33322 123444555666777777777799999999999999994 89
Q ss_pred ceEEEEeeccccc
Q 021855 143 NQVYIIDFGLAKK 155 (306)
Q Consensus 143 ~~~kl~Dfg~~~~ 155 (306)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999987754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.2e-07 Score=73.17 Aligned_cols=128 Identities=24% Similarity=0.415 Sum_probs=99.8
Q ss_pred eEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCC
Q 021855 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (306)
Q Consensus 10 ~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 88 (306)
++.+.|++|..|.||++.+ .|..+|+|+-..+.....+..|.+++..+.....-|.++.++.+ ++.|||. |..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence 4678899999999999988 56789999988888888999999999999988888888777643 3559999 447
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCC--CceeeccCCCcceEEEEeeccccc
Q 021855 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP--DNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp--~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
|.+.... .+.+. +..+++.---|-..||-|+.|.- .||++ .++.+.|+||..|+.
T Consensus 99 L~~~~~~----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 7766442 12222 24466666677788999999976 56666 566999999999863
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.2e-07 Score=74.05 Aligned_cols=139 Identities=21% Similarity=0.281 Sum_probs=90.1
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch-----------hhHHHHHHHHHHhCCC--CCCc-
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-----------QLLYEAKVYKILQGGS--GIPN- 67 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~e~~~l~~l~~~~--~~~~- 67 (306)
..+++++|.+.+.+.......|.+.. ..|+.+++|......... ...+.+..+.++.... ....
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 35788999999999988877777664 367889999776543221 2233444444443211 1111
Q ss_pred -c---eeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc
Q 021855 68 -I---KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (306)
Q Consensus 68 -~---~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~ 142 (306)
+ ...+......++++||+ |..|.+... +++ .+...+.+++..+|+.|+.|||..|.|+++ .+
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv----~~ 170 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV----SN 170 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE----EC
Confidence 1 11111234557899999 545654421 222 244567788999999999999999999999 45
Q ss_pred ceEEEEeeccccc
Q 021855 143 NQVYIIDFGLAKK 155 (306)
Q Consensus 143 ~~~kl~Dfg~~~~ 155 (306)
+.++++||+....
T Consensus 171 ~~i~iID~~~k~~ 183 (229)
T PF06176_consen 171 NGIRIIDTQGKRM 183 (229)
T ss_pred CcEEEEECccccc
Confidence 5699999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.9e-06 Score=71.14 Aligned_cols=71 Identities=18% Similarity=0.141 Sum_probs=53.2
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCC-CCcceeeceeCceeEEEEeccCC
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLGP 87 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~~~~~~~~~~~~lv~e~~~~ 87 (306)
..||.|..+.||+. .+..+++|............+|..++..+..... ++.+..+........++|+++.|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999974 2446788987765555667889999999986443 56666666666667889999955
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=7e-07 Score=72.93 Aligned_cols=136 Identities=23% Similarity=0.290 Sum_probs=92.1
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCCC--------------------Cc------hhhHHHHHHHHHHhCC-C
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------------------KH------PQLLYEAKVYKILQGG-S 63 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--------------------~~------~~~~~e~~~l~~l~~~-~ 63 (306)
+...|++|-.+.||+|.. .++..+|+|++.... .. ....+|...|.++... -
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 344778888899999974 457889999755210 00 1245677778777642 1
Q ss_pred CCCcceeeceeCceeEEEEeccCCCHH--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCC
Q 021855 64 GIPNIKWYGVDGEDNVLVLDLLGPSLE--DLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR 140 (306)
Q Consensus 64 ~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~ 140 (306)
.+|....+ ...+++|||.|..-. -.+.. -++..+.+..+..++++.+.-|-. .++||+||+.-|||+
T Consensus 131 rvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~---- 200 (268)
T COG1718 131 RVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV---- 200 (268)
T ss_pred CCCCceee----cCCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE----
Confidence 22222222 246799999965511 01111 123333677788899999998887 899999999999999
Q ss_pred CcceEEEEeeccccccC
Q 021855 141 KANQVYIIDFGLAKKYR 157 (306)
Q Consensus 141 ~~~~~kl~Dfg~~~~~~ 157 (306)
.++.+.++|++-+....
T Consensus 201 ~~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 HDGEPYIIDVSQAVTID 217 (268)
T ss_pred ECCeEEEEECccccccC
Confidence 58999999999886543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.9e-06 Score=78.90 Aligned_cols=139 Identities=22% Similarity=0.321 Sum_probs=92.1
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCC------------------------C-C--c---------------hhhH
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG------------------------T-K--H---------------PQLL 50 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~------------------------~-~--~---------------~~~~ 50 (306)
..|+.++-|+||.|+.. +|+.||||+...+ . . . -++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67889999999999965 4999999974321 0 0 0 0234
Q ss_pred HHHHHHHHHh----CCCCCCcceeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 021855 51 YEAKVYKILQ----GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125 (306)
Q Consensus 51 ~e~~~l~~l~----~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~ 125 (306)
+|...+.++. +.+.+.....+.......+++|||+ |-.+.++..-...+++.+.+...+.++ -+..+-..|+.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCcc
Confidence 4555555554 2333333345555567789999999 446666643323556755444333222 23444568999
Q ss_pred ccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 126 H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|+|..|-||++ +.+|.+.+.|||+...++
T Consensus 288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 288 HADPHPGNILV---RSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccCCCccceEE---ecCCcEEEEcCcceecCC
Confidence 99999999999 588999999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.5e-06 Score=69.70 Aligned_cols=78 Identities=17% Similarity=0.183 Sum_probs=52.2
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCC-CCcceeec---eeCceeEEEEeccCC
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYG---VDGEDNVLVLDLLGP 87 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~~~~~---~~~~~~~lv~e~~~~ 87 (306)
++.++.|..+.||.+.... ..+++|............+|..++..+..... ++.+..+. ......+++++++.|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4688999999999998644 57889987665334557788888888876533 45554422 233346889999844
Q ss_pred -CHHH
Q 021855 88 -SLED 91 (306)
Q Consensus 88 -~l~~ 91 (306)
.+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 4444
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.3e-05 Score=64.63 Aligned_cols=74 Identities=23% Similarity=0.306 Sum_probs=49.6
Q ss_pred eecccCc-cEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCCHH
Q 021855 14 KIGSGSF-GEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLE 90 (306)
Q Consensus 14 ~lg~g~~-~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~ 90 (306)
.|..|.+ +.||++... +..+++|+..... .....+|+.+++.+...-.+|.+..++...+..+++|++. |.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4445555 788988643 3567888776543 3457789999998876544555555555555678999998 44444
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.8e-05 Score=61.73 Aligned_cols=69 Identities=17% Similarity=0.118 Sum_probs=42.4
Q ss_pred eeecccCcc-EEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCC--CCCcceeeceeC---ceeEEEEeccC
Q 021855 13 RKIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--GIPNIKWYGVDG---EDNVLVLDLLG 86 (306)
Q Consensus 13 ~~lg~g~~~-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~--~~~~~~~~~~~~---~~~~lv~e~~~ 86 (306)
+.++.|+.+ .||.. +..+++|+...........+|..++..+...- .+|.....+... ...+++|+++.
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 467777766 48876 23477887665444557888999999887532 233333322221 13478899883
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00013 Score=66.99 Aligned_cols=144 Identities=24% Similarity=0.283 Sum_probs=89.6
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCC-------------------------C--------------chhhHHH
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------------------------K--------------HPQLLYE 52 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------------------------~--------------~~~~~~e 52 (306)
.+.|+..+.++|++|+-+. |+.||+|+-...- . .-+|.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4678999999999999654 9999999732110 0 0023444
Q ss_pred HHH----HHHHhCCCC---CCcceeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 021855 53 AKV----YKILQGGSG---IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124 (306)
Q Consensus 53 ~~~----l~~l~~~~~---~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 124 (306)
.+- .+.+.+.+. +.....+.......+++|||+ |..+.++-.-...+++...+..-+.++.. ..+-..|+
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf 322 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF 322 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence 433 333344331 112234455556789999999 44444442222445776655444333322 23345689
Q ss_pred cccCCCCCceeeccC-CCcceEEEEeeccccccCC
Q 021855 125 LHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 125 ~H~dlkp~Nilv~~~-~~~~~~kl~Dfg~~~~~~~ 158 (306)
+|+|=-|-||+++.+ +.++.+.+-|+|+...+..
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999622 3588999999999876543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00043 Score=55.72 Aligned_cols=132 Identities=20% Similarity=0.294 Sum_probs=84.5
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCC------------------CchhhHHHHHHHHHHh-CC----CCCCcc
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------------KHPQLLYEAKVYKILQ-GG----SGIPNI 68 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~------------------~~~~~~~e~~~l~~l~-~~----~~~~~~ 68 (306)
...||+|+...||.- ..+. ...||+..... ...+..+|+.....+. .. ..++.+
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp-~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDP-NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CCCC-CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 467899999999965 4333 34679877654 2345677777766666 22 234444
Q ss_pred eeeceeCceeEEEEecc-------CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC
Q 021855 69 KWYGVDGEDNVLVLDLL-------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 69 ~~~~~~~~~~~lv~e~~-------~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~ 141 (306)
..+........+++|.. ..+|.+++. ...++. ... ..+-+-..+|-+.+|+.+||+|.||++...++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 44444444556777765 235666664 334655 333 33444456888999999999999999975544
Q ss_pred cc-eEEEEe-ecc
Q 021855 142 AN-QVYIID-FGL 152 (306)
Q Consensus 142 ~~-~~kl~D-fg~ 152 (306)
.. .+.|+| ||.
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 44 677887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=2.9e-06 Score=77.65 Aligned_cols=241 Identities=10% Similarity=0.008 Sum_probs=150.0
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccCCC
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPS 88 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 88 (306)
|.....+++++++.+++.+...+...+ .+.+... -...-++++|.+.++++.......-...+....+.++++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 445566788999999999876554444 4544433 233447788888888662222222233455677888888333
Q ss_pred --HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccc
Q 021855 89 --LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (306)
Q Consensus 89 --l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (306)
.........-.+..-....+++.-+++++++|+.-=+|+| ||+. ..+..++.||+....+...-
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~------ 385 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM------ 385 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc------
Confidence 2222111111133334555677788899999998778888 8887 55788999999886654432
Q ss_pred ccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc-cccchHHHhhcCc
Q 021855 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-VSTPIEVLCKSHP 245 (306)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (306)
......+++.+++||+.....+....|.||+|.--.++.-|-.|-...... ...+-.+. .+...+. ..++
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~-----~~~~g~~p~s~~L~~~--~aw~ 456 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV-----LPMIGNGPNSPMLTDK--SAWS 456 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc-----cCCCCCCCCccccchh--hhcC
Confidence 224678899999999999999999999999998777777777665441111 00000000 0011110 1112
Q ss_pred hHHH-HHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 246 AEFA-SYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 246 ~~~~-~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+... +....|+...|..|+..... .+.+++.
T Consensus 457 ~~~~~~~~~~~~~g~P~~pkv~mga--cfsKvfn 488 (829)
T KOG0576|consen 457 PVFHRDFPAPCLNGLPPTPKVHMGA--CFSKVFN 488 (829)
T ss_pred cccccCCcccccCCCCCCCcchhhH--HHHHHhc
Confidence 2222 36778888888888877666 5677774
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00062 Score=56.52 Aligned_cols=72 Identities=15% Similarity=0.155 Sum_probs=46.3
Q ss_pred eeeecccCccEEEEEEEcC-CCceEEEEEccCCCCc-hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccCC
Q 021855 12 GRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP 87 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 87 (306)
.+.|..|-...+|++.... .+..+++|+....... ....+|..++..+......+.+..... ..+++||+.|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence 4567778888999986432 2567889976643221 234578889998876555555543322 2479999833
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00053 Score=67.49 Aligned_cols=78 Identities=14% Similarity=0.215 Sum_probs=50.6
Q ss_pred EeeeecccCccEEEEEEEcCCC--ceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCC--CcceeeceeC---ceeEE
Q 021855 11 LGRKIGSGSFGEIFLASHVDTN--EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGI--PNIKWYGVDG---EDNVL 80 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~--~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~--~~~~~~~~~~---~~~~l 80 (306)
-.+.++.|.++.+|+......+ ..+++|+..... ....+.+|..+++.+..+..+ +.+..++.+. +..++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677888999999998764322 357777654322 224578899999999743444 4444443332 35789
Q ss_pred EEeccCCC
Q 021855 81 VLDLLGPS 88 (306)
Q Consensus 81 v~e~~~~~ 88 (306)
+||++.|.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999553
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00088 Score=59.81 Aligned_cols=73 Identities=27% Similarity=0.326 Sum_probs=48.9
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccC---------CCCchhhHHHHHHHHHHhCC--CCCCcceeeceeCceeEE
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENS---------GTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~---------~~~~~~~~~e~~~l~~l~~~--~~~~~~~~~~~~~~~~~l 80 (306)
.+.||.|....||++.....++.++||.-.. +........|...|..+... ..+|.+..+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999998754335799997431 11223456677888777543 234544444 5566889
Q ss_pred EEeccC
Q 021855 81 VLDLLG 86 (306)
Q Consensus 81 v~e~~~ 86 (306)
+||++.
T Consensus 109 VME~L~ 114 (401)
T PRK09550 109 VMEDLS 114 (401)
T ss_pred EEecCC
Confidence 999984
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00023 Score=61.76 Aligned_cols=138 Identities=20% Similarity=0.226 Sum_probs=95.7
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCC----------------------CCc------hhhHHHHHHHHHHhCC
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----------------------TKH------PQLLYEAKVYKILQGG 62 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----------------------~~~------~~~~~e~~~l~~l~~~ 62 (306)
+-..|..|--+.||.|. ..+|..+|||+++.+ ... ..+.+|+.-|+++...
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 45667889999999997 457888999975421 001 1346688888888753
Q ss_pred CCCCcceeeceeCceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCceeeccCCC
Q 021855 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 63 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dlkp~Nilv~~~~~ 141 (306)
+||...-.. -...+|||+++|.+-+..-.-....++...+..+-.|++.-+.-|. .+++||.||.--|+|+ .
T Consensus 227 -GIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----h 299 (520)
T KOG2270|consen 227 -GIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----H 299 (520)
T ss_pred -CCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----E
Confidence 244331111 1246899999976544322211345777777777788888777655 6799999999999999 8
Q ss_pred cceEEEEeecccccc
Q 021855 142 ANQVYIIDFGLAKKY 156 (306)
Q Consensus 142 ~~~~kl~Dfg~~~~~ 156 (306)
+|.+.++|.+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 999999999887643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00029 Score=59.43 Aligned_cols=68 Identities=12% Similarity=0.066 Sum_probs=44.7
Q ss_pred eecccCccEEEEEEEcCCCceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccCC
Q 021855 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP 87 (306)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 87 (306)
.+..|-.+.+|+... ++..+++|+....... .+..+|..+++.+......|.+..... .+++++|+.|
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence 355677888998863 5667888976543222 245779999999886545555544332 3688999844
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00091 Score=53.60 Aligned_cols=124 Identities=19% Similarity=0.277 Sum_probs=80.6
Q ss_pred CceeEeeeecccCc-cEEEEEEEcCCCceEEEEEccC-----------C------------CCchhhHHHHHHHHHHhCC
Q 021855 7 VKYKLGRKIGSGSF-GEIFLASHVDTNEIVAVKIENS-----------G------------TKHPQLLYEAKVYKILQGG 62 (306)
Q Consensus 7 ~~y~i~~~lg~g~~-~~v~~~~~~~~~~~vaiK~~~~-----------~------------~~~~~~~~e~~~l~~l~~~ 62 (306)
..++..+.||.|.. |.||+++. .|+.+|+|++.. . .....+..|.....+|...
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 99999976 678999998221 0 0112467788888888753
Q ss_pred CC--C--Ccceeece-e-----------------CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 021855 63 SG--I--PNIKWYGV-D-----------------GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120 (306)
Q Consensus 63 ~~--~--~~~~~~~~-~-----------------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH 120 (306)
.. . .....|.. . ...+.||.||....- .++. .-+.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 32 2 11111110 0 011245555442111 1222 23467888889999
Q ss_pred HcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 121 ~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
+.||+-+|+++.|..= | +|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~------G--~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG------G--KLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC------C--EEEecccC
Confidence 9999999999999863 2 79999875
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0014 Score=56.58 Aligned_cols=78 Identities=14% Similarity=0.060 Sum_probs=52.5
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCC--CCCcceeece---eCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--GIPNIKWYGV---DGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~--~~~~~~~~~~---~~~~~~lv~ 82 (306)
.-.-.+.||.|..+.||..... +..+++|..........+..|...++.+.... .+|.+...+. ..+..+++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS--QGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEcC--CCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 4445778999999999998542 23466787443224457889999999997643 3455543332 235589999
Q ss_pred eccCC
Q 021855 83 DLLGP 87 (306)
Q Consensus 83 e~~~~ 87 (306)
|+..+
T Consensus 93 E~i~G 97 (297)
T PRK10593 93 ERLRG 97 (297)
T ss_pred eccCC
Confidence 99843
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00092 Score=57.61 Aligned_cols=137 Identities=15% Similarity=0.153 Sum_probs=77.9
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCC-CCCccee------eceeCceeEEEEec
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIPNIKW------YGVDGEDNVLVLDL 84 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~~~------~~~~~~~~~lv~e~ 84 (306)
.+.+..|....+|+... .+..+++|+... ........|..++..+.... .++.+.. +....+..+.++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 56677787789998864 344688898765 33455677888888886532 1222211 11223456789998
Q ss_pred cCC-CHH----HHHHH----------hcCCCC--------HHHHH------------HHHHHHHHHHHHHHH-------c
Q 021855 85 LGP-SLE----DLFVY----------CRRKFS--------LKTVL------------MLADQMIARIEYVHS-------R 122 (306)
Q Consensus 85 ~~~-~l~----~~~~~----------~~~~~~--------~~~~~------------~~~~qi~~~L~~LH~-------~ 122 (306)
+.| .+. ..... ....+. ..... .....+..++.++.+ .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 843 321 01110 000110 00000 011223334444443 3
Q ss_pred CccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 123 ~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
+++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFD---GDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence 799999999999994 55666899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0028 Score=55.52 Aligned_cols=70 Identities=17% Similarity=0.191 Sum_probs=45.0
Q ss_pred eecccCccEEEEEEEcCCCceEEEEEcc----C-----CCCchhhHHHHHHHHHHhCCC--CCCcceeeceeCceeEEEE
Q 021855 14 KIGSGSFGEIFLASHVDTNEIVAVKIEN----S-----GTKHPQLLYEAKVYKILQGGS--GIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~----~-----~~~~~~~~~e~~~l~~l~~~~--~~~~~~~~~~~~~~~~lv~ 82 (306)
.+|.|....||++.....++.++||.-. . +....+...|...+....... .+| ..+..+.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP--~vy~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVP--RIFHFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccC--eEEEEccccceehH
Confidence 5799999999999975433679999422 1 122234456777776655422 233 34555666778999
Q ss_pred ecc
Q 021855 83 DLL 85 (306)
Q Consensus 83 e~~ 85 (306)
|++
T Consensus 80 EdL 82 (370)
T TIGR01767 80 EDL 82 (370)
T ss_pred hhC
Confidence 988
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0055 Score=53.14 Aligned_cols=138 Identities=17% Similarity=0.253 Sum_probs=76.7
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCC-CCCccee------eceeCceeEEEEec
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIPNIKW------YGVDGEDNVLVLDL 84 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~~~------~~~~~~~~~lv~e~ 84 (306)
.+.++.|....+|++.. ++..+++|+............|..++..|.... .++.+.. .....+..++++++
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 56677777789998864 234577898765433445666777887775422 1233211 11223456889999
Q ss_pred cCC-CH-----H------HHHHH---hcCCCCH-------HHHH----------------HHHHHHHHHHHHHHH-----
Q 021855 85 LGP-SL-----E------DLFVY---CRRKFSL-------KTVL----------------MLADQMIARIEYVHS----- 121 (306)
Q Consensus 85 ~~~-~l-----~------~~~~~---~~~~~~~-------~~~~----------------~~~~qi~~~L~~LH~----- 121 (306)
+.| .+ . ..+.. ....++. ...+ .....+...+.++..
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 843 21 1 11110 0111100 0000 001123334555532
Q ss_pred --cCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 122 --RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 122 --~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
.+++|+|+.+.|++++ .++...++||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 5899999999999994 55666899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00084 Score=66.02 Aligned_cols=194 Identities=15% Similarity=0.099 Sum_probs=119.9
Q ss_pred HHHHHHHHhCCCCCCcceeeceeCcee----EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Q 021855 52 EAKVYKILQGGSGIPNIKWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126 (306)
Q Consensus 52 e~~~l~~l~~~~~~~~~~~~~~~~~~~----~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H 126 (306)
|...+..+.| .+...+..|....... .+..+++ +.++...+.. ....+....+.+..++.+||.++|+....|
T Consensus 232 e~~~l~k~~~-~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 232 ELESLSKIAH-DNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHhhcc-ccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 4445555555 4444444443322111 1223455 5566666654 456888899999999999999999997666
Q ss_pred cCCCCCceeeccCCCcceEEEE--eeccccccCCCCCCccccccCCccccccccccCcccccCCCCCc--hhhHHHHHHH
Q 021855 127 RDIKPDNFLMGLGRKANQVYII--DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR--RDDLESLGYV 202 (306)
Q Consensus 127 ~dlkp~Nilv~~~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~sDiwslG~i 202 (306)
.-|..+...-...+..+.+..+ ||+.+..+....... ....+.-+-+||......... ..|+|.+|..
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--------~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--------SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCcccch--------hhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 6665553322222466677666 888887765544321 223344566777776655443 4799999999
Q ss_pred HHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 203 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 203 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
...+..|..+-.... .... .++ ............+|+.-++++|+++.+++..
T Consensus 382 ~~~~~~~~~i~~~~~------~~~~--------~l~---~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA------VPVS--------LLD---VLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCccccccc------chhh--------hhc---cccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 999888764432110 0000 001 1111257788999999999999999999874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.007 Score=53.39 Aligned_cols=138 Identities=15% Similarity=0.195 Sum_probs=78.3
Q ss_pred EeeeecccCccEEEEEEEcC----CCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 11 LGRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~----~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
-...+..|-...+|++.... +++.+++|+...... .-+..+|..+++.+.....-+.+...+..+ .+++|+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 34455558888999987532 246789998765422 123467889999888766666665544332 467777
Q ss_pred CC-CHHH-----------H---HHHh-cCC------CC-HHHHHHHHHH-----------------HHHHHHHHH-----
Q 021855 86 GP-SLED-----------L---FVYC-RRK------FS-LKTVLMLADQ-----------------MIARIEYVH----- 120 (306)
Q Consensus 86 ~~-~l~~-----------~---~~~~-~~~------~~-~~~~~~~~~q-----------------i~~~L~~LH----- 120 (306)
.+ ++.. + +... ... .+ .+.+..+..+ +...+..|.
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 32 3321 0 1110 000 11 1222222211 111122222
Q ss_pred ---HcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 121 ---SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 121 ---~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...++|+|+.+.|||+. +.++.+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 12589999999999994 235789999998874
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0085 Score=52.22 Aligned_cols=73 Identities=11% Similarity=0.086 Sum_probs=42.8
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCC-CCCccee------eceeCceeEEEEec
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIPNIKW------YGVDGEDNVLVLDL 84 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~~~------~~~~~~~~~lv~e~ 84 (306)
.+.++.|....+|..... +..+++|+.. .........+..++..|.... .++.+.. +....+..++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 355667777789988642 3368889876 333344555677777775422 1233221 11234456889999
Q ss_pred cCC
Q 021855 85 LGP 87 (306)
Q Consensus 85 ~~~ 87 (306)
..|
T Consensus 104 l~G 106 (319)
T PRK05231 104 LEG 106 (319)
T ss_pred cCC
Confidence 844
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0012 Score=59.65 Aligned_cols=162 Identities=19% Similarity=0.144 Sum_probs=95.9
Q ss_pred hhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Q 021855 48 QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127 (306)
Q Consensus 48 ~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~ 127 (306)
.......+++.+.|.+...++..-........+|+|+++.++.+...... +...... +||
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~------------------~~~ 87 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL------------------AHG 87 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc------------------ccc
Confidence 45556778888888665555544433444578999999999999887522 2111110 343
Q ss_pred CCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHH
Q 021855 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207 (306)
Q Consensus 128 dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~ 207 (306)
-+ +.||+. .+| .+... | | -+.++|+||||+|.++.++.
T Consensus 88 ~~-~~~~~~----------~td-~~~t~-----------------------~--~-----~~~~pKsdVwsl~~i~~el~ 125 (725)
T KOG1093|consen 88 VL-HLNIIY----------ITD-HFLTK-----------------------Y--P-----SPIGPKSDVWSLGFIILELY 125 (725)
T ss_pred cc-eehhhh----------ccc-ccccc-----------------------C--C-----CCCCcchhhhhHHHHHHHHH
Confidence 22 233333 222 11000 0 0 01124999999999999999
Q ss_pred hCCCCCCCchhhhhHHHHHHHhhcccccch----HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 208 RGSLPWQGLKAATKKQKYDKICEKKVSTPI----EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 208 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.|...+......+....+.+.......... ..+--.++.....+..+|+...|..||...++.+
T Consensus 126 L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 126 LGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 999888765554444444333222211110 1111245677889999999999999997776654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0033 Score=54.32 Aligned_cols=70 Identities=14% Similarity=0.076 Sum_probs=45.4
Q ss_pred eeeecccCccEEEEEEEcC------CCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 12 GRKIGSGSFGEIFLASHVD------TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~------~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
++.+..|-...+|++.... +++.+++|+...... ..+..+|..++..+......+.+.....+ .++++|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 3556667777999887532 257889998765432 24567888889888765555555444432 246777
Q ss_pred c
Q 021855 85 L 85 (306)
Q Consensus 85 ~ 85 (306)
+
T Consensus 79 i 79 (302)
T cd05156 79 I 79 (302)
T ss_pred e
Confidence 6
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0016 Score=52.07 Aligned_cols=97 Identities=21% Similarity=0.264 Sum_probs=71.4
Q ss_pred HHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccC-CCHHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---C
Q 021855 51 YEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG-PSLEDL---FVYCRRKFSLKTVLMLADQMIARIEYVHSR---G 123 (306)
Q Consensus 51 ~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~---~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ 123 (306)
.|.-++..+.+..+++.+.+.. ..+++.|+.+ +++... +.. -...++..+.+++.++++.+.+|+.. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 4778888888866666654443 2457888885 444321 111 12358899999999999999999973 4
Q ss_pred ccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 124 i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
+.-.|++|+|+-++ +++.+|++|......
T Consensus 83 ~~lcDv~~~nfgv~---~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVN---DDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEe---CCCcEEEEechhcch
Confidence 78889999999994 789999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0076 Score=53.57 Aligned_cols=72 Identities=22% Similarity=0.278 Sum_probs=46.8
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEcc----C----CCCchhhHHHHHHHHHHhCC--CCCCcceeeceeCceeEEE
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIEN----S----GTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~----~----~~~~~~~~~e~~~l~~l~~~--~~~~~~~~~~~~~~~~~lv 81 (306)
.+.||.|....||++.+...++.++||.-. . +....+...|...|+..... ..+|.+ +..+.....++
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~v--y~~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKV--YLFDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeE--EEECcHHhhHH
Confidence 678999999999999874335678999422 1 11223455677788776542 234444 44556667788
Q ss_pred Eecc
Q 021855 82 LDLL 85 (306)
Q Consensus 82 ~e~~ 85 (306)
||++
T Consensus 112 MEdL 115 (409)
T PRK12396 112 MEDL 115 (409)
T ss_pred HHhC
Confidence 8887
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0013 Score=56.40 Aligned_cols=133 Identities=20% Similarity=0.312 Sum_probs=89.4
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEcc----------CCC---------C-----chhhHHHHHHHHHHhCC-C
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----------SGT---------K-----HPQLLYEAKVYKILQGG-S 63 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~----------~~~---------~-----~~~~~~e~~~l~~l~~~-~ 63 (306)
+.++.+||-|--+.||.+-+. .|++.++|.-. ..+ . +-...+|...++.|..+ .
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 568899999999999999864 47778888411 111 0 11346788888888652 2
Q ss_pred CCCcceeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc
Q 021855 64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (306)
Q Consensus 64 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~ 142 (306)
.+|... +....++|||+. +-.|..... -.+.+. +...++.-+--|-..|++|||.+-=||++ +++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~----v~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd 238 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH----VEDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD 238 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeee----cCChHH---HHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence 333222 334578899988 445543321 123333 34455555677889999999999999999 478
Q ss_pred ceEEEEeecccccc
Q 021855 143 NQVYIIDFGLAKKY 156 (306)
Q Consensus 143 ~~~kl~Dfg~~~~~ 156 (306)
+.++++||--..+.
T Consensus 239 ~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 239 DKIVVIDFPQMVST 252 (465)
T ss_pred CCEEEeechHhhcc
Confidence 99999999866543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0051 Score=52.46 Aligned_cols=50 Identities=10% Similarity=0.121 Sum_probs=30.9
Q ss_pred eeeecccCcc---EEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCC
Q 021855 12 GRKIGSGSFG---EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62 (306)
Q Consensus 12 ~~~lg~g~~~---~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~ 62 (306)
...+..++.| .|+.+. ...|..+++|............+|..++..+...
T Consensus 13 ~~~~~~~~~g~~~~v~~i~-~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 13 PETLSLNESGLDFQVVFAK-DTDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceecCCcceeEEEEEE-cCCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence 3344444444 455442 2346788889775444445678899999999754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.014 Score=51.19 Aligned_cols=70 Identities=14% Similarity=0.083 Sum_probs=43.6
Q ss_pred eeeecccCccEEEEEEEcCC---CceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 12 GRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
.+.|..|-...+|++..... +..|++|+...... .-+..+|..+++.+.....-|.+..++..+ ++.+|+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhh
Confidence 44454577778998865432 33788998765432 123467888999888766656665444322 467776
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.032 Score=49.95 Aligned_cols=73 Identities=14% Similarity=0.282 Sum_probs=45.9
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEcc-----CCC----CchhhHHHHHHHHHHhCC--CCCCcceeeceeCceeE
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGT----KHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~-----~~~----~~~~~~~e~~~l~~l~~~--~~~~~~~~~~~~~~~~~ 79 (306)
..+.+|.|....||++.+. +..++||.-. ... .......|...|..+... ..+|.+..+ +++..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~--ded~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF--DRTMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE--CCCCCE
Confidence 4778899999999999863 4568899644 111 223344566666665532 234444444 446678
Q ss_pred EEEeccCC
Q 021855 80 LVLDLLGP 87 (306)
Q Consensus 80 lv~e~~~~ 87 (306)
++||++.+
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999844
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.027 Score=48.73 Aligned_cols=30 Identities=23% Similarity=0.500 Sum_probs=25.2
Q ss_pred CccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 123 ~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
.++|||+.+.|+++. ..+.+=+.||+.+..
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEecccccc
Confidence 489999999999994 555588999998864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.013 Score=51.21 Aligned_cols=73 Identities=21% Similarity=0.282 Sum_probs=57.2
Q ss_pred eCceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 74 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
...+.|+++++-|+++.-. .....+++..++++.+.-+.-+.++ ..-||||.-.||++ +.|.+.|+||.+
T Consensus 297 e~~y~yl~~kdhgt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d~GnvtLIDfkl 367 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----DEGNVTLIDFKL 367 (488)
T ss_pred CceEEEEEEecCCceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----ecCceEEEEeee
Confidence 3445678888888777532 1245677888888888888777765 68999999999999 499999999999
Q ss_pred ccc
Q 021855 153 AKK 155 (306)
Q Consensus 153 ~~~ 155 (306)
++.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 983
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.013 Score=47.79 Aligned_cols=30 Identities=40% Similarity=0.687 Sum_probs=20.5
Q ss_pred CccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 123 ~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
.++|+||.|.||++. +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEET--SSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEec--cCCCeEEEecHHHHh
Confidence 489999999999993 378999999998874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.04 Score=47.17 Aligned_cols=74 Identities=19% Similarity=0.256 Sum_probs=49.2
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHh--CCCCCCcceeeceeCceeEEEEecc
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
.+-.+.++.|..+.+|... .+++.+.+|+-. ......+..|..-|+.|. ..-.+|.+..++......++++||.
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3456788889999999886 567788899766 444566888999999994 3445667777777667779999998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.26 Score=44.12 Aligned_cols=71 Identities=17% Similarity=0.138 Sum_probs=43.8
Q ss_pred eeeecccCccEEEEEEEcCCC-c-----eEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 12 GRKIGSGSFGEIFLASHVDTN-E-----IVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~-~-----~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
.+.+..|-...+|++...... . .|++++..... ..-+..+|..+++.+.....-|.+...+.. ++++||
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 445555888899998754321 1 24555432211 112346688999999887777777666543 488888
Q ss_pred cC
Q 021855 85 LG 86 (306)
Q Consensus 85 ~~ 86 (306)
..
T Consensus 131 Ie 132 (383)
T PTZ00384 131 VE 132 (383)
T ss_pred ec
Confidence 83
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.0012 Score=66.94 Aligned_cols=129 Identities=11% Similarity=-0.017 Sum_probs=91.5
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc-C----ccccCCCCCceeeccCCCcceEE
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHSR-G----FLHRDIKPDNFLMGLGRKANQVY 146 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~-~----i~H~dlkp~Nilv~~~~~~~~~k 146 (306)
...+.+++++ +|.+.+.+..... .++...+.....+...+..-+|+. + -+|++||+-|.++ ..+..++
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~ 1380 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYNVK 1380 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCccc
Confidence 3456778887 8888887764322 233333333333336666666643 2 6999999999999 5889999
Q ss_pred EEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 021855 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214 (306)
Q Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~ 214 (306)
+.++|+.+....... ..+...+++.|++|++...-.++.++|+|+.|+.+|....|..+|-
T Consensus 1381 ~gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1381 LGKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred ccccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 999999983222111 2235677888999988877788888999999999999999988874
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.084 Score=53.38 Aligned_cols=47 Identities=15% Similarity=0.140 Sum_probs=31.7
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhC
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~ 61 (306)
+.|+ |....+|++.. .+++.+++|+.+..........|...+..|..
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~ 77 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAA 77 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHh
Confidence 5664 45678888864 35668999999876554455556667766654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.25 Score=43.17 Aligned_cols=136 Identities=18% Similarity=0.200 Sum_probs=77.3
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcce-------eeceeCc--eeEEEEe
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK-------WYGVDGE--DNVLVLD 83 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~-------~~~~~~~--~~~lv~e 83 (306)
..|.+ .-..+|..... +..+++|+........+...|...+.-|.......-.. ....-.. ..+-+++
T Consensus 32 ~~l~s-~eN~~f~~~~~--~g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 32 RGLNS-EENSNFRVQTE--DGRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccccc-ccCceEEEEec--CCCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 34444 55678888653 34458999888755566777888888887543321111 1112223 5667778
Q ss_pred ccCCCHHH------HHHHh----------cCCC-----------CHH-------------HHHHHHHHHHHHHHHHHHc-
Q 021855 84 LLGPSLED------LFVYC----------RRKF-----------SLK-------------TVLMLADQMIARIEYVHSR- 122 (306)
Q Consensus 84 ~~~~~l~~------~~~~~----------~~~~-----------~~~-------------~~~~~~~qi~~~L~~LH~~- 122 (306)
|++|.... .+... ...+ .+. .-.....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 88443222 11110 0111 111 0111345555556665542
Q ss_pred -------C--ccccCCCCCceeeccCCCcc-eEEEEeecccc
Q 021855 123 -------G--FLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154 (306)
Q Consensus 123 -------~--i~H~dlkp~Nilv~~~~~~~-~~kl~Dfg~~~ 154 (306)
+ ++|+|+.|.||++. .+. .+-++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFD---DDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEc---CCCCeeeEEEccccc
Confidence 3 99999999999993 444 47899999874
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.4 Score=43.82 Aligned_cols=72 Identities=18% Similarity=0.065 Sum_probs=45.5
Q ss_pred EeeeecccCccEEEEEEEcC--------CCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 11 LGRKIGSGSFGEIFLASHVD--------TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
-.+.|..|-...+|++.... +++.|++|+...... --....|..+++.+.....-+.+...+. .+.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 45666667777889887542 146788998765432 1234668888888887666566554332 2356
Q ss_pred EeccC
Q 021855 82 LDLLG 86 (306)
Q Consensus 82 ~e~~~ 86 (306)
.+|..
T Consensus 185 ~efi~ 189 (442)
T PTZ00296 185 EEWLY 189 (442)
T ss_pred EEeeC
Confidence 77773
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.091 Score=42.87 Aligned_cols=86 Identities=19% Similarity=0.239 Sum_probs=55.0
Q ss_pred hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--Cc
Q 021855 47 PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--GF 124 (306)
Q Consensus 47 ~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~i 124 (306)
.-+..+..+++++.+ +..+. ..+...+.++.|.|...-.-. .. .+.+ =+.+|.-+|+. +.
T Consensus 103 ~~y~nky~v~ArmhG---ilrL~--NDn~~~yGvIlE~Cy~~~i~~----------~N--~i~a-gi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 103 ALYFNKYRVFARMHG---ILRLK--NDNNYKYGVILERCYKIKINF----------SN--FITA-GIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhhHHHHhhh---eeEee--cCCCceeEEEEeeccCcccch----------hH--HHHH-hHHHHHHhhccCCCe
Confidence 346667888887754 22222 224445668888884221101 01 1111 14667788844 69
Q ss_pred cccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 125 ~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
+|||-.|+|||- |..|.+||.|-++-
T Consensus 165 lHGD~np~NiM~---D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 165 LHGDCNPDNIMC---DKFGYLKLVDPVCL 190 (308)
T ss_pred ecCCCChhheee---cCCCCEEecChhhh
Confidence 999999999998 79999999997764
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.10 E-value=1.1 Score=39.14 Aligned_cols=68 Identities=13% Similarity=0.078 Sum_probs=39.3
Q ss_pred cCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcce-------eeceeCceeEEEEeccCC
Q 021855 18 GSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIK-------WYGVDGEDNVLVLDLLGP 87 (306)
Q Consensus 18 g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~-------~~~~~~~~~~lv~e~~~~ 87 (306)
+....||.... .++..+++|+..... .......|...+..|.... ++... .....++..+.++++.+|
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~g-ipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAE-IPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCC-CCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 45567888864 345678999876443 3344567888888776522 22111 112223456778887743
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.083 Score=45.63 Aligned_cols=71 Identities=20% Similarity=0.201 Sum_probs=43.1
Q ss_pred eEEEEeccCCCHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH----cCccccCCCCCceeeccCCCcceEEEE
Q 021855 78 NVLVLDLLGPSLEDLFV----YCRRKFSLKTVLMLADQMIARIEYVHS----RGFLHRDIKPDNFLMGLGRKANQVYII 148 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~LH~----~~i~H~dlkp~Nilv~~~~~~~~~kl~ 148 (306)
..++++.+.++...+-. ..+-.--.+.+..+..||+.-.-...+ .+.+|-||||+|||+-.++..-.+++.
T Consensus 250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~ 328 (444)
T PHA03111 250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLK 328 (444)
T ss_pred cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEEC
Confidence 46777777544433311 112122355677888888776644533 368999999999999754433444433
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.15 Score=45.55 Aligned_cols=59 Identities=24% Similarity=0.256 Sum_probs=41.8
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCceeec
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMG 137 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dlkp~Nilv~ 137 (306)
..+++.+|. |-++..++... ..+++....++.-.+.||..+- --+++|.|+.|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 456777787 66777777643 3455566666666666665443 45899999999999995
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.12 Score=44.64 Aligned_cols=29 Identities=45% Similarity=0.832 Sum_probs=24.2
Q ss_pred cCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 122 ~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
.+++|||+.+.||++. . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 4789999999999993 3 667899999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 306 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-146 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-127 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-127 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-127 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 4e-97 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 5e-97 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-95 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 7e-95 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 8e-95 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 6e-94 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-92 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-26 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 2e-25 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 2e-25 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 9e-25 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 9e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-04 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-04 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 542 bits (1397), Expect = 0.0
Identities = 233/304 (76%), Positives = 272/304 (89%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE VA+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+GIPN++W+GV+G+ NVLV+DLLGPSLEDLF +C RK SLKTVLMLADQMI R+E+VH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAKKYRD +T++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKY+KI EKKV+T IE L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
C+ +P EFASYFHYC+SL FD +PDY +LKRLF DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 TKSQ 304
+
Sbjct: 301 ASAP 304
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 529 bits (1364), Expect = 0.0
Identities = 163/305 (53%), Positives = 222/305 (72%), Gaps = 3/305 (0%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
++G +++G+KIG G+FGE+ L ++ TNE VA+K+E ++ PQL E + YK L
Sbjct: 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS 63
Query: 62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
G GIP + ++G G+ N +VL+LLGPSLEDLF C R FSLKTVLM+A Q+I+R+EYVHS
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 122 RGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
+ ++RD+KP+NFL+G + ++IIDF LAK+Y DP T +HIPYRE+K+LTGTARY
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
S NTHLG EQSRRDDLE+LG++ +YFLRGSLPWQGLKA T K++Y KI + K +TPIEV
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243
Query: 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
LC++ P E A+Y Y + L F ++PDY +L++LF DLF R+GY FD+ +DW +
Sbjct: 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPV 302
Query: 300 KTKSQ 304
Q
Sbjct: 303 GAVQQ 307
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 525 bits (1354), Expect = 0.0
Identities = 205/294 (69%), Positives = 255/294 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 523 bits (1348), Expect = 0.0
Identities = 166/295 (56%), Positives = 212/295 (71%), Gaps = 2/295 (0%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
++GV YK+GR+IG GSFG IF +++ N+ VA+K E + PQL E + YK+L
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
G +GIPN+ ++G +G NVLV+DLLGPSLEDL C RKFS+KTV M A QM+AR++ +H
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 121 SRGFLHRDIKPDNFLMGL--GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ ++RDIKPDNFL+G + AN +Y++DFG+ K YRDP T +HIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y S NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQGLKAAT KQKY++I EKK STP+
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293
LC P EF Y HY ++L FD PDY +L+ LF + R D FDW +L
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 477 bits (1230), Expect = e-171
Identities = 83/330 (25%), Positives = 145/330 (43%), Gaps = 29/330 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKHPQLLYEAKV 55
+ + +K+G IG G FG I+LA V ++ VK+E S + L E K
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS--DNGPLFTELKF 86
Query: 56 YKILQ--------------GGSGIPNIKWYGVDGED----NVLVLDLLGPSLEDLFVYCR 97
Y+ G+P G+ ++ +++D G L+ ++
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 98 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
++FS KTVL L+ +++ +EY+H ++H DIK N L+ +QVY++D+GLA +Y
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLAYRYC 205
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217
++ + GT + S + H G+ SRR DLE LGY ++ +L G LPW+
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265
Query: 218 AATKKQKYDKICEKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274
K + KI ++ + C + P E A Y + L + ++P Y L+ +
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325
Query: 275 DLFSREGYDFDFVFDWTILKYQQTQKTKSQ 304
G D D ++++ +
Sbjct: 326 QGLKAIGSKDDGKLDLSVVENGGLKAKTIT 355
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 457 bits (1177), Expect = e-163
Identities = 89/316 (28%), Positives = 142/316 (44%), Gaps = 33/316 (10%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQLLYEAKVYK 57
++ + G ++ LG+KIGSG FG I+LA + E A VK+E ++ L E K Y+
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY--QENGPLFSELKFYQ 88
Query: 58 ILQGGS--------------GIPNIKWYGV----DGEDNVLVLDLLGPSLEDLFVYCRRK 99
+ GIP G+ +V++ LG L+ +
Sbjct: 89 RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-T 147
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F TVL L +M+ +EY+H ++H DIK N L+G +QVY+ D+GL+ +Y
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQVYLADYGLSYRYCPN 206
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL--- 216
++ K GT + S + H G+ SRR D+E LGY +L +L G LPW+
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266
Query: 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
A + K + + E S S E A + SL +D++P+Y LK++ +
Sbjct: 267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326
Query: 277 FSREGYDFDFVFDWTI 292
G D++
Sbjct: 327 GIPLGP-----LDFST 337
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 440 bits (1134), Expect = e-157
Identities = 68/317 (21%), Positives = 121/317 (38%), Gaps = 33/317 (10%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT--------NEIVAVKIENSGT----------- 44
G ++KL + G ++ A+ T + ++K++
Sbjct: 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR 98
Query: 45 --KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED-NVLVLDLLGPSLEDLFVYC-RRKF 100
K Q+ K+Y IP +GV + LVL LG SL+ +
Sbjct: 99 AAKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVL 156
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
S ++VL +A +++ +E++H ++H ++ +N + + +QV + +G A +Y
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCP-- 213
Query: 161 TNRHIPYRENKN--LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
+ +H+ Y E G + S + H G SRR DL+SLGY +L +L G LPW
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273
Query: 219 ATKKQKYDKICEKKVSTPIEVLCK---SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
T+ K P C Y +LT++++P Y L+
Sbjct: 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333
Query: 276 LFSREGYDFDFVFDWTI 292
L +
Sbjct: 334 LLQDLRVSPYDPIGLPM 350
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 53/258 (20%), Positives = 92/258 (35%), Gaps = 43/258 (16%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 82
Query: 59 LQGGSGIPN---IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
LQ + I+ Y + D +V++ L ++ M+
Sbjct: 83 LQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNML 137
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ +H G +H D+KP NFL+ G + +IDFG+A + + TT+ +
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQ 188
Query: 174 TGTARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAA 219
GT Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQI--I 243
Query: 220 TKKQKYDKICEKKVSTPI 237
+ K I +
Sbjct: 244 NQISKLHAIIDPNHEIEF 261
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 53/256 (20%), Positives = 91/256 (35%), Gaps = 39/256 (15%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 59 LQGGSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
LQ S I + Y + D +V++ L ++ M+
Sbjct: 64 LQQHS--DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEA 120
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
+ +H G +H D+KP NFL+ + +IDFG+A + + TT+ + G
Sbjct: 121 VHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK-----DSQVG 171
Query: 176 TARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAATK 221
T Y N + S + D+ SLG Y + Y G P+Q + +
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII--NQ 226
Query: 222 KQKYDKICEKKVSTPI 237
K I +
Sbjct: 227 ISKLHAIIDPNHEIEF 242
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 45/269 (16%), Positives = 76/269 (28%), Gaps = 52/269 (19%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQ 60
K KL + G +FL V+ E A+K+ ENS ++ +L L
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 61 G--------------------GSGIPNIKWYGVDGEDN-----VLVLDLLGPSLEDLF-- 93
G P +D +L++ LE LF
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 94 ----VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149
R + + +L Q+I + S+G +H PDN + ++ + D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGD 237
Query: 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYAS--CNTHLGIEQSRRDDLESLGYVLLYFL 207
K + YA + + LG +
Sbjct: 238 VSALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 208 RGSLPWQGLKAATKKQKYDKICEKKVSTP 236
LP+ GL K + + + T
Sbjct: 288 CLFLPF-GLVTPGIKGSWKRPSLRVPGTD 315
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 51/258 (19%), Positives = 90/258 (34%), Gaps = 43/258 (16%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 59 LQGGSGIPN---IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
LQ + I+ Y + D +V++ L ++ M+
Sbjct: 111 LQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNML 165
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ +H G +H D+KP NFL+ + +IDFG+A + + TT+ +
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK-----DSQ 216
Query: 174 TGTARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAA 219
G Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQI--I 271
Query: 220 TKKQKYDKICEKKVSTPI 237
+ K I +
Sbjct: 272 NQISKLHAIIDPNHEIEF 289
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 35/272 (12%), Positives = 72/272 (26%), Gaps = 45/272 (16%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQ 60
G +G A+ +T E V + Q+ E ++L+
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 61 GG---------------------SGIPNIKWYGVDGEDN-----VLVLDLLGPSLEDLFV 94
G + +D D + + +L+
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 95 Y------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
+ L L Q+I + +H G +H ++P + ++ + V++
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLT 248
Query: 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FL 207
F + + E L S + + D +LG +++Y
Sbjct: 249 GFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIW 307
Query: 208 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
LP + I + P V
Sbjct: 308 CADLPITK---DAALGGSEWIFRSCKNIPQPV 336
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 34/286 (11%), Positives = 76/286 (26%), Gaps = 61/286 (21%)
Query: 1 MERIIGVKYKL---GRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYE 52
+E +G + + G +G A+ +T E V + Q+ E
Sbjct: 69 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 128
Query: 53 AKVYKILQG---------------------GSGIPNIKWYGVDGEDN-----VLVLDLLG 86
++L+G + +D D + +
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 188
Query: 87 PSLEDLFVYCRRK------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140
+L+ L L Q+I + +H G +H ++P + ++
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--- 245
Query: 141 KANQVYIIDFGLAKKYRDPT-TNRHIPYRENKNLTGTARYASCNTHLGIEQ-----SRRD 194
+ V++ F + + + + + +
Sbjct: 246 QRGGVFLTGFEHLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAF 298
Query: 195 DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
D +LG + +Y+ LP + I + P V
Sbjct: 299 DTWTLG-LAIYWIWCADLPNTD---DAALGGSEWIFRSCKNIPQPV 340
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 61/305 (20%), Positives = 113/305 (37%), Gaps = 50/305 (16%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ + L +G G+ +F H T ++ A+K+ + + E +V K
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 59 LQGGSGIPNI-KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSL--KTVLMLAD 110
L NI K + ++ E VL+++ SL + + L L++
Sbjct: 64 LNH----KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRE 169
++ + ++ G +HR+IKP N + +G VY + DFG A++ D
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----------- 168
Query: 170 NKNLT---GTARYAS--------CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
++ GT Y + DL S+G V Y GSLP++ +
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFE 227
Query: 218 AA-TKKQKYDKICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274
K+ KI K S I + ++ P +++ SL+ L+ L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-------RGLQVLLT 280
Query: 275 DLFSR 279
+ +
Sbjct: 281 PVLAN 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 56/277 (20%), Positives = 102/277 (36%), Gaps = 41/277 (14%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ + L +G G+ +F H T ++ A+K+ + + E +V K
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 59 LQGGSGIPNI-KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSL--KTVLMLAD 110
L NI K + ++ E VL+++ SL + + L L++
Sbjct: 64 LNH----KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRE 169
++ + ++ G +HR+IKP N + +G VY + DFG A++ D
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----------- 168
Query: 170 NKNLT---GTARYAS----CNTHLGIEQSRRDDLE----SLGYVLLY-FLRGSLPWQGLK 217
++ GT Y L + ++ S+G V Y GSLP++ +
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFE 227
Query: 218 AA-TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFH 253
K+ KI K S I + K+
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD 264
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 62/266 (23%), Positives = 102/266 (38%), Gaps = 70/266 (26%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEA 53
E +Y+LG +G G FG +F + VA+K+ + + E
Sbjct: 27 EAFEA-EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 54 KVYKILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVY-----------CRRK 99
+ + G G P + + E +LVL+ P+ +DLF Y R
Sbjct: 86 ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA-QDLFDYITEKGPLGEGPSRCF 144
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F Q++A I++ HSRG +HRDIK +N L + + +IDFG D
Sbjct: 145 FG---------QVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHD- 192
Query: 160 TTNRHIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GS 210
+ T GT Y+ S + + + + SLG +LLY + G
Sbjct: 193 -----------EPYTDFDGTRVYSPPEWISRHQYHALPA----TVWSLG-ILLYDMVCGD 236
Query: 211 LPWQGLKAATKKQKYDKICEKKVSTP 236
+P++ +I E ++ P
Sbjct: 237 IPFER---------DQEILEAELHFP 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 47/251 (18%), Positives = 89/251 (35%), Gaps = 29/251 (11%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGS 63
Y +K+G G F + L + A+K + + EA ++++
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-- 85
Query: 64 GIPNI-KWYGV-----DGEDNV-LVLDL-LGPSLEDLFVYCRRK---FSLKTVLMLADQM 112
PNI + + L+L +L + + K + +L L +
Sbjct: 86 --PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH--IPYREN 170
+E +H++G+ HRD+KP N L+G Q ++D G + + ++
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 171 KNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYD 226
T Y + + R D+ SLG +LY + G P+ K
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDM--VFQKGDSVA 257
Query: 227 KICEKKVSTPI 237
+ ++S P
Sbjct: 258 LAVQNQLSIPQ 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 44/199 (22%), Positives = 77/199 (38%), Gaps = 32/199 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
++ +G G+FG++ A + + A+K I ++ K +L E + L
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH----Q 62
Query: 67 NI-KWYGVDGEDNV---------------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLA 109
+ ++Y E + ++ +L DL L
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP--- 166
Q++ + Y+HS+G +HRD+KP N + ++ V I DFGLAK +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 167 -YRENKNLT---GTARYAS 181
+ NLT GTA Y +
Sbjct: 180 LPGSSDNLTSAIGTAMYVA 198
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 60/242 (24%), Positives = 97/242 (40%), Gaps = 34/242 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQG 61
+K+G +G GSF ++ A + T VA+K+ +G ++ E K++ L+
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLKH 70
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
P+I + Y + + V LVL++ + + FS Q+I +
Sbjct: 71 ----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--G 175
Y+HS G LHRD+ N L+ + + I DFGLA + + P + T G
Sbjct: 127 YLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHY---------TLCG 174
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVS 234
T Y S D+ SLG + Y L G P+ T K +K+
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVVLADYE 230
Query: 235 TP 236
P
Sbjct: 231 MP 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 42/225 (18%), Positives = 84/225 (37%), Gaps = 20/225 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
+ + + + +G G+ G I + N VAVK E + +L+
Sbjct: 18 VVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP-ECFSFADREVQ---LLR 72
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
PN+ +++ + ++L +L++ + L Q + +
Sbjct: 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
++HS +HRD+KP N L+ + + I DFGL KK + + + G
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPG 188
Query: 176 TARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL--RGSLPWQG 215
T + + + + D+ S G + Y++ GS P+
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-24
Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 45/236 (19%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEA 53
E + +Y++G +GSG FG ++ V N VA+K ++ E
Sbjct: 39 EPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 54 KVYKILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL--ML 108
+ K + SG + + + VL+L+ P +DLF + + +L+ L
Sbjct: 98 VLLKKVS--SGFSGVIRLLDWFERPDSFVLILERPEPV-QDLFDFITERGALQEELARSF 154
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
Q++ + + H+ G LHRDIK +N L + ++ +IDFG +D
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKD---------- 202
Query: 169 ENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQG 215
T GT Y+ + + G + SLG +LLY + G +P++
Sbjct: 203 --TVYTDFDGTRVYSPPEWIRYHRYHGRSA----AVWSLG-ILLYDMVCGDIPFEH 251
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-24
Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 45/249 (18%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKIL 59
+Y GR +G G F + F S DT E+ A KI + ++ E +++ L
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSL 98
Query: 60 QGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
++ ++G + D V +VL+L SL +L R+ + Q++
Sbjct: 99 AH----QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLG 153
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT- 174
+Y+H +HRD+K N L V I DFGLA K +
Sbjct: 154 CQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATKVEYDGERKK---------VL 201
Query: 175 -GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDK 227
GT Y S H S D+ S+G ++Y L G P++ + K+ Y +
Sbjct: 202 CGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKETYLR 252
Query: 228 ICEKKVSTP 236
I + + S P
Sbjct: 253 IKKNEYSIP 261
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-24
Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 45/247 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQG 61
+Y GR +G G F + F S DT E+ A KI + ++ E +++ L
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAH 74
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
++ ++G + D V +VL+L SL +L R+ + Q++ +
Sbjct: 75 ----QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQ 129
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--G 175
Y+H +HRD+K N L V I DFGLA K + G
Sbjct: 130 YLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATKVEYDGERKK---------VLCG 177
Query: 176 TARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKIC 229
T Y S H S D+ S+G ++Y L G P++ + K+ Y +I
Sbjct: 178 TPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKETYLRIK 228
Query: 230 EKKVSTP 236
+ + S P
Sbjct: 229 KNEYSIP 235
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 39/257 (15%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ G +++ ++G+G FG + H DT E VA+K E S + E ++ K
Sbjct: 10 TQTCG-PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68
Query: 59 LQGGSGIPNI---------KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSL--KTVL 106
L PN+ + +L ++ G L L +
Sbjct: 69 LNH----PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
L + + + Y+H +HRD+KP+N ++ G + IID G AK+
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-------- 176
Query: 167 YRENKNLT---GTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKK 222
+ T GT +Y + + + D S G L + G P+ +
Sbjct: 177 ---GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG-TLAFECITGFRPFLP---NWQP 229
Query: 223 QKYDKICEKKVSTPIEV 239
++ +K + I V
Sbjct: 230 VQWHGKVREKSNEHIVV 246
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 37/239 (15%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
E+ + + +G GS G + VAVK L E K +L
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-FCDIALMEIK---LLTE 64
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQM 112
PN+ ++Y + + + L+L +L+DL + + L Q+
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 113 IARIEYVHSRGFLHRDIKPDNFL----------MGLGRKANQVYIIDFGLAKKYRDPTTN 162
+ + ++HS +HRD+KP N L G + ++ I DFGL KK
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS---G 181
Query: 163 RHIPYRENKNLTGTARYA-------SCNTHLGIEQSRRDDLESLGYVLLYFL--RGSLP 212
+ N +GT+ + S N +R D+ S+G + Y++ +G P
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 35/154 (22%), Positives = 60/154 (38%), Gaps = 13/154 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
++ ++G GS+GE+F + + AVK S + P+ L E +
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG---SHEKVG 114
Query: 64 GIPNI-KWYGVDGEDNVL--VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P + E +L +L GPSL+ V + + ++H
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S+G +H D+KP N +G + + DFGL
Sbjct: 175 SQGLVHLDVKPANIFLG---PRGRCKLGDFGLLV 205
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-23
Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 35/241 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQG 61
+++GR +G G FG ++LA + I+A+K +E +G +H QL E ++ L+
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH 68
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARI 116
PNI + YG D L+L+ L ++ ++ KF + ++ +
Sbjct: 69 ----PNILRLYGYFHDATRVYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y HS+ +HRDIKP+N L+G A ++ I DFG + H P +L GT
Sbjct: 123 SYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTDLCGT 170
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
Y G + DL SLG VL Y FL G P++ A T ++ Y +I + +
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQETYKRISRVEFTF 226
Query: 236 P 236
P
Sbjct: 227 P 227
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 68/248 (27%), Positives = 117/248 (47%), Gaps = 37/248 (14%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQ 60
+ Y+ +K+GSG++GE+ L T+ A+KI S + + +LL E V K+L
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
PNI K Y + + N LV++ G L D ++ R KF+ ++ Q+++ +
Sbjct: 95 H----PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGV 149
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y+H +HRD+KP+N L+ K + I+DFGL+ + ++ K GT
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--------NQKKMKERLGT 201
Query: 177 ARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICE 230
A Y + E R+ D+ S+G V+L+ L G P+ G T ++ K+ +
Sbjct: 202 AYYIA------PEVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILRKVEK 251
Query: 231 KKVSTPIE 238
K +
Sbjct: 252 GKYTFDSP 259
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-23
Identities = 70/249 (28%), Positives = 108/249 (43%), Gaps = 38/249 (15%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKIL 59
+YK R +G GSFGE+ L T + AVK+ T LL E ++ K L
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 60 QGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
PNI K Y + + LV ++ G L D + R++FS + Q+++
Sbjct: 84 DH----PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSG 138
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
I Y+H +HRD+KP+N L+ K + IIDFGL+ + ++ K+ G
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--------ASKKMKDKIG 190
Query: 176 TARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKIC 229
TA Y + E D+ S G V+LY L G P+ G A + K+
Sbjct: 191 TAYYIA------PEVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDILKKVE 240
Query: 230 EKKVSTPIE 238
+ K + +
Sbjct: 241 KGKYTFELP 249
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 7e-23
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++G+G+FG + + T A K + + E + +L+
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH---- 213
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P + + D + V++ + + G L + K S + Q+ + ++H
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
++H D+KP+N + +++N++ +IDFGL P + K TGTA +A+
Sbjct: 274 NNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKVTTGTAEFAA 324
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL 207
G D+ S+G VL Y L
Sbjct: 325 PEVAEGKPVGYYTDMWSVG-VLSYIL 349
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
+Y + + +GSG+ GE+ LA T + VA+KI + E ++ K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 58 ILQGGSGIPNI-KWYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQ 111
L P I K ++ +VL+L+ G +LF V ++ T + Q
Sbjct: 71 KLNH----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQ 122
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
M+ ++Y+H G +HRD+KP+N L+ + + I DFG +K +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 35/241 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQG 61
+ +GR +G G FG ++LA I+A+K +E G +H QL E ++ L+
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLRH 73
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARI 116
PNI + Y D + L+L+ +L+ ++ +F + +++ +
Sbjct: 74 ----PNILRMYNYFHDRKRIYLMLEFA--PRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y H R +HRDIKP+N LMG ++ I DFG + H P + + GT
Sbjct: 128 HYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRRRTMCGT 175
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
Y G + DL G VL Y FL G P+ + + + + +I +
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTETHRRIVNVDLKF 231
Query: 236 P 236
P
Sbjct: 232 P 232
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
+Y + + +GSG+ GE+ LA T + VA++I + E ++ K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 58 ILQGGSGIPNI-KWYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQ 111
L P I K ++ +VL+L+ G +LF V ++ T + Q
Sbjct: 196 KLNH----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQ 247
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
M+ ++Y+H G +HRD+KP+N L+ + + I DFG +K +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 44/175 (25%), Positives = 64/175 (36%), Gaps = 22/175 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGI 65
++G GSFGE+ T AVK +E + E L
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSS---- 109
Query: 66 PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I YG E + ++LL G SL L L Q + +EY+H+
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHT 168
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
R LH D+K DN L L ++ + DFG A + + + + GT
Sbjct: 169 RRILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 48/247 (19%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
I + RK+GSG+FG++ L + +K + S Q+ E +V K L
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLAD 110
PNI K + V D + +V++ G +L + S V L
Sbjct: 80 ----PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMK 131
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
QM+ + Y HS+ +H+D+KP+N L + + IIDFGLA+ ++ +
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--------SDEHS 183
Query: 171 KNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLP-W----QGLKAA 219
N GTA Y + E +RD D+ S G V++YF L G LP + ++
Sbjct: 184 TNAAGTALYMA------PEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 220 TKKQKYD 226
++ +
Sbjct: 237 ATYKEPN 243
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 54/262 (20%), Positives = 90/262 (34%), Gaps = 75/262 (28%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----------SGTKHPQLLYEAKVYK 57
KY +GSG+FG ++ A + N+ V VK K ++ E +
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 58 ILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVY-----------CRRKFSLK 103
++ NI K + + LV++ G L+ LF + F
Sbjct: 85 RVEH----ANIIKVLDIFENQGFFQLVMEKHGSGLD-LFAFIDRHPRLDEPLASYIFR-- 137
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163
Q+++ + Y+ + +HRDIK +N + + + +IDFG A
Sbjct: 138 -------QLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLER----- 182
Query: 164 HIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 214
K GT Y N + G E ++ SLG V LY L P+
Sbjct: 183 ------GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSLG-VTLYTLVFEENPFC 231
Query: 215 GLKAATKKQKYDKICEKKVSTP 236
++ E + P
Sbjct: 232 E---------LEETVEAAIHPP 244
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-22
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 19/165 (11%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
+Y + +G GSFGE+ T + AVK+ N +L E ++ K L
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
PNI K + + + + +V +L G +LF + R++FS + Q+
Sbjct: 80 H----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ I Y+H +HRD+KP+N L+ K + IIDFGL+ ++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 32/227 (14%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
++ ++ R + G F ++ A V + A+K N K+ ++ E K L G
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH- 85
Query: 64 GIPNI----------KWYGVDGEDNVLVL-DLLGPSLEDLFVYCRRK--FSLKTVLMLAD 110
PNI K G+ L+L +L L + + S TVL +
Sbjct: 86 --PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 111 QMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
Q ++++H + +HRD+K +N L+ + + DFG A R
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 169 -----ENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL 207
E T Y + + + + D+ +LG +LY L
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLL 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 64/251 (25%), Positives = 106/251 (42%), Gaps = 43/251 (17%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
+Y + +G GSFGE+ T + AVK+ N +L E ++ K L
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
PNI K + + + + +V +L G L D + R++FS + Q+ + I
Sbjct: 80 H----PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGI 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-- 174
Y+H +HRD+KP+N L+ K + IIDFGL+ +++N +
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-----------FQQNTKMKDR 183
Query: 175 -GTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDK 227
GTA Y + E R D+ S G V+LY L G+ P+ G + +
Sbjct: 184 IGTAYYIA------PEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDILKR 233
Query: 228 ICEKKVSTPIE 238
+ K + +
Sbjct: 234 VETGKYAFDLP 244
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-22
Identities = 33/182 (18%), Positives = 75/182 (41%), Gaps = 18/182 (9%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGS 63
+ KY + +G G FG + + + K ++ GT + E + I +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-- 60
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
NI + E+ V++ + + G + + + + + ++ Q+ ++++
Sbjct: 61 --RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS H DI+P+N + R+++ + II+FG A++ + P + L Y
Sbjct: 119 HSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLK--------PGDNFRLLFTAPEY 169
Query: 180 AS 181
+
Sbjct: 170 YA 171
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-21
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 17/163 (10%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGG 62
I Y L IG GS+GE+ +A T A K I + E ++ K L
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH- 65
Query: 63 SGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIAR 115
PNI + Y + ++ LV++L G +LF V +R F + +++
Sbjct: 66 ---PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ Y H HRD+KP+NFL + + +IDFGLA +++
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-21
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
Y + ++G G+F + H T A KI N S +L EA++ + LQ
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-- 64
Query: 64 GIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARI 116
PNI + + E LV DL+ G +LF + R +S Q++ I
Sbjct: 65 --PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQILESI 118
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
Y HS G +HR++KP+N L+ K V + DFGLA + D
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 53/256 (20%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVY 56
++IG KY +G +G GS+G++ +T AVKI + E ++
Sbjct: 2 KLIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 57 KILQGGSGIPNI-KWYGVDGEDN----VLVLDLLGPSLEDLFVY-CRRKFSLKTVLMLAD 110
+ L+ N+ + V + +V++ ++++ ++F +
Sbjct: 61 RRLRH----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC 116
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q+I +EY+HS+G +H+DIKP N L L + I G+A P+ +
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVA--------EALHPFAAD 165
Query: 171 KNLT---GTARYAS------CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAAT 220
G+ + +T G + D+ S G V LY G P++G
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAG-VTLYNITTGLYPFEG---DN 217
Query: 221 KKQKYDKICEKKVSTP 236
+ ++ I + + P
Sbjct: 218 IYKLFENIGKGSYAIP 233
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 41/200 (20%), Positives = 72/200 (36%), Gaps = 33/200 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
++ + +G G FG +F A + + A+K + N +++ E K L+
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH--- 62
Query: 65 IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFV---YCRRK--------------FSLKTVL 106
P I +++ E N L++ CR++ L
Sbjct: 63 -PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTT 161
+ Q+ +E++HS+G +HRD+KP N + V + DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 162 NRHIPYRENKNLTGTARYAS 181
Y + GT Y S
Sbjct: 179 TPMPAYARHTGQVGTKLYMS 198
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 71/261 (27%), Positives = 101/261 (38%), Gaps = 60/261 (22%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYK 57
+ + L + +G G++GE+ LA + T E VAVKI + + E + K
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINK 60
Query: 58 ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKF 100
+L N+ K+YG E N+ L LE +LF +R F
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYL-----FLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Q++A + Y+H G HRDIKP+N L L + N + I DFGLA +R
Sbjct: 112 H---------QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNN 159
Query: 161 TNRHIPYRENKNLTGTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
R + + GT Y D+ S G VL L G LPW
Sbjct: 160 RERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ 210
Query: 216 LKAATKKQKYDKICEKKVSTP 236
+ Q+Y EKK
Sbjct: 211 --PSDSCQEYSDWKEKKTYLN 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 71/259 (27%), Positives = 114/259 (44%), Gaps = 57/259 (22%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY 56
+ IG Y+L + IG G+F ++ LA H+ T VA+KI + + T +L E ++
Sbjct: 10 EQPHIG-NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 57 KILQGGSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDLFVY-----------CRRKFSL 102
KIL PNI K + V + E + L+++ S ++F Y R KF
Sbjct: 69 KILNH----PNIVKLFEVIETEKTLYLIMEYA--SGGEVFDYLVAHGRMKEKEARSKFR- 121
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
Q+++ ++Y H + +HRD+K +N L L N + I DFG + ++
Sbjct: 122 --------QIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV---- 166
Query: 163 RHIPYRENKNLT---GTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLR-GSLPWQGLK 217
L G YA+ G + D+ SLG V+LY L GSLP+ G
Sbjct: 167 -------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG-VILYTLVSGSLPFDG-- 216
Query: 218 AATKKQKYDKICEKKVSTP 236
K+ +++ K P
Sbjct: 217 -QNLKELRERVLRGKYRIP 234
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 21/168 (12%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY---K 57
KY IG G + H T AVKI +
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 58 ILQGGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLAD 110
IL+ +G P+I + + LV DL+ G +LF + + S K +
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
++ + ++H+ +HRD+KP+N L L + + DFG +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEP 252
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 22/166 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVY-------KIL 59
Y+ +G G + H T + AVK I+ +G ++ IL
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 60 QGGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQM 112
+ SG PNI + + LV DL+ G +LF + + S K + +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKETRKIMRAL 133
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ I +H +HRD+KP+N L L N + + DFG + +
Sbjct: 134 LEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDP 176
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
+Y+L ++G G+F + V + A I N S H +L EA++ ++L+
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-- 69
Query: 64 GIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARI 116
PNI + + E + L+ DL+ G +LF + R +S Q++ +
Sbjct: 70 --PNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
+ H G +HR++KP+N L+ K V + DFGLA +
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-21
Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
Y + ++G G+F + H T A KI N S +L EA++ + LQ
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
PNI + + E LV DL+ G +LF + R +S Q++
Sbjct: 87 H----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQIL 138
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
I Y HS G +HR++KP+N L+ K V + DFGLA + D
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-21
Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
+G G++G ++ + +A+K E L E ++K L+ NI
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH----KNIV 82
Query: 69 KWYGVDGEDNVL--VLDLL-GPSLEDL--FVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
++ G E+ + ++ + G SL L + K + +T+ Q++ ++Y+H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+HRDIK DN L + + + I DFG +K+ + TGT
Sbjct: 143 IVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPCT-------ETFTGT 186
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-21
Identities = 56/234 (23%), Positives = 95/234 (40%), Gaps = 47/234 (20%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----------E 52
+II +YK+ K+G G ++LA N VA+K E
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFERE 61
Query: 53 AKVYKILQGGSGIPNI-KWY--GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLML 108
L NI + + LV++ + GP+L + + S+ T +
Sbjct: 62 VHNSSQLSH----QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEY-IESHGPLSVDTAINF 116
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+Q++ I++ H +HRDIKP N L+ + I DFG+AK + +
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLT------ 167
Query: 169 ENKNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLY-FLRGSLPWQG 215
+ ++ GT +Y S EQ++ D+ S+G ++LY L G P+ G
Sbjct: 168 QTNHVLGTVQYFS------PEQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-21
Identities = 63/255 (24%), Positives = 106/255 (41%), Gaps = 48/255 (18%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------------ENSGTKHPQL 49
IG Y RK+GSG++GE+ L + + A+K+ +N H ++
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 50 LYEAKVYKILQGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTV 105
E + K L PNI K + V + + LV + G L + + R KF
Sbjct: 94 YNEISLLKSLDH----PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDA 148
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
+ Q+++ I Y+H +HRDIKP+N L+ + I+DFGL+ +
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-------- 200
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAA 219
+ ++ GTA Y + E ++ D+ S G V++Y L G P+ G
Sbjct: 201 KDYKLRDRLGTAYYIA------PEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG---Q 250
Query: 220 TKKQKYDKICEKKVS 234
+ K+ + K
Sbjct: 251 NDQDIIKKVEKGKYY 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-21
Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 42/231 (18%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLY----EAKVYK 57
G Y+L R +G G G+++ A IVA+K+ + + P EA+
Sbjct: 31 TQFG-PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAG 89
Query: 58 ILQGGSGIPNIKW---YGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
LQ P++ +G + + L+ G L + + + + + + Q+
Sbjct: 90 RLQE----PHVVPIHDFGEIDGQLYVDMRLINGVDLAAM-LRRQGPLAPPRAVAIVRQIG 144
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIPYREN 170
+ ++ H+ G HRD+KP+N L+ + Y++DFG+A D
Sbjct: 145 SALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLG-------- 193
Query: 171 KNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLYFLRGSLPWQG 215
N GT Y + E+ R D+ +L VL L GS P+QG
Sbjct: 194 -NTVGTLYYMA------PERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-21
Identities = 41/160 (25%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
+ +GSG+F E+FL T ++ A+K ++ + L E V K ++
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH---- 65
Query: 66 PNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEY 118
NI + + + LV+ L+ G +LF + R ++ K ++ Q+++ ++Y
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+H G +HRD+KP+N L + +++ I DFGL+K ++
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 43/188 (22%), Positives = 77/188 (40%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y +G ++GSG F + T A K G ++ E + + +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSL--KTVLMLADQM 112
N+ + V + D VL+L+L+ G +LF + +K SL + Q+
Sbjct: 73 LH----HNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQI 124
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+H++ H D+KP+N ++ + +IDFGLA + E K
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFK 176
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 177 NIFGTPEF 184
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 70/262 (26%), Positives = 102/262 (38%), Gaps = 62/262 (23%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYK 57
+ + L + +G G++GE+ LA + T E VAVKI + + E + K
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINK 60
Query: 58 ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKF 100
+L N+ K+YG E N+ L LE +LF +R F
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYL-----FLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Q++A + Y+H G HRDIKP+N L L + N + I DFGLA +R
Sbjct: 112 H---------QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNN 159
Query: 161 TNRHIPYRENKNLTGTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQ 214
R + + GT Y D+ S G ++L L G LPW
Sbjct: 160 RERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCG-IVLTAMLAGELPWD 209
Query: 215 GLKAATKKQKYDKICEKKVSTP 236
+ Q+Y EKK
Sbjct: 210 Q--PSDSCQEYSDWKEKKTYLN 229
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 44/231 (19%), Positives = 85/231 (36%), Gaps = 46/231 (19%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKI-ENSGTKHPQ--LLYEAKVY 56
I+ +Y++ I G G I+LA +D N V +K +SG Q + E +
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 57 KILQGGSGIPNIKWYGVDGEDNV-----LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLAD 110
+ I I + + + +V++ + G SL+ +K + +
Sbjct: 134 AEVVH-PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLL 189
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
+++ + Y+HS G ++ D+KP+N ++ Q+ +ID G +
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRINSFGY--------- 236
Query: 171 KNLTGTARYASCNTHLGIEQSR-----RDDLESLGYVLLY-FLRGSLPWQG 215
L GT + + E R D+ ++G L G
Sbjct: 237 --LYGTPGFQA------PEIVRTGPTVATDIYTVG-RTLAALTLDLPTRNG 278
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 46/275 (16%), Positives = 94/275 (34%), Gaps = 40/275 (14%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
++G IG G FG+++ VA+++ + + L E Y+ +
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH---- 88
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVH 120
N+ + G ++ L G +L + + + +A + I + + Y+H
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE-IVKGMGYLH 147
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRENKNLTGTARY 179
++G LH+D+K N G+ V I DFGL R R G +
Sbjct: 148 AKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQ---NGWLCH 200
Query: 180 ---------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
+ + S+ D+ +LG + P++ A ++
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIWQMGT 257
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
++ E + +C + ++RP
Sbjct: 258 GMKPNLSQIGM---GKEISDILLFCWAFEQEERPT 289
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-20
Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 29/278 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYKILQGGSGI 65
+G++IGSGSFG ++ + VAVK+ N PQ L E V + +
Sbjct: 27 TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH---- 79
Query: 66 PNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHS 121
NI + G + +V G SL KF +K ++ +A Q AR ++Y+H+
Sbjct: 80 VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ-TARGMDYLHA 138
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+ +HRD+K +N + + N V I DFGLA +R + + L+G+ + +
Sbjct: 139 KSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT-----EKSRWSGSHQFEQLSGSILWMA 190
Query: 182 ---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
S + D+ + G VL + G LP+ + Q + + +S +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRGSLSPDLS 248
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
+ + P C D+RP + + +L
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 51/250 (20%), Positives = 90/250 (36%), Gaps = 47/250 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQ 60
Y+L IG G F + + +T + AVKI + G L EA + +L+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLA 109
P+I + + + +V + + DL +S
Sbjct: 85 H----PHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHYM 136
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q++ + Y H +HRD+KP L+ + V + FG+A + +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLV 189
Query: 170 NKNLTGTARYAS----CNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQK 224
GT + + G D+ G V+L+ L G LP+ G TK++
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFYG----TKERL 240
Query: 225 YDKICEKKVS 234
++ I + K
Sbjct: 241 FEGIIKGKYK 250
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP-QLLYEAKVYKILQGGSGIPN 67
G +G G FG+ +H +T E++ +K + + L E KV + L+ PN
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH----PN 68
Query: 68 I-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSR 122
+ K+ GV +D L + + + G +L + ++ + A IA + Y+HS
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD-IASGMAYLHSM 127
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
+HRD+ N L+ + V + DFGLA+ D T R K RY
Sbjct: 128 NIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGL-RSLKKPDRKKRYTVV 183
Query: 183 NT 184
Sbjct: 184 GN 185
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 38/274 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP----QLLYEAKVYKILQGG 62
+++ +KIG G F E++ A+ + VA+K ++ + E + K L
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH- 91
Query: 63 SGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIAR 115
PN+ K+Y EDN L VL+L L + + +++ +TV Q+ +
Sbjct: 92 ---PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 116 IEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
+E++HSR +HRDIKP N F+ V + D GL + + TT +L
Sbjct: 149 LEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAA-------HSLV 197
Query: 175 GTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
GT Y S + + + D+ SLG +L P+ G KI +
Sbjct: 198 GTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQC 253
Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
P+ S E + C + ++RPD
Sbjct: 254 DYP-PLPSDHYS--EELRQLVNMCINPDPEKRPD 284
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 3e-20
Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y++G ++GSG F + T + A K G ++ E + + +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYC--RRKFSLKTVLMLADQM 112
+ PNI + + + D VL+L+L+ G +LF + + + Q+
Sbjct: 66 RH----PNIITLHDIFENKTDVVLILELVSGG----ELFDFLAEKESLTEDEATQFLKQI 117
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+HS+ H D+KP+N ++ ++ +IDFG+A K E K
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--------AGNEFK 169
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 170 NIFGTPEF 177
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-20
Identities = 52/223 (23%), Positives = 83/223 (37%), Gaps = 45/223 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+K IGSG FG++F A H + +K + + E K L NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE--KAEREVKALAKLDH----VNI 66
Query: 69 -----KWYGVDGEDNVLVLDLLGPSLEDLFV---YC-------------RRKFSLKTVLM 107
W G D + + + LF+ +C K L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
L +Q+ ++Y+HS+ ++RD+KP N + QV I DFGL ++
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDG------- 176
Query: 168 RENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL 207
+ GT RY S + + + DL +LG ++L L
Sbjct: 177 -KRTRSKGTLRYMSPEQIS---SQDYGKEVDLYALG-LILAEL 214
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-20
Identities = 37/186 (19%), Positives = 66/186 (35%), Gaps = 31/186 (16%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY---------EAKVYKILQ 60
+ ++IG G FG + V +VA+K G + E + L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 61 GGSGIPNI-KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
PNI K YG+ +V++ + L + L L IA IE
Sbjct: 82 H----PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD-IALGIE 136
Query: 118 YVHSRG--FLHRDIKPDNFLMGLGRKANQVY--IIDFGLAKKYRDPTTNRHIPYRENKNL 173
Y+ ++ +HRD++ N + + V + DFGL+++ +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL---------- 186
Query: 174 TGTARY 179
G ++
Sbjct: 187 LGNFQW 192
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-20
Identities = 48/180 (26%), Positives = 73/180 (40%), Gaps = 19/180 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++GSG+FG + T + K N + E + L
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH---- 107
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P + + D + VL+L+ L G L D K S V+ Q ++++H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+H DIKP+N + +KA+ V IIDFGLA K P K T TA +A+
Sbjct: 168 HSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLN--------PDEIVKVTTATAEFAA 218
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-20
Identities = 67/251 (26%), Positives = 97/251 (38%), Gaps = 56/251 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
Y++ IG GS+ H TN AVKI + E +IL PN
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID--KSKRDPTEEI---EILLRYGQHPN 77
Query: 68 I-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYVH 120
I V D V +V +L+ G +L + ++ FS + + + +EY+H
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 121 SRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT---GT 176
++G +HRD+KP N L + I DFG AK+ R EN L T
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLLMTPCYT 183
Query: 177 ARY------------ASCNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQ 223
A + A+C D+ SLG VLLY L G P+ T ++
Sbjct: 184 ANFVAPEVLERQGYDAAC------------DIWSLG-VLLYTMLTGYTPFANGPDDTPEE 230
Query: 224 KYDKICEKKVS 234
+I K S
Sbjct: 231 ILARIGSGKFS 241
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 41/201 (20%), Positives = 67/201 (33%), Gaps = 41/201 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGS 63
++ KIGSG FG +F I A+K +G+ Q L E + +L
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL---G 68
Query: 64 GIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARI 116
++ +++ ED+ + + G SL D R F + L Q+ +
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYII---------------DFGLAKKYRDPT 160
Y+HS +H DIKP N F+ D G + P
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 161 TNRHIPYRENKNLTGTARYAS 181
G +R+ +
Sbjct: 189 V-----------EEGDSRFLA 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 8 KYKLGRK-IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP 66
Y+L +G G+ + ++ T++ AVKI H + +V ++L G
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV-EMLYQCQGHR 71
Query: 67 NI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYV 119
N+ + + ED LV + + G + ++ RR F+ ++ + + ++++
Sbjct: 72 NVLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H++G HRD+KP+N L + + V I DF L + I E G+A Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 180 AS-----CNTHLGIEQSRRDDLESLGYVLLYFL 207
+ + +R DL SLG V+LY L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y +G ++GSG F + T A K G ++ E + + +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSL--KTVLMLADQM 112
PNI + V + D VL+L+L+ G +LF + +K SL + Q+
Sbjct: 73 LH----PNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQI 124
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+H++ H D+KP+N ++ + +IDFGLA + E K
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFK 176
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 177 NIFGTPEF 184
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 59/273 (21%), Positives = 99/273 (36%), Gaps = 70/273 (25%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGI 65
+Y L +IG GS+G + LA + + N A+K+ + + G
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 66 ----------------------PNI-KWYGV---DGEDNV-LVLDLL-----------GP 87
PN+ K V ED++ +V +L+ P
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147
ED R F +I IEY+H + +HRDIKP N L+G + + I
Sbjct: 134 LSEDQ---ARFYFQ---------DLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKI 178
Query: 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLL 204
DFG++ +++ N GT + + + I + D+ ++G V L
Sbjct: 179 ADFGVSNEFKGSDALLS-------NTVGTPAFMAPESLSETRKIFSGKALDVWAMG-VTL 230
Query: 205 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
Y F+ G P+ + KI + + P
Sbjct: 231 YCFVFGQCPFMD---ERIMCLHSKIKSQALEFP 260
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 54/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVY 56
+R IG Y + +G GSFG++ LA+H T + VA+K + H ++ E
Sbjct: 5 KRHIG-PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63
Query: 57 KILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
K+L+ P+I K Y V D V+V++ G L D V +++ + Q+I
Sbjct: 64 KLLRH----PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQII 118
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
IEY H +HRD+KP+N L L N V I DFGL+ D
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLL--LDDNLN-VKIADFGLSNIMTD 160
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 61/281 (21%), Positives = 103/281 (36%), Gaps = 69/281 (24%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYK 57
+ KY L IG GS+G + +A T I A+KI + + ++ E ++ K
Sbjct: 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 58 ILQGGSGIPNIKW-YGV-DGEDNV-LVLDLL----------------------------- 85
L PNI Y V + E + LV++L
Sbjct: 84 KLHH----PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139
Query: 86 -----------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 134
S+ K + + Q+ + + Y+H++G HRDIKP+NF
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199
Query: 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQS 191
L K+ ++ ++DFGL+K++ + GT + + NT
Sbjct: 200 LF-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNT-TNESYG 254
Query: 192 RRDDLESLGYVLLYF-LRGSLP-W----QGLKAATKKQKYD 226
+ D S G VLL+ L G++P + +K
Sbjct: 255 PKCDAWSAG-VLLHLLLMGAVPFPGVNDADTISQVLNKKLC 294
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 45/188 (23%), Positives = 75/188 (39%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y G ++GSG F + T A K G + E + K +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYC--RRKFSLKTVLMLADQM 112
Q PN+ + V + D +L+L+L+ G +LF + + + + Q+
Sbjct: 72 QH----PNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQI 123
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+HS H D+KP+N ++ ++ IIDFGLA K E K
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--------FGNEFK 175
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 176 NIFGTPEF 183
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-19
Identities = 39/186 (20%), Positives = 74/186 (39%), Gaps = 29/186 (15%)
Query: 8 KYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGG 62
Y L +++G G F + T + A K ++L+E +L+
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA---VLELA 85
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRK----FSLKTVLMLADQMI 113
P + + V + + +L+L+ G ++F C + S V+ L Q++
Sbjct: 86 KSCPRVINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ Y+H +H D+KP N L+ + I+DFG+++K E + +
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--------HACELREI 193
Query: 174 TGTARY 179
GT Y
Sbjct: 194 MGTPEY 199
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 6e-19
Identities = 36/175 (20%), Positives = 71/175 (40%), Gaps = 21/175 (12%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTKHPQLLYEAKVYK 57
++ + +G G+F +++ A+ D N + +K++ + ++ +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGTQLME 119
Query: 58 ILQGGSGIPNIKWYGVDGEDN--VLVLDLL-GPSLEDLFVYCR----RKFSLKTVLMLAD 110
L+ +K+Y N VLV +L +L + + + V+ A
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--------VYIIDFGLAKKYR 157
+M+ IE VH +H DIKPDNF++G G + +ID G + +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-19
Identities = 37/162 (22%), Positives = 65/162 (40%), Gaps = 15/162 (9%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
II + +G G G++ + T E A+K+ P+ E ++
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREV---ELHWR 66
Query: 62 GSGIPNI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQM 112
S P+I + V G + +V++ L G + + F+ + + +
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 126
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
I+Y+HS HRD+KP+N L R + + DFG AK
Sbjct: 127 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-19
Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 19/160 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSGIP 66
+Y + IGSG+FG L T E+VAVK G + + E ++ L+ P
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH----P 76
Query: 67 NI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY--CRRKFSLKTVLMLADQMIARIEY 118
NI ++ V L + +E +L+ +FS Q+++ + Y
Sbjct: 77 NIVRFKEVILTPTHLAI-----IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
HS HRD+K +N L+ G A ++ I DFG +K
Sbjct: 132 CHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 27/178 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
++ +G G+FG + A + VA+K S ++ + E + + PNI
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH----PNIV 64
Query: 69 KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIAR-IEYVHSR-- 122
K YG LV++ G SL ++ ++ + Q ++ + Y+HS
Sbjct: 65 KLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ-CSQGVAYLHSMQP 123
Query: 123 -GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
+HRD+KP N L L + I DFG A + TN G+A +
Sbjct: 124 KALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMTNN----------KGSAAW 169
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 8 KYKLGRK--IGSGSFGEIFLASHVDTNEIVAVK-IENSGTK-HPQLLYEAKVYKILQGGS 63
Y + + +G G FG++ T +A K I+ G K ++ E V L
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-- 145
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
N+ + Y D VLV++ + G L D + + ++ Q+ I ++
Sbjct: 146 --ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H LH D+KP+N L + R A Q+ IIDFGLA++Y+ P + K GT +
Sbjct: 204 HQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK--------PREKLKVNFGTPEF 254
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 41/162 (25%), Positives = 64/162 (39%), Gaps = 26/162 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS 63
KY +KIG GSFG+ L + +K N + E V ++
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-- 82
Query: 64 GIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYCRRK----FSLKTVLMLADQMI 113
PNI ++ E+ L + ++ DLF + F +L Q+
Sbjct: 83 --PNIVQYRESFEENGSLYI-----VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+++VH R LHRDIK N + K V + DFG+A+
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARV 174
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 62/241 (25%), Positives = 97/241 (40%), Gaps = 55/241 (22%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT--NEIVAVKIENSGTKHPQLLY--------- 51
+ +Y+LG +G G E+ LA D + VAVK+ L
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLA--RDLRDHRDVAVKV-----LRADLARDPSFYLRFR 60
Query: 52 -EAKVYKILQGGSGIPNI-KWYGVDGEDNV-------LVLDLL-GPSLEDLFVYCRRKFS 101
EA+ L P I Y GE +V++ + G +L D+ V+ +
Sbjct: 61 REAQNAAALNH----PAIVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDI-VHTEGPMT 114
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
K + + + + H G +HRD+KP N ++ N V ++DFG+A+ D
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGN 171
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLY-FLRGSLPWQ 214
+ + GTA+Y S EQ+R R D+ SLG +LY L G P+
Sbjct: 172 ----SVTQTAAVIGTAQYLS------PEQARGDSVDARSDVYSLG-CVLYEVLTGEPPFT 220
Query: 215 G 215
G
Sbjct: 221 G 221
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 69/282 (24%), Positives = 107/282 (37%), Gaps = 53/282 (18%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R I L IG G FGE++ E VAVKI +S + EA++Y+ +
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVML 93
Query: 62 GSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
NI + D +DN LV D SL D R +++ ++ LA
Sbjct: 94 RH--ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALS-T 148
Query: 114 AR-IEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
A + ++H HRD+K N L+ +K I D GLA ++ T
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTID 205
Query: 165 IPYRENKNLTGTARY--------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGS------ 210
I + GT RY + H E +R D+ ++G V R
Sbjct: 206 IA---PNHRVGTKRYMAPEVLDDSINMKHF--ESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 211 ----LPWQGLKA--ATKKQKYDKICEKKVSTPIEVLCKSHPA 246
LP+ L + ++ +CE+K+ I +S A
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 302
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 5 IGVKYKLG---RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
Y L + +G GSF H +N+ AVKI + K + + ++ L+
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEI-TALKL 61
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIA 114
G PNI K + V + + LV++LL G +LF + ++ FS + ++++
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEASYIMRKLVS 117
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
+ ++H G +HRD+KP+N L ++ IIDFG A+ +N+ L
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLK 167
Query: 175 ---GTARYAS-----CNTHLGIEQSRRDDLESLGYVLLYFL 207
T YA+ N + DL SLG V+LY +
Sbjct: 168 TPCFTLHYAAPELLNQNGY-----DESCDLWSLG-VILYTM 202
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 61/249 (24%), Positives = 100/249 (40%), Gaps = 43/249 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS 63
Y++ IG+GS+G +I+ K + G+ L+ E + + L+
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-- 64
Query: 64 GIPNI-KWYG--VDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIA 114
PNI ++Y +D + L V++ G L + ++ + VL + Q+
Sbjct: 65 --PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 115 RIEYVHSRGF-----LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
++ H R LHRD+KP N + V + DFGLA+ T+
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFA------ 173
Query: 170 NKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKY 225
K GT Y S N + + + D+ SLG LLY L P+ A ++K+
Sbjct: 174 -KTFVGTPYYMSPEQMN---RMSYNEKSDIWSLG-CLLYELCALMPPFT---AFSQKELA 225
Query: 226 DKICEKKVS 234
KI E K
Sbjct: 226 GKIREGKFR 234
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 37/161 (22%), Positives = 69/161 (42%), Gaps = 15/161 (9%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
+ +++ ++G G+ ++ T + A+K+ + E V L
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH--- 107
Query: 65 IPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIE 117
PNI K + + + LVL+L+ G +LF + + +S + Q++ +
Sbjct: 108 -PNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
Y+H G +HRD+KP+N L + I DFGL+K
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 29/194 (14%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R I + ++ ++IG G +GE+++ E VAVK+ + + E ++Y+ +
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEA-SWFRETEIYQTVLM 88
Query: 62 GSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
NI + D + L+ D SL D K++L LA +
Sbjct: 89 RH--ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSV 144
Query: 114 ARIEYVHSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
+ + ++H+ F HRD+K N L+ +K I D GLA K+ T I
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 166 PYRENKNLTGTARY 179
P GT RY
Sbjct: 202 P---PNTRVGTKRY 212
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y+L IGSG+ + A E VA+K E T +LL E +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH---- 72
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
PNI +Y V ++ LV+ LL G S+ D+ + K K+ ++ IA I
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVL 131
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
EY+H G +HRD+K N L+G + V I DFG++
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVS 168
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 16/162 (9%)
Query: 8 KYKLGRK-IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP 66
Y+L ++ +G G G++ H T + A+K+ P+ E SG P
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---DSPKARQEVD---HHWQASGGP 82
Query: 67 NI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
+I V G+ + ++++ + G + + F+ + + + I+
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
++HS HRD+KP+N L K + + DFG AK+
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-18
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ KIG GS+G +F + DT +IVA+K ++ K L E ++ K L+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQLKH- 61
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN+ V LV + ++ +R V + Q + + +
Sbjct: 62 ---PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
H +HRD+KP+N L+ K + + + DFG A+ P+
Sbjct: 119 HKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPS 156
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 37/166 (22%), Positives = 66/166 (39%), Gaps = 15/166 (9%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
II + +G G G++ + T E A+K+ P+ E ++
Sbjct: 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREV---ELHWR 110
Query: 62 GSGIPNI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQM 112
S P+I + V G + +V++ L G + + F+ + + +
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 170
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
I+Y+HS HRD+KP+N L R + + DFG AK+
Sbjct: 171 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 16/160 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ +G GS+G + + DT IVA+K ++ K + E K+ K L+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRH- 83
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
N+ V + LV + + ++ D + V Q+I I +
Sbjct: 84 ---ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
HS +HRDIKP+N L+ ++ V + DFG A+ P
Sbjct: 141 HSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAP 177
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 25/164 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQGG 62
Y LG +G G+FG++ + H T VAVKI N S ++ E + K+ +
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH- 70
Query: 63 SGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYC--RRKFSLKTVLMLADQMIA 114
P+I K Y V + +E +LF Y + L Q+++
Sbjct: 71 ---PHIIKLYQVISTPTDFFM-----VMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
++Y H +HRD+KP+N L L N I DFGL+ D
Sbjct: 123 AVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 51/182 (28%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYK 57
+R V Y + IG+GSFG ++ A D+ E+VA+K K Q E ++ +
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMR 102
Query: 58 ILQGGSGIPNI---KWY---GVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLML 108
L NI +++ + +D V LVLD + E ++ R K L +
Sbjct: 103 KLDH----CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPV 155
Query: 109 AD------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
Q+ + Y+HS G HRDIKP N L L + + DFG AK+ N
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 163 RH 164
Sbjct: 214 VS 215
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 52/299 (17%), Positives = 101/299 (33%), Gaps = 58/299 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKILQGGSGI- 65
Y++ R + G F +I L N+ A+K E S + + ++ KI
Sbjct: 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 66 -------------PNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRR-------KFS 101
G+ D V ++ + + S+ Y
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 102 LKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
++ + + ++ Y+H+ + HRD+KP N LM K +V + DFG ++
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESE------ 200
Query: 161 TNRHIPYRENKNLT---GTARYAS---CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPW 213
Y +K + GT + + + D+ SLG + LY +P+
Sbjct: 201 ------YMVDKKIKGSRGTYEFMPPEFFSNESSY-NGAKVDIWSLG-ICLYVMFYNVVPF 252
Query: 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272
+ + ++ I K + P++ +P L+ + FLK
Sbjct: 253 SL--KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI---DFLKLF 306
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 28/161 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
Y+L RK+G G + E+F A ++ NE V VKI K ++ E K+ + L+GG PN
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGG---PN 92
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVY------------CRRKFSLKTVLMLADQMIAR 115
I + + D++ + + + + +++
Sbjct: 93 I----------ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKA 142
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
++Y HS G +HRD+KP N + + + ++ +ID+GLA+ Y
Sbjct: 143 LDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFY 181
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-17
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKIL- 59
E +Y L RK+G G F ++LA + N VA+KI E K+ + +
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 73
Query: 60 ------QGGSGIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTV 105
+ G +I G +G V+V ++LG +L L R L V
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 106 LMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRK---ANQVYIIDFGLA 153
++ Q++ ++Y+H R G +H DIKP+N LM + Q+ I D G A
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 7e-17
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ KIG G++G +F A + +T+EIVA+K ++ G L E + K L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKH- 60
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
NI + + V D LV + L+ F C + V Q++ + +
Sbjct: 61 ---KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
HSR LHRD+KP N L+ + ++ + +FGLA+ + P
Sbjct: 118 HSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPV 155
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 48/181 (26%), Positives = 71/181 (39%), Gaps = 34/181 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGT--------------KHPQ 48
KY+ KIG G+FGE+F A H T + VA+K E G KH
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 49 L--LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL 106
+ L E K +I Y LV D L L KF+L +
Sbjct: 78 VVNLIEICRTKASPYNRCKGSI--Y--------LVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
+ ++ + Y+H LHRD+K N L+ + + + DFGLA+ + ++
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 167 Y 167
Y
Sbjct: 185 Y 185
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 8e-17
Identities = 42/223 (18%), Positives = 75/223 (33%), Gaps = 40/223 (17%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI--PN 67
KL IG G +G ++ S VAVK+ + + + E +Y++ + N
Sbjct: 16 KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ-NFINEKNIYRV----PLMEHDN 68
Query: 68 I-KWYGVDGEDNV-------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
I ++ D LV++ SL + LA + + Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 119 VHS---------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPTTNRHIPYR 168
+H+ HRD+ N L+ + I DFGL+ + +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 169 ENKNLTGTARY-------ASCNTHLGIEQSRRDDLESLGYVLL 204
+ GT RY + N ++ D+ +LG +
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 41/175 (23%), Positives = 81/175 (46%), Gaps = 32/175 (18%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
++L +G+G++G+++ HV T ++ A+K ++ +G + ++ E +L+ S N
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE---INMLKKYSHHRN 82
Query: 68 I-KWYG------VDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI- 116
I +YG G D+ L V++ S+ DL + L ++ IA I
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYIC 135
Query: 117 -------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
++H +HRDIK N L+ + +V ++DFG++ + R+
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRN 187
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 44/176 (25%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKIL 59
IG Y LG +G G+FG++ + H T VAVKI N S ++ E + K+
Sbjct: 15 IG-HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 60 QGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKFSL 102
+ P+I K Y V + + + +E +LF Y RR F
Sbjct: 74 RH----PHIIKLYQVISTPSDIFM-----VMEYVSGGELFDYICKNGRLDEKESRRLFQ- 123
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
Q+++ ++Y H +HRD+KP+N L L N I DFGL+ D
Sbjct: 124 --------QILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 168
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 15/154 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+ R+IG GSFG ++ A V +E+VA+K + S K ++ E + + L+
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 113
Query: 63 SGIPNI-KWYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN ++ G + LV++ S DL ++ + + + + Y+
Sbjct: 114 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
HS +HRD+K N L+ + V + DFG A
Sbjct: 171 HSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 201
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 46/195 (23%), Positives = 71/195 (36%), Gaps = 29/195 (14%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+R + L +G G +GE++ S E VAVKI +S + E ++Y +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEK-SWFRETELYNTVM 58
Query: 61 GGSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM 112
NI + D L+ SL D + L + +
Sbjct: 59 LRH--ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSI 114
Query: 113 IARIEYVHSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ + ++H F HRD+K N L+ +K Q I D GLA + T
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 165 IPYRENKNLTGTARY 179
+ N GT RY
Sbjct: 172 VG---NNPRVGTKRY 183
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 17/163 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL----LYEAKVYKILQ 60
+Y+ +G G F ++ A +TN+IVA +K+ + + L E K+ + L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 61 GGSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
PNI G + LV D + LE + + + + +E
Sbjct: 71 H----PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Y+H LHRD+KP+N L+ + + + DFGLAK + P
Sbjct: 127 YLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPN 166
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 45/189 (23%), Positives = 71/189 (37%), Gaps = 37/189 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------QLLYEAKVYKILQGGS 63
L IG G FG+++ A + VAVK + EAK++ +L+
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-- 65
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEY 118
PNI GV + LV++ G L + ++ ++ A Q IAR + Y
Sbjct: 66 --PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQ-IARGMNY 120
Query: 119 VHSRG---FLHRDIKPDNFLMGLGRKANQVY-----IIDFGLAKKYRDPTTNRHIPYREN 170
+H +HRD+K N L+ + + I DFGLA R
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---------REWHRTTK 171
Query: 171 KNLTGTARY 179
+ G +
Sbjct: 172 MSAAGAYAW 180
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 74/259 (28%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI------------EN--------SGTKHP---QL 49
R IG GSFG++ + DT ++ A+K N G +HP L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 50 LY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFS 101
Y E ++ +V+DLL G DL + ++ F
Sbjct: 81 WYSFQDEEDMF-----------------------MVVDLLLGG----DLRYHLQQNVHFK 113
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
+TV + +++ ++Y+ ++ +HRD+KPDN L+ + V+I DF +A T
Sbjct: 114 EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRETQ 170
Query: 162 NRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
+ GT Y + ++ G S D SLG V Y LRG P+
Sbjct: 171 --------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRRPYHIRS 221
Query: 218 AATKKQKYDKICEKKVSTP 236
+ + K+ V+ P
Sbjct: 222 STSSKEIVHTFETTVVTYP 240
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 66/278 (23%), Positives = 104/278 (37%), Gaps = 54/278 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
+ KIG+GSFG + A VAVKI H + + E + K L+
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH---- 93
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLF--VYCRRKFSLKTVLMLADQMIAR-IEY 118
PNI + G + +V + L SL L R + + L +A +A+ + Y
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD-VAKGMNY 152
Query: 119 VHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRENKNLTG 175
+H+R +HR++K N L+ K V + DFGL++ K + +K+ G
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKASTFLS--------SKSAAG 201
Query: 176 TARY--------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
T + N E+S D+ S G +L PW L A Q
Sbjct: 202 TPEWMAPEVLRDEPSN-----EKS---DVYSFGVILWELATLQQPWGNLNPA---QVVAA 250
Query: 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
+ K I + A+ C + +RP
Sbjct: 251 VGFKCKRLEIPRNL---NPQVAAIIEGCWTNEPWKRPS 285
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 37/209 (17%), Positives = 83/209 (39%), Gaps = 14/209 (6%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQ-- 60
+ +Y + RK+G G F ++L+ + + VA+K+ S + + L E ++ K ++
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS 93
Query: 61 -----GGSGIPNI----KWYGVDGEDNVLVLDLLGPSLEDL-FVYCRRKFSLKTVLMLAD 110
+ + K GV+G +V ++LG L + L V +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 111 QMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q++ ++Y+H++ +H DIKP+N L+ + + + + ++ P +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLES 198
+ + + DL +
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-16
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 67/258 (25%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
+K G+ +G GSF + LA + T+ A+KI E S HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 48 --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--K 99
+L + + K+Y L Y +GE L Y R+
Sbjct: 92 FVKLYFTFQDDEKLYFGLS----------YAKNGE---------------LLKYIRKIGS 126
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F ++++ +EY+H +G +HRD+KP+N L+ + + I DFG AK
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPE 183
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
+ + GTA+Y S + DL +LG ++Y + G P+ +A
Sbjct: 184 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF---RA 234
Query: 219 ATKKQKYDKICEKKVSTP 236
+ + KI + + P
Sbjct: 235 GNEYLIFQKIIKLEYDFP 252
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-16
Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 13/159 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
Y K+G G++ ++ T+ +VA+K +E+ + E + K L+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH--- 59
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
NI + + + LV + L L+ C ++ V + Q++ + Y H
Sbjct: 60 -ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
+ LHRD+KP N L+ + ++ + DFGLA+ PT
Sbjct: 119 QKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 154
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 56/234 (23%), Positives = 81/234 (34%), Gaps = 44/234 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-- 65
+L G FG ++ A NE VAVKI K E +VY + G+
Sbjct: 25 PLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQ-SWQNEYEVYSL----PGMKH 77
Query: 66 PNI-KWYGVDGEDNVLVLDLL-------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
NI ++ G + + +DL SL D S + +A+ M +
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLA 135
Query: 118 YVHSRGF----------LHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIP 166
Y+H HRDIK N L+ K N I DFGLA K+ +
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLL----KNNLTACIADFGLALKFEAGKS----- 186
Query: 167 YRENKNLTGTARY-----ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+ GT RY + + R D+ ++G VL G
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 37/159 (23%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGG 62
+ +Y++ + IG GSFG++ A ++ VA+K + N H Q E ++ + L+
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 63 SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIA 114
+ + +N + +LL +L +L + + FSL V A ++
Sbjct: 154 D--KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
++ +H +H D+KP+N L+ + + + +IDFG +
Sbjct: 212 CLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSS 249
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
+ KIG GSFGE+F T ++VA+KI E + + + E V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 79
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P + K+YG + ++++ L G S DL + + +++ ++Y+HS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDL--LEPGPLDETQIATILREILKGLDYLHS 137
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+HRDIK N L+ + +V + DFG+A + D R+
Sbjct: 138 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN 177
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+ + K+G GS+G ++ A H +T +IVA+K + +++ E + + P+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS----PH 85
Query: 68 I-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ K+YG D +V++ S+ D+ + + + + + +EY+H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+HRDIK N L+ + DFG+A + D R+
Sbjct: 146 KIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRN 183
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 60/245 (24%), Positives = 92/245 (37%), Gaps = 46/245 (18%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGI 65
R IG G FGE++ DT ++ A+K G L E + ++ G
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIMLSLVSTGDC- 251
Query: 66 PNIK--WYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEY 118
P I Y D + +LDL+ G DL + FS + A ++I +E+
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGG----DLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+H+R ++RD+KP N L+ + V I D GLA + + GT
Sbjct: 308 MHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPH---------ASVGTHG 355
Query: 179 Y------ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEK 231
Y + D SLG +L+ LRG P++ K K +
Sbjct: 356 YMAPEVLQKGVAY-----DSSADWFSLG-CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 232 KVSTP 236
V P
Sbjct: 410 AVELP 414
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 38/189 (20%), Positives = 65/189 (34%), Gaps = 36/189 (19%)
Query: 8 KYKLGRKIGSG--SFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLY-EAKVYKILQG 61
Y+L IG G + LA + T E V V+ E + L E V K+
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH 85
Query: 62 GSGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLM--LADQMIAR 115
PNI + + + +V + S +DL + T M + + IA
Sbjct: 86 ----PNIVPYRATFIADNELWVVTSFMAYGSAKDL---------ICTHFMDGMNELAIAY 132
Query: 116 I--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
I +Y+H G++HR +K + L+ +VY+ + + +
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 168 RENKNLTGT 176
K
Sbjct: 190 DFPKYSVKV 198
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 33/163 (20%), Positives = 74/163 (45%), Gaps = 13/163 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
+++ ++G G+FG+++ A + +T + A K+ S + + E ++
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH---- 75
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I K G ++++ G +++ + + R + + ++ QM+ + ++HS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ +HRD+K N LM L + + DFG++ K R
Sbjct: 136 KRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRD 175
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQ-LLYEAKVYKILQG 61
+Y+ K+G G++GE++ A TNE VA+K E G P + E + K LQ
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQH 92
Query: 62 GSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
NI + V ++ L+ + L+ S++ + Q+I + +
Sbjct: 93 ----RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNF 147
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKAN--QVYIIDFGLAKKYRDPT 160
HSR LHRD+KP N L+ + + + I DFGLA+ + P
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 72.5 bits (179), Expect = 6e-15
Identities = 49/161 (30%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY KIG G++G ++ A + + E A+K E+ G + E + K L+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIP-STTIREISILKELKH- 59
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
NI K Y V VLV + L L+ L C T Q++ I Y
Sbjct: 60 ---SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
H R LHRD+KP N L+ + ++ I DFGLA+ + P
Sbjct: 117 HDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPV 154
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-15
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 17/161 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ K+G G++G ++ A IVA+K E+ G + E + K L
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI-PSTAIREISLLKELHH- 78
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI V + LV + + L+ + + + + Q++ + +
Sbjct: 79 ---PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
H LHRD+KP N L+ + + DFGLA+ + P
Sbjct: 136 HQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPV 173
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-15
Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 17/162 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
++ KIG G++G ++ A + T E+VA+K E G + E + K L
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-STAIREISLLKELNH- 61
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEY 118
PNI K V +N LV + L L+ L + Q++ + +
Sbjct: 62 ---PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
HS LHRD+KP N L+ + + DFGLA+ + P
Sbjct: 119 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPV 157
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 31/171 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA++ N K ++ E V + +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN---- 76
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
PNI + + G++ +V++ L G SL D+ + + IA +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECL 126
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
E++HS +HRDIK DN L+G+ V + DFG + + R
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRS 174
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-15
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 24/159 (15%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
K R +G G FG++ L ++ T E+VAVK ++G +H E + + L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH- 92
Query: 63 SGIPNI-KWYGV---DGEDNV-LVLDLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIAR- 115
+I K+ G G ++ LV++ + L L Y R L +L+ A Q I
Sbjct: 93 ---EHIIKYKGCCEDAGAASLQLVMEYV--PLGSLRDYLPRHSIGLAQLLLFAQQ-ICEG 146
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Y+H++ ++HRD+ N L+ V I DFGLAK
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 20/170 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL----LYEAKVYKILQ 60
+Y+ +IG G++G ++ A + VA V++ N G L + E + + L+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 61 GGSGIPNI-------KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQ 111
PN+ D E V LV + + L +T+ L Q
Sbjct: 70 AFEH-PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
+ ++++H+ +HRD+KP+N L+ V + DFGLA+ Y
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMA 175
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 31/171 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KIG GS G + LA + VAVK+ + + L E + + Q
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH---- 101
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
N+ + Y + GE+ ++++ L G +L D+ + + L ++ IA +
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----------SQVRLNEEQIATVCEAVL 151
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
Y+H++G +HRDIK D+ L+ L +V + DFG + R
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRK 199
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 37/239 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
IG G+FGE+ L H T ++ A+K+ +++ + I+ + +
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 67 NIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG 123
+ + D +V++ + G DL K +++ ++ +HS G
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGG----DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS-- 181
F+HRD+KPDN L+ K+ + + DFG K R GT Y S
Sbjct: 189 FIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEGMVR------CDTAVGTPDYISPE 239
Query: 182 --CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ R D S+G V LY L G P+ A + Y KI K S
Sbjct: 240 VLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTPF---YADSLVGTYSKIMNHKNSLTF 294
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 34/196 (17%), Positives = 64/196 (32%), Gaps = 46/196 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------------------------- 38
KY LG+ +G+GSFG + +++ + A+K
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVD 67
Query: 39 -----IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV-LVLDLLGPSLEDL 92
+ K+ G + + ++++ + + L
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---DTL 124
Query: 93 FVYCRRKFSLKTVLMLAD------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
+ + + Q+ + ++HS G HRDIKP N L + K N +
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNSKDNTLK 182
Query: 147 IIDFGLAKKYRDPTTN 162
+ DFG AKK +
Sbjct: 183 LCDFGSAKKLIPSEPS 198
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 19/171 (11%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL---LYEAKVYKILQGGSGIP 66
LG +IG G+FGE+F N +VAVK L EA++ K P
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH----P 172
Query: 67 NI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
NI + GV + +V++L+ G + +KT+L + A +EY+ S+
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH-----IPYR 168
+HRD+ N L+ + N + I DFG++++ D +P +
Sbjct: 233 CCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 27/170 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
K +IG GSF ++ +T VA + + ++ + EA++ K LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--- 84
Query: 65 IPNI-----KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIA 114
PNI W + V +L+ +L+ Y +R +K + Q++
Sbjct: 85 -PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT---YLKRFKVMKIKVLRSWCRQILK 140
Query: 115 RIEYVHSRG--FLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTT 161
++++H+R +HRD+K DN F+ G V I D GLA R
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFA 187
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
++K K+G+G++ ++ + T VA+K +++ + E + K L+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH--- 62
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDL-----FVYCRRKFSLKTVLMLADQMIARI 116
NI + Y V +N LV + + L+ R L V Q++ +
Sbjct: 63 -ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
+ H LHRD+KP N L+ K Q+ + DFGLA+ + P
Sbjct: 122 AFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPV 162
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 22/175 (12%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVD--TNEIVAVK-IENSGTKHPQLLYEAKVYKI 58
ER+ + G K+G G++G ++ A D ++ A+K IE +G E + +
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRE 74
Query: 59 LQGGSGIPNI-KWYGV---DGEDNV-LVLD--------LLGPSLEDLFVYCRRKFSLKTV 105
L+ PN+ V + V L+ D ++ + V
Sbjct: 75 LKH----PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
L Q++ I Y+H+ LHRD+KP N L MG G + +V I D G A+ + P
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 24/160 (15%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
K R +G G FG++ L +T E VAVK SG H L E ++ + L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH- 82
Query: 63 SGIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
NI K+ G+ DG + + L+++ L G SL++ + K +LK L A Q I +
Sbjct: 83 ---ENIVKYKGICTEDGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQLKYAVQ-ICK 137
Query: 116 -IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
++Y+ SR ++HRD+ N L+ +QV I DFGL K
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 35/177 (19%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
+ Y + IG+GSFG +F A V+++E VA+K K Q E ++ +I++
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK------KVLQDKRFKNRELQIMRIVKH- 91
Query: 63 SGIPNI---KWY---GVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--- 110
PN+ K + D +D V LVL+ + E ++ R LK + +
Sbjct: 92 ---PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKL 145
Query: 111 ---QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
Q++ + Y+HS G HRDIKP N L L + + +IDFG AK N
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAKILIAGEPNVS 200
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
K +++G G+FG + + +T E+VAVK ++ E ++ K LQ
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-- 70
Query: 64 GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
NI K+ GV G N+ L+++ L G SL D + + +L Q I +
Sbjct: 71 --DNIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQ-ICKG 126
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+EY+ ++ ++HRD+ N L+ N+V I DFGL K
Sbjct: 127 MEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ--LLYEAKVYKILQGGS 63
K +++G G+FG + + +T E+VAVK T+ E ++ K LQ
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-- 101
Query: 64 GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
NI K+ GV G N+ L+++ L G SL D + + +L Q I +
Sbjct: 102 --DNIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQ-ICKG 157
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+EY+ ++ ++HRD+ N L+ N+V I DFGL K
Sbjct: 158 MEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-14
Identities = 30/149 (20%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
++GSG+ G+++ T ++AVK + ++ ++L + ++ P I +
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---LDVVLKSHDCPYIVQ 88
Query: 70 WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLH 126
+G + D + ++L+G E L + + + + ++ + Y+ G +H
Sbjct: 89 CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
RD+KP N L+ + Q+ + DFG++ +
Sbjct: 149 RDVKPSNILLD---ERGQIKLCDFGISGR 174
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 23/159 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
K ++G G+FG + L +T +VAVK +++SG + E ++ K L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-- 83
Query: 64 GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
I K+ GV G ++ LV++ L G L D R + +L+ + Q I +
Sbjct: 84 --DFIVKYRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLLLYSSQ-ICKG 139
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+EY+ SR +HRD+ N L+ V I DFGLAK
Sbjct: 140 MEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 59/242 (24%), Positives = 94/242 (38%), Gaps = 40/242 (16%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
IG G+FGE+ + + +++ A+KI ++L A+ +L G I
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKI----LNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 67 NIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHS 121
+ + D + LV+D G DL + + + +M+ I+ VH
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGG----DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
++HRDIKPDN LM + + DFG K + T + + GT Y S
Sbjct: 194 LHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYIS 244
Query: 182 CNTHLGIEQSRRD-----DLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
+E + D SLG V +Y L G P+ A + + Y KI K
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLG-VCMYEMLYGETPFY---AESLVETYGKIMNHKERF 300
Query: 236 PI 237
Sbjct: 301 QF 302
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 28/220 (12%), Positives = 53/220 (24%), Gaps = 49/220 (22%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYK 57
RI +Y+L G + + A + VA+ + P L
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 58 ILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
+ G+ + ++V + + G SL+++ S + + A
Sbjct: 87 RIDK-PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAA 142
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+ H G P + V +
Sbjct: 143 DAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA----TMPDAN--------------- 180
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQG 215
+DD+ +G LY L P
Sbjct: 181 ---------------PQDDIRGIG-ASLYALLVNRWPLPE 204
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 21/168 (12%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
KL + IG G FG++ L + VAVK + L EA V L+ N+
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLRH----SNLV 77
Query: 69 KWYGV--DGEDNV-LVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIAR-IEYVH 120
+ GV + + + +V + + + L Y R +L + + +EY+
Sbjct: 78 QLLGVIVEEKGGLYIVTEYM--AKGSLVDYLRSRGRSVLGGDCLLKFSLD-VCEAMEYLE 134
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
F+HRD+ N L+ + N + DFGL K+ +P +
Sbjct: 135 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 54/245 (22%), Positives = 86/245 (35%), Gaps = 44/245 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
IG G+F E+ + T ++ A+K ++ E +L G I
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC--FREERD---VLVNGDRRWI 123
Query: 66 PNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVH 120
+ + D LV++ G DL + + + +++ I+ VH
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGG----DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY- 179
G++HRDIKPDN L+ + + + DFG K R T R + GT Y
Sbjct: 180 RLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKLRADGTVR------SLVAVGTPDYL 230
Query: 180 ------ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKK 232
A D +LG V Y G P+ A + + Y KI K
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALG-VFAYEMFYGQTPFY---ADSTAETYGKIVHYK 286
Query: 233 VSTPI 237
+
Sbjct: 287 EHLSL 291
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-13
Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
+ K+G G +GE++ + VAVK T + L EA V K ++ PN
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNL 71
Query: 68 IKWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRK-FSLKTVLMLADQMIAR-IEYVHS 121
++ GV ++ + + G +L D C R+ S +L +A Q I+ +EY+
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEK 129
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ F+HRD+ N L+G + + V + DFGL++
Sbjct: 130 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 40/175 (22%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK-----ILQG 61
++++ R G G+FG + L T VA+K K + + ++ I+Q
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK------K----VIQDPRFRNRELQIMQD 72
Query: 62 GSGI--PNI-------KWYGVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLMLA 109
+ + PNI G ++ +V++ + + L CR + +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPI 129
Query: 110 D------QMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
Q+I I +H S HRDIKP N L + + + DFG AKK
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAKKL 182
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 34/178 (19%), Positives = 71/178 (39%), Gaps = 38/178 (21%)
Query: 8 KYKLGRKIGSGSFGEIFLASHV-DTNEIVA---VKIEN-------------------SGT 44
+Y+ +IG G++G++F A + + VA V+++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 45 KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF-SLK 103
+HP ++ +++ + K LV + + L +
Sbjct: 72 EHPNVV---RLFDVCTVSRTDRETKLT--------LVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
T+ + Q++ ++++HS +HRD+KP N L+ + Q+ + DFGLA+ Y
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMA 175
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGG 62
+Y++ IG GSFG++ A E VA+K I+N Q E ++ +++
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH 110
Query: 63 SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIA 114
+K+Y V + + LV ++L +L DL R SL A QM
Sbjct: 111 D--TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 115 RIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+ ++ + +H D+KP+N L+ K + + I+DFG +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSS 208
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-13
Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 13/154 (8%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
++IGSG FG + L ++ ++ VA+K G + + EA+V L P +
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSH----PKL 65
Query: 69 -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ YGV + LV + + L D R F+ +T+L + + + Y+
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+HRD+ N L+G + + + DFG+ + D
Sbjct: 126 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD 156
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 43/166 (25%), Positives = 68/166 (40%), Gaps = 17/166 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
KL + IG G FG++ L + VAVK + L EA V L+ N+
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLRH----SNLV 249
Query: 69 KWYGV---DGEDNVLVLDLL--GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ GV + +V + + G SL D L R +L + + +EY+
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
F+HRD+ N L+ + N + DFGL K+ +P +
Sbjct: 309 NFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
+ K+G G +GE++ + VAVK T + L EA V K ++ PN
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNL 278
Query: 68 IKWYGV--DGEDNVLVLDLL-GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
++ GV ++ + + +L D L R++ S +L +A Q+ + +EY+ +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
F+HR++ N L+G + + V + DFGL++ P +
Sbjct: 339 FIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-13
Identities = 60/258 (23%), Positives = 99/258 (38%), Gaps = 72/258 (27%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
+ + +G+GSFG + L H ++ A+KI E P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 48 --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--K 99
+L + + +Y +++ +G GE +F + RR +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAG----------GE---------------MFSHLRRIGR 137
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
FS A Q++ EY+HS ++RD+KP+N L+ + + + DFG AK+ +
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGR 194
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
T L GT + L ++ D +LG VL+Y G P+ A
Sbjct: 195 T----------WTLCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF---FA 240
Query: 219 ATKKQKYDKICEKKVSTP 236
Q Y+KI KV P
Sbjct: 241 DQPIQIYEKIVSGKVRFP 258
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-13
Identities = 38/168 (22%), Positives = 68/168 (40%), Gaps = 17/168 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+++G+G FG + + VA+K+ G+ + EAKV L +
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSH----EKL 81
Query: 69 -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ YGV ++ + + L + R +F + +L + + +EY+ S+ F
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
LHRD+ N L+ V + DFGL++ D P R
Sbjct: 142 LHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K + +GSG+FG ++ + +I VA+K T +L EA V +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN- 76
Query: 63 SGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
P++ + G+ V L+ L G L D + + +L Q IA+ +
Sbjct: 77 ---PHVCRLLGICLTSTVQLITQLMPFG-CLLDYVREHKDNIGSQYLLNWCVQ-IAKGMN 131
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ R +HRD+ N L+ V I DFGLAK
Sbjct: 132 YLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 44/203 (21%), Positives = 75/203 (36%), Gaps = 62/203 (30%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQL----LYEAKV 55
I ++L +G G++G + A+H T EIVA+K K P L E K+
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKI 62
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--- 110
K + NI + + ++ P + F VY + LM D
Sbjct: 63 LKHFKH----ENI----------ITIFNIQRPDSFENFNEVY------IIQELMQTDLHR 102
Query: 111 -----------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGL 152
Q + ++ +H +HRD+KP N L+ +N + + DFGL
Sbjct: 103 VISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGL 158
Query: 153 AKKYRDPTTNRHIPYRENKNLTG 175
A+ + + P + +
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVE 181
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 32/153 (20%), Positives = 67/153 (43%), Gaps = 25/153 (16%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
+IG G++G + H + +I+AVK + QLL + ++ S P I +
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---LDVVMRSSDCPYIVQ 85
Query: 70 WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI--------EYV 119
+YG D + ++L+ S + + + ++ ++++ +I ++
Sbjct: 86 FYGALFREGDCWICMELMSTSFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 120 HS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
+HRDIKP N L+ ++ + + DFG
Sbjct: 142 KENLKIIHRDIKPSNILLD---RSGNIKLCDFG 171
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-12
Identities = 36/168 (21%), Positives = 65/168 (38%), Gaps = 17/168 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
L +++GSG FG + L + VAVK+ G+ EA+ L P +
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSH----PKL 65
Query: 69 -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
K+YGV +V + + L + + +L + + + ++ S F
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
+HRD+ N L+ + V + DFG+ + D P +
Sbjct: 126 IHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 19/184 (10%), Positives = 45/184 (24%), Gaps = 36/184 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
K+ GE++ + VK+ + E +I
Sbjct: 13 NFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH---- 66
Query: 66 PNI-KWYGV----DGEDNVLVLDLL-GPSLED-LFVYCRRKFSLKTVLMLADQMIAR-IE 117
PN+ G L+ + SL + L + A +AR +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD-MARGMA 125
Query: 118 YVHSRGF--LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
++H+ + + ++ + I + ++
Sbjct: 126 FLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKF------------SFQSPGRMY 170
Query: 176 TARY 179
+
Sbjct: 171 APAW 174
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 3e-12
Identities = 55/271 (20%), Positives = 95/271 (35%), Gaps = 98/271 (36%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
+++ R +G+GSFG + L A+K+ E S HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 48 --QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR 98
++ +++ I+ +GG +LF R+
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGG----------------------------ELFSLLRK 99
Query: 99 --KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
+F A ++ +EY+HS+ ++RD+KP+N L+ K + I DFG AK
Sbjct: 100 SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYV 156
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY----------VLLY- 205
D T L GT Y + E + + Y +L+Y
Sbjct: 157 PDVT----------YTLCGTPDY------IAPEV-----VSTKPYNKSIDWWSFGILIYE 195
Query: 206 FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
L G P+ + + Y+KI ++ P
Sbjct: 196 MLAGYTPFY---DSNTMKTYEKILNAELRFP 223
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
+ + +GSG FG + ++ +I V +K+ + SG + Q + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH- 74
Query: 63 SGIPNI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
+I + G+ G LV LG SL D R + +L Q IA+ +
Sbjct: 75 ---AHIVRLLGLCPGSSLQLVTQYLPLG-SLLDHVRQHRGALGPQLLLNWGVQ-IAKGMY 129
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ G +HR++ N L+ +QV + DFG+A
Sbjct: 130 YLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 26/157 (16%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
++G G++G + HV + +I+AVK + + +LL + I P
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRTVDCPFTVT 70
Query: 70 WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI--------EYV 119
+YG D + ++L+ SL+ + K + + + ++ +I E++
Sbjct: 71 FYGALFREGDVWICMELMDTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 120 HS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
HS +HRD+KP N L+ QV + DFG++
Sbjct: 126 HSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGY 159
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-12
Identities = 55/292 (18%), Positives = 107/292 (36%), Gaps = 38/292 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
++ ++G+G+ G +F SH + ++A K+ E Q++ E +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS---- 90
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I +YG + + ++ + G SL+ + R + + ++ +I + Y+
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 149
Query: 122 RG-FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+ +HRD+KP N L+ ++ + DFG++ + D N + GT Y
Sbjct: 150 KHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYM 197
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S G S + D+ S+G L+ G P A + + E +
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 241 CKSHPAEFASYFHYCQSLTF--------DQRPDYGFLKRLFHDLFSREGYDF 284
+ ++ P +L +FS E DF
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-----PKLPSGVFSLEFQDF 304
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 43/285 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+ +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----EKL 324
Query: 69 -KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----EYVHS 121
+ Y V E+ + +V + + SL D K+ L+ M A+I YV
Sbjct: 325 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV---DMAAQIASGMAYVER 381
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRENKNLTGTA 177
++HRD++ N L+G + + DFGLA+ D P + TA
Sbjct: 382 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 432
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
A+ + + D+ S G +LL +G +P+ G+ ++ D++ E+
Sbjct: 433 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRM 483
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
P C P C ++RP + +L+ D F+
Sbjct: 484 PCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 45/185 (24%), Positives = 73/185 (39%), Gaps = 43/185 (23%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGG 62
+G +Y + +G G G +F A D ++ VA+K I + + + E K+ + L
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH- 67
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV-----LMLAD------- 110
NI V V ++LGPS L L +V M D
Sbjct: 68 ---DNI----------VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ 114
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
Q++ ++Y+HS LHRD+KP N + + + I DFGLA+
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLARIMD 172
Query: 158 DPTTN 162
++
Sbjct: 173 PHYSH 177
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEIVAVKIENSGTKHPQL---LYEAKVYKILQGGS 63
+LGR IG G FG++ S + VA+K + T L EA +
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-- 75
Query: 64 GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYV 119
P+I K GV ++++L L + L ++++ A Q ++ + Y+
Sbjct: 76 --PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ-LSTALAYL 132
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
S+ F+HRDI N L+ + V + DFGL++ D
Sbjct: 133 ESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMED 168
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 34/181 (18%), Positives = 62/181 (34%), Gaps = 42/181 (23%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLAS-HVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQG 61
+ +Y++ +G G+FG++ H VA+K I N G E +L+
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VLK- 71
Query: 62 GSGIPNIKWYGVDGEDNV--------------LVLDLLGPSLEDLFVYCRRK-FSLKTVL 106
IK + + + +LLG + + + + L V
Sbjct: 72 -----KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR 126
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------GLGRKANQVYIIDF 150
+A Q+ + ++H H D+KP+N L K + + DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 151 G 151
G
Sbjct: 187 G 187
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 61/263 (23%), Positives = 98/263 (37%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++FLA TN+ A+K E +HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFS 101
+ ++ +++ GG DL + KF
Sbjct: 85 CTFQTKENLFFVMEYLNGG----------------------------DLMYHIQSCHKFD 116
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
L A ++I ++++HS+G ++RD+K DN L+ K + I DFG+ K+ D
Sbjct: 117 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDA 173
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TN T GT Y + LG + + D S G VLLY L G P+ G
Sbjct: 174 KTN-----------TFCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEMLIGQSPFHG- 220
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+++ + I P +
Sbjct: 221 --QDEEELFHSIRMDNPFYPRWL 241
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 54/263 (20%), Positives = 94/263 (35%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++ LA +T ++ AVK+ E HP QL
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFS 101
+++ +++ GG DL + R+F
Sbjct: 91 CCFQTPDRLFFVMEFVNGG----------------------------DLMFHIQKSRRFD 122
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
A ++I+ + ++H +G ++RD+K DN L+ + DFG+ K+
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGICNGV 179
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT T GT Y + + D ++G VLLY L G P++
Sbjct: 180 TTA-----------TFCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYEMLCGHAPFEA- 226
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+ ++ I +V P +
Sbjct: 227 --ENEDDLFEAILNDEVVYPTWL 247
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 56/259 (21%), Positives = 96/259 (37%), Gaps = 82/259 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++ L+ T+E+ AVKI E K P QL
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 51 Y----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSL 102
++Y V++ + G DL + ++ +F
Sbjct: 88 SCFQTMDRLY-----------------------FVMEYVNGG----DLMYHIQQVGRFKE 120
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
+ A ++ + ++ S+G ++RD+K DN ++ + I DFG+ K+ + T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWDGVT 177
Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
T T GT Y + + D + G VLLY L G P++G
Sbjct: 178 TK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAPFEG-- 223
Query: 218 AATKKQKYDKICEKKVSTP 236
+ + + I E V+ P
Sbjct: 224 -EDEDELFQSIMEHNVAYP 241
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 12/104 (11%)
Query: 86 GPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKA 142
+L+D L + Q+ +E++HS+G +HRD+KP N F
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MD 200
Query: 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-----GTARYAS 181
+ V + DFGL + + T GT Y S
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 15/67 (22%), Positives = 28/67 (41%), Gaps = 7/67 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
++ + +G G FG +F A + + A+K + N +++ E K L+
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE---- 62
Query: 65 IPNIKWY 71
P I Y
Sbjct: 63 HPGIVRY 69
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-11
Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 21/170 (12%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL ++G+G FGE+++ + + VAVK G+ P L EA + K LQ +
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQH----QRL 70
Query: 69 -KWYGV-DGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSR 122
+ Y V E ++ + + L + + K ++ +L +A Q+ + ++ R
Sbjct: 71 VRLYAVVTQEPIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
++HRD++ N L+ I DFGLA+ D P +
Sbjct: 129 NYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 61/201 (30%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVY------- 56
+ KY+L +K+G G++G ++ + T E+VAVK I + ++
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------AFQNSTDAQRTFRE 58
Query: 57 -KILQGGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLAD---- 110
IL SG NI V +L++L + D+++ M D
Sbjct: 59 IMILTELSGHENI----------VNLLNVLRADNDRDVYLV--------FDYMETDLHAV 100
Query: 111 ----------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
Q+I I+Y+HS G LHRD+KP N L+ A V + DFGL+
Sbjct: 101 IRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
Query: 154 KKYRDPTTNRHIPYRENKNLT 174
+ + + + T
Sbjct: 157 RSFVNIRRVTNNIPLSINENT 177
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 60/263 (22%), Positives = 91/263 (34%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
IG GSFG++ LA H AVK+ E + KHP L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
+ K+Y +L GG +LF + +R F
Sbjct: 106 FSFQTADKLYFVLDYINGG----------------------------ELFYHLQRERCFL 137
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
A ++ + + Y+HS ++RD+KP+N L+ + + DFGL K+ +
Sbjct: 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNS 194
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT+ T GT Y + R D LG +LY L G P+
Sbjct: 195 TTS-----------TFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEMLYGLPPFYS- 241
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+ YD I K + +
Sbjct: 242 --RNTAEMYDNILNKPLQLKPNI 262
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 43/285 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+ +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----EKL 241
Query: 69 -KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----EYVHS 121
+ Y V E+ + +V + + SL D K+ L+ M A+I YV
Sbjct: 242 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV---DMAAQIASGMAYVER 298
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRENKNLTGTA 177
++HRD++ N L+G + + DFGLA+ D P + TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
A+ + + D+ S G +LL +G +P+ G+ ++ D++ E+
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRM 400
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
P C P C ++RP + +L+ D F+
Sbjct: 401 PCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 34/160 (21%), Positives = 67/160 (41%), Gaps = 18/160 (11%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
+ IG+G FGE++ S VA+K +G Q L EA +
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH- 105
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
NI + GV + +++ + + +L+ +FS+ ++ + + A ++Y
Sbjct: 106 ---HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ + ++HRD+ N L+ + DFGL++ D
Sbjct: 163 LANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 42/157 (26%), Positives = 65/157 (41%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K + +GSG+FG ++ + E VA+K T +L EA V +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN- 76
Query: 63 SGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
P++ + G+ V L+ L G L D + + +L Q IA+ +
Sbjct: 77 ---PHVCRLLGICLTSTVQLITQLMPFG-CLLDYVREHKDNIGSQYLLNWCVQ-IAKGMN 131
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ R +HRD+ N L+ V I DFGLAK
Sbjct: 132 YLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 51/239 (21%), Positives = 89/239 (37%), Gaps = 38/239 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
+G G FGE+ T ++ A K + G L E + IL+ + +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQ---ILEKVNSRFV 246
Query: 66 PNIKWYGVDGEDNVLVLDLL--GPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYV 119
++ + + LVL L+ G DL + + F + A ++ +E +
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGG----DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H ++RD+KP+N L+ + I D GLA + T + GT Y
Sbjct: 303 HRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIK--------GRVGTVGY 351
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK-YDKICEKKVSTP 236
+ + D +LG LLY + G P+Q K K+++ + E
Sbjct: 352 MAPEVVKNERYTFSPDWWALG-CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 54/262 (20%), Positives = 97/262 (37%), Gaps = 83/262 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP---QLLY 51
+G G+FG++ L T A+KI E+ T+HP L Y
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 52 ----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSL 102
++ +++ GG +LF + R F+
Sbjct: 73 AFQTHDRLCFVMEYANGG----------------------------ELFFHLSRERVFTE 104
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
+ ++++ +EY+HSR ++RDIK +N ++ K + I DFGL K+ T
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGAT 161
Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
T GT Y + + R D LG V++Y + G LP+
Sbjct: 162 MK-----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPFYN-- 207
Query: 218 AATKKQKYDKICEKKVSTPIEV 239
++ ++ I +++ P +
Sbjct: 208 -QDHERLFELILMEEIRFPRTL 228
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 37/159 (23%), Positives = 66/159 (41%), Gaps = 17/159 (10%)
Query: 10 KLGRKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+ + IGSG GE+ + VA+K +G Q L EA +
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-- 109
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI + GV G ++V + + SL+ +F++ ++ + + A + Y+
Sbjct: 110 --PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
G++HRD+ N L+ + DFGL++ D
Sbjct: 168 SDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLED 203
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 56/263 (21%), Positives = 97/263 (36%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++ L+ T+E+ AVKI E K P QL
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
++Y +++ GG DL + ++ +F
Sbjct: 409 SCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQQVGRFK 440
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
+ A ++ + ++ S+G ++RD+K DN ++ + I DFG+ K+ +
Sbjct: 441 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWDGV 497
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT T GT Y + + D + G VLLY L G P++G
Sbjct: 498 TTK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAPFEG- 544
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+ + + I E V+ P +
Sbjct: 545 --EDEDELFQSIMEHNVAYPKSM 565
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 52/250 (20%), Positives = 95/250 (38%), Gaps = 57/250 (22%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
+G G FGE+F T ++ A K + G + + E K IL I
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG--AMVEKK---ILAKVHSRFI 247
Query: 66 PNIKWYGVDGEDNV-LVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLADQMIARI 116
++ Y + + ++ LV+ ++ G D+ F + Q+++ +
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGG----DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
E++H R ++RD+KP+N L+ V I D GLA + + + T
Sbjct: 303 EHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLAVE-----------LKAGQTKTKG 348
Query: 177 ARYASCNTH--------LGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK-YD 226
T LG E D +LG V LY + P++ + ++
Sbjct: 349 ----YAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYEMIAARGPFRARGEKVENKELKQ 403
Query: 227 KICEKKVSTP 236
++ E+ V+ P
Sbjct: 404 RVLEQAVTYP 413
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 36/159 (22%), Positives = 67/159 (42%), Gaps = 17/159 (10%)
Query: 10 KLGRKIGSGSFGEIFLA--SHVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+ + +G+G FGE+ EI VA+K G Q L EA +
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-- 105
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI + GV + ++V + + SL+ +F++ ++ + + + ++Y+
Sbjct: 106 --PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
G++HRD+ N L+ + DFGL + D
Sbjct: 164 SDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLED 199
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 50/221 (22%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
I +Y++ IG+GS+G + A +VA+K I + + E + L
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKF---SLKTVLM----LAD- 110
++ V VLD++ P + F +Y + K + L +
Sbjct: 111 H----DHV----------VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL 156
Query: 111 -------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162
++ ++YVHS G LHRD+KP N L+ + V + DFGLA
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV----NQDCSVKVCDFGLA--------- 203
Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESL-GYV 202
R + Y EN N + +L ++ L G+V
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 25/172 (14%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ Y +GSG++G + A + E VA+K + + Y E + K +Q
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 61 GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
N+ + D LV+ + DL KFS + + L Q
Sbjct: 82 H----ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---TDLQKIMGLKFSEEKIQYLVYQ 134
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162
M+ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+ T
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHADAEMTG 182
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 52/269 (19%), Positives = 99/269 (36%), Gaps = 87/269 (32%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
IG GS+ ++ L T+ I A+K+ E + HP L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
E++++ +++ GG DL + +R K
Sbjct: 77 SCFQTESRLFFVIEYVNGG----------------------------DLMFHMQRQRKLP 108
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
+ + ++ + Y+H RG ++RD+K DN L+ + + D+G+ K+
Sbjct: 109 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGD 165
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT+ T GT Y + G + D +LG VL++ + G P+ +
Sbjct: 166 TTS-----------TFCGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIV 213
Query: 217 KAA------TKKQKYDKICEKKVSTPIEV 239
++ T+ + I EK++ P +
Sbjct: 214 GSSDNPDQNTEDYLFQVILEKQIRIPRSL 242
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 51/268 (19%), Positives = 99/268 (36%), Gaps = 85/268 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
IG GS+ ++ L T+ I A+++ E + HP L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 51 Y----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSL 102
E++++ V++ + G DL + +R K
Sbjct: 120 SCFQTESRLF-----------------------FVIEYVNGG----DLMFHMQRQRKLPE 152
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
+ + ++ + Y+H RG ++RD+K DN L+ + + D+G+ K+ T
Sbjct: 153 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDT 209
Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
T+ T GT Y + G + D +LG VL++ + G P+ +
Sbjct: 210 TS-----------TFCGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVG 257
Query: 218 AA------TKKQKYDKICEKKVSTPIEV 239
++ T+ + I EK++ P +
Sbjct: 258 SSDNPDQNTEDYLFQVILEKQIRIPRSL 285
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-11
Identities = 37/154 (24%), Positives = 65/154 (42%), Gaps = 16/154 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQL---LYEAKVYKILQGGS 63
L R +G G FGE++ + + VAVK + EA + K L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH-- 72
Query: 64 GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P+I K G+ + E ++++L L + + T+++ + Q+ + Y+
Sbjct: 73 --PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S +HRDI N L+ V + DFGL++
Sbjct: 131 SINCVHRDIAVRNILVA---SPECVKLGDFGLSR 161
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 6e-11
Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ +Y+ + IGSG+ G + A + VA+K + H + Y E + K +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 61 GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
NI + + +D LV++L+ +L + + + + L Q
Sbjct: 120 H----KNIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQ 172
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKY 156
M+ I+++HS G +HRD+KP N ++ K++ + I+DFGLA+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA 214
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 36/177 (20%), Positives = 65/177 (36%), Gaps = 52/177 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ Y + IG GS+G ++LA +T + VA+K + + + E + L+
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD-------- 110
I + + DL+ P F +Y + + +D
Sbjct: 84 S----DYI----------IRLYDLIIPDDLLKFDELY------IVLEIADSDLKKLFKTP 123
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
++ ++H G +HRD+KP N L+ + V + DFGLA
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL----NQDCSVKVCDFGLA 176
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 38/187 (20%), Positives = 71/187 (37%), Gaps = 50/187 (26%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG 62
++ + + RK+G G+FG + L H+D + AVK+ + K EA + K +Q
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND 91
Query: 63 SGIPNIKWYGVDGEDN---------------VLVLDLLGPSLEDLFVYCRRK-FSLKTVL 106
D +N L+ + LGPSL ++ F ++ +
Sbjct: 92 -----------DINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK 140
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------------GLGRKANQ 144
+ +++ + Y+ H D+KP+N L+ K+
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 145 VYIIDFG 151
+ +IDFG
Sbjct: 201 IKLIDFG 207
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+LGR IG G FG++ ++ VA+K + T L EA +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-- 450
Query: 64 GIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P+I K GV E+ V ++++L L + L ++++ A Q+ + Y+
Sbjct: 451 --PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
S+ F+HRDI N L+ + V + DFGL++ D + +P +
Sbjct: 509 SKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 40/184 (21%), Positives = 65/184 (35%), Gaps = 50/184 (27%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN-SGTKHPQLLY-EAKVYKILQG 61
+G +Y IG G++G + A VA+K I + Q E K+ +
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--------- 110
NI + + D++ + VY + LM D
Sbjct: 85 ----ENI----------IGINDIIRAPTIEQMKDVY------IVQDLMETDLYKLLKTQH 124
Query: 111 -----------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRD 158
Q++ ++Y+HS LHRD+KP N L+ + I DFGLA+
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLARVADP 180
Query: 159 PTTN 162
+
Sbjct: 181 DHDH 184
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 56/188 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQ 60
+ +Y+ +GSG++G + A T VAVK + + E ++ K ++
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGP-----SLEDLFVYCRRKFSLKTVLMLAD----- 110
N+ + +LD+ P D+++ T LM AD
Sbjct: 87 H----ENV----------IGLLDVFTPARSLEEFNDVYLV--------THLMGADLNNIV 124
Query: 111 ---------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS +HRD+KP N + + ++ I+DFGLA+
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLAR 180
Query: 155 KYRDPTTN 162
D T
Sbjct: 181 HTADEMTG 188
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 11 LGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTKHPQL----LYEAKVYKILQGGSG 64
+++GSG+FG + + + VAVKI + P L L EA V + L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--- 77
Query: 65 IPNI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P I + G+ + E +LV+++ LG L ++ R K ++ L Q+ ++Y+
Sbjct: 78 -PYIVRMIGICEAESWMLVMEMAELG-PLNK-YLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HRD+ N L+ + I DFGL+K
Sbjct: 135 ESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 44/158 (27%), Positives = 65/158 (41%), Gaps = 22/158 (13%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQG 61
+L K+G GSFG + + VAVK + E L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 62 GSGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-I 116
N+ + YGV + +V +L LG SL D + F L T+ A Q +A +
Sbjct: 81 ----RNLIRLYGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLSRYAVQ-VAEGM 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ S+ F+HRD+ N L+ + V I DFGL +
Sbjct: 135 GYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 27/182 (14%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
L R +G G+FGE++ + + VAVK E + L EA +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM----- 112
NI + GV ++++L+ G L+ R + S + L + D +
Sbjct: 93 ----QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTTNRHIP 166
IA +Y+ F+HRDI N L+ I DFG+A+ Y +P
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 167 YR 168
+
Sbjct: 209 VK 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 35/181 (19%), Positives = 62/181 (34%), Gaps = 42/181 (23%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLA-SHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQG 61
++ +Y++ +G G+FG++ H VAVK ++N E +V + L
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNT 70
Query: 62 GSGIPNIKWYGVDGEDNV--------------LVLDLLGPSLEDLF-VYCRRKFSLKTVL 106
+ +V +LLG S D F L +
Sbjct: 71 ---------TDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------GLGRKANQVYIIDF 150
+A Q+ + ++HS H D+KP+N L + ++DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 151 G 151
G
Sbjct: 182 G 182
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 17/168 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
KL +K+G+G FGE+++A++ + VAVK G+ + L EA V K LQ
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQH----DKL 245
Query: 68 IKWYGVDGEDNVLVLDLLGP--SLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+K + V ++ + ++ SL D L K L ++ + Q+ + ++ R +
Sbjct: 246 VKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
+HRD++ N L+ + I DFGLA+ D P +
Sbjct: 306 IHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 38/176 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ--LLYEAKVYKILQGG 62
L R++G G+FG++FLA + + +VAVK T + EA++ LQ
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH- 76
Query: 63 SGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSLK 103
+I K+YGV DG+ ++V DL ++ + + L
Sbjct: 77 ---EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 104 TVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+L +A Q IA + Y+ S+ F+HRD+ N L+G V I DFG++ RD
Sbjct: 134 QMLHIASQ-IASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---RD 182
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 32/163 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE---IVAVKI--ENSGTKHPQ-LLYEAKVYKILQGGS 63
R IG G FG ++ ++D + A+K + + + L E + + L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH-- 81
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVY---CRRKFSLKTVLMLADQM 112
PN+ G+ E VL L DL + +R ++K ++ Q
Sbjct: 82 --PNVLALIGIMLPPEGLPHVL------LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ- 132
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+AR +EY+ + F+HRD+ N ++ ++ V + DFGLA+
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLAR 172
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 39/184 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
IG G FG ++ + +D + AVK N T + L E + K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 85
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVYCR---RKFSLKTVLMLADQM 112
PN+ G+ E + LV+ L DL + R ++K ++ Q
Sbjct: 86 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ- 136
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YR-DPTTNRH 164
+A+ ++Y+ S+ F+HRD+ N ++ + V + DFGLA+ Y T
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 165 IPYR 168
+P +
Sbjct: 194 LPVK 197
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 27/169 (15%), Positives = 61/169 (36%), Gaps = 26/169 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI-------VAVKIENSGTKHPQ--LLYEAKVYKILQ 60
+G G+F +IF + + V +K+ + ++ A + L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 61 GGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIA 114
++ YGV G++N+LV + + L Y ++ ++ L +A Q+ A
Sbjct: 71 H----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 115 RIEYVHSRGFLHRDIKPDNFL-----MGLGRKANQVYIIDFGLAKKYRD 158
+ ++ +H ++ N L + + D G++
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 35/177 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
IG G FG ++ + +D + AVK N T + L E + K
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 149
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVY---CRRKFSLKTVLMLADQM 112
PN+ G+ E + LV+ L DL + ++K ++ Q
Sbjct: 150 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ- 200
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+A+ ++++ S+ F+HRD+ N ++ + V + DFGLA RD
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---RDMYDKEFDSVH 251
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-10
Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 41/191 (21%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ--LLYEAKVYKILQGG 62
L ++G G+FG++FLA +VAVK ++ + EA++ +LQ
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH- 102
Query: 63 SGIPNI-KWYGV--DGEDNVLVL------DLL---------GPSLEDLFVYCRRKFSLKT 104
+I +++GV +G ++V DL L L
Sbjct: 103 ---QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 105 VLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YR 157
+L +A Q +A + Y+ F+HRD+ N L+G G V I DFG+++ YR
Sbjct: 160 LLAVASQ-VAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDYYR 215
Query: 158 DPTTNRHIPYR 168
+P R
Sbjct: 216 -VGGRTMLPIR 225
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 5e-10
Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 85/261 (32%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKI----------------EN---SGTKHP---QL 49
+G GSFG++FL + D ++ A+K+ E HP +L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 50 LY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKF 100
Y E K+Y IL +GG DLF + F
Sbjct: 92 HYAFQTEGKLYLILDFLRGG----------------------------DLFTRLSKEVMF 123
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRD 158
+ + V ++ ++++HS G ++RD+KP+N L+ + + + DFGL+K+ +
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHE 180
Query: 159 PTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 215
+ GT Y + ++ D S G VL++ L G+LP+QG
Sbjct: 181 KKAY-----------SFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGTLPFQG 228
Query: 216 LKAATKKQKYDKICEKKVSTP 236
+K+ I + K+ P
Sbjct: 229 ---KDRKETMTMILKAKLGMP 246
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 44/187 (23%), Positives = 70/187 (37%), Gaps = 37/187 (19%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
L R +G G+FGE++ + + VAVK E + L EA +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRR---------KFSLKTVLM 107
NI + GV ++L+L+ G DL + R ++ +L
Sbjct: 134 ----QNIVRCIGVSLQSLPRFILLELMAGG----DLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 108 LADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTT 161
+A IA +Y+ F+HRDI N L+ I DFG+A+ Y
Sbjct: 186 VARD-IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 162 NRHIPYR 168
+P +
Sbjct: 245 CAMLPVK 251
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 56/188 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ Y+ + +GSG++G + A T VA+K + + Y E ++ K ++
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGP-----SLEDLFVYCRRKFSLKTVLMLAD----- 110
N+ + +LD+ P D ++ M D
Sbjct: 83 H----ENV----------IGLLDVFTPDETLDDFTDFYLV--------MPFMGTDLGKLM 120
Query: 111 ---------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
QM+ + Y+H+ G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLAR 176
Query: 155 KYRDPTTN 162
+ T
Sbjct: 177 QADSEMTG 184
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 51/261 (19%), Positives = 94/261 (36%), Gaps = 80/261 (30%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP---QLLY 51
+G G+FG++ L T A+KI EN ++HP L Y
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 52 ----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSL 102
++ ++ GG +LF + R FS
Sbjct: 216 SFQTHDRLCFVMEYANGG----------------------------ELFFHLSRERVFSE 247
Query: 103 KTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
++++ ++Y+HS + ++RD+K +N ++ K + I DFGL K+
Sbjct: 248 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGA 304
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
T GT Y + + R D LG V++Y + G LP+
Sbjct: 305 TMK---------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPFYN--- 351
Query: 219 ATKKQKYDKICEKKVSTPIEV 239
++ ++ I +++ P +
Sbjct: 352 QDHEKLFELILMEEIRFPRTL 372
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 7e-10
Identities = 42/195 (21%), Positives = 73/195 (37%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
G+ +G+G+FG++ A D VAVK+ ++ + L+ E KV L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL-- 83
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------------GPSLEDLFVYCRRKF 100
NI G G +++ DLL + +
Sbjct: 84 -GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
L+ +L + Q +A+ + ++ S+ +HRD+ N L+ I DFGLA+
Sbjct: 143 DLEDLLSFSYQ-VAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKND 198
Query: 156 --YRDPTTNRHIPYR 168
Y N +P +
Sbjct: 199 SNYV-VKGNARLPVK 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 9e-10
Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 11 LGRKIGSGSFGEIFLAS-HVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGGSGI 65
++G G+FG + + +I VA+K+ GT+ ++ EA++ L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395
Query: 66 PNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
P I + GV E +LV+++ G L V R + + V L Q+ ++Y+ +
Sbjct: 396 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HR++ N L+ + I DFGL+K
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 25/163 (15%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ +Y+ + IGSG+ G + A VA+K + H + Y E + K +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 61 GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
NI + + +D +V++L+ +L + + + + L Q
Sbjct: 83 H----KNIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQ 135
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
M+ I+++HS G +HRD+KP N ++ K++ + I+DFGLA
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 61/266 (22%), Positives = 102/266 (38%), Gaps = 87/266 (32%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKI------------------ENS---GTKHP--- 47
+G G +G++F V +T +I A+K+ E + KHP
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 48 QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR-- 98
L+Y K+Y IL GG +LF+ R
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGG----------------------------ELFMQLEREG 116
Query: 99 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--Y 156
F T ++ + ++H +G ++RD+KP+N ++ V + DFGL K+ +
Sbjct: 117 IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKESIH 173
Query: 157 RDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPW 213
T+ T GT Y + + +R D SLG L+Y L G+ P+
Sbjct: 174 DGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALMYDMLTGAPPF 221
Query: 214 QGLKAATKKQKYDKICEKKVSTPIEV 239
G +K+ DKI + K++ P +
Sbjct: 222 TG---ENRKKTIDKILKCKLNLPPYL 244
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 13 RKIGSGSFGEIFLAS-HVDTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGGSGIPN 67
++G G+FG + + +I VA+K+ + + + ++ EA++ L P
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 71
Query: 68 I-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I + GV E +LV+++ G L V R + + V L Q+ ++Y+ + F
Sbjct: 72 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+HRD+ N L+ + I DFGL+K
Sbjct: 132 VHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-09
Identities = 35/177 (19%), Positives = 61/177 (34%), Gaps = 39/177 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ ++G FG+++ + + + VA+K + P +EA + LQ
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSL 102
PN+ GV + ++ DL D +
Sbjct: 72 ----PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 103 KTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ L Q IA +EY+ S +H+D+ N L+ V I D GL R+
Sbjct: 128 PDFVHLVAQ-IAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF---RE 177
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 42/189 (22%), Positives = 76/189 (40%), Gaps = 41/189 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ R++G GSFG ++ + VA+K N + L EA V K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------GPSLEDLFVYCRRKFSLKTVL 106
++ + GV G+ ++++ DL P++ + V SL ++
Sbjct: 88 ----HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV--LAPPSLSKMI 141
Query: 107 MLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YRDP 159
+A + IA + Y+++ F+HRD+ N ++ V I DFG+ + YR
Sbjct: 142 QMAGE-IADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYR-K 196
Query: 160 TTNRHIPYR 168
+P R
Sbjct: 197 GGKGLLPVR 205
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 38/188 (20%), Positives = 61/188 (32%), Gaps = 63/188 (33%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL------------L 50
+ Y + R I SGS+G + VA+K + N+ + + L
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 51 YEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLML 108
E ++ PNI + + D+ E +Y L T LM
Sbjct: 78 REIRLLNHFHH----PNI----------LGLRDIFVHFEEPAMHKLY------LVTELMR 117
Query: 109 AD----------------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QV 145
D ++ + +H G +HRD+ P N L+ N +
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDI 173
Query: 146 YIIDFGLA 153
I DF LA
Sbjct: 174 TICDFNLA 181
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 43/194 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
KLG+ +G G+FG++ A T VAVK+ G H + L+ E K+ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI-- 87
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL-------DLL----------GPSLEDLFVYCRRKFS 101
N+ G ++V+ +L P + +
Sbjct: 88 -GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 102 LKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK----- 155
L+ ++ + Q +A+ +E++ SR +HRD+ N L+ + N V I DFGLA+
Sbjct: 147 LEHLICYSFQ-VAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 202
Query: 156 -YRDPTTNRHIPYR 168
Y + +P +
Sbjct: 203 DYV-RKGDARLPLK 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 43/190 (22%), Positives = 76/190 (40%), Gaps = 38/190 (20%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ G+ +G+G+FG++ A+ + VAVK+ S + L+ E K+ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL-- 106
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL--------GPSLEDLFVYCRRKFSLKT 104
NI G G +++ DLL + F S +
Sbjct: 107 -GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 105 VLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDP--- 159
+L + Q +A+ + ++ S+ +HRD+ N L+ G + I DFGLA+ D
Sbjct: 166 LLHFSSQ-VAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIMNDSNYI 221
Query: 160 -TTNRHIPYR 168
N +P +
Sbjct: 222 VKGNARLPVK 231
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G+FG++ +A VAVK+ L+ E ++ K++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
NI G +++ +L D+ +
Sbjct: 98 ---GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
+ K ++ Q +AR +EY+ S+ +HRD+ N L+ + I DFGLA+
Sbjct: 155 TFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDINNI 210
Query: 156 --YRDPTTNRHIPYR 168
Y+ TTN +P +
Sbjct: 211 DYYK-KTTNGRLPVK 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 41/187 (21%), Positives = 62/187 (33%), Gaps = 36/187 (19%)
Query: 10 KLGRKIGSGSFGEIFLA--SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSG 64
K IG G+FG++ A A+K E +V L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH-- 85
Query: 65 IPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSLKTV 105
PNI G L + +LL + S + +
Sbjct: 86 -PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 106 LMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTT 161
L A +AR ++Y+ + F+HRD+ N L+G I DFGL++ Y T
Sbjct: 145 LHFAAD-VARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEVYV-KKT 199
Query: 162 NRHIPYR 168
+P R
Sbjct: 200 MGRLPVR 206
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G+FG++ LA + VAVK+ S L+ E ++ K++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
NI G +++ +L + +
Sbjct: 132 ---GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
S K ++ A Q +AR +EY+ S+ +HRD+ N L+ + I DFGLA+
Sbjct: 189 SSKDLVSCAYQ-VARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLARDIHHI 244
Query: 156 --YRDPTTNRHIPYR 168
Y+ TTN +P +
Sbjct: 245 DYYK-KTTNGRLPVK 258
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 9e-09
Identities = 45/192 (23%), Positives = 70/192 (36%), Gaps = 46/192 (23%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
LGR +G G FG + A + VAVK+ + L EA K
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH- 84
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL--------GPSLEDLFVYCR--------RKFSLK 103
P++ K GV + + G DL + L+
Sbjct: 85 ---PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG----DLHAFLLASRIGENPFNLPLQ 137
Query: 104 TVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------Y 156
T++ IA +EY+ SR F+HRD+ N ++ + V + DFGL++K Y
Sbjct: 138 TLVRFMVD-IACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGDYY 193
Query: 157 RDPTTNRHIPYR 168
R +P +
Sbjct: 194 R-QGCASKLPVK 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 42/195 (21%), Positives = 74/195 (37%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G FG++ +A VAVK+ L+ E ++ K++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
NI G +++ +L D+ +
Sbjct: 144 GKH---KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
+ K ++ Q +AR +EY+ S+ +HRD+ N L+ + I DFGLA+
Sbjct: 201 TFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDINNI 256
Query: 156 --YRDPTTNRHIPYR 168
Y+ TTN +P +
Sbjct: 257 DYYK-KTTNGRLPVK 270
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 47/187 (25%), Positives = 70/187 (37%), Gaps = 37/187 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
LG+ +G G FG + + + VAVK + L EA K
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH- 95
Query: 63 SGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYCR--------RKFSLKTVLML 108
PN+ + GV E + + L DL Y + L+T+L
Sbjct: 96 ---PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 109 ADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YRDPTT 161
IA +EY+ +R FLHRD+ N ++ V + DFGL+KK YR
Sbjct: 153 MVD-IALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDYYRQ-GR 207
Query: 162 NRHIPYR 168
+P +
Sbjct: 208 IAKMPVK 214
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 89/271 (32%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKI------------------EN----SGTKHP-- 47
+G+G++G++FL + DT ++ A+K+ E + P
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 48 -QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCR 97
L Y E K++ IL GG +LF + R
Sbjct: 122 VTLHYAFQTETKLHLILDYINGG----------------------------ELFTHLSQR 153
Query: 98 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAK 154
+F+ V + +++ +E++H G ++RDIK +N L+ G V + DFGL+K
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVLTDFGLSK 207
Query: 155 KYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQ--SRRDDLESLGYVLLY-FLRG 209
+ + GT Y + + G + + D SLG VL+Y L G
Sbjct: 208 --------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG-VLMYELLTG 258
Query: 210 SLPWQGL-KAATKKQKYDKICEKKVSTPIEV 239
+ P+ + ++ + +I + + P E+
Sbjct: 259 ASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 4e-08
Identities = 39/212 (18%), Positives = 61/212 (28%), Gaps = 59/212 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------------------------- 39
K + KIG G FGE+F + VA+KI
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 40 ------ENSGTKH----------------PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77
+ P LL +A + GS ++ D
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLM 136
VL + G LE + SL T + Q+ A + + F HRD+ N L+
Sbjct: 139 IVLEFEFGGIDLEQ---MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+K + + K P+ +
Sbjct: 196 ---KKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 4e-08
Identities = 42/201 (20%), Positives = 73/201 (36%), Gaps = 51/201 (25%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
LG+ +G G FG++ A VAVK+ + LL E V K +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------------------GPSLEDLFV 94
P++ K YG +L++ L + L
Sbjct: 86 ----PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 95 YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
R ++ ++ A Q I++ ++Y+ +HRD+ N L+ G ++ I DFGL+
Sbjct: 142 PDERALTMGDLISFAWQ-ISQGMQYLAEMKLVHRDLAARNILVAEG---RKMKISDFGLS 197
Query: 154 KK------YRDPTTNRHIPYR 168
+ Y + IP +
Sbjct: 198 RDVYEEDSYV-KRSQGRIPVK 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 49/201 (24%), Positives = 70/201 (34%), Gaps = 51/201 (25%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ R IG G+FG +F A + +VAVK+ EA +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------------------GPSLEDLFV 94
PNI K GV G+ L+ DL + +
Sbjct: 110 ----PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 95 YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
S L +A Q +A + Y+ R F+HRD+ N L+G V I DFGL+
Sbjct: 166 PGPPPLSCAEQLCIARQ-VAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGLS 221
Query: 154 KK------YRDPTTNRHIPYR 168
+ Y+ N IP R
Sbjct: 222 RNIYSADYYK-ADGNDAIPIR 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 43/200 (21%), Positives = 70/200 (35%), Gaps = 49/200 (24%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ G+ +GSG+FG++ A S + VAVK+ + L+ E K+ L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL-- 105
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL-----------------GPSLEDLFVY 95
NI G L+ DLL
Sbjct: 106 -GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 96 CRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ + +L A Q +A+ +E++ + +HRD+ N L+ V I DFGLA+
Sbjct: 165 DLNVLTFEDLLCFAYQ-VAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 220
Query: 155 K------YRDPTTNRHIPYR 168
Y N +P +
Sbjct: 221 DIMSDSNYV-VRGNARLPVK 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 3e-06
Identities = 48/310 (15%), Positives = 96/310 (30%), Gaps = 106/310 (34%)
Query: 28 HVDT---NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP----NIKWYGVDGEDNVL 80
HV+ I+ + + +++ + + IP ++ W+ V D ++
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLS--VFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI--KPDNFLMGL 138
V++ L K+SL + Q + S ++ ++ K +N L
Sbjct: 407 VVNKL------------HKYSL-----VEKQPKESTISIPS---IYLELKVKLEN-EYAL 445
Query: 139 GRKANQVYIID-FGLAKKY--RDPTTNR-------HIPYRENKNLTGTARYASCNTHL-G 187
R I+D + + K + D HI + HL
Sbjct: 446 HRS-----IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-----------------HLKN 483
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247
IE R L + ++ FL +K ++D + + L +
Sbjct: 484 IEHPERMTLFRMVFLDFRFLE------------QKIRHDSTAWNASGSILNTL-----QQ 526
Query: 248 FASYFHYCQSLTFDQRPDY--------GFLKRLFHDLFSREGYDF---------DFVFDW 290
Y Y D P Y FL ++ +L + D + +F+
Sbjct: 527 LKFYKPY----ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEE 582
Query: 291 TILKYQQTQK 300
++Q Q+
Sbjct: 583 A---HKQVQR 589
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
E + +L+ ++ + Q+ +E++ SR +HRD+ N L+ V
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 147 IIDFGLAKK-YRDP----TTNRHIPYR 168
I DFGLA+ Y+DP + +P +
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLK 260
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 15/93 (16%)
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
GIP + VD ++ +++ + G +D+ + +++ ++ H
Sbjct: 399 FGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIE------DNLDIAYKIGEIVGKL---HK 449
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+H D+ NF+ +YIIDFGL K
Sbjct: 450 NDVIHNDLTTSNFIFD-----KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 306 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.53 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.49 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.28 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.78 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.58 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.8 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.59 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.47 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.99 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.38 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.22 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-58 Score=397.28 Aligned_cols=255 Identities=19% Similarity=0.290 Sum_probs=213.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC--CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
..|++.+.||+|+||.||+|+++.+|+.||||++... .....+.+|+.+++.+.| ++|..+..++.+....||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeC
Confidence 4699999999999999999999999999999987633 344568899999999976 6666777777788899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
| +|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.+|.+||+|||+|+........
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~- 226 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPR- 226 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC-
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCc-
Confidence 9 7899998874 469999999999999999999999999999999999999 58899999999999876543321
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+... .+..+........ + ....
T Consensus 227 ------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~~~~~~-~-~~~~ 295 (346)
T 4fih_A 227 ------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDNLPPRL-K-NLHK 295 (346)
T ss_dssp ------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSSCCCC-S-CGGG
T ss_pred ------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCCCCCC-C-cccc
Confidence 236689999999999999999999999999999999999999998765442 3333333221111 1 1256
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
+|+++.+||.+||+.||++|||++|+++ +.++.+..
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~--Hp~~~~~~ 331 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAG 331 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhcCCC
Confidence 7899999999999999999999999987 67776443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-58 Score=386.11 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=200.6
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||.||+|+++.+|+.||+|++.... ....+.+|+.+++.+.| +++..+..++......|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-PHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999886432 23457889999999976 6666776677788899999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|||++|+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 92 mEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence 99999999999876 5679999999999999999999999999999999999999 5889999999999976543322
Q ss_pred CccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.....||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.+.+.. ..+..+.......+
T Consensus 168 --------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i~~~~~~~p---- 232 (275)
T 3hyh_A 168 --------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNISNGVYTLP---- 232 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCC----
T ss_pred --------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC----
Confidence 125689999999999999886 68999999999999999999999875433 44445555554444
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+|+++.+||.+||+.||++|||++|+++ +.+++
T Consensus 233 -~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k 267 (275)
T 3hyh_A 233 -KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFK 267 (275)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHH
T ss_pred -CCCCHHHHHHHHHHccCChhHCcCHHHHHc--Ccccc
Confidence 567899999999999999999999999988 67775
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=394.94 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=212.7
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
.++|++++.||+|+||.||+|+++.+++.||+|++.. ......+.+|+.+++.+.| +++..+...+.+....|+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 4679999999999999999999999999999998763 2344568899999999976 666677777778889999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
||||+ +|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence 99999 7899999986 4579999999999999999999999999999999999999 58899999999999876543
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+. ...+.++.......+
T Consensus 186 ~~~~-----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~~~~p--- 254 (311)
T 4aw0_A 186 SKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAKIIKLEYDFP--- 254 (311)
T ss_dssp TTCC-----CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCC---
T ss_pred CCcc-----cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCC---
Confidence 2211 12366899999999999999999999999999999999999999987544 345556666665554
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..+++++++||.+||++||++|||++|+.+
T Consensus 255 --~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 255 --EKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp --TTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred --cccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 567999999999999999999999998643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=392.87 Aligned_cols=260 Identities=22% Similarity=0.221 Sum_probs=212.4
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
..|++.++||+|+||.||+|+++.+|+.||+|++..+.. ..+|+.+++.+.| ++|..+..++.+....||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSS-PRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCC-TTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeccC
Confidence 468899999999999999999999999999999876533 3579999999876 66666767777888999999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc-eEEEEeeccccccCCCCCCcc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .+| .+||+|||+|+..........
T Consensus 134 gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 134 GGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCCcccc
Confidence 7899999986 45799999999999999999999999999999999999994 666 699999999987654322111
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
. ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+... ...++..... +...+.+.+
T Consensus 210 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~~~~--~~~~~~~~~ 282 (336)
T 4g3f_A 210 L--LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKIASEPP--PIREIPPSC 282 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHHHHSCC--GGGGSCTTS
T ss_pred e--ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHcCCC--CchhcCccC
Confidence 0 01224579999999999999999999999999999999999999998755432 2333333332 222344678
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
|+.+.++|.+||++||.+|||+.||++.|...+...+
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=396.38 Aligned_cols=247 Identities=21% Similarity=0.214 Sum_probs=203.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++++.||+|+||.||+|+++.+|+.||+|++...... ..+.+|+.+++++.| ++|..+..++.+....|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-PNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEE
Confidence 5899999999999999999999999999999998765432 357889999999976 66666777777888999999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||| +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCc
Confidence 999 789999997543 347999999999999999999999999999999999999 588999999999998654321
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
. .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.. ..+.++.....+. .
T Consensus 180 ~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~----~ 245 (350)
T 4b9d_A 180 E-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVLKIISGSFPP----V 245 (350)
T ss_dssp H-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTCCCC----C
T ss_pred c-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcCCCCC----C
Confidence 1 112457999999999999999999999999999999999999999876543 4444555444332 1
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...+|+++.+||.+||+.||++|||++++++
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2567899999999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-57 Score=398.93 Aligned_cols=254 Identities=19% Similarity=0.279 Sum_probs=212.6
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC--CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
..|++.+.||+|+||.||+|+++.+|+.||||++... .....+.+|+.+++.+.| ++|..+..++......||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCCCceEEEEEECCEEEEEEeC
Confidence 5699999999999999999999999999999988643 334568899999999976 6666776777788899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
| +|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.+|.+||+|||+|+........
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~~- 303 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPR- 303 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCCC-
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCcc-
Confidence 9 7899998864 469999999999999999999999999999999999999 58899999999999876543321
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+... .+..+........ .....
T Consensus 304 ------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~~~~~~--~~~~~ 372 (423)
T 4fie_A 304 ------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDNLPPRL--KNLHK 372 (423)
T ss_dssp ------BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSCCCCC--SCTTS
T ss_pred ------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCCCCCC--ccccc
Confidence 236789999999999999999999999999999999999999998765443 3333332221111 11256
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
+|+++.+||.+||+.||++|||++|+++ +.++.+.
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~--Hp~~~~~ 407 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKA 407 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc--CHHhcCC
Confidence 7899999999999999999999999987 6777643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=377.63 Aligned_cols=294 Identities=70% Similarity=1.243 Sum_probs=258.4
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
|...++++|++.+.||+|++|.||+|++..+++.||+|++........+.+|+.+++.+.|+++++.+..++......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 45568899999999999999999999999999999999988777777899999999999999999988888888888999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
++|+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||++..+.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999999999998766779999999999999999999999999999999999999654578899999999998776655
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.....++.......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..+.......+.+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 44334444455678999999999999999999999999999999999999999876555545555555555666666667
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceecc
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 294 (306)
+..+|+.+.++|.+||+.||.+|||+.++++.|++++...+...+.+++|+.++
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGCC
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 788899999999999999999999999999999999999999999999998763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=377.41 Aligned_cols=293 Identities=70% Similarity=1.244 Sum_probs=252.4
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
|...++++|++.+.||+|+||.||+|++..+++.||+|++........+.+|+.++..+.|+++++.+..++......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 45568899999999999999999999999999999999988777777899999999999999999998888888889999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
++|+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+...+.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999999999998766779999999999999999999999999999999999999544578899999999998876655
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.....++.......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..........+.+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 44444444455678999999999999999999999999999999999999999886665555566666666666777777
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceec
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 293 (306)
...+|+++.++|.+||+.||++|||+.++++.|+.++.+.+...+.++||+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 78889999999999999999999999999999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=379.38 Aligned_cols=254 Identities=21% Similarity=0.275 Sum_probs=200.4
Q ss_pred cCCce-eEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeece---eCc
Q 021855 5 IGVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV---DGE 76 (306)
Q Consensus 5 ~~~~y-~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~---~~~ 76 (306)
.+++| ++.+.||+|+||.||+|++..+++.||+|.+..... ...+.+|+.+++++.|++.+..+..+.. ...
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 34565 788899999999999999999999999998764432 2357889999999987544443333322 235
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
..++||||| +|+|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++ +.++.+||+|||+|
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla 179 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCC
Confidence 679999999 7899999876 457999999999999999999999998 99999999999994 24789999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
+...... ....+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.... ......+.....
T Consensus 180 ~~~~~~~---------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i~~~~~ 247 (290)
T 3fpq_A 180 TLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVK 247 (290)
T ss_dssp GGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCC
T ss_pred EeCCCCc---------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHHHcCCC
Confidence 7543322 125689999999999875 6999999999999999999999999764332 222333322222
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+. ......++++.+||.+||+.||++|||++++++ +.+++
T Consensus 248 ~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~--Hp~~~ 287 (290)
T 3fpq_A 248 PA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQ 287 (290)
T ss_dssp CG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC
T ss_pred CC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--Ccccc
Confidence 21 223566889999999999999999999999987 55554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=382.23 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=211.9
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
+.|-..+|.+.+.||+|+||.||+|++. .++..||||++..... ...+.+|+.++++++| +++..+..++.+
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~ 86 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVE 86 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCC-CCCccEEEEEee
Confidence 3455578999999999999999999875 3578899999875432 3458899999999976 666666666777
Q ss_pred CceeEEEEecc-CCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCR------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~ 141 (306)
....++||||| +|+|.+++...+ ..+++..+..++.||+.||.|||+++|+||||||+|||+ ++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~ 163 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GE 163 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CC
Confidence 78899999999 899999987532 358999999999999999999999999999999999999 58
Q ss_pred cceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhh
Q 021855 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (306)
Q Consensus 142 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~ 220 (306)
++.+||+|||+|+........ .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~- 237 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN- 237 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCE-----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred CCcEEECCcccceecCCCCce-----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 999999999999765432221 11224568999999999999999999999999999999999 99999886554
Q ss_pred hHHHHHHHhhccc-ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 221 KKQKYDKICEKKV-STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 221 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+..+..+.. ..+ ..+|+++.+||.+||+.||++|||+.+|.+.|+.+.+.
T Consensus 238 --~~~~~i~~~~~~~~p-----~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 238 --EVIECITQGRVLQRP-----RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp --HHHHHHHHTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHcCCCCCCC-----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 33333333322 222 56789999999999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=373.25 Aligned_cols=292 Identities=57% Similarity=0.994 Sum_probs=253.9
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+.+++++|++.+.||+|++|.||+|++..+++.||+|++........+.+|+.++..+.++++++.+..++......+++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 46789999999999999999999999999999999999887777778899999999998888899988888888899999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC--CCcceEEEEeeccccccCCC
Q 021855 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~--~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.. +..+.++|+|||++......
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9999999999998766679999999999999999999999999999999999999421 12334999999999877665
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
......++.......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..+.......+.+.
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence 54443344444567899999999999999999999999999999999999999988665555555556555555566666
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceec
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 293 (306)
....+|+++.++|.+||+.||++|||+++|++.|++++++.+...+.++||+.+
T Consensus 245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~l 298 (298)
T 1csn_A 245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298 (298)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCCC
Confidence 667889999999999999999999999999999999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=382.74 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=198.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc---CCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+-..+|++.+.||+|+||.||+|++. .+++.||+|++.... ....+.+|+.+++++.| +++..+...+.+..
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCC-TTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECC
Confidence 34468999999999999999999874 468899999886432 22357789999998876 66666767777888
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..|+||||| +|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEeccccccee
Confidence 999999999 8899999986 4579999999999999999999999999999999999999 5889999999999986
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.. ..+..+.......
T Consensus 176 ~~~~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~ 245 (304)
T 3ubd_A 176 SIDHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTMILKAKLGM 245 (304)
T ss_dssp -----C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCC
T ss_pred ccCCCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHHHHcCCCCC
Confidence 543322 123568999999999999999999999999999999999999999886543 4455555555555
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCCh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 266 (306)
+ ..+|+++.+||.+||+.||++|||+
T Consensus 246 p-----~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 246 P-----QFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp C-----TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred C-----CcCCHHHHHHHHHHcccCHHHCCCC
Confidence 4 5679999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=376.50 Aligned_cols=258 Identities=23% Similarity=0.292 Sum_probs=201.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
+-.+++++.+.||+|+||.||+|++. ..||||+++..... ..+.+|+.++++++|++ +..+..+.. .+..+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpN-IV~l~g~~~-~~~~~ 107 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVN-ILLFMGYMT-KDNLA 107 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTT-BCCEEEEEC-SSSCE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCC-EeeEEEEEE-CCeEE
Confidence 34567889999999999999999864 35899988754332 35788999999998755 444544443 35689
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+||||| +|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+ ++++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceeccc
Confidence 999999 899999997656679999999999999999999999999999999999999 5899999999999976543
Q ss_pred CCCCccccccCCccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc-c
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-S 234 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~ 234 (306)
..... ......||+.|+|||++.+ .+|+.++|||||||++|||+||+.||.+.+... .+...+.... .
T Consensus 185 ~~~~~-----~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~~~~~~~~~~~~ 256 (307)
T 3omv_A 185 WSGSQ-----QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QIIFMVGRGYAS 256 (307)
T ss_dssp --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHTTCCC
T ss_pred CCcce-----eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---HHHHHHhcCCCC
Confidence 22211 1235679999999999964 358999999999999999999999998755432 2222222222 2
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
...+.....+|+.+.+||.+||+.||++|||+.+|++.|+.+-
T Consensus 257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2233344678899999999999999999999999999998663
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-55 Score=396.69 Aligned_cols=299 Identities=78% Similarity=1.329 Sum_probs=267.4
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
|+..++++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.++..+.++++++.+..++......++
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 67889999999999999999999999999999999999988877778899999999999999999999888888999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.......
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999999998767789999999999999999999999999999999999999554578999999999998877665
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.....++.......+|..|+|||++.+..++.++|||||||++|+|++|..||.+.........+..+...........+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 55444555556778999999999999999999999999999999999999999987766666677777666666677777
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceecchhhhH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (306)
+..+++++.++|..||+.||.+||++.+|++.|+.++...+..++.+|||+.+..++..
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~ 299 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC----
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcccccc
Confidence 78899999999999999999999999999999999999999999999999998877643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=377.16 Aligned_cols=258 Identities=18% Similarity=0.228 Sum_probs=208.5
Q ss_pred cccCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
.+--..+++.+.||+|+||.||+|++. .+++.||||++..... ...+.+|+.++++++| +++..+..++..
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH-PNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCC-CCCCCcceEEEE
Confidence 344567889999999999999999864 4678899999875432 3568899999999977 556666666667
Q ss_pred CceeEEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~ 138 (306)
....++||||| +|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl-- 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV-- 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE--
Confidence 77899999999 89999998642 1358899999999999999999999999999999999999
Q ss_pred CCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 021855 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (306)
Q Consensus 139 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~ 217 (306)
++++.+||+|||+|+........ .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.+
T Consensus 179 -~~~~~~Ki~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 179 -YDKLNVKISDLGLFREVYAADYY-----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp -CGGGCEEECCSCCBCGGGGGGCB-----CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred -CCCCCEEECCcccceeccCCCce-----eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 58999999999999765432211 11235578999999999999999999999999999999998 899998866
Q ss_pred hhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
... .+..+..+. ..+.+ ..+|+++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 253 ~~~---~~~~i~~~~-~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 253 NQD---VVEMIRNRQ-VLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHH---HHHHHHTTC-CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHH---HHHHHHcCC-CCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 542 333333222 22222 56789999999999999999999999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=379.18 Aligned_cols=258 Identities=23% Similarity=0.325 Sum_probs=204.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+-..+|.+.+.||+|+||.||+|++. .+++.||||++..... ...+.+|+.++++++| +++..+..++.+..
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH-QHIVRFFGVCTEGR 116 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECC
Confidence 33467899999999999999999865 4688999999875432 2458899999999976 66666666677778
Q ss_pred eeEEEEecc-CCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR--------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~--------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~ 141 (306)
..++||||| +|+|.+++.... .++++..+..++.||+.||.|||+++|+||||||+|||+ ++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CC
Confidence 899999999 899999986532 358999999999999999999999999999999999999 58
Q ss_pred cceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhh
Q 021855 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (306)
Q Consensus 142 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~ 220 (306)
++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+...
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp TTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred CCcEEEcccccceeccCCCcc-----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999865433221 11224578999999999999999999999999999999999 899998866543
Q ss_pred hHHHHHHHhhcc-cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 221 KKQKYDKICEKK-VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 221 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.+..+.... ...+ ..+|+++.+||.+||+.||++|||+.+|++.|+.+.+
T Consensus 269 ---~~~~i~~g~~~~~p-----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 ---AIDCITQGRELERP-----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ---HHHHHHHTCCCCCC-----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHcCCCCCCc-----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 333333322 2222 5678999999999999999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-55 Score=382.51 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=213.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCC-----CceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeece-eC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV-DG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~ 75 (306)
--++|++.+.||+|+||.||+|++..+ ++.||+|.+...... ..+.+|+.++.++.||+++..+..++. ..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 346899999999999999999998654 367999988765443 357889999999999888777765543 45
Q ss_pred ceeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~ 139 (306)
...++||||| +|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl--- 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--- 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee---
Confidence 6789999999 889999987532 247899999999999999999999999999999999999
Q ss_pred CCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchh
Q 021855 140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA 218 (306)
Q Consensus 140 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~ 218 (306)
++++.+||+|||+|+........ .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.+.
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred CCCCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 58999999999999865443321 12235578999999999999999999999999999999998 9999987543
Q ss_pred hhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
. ..+.+.+......+.+ ..+++++.++|.+||+.||++|||+.+|++.|+.+++.+
T Consensus 294 ~---~~~~~~i~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 294 D---EEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp S---HHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H---HHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 2 2222233332222222 566899999999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=385.54 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=210.5
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeec------ee
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYG------VD 74 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~------~~ 74 (306)
++++|++++.||+|+||.||+|+++.+|+.||||++...... ..+.+|+.+++.+.|+ ++..+..++ .+
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD-NIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCT-TBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCC-CcceEeeeeeccccccc
Confidence 567899999999999999999999999999999998765433 3467899999999874 444443332 23
Q ss_pred CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
....|+||||++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceee
Confidence 467899999999999998875 4579999999999999999999999999999999999999 589999999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc-
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK- 232 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~- 232 (306)
.+........ ......+||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 207 ~~~~~~~~~~---~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEHQ---YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp CC-------C---CCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ecccCccccc---cccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 6543322111 1223678999999999998865 6999999999999999999999999876654444443332211
Q ss_pred ----------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 233 ----------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 233 ----------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.+.+.....+.+++++.+||.+||++||.+|||++|+++ +.++.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~ 350 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR--HPFLAK 350 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGGTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc--CHhhCc
Confidence 111223344567889999999999999999999999988 777764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=372.80 Aligned_cols=287 Identities=56% Similarity=1.018 Sum_probs=250.7
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.+++++|++.+.||+|+||.||+|++..+++.||+|++........+.+|+.+++.+.++++++.+..++......+++|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 36789999999999999999999999999999999998877777788999999999977788888888888888999999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce-----EEEEeeccccccC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ-----VYIIDFGLAKKYR 157 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~-----~kl~Dfg~~~~~~ 157 (306)
|+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||++ .++. +||+|||++....
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESB
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeee
Confidence 9999999999987666799999999999999999999999999999999999994 5565 9999999998776
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
........++.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..+.......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 65554444444455778999999999999999999999999999999999999999886655555556666555555665
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceec
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 293 (306)
+..+..+| ++.++|..||+.||.+||++++|.+.|++++.+.+...+..++|+..
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 296 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGK 296 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTS
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCC
Confidence 65666677 99999999999999999999999999999999999999999999843
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=369.35 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=205.9
Q ss_pred cCCceeEeeeecccCccEEEEEEEc---CCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+.++|++.+.||+|+||.||+|+++ .+++.||+|.+..........+|+.++..+.+|+++..+...+......|+|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 5688999999999999999999875 4678999999887766677889999999998778888888888888999999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++. .+++..+..++.||+.||.|||++||+||||||+|||++ .+.+.+||+|||+|+......
T Consensus 99 mE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 99 MPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCS
T ss_pred EeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCcc
Confidence 9999 789988873 589999999999999999999999999999999999995 334899999999997654322
Q ss_pred CCcc---------------------ccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchh
Q 021855 161 TNRH---------------------IPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (306)
Q Consensus 161 ~~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~ 218 (306)
.... .........+||+.|+|||++.+.. |+.++||||+||++|+|++|+.||...+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1100 0000112457999999999998865 89999999999999999999999965332
Q ss_pred -hhhHHHHHHHhhcc-----------------------------------cccc-----------hHHHhhcCchHHHHH
Q 021855 219 -ATKKQKYDKICEKK-----------------------------------VSTP-----------IEVLCKSHPAEFASY 251 (306)
Q Consensus 219 -~~~~~~~~~~~~~~-----------------------------------~~~~-----------~~~~~~~~~~~~~~l 251 (306)
.+....+....+.. ...+ .......+|+++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 11111111111100 0000 001124568889999
Q ss_pred HHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 252 FHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 252 i~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
|.+||+.||++|||++|+++ +.+++.
T Consensus 333 l~~lL~~dP~~R~ta~eaL~--Hp~f~~ 358 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALL--HPFFKD 358 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHT--SGGGTT
T ss_pred HHHHCcCChhHCcCHHHHhc--CcccCC
Confidence 99999999999999999987 666653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=362.23 Aligned_cols=258 Identities=20% Similarity=0.253 Sum_probs=186.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeecee---------
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD--------- 74 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--------- 74 (306)
.+|++.+.||+|+||.||+|+++.+|+.||+|++..... ...+.+|+.+++.+.|++.+..+..+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 359999999999999999999999999999998865433 24578899999999875444444333322
Q ss_pred --CceeEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEe
Q 021855 75 --GEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 75 --~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
....|++|||| +++|.+++..... ..+...++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEcc
Confidence 22468999999 8899999875322 24566788999999999999999999999999999999 4889999999
Q ss_pred eccccccCCCCCCccc-----cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHH
Q 021855 150 FGLAKKYRDPTTNRHI-----PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 224 (306)
||+|+........... ........+||+.|+|||++.+..|+.++|||||||++|||++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHHH
Confidence 9999876543222110 1112234579999999999999999999999999999999996 8875332 2222
Q ss_pred HHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+..+.....+. .....++.+.+||.+||+.||.+|||+.++++ +.+++
T Consensus 237 ~~~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~--h~~~~ 284 (299)
T 4g31_A 237 LTDVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFE 284 (299)
T ss_dssp HHHHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGC
T ss_pred HHHHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhC
Confidence 33332222221 12333567889999999999999999999987 56664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=364.69 Aligned_cols=266 Identities=24% Similarity=0.252 Sum_probs=192.9
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHH--HHHHHhCCCCCCcceeece-eC---cee
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAK--VYKILQGGSGIPNIKWYGV-DG---EDN 78 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~--~l~~l~~~~~~~~~~~~~~-~~---~~~ 78 (306)
++++|.+.+.||+|+||.||+|++ +|+.||||++..... ..+..|.+ .+..++| +++..+..++. .. ...
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~H-pNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCC-CCCCcEEEEEEecCCCceEE
Confidence 467899999999999999999987 688999999875432 23344443 4445666 45555444433 22 257
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCceeeccCCCcceEEEEe
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
++||||+ +|+|.+++.. .+++++.+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~D 151 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEe
Confidence 9999999 7899999874 4689999999999999999999987 99999999999999 5899999999
Q ss_pred eccccccCCCCCCccccccCCccccccccccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCch------
Q 021855 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRGSLPWQGLK------ 217 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~il~~l~tg~~pf~~~~------ 217 (306)
||+|+.......... .......||+.|+|||++.+. .++.++|||||||++|||+||..||....
T Consensus 152 FGla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 152 LGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred CCCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 999987654332211 011245799999999999765 36789999999999999999977664321
Q ss_pred ----hh--hhHHHHHHHhhcccccchHHHh--hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 218 ----AA--TKKQKYDKICEKKVSTPIEVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 218 ----~~--~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
.. ..............+...+... ...++.+.+||.+||+.||++|||+.+|++.|+++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 11 0111222233333332222211 22345789999999999999999999999999999887654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=383.57 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=210.1
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHh--CCCCCCcceeeceeCcee
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~ 78 (306)
-++|++.+.||+|+||.||+|+++.+|+.||+|++... .......+|..++..+. +|++|..+...+.+....
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36799999999999999999999999999999987632 22334555655555554 457777777778888999
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|+||||+ ||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.+|.+||+|||+|+...
T Consensus 268 ylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecC
Confidence 9999999 8899999986 4579999999999999999999999999999999999999 589999999999998765
Q ss_pred CCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
.... ...+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..........+.......+
T Consensus 344 ~~~~---------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p 414 (689)
T 3v5w_A 344 KKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414 (689)
T ss_dssp SCCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC
T ss_pred CCCC---------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC
Confidence 4332 25689999999999975 5799999999999999999999999987655444445555555555554
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHHHHHHhH
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKRLFHDLF 277 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~l~~~~ 277 (306)
..+|+++.+||.+||+.||++|++ +++|++ +.++
T Consensus 415 -----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~--HpfF 453 (689)
T 3v5w_A 415 -----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFF 453 (689)
T ss_dssp -----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT--SGGG
T ss_pred -----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc--Cccc
Confidence 667999999999999999999997 688876 4554
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=355.98 Aligned_cols=289 Identities=27% Similarity=0.505 Sum_probs=218.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCC-----CceEEEEEccCCCCchhhHHHHHHHHHHhC--------------CCC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKHPQLLYEAKVYKILQG--------------GSG 64 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~--------------~~~ 64 (306)
+.+++|++.+.||+|+||.||+|.+..+ ++.||+|++.... ....+|+.++..+.+ |++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC--HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc--hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 4567999999999999999999998764 5789999887643 345566666665544 566
Q ss_pred CCcceeeceeC----ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC
Q 021855 65 IPNIKWYGVDG----EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (306)
Q Consensus 65 ~~~~~~~~~~~----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~ 140 (306)
++.+..++... ...+++|||++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||++. +
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~ 188 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K 188 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred CCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence 66665544432 457999999999999999876567999999999999999999999999999999999999931 2
Q ss_pred CcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh
Q 021855 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (306)
Q Consensus 141 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 220 (306)
.++.+||+|||++.....................||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 67899999999997665432221111112235569999999999999999999999999999999999999998643322
Q ss_pred hHHHHH-HHhhcccccchHHH--hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceecch
Q 021855 221 KKQKYD-KICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295 (306)
Q Consensus 221 ~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 295 (306)
...... .............. ...+|+++.++|..||+.||.+|||+.+|++.|+.++...+...+.++||+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 346 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVEN 346 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-----
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEeccC
Confidence 111111 11111111111100 1566899999999999999999999999999999999999999999999997664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=379.25 Aligned_cols=256 Identities=18% Similarity=0.257 Sum_probs=214.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
++|++.+.||+|+||.||+|+++.+|+.||+|++..... ...+.+|+.+++.+.| +++..+...+.+....+++|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEEee
Confidence 689999999999999999999999999999998875432 2457789999999976 6666777777788899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
| +|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~-- 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS-- 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc--
Confidence 9 78999988765567999999999999999999999999999999999999941 2358999999999987654322
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.. ..+..+.......+. .....
T Consensus 313 ------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i~~~~~~~~~-~~~~~ 382 (573)
T 3uto_A 313 ------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDWNMDD-SAFSG 382 (573)
T ss_dssp ------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTTCCCCCS-GGGTT
T ss_pred ------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHhCCCCCCc-ccccC
Confidence 12557999999999999999999999999999999999999999886554 334444444433332 22367
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+|+++.+||.+||+.||.+|||+.|+++ +.++.
T Consensus 383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~--Hpw~~ 415 (573)
T 3uto_A 383 ISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLT 415 (573)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc--CcCcC
Confidence 8999999999999999999999999987 56654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=342.08 Aligned_cols=284 Identities=22% Similarity=0.361 Sum_probs=219.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCC--------CceEEEEEccCCCCchhhHHHHHHHHHHhCCCC------------
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDT--------NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG------------ 64 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~------------ 64 (306)
.+++|++.+.||+|+||.||+|++..+ ++.||+|++... ..+.+|+.++..+.|.+.
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 368999999999999999999999874 889999998754 457889999999876332
Q ss_pred --CCcceeecee-CceeEEEEeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC
Q 021855 65 --IPNIKWYGVD-GEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (306)
Q Consensus 65 --~~~~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~ 140 (306)
++.+..++.. ....+++|||++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~--- 193 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD--- 193 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc---
Confidence 2223334433 6788999999999999999864 35699999999999999999999999999999999999994
Q ss_pred Ccc--eEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchh
Q 021855 141 KAN--QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (306)
Q Consensus 141 ~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~ 218 (306)
.++ .++|+|||++.....................+++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 566 899999999976543322111111112345789999999999999999999999999999999999999987542
Q ss_pred hh-hHHHHHHHhhcccccchHH--HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceecc
Q 021855 219 AT-KKQKYDKICEKKVSTPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294 (306)
Q Consensus 219 ~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 294 (306)
.. ................... ....+++.+.++|.+||+.||++|||+.++++.|+.++.+.+...+.+++|+..+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~~p 352 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPMVP 352 (352)
T ss_dssp CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC--
T ss_pred CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcCCC
Confidence 11 1111111111111111100 1135688999999999999999999999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=334.73 Aligned_cols=270 Identities=23% Similarity=0.326 Sum_probs=218.2
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
++++++++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.++..+.| +++..+..++...
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~ 83 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH-QNIVSMIDVDEED 83 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCB-TTBCCEEEEEECS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCC-CCCceEEEeeeeC
Confidence 4678999999999999999999999999999999999987543322 346778888988876 5666666667778
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...+++|||+ +++|.+++.. ..++++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAK 159 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSST
T ss_pred CeEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcc
Confidence 8899999999 7799999876 4579999999999999999999999999999999999999 588999999999997
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ....+......+
T Consensus 160 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~~~ 230 (294)
T 4eqm_A 160 ALSETSLT------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV---SIAIKHIQDSVP 230 (294)
T ss_dssp TC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH---HHHHHHHSSCCC
T ss_pred cccccccc------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhhccCC
Confidence 65433221 112456899999999999999999999999999999999999999875443 223333344444
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCC-ChHHHHHHHHHhHhhcCCCC
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSREGYDF 284 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~~~~~~~~ 284 (306)
.........+|+.+.++|.+||+.||.+|| +++++.+.|+.++.......
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 444445577899999999999999999999 99999999999887655543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=333.93 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=210.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
.-++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+.+|+.+++.+.| +++..+..++......++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-PNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEE
Confidence 446899999999999999999999999999999988654332 346789999999976 666666666677788999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred EEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence 99999 7899998876 4569999999999999999999999999999999999999 58899999999999765433
Q ss_pred CCCccccccCCccccccccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.. .....||+.|+|||++.+..++ +++|||||||++|+|++|..||.+.+.. .....+.......+
T Consensus 168 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~p-- 234 (328)
T 3fe3_A 168 GK--------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRERVLRGKYRIP-- 234 (328)
T ss_dssp CG--------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC--
T ss_pred Cc--------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC--
Confidence 22 1255789999999999988864 8999999999999999999999876543 33444444444444
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+++++.++|.+||+.||.+|||++++++ +.++.
T Consensus 235 ---~~~s~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~ 269 (328)
T 3fe3_A 235 ---FYMSTDCENLLKRFLVLNPIKRGTLEQIMK--DRWIN 269 (328)
T ss_dssp ---TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT--CTTTT
T ss_pred ---CCCCHHHHHHHHHHCCCChhHCcCHHHHhc--CHhhc
Confidence 456889999999999999999999999988 56664
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=330.13 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=208.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC--CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
..++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++......+++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCC-CCCCeEeEEEEECCEEEEEE
Confidence 346899999999999999999999999999999987533 334557889999999876 56666666667788899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc
Confidence 999 8899998875 368999999999999999999999999999999999999 5889999999999876554332
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..................+
T Consensus 172 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 239 (297)
T 3fxz_A 172 K-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP----- 239 (297)
T ss_dssp C-------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCG-----
T ss_pred c-------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCc-----
Confidence 1 1255789999999999999999999999999999999999999987654432222222111111122
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+++.+.++|.+||+.||.+|||+.++++ +.+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~ 274 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLK 274 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGG
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh--Chhhc
Confidence 567889999999999999999999999987 56664
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=328.38 Aligned_cols=266 Identities=17% Similarity=0.237 Sum_probs=205.4
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-------CchhhHHHHHHHHHHh--CCCCCCcceee
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQ--GGSGIPNIKWY 71 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~--~~~~~~~~~~~ 71 (306)
++.++.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+|+.+++.+. .|+++..+..+
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 35678899999999999999999999999999999999876322 2345778888888887 24666665544
Q ss_pred ceeCc-----eeEEEEeccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceE
Q 021855 72 GVDGE-----DNVLVLDLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (306)
Q Consensus 72 ~~~~~-----~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~ 145 (306)
+.... ..++++|+++++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~ 159 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTV 159 (308)
T ss_dssp EEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCE
T ss_pred eeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCE
Confidence 43322 5799999999999999876433 38999999999999999999999999999999999999 488999
Q ss_pred EEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHH
Q 021855 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY 225 (306)
Q Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~ 225 (306)
||+|||++......... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+
T Consensus 160 kl~Dfg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 231 (308)
T 3g33_A 160 KLADFGLARIYSYQMAL--------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231 (308)
T ss_dssp EECSCSCTTTSTTCCCS--------GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred EEeeCccccccCCCccc--------CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999765433221 2557899999999999999999999999999999999999999886655444333
Q ss_pred HHHhhcc-------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 226 DKICEKK-------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 226 ~~~~~~~-------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
....... ...+.....+.+++.+.++|.+||+.||.+|||+.++++ +.++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--h~~~~~ 302 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ--HSYLHK 302 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--STTC--
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc--CccccC
Confidence 3322111 111223344567889999999999999999999999987 555543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=338.54 Aligned_cols=253 Identities=19% Similarity=0.292 Sum_probs=208.4
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+.-++|++.+.||+|+||.||+|+++.+++.||+|++... .......+|..++..+.+|+++..+..++......
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3457899999999999999999999999999999987642 23345678889998887778888888888888899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecc
Confidence 9999999 7799988876 4569999999999999999999999999999999999999 588999999999997543
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+
T Consensus 176 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~p- 244 (353)
T 3txo_A 176 CNGV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILNDEVVYP- 244 (353)
T ss_dssp C----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred cCCc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC-
Confidence 3221 122567899999999999888999999999999999999999999876543 44555555555544
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCCh------HHHHHHHHHhH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY------GFLKRLFHDLF 277 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~l~~~l~~~~ 277 (306)
..+++.+.++|.+||+.||.+||++ +++++ +.++
T Consensus 245 ----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~--hp~f 284 (353)
T 3txo_A 245 ----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR--HPFF 284 (353)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT--SGGG
T ss_pred ----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh--CCcc
Confidence 5578999999999999999999998 77766 4444
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=334.80 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=210.1
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--------chhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
..+.++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.++..+.| +++..+..++..
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH-PNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCC-cCCCcEEEEEEe
Confidence 4567889999999999999999999999999999998765432 2457889999999876 666667666777
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc----eEEEEe
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIID 149 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~----~~kl~D 149 (306)
....++++||+ +++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+. .++ .+||+|
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~~~~~vkl~D 162 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID 162 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---CCCCCccCEEEEe
Confidence 88899999999 8899998875 45699999999999999999999999999999999999995 333 799999
Q ss_pred eccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh
Q 021855 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 229 (306)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.
T Consensus 163 FG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~~i~ 231 (361)
T 2yab_A 163 FGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANIT 231 (361)
T ss_dssp CSSCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH
T ss_pred cCCceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence 999987654322 12557899999999999999999999999999999999999999876543 3344444
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
......+ +.....+++.+.++|.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 AVSYDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCCCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 4443333 3344678899999999999999999999999976
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=330.81 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=207.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+.-++|++.+.||+|+||.||+|+++.+++.||+|++... .....+.+|..+++.+.| +++..+...+......
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCC-CcCcceEEEEEeCCEE
Confidence 3457899999999999999999999999999999987632 334457789999988865 6666777777778899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 81 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcc
Confidence 9999999 7799888876 4569999999999999999999999999999999999999 588999999999997643
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+
T Consensus 157 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p- 225 (337)
T 1o6l_A 157 SDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEEIRFP- 225 (337)
T ss_dssp CTTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred cCCC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-
Confidence 3222 113567999999999999999999999999999999999999999875443 33444444444444
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
..+++++.++|.+||+.||.+|| +++++++
T Consensus 226 ----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 226 ----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 56789999999999999999999 8999877
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=336.24 Aligned_cols=246 Identities=20% Similarity=0.301 Sum_probs=205.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
--++|++.+.||+|+||.||+|+++.+++.||+|++... .....+..|..++..+..|+++..+..++......+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 346899999999999999999999999999999987643 223447789999998877788888888888888999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 130 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeeccc
Confidence 999999 7799888876 4579999999999999999999999999999999999999 5899999999999975332
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhh------hhHHHHHHHhhcc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKK 232 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~------~~~~~~~~~~~~~ 232 (306)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........+....
T Consensus 206 ~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 206 PGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp TTC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred CCC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 222 123567999999999999999999999999999999999999999643211 1222344455555
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCCh
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 266 (306)
...+ ..+++++.+||.+||+.||.+||++
T Consensus 279 ~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 IRIP-----RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCC-----TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cCCC-----CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 5544 5678999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=327.87 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=210.2
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+-+.++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+|+.+++.+.| +++..+..++......
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH-PNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCC-TTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCC-CCEeeeeeEEccCCEE
Confidence 456789999999999999999999985 5889999988754332 357789999999976 6666666666677889
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++|||+.++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTS
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCC
Confidence 9999999999999888756669999999999999999999999999999999999999 5889999999999987643
Q ss_pred CCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc---
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS--- 234 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--- 234 (306)
.... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+........+
T Consensus 172 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 172 PVRS-------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp CCC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred Cccc-------ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 3221 124467999999999986 46899999999999999999999999886655544444433322211
Q ss_pred -------------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 235 -------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 235 -------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.+.....+.+++++.+||.+||+.||++|||++++++ +.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~ 306 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN--HPYFKD 306 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTT
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc--Cccccc
Confidence 1122333557789999999999999999999999987 666653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=331.35 Aligned_cols=259 Identities=17% Similarity=0.237 Sum_probs=214.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+.++|++.+.||+|+||.||+|++..+++.||+|.+..... ...+.+|+.+++.+.| +++..+..++......+++||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCC-CCCCeEeEEEecCCEEEEEEE
Confidence 56899999999999999999999999999999998875433 2346789999999876 566666666677889999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+.+......+++..++.++.||+.||.|||+.||+||||||+|||++. +.++.+||+|||++........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE-
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCc-
Confidence 99 67999988764556999999999999999999999999999999999999941 1278999999999987644321
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+.......+. ....
T Consensus 160 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~-~~~~ 228 (321)
T 1tki_A 160 -------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEYTFDE-EAFK 228 (321)
T ss_dssp -------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCCH-HHHT
T ss_pred -------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHcCCCCCCh-hhhc
Confidence 12456899999999999988999999999999999999999999875543 344444444444432 2336
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.+|+++.++|.+||+.||.+|||+.++++ +.++.+
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~ 263 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQ 263 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc--Chhhcc
Confidence 78999999999999999999999999988 667653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=342.18 Aligned_cols=259 Identities=21% Similarity=0.257 Sum_probs=212.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|++...... ..+.+|+.+++.+.| +++..+..++......+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-PNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB-TTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-cCCCeEEEEEEECCEEE
Confidence 3567899999999999999999999999999999988765432 347789999999976 66666666777888999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++|||+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++....++.+||+|||++.....
T Consensus 87 lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999 7899988876 45699999999999999999999999999999999999996444578999999999976554
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+.+
T Consensus 166 ~~~~-------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~ 235 (444)
T 3soa_A 166 EQQA-------WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQIKAGAYDFPSP 235 (444)
T ss_dssp TCCB-------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTCCCCCTT
T ss_pred CCce-------eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhCCCCCCcc
Confidence 3321 12457899999999999999999999999999999999999999875543 3344444444443322
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
....+++++.++|.+||+.||.+|||+.++++ +.++
T Consensus 236 -~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~--hp~~ 271 (444)
T 3soa_A 236 -EWDTVTPEAKDLINKMLTINPSKRITAAEALK--HPWI 271 (444)
T ss_dssp -TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SCTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc--Cccc
Confidence 22567899999999999999999999999987 4444
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=334.27 Aligned_cols=262 Identities=23% Similarity=0.249 Sum_probs=215.3
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
+.++|++.+.||+|+||.||+|+++.+++.||+|++..... ...+|+.++.++.+|+++..+..++.+....+++|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 46789999999999999999999999999999999876543 4567899999997778888888888888899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC-CcceEEEEeeccccccCCCCCC
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~-~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++.........
T Consensus 98 ~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 176 (342)
T 2qr7_A 98 MKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176 (342)
T ss_dssp CCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence 9 7899988875 45699999999999999999999999999999999999985322 2356999999999876543321
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+............+.......+ .....
T Consensus 177 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~~~ 248 (342)
T 2qr7_A 177 -------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS-GGYWN 248 (342)
T ss_dssp -------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-STTTT
T ss_pred -------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-ccccc
Confidence 1245689999999999888899999999999999999999999987544444445555554444333 22235
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.+++.+.++|.+||+.||.+|||+.++++ +.++..
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~~~ 283 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLR--HPWIVH 283 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhc--CCeecC
Confidence 67899999999999999999999999987 666643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=332.40 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=208.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+..++|++.+.||+|+||.||+|+++.+++.||+|++... ........|..++..+.+|+++..+...+......
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 4457899999999999999999999999999999987642 33445677888898886678888888788888899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence 9999999 7899998876 4569999999999999999999999999999999999999 588999999999997543
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+
T Consensus 170 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p- 238 (345)
T 1xjd_A 170 LGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNPFYP- 238 (345)
T ss_dssp CTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred cCCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHhCCCCCC-
Confidence 2221 113567899999999999999999999999999999999999999875543 33444444443333
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChH-HHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYG-FLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-~l~~ 271 (306)
..+++++.++|.+||+.||++||++. ++++
T Consensus 239 ----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 239 ----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 56789999999999999999999987 6654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=333.54 Aligned_cols=261 Identities=19% Similarity=0.221 Sum_probs=211.2
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-------CCchhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
..+.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++...
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~ 98 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH-PHIVELLETYSSD 98 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC-TTBCCEEEEEEET
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 35678899999999999999999999999999999987521 134567899999999976 6666666666778
Q ss_pred ceeEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeec
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg 151 (306)
...+++|||+ +++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 8899999999 68998777543 2348999999999999999999999999999999999999643445669999999
Q ss_pred cccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc
Q 021855 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
++......... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+... .....+...
T Consensus 179 ~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~~~ 247 (351)
T 3c0i_A 179 VAIQLGESGLV-------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGIIKG 247 (351)
T ss_dssp TCEECCTTSCB-------CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHHHT
T ss_pred ceeEecCCCee-------ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHHcC
Confidence 99876543221 1245789999999999999999999999999999999999999987432 333444444
Q ss_pred ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
....+. .....+++.+.++|.+||+.||++|||+.++++ +.++.
T Consensus 248 ~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--hp~~~ 291 (351)
T 3c0i_A 248 KYKMNP-RQWSHISESAKDLVRRMLMLDPAERITVYEALN--HPWLK 291 (351)
T ss_dssp CCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred CCCCCc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Chhhc
Confidence 433332 233677899999999999999999999999987 55554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=325.43 Aligned_cols=252 Identities=19% Similarity=0.215 Sum_probs=204.2
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch----hhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
.++.++|++.+.||+|+||.||+|++..+++.||+|++....... ....|+..+..+..++++..+..++......
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 345578999999999999999999999999999999876543322 3455666666665678888888788888899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++++|+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 133 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 133 YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC-
T ss_pred EEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeeccc
Confidence 9999999999999988767779999999999999999999999999999999999999 5889999999999876544
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ......... .+
T Consensus 210 ~~~~--------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------~~~~~~~~~---~~ 271 (311)
T 3p1a_A 210 AGAG--------EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------WQQLRQGYL---PP 271 (311)
T ss_dssp -------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------HHHHTTTCC---CH
T ss_pred CCCC--------cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHhccCC---Cc
Confidence 3221 24468999999999886 799999999999999999999777765322 122222221 12
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.....+++.+.++|.+||+.||++|||+.++++ ..++
T Consensus 272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~ 308 (311)
T 3p1a_A 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA--LPVL 308 (311)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGG
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh--Cccc
Confidence 334677899999999999999999999999987 4444
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=324.88 Aligned_cols=259 Identities=25% Similarity=0.321 Sum_probs=204.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++.+.||+|+||.||+|++ .+++.||+|.+..... ...+.+|+.+++.+.| +++..+..++......++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCC-CCEeeeeeEEccCCeEEEEE
Confidence 5799999999999999999998 6789999998865432 3457789999999876 56666666666778899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|++.++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.........
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccccc
Confidence 999989999988766679999999999999999999999999999999999999 58899999999999765433221
Q ss_pred ccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc-------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS------- 234 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------- 234 (306)
.....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.+.......
T Consensus 157 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 157 -------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -------cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 1244679999999999764 5899999999999999999999999886554433333332211110
Q ss_pred --------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 235 --------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 235 --------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.+.......+++.+.++|.+||+.||++|||++++++ +.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~ 286 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE--HAYFKE 286 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGGC
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc--Ccchhh
Confidence 1111223457889999999999999999999999987 556543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=333.23 Aligned_cols=253 Identities=25% Similarity=0.299 Sum_probs=209.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++......++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 456899999999999999999999999999999998765432 346789999999976 666667666777888999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
++||+ +++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++..+.++.+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999 7799888865 456899999999999999999999999999999999999964444567999999999765533
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+.+
T Consensus 185 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~- 252 (362)
T 2bdw_A 185 EA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGAYDYPSP- 252 (362)
T ss_dssp CS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCTT-
T ss_pred cc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCcc-
Confidence 22 12457899999999999999999999999999999999999999875543 3333444444433322
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....+++++.++|.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22567899999999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=323.22 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=205.4
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++......+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCC-CCEeeEEeEEEeCCEEEEEE
Confidence 5799999999999999999999999999999988754332 456789999999876 66666666677788999999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
||+.+++.+.+......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....+..
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS-
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc-
Confidence 999999998887766789999999999999999999999999999999999999 5889999999999987643322
Q ss_pred ccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCC-CchhhhhHHHHHHHhhccccc-----
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ-GLKAATKKQKYDKICEKKVST----- 235 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~----- 235 (306)
......+|..|+|||++.+.. ++.++|||||||++|+|++|..||. +.+.......+..........
T Consensus 157 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp ------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 122457799999999998776 7999999999999999999888854 333322222222221111000
Q ss_pred ----------------chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 236 ----------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 236 ----------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
......+.+++.+.++|.+||+.||++|||++++++ +.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~ 287 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFS 287 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc--Ccccc
Confidence 001112356788999999999999999999999987 55554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=332.25 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=208.8
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
++.-++|++.+.||+|+||.||+|++..+++.||+|++... .....+..|..++..+.+|+++..+..++.....
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 34457899999999999999999999999999999987642 3334567788888877777888888888888889
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.+++|||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCccccc
Confidence 99999999 7899998876 3569999999999999999999999999999999999999 58899999999999754
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+
T Consensus 172 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~p 241 (353)
T 2i0e_A 172 IWDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIMEHNVAYP 241 (353)
T ss_dssp CCTTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC
T ss_pred ccCCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHHHHhCCCCCC
Confidence 32221 123567899999999999999999999999999999999999999875543 44455555555544
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
..+++++.++|.+||+.||.+||+ ++++++
T Consensus 242 -----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 242 -----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 567899999999999999999995 466655
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=333.39 Aligned_cols=254 Identities=26% Similarity=0.317 Sum_probs=208.3
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
...-++|++.+.||+|+||.||+|++..+++.||+|++.. ......+.+|+.+++.+.| +++..+..++.....
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-PHIIKLYDVITTPTD 83 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCE
Confidence 3445789999999999999999999999999999998753 2334567889999998876 566666666677788
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
.++++||++++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 84 ~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTT
T ss_pred EEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceecc
Confidence 999999999999998876 4569999999999999999999999999999999999999 588999999999997654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
.... .....||+.|+|||++.+..+ ++++|||||||++|+|++|..||.+..... ....+.......+
T Consensus 160 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~~~~~~~p 228 (336)
T 3h4j_B 160 DGNF--------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---LFKKVNSCVYVMP 228 (336)
T ss_dssp TSBT--------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---CBCCCCSSCCCCC
T ss_pred CCcc--------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---HHHHHHcCCCCCc
Confidence 3322 125578999999999998876 789999999999999999999998743321 1111111122222
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+++.+.++|.+||+.||.+|||++++++ +.++..
T Consensus 229 -----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 264 (336)
T 3h4j_B 229 -----DFLSPGAQSLIRRMIVADPMQRITIQEIRR--DPWFNV 264 (336)
T ss_dssp -----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT--CHHHHT
T ss_pred -----ccCCHHHHHHHHHHcCCChhHCcCHHHHHh--Chhhcc
Confidence 556889999999999999999999999988 667653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=328.08 Aligned_cols=259 Identities=20% Similarity=0.309 Sum_probs=210.5
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
|..+.-++|++.+.||+|+||.||+|+++.+++.||+|++..... ...+.+|..++..+.+|+++..+..++...
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 345566889999999999999999999999999999998875422 123667888898886678888887778888
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCK 158 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCB
T ss_pred CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccc
Confidence 8999999999 7899988876 4569999999999999999999999999999999999999 588999999999997
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchh------hhhHHHHHHH
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA------ATKKQKYDKI 228 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~------~~~~~~~~~~ 228 (306)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .........+
T Consensus 159 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 159 EGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp CSCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred cccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 5432221 12356789999999999999999999999999999999999999965211 1122233444
Q ss_pred hhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCCh------HHHHHHHHHhH
Q 021855 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY------GFLKRLFHDLF 277 (306)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~------~~l~~~l~~~~ 277 (306)
.......+ ..+++.+.++|.+||+.||.+||++ .++++ +.++
T Consensus 232 ~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~--hp~f 279 (345)
T 3a8x_A 232 LEKQIRIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--HPFF 279 (345)
T ss_dssp HHCCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT--SGGG
T ss_pred HcCCCCCC-----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc--CCcc
Confidence 44444444 5678999999999999999999986 56655 4444
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=329.08 Aligned_cols=263 Identities=19% Similarity=0.269 Sum_probs=211.0
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCc---eEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
.+..++|++.+.||+|+||.||+|++..+++ .||+|++...... ..+.+|+.+++.+.| +++..+..++....
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-PNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCC
Confidence 4667899999999999999999999986554 4999998765332 357789999999875 66666666677778
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..+++|||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRV 200 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccc
Confidence 899999999 779999987655679999999999999999999999999999999999999 5889999999999987
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
......... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+........ .+.. ...
T Consensus 201 ~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~~~~-~~~ 272 (325)
T 3kul_A 201 LEDDPDAAY----TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS---SVEE-GYR 272 (325)
T ss_dssp CC----CCE----ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH---HHHT-TCC
T ss_pred cccCcccee----eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH---HHHc-CCC
Confidence 654322211 1123345778999999998899999999999999999999 999998765442222 2222 222
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.+. ...+++.+.++|.+||+.||.+|||+.++++.|+.+++..
T Consensus 273 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 273 LPA---PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCC---CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 221 1567899999999999999999999999999999998743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=325.27 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=201.5
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
.+..++|++.+.||+|+||.||+|++ +++.||+|++...... ..+.+|+.+++++.| +++..+..++......
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCce
Confidence 35678999999999999999999987 5788999998765443 246789999999986 5666666666677789
Q ss_pred EEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 79 VLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
++++||+ +++|.+++..... .+++..++.++.||+.||.|||+.| |+||||||+||++ +.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCC
Confidence 9999999 7799998875321 2899999999999999999999999 9999999999999 58899999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..... ........
T Consensus 187 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~~~~~ 256 (309)
T 3p86_A 187 RLKASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVGFKCK 256 (309)
T ss_dssp ----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---HHHHHSCC
T ss_pred cccccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcCC
Confidence 75433221 112557899999999999999999999999999999999999999876543222 22211111
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
... ....+++.+.++|.+||+.||.+|||+.++++.|+.+++..
T Consensus 257 ~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 RLE---IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111 12567899999999999999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=332.98 Aligned_cols=284 Identities=29% Similarity=0.446 Sum_probs=204.1
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcC---CCceEEEEEccCCCC-------------chhhHHHHHHHHHHhCCCCCC
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK-------------HPQLLYEAKVYKILQGGSGIP 66 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~-------------~~~~~~e~~~l~~l~~~~~~~ 66 (306)
.+.+++|++.+.||+|+||.||+|++.. ++..+|+|+...... ...+.+|+..+..+.| +++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h-~ni~ 111 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY-LGIP 111 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC-CCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc-cCcc
Confidence 4567899999999999999999999987 788999998876532 1224455555655555 5555
Q ss_pred cceeecee----CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc
Q 021855 67 NIKWYGVD----GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (306)
Q Consensus 67 ~~~~~~~~----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~ 142 (306)
.+..++.. ....+++||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~ 187 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG---YK 187 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---SS
T ss_pred eeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc---cC
Confidence 55554444 67889999999999999887633 799999999999999999999999999999999999994 44
Q ss_pred c--eEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh
Q 021855 143 N--QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (306)
Q Consensus 143 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 220 (306)
+ .+||+|||++.....................++..|+|||++.+..++.++|||||||++|+|++|..||.+.....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 4 99999999997764332211111111135578999999999999999999999999999999999999996532211
Q ss_pred h-HHHHHHHhhcccccchHHHhh--cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceecchh
Q 021855 221 K-KQKYDKICEKKVSTPIEVLCK--SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQ 296 (306)
Q Consensus 221 ~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 296 (306)
. ............+........ .+++++.++|.+||+.||++|||+++|++.|+... . ...+++|+-..+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~----~-~~~~~d~~~~~~~ 341 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG----I-PLGPLDFSTKGQS 341 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC----C-CCCCCCCCCTTC-
T ss_pred HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC----C-cccCCCcccCCcc
Confidence 1 111111112222221111111 67889999999999999999999999999887653 2 3455677655443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=326.06 Aligned_cols=265 Identities=19% Similarity=0.264 Sum_probs=210.5
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
-.++|++.+.||+|+||.||+|++..+++.||+|.+..... ...+.+|+.++..+.| +++..+..++......++++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-cCcccEEEEEecCCeeEEEE
Confidence 35899999999999999999999999999999998754322 2457789999999975 66666666677788899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+++......+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccccc
Confidence 999 779999998766779999999999999999999999999999999999999 5889999999999987544332
Q ss_pred Cccc-------cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHH--HHHHHhhcc
Q 021855 162 NRHI-------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ--KYDKICEKK 232 (306)
Q Consensus 162 ~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~--~~~~~~~~~ 232 (306)
.... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--
Confidence 1100 0001114578999999999999999999999999999999999999997643221111 0111111
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
......+|+.+.++|.+||+.||++|||+.++++.|+.+....
T Consensus 242 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 242 -----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1112567889999999999999999999999999999986543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=333.44 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=210.0
Q ss_pred ccCCceeEeeeecccCccEEEEEE-----EcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee-
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD- 74 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~-----~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~- 74 (306)
+..++|++.+.||+|+||.||+|+ +..+++.||+|++...... ..+.+|+.++..+.+|+++..+..++..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 456899999999999999999998 4566789999998765443 3478899999999777777777655444
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcC-------------------------------------------------------
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRR------------------------------------------------------- 98 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~------------------------------------------------------- 98 (306)
....++++||+ +++|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 45589999999 7799999875321
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcccccc
Q 021855 99 ----------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (306)
Q Consensus 99 ----------~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (306)
.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..........
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~----- 250 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYV----- 250 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCE-----
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccch-----
Confidence 18899999999999999999999999999999999999 588999999999997654332211
Q ss_pred CCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchH
Q 021855 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (306)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (306)
......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+..... .............. ...++++
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~ 324 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLKEGTRMRA---PDYTTPE 324 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHHHTCCCCC---CTTCCHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHHHHHHcCCCCCC---CCCCCHH
Confidence 1235567889999999999999999999999999999998 999998754322 12222222222221 1456889
Q ss_pred HHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 248 FASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 248 ~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
+.++|.+||+.||.+|||+.++++.|+.++..+
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999998643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=330.95 Aligned_cols=261 Identities=19% Similarity=0.313 Sum_probs=210.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc-------CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
+..++|++.+.||+|+||.||+|++. .++..||+|++...... ..+.+|+.+++.+..|+++..+..++.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 34578999999999999999999874 34567999998765432 347889999999965677777777777
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeec
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~ 137 (306)
.....++++||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll- 236 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 236 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE-
Confidence 778899999999 779999987643 247899999999999999999999999999999999999
Q ss_pred cCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 021855 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (306)
Q Consensus 138 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~ 216 (306)
+.++.+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 237 --~~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 --TENNVMKIADFGLARDINNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp --CTTCCEEECCCSSCEETTCCCTTC-----TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --CCCCCEEEccccCCcccCccccee-----cccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 588999999999998654432211 1124456788999999999999999999999999999999 99999875
Q ss_pred hhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..... ...+ ....... ....+++++.++|.+||+.||.+|||+.++++.|+.++..
T Consensus 310 ~~~~~---~~~~-~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 310 PVEEL---FKLL-KEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp CGGGH---HHHH-HTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHH---HHHH-hcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 54322 2222 2221111 1256688999999999999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=338.26 Aligned_cols=271 Identities=22% Similarity=0.277 Sum_probs=199.6
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeecee--
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-- 74 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-- 74 (306)
+++.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+|+.++..+.+|+++..+..++..
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 355677899999999999999999999999999999998765432 23467899999999866777776555443
Q ss_pred CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
....+++|||+.++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 83 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 83 DRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR 157 (388)
T ss_dssp SSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence 346899999999999988875 468999999999999999999999999999999999999 588999999999997
Q ss_pred ccCCCCCCcc--------------ccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhh
Q 021855 155 KYRDPTTNRH--------------IPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (306)
Q Consensus 155 ~~~~~~~~~~--------------~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~ 219 (306)
.......... ..........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6543111100 00011224578999999999987 56899999999999999999999999886655
Q ss_pred hhHHHHHHHhhcccccc------------------------------hHH---------HhhcCchHHHHHHHhhhcCCC
Q 021855 220 TKKQKYDKICEKKVSTP------------------------------IEV---------LCKSHPAEFASYFHYCQSLTF 260 (306)
Q Consensus 220 ~~~~~~~~~~~~~~~~~------------------------------~~~---------~~~~~~~~~~~li~~cl~~dP 260 (306)
.....+........... .+. ....+++++.+||.+||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 44333322221110000 000 012568899999999999999
Q ss_pred CCCCChHHHHHHHHHhHh
Q 021855 261 DQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 261 ~~Rps~~~l~~~l~~~~~ 278 (306)
++|||++++++ +.++.
T Consensus 318 ~~R~t~~e~l~--Hp~~~ 333 (388)
T 3oz6_A 318 NKRISANDALK--HPFVS 333 (388)
T ss_dssp GGSCCHHHHTT--STTTT
T ss_pred ccCCCHHHHhC--CHHHH
Confidence 99999999988 55554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=325.86 Aligned_cols=255 Identities=20% Similarity=0.262 Sum_probs=209.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--------chhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++...
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~ 86 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENK 86 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 456789999999999999999999999999999998764322 2457889999999976 6666666667778
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc----eEEEEee
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIIDF 150 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~----~~kl~Df 150 (306)
...++++||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++ .++ .+||+||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~---~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL---DRNVPKPRIKIIDF 162 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES---CSSSSSCCEEECCC
T ss_pred CEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEe---cCCCCCCCEEEEEC
Confidence 8899999999 7899998865 45699999999999999999999999999999999999995 444 8999999
Q ss_pred ccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
|++......... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+..
T Consensus 163 g~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~ 231 (326)
T 2y0a_A 163 GLAHKIDFGNEF--------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVSA 231 (326)
T ss_dssp TTCEECCTTSCC--------CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH
T ss_pred CCCeECCCCCcc--------ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHh
Confidence 999876433221 24568999999999999999999999999999999999999998755432 2333333
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.....+ ......+++.+.++|.+||+.||.+|||+.++++ +.++
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~ 275 (326)
T 2y0a_A 232 VNYEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWI 275 (326)
T ss_dssp TCCCCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTT
T ss_pred cCCCcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--CCCc
Confidence 333332 3334677899999999999999999999999987 4444
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=331.53 Aligned_cols=263 Identities=19% Similarity=0.236 Sum_probs=199.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.+.++|++.+.||+|+||.||+|++..+++.||+|++........+.+|+.+++.+.| +++..+..++......++++|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCC-TTBCCEEEEEECSSEEEEEEC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCC-CCCcceeeeEecCCeEEEEEE
Confidence 4567899999999999999999999999999999999877666678889999999986 566666666677788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++..+.++.+||+|||++........
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 206 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence 99 7899988875 45689999999999999999999999999999999999996444589999999999976543221
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+.......+ .....
T Consensus 207 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~~~~~~~~-~~~~~ 276 (349)
T 2w4o_A 207 -------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRILNCEYYFI-SPWWD 276 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHHTTCCCCC-TTTTT
T ss_pred -------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHHhCCCccC-Cchhh
Confidence 12456899999999999999999999999999999999999999764432 223333333333222 22235
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
.+++++.++|.+||+.||++|||+.++++ +.++....
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~~~ 313 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQ--HPWVTGKA 313 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTTSTT
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhc--CcccCCCc
Confidence 67889999999999999999999999987 67765433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=333.75 Aligned_cols=260 Identities=21% Similarity=0.324 Sum_probs=206.9
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHh----CCCCCCcceeeceeCc
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQ----GGSGIPNIKWYGVDGE 76 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~----~~~~~~~~~~~~~~~~ 76 (306)
+.+++++|++.+.||+|+||.||+|++..+++.||+|++..... ......|..+++.+. .|+++..+..++....
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 45788999999999999999999999999999999999875322 234667889999987 3566777777777788
Q ss_pred eeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC----------------
Q 021855 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG---------------- 139 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~---------------- 139 (306)
..+++||+++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+...
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 899999999999999988643 348999999999999999999999999999999999999421
Q ss_pred ------CCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 021855 140 ------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213 (306)
Q Consensus 140 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf 213 (306)
...+.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 127899999999997644322 2457899999999999999999999999999999999999999
Q ss_pred CCchhhhhHHHHHHHhhcccccc--------------------------------------hHHHhhcCchHHHHHHHhh
Q 021855 214 QGLKAATKKQKYDKICEKKVSTP--------------------------------------IEVLCKSHPAEFASYFHYC 255 (306)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~li~~c 255 (306)
...........+........... .+......++.+.++|.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 87655443333333221111000 0011122346788999999
Q ss_pred hcCCCCCCCChHHHHH
Q 021855 256 QSLTFDQRPDYGFLKR 271 (306)
Q Consensus 256 l~~dP~~Rps~~~l~~ 271 (306)
|+.||.+|||+.++++
T Consensus 340 L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 340 LQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCSSGGGSCCHHHHTT
T ss_pred hcCChhhCCCHHHHhc
Confidence 9999999999999976
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=332.73 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=208.9
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
.+.-++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++.....
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH-PFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCE
Confidence 45567899999999999999999999999999999987532 333567789999999866 666667677777888
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++||+ +++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeec
Confidence 99999999 7899888875 4569999999999999999999999999999999999999 58999999999999875
Q ss_pred CCCCCCccccccCCccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..............+.....
T Consensus 166 ~~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 237 (384)
T 4fr4_A 166 PRETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237 (384)
T ss_dssp CTTCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred cCCCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence 43322 125678999999999974 4589999999999999999999999987655444455555444444
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCC-hHHHHH
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKR 271 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~l~~ 271 (306)
..+ ..+++.+.++|.+||+.||.+||+ ++++++
T Consensus 238 ~~p-----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYP-----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCC-----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCC-----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 444 567899999999999999999997 777765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=325.22 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=208.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
.-++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|..+++.+.| +++..+...+.+....+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCC-CCCceEeEEEEeCCEEE
Confidence 346899999999999999999999999999999987642 233456778888888866 66666666777788899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS
T ss_pred EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC
Confidence 999999 7799999876 4569999999999999999999999999999999999999 5889999999999986543
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+
T Consensus 159 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~p-- 223 (318)
T 1fot_A 159 VT----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKILNAELRFP-- 223 (318)
T ss_dssp CB----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHCCCCCC--
T ss_pred cc----------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC--
Confidence 21 2457899999999999999999999999999999999999999875443 34445555554444
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHHHHHHhH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRLFHDLF 277 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~l~~~~ 277 (306)
..+++++.++|.+||+.||++|| +++++++ +.++
T Consensus 224 ---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~--hp~f 262 (318)
T 1fot_A 224 ---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWF 262 (318)
T ss_dssp ---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGG
T ss_pred ---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc--Cccc
Confidence 56789999999999999999999 8888876 4444
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=328.76 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=209.5
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
.-++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+...+.+....+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEEE
Confidence 447899999999999999999999999999999987532 233457789999988865 66666777777788899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 118 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccC
Confidence 999999 7899999876 3569999999999999999999999999999999999999 5889999999999986543
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+
T Consensus 194 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p-- 258 (350)
T 1rdq_E 194 RT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIVSGKVRFP-- 258 (350)
T ss_dssp CB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC--
T ss_pred Cc----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHHHHHcCCCCCC--
Confidence 22 2557899999999999999999999999999999999999999875443 44455555554444
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHHHHHHhH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKRLFHDLF 277 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~l~~~~ 277 (306)
..+++++.++|.+||+.||.+||+ ++++++ +.++
T Consensus 259 ---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~--h~~f 297 (350)
T 1rdq_E 259 ---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWF 297 (350)
T ss_dssp ---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGG
T ss_pred ---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh--CcCc
Confidence 567899999999999999999998 888876 4444
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=325.45 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=193.7
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++......++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH-ENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCB-TTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCC-CCcceEEEEEEECCeEEEEE
Confidence 468999999999999999999999999999999876443 23567889999999976 56666666666778899999
Q ss_pred eccCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 83 DLLGPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 83 e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
||+.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETT
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceecC
Confidence 999999999887542 358999999999999999999999999999999999999 588999999999998754
Q ss_pred CCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc-
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST- 235 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~- 235 (306)
..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+..........
T Consensus 160 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVNT-------FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCCC-------CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCccc-------CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 33221 1245679999999999874 58999999999999999999999998866544443333322211000
Q ss_pred --------------------c-----hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 236 --------------------P-----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 236 --------------------~-----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
. .+.....+++++.++|.+||+.||++|||+.++++ +.++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~--hp~f~ 298 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH--HPWFA 298 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGG
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC--Chhhh
Confidence 0 01111356788999999999999999999999987 55554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=328.61 Aligned_cols=266 Identities=20% Similarity=0.297 Sum_probs=215.4
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCC-------CceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeec
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYG 72 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~-------~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~ 72 (306)
.+..++|++.+.||+|+||.||+|++..+ +..||+|++...... ..+.+|+.+++.+..|+++..+..++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 35678999999999999999999997543 357999998765443 34778999999996667777777777
Q ss_pred eeCceeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceee
Q 021855 73 VDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 136 (306)
Q Consensus 73 ~~~~~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv 136 (306)
......++++||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 7788899999999 779999998643 248999999999999999999999999999999999999
Q ss_pred ccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 021855 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQG 215 (306)
Q Consensus 137 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~ 215 (306)
+.++.+||+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 225 ---~~~~~~kL~DFG~a~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 225 ---TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp ---CTTCCEEECSCSCCCCSSCCCTTC-----CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---cCCCcEEEcccCcccccccccccc-----cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 478999999999998654432211 1124456788999999999999999999999999999999 9999987
Q ss_pred chhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
...... ... +........ ...+++++.++|.+||+.||++|||+.++++.|+.++......
T Consensus 297 ~~~~~~---~~~-~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 297 VPVEEL---FKL-LKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp CCHHHH---HHH-HHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred CCHHHH---HHH-HHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 554322 222 222212111 1567889999999999999999999999999999998755444
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=326.88 Aligned_cols=264 Identities=23% Similarity=0.278 Sum_probs=194.8
Q ss_pred CCceeEe---eeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 6 GVKYKLG---RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 6 ~~~y~i~---~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.++|++. +.||+|+||.||+|++..+++.||+|++... ......+|+.+++.+.+|+++..+..++.+....+++|
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 3578875 8899999999999999999999999988643 33457789999999987788888888888888999999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++........
T Consensus 86 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 86 ELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred EccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999 7799998876 45799999999999999999999999999999999999996333344899999999976543322
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhh----hhHHHHHHHhhcccccch
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~ 237 (306)
. .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ........+.......+.
T Consensus 165 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 165 P-------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp --------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred c-------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence 1 12456799999999999999999999999999999999999999864432 112333444333333332
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
.....+++++.++|.+||+.||.+|||+.++++ +.++....
T Consensus 238 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--h~w~~~~~ 278 (325)
T 3kn6_A 238 -EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY--NEWLQDGS 278 (325)
T ss_dssp -HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT--CGGGCTTC
T ss_pred -ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc--ChhhccCc
Confidence 223567899999999999999999999999977 67776443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=333.45 Aligned_cols=261 Identities=19% Similarity=0.180 Sum_probs=199.9
Q ss_pred CCceeEe-eeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeecee----CceeEE
Q 021855 6 GVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVL 80 (306)
Q Consensus 6 ~~~y~i~-~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~~~~l 80 (306)
-++|.+. +.||.|+||.||+|++..+++.||+|++.. .....+|+.++.++.+|+++..+..++.. ....++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 3456665 799999999999999999999999999863 35677899888777777777776554432 567899
Q ss_pred EEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 81 VLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+|||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++..+.++.+||+|||++.....
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999 779999987532 3599999999999999999999999999999999999996333378999999999986543
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhH-HHHHHHhhcccccch
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDKICEKKVSTPI 237 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (306)
... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+....... .....+.......+.
T Consensus 217 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 217 HNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp ------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred CCc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 221 12557899999999999999999999999999999999999999875432211 122223333333322
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
+ ....+++++.+||.+||+.||++|||+.++++ +.++...
T Consensus 289 ~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~~ 328 (400)
T 1nxk_A 289 P-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQS 328 (400)
T ss_dssp T-TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHTT
T ss_pred c-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CccccCC
Confidence 1 22467899999999999999999999999988 5565543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=328.86 Aligned_cols=263 Identities=20% Similarity=0.259 Sum_probs=206.7
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++......+++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCC-TTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCC-CCCCeeeeEEeeCCEEEEEec
Confidence 579999999999999999999999999999998864432 2245678999998876 666666666777788999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
|+.++|.+++......+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~- 156 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKT- 156 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCccc-
Confidence 99999999988766679999999999999999999999999999999999999 58899999999999765433221
Q ss_pred cccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc------
Q 021855 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP------ 236 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 236 (306)
.....+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+.........
T Consensus 157 ------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 157 ------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ------cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 124467999999999987 5689999999999999999999999988766554444444333221111
Q ss_pred ----------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 237 ----------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 237 ----------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
.....+.+++++.+||.+||+.||.+|||++++++ +.++...+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~ 290 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK--HPFFLSLGE 290 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGGGGCS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc--Chhhhhccc
Confidence 11222456888999999999999999999999988 777764443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=334.27 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=210.7
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
-.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++......+++
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCC-TTBCCEEEEECSSSSCEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEecCCCcEEE
Confidence 457899999999999999999999989999999998754322 357889999999976 5566666666677789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCc
Confidence 9999 789999988766679999999999999999999999999999999999999 578999999999997643321
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+ ......+.+
T Consensus 268 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~- 337 (377)
T 3cbl_A 268 YAA-----SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV----EKGGRLPCP- 337 (377)
T ss_dssp EEC-----CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH----HTTCCCCCC-
T ss_pred eee-----cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCCC-
Confidence 110 1112345678999999998889999999999999999998 99999886554322222 222222222
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+|+.+.++|.+||+.||++|||+.+|++.|+.+.++
T Consensus 338 --~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 338 --ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 45688999999999999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=315.97 Aligned_cols=260 Identities=24% Similarity=0.285 Sum_probs=211.5
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
..+.++|++.+.||+|++|.||+|.+..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++......
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEcCCEE
Confidence 35789999999999999999999999999999999988654332 346789999999976 6666666666777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++|++ +++|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.+...+.++|+|||.+....
T Consensus 81 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999 7788888776 4569999999999999999999999999999999999999644445669999999997654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... ....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.... .....+.......+.
T Consensus 160 ~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 160 DSEAW--------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGAYDYPS 228 (284)
T ss_dssp SSCBC--------CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCT
T ss_pred cCccc--------cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHhccccCCc
Confidence 43221 2456899999999999999999999999999999999999999875543 233333333333332
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+ ....+++.+.++|.+||+.||++|||+.++++ +.++.
T Consensus 229 ~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~ 266 (284)
T 3kk8_A 229 P-EWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWIC 266 (284)
T ss_dssp T-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SHHHH
T ss_pred h-hhcccCHHHHHHHHHHcccChhhCCCHHHHhc--Ccccc
Confidence 2 22567889999999999999999999999988 56664
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=322.50 Aligned_cols=272 Identities=21% Similarity=0.256 Sum_probs=206.8
Q ss_pred cccCCceeEe-eeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 3 RIIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 3 ~~~~~~y~i~-~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
..+.++|++. +.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++.++..|+++..+..++......+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3567889995 789999999999999999999999999865432 3567889999998776788888877778888999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++||++ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.+.....+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999 6899999876 35699999999999999999999999999999999999995322334599999999876543
Q ss_pred CCCCccccccCCccccccccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh------------h
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------------K 221 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~------------~ 221 (306)
................+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 22111100011124458999999999875 457899999999999999999999997653221 1
Q ss_pred HHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
......+.......+.. ....+++.+.++|.+||+.||.+|||+.++++ +.++.
T Consensus 247 ~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~ 300 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDK-DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ--HPWVQ 300 (316)
T ss_dssp HHHHHHHHHCCCCCCHH-HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--STTCC
T ss_pred HHHHHHHhccCcccCch-hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc--Chhhc
Confidence 22333444444433322 23567899999999999999999999999987 55554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=321.96 Aligned_cols=267 Identities=21% Similarity=0.251 Sum_probs=205.0
Q ss_pred CcccCCceeEeeeecccCccEEEEEE----EcCCCceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCcceeec--e
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYG--V 73 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~----~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~~~--~ 73 (306)
.++..++|++.+.||+|+||.||+|+ +..+++.||+|++...... ..+.+|+.+++.+.|+ ++..+..++ .
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~ 83 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD-NIVKYKGVCYSA 83 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCT-TBCCEEEEECHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCC-CEeeEEEEEecC
Confidence 35778999999999999999999998 5678899999998754332 3577899999999874 444443332 2
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
.....++++||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCcc
Confidence 345689999999 789999998765569999999999999999999999999999999999999 4789999999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhH----------
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK---------- 222 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~---------- 222 (306)
+.......... .......++..|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 161 ~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 161 TKVLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236 (295)
T ss_dssp CC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred cccccCCccee----eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence 98654432211 1112345677899999999999999999999999999999999999764322110
Q ss_pred --HHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 223 --QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 223 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.............+. ...+|+++.++|.+||+.||++|||+.++++.|+.+.++
T Consensus 237 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPR---PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhccCcCCC---CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 011111111111111 256789999999999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=323.85 Aligned_cols=266 Identities=19% Similarity=0.241 Sum_probs=206.8
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeecee--Cce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~ 77 (306)
.+++++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++.. ...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTRH 83 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTCC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCcceEEEEeecCCCce
Confidence 56789999999999999999999999999999999988743 233457789999999986 455555444333 337
Q ss_pred eEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc-CCCcceEEEEeeccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~-~~~~~~~kl~Dfg~~ 153 (306)
.+++|||+ +++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||+.. .+..+.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 79999999 7899999875332 3899999999999999999999999999999999999832 246778999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhh-hhHHH
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQK 224 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~-~~~~~ 224 (306)
......... ....+|..|+|||++. +..++.++|||||||++|+|++|..||...... .....
T Consensus 164 ~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 164 RELEDDEQF--------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp EECCTTCCB--------CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred eecCCCCce--------eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 876543321 2456899999999986 567899999999999999999999999754322 22333
Q ss_pred HHHHhhccccc-------------------c-hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 225 YDKICEKKVST-------------------P-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 225 ~~~~~~~~~~~-------------------~-~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
+.++....... + ...+...+++.+.++|.+||+.||++|||++++++...+..
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 33333332211 0 00112344668999999999999999999999999877653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=316.19 Aligned_cols=258 Identities=19% Similarity=0.279 Sum_probs=210.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+|+.+++.+.| +++..+..++......+++|
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCceEEEE
Confidence 44678999999999999999999986 46779999887654 34568889999999986 56666666666777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+++......+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccccc
Confidence 999 779999987656669999999999999999999999999999999999999 4789999999999976543221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
. ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+... .....
T Consensus 162 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~~~~-~~~~~--- 228 (269)
T 4hcu_A 162 T------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTG-FRLYK--- 228 (269)
T ss_dssp H------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT-CCCCC---
T ss_pred c------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhcC-ccCCC---
Confidence 1 1124456778999999998899999999999999999999 999998755432 22222222 11111
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
....++.+.++|.+||+.||.+|||+.++++.|+++.++
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 144688999999999999999999999999999998763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.94 Aligned_cols=258 Identities=21% Similarity=0.317 Sum_probs=200.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeC-----
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~----- 75 (306)
+.++|++.+.||+|+||.||+|++..+|+.||+|.+...... ..+.+|+.+++.+.|.+.+..+..+....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 568899999999999999999999999999999998654332 34678999999998755444444433221
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++|+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 177 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeecccc
Confidence 35699999999999998875 469999999999999999999999999999999999999 5889999999999987
Q ss_pred cCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-- 232 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-- 232 (306)
..... ....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 178 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 178 ADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp CCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccc----------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 54322 14567999999999987 679999999999999999999999998866544333332222111
Q ss_pred ---------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 233 ---------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 233 ---------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
............++.+.+||.+||+.||.+|||++++++ +.++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~--hp~f~~ 313 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA--HPYFES 313 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTT
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc--ChHHHh
Confidence 011122233566889999999999999999999999988 666654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=331.81 Aligned_cols=264 Identities=18% Similarity=0.251 Sum_probs=208.6
Q ss_pred cccCCceeEeeeecccCccEEEEEEE-----cCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~-----~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
.+..++|++.+.||+|+||.||+|++ ..+++.||+|++...... ..+.+|+.++..+.| +++..+..++..
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCC-CCCCeEEEEEec
Confidence 45678999999999999999999994 456788999998654332 347789999999976 566666666667
Q ss_pred CceeEEEEecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEE
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl 147 (306)
....+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++....+..+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 77889999999 779999988643 34889999999999999999999999999999999999953334556999
Q ss_pred EeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHH
Q 021855 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYD 226 (306)
Q Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~ 226 (306)
+|||++......... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 226 ~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~ 297 (367)
T 3l9p_A 226 GDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE 297 (367)
T ss_dssp CCCHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH
T ss_pred CCCcccccccccccc-----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 999999754322111 11224567889999999999999999999999999999998 999998755432 222
Q ss_pred HHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.+.... .... ...+++.+.++|.+||+.||.+|||+.+|++.|+.+...
T Consensus 298 ~i~~~~-~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 298 FVTSGG-RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHTTC-CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHcCC-CCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 222222 1111 156688999999999999999999999999999998763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=326.12 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=202.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCC-CCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGG-SGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~-~~~~~~~~~~~~~~~~ 78 (306)
+.+++|++.+.||+|+||.||+|.+ .+++.||+|++...... ..+.+|+.++..+.|+ +++..+..++......
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 5688999999999999999999987 46889999988755433 3467899999999864 7787887788888899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++||+.+++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ .++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll----~~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTEEEECCCSSSCCC--
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----ECCcEEEeecccccccCc
Confidence 99999889999999886 5579999999999999999999999999999999999999 468899999999976544
Q ss_pred CCCCccccccCCccccccccccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (306)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+..
T Consensus 160 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~ 232 (343)
T 3dbq_A 160 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHA 232 (343)
T ss_dssp ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHH
T ss_pred ccccc-----cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHH
Confidence 32211 1124578999999999864 66899999999999999999999999764322 222333
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.......... ....++.+.++|.+||+.||.+|||+.++++ +.++.
T Consensus 233 ~~~~~~~~~~---~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~--hp~~~ 278 (343)
T 3dbq_A 233 IIDPNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQ 278 (343)
T ss_dssp HHCTTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred HhcCCcccCC---cccCCHHHHHHHHHHcCCChhHCCCHHHHHh--Ccccc
Confidence 3322222221 1445678999999999999999999999987 55655
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=327.30 Aligned_cols=259 Identities=24% Similarity=0.305 Sum_probs=198.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++......++++|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCC-CCCCcEEEEEeeCCEEEEEEE
Confidence 4679999999999999999999999999999999887543 34567889999999976 666666666677788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++ .+..+.+||+|||++........
T Consensus 97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~-~~~~~~~kl~Dfg~a~~~~~~~~- 173 (361)
T 3uc3_A 97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQ- 173 (361)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEEC-SSSSCCEEECCCCCC---------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc-CCCCceEEEeecCccccccccCC-
Confidence 99 7899988876 45699999999999999999999999999999999999994 11233599999999874332221
Q ss_pred ccccccCCccccccccccCcccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCchhhhh-HHHHHHHhhcccccchHHH
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRR-DDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (306)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+...... ...+..+.......+..
T Consensus 174 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 244 (361)
T 3uc3_A 174 -------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD-- 244 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT--
T ss_pred -------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc--
Confidence 124578999999999988887655 8999999999999999999987544322 22333333333333321
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+++.+.+||.+||+.||.+|||+.++++ +.++.+
T Consensus 245 -~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~ 280 (361)
T 3uc3_A 245 -IRISPECCHLISRIFVADPATRISIPEIKT--HSWFLK 280 (361)
T ss_dssp -SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SHHHHT
T ss_pred -CCCCHHHHHHHHHHccCChhHCcCHHHHHh--Ccchhc
Confidence 356889999999999999999999999988 666643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=326.92 Aligned_cols=261 Identities=26% Similarity=0.319 Sum_probs=206.7
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
|..-+-++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++.....
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~ 79 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNI 79 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCe
Confidence 455677899999999999999999999999999999998764432 3557889999999876 566666667777888
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 155 (323)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeecccee
Confidence 99999999 6799888764 4469999999999999999999999999999999999999 58899999999999765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... +..........
T Consensus 156 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~ 228 (323)
T 3tki_A 156 RYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYL 228 (323)
T ss_dssp EETTEEC-----CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHHHTTCTTS
T ss_pred ccCCccc-----ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHHhcccccC
Confidence 4322111 1125578999999999988775 78999999999999999999999875433221 22221111111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+ ....+++.+.+||.+||+.||.+|||++++++ +.++.
T Consensus 229 ~---~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~ 266 (323)
T 3tki_A 229 N---PWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYN 266 (323)
T ss_dssp T---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTT
T ss_pred C---ccccCCHHHHHHHHHHccCChhhCcCHHHHhh--Chhhc
Confidence 1 12556889999999999999999999999987 55554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=324.62 Aligned_cols=265 Identities=23% Similarity=0.276 Sum_probs=207.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeecee--------
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-------- 74 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-------- 74 (306)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.|. ++..+..++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE-NVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCT-TBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCC-CcccHhheeeccccccccC
Confidence 689999999999999999999999999999998765433 23577899999999874 44444333332
Q ss_pred CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
....++++||+.+++.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcc
Confidence 45689999999999998887666679999999999999999999999999999999999999 588999999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
........... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+........
T Consensus 173 ~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQPN---RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSCC---CCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccccccc---ccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 76533222111 12355789999999999864 589999999999999999999999998766554444444333222
Q ss_pred ccchHHH------------------------hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 234 STPIEVL------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 234 ~~~~~~~------------------------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
....+.. ....++.+.+||.+||+.||.+|||++++++ +.++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~ 318 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWSD 318 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC--CCCcCCC
Confidence 2111000 0113677999999999999999999999988 6776543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=320.20 Aligned_cols=263 Identities=21% Similarity=0.326 Sum_probs=213.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEE-----cCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~-----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+..++|++.+.||+|+||.||+|++ ..+++.||+|++..... ...+.+|+.++.++..|+++..+..++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 4568999999999999999999985 45678999999876543 245788999999996667777777777777
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeec
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRR-----------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~-----------------~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~ 137 (306)
...++++|++ +++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~- 178 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE-
Confidence 8899999999 6799999876432 38999999999999999999999999999999999999
Q ss_pred cCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 021855 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (306)
Q Consensus 138 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~ 216 (306)
+.++.+||+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 179 --~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 179 --THGRITKICDFGLARDIKNDSNYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp --ETTTEEEECCCGGGSCTTSCTTSE-----ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred --cCCCCEEEccccccccccccccce-----eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 488999999999998665433211 1224457788999999999899999999999999999999 99999875
Q ss_pred hhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.... .............. ...+++.+.++|.+||+.||.+|||+.++++.|++++.+.
T Consensus 252 ~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 252 PVDS---KFYKMIKEGFRMLS---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp CSSH---HHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cchh---HHHHHhccCCCCCC---cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 4332 22222222222221 1556889999999999999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=337.20 Aligned_cols=262 Identities=24% Similarity=0.338 Sum_probs=214.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+.++|++.+.||+|+||.||+|++..+++.||+|++.. ......+.+|+.+++.+.| +++..+..++......++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC-CCcCeEEEEEEcCCEEEE
Confidence 56789999999999999999999999999999998752 3344568899999999976 666666666777888999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
++||+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999 7899888876 356999999999999999999999999999999999999965456778999999999765443
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.. ..+..+.......+.+.
T Consensus 178 ~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~ 245 (486)
T 3mwu_A 178 TK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETGKYAFDLPQ 245 (486)
T ss_dssp ------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCSCSGG
T ss_pred Cc--------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCCCcc
Confidence 22 124578999999999976 5999999999999999999999999886543 33344444444333322
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
...+|+.+.++|.+||+.||.+|||+.++++ +.+++.....
T Consensus 246 -~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--hp~~~~~~~~ 286 (486)
T 3mwu_A 246 -WRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYSSE 286 (486)
T ss_dssp -GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH--CHHHHHTCCC
T ss_pred -cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CHhhccCccc
Confidence 2567899999999999999999999999988 6777654433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=337.15 Aligned_cols=260 Identities=22% Similarity=0.292 Sum_probs=211.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+..++|++.+.||+|+||.||+|+++.+++.||+|++.. ......+.+|..++..+.| +++..+..++.+....
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS-KWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCEE
Confidence 456789999999999999999999999999999998763 2233457889999988755 6777777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++||||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence 9999999 889999998655679999999999999999999999999999999999999 589999999999997655
Q ss_pred CCCCCccccccCCccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
..... ......||+.|+|||++. ...++.++|||||||++|||++|..||.+.+.... +.++....
T Consensus 227 ~~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~ 297 (437)
T 4aw2_A 227 EDGTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHK 297 (437)
T ss_dssp TTSCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHH
T ss_pred cCCCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhcc
Confidence 43321 112457899999999997 55689999999999999999999999987654433 33333222
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCC--CCChHHHHHHHHHhHh
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKRLFHDLFS 278 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~l~~~~~ 278 (306)
.....+.....+++++.+||++||..+|++ ||+++++++ +.+++
T Consensus 298 ~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~--Hpff~ 343 (437)
T 4aw2_A 298 ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK--HPFFS 343 (437)
T ss_dssp HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT--SGGGT
T ss_pred ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC--CCccC
Confidence 111112222457899999999999998888 999999987 66764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=315.87 Aligned_cols=259 Identities=16% Similarity=0.215 Sum_probs=210.5
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.+..++|++.+.||+|+||.||+|++. ++..||+|++.... ....+.+|+.++..+.| +++..+..++......+++
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH-PKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCceEEE
Confidence 356789999999999999999999876 46779999887654 34568889999999986 6666666666777789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|++ +++|.+++......+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||.+.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhh
Confidence 9999 788999988766679999999999999999999999999999999999999 588999999999997654432
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |..||......... ....... ....+
T Consensus 159 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~-~~~~~- 227 (268)
T 3sxs_A 159 YV------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV---LKVSQGH-RLYRP- 227 (268)
T ss_dssp EE------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHTTC-CCCCC-
T ss_pred hh------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH---HHHHcCC-CCCCC-
Confidence 21 1123455778999999998889999999999999999999 99999875543222 2222221 11111
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
...++.+.++|.+||+.||.+|||+.++++.|+.+.++
T Consensus 228 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 --HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 44578899999999999999999999999999988653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=324.40 Aligned_cols=267 Identities=22% Similarity=0.232 Sum_probs=204.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
..-++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++......+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-RNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC-TTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC-CCcceEEEEEecCCEEE
Confidence 345789999999999999999999999999999999875433 2346789999999976 66666766777888999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC--CCcceEEEEeeccccccC
Q 021855 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~--~~~~~~kl~Dfg~~~~~~ 157 (306)
+++||+.++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +..+.+||+|||++....
T Consensus 110 lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999999999999876 4569999999999999999999999999999999999999532 245679999999998764
Q ss_pred CCCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc-
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST- 235 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~- 235 (306)
..... .....+|..|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+..........
T Consensus 189 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 189 IPIRQ-------FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp ------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred Ccccc-------cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 33221 12446799999999998754 8999999999999999999999998865544333332221111100
Q ss_pred ---------------------chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 236 ---------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 236 ---------------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
........+++++.+||.+||+.||.+|||++++++ +.+++..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~ 326 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE--HPYFSHND 326 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGSSSC
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC--CcccCCCC
Confidence 011122336789999999999999999999999987 67775443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=332.60 Aligned_cols=270 Identities=18% Similarity=0.233 Sum_probs=199.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeC----
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG---- 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~---- 75 (306)
.+.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+.|. ++..+..++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD-YIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCT-TBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCC-CcceEEEEEecCCCCc
Confidence 3678999999999999999999999999999999998754333 3577899999999874 444444443332
Q ss_pred -ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...|+++|+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 102 FDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLAR 177 (432)
T ss_dssp CCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcc
Confidence 56899999999999998875 4569999999999999999999999999999999999999 588999999999998
Q ss_pred ccCCCCCCccc---------------cccCCccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCC-----
Q 021855 155 KYRDPTTNRHI---------------PYRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLRGSLPW----- 213 (306)
Q Consensus 155 ~~~~~~~~~~~---------------~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~tg~~pf----- 213 (306)
........... .........+|+.|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 76543221000 00012356789999999986 4556999999999999999999854443
Q ss_pred ------CCchh-----------------hhhHHHHHHHh-----------------------hcccccchHHHhhcCchH
Q 021855 214 ------QGLKA-----------------ATKKQKYDKIC-----------------------EKKVSTPIEVLCKSHPAE 247 (306)
Q Consensus 214 ------~~~~~-----------------~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~ 247 (306)
.+.+. ......+...+ ......+.....+.++++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 33210 00111111111 111112222333567899
Q ss_pred HHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 248 FASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 248 ~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
+.+||.+||+.||.+|||++++++ +.+++..
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~ 368 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALD--HPYLKDV 368 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT--CGGGTTT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc--Chhhhhc
Confidence 999999999999999999999988 7777643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=316.26 Aligned_cols=254 Identities=18% Similarity=0.296 Sum_probs=201.3
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc---------hhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---------PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
.+.+++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH-PNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCC-TTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCC-CCchhhheeec
Confidence 46789999999999999999999999999999999988654322 457789999999876 45544444333
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeccCCCcce-----E
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQ-----V 145 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~Nilv~~~~~~~~-----~ 145 (306)
. ..++++||+ +++|.+.+......+++..++.++.|++.||.|||+.| |+||||||+||+++ .++. +
T Consensus 94 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~---~~~~~~~~~~ 168 (287)
T 4f0f_A 94 N--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ---SLDENAPVCA 168 (287)
T ss_dssp T--TTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES---CCCTTCSCCE
T ss_pred C--CCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe---ccCCCCceeE
Confidence 2 347999999 68998888765667999999999999999999999999 99999999999994 4443 9
Q ss_pred EEEeeccccccCCCCCCccccccCCccccccccccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHH
Q 021855 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223 (306)
Q Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 223 (306)
||+|||++....... ....+++.|+|||++. ...++.++|||||||++|+|++|..||........ .
T Consensus 169 kl~Dfg~~~~~~~~~----------~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~ 237 (287)
T 4f0f_A 169 KVADFGLSQQSVHSV----------SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-K 237 (287)
T ss_dssp EECCCTTCBCCSSCE----------ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-H
T ss_pred EeCCCCccccccccc----------cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-H
Confidence 999999987533321 2456899999999984 45578999999999999999999999986543221 1
Q ss_pred HHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
............. ....+++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 238 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 238 FINMIREEGLRPT---IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHhccCCCCC---CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 2222222222222 2256789999999999999999999999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=335.17 Aligned_cols=270 Identities=20% Similarity=0.255 Sum_probs=190.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeec-----ee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYG-----VD 74 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~ 74 (306)
.+.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++ ..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH-DHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCC-CCCCceEEEEecCCccc
Confidence 3568999999999999999999999999999999988654332 347789999999976 4454554433 22
Q ss_pred CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
....|+++|+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 129 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccch
Confidence 356899999999999998875 4569999999999999999999999999999999999999 588999999999998
Q ss_pred ccCCCCCCccc-c-------------------ccCCccccccccccCcccc-cCCCCCchhhHHHHHHHHHHHHh-----
Q 021855 155 KYRDPTTNRHI-P-------------------YRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLR----- 208 (306)
Q Consensus 155 ~~~~~~~~~~~-~-------------------~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~t----- 208 (306)
........... + ........||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 76433211100 0 0112345789999999986 45669999999999999999999
Q ss_pred ------CCCCCCCchh--------------------hhhHHHHHHHhhc-----------------------ccccchHH
Q 021855 209 ------GSLPWQGLKA--------------------ATKKQKYDKICEK-----------------------KVSTPIEV 239 (306)
Q Consensus 209 ------g~~pf~~~~~--------------------~~~~~~~~~~~~~-----------------------~~~~~~~~ 239 (306)
|..+|.+.+. ......+....+. ........
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 6677765321 1111111111111 01111122
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
..+..++++.+||.+||+.||.+|||++++++ +.+++..
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~--Hp~f~~~ 403 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLA--HPFFKEV 403 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTT
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhc--CHhhhhc
Confidence 23556889999999999999999999999988 7777643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=332.67 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=207.5
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCC-----CCCCcceeeceeCc
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG-----SGIPNIKWYGVDGE 76 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~-----~~~~~~~~~~~~~~ 76 (306)
..++.+|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++..+.+. +++..+...+....
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 4567889999999999999999999999999999999876432 24567789999998754 24555556666778
Q ss_pred eeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce--EEEEeeccc
Q 021855 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLA 153 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~--~kl~Dfg~~ 153 (306)
..++++|+++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++ .++. +||+|||++
T Consensus 173 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 173 HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTC
T ss_pred eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccc
Confidence 899999999999999987644 3489999999999999999999999999999999999994 5555 999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
........ ...+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 250 ~~~~~~~~----------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 250 CYEHQRVY----------TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp EETTCCCC----------SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecCCccc----------ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 76443222 45789999999999999999999999999999999999999988665544333332221110
Q ss_pred cc---------------------------------------------------chHHHhhcCchHHHHHHHhhhcCCCCC
Q 021855 234 ST---------------------------------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQ 262 (306)
Q Consensus 234 ~~---------------------------------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~ 262 (306)
.. ....+....++.+.+||.+||++||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 00 001111234677999999999999999
Q ss_pred CCChHHHHHHHHHhHh
Q 021855 263 RPDYGFLKRLFHDLFS 278 (306)
Q Consensus 263 Rps~~~l~~~l~~~~~ 278 (306)
|||+.++++ +.++.
T Consensus 400 Rpta~e~L~--Hpw~~ 413 (429)
T 3kvw_A 400 RMTPGQALR--HPWLR 413 (429)
T ss_dssp SCCHHHHHT--STTTC
T ss_pred CCCHHHHhC--Chhhc
Confidence 999999987 55554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=329.11 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=202.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhC-CCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQG-GSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~~~ 78 (306)
+.+.+|++.+.||+|+||.||+|.+.. ++.||+|++...... ..+.+|+.++..+.+ ++++..+..++......
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 345679999999999999999999765 889999988765433 457889999999986 67788887777788889
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++||+.+++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ .++.+||+|||++.....
T Consensus 132 ~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----SSSCEEECCCSSSCCC--
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----ECCeEEEEecCccccccC
Confidence 99999778999999886 4578999999999999999999999999999999999999 458899999999986543
Q ss_pred CCCCccccccCCccccccccccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (306)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+..
T Consensus 207 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~~ 279 (390)
T 2zmd_A 207 DTTSV-----VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHA 279 (390)
T ss_dssp ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHH
T ss_pred CCccc-----cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HHHHHH
Confidence 32211 1124578999999999875 36889999999999999999999999764322 223333
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+.........+ ...++.+.++|.+||+.||.+|||+.++++ +.++.
T Consensus 280 ~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~~~ 325 (390)
T 2zmd_A 280 IIDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQ 325 (390)
T ss_dssp HHCTTSCCCCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred HhCccccCCCC---ccchHHHHHHHHHHcccChhhCCCHHHHhh--CcCcc
Confidence 33333222211 344778999999999999999999999987 45554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=313.30 Aligned_cols=258 Identities=24% Similarity=0.283 Sum_probs=211.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC--CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
-+.++|++.+.||+|+||.||+|++..++..+|+|.+... .....+.+|+.+++.+.| +++..+..++......+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-PNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCeEEEE
Confidence 3567899999999999999999999999999999987643 334568889999999966 6666666677778889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+||+ +++|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+||++..++.++.++|+|||.+.......
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999 7799888876 4569999999999999999999999999999999999999655578999999999997755433
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. ....+++.|+|||++.+. +++++||||||+++|+|++|..||...... .....+.......+.. .
T Consensus 164 ~~--------~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~-~ 230 (277)
T 3f3z_A 164 MM--------RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVMLKIREGTFTFPEK-D 230 (277)
T ss_dssp CB--------CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCCHH-H
T ss_pred ch--------hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCch-h
Confidence 21 245689999999998765 899999999999999999999999875543 3333444444444322 2
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+++.+.++|.+||+.||.+|||+.++++ +.+++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~--h~~~~ 266 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE--HEWFE 266 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHH
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHh
Confidence 3567899999999999999999999999987 45543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=316.84 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=202.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
.+.++|++.+.||+|+||.||+|++..++..+|+|++.... ....+.+|+.+++.+.| +++..+..++......++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH-PNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCC-chHHhHHHheecCCeEEE
Confidence 35678999999999999999999999999999999876543 23567889999999976 566666666677788999
Q ss_pred EEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 81 VLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
++||+ +++|.+.+... ...+++..++.++.||+.||.|||+.||+||||||+||++...+.++.++|+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999 67999887542 356999999999999999999999999999999999999964446789999999999765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
...... ....++..|+|||++. ..++.++|||||||++|+|++|..||.+.+..... ...........
T Consensus 178 ~~~~~~--------~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~ 245 (285)
T 3is5_A 178 KSDEHS--------TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ---QKATYKEPNYA 245 (285)
T ss_dssp -----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHCCCCCC
T ss_pred CCcccC--------cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH---hhhccCCcccc
Confidence 443221 2456899999999986 46899999999999999999999999875543222 22222222221
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
. ....+++.+.++|.+||+.||.+|||+.++++ +.+++
T Consensus 246 ~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~f~ 283 (285)
T 3is5_A 246 V--ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH--HEWFK 283 (285)
T ss_dssp C----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGGG
T ss_pred c--ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHhh
Confidence 1 12446889999999999999999999999987 45443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=333.83 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=208.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+..++|++.+.||+|+||.||+|+++.+++.||+|++... .....+.+|..++..+.| +++..+...+.+....
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR-RWITQLHFAFQDENYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEeeCCEE
Confidence 4567899999999999999999999999999999987632 223347788899988765 6777777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|++|||+ +++|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheecc
Confidence 9999999 889999998765679999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCCCccccccCCccccccccccCccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHL-------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
..... ......||+.|+|||++. +..++.++|||||||++|||++|..||.+.+... .+.++..
T Consensus 214 ~~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~ 284 (412)
T 2vd5_A 214 ADGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---TYGKIVH 284 (412)
T ss_dssp TTSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHT
T ss_pred CCCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---HHHHHHh
Confidence 43321 112457899999999997 4568999999999999999999999998765443 2333332
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCC---CChHHHHHHHHHhHh
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR---PDYGFLKRLFHDLFS 278 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---ps~~~l~~~l~~~~~ 278 (306)
.......+.....+|+++.++|.+||+ +|.+| |+++++++ +.+++
T Consensus 285 ~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~--Hpff~ 332 (412)
T 2vd5_A 285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT--HPFFF 332 (412)
T ss_dssp HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT--SGGGT
T ss_pred cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc--CCCcC
Confidence 221111122235679999999999999 99998 58999977 66664
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=334.17 Aligned_cols=254 Identities=20% Similarity=0.282 Sum_probs=207.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+..++|++.+.||+|+||.||+|.+. ++.||+|++........+.+|+.+++.+.|++.+..+..+.......+++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 34578999999999999999999874 7799999998877778899999999999875544444443444457899999
Q ss_pred cc-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~-~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+ +++|.+++...... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~ 344 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD 344 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCccccccccc
Confidence 99 77999999865443 7999999999999999999999999999999999999 5789999999999975432211
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
...++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+. .....+.
T Consensus 345 ----------~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~----~~~~~~~--- 407 (450)
T 1k9a_A 345 ----------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----KGYKMDA--- 407 (450)
T ss_dssp ------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH----TTCCCCC---
T ss_pred ----------CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----cCCCCCC---
Confidence 2345788999999999999999999999999999998 999998765443322222 2222221
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
...+|+.+.++|.+||+.||++|||+.+|++.|+.+...
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 156789999999999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=319.01 Aligned_cols=252 Identities=20% Similarity=0.284 Sum_probs=207.6
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--------chhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
+.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++..+.| +++..+..++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH-HNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC-CCcceEEEEEec
Confidence 4467789999999999999999999999999999998764322 2457889999999986 556666666677
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc----eEEEEe
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIID 149 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~----~~kl~D 149 (306)
....++++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++ .++ .++|+|
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~D 162 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID 162 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEcc
Confidence 78899999999 7899998875 45689999999999999999999999999999999999994 444 799999
Q ss_pred eccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh
Q 021855 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 229 (306)
||++......... ....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+.
T Consensus 163 fg~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~ 231 (321)
T 2a2a_A 163 FGLAHEIEDGVEF--------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANIT 231 (321)
T ss_dssp CTTCEECCTTCCC--------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH
T ss_pred CccceecCccccc--------cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH
Confidence 9999876543221 2456899999999999999999999999999999999999999875543 2233333
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
......+ +.....+++.+.++|.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 232 SVSYDFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TTCCCCC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hcccccC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3332222 3344677899999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=316.45 Aligned_cols=259 Identities=19% Similarity=0.302 Sum_probs=208.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+|+.++..+.| +++..+..++......++++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCC-CCEeeEEEEEecCCCeEEEE
Confidence 45679999999999999999999876 56789999987654 34568889999999986 56666666667777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||.+........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccccc
Confidence 999 789999987655679999999999999999999999999999999999999 5889999999999976543211
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
. ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......... .+... .....+
T Consensus 176 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~~~~-~~~~~~-- 243 (283)
T 3gen_A 176 T------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---HIAQG-LRLYRP-- 243 (283)
T ss_dssp H------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---HHHTT-CCCCCC--
T ss_pred c------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH---HHhcc-cCCCCC--
Confidence 1 1123456778999999998899999999999999999998 999998765443222 22222 111111
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...++.+.++|.+||+.||.+|||+.++++.|.+++.++
T Consensus 244 -~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 -HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 455789999999999999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=336.32 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=211.8
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+++.-++|.+.+.||+|+||.||+|++..+|+.||+|++... .....+.+|+.+++.+.| +++..+..++....
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~ 89 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-PHIIKLYQVISTPS 89 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCC-TTBCCEEEEEECSS
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECC
Confidence 345668899999999999999999999999999999987643 223457889999998876 56666666667778
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++||+ +++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhh
Confidence 899999999 7899998865 4569999999999999999999999999999999999999 5889999999999987
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.. ....++......
T Consensus 166 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~ 234 (476)
T 2y94_A 166 MSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKICDGIFY 234 (476)
T ss_dssp CCTTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHHHTTCCC
T ss_pred cccccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCCcC
Confidence 544322 125578999999999998775 78999999999999999999999875433 334444444443
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.+ ..+++.+.++|.+||+.||.+|||+.++++ +.++.+.
T Consensus 235 ~p-----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~--hp~~~~~ 273 (476)
T 2y94_A 235 TP-----QYLNPSVISLLKHMLQVDPMKRATIKDIRE--HEWFKQD 273 (476)
T ss_dssp CC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHHTT
T ss_pred CC-----ccCCHHHHHHHHHHcCCCchhCcCHHHHHh--CHHhhhc
Confidence 33 556889999999999999999999999988 5666543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=319.56 Aligned_cols=255 Identities=19% Similarity=0.295 Sum_probs=206.7
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
.|+..+.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.+++.+.| +++..+..++......+++|||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-FNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEecC
Confidence 48888999999999999999998999999998765433 3457889999999876 55656666666778899999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
+++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.........
T Consensus 125 ~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~-- 197 (321)
T 2c30_A 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK-- 197 (321)
T ss_dssp CSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccc--
Confidence 788988876 3469999999999999999999999999999999999999 57899999999998765443221
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.....+.. .....+
T Consensus 198 -----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~--~~~~~~ 267 (321)
T 2c30_A 198 -----RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRDSPPPKL--KNSHKV 267 (321)
T ss_dssp -----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSSCCCC--TTGGGS
T ss_pred -----cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCCCCCc--CccccC
Confidence 125578999999999999999999999999999999999999998754432 2222222222111 112456
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
++.+.++|.+||+.||++|||+.++++ +.++.+.+.
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~~~~~ 303 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLD--HPFLLQTGL 303 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGGGCCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc--ChhhccCCC
Confidence 889999999999999999999999988 667765543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=315.13 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=197.4
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCC---CceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
.+..++|++.+.||+|+||.||+|++..+ +..||+|+...... ...+.+|+.+++.+.| +++..+..+. .+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~-~~~ 88 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVI-TEN 88 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-CSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CccceEEEEE-ccC
Confidence 35678999999999999999999998653 45699998775433 2347789999998876 4555554443 345
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..+++||++ +++|.+++......+++..++.++.|++.||.|||+.|++||||||+||++ +.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECccccccc
Confidence 689999999 669999988755679999999999999999999999999999999999999 4789999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....... ..+.... .
T Consensus 166 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~~~~-~ 235 (281)
T 1mp8_A 166 MEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGE-R 235 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTC-C
T ss_pred cCccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHHcCC-C
Confidence 5443221 1123356778999999998899999999999999999997 99999876543322 2222221 1
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.+ ....+++.+.++|.+||+.||++|||+.++++.|+++++++
T Consensus 236 ~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 236 LP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11 12567899999999999999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=316.89 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=201.0
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
-++|++.+.||+|++|.||+|++..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++......+++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH-PNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CCccchhheeecCCeEEEE
Confidence 46899999999999999999999999999999988765443 336679999999986 5666666667778889999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
+|++.+.+...+......+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||.+........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCccc
Confidence 9999655444444335679999999999999999999999999999999999999 5889999999999987553322
Q ss_pred CccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc------
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS------ 234 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------ 234 (306)
. .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+........+
T Consensus 158 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 158 Y-------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred c-------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 1 124567899999999986 56899999999999999999999999886655444433333222111
Q ss_pred -----------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 -----------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 -----------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.+.....+.+++.+.++|.+||+.||.+|||++++++ +.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~ 289 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH--HPYFE 289 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT--SGGGT
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc--ChHHH
Confidence 1112223567888999999999999999999999987 66665
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=338.39 Aligned_cols=258 Identities=20% Similarity=0.237 Sum_probs=196.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeece-----eC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~ 75 (306)
+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.|++.+..+..+.. ..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 45789999999999999999999999999999998875422 2346789999999977554444443322 22
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++||||+.+++.+.+. ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 140 ~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeee
Confidence 4679999999888877764 358999999999999999999999999999999999999 5889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc-
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS- 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~- 234 (306)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+........+
T Consensus 214 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 214 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp ---CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 544321 12567899999999999999999999999999999999999999886654443333322221100
Q ss_pred ---------------------cchHHHh------------hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 ---------------------TPIEVLC------------KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 ---------------------~~~~~~~------------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+... ...++++.+||.+||+.||.+|||++++++ +.++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~~~ 360 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--HPYIN 360 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTG
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc--Chhhh
Confidence 0001100 011567999999999999999999999988 66664
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=322.76 Aligned_cols=278 Identities=19% Similarity=0.214 Sum_probs=212.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee----Cce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD----GED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~~ 77 (306)
++++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.++..+.|++.+..+..+... ...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 358999999999999999999999999999999998754332 4577899999999875544444333222 246
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
.++++|+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecC
Confidence 899999999999998874 469999999999999999999999999999999999999 588999999999997654
Q ss_pred CCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc----
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---- 232 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---- 232 (306)
....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 180 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 180 PDHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp GGGCBCC----TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred CCCCccc----cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 3322110 11245789999999987654 48999999999999999999999998866554433333222111
Q ss_pred -------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc-----CCCCCccc
Q 021855 233 -------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE-----GYDFDFVF 288 (306)
Q Consensus 233 -------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~-----~~~~~~~~ 288 (306)
...+.....+.+++++.+||.+||+.||.+|||+.++++ +.++++. ......||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~~~~~~~~~~~~~~~~ 333 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLEQYYDPSDEPIAEAPF 333 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTTTCCGGGSCCCSSCC
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcchhhccCcccccCCCCcC
Confidence 111223334567889999999999999999999999988 6776532 22234455
Q ss_pred cceec
Q 021855 289 DWTIL 293 (306)
Q Consensus 289 ~~~~~ 293 (306)
.++..
T Consensus 334 ~~~~~ 338 (364)
T 3qyz_A 334 KFDME 338 (364)
T ss_dssp CCC--
T ss_pred Ccccc
Confidence 55543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=323.70 Aligned_cols=262 Identities=19% Similarity=0.267 Sum_probs=209.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+..++|++.+.||+|+||.||+|++. .++..||+|++.... ....+.+|+.++.++..|+++..+..++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34578999999999999999999973 456789999887432 3456889999999996667777777777777
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRR----------------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~----------------------~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~ 132 (306)
...+++|||+ +++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 8899999999 7799999875432 2788999999999999999999999999999999
Q ss_pred ceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCC
Q 021855 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSL 211 (306)
Q Consensus 133 Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~ 211 (306)
||++ +.++.++|+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 202 NIll---~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 202 NVLV---THGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp GEEE---ETTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred hEEE---cCCCcEEeCCCccCcccccCccce-----eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 9999 488999999999997654432211 1124456788999999999899999999999999999998 999
Q ss_pred CCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 212 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 212 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
||.+.... ..+............ ...+++.+.++|.+||+.||.+|||+.++++.|+.++..
T Consensus 274 p~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 274 PYPGIPVD---ANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SSTTCCCS---HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcccCCcH---HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 99875432 222222232222221 145688999999999999999999999999999998763
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=323.31 Aligned_cols=251 Identities=21% Similarity=0.312 Sum_probs=205.9
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++......++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCeEEE
Confidence 45699999999999999999999999999999988754332 346789999999976 556666666677888999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
++||+.|++.+++......+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++......
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB-
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCCC-
Confidence 99999999999887666779999999999999999999999999999999999999 48899999999999764322
Q ss_pred CCccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
....+|+.|+|||++. +..++.++|||||||++|+|++|..||.+.+... ....+.....+..
T Consensus 208 ----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---~~~~~~~~~~~~~- 273 (348)
T 1u5q_A 208 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPAL- 273 (348)
T ss_dssp ----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSCCCCC-
T ss_pred ----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCC-
Confidence 1456899999999985 5678999999999999999999999998755432 2223332222221
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
....+++.+.++|.+||+.||++|||++++++ +.++..
T Consensus 274 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~--h~~~~~ 311 (348)
T 1u5q_A 274 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 311 (348)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred --CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh--Chhhhc
Confidence 12456889999999999999999999999987 455543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=327.47 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=195.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+..++|++.+.||+|+||.||+|+++.+++.||+|++.... .......|..++.+..+|+++..+...+......
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34578999999999999999999999999999999876432 1223444555432223457777777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence 9999999 7799988876 4568999999999999999999999999999999999999 588999999999997643
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+
T Consensus 191 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~~- 259 (373)
T 2r5t_A 191 EHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNKPLQLK- 259 (373)
T ss_dssp CCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHHHHHHHSCCCCC-
T ss_pred cCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcccCCC-
Confidence 3222 123567899999999999999999999999999999999999999875543 34445555444443
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 267 (306)
..+++.+.++|.+||+.||.+||++.
T Consensus 260 ----~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 260 ----PNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp ----SSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ----CCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 56789999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=320.15 Aligned_cols=264 Identities=22% Similarity=0.283 Sum_probs=198.6
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHH--HhCCCCCCcceeece----e
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSGIPNIKWYGV----D 74 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~--l~~~~~~~~~~~~~~----~ 74 (306)
|+++++++|++.+.||+|+||.||+|++ +++.||+|++... ....+..|..++.. +.| +++..+..++. .
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h-~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-DEKSWFRETELYNTVMLRH-ENILGFIASDMTSRHS 77 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCC-TTBCCEEEEEEEEETT
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-cchhhHHHHHHHHHhhccC-cCeeeEEEeeccccCC
Confidence 6789999999999999999999999987 6889999988653 23445667777766 445 55555433322 2
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCccccCCCCCceeeccCCCcceE
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH--------SRGFLHRDIKPDNFLMGLGRKANQV 145 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--------~~~i~H~dlkp~Nilv~~~~~~~~~ 145 (306)
....++++||+ +++|.+++. ...+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~ 152 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQC 152 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCE
T ss_pred CceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCE
Confidence 34579999999 779999985 456999999999999999999999 9999999999999999 588999
Q ss_pred EEEeeccccccCCCCCCccccccCCccccccccccCcccccCC------CCCchhhHHHHHHHHHHHHhC----------
Q 021855 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRG---------- 209 (306)
Q Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~il~~l~tg---------- 209 (306)
||+|||++............ ......+|+.|+|||++.+. .+++++|||||||++|+|++|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDV---GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp EECCCTTCEEEETTTTEEEC---CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred EEeeCCCeeecccccccccc---cccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 99999999765443332111 11244789999999999877 455799999999999999999
Q ss_pred CCCCCCchhhh-hHHHHHHHhh---cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 210 SLPWQGLKAAT-KKQKYDKICE---KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 210 ~~pf~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
..||....... .......... .....+........++.+.++|.+||+.||.+|||+.++++.|+.+
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88886543221 1112222111 1111221222234567899999999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=331.37 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=198.8
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhC-------CCCCCcceeece
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQG-------GSGIPNIKWYGV 73 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~-------~~~~~~~~~~~~ 73 (306)
++++.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.+ ++++..+...+.
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 56788999999999999999999999999999999999875422 3457789999999974 233444433333
Q ss_pred ----eCceeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCC-------
Q 021855 74 ----DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGR------- 140 (306)
Q Consensus 74 ----~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~------- 140 (306)
.....+++||++++++.+.+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++...
T Consensus 112 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred ecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 455789999999999988877543 4599999999999999999999998 999999999999995111
Q ss_pred ---------------------------------------CcceEEEEeeccccccCCCCCCccccccCCccccccccccC
Q 021855 141 ---------------------------------------KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181 (306)
Q Consensus 141 ---------------------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a 181 (306)
....+||+|||.+........ ...+|..|+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~----------~~~gt~~y~a 261 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT----------EDIQTRQYRS 261 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC----------SCCSCGGGCC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc----------cCCCCCcccC
Confidence 113899999999976543321 4468999999
Q ss_pred cccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh---hHHHHHHHhhcccccchHH-------------------
Q 021855 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT---KKQKYDKICEKKVSTPIEV------------------- 239 (306)
Q Consensus 182 PE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~------------------- 239 (306)
||++.+..++.++|||||||++|+|++|..||.+.+... .......+.......+...
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999999999999999999999999999999997643221 1111111111110110000
Q ss_pred ------------------HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 ------------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ------------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....++.+.+||.+||+.||++|||+.++++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01223567899999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=317.57 Aligned_cols=258 Identities=19% Similarity=0.284 Sum_probs=205.3
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
....++|++.+.||+|++|.||+|.+..+++.||+|.+........+.+|+.++..+.| +++..+..++......++++
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS-PHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEEEe
Confidence 44678899999999999999999999999999999999887777888999999999876 55666666666777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|++ +++|.+++......+++..++.++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc
Confidence 999 569999987656779999999999999999999999999999999999999 4789999999999976544322
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. .....++..|+|||++.+..++.++|||||||++|+|++|..||.......... .......... ...
T Consensus 181 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~--~~~ 248 (314)
T 3com_A 181 K-------RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---MIPTNPPPTF--RKP 248 (314)
T ss_dssp C-------BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSCCCCC--SSG
T ss_pred c-------cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhcCCCccc--CCc
Confidence 1 124568899999999999899999999999999999999999998754432222 1111111111 112
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+++.+.++|.+||+.||.+|||+.++++ +.++.
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~--~~~~~ 283 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ--HPFVR 283 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHh
Confidence 456889999999999999999999999987 56665
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=328.93 Aligned_cols=265 Identities=18% Similarity=0.242 Sum_probs=203.9
Q ss_pred cCCceeEeeeeccc--CccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 5 IGVKYKLGRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 5 ~~~~y~i~~~lg~g--~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
-+++|++.+.||+| ++|.||+|++..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++......
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCCCcEeEEEEECCEE
Confidence 46889999999999 9999999999999999999988754322 346679999999976 5666666667778889
Q ss_pred EEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 79 VLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
++++||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence 9999999 78999998764 2459999999999999999999999999999999999999 58899999999998654
Q ss_pred CCCCCCccccccCCccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
..................+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...... .......+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~ 255 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL---EKLNGTVP 255 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH---HC------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHhcCCCC
Confidence 3322211111112234578899999999988 578999999999999999999999998754332211 11111100
Q ss_pred -----------------------------------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHH
Q 021855 235 -----------------------------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (306)
Q Consensus 235 -----------------------------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l 273 (306)
.+.......+++.+.+||.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~-- 333 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN-- 333 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT--
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc--
Confidence 0011123456888999999999999999999999987
Q ss_pred HHhHh
Q 021855 274 HDLFS 278 (306)
Q Consensus 274 ~~~~~ 278 (306)
+.+++
T Consensus 334 hp~f~ 338 (389)
T 3gni_B 334 HSFFK 338 (389)
T ss_dssp SGGGG
T ss_pred CHHHH
Confidence 55554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=318.99 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=200.6
Q ss_pred cccCCceeEeeeecccCccEEEEEEEc---CCCceEEEEEccCCC------CchhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
.+..++|++.+.||+|+||.||+|++. .+++.||+|++.... ....+.+|+.+++.+.| +++..+..++.
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~ 91 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH-PFIVDLIYAFQ 91 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCC-TTBCCEEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCC-CCccceeEEEE
Confidence 456789999999999999999999985 689999999887542 23446779999999976 56666666667
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
.....+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGL 167 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCc
Confidence 778899999999 7899988876 4568999999999999999999999999999999999999 5889999999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
+......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+....
T Consensus 168 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~ 237 (327)
T 3a62_A 168 CKESIHDGTV-------THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKILKCK 237 (327)
T ss_dssp C-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTC
T ss_pred ccccccCCcc-------ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCC
Confidence 8754332211 12457899999999999999999999999999999999999999875543 3344444444
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHHHHHHhHh
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRLFHDLFS 278 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~l~~~~~ 278 (306)
...+ ..+++.+.++|.+||+.||.+|| +++++++ +.+++
T Consensus 238 ~~~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~--hp~f~ 281 (327)
T 3a62_A 238 LNLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA--HPFFR 281 (327)
T ss_dssp CCCC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH--SGGGS
T ss_pred CCCC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc--CCccc
Confidence 4443 56688999999999999999999 6778876 45553
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=317.73 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=197.5
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
.++.+++|++.+.||+|+||.||+|++. ..||+|++...... ..+.+|+.+++.+.|.+ +..+..+. ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN-ILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTT-BCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc-EEEEEeec-cCCc
Confidence 4678999999999999999999999864 35999988765433 34778999999888754 44444433 4456
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEK 170 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC-----
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceecccc
Confidence 89999999 689988887655679999999999999999999999999999999999999 47899999999999755
Q ss_pred CCCCCCccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
....... ......++..|+|||++. +..++.++|||||||++|+|++|..||....... ...........
T Consensus 171 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~ 243 (289)
T 3og7_A 171 SRWSGSH-----QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRGSL 243 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHTSC
T ss_pred ccccccc-----cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhccccc
Confidence 4322211 112456899999999987 5678899999999999999999999998754332 22222233333
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..........+|+.+.++|.+||+.||.+|||+.++++.|+++.+
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 333344446778999999999999999999999999999998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=348.09 Aligned_cols=249 Identities=20% Similarity=0.284 Sum_probs=212.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+.-++|++.+.||+|+||.||+|++..+++.||+|++.. .........|..++..+.+++++..+..++......
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 345689999999999999999999999999999998763 334455778888888888889998888888888899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++...
T Consensus 418 ~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccc
Confidence 9999999 7899988876 3569999999999999999999999999999999999999 589999999999998643
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.. ..+..+.......+
T Consensus 494 ~~~~~-------~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~~p- 562 (674)
T 3pfq_A 494 WDGVT-------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIMEHNVAYP- 562 (674)
T ss_dssp CTTCC-------BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHSSCCCCC-
T ss_pred cCCcc-------cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHHHHHhCCCCCC-
Confidence 32221 23567999999999999999999999999999999999999999885543 45556666555555
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCCh-----HHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY-----GFLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~l~~ 271 (306)
..+++++.+||.+||+.||++||++ ++|++
T Consensus 563 ----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 ----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 5678999999999999999999987 66665
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=329.96 Aligned_cols=258 Identities=22% Similarity=0.235 Sum_probs=209.3
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++......+++|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCC-cCCCeEEEEEEeCCEEEEEE
Confidence 34689999999999999999999999999999998876532 2357789999998876 56666666667788899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||++........
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCcc
Confidence 999 78999888764557999999999999999999999999999999999999941 2457899999999987644322
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
. ....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+ ....
T Consensus 207 ~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~ 274 (387)
T 1kob_A 207 V--------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRCDWEFD-EDAF 274 (387)
T ss_dssp E--------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHCCCCCC-SSTT
T ss_pred e--------eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-cccc
Confidence 1 2446899999999999999999999999999999999999999876543 22333333322222 1222
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+++++.++|.+||+.||.+|||+.++++ +.++.
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~ 309 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLK 309 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhh--Ccccc
Confidence 567899999999999999999999999987 55554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=330.30 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=209.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+..++|++.+.||+|+||.||+|+++.+++.||+|++.. ......+.+|..++..+.| +++..+..++.+....
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYL 144 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEE
Confidence 456789999999999999999999999999999998753 2334457789999988865 6666777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeec
Confidence 9999999 8899998864 468999999999999999999999999999999999999 589999999999998654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc-
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK- 232 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~- 232 (306)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+... .+.++....
T Consensus 220 ~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~~ 290 (410)
T 3v8s_A 220 KEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKIMNHKN 290 (410)
T ss_dssp TTSEE------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTHHH
T ss_pred cCCcc------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---HHHHHHhccc
Confidence 43211 112567999999999998765 7899999999999999999999998765543 333333222
Q ss_pred -cccchHHHhhcCchHHHHHHHhhhcCCCCC--CCChHHHHHHHHHhHhh
Q 021855 233 -VSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~~l~~~l~~~~~~ 279 (306)
...+. ...+++++.+||.+||+.+|.+ ||++++|++ +.+++.
T Consensus 291 ~~~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~--Hp~f~~ 335 (410)
T 3v8s_A 291 SLTFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR--HLFFKN 335 (410)
T ss_dssp HCCCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT--SGGGCC
T ss_pred cccCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhc--CccccC
Confidence 12221 1467899999999999999988 999999988 677753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=326.50 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=190.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeece-----eC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~ 75 (306)
+.++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+.+|+.+++.+.|.+.+..+..+.. ..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 468899999999999999999999999999999998754332 346789999999987554444443322 22
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++|+++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC------
T ss_pred CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccc
Confidence 56799999999999988864 569999999999999999999999999999999999999 5889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-- 232 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-- 232 (306)
..... ....+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+.....
T Consensus 182 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 182 TADEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccccC----------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 54322 24578999999999987 678999999999999999999999998866544433333322111
Q ss_pred ---------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 233 ---------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 233 ---------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
............++.+.+||.+||+.||.+|||+.++++ +.++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~--hp~~~~ 317 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQ 317 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc--Chhhhh
Confidence 111223334567889999999999999999999999987 666654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=317.23 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=194.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----------------------------chhhHHHHHH
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------------------HPQLLYEAKV 55 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----------------------------~~~~~~e~~~ 55 (306)
+.-++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 345789999999999999999999999999999998764321 2457889999
Q ss_pred HHHHhCCCCCCcceeecee--CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCC
Q 021855 56 YKILQGGSGIPNIKWYGVD--GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132 (306)
Q Consensus 56 l~~l~~~~~~~~~~~~~~~--~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~ 132 (306)
++.+.| +++..+..++.. ....+++|||+ +++|.++.. ...+++..++.++.||+.||.|||+.||+||||||+
T Consensus 90 l~~l~h-~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDH-PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCC-TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCC-CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999976 455555444333 56789999999 677766543 346999999999999999999999999999999999
Q ss_pred ceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCC---CCchhhHHHHHHHHHHHHhC
Q 021855 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRG 209 (306)
Q Consensus 133 Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~il~~l~tg 209 (306)
|||+ +.++.+||+|||++......... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 167 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 167 NLLV---GEDGHIKIADFGVSNEFKGSDAL-------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp GEEE---CTTSCEEECCCTTCEECSSSSCE-------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred HEEE---CCCCCEEEecCCCcccccccccc-------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999 48899999999999875543221 12457899999999998765 37889999999999999999
Q ss_pred CCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..||...... .....+.......+. ...+++.+.++|.+||+.||++|||+.++++
T Consensus 237 ~~pf~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 237 QCPFMDERIM---CLHSKIKSQALEFPD---QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCSSCCSSHH---HHHHHHHHCCCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCccHH---HHHHHHhcccCCCCC---ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 9999875432 222223233222221 1467889999999999999999999999976
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=314.31 Aligned_cols=262 Identities=19% Similarity=0.322 Sum_probs=214.7
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.+..++|++.+.||+|++|.||+|.+..++..||+|++...... ..+.+|+.+++.+.| +++..+..++......+++
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCEEEE
Confidence 35678999999999999999999999999999999988765433 457889999999986 5566666666777789999
Q ss_pred Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|++ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||.+......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceeccCC
Confidence 9999 689999987633 348999999999999999999999999999999999999 58899999999999865543
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
... ......++..|+|||++.+..++.++||||||+++|+|++ |..||...+.......+ ........
T Consensus 165 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~----~~~~~~~~- 233 (288)
T 3kfa_A 165 TYT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMER- 233 (288)
T ss_dssp SSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HTTCCCCC-
T ss_pred ccc------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hccCCCCC-
Confidence 321 1124456788999999998899999999999999999999 99999875543222222 22222211
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
...+|+.+.++|.+||+.||.+|||+.++++.|+.++.+..
T Consensus 234 --~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 15668899999999999999999999999999999987543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=320.68 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=200.8
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceE----EEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIV----AVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~v----aiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
.+..++|++.+.||+|+||.||+|++..+++.+ |+|.+... .....+.+|+.+++.+.| +++..+..++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 89 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS 89 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCB-TTBCCEEEEEESS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecC
Confidence 456789999999999999999999998777654 77776533 233568889999999987 5555555554444
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
..+++++++ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAK 165 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHH
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCccee
Confidence 366777777 889999998766779999999999999999999999999999999999999 488999999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
......... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+........ ......
T Consensus 166 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~~~ 236 (327)
T 3poz_A 166 LLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGE 236 (327)
T ss_dssp HHTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----HHHTTC
T ss_pred EccCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH----HHHcCC
Confidence 765443221 1123456778999999999999999999999999999999 999998765433222 222222
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+.+ ..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 237 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 RLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCC---TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCC---ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22211 4568899999999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=318.58 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=210.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEE-----cCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeece-e
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV-D 74 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~-----~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~-~ 74 (306)
+..++|++.+.||+|+||.||+|++ ..+++.||+|++...... ..+.+|+.++..+.+|+++..+..++. .
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 4568999999999999999999985 356789999998765443 347789999999977777777655544 4
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRRK---------------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~---------------~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~ 138 (306)
....++++||+ +++|.+++...... +++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~-- 181 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 181 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--
Confidence 45689999999 67999998764321 7899999999999999999999999999999999999
Q ss_pred CCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 021855 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (306)
Q Consensus 139 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~ 217 (306)
+.++.+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 182 -~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 182 -SEKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -CCCCCEEECCCccccccccCccce-----eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 588999999999997654432211 1224567889999999999999999999999999999998 999997754
Q ss_pred hhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
... .+............ ...+++.+.++|.+||+.||.+|||+.++++.|+.++....
T Consensus 256 ~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 256 IDE---EFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CSH---HHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhH---HHHHHhccCccCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 321 11122222111111 14568899999999999999999999999999999987544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=319.08 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=197.9
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhCCCCCCcceeeceeCc-
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGE- 76 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~- 76 (306)
..+.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.++..+.| +++..+..++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH-PAIVAVYDTGEAETP 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCC-TTBCCEEEEEEEEET
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCC-CCcceEEEeeeccCC
Confidence 35678999999999999999999999999999999998765332 245678888888866 45555544433322
Q ss_pred ---eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 77 ---DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 77 ---~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
..+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGI 162 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSC
T ss_pred CCcccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccC
Confidence 349999999 7899999876 4569999999999999999999999999999999999999 4789999999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
+.......... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..........
T Consensus 163 a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~ 235 (311)
T 3ork_A 163 ARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHVRED 235 (311)
T ss_dssp C----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCC
T ss_pred ccccccccccc----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhcCC
Confidence 97654432211 1122456899999999999999999999999999999999999999875543 2222222222
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCC-hHHHHHHHHHhHh
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKRLFHDLFS 278 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~~l~~~l~~~~~ 278 (306)
..+.......+++++.++|.+||+.||.+||+ ++++.+.|..+..
T Consensus 236 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 236 -PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 23333344678999999999999999999995 5555555555543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=319.94 Aligned_cols=258 Identities=18% Similarity=0.230 Sum_probs=203.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCce----EEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~----vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+..++|++.+.||+|+||.||+|++..+++. |++|.+.... ....+.+|+.++..+.| +++..+..++. ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH-AHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCC-TTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEc-CC
Confidence 4467999999999999999999999888776 6777765432 23457789999988876 55555544443 45
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 688999999 789999987655578999999999999999999999999999999999999 5889999999999987
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+ .....
T Consensus 165 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~ 235 (325)
T 3kex_A 165 LPPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL----EKGER 235 (325)
T ss_dssp SCCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH----HTTCB
T ss_pred cCcccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH----HcCCC
Confidence 65443221 1124567789999999998899999999999999999999 99999875543222222 22111
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+ ..+++++.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 236 ~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 LAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111 4457889999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=339.04 Aligned_cols=260 Identities=26% Similarity=0.352 Sum_probs=214.4
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
.++.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++.....
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH-PNIMKLYEFFEDKGY 100 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCE
Confidence 356789999999999999999999999999999999876432 23457889999999976 666667666777888
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++|++ +++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||+...+.++.+||+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999 7899888875 456999999999999999999999999999999999999965456889999999999876
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
...... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.. .....+.......+
T Consensus 180 ~~~~~~--------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 180 EASKKM--------KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKVEKGKYTFE 247 (484)
T ss_dssp CCCCSH--------HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC
T ss_pred cccccc--------ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC
Confidence 543321 24568999999999877 6999999999999999999999999886543 33444444444433
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.+. ...+|+.+.++|.+||+.||.+|||+.++++ +.++..
T Consensus 248 ~~~-~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--h~~~~~ 287 (484)
T 3nyv_A 248 LPQ-WKKVSESAKDLIRKMLTYVPSMRISARDALD--HEWIQT 287 (484)
T ss_dssp SGG-GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHHH
T ss_pred Ccc-cccCCHHHHHHHHHHCCCChhHCcCHHHHhh--Chhhcc
Confidence 322 2567899999999999999999999999988 666654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=318.73 Aligned_cols=258 Identities=18% Similarity=0.252 Sum_probs=203.6
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCC-------ceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeec
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTN-------EIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYG 72 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~-------~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 72 (306)
.++..++|++.+.||+|+||.||+|++..++ ..||+|++.... ....+.+|+.+++.+.| +++..+..++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~ 81 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH-KHLVLNYGVC 81 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCC-TTBCCEEEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEE
Confidence 5788899999999999999999999988776 469999876432 23457889999999976 5666666666
Q ss_pred eeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce-------
Q 021855 73 VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ------- 144 (306)
Q Consensus 73 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~------- 144 (306)
......++++||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~~ 158 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNPP 158 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBCC
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCcccccccc
Confidence 6777889999999 6899999987555599999999999999999999999999999999999994 4444
Q ss_pred -EEEEeeccccccCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCC-CCCCCchhhhh
Q 021855 145 -VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGS-LPWQGLKAATK 221 (306)
Q Consensus 145 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~-~pf~~~~~~~~ 221 (306)
++|+|||.+...... ....++..|+|||++.+ ..++.++|||||||++|+|++|. .||.......
T Consensus 159 ~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~- 226 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR- 226 (289)
T ss_dssp EEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred eeeeccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-
Confidence 999999998653221 13457889999999988 67999999999999999999954 5554433221
Q ss_pred HHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
...........+ ...++++.++|.+||+.||.+|||+.++++.|+.++...+..
T Consensus 227 ---~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 227 ---KLQFYEDRHQLP-----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp ---HHHHHHTTCCCC-----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred ---HHHHhhccCCCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 112222222222 445788999999999999999999999999999998754433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=334.47 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=210.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---------------CchhhHHHHHHHHHHhCCCCCCcc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------------KHPQLLYEAKVYKILQGGSGIPNI 68 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~e~~~l~~l~~~~~~~~~ 68 (306)
.++++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~ 111 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH-PNIIKL 111 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC-TTBCCE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC-CCCCeE
Confidence 46788999999999999999999999999999999876432 23457889999999976 666677
Q ss_pred eeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEE
Q 021855 69 KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (306)
Q Consensus 69 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl 147 (306)
..++......++++||+ +++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.......+||
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 67777888899999999 7799888876 456999999999999999999999999999999999999953323347999
Q ss_pred EeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 021855 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (306)
+|||++......... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.. ..+..
T Consensus 191 ~Dfg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~ 258 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKL--------RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIKK 258 (504)
T ss_dssp CCCTTCEECCTTSCB--------CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred EECCCCEEcCCCCcc--------ccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH
Confidence 999999876543221 24568999999999874 6899999999999999999999999886543 34444
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
+.......+.+. ...+|+++.++|.+||+.||.+|||+.++++ +.+++..
T Consensus 259 i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~ 308 (504)
T 3q5i_A 259 VEKGKYYFDFND-WKNISDEAKELIKLMLTYDYNKRCTAEEALN--SRWIKKY 308 (504)
T ss_dssp HHHCCCCCCHHH-HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHHT
T ss_pred HHcCCCCCCccc-cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--CHhhhhc
Confidence 444444444332 3678999999999999999999999999988 6776643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=334.24 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=201.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+..++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.++..+.| +++..+..++......
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSC-TTSCCEEEEEEETTEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCC-CeEeeEEEEEeeCCEE
Confidence 4457899999999999999999999999999999987632 233456678888887765 6666777777788889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTT
T ss_pred EEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceec
Confidence 9999999 7789888876 4579999999999999999999998 999999999999999 58899999999999754
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......+
T Consensus 300 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p 369 (446)
T 4ejn_A 300 IKDGAT-------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRFP 369 (446)
T ss_dssp CC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC
T ss_pred cCCCcc-------cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHHhCCCCCC
Confidence 332221 12567899999999999999999999999999999999999999875543 33444444444444
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHHHHHHhHh
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRLFHDLFS 278 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~l~~~~~ 278 (306)
..+++++.++|.+||+.||.+|| |++++++ +.++.
T Consensus 370 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~--hp~f~ 409 (446)
T 4ejn_A 370 -----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ--HRFFA 409 (446)
T ss_dssp -----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGGT
T ss_pred -----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh--Ccccc
Confidence 56789999999999999999999 9999987 55553
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=313.44 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=198.1
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
..+-.++|++.+.||+|+||.||+|++ +++.||+|.+........+.+|+.+++++.| +++..+..++. +..+++
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~--~~~~lv 77 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH-PNIVKLYGACL--NPVCLV 77 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCC-TTBCCEEEBCT--TTTEEE
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCC-CCcCeEEEEEc--CCcEEE
Confidence 345568999999999999999999987 4788999999877666778899999999976 44444443333 458999
Q ss_pred Eecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---cCccccCCCCCceeeccCCCcc-eEEEEeecccc
Q 021855 82 LDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHS---RGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~Nilv~~~~~~~-~~kl~Dfg~~~ 154 (306)
+||+ +++|.+++..... .++...++.++.|++.||.|||+ +||+||||||+||+++ .++ .+||+|||.+.
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTAC 154 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC--
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccccccc
Confidence 9999 7899999875332 37889999999999999999999 8999999999999995 555 48999999997
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
....... ...++..|+|||++.+..++.++|||||||++|+|++|..||......... ......... .
T Consensus 155 ~~~~~~~----------~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~-~ 222 (307)
T 2eva_A 155 DIQTHMT----------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNGT-R 222 (307)
T ss_dssp --------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHTTC-C
T ss_pred ccccccc----------cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhcCC-C
Confidence 5543221 345899999999999999999999999999999999999999764332211 111111111 1
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.+ ....+++.+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 223 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 223 PP---LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CC---CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CC---cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 12567889999999999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=321.76 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=209.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+..++|++.+.||+|+||.||+|++. .+++.||+|++...... ..+.+|+.+++.+.| +++..+..++...
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAVG 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEccC
Confidence 45689999999999999999999987 34588999998765432 347789999999965 6666666666677
Q ss_pred ceeEEEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCC
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp 131 (306)
...++++||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 7899999999 779999987632 4689999999999999999999999999999999
Q ss_pred CceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CC
Q 021855 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GS 210 (306)
Q Consensus 132 ~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~ 210 (306)
+||++ +.++.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 203 ~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 203 RNCLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp GGEEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEE---CCCCeEEEeecCCCcccccCccc-----cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999 58899999999999765432211 11224567889999999998899999999999999999999 99
Q ss_pred CCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 211 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.||.+..... ....+....... ....+++.+.++|.+||+.||.+|||+.++++.|+++..+.
T Consensus 275 ~p~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 275 QPYYGMAHEE---VIYYVRDGNILA----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp CTTTTSCHHH---HHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CcCCCCChHH---HHHHHhCCCcCC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 9998755432 222222222211 12567889999999999999999999999999999987643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=319.38 Aligned_cols=259 Identities=20% Similarity=0.278 Sum_probs=199.2
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceE----EEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIV----AVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~v----aiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
.+..++|++.+.||+|+||.||+|++..+++.+ ++|.+... .....+.+|+.+++.+.|+ ++..+..++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP-HVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBT-TBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCC-CeeEEEEEEecC
Confidence 355789999999999999999999998888765 66655432 2345678899999999874 444444444443
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
..+++++++ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAK 165 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC--
T ss_pred -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCccee
Confidence 367777777 889999998766779999999999999999999999999999999999999 478999999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+......... .....
T Consensus 166 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~~~~~ 236 (327)
T 3lzb_A 166 LLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----LEKGE 236 (327)
T ss_dssp -------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HHTTC
T ss_pred EccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHcCC
Confidence 754433221 1123456778999999999999999999999999999999 9999987654432222 22222
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+. ...+++++.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 237 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 RLPQ---PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2221 14568899999999999999999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=317.07 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=200.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
-++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+|+.++..+.| +++..+..++......++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-PHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCC-CCeeEEEEEEeeCCeEEE
Confidence 4689999999999999999999999999999999875422 1456788999988876 666666666777888999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccccc
Confidence 99999 5699998876 4569999999999999999999999999999999999999 47899999999998765433
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
... ......++..|+|||++.+..++.++||||||+++|+|++|..||.+.... ............ ...
T Consensus 188 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~-~~~ 256 (309)
T 2h34_A 188 KLT------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIPR-PST 256 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCCC-GGG
T ss_pred ccc------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCCC-ccc
Confidence 221 112456889999999999999999999999999999999999999875543 222222222222 223
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCC-ChHHHHHHHHHhHhhc
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSRE 280 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~~~~ 280 (306)
....+|+.+.++|.+||+.||++|| |++++++.|+.++...
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 3467889999999999999999999 9999999999887643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=324.02 Aligned_cols=263 Identities=21% Similarity=0.278 Sum_probs=205.2
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCC-----CCcceeeceeCc
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSG-----IPNIKWYGVDGE 76 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~-----~~~~~~~~~~~~ 76 (306)
..+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+..|+.++..+.++++ +..+..++....
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4456899999999999999999999999999999999875432 2346678889998886664 455556666778
Q ss_pred eeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
..+++||+++++|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+|||++ .+.++.+||+|||++
T Consensus 130 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~-~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLC-NPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEES-STTSCCEEECCCTTC
T ss_pred ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEe-cCCCCcEEEEeccCc
Confidence 899999999999999988643 45899999999999999999999 57999999999999994 124788999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
........ ...+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 209 ~~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 209 CQLGQRIY----------QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp EETTCCCC----------SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred eecccccc----------cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 87643322 45789999999999999999999999999999999999999988655443333322211110
Q ss_pred ccchH------HHhh--------------------------------------------------cCchHHHHHHHhhhc
Q 021855 234 STPIE------VLCK--------------------------------------------------SHPAEFASYFHYCQS 257 (306)
Q Consensus 234 ~~~~~------~~~~--------------------------------------------------~~~~~~~~li~~cl~ 257 (306)
....+ .... ..++.+.+||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 00000 0000 001368999999999
Q ss_pred CCCCCCCChHHHHHHHHHhHh
Q 021855 258 LTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 258 ~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.||++|||+.++++ +.++.
T Consensus 359 ~dP~~Rpta~e~L~--hp~f~ 377 (382)
T 2vx3_A 359 YDPKTRIQPYYALQ--HSFFK 377 (382)
T ss_dssp SCTTTSCCHHHHTT--SGGGC
T ss_pred CChhhCCCHHHHhc--Ccccc
Confidence 99999999999987 55554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=321.09 Aligned_cols=266 Identities=19% Similarity=0.237 Sum_probs=207.9
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCC-ceEEEEEccCCCC-chhhHHHHHHHHHHhCCCC-----CCcceeece
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTK-HPQLLYEAKVYKILQGGSG-----IPNIKWYGV 73 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~-~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~-----~~~~~~~~~ 73 (306)
+++++.++|++.+.||+|+||.||+|++..++ +.||+|++..... ...+.+|+.+++.+.|.+. +..+..++.
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 35778999999999999999999999998776 6899999875422 3456779999999986543 333455566
Q ss_pred eCceeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC-------------
Q 021855 74 DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG------------- 139 (306)
Q Consensus 74 ~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~------------- 139 (306)
.....+++||++++++.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++..
T Consensus 93 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 93 FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 778899999999999998887643 459999999999999999999999999999999999999432
Q ss_pred ---CCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 021855 140 ---RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (306)
Q Consensus 140 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~ 216 (306)
+..+.+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCccccccccc----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 257899999999997643322 2457899999999999999999999999999999999999999876
Q ss_pred hhhhhHHHHHHHhhcccccch--------------------------H----------HHhhcCchHHHHHHHhhhcCCC
Q 021855 217 KAATKKQKYDKICEKKVSTPI--------------------------E----------VLCKSHPAEFASYFHYCQSLTF 260 (306)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~--------------------------~----------~~~~~~~~~~~~li~~cl~~dP 260 (306)
........+............ . ......++.+.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 654444444333221110000 0 0001124578899999999999
Q ss_pred CCCCChHHHHHHHHHhHh
Q 021855 261 DQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 261 ~~Rps~~~l~~~l~~~~~ 278 (306)
++|||+.++++ +.++.
T Consensus 323 ~~Rpt~~e~l~--hp~f~ 338 (355)
T 2eu9_A 323 AQRITLAEALL--HPFFA 338 (355)
T ss_dssp TTSCCHHHHTT--SGGGG
T ss_pred hhCcCHHHHhc--Chhhc
Confidence 99999999976 55554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=316.39 Aligned_cols=261 Identities=18% Similarity=0.277 Sum_probs=209.8
Q ss_pred cccCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
++..++|++.+.||+|+||.||+|++. .+++.||+|++...... ..+.+|+.+++.+.| +++..+..++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH-PHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CceeeEEEEEec
Confidence 356789999999999999999999873 45588999998765432 346789999998865 666666666667
Q ss_pred CceeEEEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlk 130 (306)
....++++||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 77899999999 689999987632 238899999999999999999999999999999
Q ss_pred CCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-C
Q 021855 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 209 (306)
Q Consensus 131 p~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g 209 (306)
|+||++ +.++.++|+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 178 p~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 178 ARNILV---AEGRKMKISDFGLSRDVYEEDSYV-----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp GGGEEE---ETTTEEEECCCTTCEECTTTSCEE-----CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred hheEEE---cCCCCEEEccccccccccccccce-----eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 999999 478999999999997654432211 1124456788999999998889999999999999999999 9
Q ss_pred CCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..||.+.........+ ....... ....+++.+.++|.+||+.||++|||+.++++.|++++.+
T Consensus 250 ~~p~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLL----KTGHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCSSTTCCGGGHHHHH----HTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHh----hcCCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9999876543222222 2221111 1256789999999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=320.71 Aligned_cols=262 Identities=20% Similarity=0.236 Sum_probs=204.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-------chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
..++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCC-CCCCeEEEEEeeCCc
Confidence 35789999999999999999999999999999998764321 2457789999999976 566666666667778
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
.++++|++.++|.+.+......+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceecc
Confidence 99999999889998887655568999999999999999999999999999999999999 588999999999998764
Q ss_pred CCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc---
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV--- 233 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--- 233 (306)
..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 164 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 164 SPNRA-------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp SCCCC-------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCccc-------CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 43221 1245679999999999765 489999999999999999999999988655433333322221110
Q ss_pred -----------------ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 234 -----------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 234 -----------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+.......+++++.++|.+||+.||++|||+.++++ +.++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--h~~f~~ 297 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSN 297 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc--Chhhhc
Confidence 11122333566789999999999999999999999988 677754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=311.77 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=208.0
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
++.-++|++.+.||+|++|.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++.....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATR 83 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC-CCCcchhheEecCCE
Confidence 34567899999999999999999999999999999987532 233457789999988876 666667667777788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++||+ +++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||.+...
T Consensus 84 ~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccC
Confidence 99999999 6789888876 3569999999999999999999999999999999999999 58899999999998654
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
..... ....++..|+|||++.+..++.++||||||+++|+|++|..||....... ....+.......+
T Consensus 160 ~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~ 227 (279)
T 3fdn_A 160 PSSRR---------TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRISRVEFTFP 227 (279)
T ss_dssp -----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCCCC
T ss_pred Ccccc---------cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---HHHHHHhCCCCCC
Confidence 33221 24568999999999999999999999999999999999999998755432 2233333333333
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
..+++.+.++|.+||+.||.+|||+.++++ +.++.....
T Consensus 228 -----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--h~~~~~~~~ 266 (279)
T 3fdn_A 228 -----DFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITANSS 266 (279)
T ss_dssp -----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH--CHHHHHHCS
T ss_pred -----CcCCHHHHHHHHHHhccChhhCCCHHHHhh--CccccCCcc
Confidence 456889999999999999999999999998 677765443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=319.46 Aligned_cols=265 Identities=19% Similarity=0.253 Sum_probs=207.1
Q ss_pred CcccCCceeEeeeecccCccEEEEEEE-cCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCC-----CCCcceeecee
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASH-VDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS-----GIPNIKWYGVD 74 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~-~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~-----~~~~~~~~~~~ 74 (306)
+.++.++|++.+.||+|+||.||+|.+ ..+++.||+|++..... ...+.+|+.++..+.+.+ ++..+..++..
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 567889999999999999999999998 56789999999875422 245778999999988654 24445556667
Q ss_pred CceeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC------------
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK------------ 141 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~------------ 141 (306)
....++++|+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 78899999999999999987643 25899999999999999999999999999999999999952211
Q ss_pred ----cceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 021855 142 ----ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (306)
Q Consensus 142 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~ 217 (306)
++.++|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHH----------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCC----------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccCCCceEeeCcccccCcccc----------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6689999999997644322 24578999999999999999999999999999999999999998766
Q ss_pred hhhhHHHHHHHhhcccccchH------------------------------------HHhhcCchHHHHHHHhhhcCCCC
Q 021855 218 AATKKQKYDKICEKKVSTPIE------------------------------------VLCKSHPAEFASYFHYCQSLTFD 261 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~li~~cl~~dP~ 261 (306)
.......+............. ......++.+.++|.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 544444443332211100000 00012256789999999999999
Q ss_pred CCCChHHHHHHHHHhHh
Q 021855 262 QRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 262 ~Rps~~~l~~~l~~~~~ 278 (306)
+|||+.++++ +.+++
T Consensus 319 ~Rpt~~ell~--hp~f~ 333 (339)
T 1z57_A 319 KRITLREALK--HPFFD 333 (339)
T ss_dssp TSCCHHHHTT--SGGGG
T ss_pred cccCHHHHhc--CHHHH
Confidence 9999999977 45554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=326.37 Aligned_cols=263 Identities=17% Similarity=0.283 Sum_probs=200.4
Q ss_pred cccCCceeEeeeecccCccEEEEEEEc---CCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
.+...+|++.+.||+|+||.||+|++. .++..||+|++..... ...+.+|+.++.++.| +++..+..++....
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-PNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCC
Confidence 455678999999999999999999876 4677899999875433 2357889999999876 56666666667777
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..+++|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccc
Confidence 899999999 789999998655679999999999999999999999999999999999999 5889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..... ..+ .....
T Consensus 197 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---~~i-~~~~~ 268 (373)
T 2qol_A 197 LEDDPEAAY----TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---KAV-DEGYR 268 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---HHH-HTTEE
T ss_pred cccCCccce----eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH-HcCCC
Confidence 544322110 1112235678999999999999999999999999999998 99999876543222 222 22222
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.+. ...+++.+.++|.+||+.||.+|||+.++++.|+.++...
T Consensus 269 ~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 LPP---PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp CCC---CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCC---CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 221 1456889999999999999999999999999999998643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=315.00 Aligned_cols=265 Identities=22% Similarity=0.244 Sum_probs=206.4
Q ss_pred cccCCceeEeeeecccCccEEEEEE----EcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~----~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
.+...+|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-ENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCC-TTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCC-CCeeeeeeEEecC
Confidence 4556789999999999999999998 56789999999887543 23457889999999976 4555554444333
Q ss_pred --ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 76 --EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 76 --~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
...++++||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECcccc
Confidence 5689999999 779999997766779999999999999999999999999999999999999 4789999999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhh-----------hh
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-----------TK 221 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~-----------~~ 221 (306)
+.......... .......++..|+|||++.+..++.++|||||||++|+|++|..|+...... ..
T Consensus 173 ~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 173 TKAIETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248 (302)
T ss_dssp CEECCTTCCEE----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred cccccCCCcce----eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence 98765443211 1122456788899999999989999999999999999999999987543211 11
Q ss_pred HHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..............+ ....+++.+.++|.+||+.||.+|||+.++++.|+.+++
T Consensus 249 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 111112222222221 125678899999999999999999999999999998863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=314.22 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=210.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.+.++|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++......+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-ENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCC-CCeeehhhhcccCCEEEEE
Confidence 35678999999999999999999999999999999887543 23457889999999976 5666666666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|++ +++|.+.+.. ...+++..++.++.||+.||.|||+.|++||||||+||++...+.++.++|+|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 85 MQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp ECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred EEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 9999 7799988876 3468999999999999999999999999999999999999544578999999999986543221
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.....+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.......+ ...
T Consensus 164 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~-~~~ 230 (304)
T 2jam_A 164 ---------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEGYYEFE-SPF 230 (304)
T ss_dssp ---------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHCCCCCC-TTT
T ss_pred ---------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC-ccc
Confidence 12446899999999999999999999999999999999999999875443 23333333332222 122
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...+++.+.++|.+||+.||++|||+.++++ +.++...
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~ 268 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS--HPWIDGN 268 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHSS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CccccCC
Confidence 3567899999999999999999999999987 6666543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=322.22 Aligned_cols=262 Identities=18% Similarity=0.263 Sum_probs=209.9
Q ss_pred ccCCceeEe-eeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~-~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
.++++|.+. +.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++..+.+++++..+..++......
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 456788887 899999999999999999999999998775322 345788999999998888888888888888889
Q ss_pred EEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 79 VLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
++++||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||+++.....+.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999 67888887532 346899999999999999999999999999999999999953233789999999999876
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
...... ....+++.|+|||++.+..++.++|||||||++|+|++|..||.+....... ..+.......+
T Consensus 185 ~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~ 253 (327)
T 3lm5_A 185 GHACEL--------REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY---LNISQVNVDYS 253 (327)
T ss_dssp -----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHTCCCCC
T ss_pred CCcccc--------ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---HHHHhcccccC
Confidence 443221 2456899999999999999999999999999999999999999876544322 22222222222
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
......+++.+.++|.+||+.||.+|||++++++ +.+++.
T Consensus 254 -~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~--h~~~~~ 293 (327)
T 3lm5_A 254 -EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS--HSWLQQ 293 (327)
T ss_dssp -TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--CGGGCC
T ss_pred -chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC--CHhhcc
Confidence 2222567889999999999999999999999977 666653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=335.33 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=204.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+.++|++.+.||+|+||.||+|++..++..||+|++... .....+.+|+.+++.+.| +++..+..++......++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH-PNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 345799999999999999999999999999999987643 234567889999999876 666666666777888999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
++||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++......
T Consensus 114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999 7799888876 456999999999999999999999999999999999999964445677999999999776543
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.. ..+..+.......+.+
T Consensus 193 ~~~--------~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~- 259 (494)
T 3lij_A 193 KKM--------KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILRKVEKGKYTFDSP- 259 (494)
T ss_dssp BCB--------CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCSG-
T ss_pred ccc--------cccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCCch-
Confidence 221 24578999999999864 6899999999999999999999999886543 3344444444333322
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
....+|+.+.++|.+||+.||.+|||+.++++
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 23567899999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=324.67 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=198.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeec-----------
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG----------- 72 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~----------- 72 (306)
...++|++.+.||+|+||.||+|++..+++.||+|++..... ...+|+.+++.+.|.+.+..+..+.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 457899999999999999999999999999999998875433 3347999999997754444443332
Q ss_pred --------------------------eeCceeEEEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 021855 73 --------------------------VDGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRG 123 (306)
Q Consensus 73 --------------------------~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~ 123 (306)
......+++|||+.++|.+.+.. ....+++..++.++.||+.||.|||+.|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 22334789999999898877653 3456999999999999999999999999
Q ss_pred ccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHH
Q 021855 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYV 202 (306)
Q Consensus 124 i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~i 202 (306)
|+||||||+|||+. ..++.+||+|||++......... ....+|..|+|||++.+.. ++.++||||+||+
T Consensus 162 i~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 162 ICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPS--------VAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp EECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCC--------CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred CccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCC--------cCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999994 25789999999999865443321 2456789999999988765 8999999999999
Q ss_pred HHHHHhCCCCCCCchhhhhHHHHHHHhhcccc---------------------cchHHHhhcCchHHHHHHHhhhcCCCC
Q 021855 203 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVS---------------------TPIEVLCKSHPAEFASYFHYCQSLTFD 261 (306)
Q Consensus 203 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~cl~~dP~ 261 (306)
+|+|++|..||.+.+.......+.+....... .....+....++.+.+||.+||+.||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999986655443333332221100 011122345788899999999999999
Q ss_pred CCCChHHHHH
Q 021855 262 QRPDYGFLKR 271 (306)
Q Consensus 262 ~Rps~~~l~~ 271 (306)
+|||+.++++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=318.24 Aligned_cols=262 Identities=19% Similarity=0.295 Sum_probs=210.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCc-----eEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~-----~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+..++|++.+.||+|+||.||+|++..+++ .||+|.+...... ..+.+|+.++..+..|+++..+..++...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 456789999999999999999999876654 7999988765432 34778999999996567777777777777
Q ss_pred ceeEEEEecc-CCCHHHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCC
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYC-------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~ 141 (306)
...++++||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||++ +.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---EG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---CC
Confidence 8899999999 67999998753 2357899999999999999999999999999999999999 48
Q ss_pred cceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhh
Q 021855 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (306)
Q Consensus 142 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~ 220 (306)
++.++|+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYI-----VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSE-----ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCeEEECcccccccccccccee-----ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 8999999999997654332211 1224456788999999998899999999999999999998 999998754332
Q ss_pred hHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.............. ....++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 275 ---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 275 ---KFYKLVKDGYQMAQ---PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ---HHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 22222222222221 145688999999999999999999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=318.90 Aligned_cols=284 Identities=17% Similarity=0.245 Sum_probs=210.4
Q ss_pred CcccCCceeEeeeecccCccEEEEEE-----EcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~-----~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
..+..++|++.+.||+|+||.||+|+ +..+++.||+|.+..... ...+.+|+.+++.+.| +++..+..++.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~ 103 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSL 103 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCC-CCCCeEEEEEc
Confidence 56788999999999999999999998 456788999999865433 2347789999999965 66666666666
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEE
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~k 146 (306)
.....++++|++ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.......++
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 777889999999 889999998643 3488999999999999999999999999999999999995333466799
Q ss_pred EEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHH
Q 021855 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKY 225 (306)
Q Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~ 225 (306)
|+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 184 l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYR-----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL 255 (327)
T ss_dssp ECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH
T ss_pred ECccccccccccccccc-----cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HH
Confidence 99999987554332211 1224567889999999998899999999999999999998 999998754432 22
Q ss_pred HHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC-CCCCccccceecchhhh
Q 021855 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG-YDFDFVFDWTILKYQQT 298 (306)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~ 298 (306)
..+....... ....+++.+.++|.+||+.||.+|||+.++++.|+.+..... .....+..|..+.+++.
T Consensus 256 ~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~~~~ee~~ 325 (327)
T 2yfx_A 256 EFVTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 325 (327)
T ss_dssp HHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCCCC---------
T ss_pred HHHhcCCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhccccccccCCcchhhc
Confidence 2222221111 125678899999999999999999999999999998876332 33445566666666554
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=310.01 Aligned_cols=254 Identities=19% Similarity=0.279 Sum_probs=204.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--------CchhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
++.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH-PNIITLHDIFENK 80 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC-CCeeehhheecCC
Confidence 46789999999999999999999999999999999876432 23457889999999976 6666666666777
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC-CcceEEEEeeccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLA 153 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~-~~~~~kl~Dfg~~ 153 (306)
...++++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++... ....++|+|||.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 8899999999 7899998876 45699999999999999999999999999999999999995211 1238999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
......... ....+++.|+|||++.+..++.++||||||+++|+|++|..||.+..... ....+.....
T Consensus 160 ~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~ 228 (283)
T 3bhy_A 160 HKIEAGNEF--------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLTNISAVNY 228 (283)
T ss_dssp EECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTTCC
T ss_pred eeccCCCcc--------cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHHHhHhccc
Confidence 765443221 24468899999999999999999999999999999999999998755432 2222222222
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..+ ......+++.+.++|.+||+.||++|||+.++++
T Consensus 229 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 DFD-EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCC-HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc-chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 222 3334677899999999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=319.30 Aligned_cols=261 Identities=20% Similarity=0.354 Sum_probs=189.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCc---eEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+..++|++.+.||+|+||.||+|++..++. .||+|++..... ...+.+|+.+++.+.| +++..+..++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH-PHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCC-TTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCC-Cceehhhceeeccc
Confidence 567889999999999999999999877665 799998875432 2457889999999966 55555544444333
Q ss_pred ee------EEEEecc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce
Q 021855 77 DN------VLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (306)
Q Consensus 77 ~~------~lv~e~~-~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~ 144 (306)
.. ++++||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCC
Confidence 33 8999999 779999886432 158999999999999999999999999999999999999 47899
Q ss_pred EEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHH
Q 021855 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (306)
Q Consensus 145 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~ 223 (306)
+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-- 248 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYR-----QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-- 248 (323)
T ss_dssp EEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--
T ss_pred EEEeecccccccccccccc-----ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--
Confidence 9999999997654432211 1123456778999999999999999999999999999999 9999987654322
Q ss_pred HHHHHhhcc-cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 224 KYDKICEKK-VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 224 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
...+.... ...+ ..+++.+.++|.+||+.||.+|||+.++++.|++++....
T Consensus 249 -~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 249 -YNYLIGGNRLKQP-----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp -HHHHHTTCCCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -HHHHhcCCCCCCC-----CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 22222222 1222 5678899999999999999999999999999999997543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=312.07 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=198.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
+..++|++.+.||+|++|.||+|++ +++.||+|++........+.+|+.+++.+.|++.+..+..+.......++++|
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 4457899999999999999999987 47899999998877777889999999999875544444444445557899999
Q ss_pred cc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
++ +++|.+++..... .+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeecccccccccccc
Confidence 99 5699999875432 38899999999999999999999999999999999999 4789999999999875443221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
...++..|+|||++.+..++.++||||||+++|+|++ |..||......... .... ...... .
T Consensus 173 ----------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~~~-~~~~~~---~ 235 (278)
T 1byg_A 173 ----------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVE-KGYKMD---A 235 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHHT-TTCCCC---C
T ss_pred ----------CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHh-cCCCCC---C
Confidence 3356788999999998899999999999999999998 99999875443222 2221 111111 1
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
...+++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 256789999999999999999999999999999998653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=316.08 Aligned_cols=262 Identities=19% Similarity=0.303 Sum_probs=209.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEc-------CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
+..++|++.+.||+|+||.||+|++. .+++.||+|++...... ..+.+|+.+++.+..|+++..+..++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 45689999999999999999999975 45678999998765432 347789999999966677777777777
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeec
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~ 137 (306)
.....++++||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll- 190 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 190 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE-
Confidence 778899999999 779999987533 138899999999999999999999999999999999999
Q ss_pred cCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 021855 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (306)
Q Consensus 138 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~ 216 (306)
+.++.+||+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 191 --~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 191 --TENNVMKIADFGLARDINNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp --CTTCCEEECCCTTCEECTTTSSEE-----CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --cCCCCEEEcccccccccccccccc-----ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 588999999999998654432211 1123456788999999998889999999999999999999 99999875
Q ss_pred hhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...... ..+.... ... ....+++.+.++|.+||+.||.+|||+.++++.|+.++...
T Consensus 264 ~~~~~~---~~~~~~~-~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 264 PVEELF---KLLKEGH-RMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp CHHHHH---HHHHHTC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHH---HHHhcCC-CCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 543222 2222211 111 12567889999999999999999999999999999998643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=309.02 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=194.7
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC------chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
.+-.++|++.+.||+|+||.||+|++ +++.||+|++..... ...+.+|+.+++.+.| +++..+..++....
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-PNIIALRGVCLKEP 79 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCC-TTBCCEEEEECCC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCC-CCEeeEEEEEecCC
Confidence 45568999999999999999999987 478899998764322 2457789999999876 66666666666777
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccCCCCCceeeccCC-----CcceEEE
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG---FLHRDIKPDNFLMGLGR-----KANQVYI 147 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~Nilv~~~~-----~~~~~kl 147 (306)
..++++||+ +++|.+++. ...+++..++.++.|++.||.|||+.| |+||||||+||+++... .++.++|
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 899999999 778888875 457999999999999999999999999 89999999999995211 2788999
Q ss_pred EeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 021855 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (306)
+|||++........ ....+++.|+|||++.+..+++++||||||+++|+|++|..||.+.+.. .....
T Consensus 158 ~Dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~ 225 (271)
T 3dtc_A 158 TDFGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---AVAYG 225 (271)
T ss_dssp CCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHH
T ss_pred ccCCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHh
Confidence 99999976543322 1446889999999999989999999999999999999999999875543 22222
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHh
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~ 276 (306)
........+. ...+++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 226 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 VAMNKLALPI---PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHTSCCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hhcCCCCCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 2222222222 256688999999999999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=307.73 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=201.5
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
+++..++|++.+.||+|++|.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-PHIIKLYQVISTPT 84 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSS
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCC
Confidence 456778999999999999999999999999999999987532 233457789999998876 55666666667778
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++|++ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGC
T ss_pred eEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccc
Confidence 899999999 6799999876 3568999999999999999999999999999999999999 5889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
....... ....+++.|+|||++.+..+ +.++||||||+++|+|++|..||...... .....+......
T Consensus 161 ~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~ 229 (276)
T 2h6d_A 161 MSDGEFL--------RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIRGGVFY 229 (276)
T ss_dssp CCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCC
T ss_pred cCCCcce--------ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhcCccc
Confidence 5443211 24467899999999988775 68999999999999999999999875433 223333333322
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.+ ..+++.+.++|.+||+.||++|||+.++++ +.++.+.
T Consensus 230 ~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~~~ 268 (276)
T 2h6d_A 230 IP-----EYLNRSVATLLMHMLQVDPLKRATIKDIRE--HEWFKQD 268 (276)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHTT
T ss_pred Cc-----hhcCHHHHHHHHHHccCChhhCCCHHHHHh--ChhhccC
Confidence 22 456889999999999999999999999988 6677543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=318.09 Aligned_cols=250 Identities=20% Similarity=0.220 Sum_probs=206.2
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----------chhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
.++|++.+.||+|++|.||+|++..+|+.||+|++..... ...+.+|+.++..+..++++..+..++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 3679999999999999999999998999999998875432 234677899999996667787777777788
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||||+|||+ +.++.++|+|||++.
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSC 248 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCccc
Confidence 8999999999 6799998876 4569999999999999999999999999999999999999 588999999999987
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 228 (306)
........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+
T Consensus 249 ~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~i 317 (365)
T 2y7j_A 249 HLEPGEKL--------RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLRMI 317 (365)
T ss_dssp ECCTTCCB--------CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred ccCCCccc--------ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHHHH
Confidence 76543221 24578999999999863 35788999999999999999999999875433 233333
Q ss_pred hhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.......+.+ .....++.+.++|.+||+.||++|||+.++++
T Consensus 318 ~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3344333332 22567889999999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=328.18 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=194.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----------CchhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++++.|+ ++..+..++ .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~-~ 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP-CIIKIKNFF-D 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCT-TBCCCCEEE-E
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCC-CEeeEEEEE-e
Confidence 4578999999999999999999999999999999876321 123478899999999774 455554444 3
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
....+++|||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 45689999999 7799887764 456999999999999999999999999999999999999964445667999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .....+..
T Consensus 290 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~~ 359 (419)
T 3i6u_A 290 KILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS 359 (419)
T ss_dssp TSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHHT
T ss_pred eecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHhc
Confidence 86543322 125578999999999864 567889999999999999999999998643321 12222222
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.... ..+.....+++.+.++|.+||+.||.+|||++++++
T Consensus 360 ~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 2222 233444678999999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=307.86 Aligned_cols=257 Identities=18% Similarity=0.269 Sum_probs=209.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
-.++|++.+.||+|++|.||+|++. +++.||+|++..... ...+.+|+.+++.+.| +++..+..++......++++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCeEEEEe
Confidence 4578999999999999999999986 577899999876543 3568889999999975 566666666667778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
++ +++|.+++......+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+|||.+.........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccccccccc
Confidence 99 779999998765679999999999999999999999999999999999999 58899999999999765332111
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+... ..... .
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~~~-~~~~~---~ 227 (267)
T 3t9t_A 161 ------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTG-FRLYK---P 227 (267)
T ss_dssp ------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT-CCCCC---C
T ss_pred ------ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHhcC-CcCCC---C
Confidence 1123456778999999998899999999999999999999 899998754432 22222222 11111 1
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+++.+.++|.+||+.||++|||+.++++.|+++.++
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 45688999999999999999999999999999998763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=316.59 Aligned_cols=261 Identities=22% Similarity=0.282 Sum_probs=202.0
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch----hhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
-++|++.+.||+|++|.||+|++..+++.||+|++....... .+.+|+.+++.+.| +++..+..++......+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH-ENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC-CCEeeEEEEeecCCEEEEE
Confidence 468999999999999999999999999999999876554432 35679999999986 6666666667788889999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
+||+.+.+...+......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++........
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCcc
Confidence 9999665555544445679999999999999999999999999999999999999 5889999999999976544322
Q ss_pred CccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--------
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-------- 232 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------- 232 (306)
. .....++..|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 180 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 180 V-------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred c-------cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 1 1244678999999999876 68999999999999999999999998765543333222211111
Q ss_pred ---------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 233 ---------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 233 ---------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
...+.....+.+++.+.++|.+||+.||.+|||+.++++ +.+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~f~~ 312 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH--HDFFQM 312 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc--Cchhcc
Confidence 011122233467889999999999999999999999988 666653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=316.81 Aligned_cols=272 Identities=18% Similarity=0.227 Sum_probs=195.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeec--------e
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYG--------V 73 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~--------~ 73 (306)
+.+.+|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++..+..|+++..+..++ .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 346689999999999999999999999999999998754332 345778999999998556666664443 3
Q ss_pred eCceeEEEEeccCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeccCCCcceEEEEe
Q 021855 74 DGEDNVLVLDLLGPSLEDLFVY--CRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 74 ~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
.....++++|+++++|.+++.. ....+++..++.++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~D 181 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCD 181 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCC
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEec
Confidence 4456899999999999998865 2345999999999999999999999999 9999999999999 4788999999
Q ss_pred eccccccCCCCCCccc-----cccCCccccccccccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh
Q 021855 150 FGLAKKYRDPTTNRHI-----PYRENKNLTGTARYASCNTH---LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~---~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~ 221 (306)
||++............ .........+++.|+|||++ .+..++.++|||||||++|+|++|..||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 9999865443221100 00011144588999999998 5667899999999999999999999999764321
Q ss_pred HHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccc
Q 021855 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVF 288 (306)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~ 288 (306)
.........+. ....++.+.++|.+||+.||.+|||+.++++.|+.+....+.....+.
T Consensus 260 -----~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~ 318 (337)
T 3ll6_A 260 -----RIVNGKYSIPP---HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI 318 (337)
T ss_dssp -----------CCCCT---TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred -----HhhcCcccCCc---ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccH
Confidence 11122222221 144567899999999999999999999999999999887766654433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=313.35 Aligned_cols=258 Identities=20% Similarity=0.291 Sum_probs=190.9
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchh---hHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
++..++|++.+.||+|+||.||+|++..+++.||+|++........ ...+...+.+...|+++..+..++......+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 3567899999999999999999999999999999999876543322 2333333333335577777777777788899
Q ss_pred EEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 80 LVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
+++|++.++|.+++.. ....+++..++.++.||+.||.|||++ |++||||||+||++ +.++.+||+|||++..
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-----
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCccc
Confidence 9999999899887654 345699999999999999999999998 99999999999999 5789999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTH----LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
....... ....+++.|+|||++ .+..++.++|||||||++|+|++|..||...... ..........
T Consensus 160 ~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~ 229 (290)
T 3fme_A 160 LVDDVAK--------DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEE 229 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHHHHHHHS
T ss_pred ccccccc--------cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHHHHHhcc
Confidence 5443221 134688999999996 5567899999999999999999999999753221 2222233333
Q ss_pred ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...... ...+++++.++|.+||+.||++|||+.++++ +.++.
T Consensus 230 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~--hp~f~ 271 (290)
T 3fme_A 230 PSPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ--HPFFT 271 (290)
T ss_dssp CCCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--SHHHH
T ss_pred CCCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh--Ccccc
Confidence 222221 1456889999999999999999999999988 55554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=319.50 Aligned_cols=245 Identities=19% Similarity=0.233 Sum_probs=203.7
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----------CchhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH-ANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEee
Confidence 3568999999999999999999999999999999887543 23357789999999966 666666667777
Q ss_pred CceeEEEEecc-CC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 75 GEDNVLVLDLL-GP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 75 ~~~~~lv~e~~-~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
....++++|++ ++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence 88899999988 44 88888775 4569999999999999999999999999999999999999 4789999999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
+......... ....+|+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ...
T Consensus 177 a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~ 239 (335)
T 3dls_A 177 AAYLERGKLF--------YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VEA 239 (335)
T ss_dssp CEECCTTCCB--------CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TTT
T ss_pred ceECCCCCce--------eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------Hhh
Confidence 9876543321 24568999999999998876 88999999999999999999999763321 112
Q ss_pred ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
....+ ..+++++.++|.+||+.||.+|||+.++++ +.++.
T Consensus 240 ~~~~~-----~~~~~~l~~li~~~L~~dP~~Rps~~ell~--hp~~~ 279 (335)
T 3dls_A 240 AIHPP-----YLVSKELMSLVSGLLQPVPERRTTLEKLVT--DPWVT 279 (335)
T ss_dssp CCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH--CTTTT
T ss_pred ccCCC-----cccCHHHHHHHHHHccCChhhCcCHHHHhc--Ccccc
Confidence 22222 446889999999999999999999999988 56654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=334.98 Aligned_cols=259 Identities=19% Similarity=0.316 Sum_probs=212.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
-..+|++.+.||+|+||.||+|++..++..||+|++.... ....+.+|+.+++.+.| +++..+..++......+++||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCC-CCEeeEEEEEecCCcEEEEEE
Confidence 3467999999999999999999999889999999987654 34568899999999976 566666666667778999999
Q ss_pred cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCCce
Confidence 99 789999987643 458999999999999999999999999999999999999 5889999999999986543221
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
. ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+....... +........
T Consensus 374 ~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~~--- 440 (495)
T 1opk_A 374 T------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LEKDYRMER--- 440 (495)
T ss_dssp E------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----HHTTCCCCC---
T ss_pred e------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCCCCC---
Confidence 1 1123445778999999998899999999999999999999 9999987654432222 222222221
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...+++.+.+||.+||+.||.+|||+.+|++.|+.++...
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 1567899999999999999999999999999999887543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=318.46 Aligned_cols=266 Identities=22% Similarity=0.252 Sum_probs=207.2
Q ss_pred CCceeEeeeecccCccEEEEEE----EcCCCceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCcceeec--eeCce
Q 021855 6 GVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYG--VDGED 77 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~----~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~~~--~~~~~ 77 (306)
.++|++.+.||+|+||.||+|+ +..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++ .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCC-CceeEEEEEEecCCCce
Confidence 5799999999999999999998 4678899999998765332 347889999999966 5555554333 35567
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGCEEC
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccceec
Confidence 89999999 889999998756679999999999999999999999999999999999999 48899999999999876
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh-----------HHHH
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-----------KQKY 225 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~-----------~~~~ 225 (306)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..||........ ....
T Consensus 178 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 178 PLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CTTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ccCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 5433211 112244678889999999998899999999999999999999999976443211 0111
Q ss_pred HHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
..........+ ....+++.+.++|.+||+.||.+|||+.++++.|+.+......
T Consensus 254 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 254 LELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred HHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 12222222221 1256789999999999999999999999999999999865443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=319.55 Aligned_cols=273 Identities=19% Similarity=0.279 Sum_probs=213.6
Q ss_pred cccCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
++..++|++.+.||+|+||.||+|++. .+++.||+|.+...... ..+.+|+.+++.+.| +++..+..++..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCEeeeEEEEcc
Confidence 456789999999999999999999876 35788999998755432 246789999998876 556566666667
Q ss_pred CceeEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~ 144 (306)
....++++|++ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCCe
Confidence 77899999999 679999887532 356899999999999999999999999999999999999 47899
Q ss_pred EEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHH
Q 021855 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (306)
Q Consensus 145 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~ 223 (306)
+||+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 248 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 248 (322)
T ss_dssp EEECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---
T ss_pred EEECcCcccccccccccc-----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---
Confidence 999999998765432211 11124456888999999998899999999999999999999 899998755432
Q ss_pred HHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccce
Q 021855 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT 291 (306)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~ 291 (306)
............ ....+++.+.++|.+||+.||.+|||+.++++.|+.++..........++|+
T Consensus 249 ~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~~~ 312 (322)
T 1p4o_A 249 VLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 312 (322)
T ss_dssp HHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTSTT
T ss_pred HHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccccccc
Confidence 222222222111 1256788999999999999999999999999999998764443333444443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=322.08 Aligned_cols=257 Identities=22% Similarity=0.241 Sum_probs=203.1
Q ss_pred CCceeE--eeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 6 GVKYKL--GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 6 ~~~y~i--~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+..|.+ .+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+..++......+++
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-ANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEE
Confidence 345655 678999999999999999999999999987653 23457889999999976 6666666667777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+.+......+++..++.++.||+.||.|||+.||+||||||+|||+.. +..+.+||+|||++.......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCcc
Confidence 9999 77998888765556999999999999999999999999999999999999831 256799999999998764432
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. ....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+. ..
T Consensus 244 ~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~-~~ 311 (373)
T 2x4f_A 244 KL--------KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLNNILACRWDLED-EE 311 (373)
T ss_dssp BC--------CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCSCS-GG
T ss_pred cc--------ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCCh-hh
Confidence 21 2446899999999999999999999999999999999999999876543 333334333333222 22
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+++++.++|.+||+.||.+|||+.++++ +.++.
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~--hp~~~ 347 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK--HPWLS 347 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcCcC
Confidence 3567899999999999999999999999987 45543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=306.51 Aligned_cols=258 Identities=19% Similarity=0.248 Sum_probs=202.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcC---CCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+..++|++.+.||+|++|.||+|++.. ++..||+|.+..... ...+.+|+.+++.+.| +++..+..+.. ...
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~-~~~ 86 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH-PHIVKLIGIIE-EEP 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCC-TTBCCEEEEEC-SSS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCC-CCcceEEEEEc-CCC
Confidence 456889999999999999999998653 345699998876533 2457789999999976 44545544433 345
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++|++ +++|.+++......+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||.+...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCccc
Confidence 78999999 689999998766679999999999999999999999999999999999999 47899999999999765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ....+.
T Consensus 164 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~--~~~~~~ 235 (281)
T 3cc6_A 164 EDEDYY------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK--GDRLPK 235 (281)
T ss_dssp ---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH--TCCCCC
T ss_pred cccccc------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc--CCCCCC
Confidence 443221 1123456788999999998899999999999999999998 9999986544332222221 111122
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+ ..+++.+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 236 ~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 236 P-----DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp C-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 2 45688999999999999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=319.00 Aligned_cols=265 Identities=18% Similarity=0.206 Sum_probs=181.3
Q ss_pred ccCCceeEee-eecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeecee----Ccee
Q 021855 4 IIGVKYKLGR-KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~-~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~~~ 78 (306)
.+.++|.+.+ .||+|+||.||+|++..+++.||+|++... ....+|+..+.+...++++..+..++.. ....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4678999955 699999999999999999999999998653 3344555555555555666666544433 4457
Q ss_pred EEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++..+.++.+||+|||++...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999999 669999987643 35999999999999999999999999999999999999964445778999999999765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH-HHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD-KICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~~~~~~~~~ 235 (306)
..... ....+++.|+|||++.+..++.++|||||||++|+|++|..||............. .........
T Consensus 182 ~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 182 TQNAL---------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp -------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccc---------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 43322 24567999999999988889999999999999999999999997754432211111 111111111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
+ ......+++.+.++|.+||+.||.+|||+.++++ +.++.+....
T Consensus 253 ~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~~~ 297 (336)
T 3fhr_A 253 P-NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--HPWINQSMVV 297 (336)
T ss_dssp C-TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHTGGGS
T ss_pred C-chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CccccccccC
Confidence 1 1122467899999999999999999999999988 6677654333
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=308.38 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=209.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+.-++|++.+.||+|++|.||+|++..+++.||+|++.. ......+.+|+.+++.+.| +++..+..++......
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH-PNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCC-CCEeeEEEEEEcCCEE
Confidence 455789999999999999999999999999999998753 2233567889999999876 5666666666777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||.+....
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECS
T ss_pred EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCc
Confidence 9999999 6799998876 3469999999999999999999999999999999999999 478999999999986544
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
.... ....++..|+|||++.+..++.++||||||+++|+|++|..||....... ....+.......+
T Consensus 166 ~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~- 232 (284)
T 2vgo_A 166 SLRR---------RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---THRRIVNVDLKFP- 232 (284)
T ss_dssp SSCB---------CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTTCCCCC-
T ss_pred cccc---------ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HHHHHhccccCCC-
Confidence 3221 24568999999999999999999999999999999999999998754432 2233333333333
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
..+++.+.++|.+||+.||.+|||+.++++ +.++....
T Consensus 233 ----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--h~~~~~~~ 270 (284)
T 2vgo_A 233 ----PFLSDGSKDLISKLLRYHPPQRLPLKGVME--HPWVKANS 270 (284)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--CHHHHHHC
T ss_pred ----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh--CHHHHhhc
Confidence 556889999999999999999999999988 56666443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=308.38 Aligned_cols=263 Identities=18% Similarity=0.237 Sum_probs=202.5
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCc---eEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.|++.+.||+|+||.||+|++..+++ .||+|.+...... ..+.+|+.+++.+.|++.+..+..+.......+++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677999999999999999765544 7999988764442 34678999999997755444444444444555899
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|++ +++|.+++......+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++.......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCc
Confidence 9998 889999988656679999999999999999999999999999999999999 588999999999997654322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-WQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
... ........++..|+|||.+.+..++.++|||||||++|+|++|..| |...+.... .... ......+.
T Consensus 179 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~---~~~~-~~~~~~~~-- 249 (298)
T 3pls_A 179 YYS---VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL---THFL-AQGRRLPQ-- 249 (298)
T ss_dssp GGC---SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH---HHHH-HTTCCCCC--
T ss_pred ccc---cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH---HHHh-hcCCCCCC--
Confidence 111 1122245678899999999999999999999999999999995555 444333221 1111 11111111
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
...+++.+.++|.+||+.||.+|||+.++++.|+.++++..-.
T Consensus 250 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 250 -PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred -CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 1556889999999999999999999999999999999865443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=316.75 Aligned_cols=260 Identities=19% Similarity=0.221 Sum_probs=208.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceE--EEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIV--AVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~v--aiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
--++|++.+.||+|+||.||+|++..++..+ ++|.+... .....+.+|+.++.++.+|+++..+..++......+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 3478999999999999999999998888765 88877642 234557889999999966678878877778888999
Q ss_pred EEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc
Q 021855 80 LVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~ 143 (306)
++||++ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence 999999 779999987532 368999999999999999999999999999999999999 5889
Q ss_pred eEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhH
Q 021855 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKK 222 (306)
Q Consensus 144 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 222 (306)
.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 180 ~~kL~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-- 249 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-- 249 (327)
T ss_dssp CEEECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred eEEEcccCcCcccccccc--------ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--
Confidence 999999999874322111 113456788999999998889999999999999999998 999998765432
Q ss_pred HHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
....+... .... ....+++.+.++|.+||+.||.+|||+.++++.|+.++.....
T Consensus 250 -~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 250 -LYEKLPQG-YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp -HHHHGGGT-CCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -HHHHhhcC-CCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 22222221 1111 1145688999999999999999999999999999999875543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=314.05 Aligned_cols=272 Identities=19% Similarity=0.230 Sum_probs=201.6
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeec--------
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYG-------- 72 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~-------- 72 (306)
..++++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+|+.+++.+.|++.+..+..+.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 4578999999999999999999999999999999998765432 245778999999997755444433321
Q ss_pred -----eeCceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEE
Q 021855 73 -----VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (306)
Q Consensus 73 -----~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl 147 (306)
......++++|++.++|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+||++. ..++.+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl 162 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKI 162 (320)
T ss_dssp ----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEE
T ss_pred ccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEE
Confidence 2346789999999999998886 45689999999999999999999999999999999999994 25679999
Q ss_pred EeeccccccCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH
Q 021855 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (306)
Q Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 226 (306)
+|||.+.......... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 163 ~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp CCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999998654322111 01124456889999998876 678999999999999999999999998765433222221
Q ss_pred HHhh----------------------cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCC
Q 021855 227 KICE----------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284 (306)
Q Consensus 227 ~~~~----------------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~ 284 (306)
.... .....+.......+++.+.++|.+||+.||.+|||+.++++ +.++.....+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~~p~ 316 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS--HPYMSIYSFPM 316 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SHHHHTTCC--
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC--CcccccccCcc
Confidence 1100 00112223344567899999999999999999999999988 77776554443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=329.39 Aligned_cols=268 Identities=19% Similarity=0.235 Sum_probs=208.1
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeecee--Cce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~ 77 (306)
.+.+++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++.. ...
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTRH 83 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTCC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCCCeEEEeeccCCCCe
Confidence 46789999999999999999999999999999999988743 223456789999999987 455555444433 336
Q ss_pred eEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc-CCCcceEEEEeeccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~-~~~~~~~kl~Dfg~~ 153 (306)
.+++|||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+.. .+..+.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 79999999 7899998875332 3899999999999999999999999999999999999832 246778999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCchhh-hhHHH
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQK 224 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~-~~~~~ 224 (306)
........ .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....
T Consensus 164 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 164 RELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp EECCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred eEccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 86544321 124568999999999865 45788999999999999999999999754322 22333
Q ss_pred HHHHhhcccccc--------------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 225 YDKICEKKVSTP--------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 225 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+.++........ ...+...+++.+.++|.+||+.||++|||++++++.++.++.+
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 344433332110 0011133466789999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=318.14 Aligned_cols=282 Identities=17% Similarity=0.216 Sum_probs=206.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-------------hhhHHHHHHHHHHhCCCCCCccee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------------PQLLYEAKVYKILQGGSGIPNIKW 70 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~e~~~l~~l~~~~~~~~~~~ 70 (306)
.+.++|++.+.||+|+||.||+|.+.. ++.||+|++...... ..+.+|+.+++.+.|++.+..+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 467899999999999999999999765 899999987543221 457889999999987554444443
Q ss_pred ece----eCceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEE
Q 021855 71 YGV----DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146 (306)
Q Consensus 71 ~~~----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~k 146 (306)
+.. .....++++|++.++|.+.+......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCEE
Confidence 322 233679999999999999988655579999999999999999999999999999999999999 4789999
Q ss_pred EEeeccccccCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHH
Q 021855 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY 225 (306)
Q Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~ 225 (306)
|+|||++......... ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+
T Consensus 175 l~Dfg~~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 175 ICDFNLAREDTADANK--------THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp ECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred EEecCccccccccccc--------ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999754333221 24567899999999987 66899999999999999999999999876544333332
Q ss_pred HHHhhcc------------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh---
Q 021855 226 DKICEKK------------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS--- 278 (306)
Q Consensus 226 ~~~~~~~------------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~--- 278 (306)
....... .........+..++.+.++|.+||+.||.+|||+.++++ +.+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~ 324 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR--HPYFESLF 324 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGTTTC
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc--Cchhhhcc
Confidence 2221111 111122333566888999999999999999999999988 55554
Q ss_pred -----hcCCCCCccccceecchhhhH
Q 021855 279 -----REGYDFDFVFDWTILKYQQTQ 299 (306)
Q Consensus 279 -----~~~~~~~~~~~~~~~~~~~~~ 299 (306)
..+......|.++..+..+.+
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (362)
T 3pg1_A 325 DPLDLTEGLSERFHFDESVTDVYDMH 350 (362)
T ss_dssp CGGGGTTTCCCCCCCCTTCCCHHHHH
T ss_pred CccccccccccccChhhhhhhHHHHH
Confidence 233344455555555544443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=313.45 Aligned_cols=264 Identities=17% Similarity=0.252 Sum_probs=203.9
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCC----ceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
.+...+|++.+.||+|+||.||+|++..++ ..||+|++...... ..+.+|+.++..+.| +++..+..++...
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEecC
Confidence 456789999999999999999999886543 35999998765432 346789999999876 5666666666677
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...++++|++ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence 7899999999 669999988766679999999999999999999999999999999999999 588999999999997
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+... .
T Consensus 196 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~~~~-~ 267 (333)
T 1mqb_A 196 VLEDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAINDG-F 267 (333)
T ss_dssp -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT-C
T ss_pred hhcccccccc----ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHCC-C
Confidence 6543322110 1112345778999999999999999999999999999999 999998755432 22222222 1
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
..+. ...+++.+.++|.+||+.||.+|||+.++++.|+.++....
T Consensus 268 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 268 RLPT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CCCC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred cCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 2221 14678899999999999999999999999999999987443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=307.85 Aligned_cols=256 Identities=19% Similarity=0.191 Sum_probs=209.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----------chhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----------HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
+.++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+|+.++.++.+|+++..+..++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 46789999999999999999999999999999999875431 2346789999999986678877777777
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
.....++++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.|++||||+|+||++ +.++.++|+|||.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence 888899999999 6799999876 4569999999999999999999999999999999999999 5889999999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 226 (306)
+......... ....++..|+|||++. ...++.++|||||||++|+|++|..||...... ....
T Consensus 171 ~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~ 239 (298)
T 1phk_A 171 SCQLDPGEKL--------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR 239 (298)
T ss_dssp CEECCTTCCB--------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH
T ss_pred hhhcCCCccc--------ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHH
Confidence 9765443221 2456889999999985 456889999999999999999999999875443 2233
Q ss_pred HHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.+.......+.+ ....+++.+.++|.+||+.||.+|||+.++++ +.++.
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~ 288 (298)
T 1phk_A 240 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQ 288 (298)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGC
T ss_pred HHhcCCcccCcc-cccccCHHHHHHHHHHccCCcccCCCHHHHHh--ChHhh
Confidence 333333332222 22467889999999999999999999999977 55554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=310.09 Aligned_cols=256 Identities=25% Similarity=0.310 Sum_probs=209.8
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
....++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 89 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDNDF 89 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCC-CCEeeeeeeeccCCE
Confidence 3567899999999999999999999999999999998764421 2346778899998866 566666666777788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||.+...
T Consensus 90 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceec
Confidence 99999999 6788888765 4579999999999999999999999999999999999999 58899999999999875
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
...... .....++..|+|||++.+..++.++||||||+++|+|++|..||...... .....+.......+
T Consensus 166 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~ 235 (294)
T 2rku_A 166 EYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIKKNEYSIP 235 (294)
T ss_dssp CSTTCC-------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCCCCC
T ss_pred ccCccc-------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhhccCCCc
Confidence 433221 12456889999999999988999999999999999999999999875443 22333333333333
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
..+++.+.++|.+||+.||++|||++++++ +.++.+.
T Consensus 236 -----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--~~~~~~~ 272 (294)
T 2rku_A 236 -----KHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTSG 272 (294)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHTS
T ss_pred -----cccCHHHHHHHHHHcccChhhCcCHHHHhh--ChheecC
Confidence 566889999999999999999999999988 6666644
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=334.73 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=209.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+..++|++.+.||+|+||.||+|++..+|+.||+|++.. ......+.+|+.++..+.| +++..+...+......
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC-CCEeeEEEEEeeCCEE
Confidence 556789999999999999999999999999999998753 2334457889999999876 5666666667777889
Q ss_pred EEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceec
Confidence 9999999 889998887533 249999999999999999999999999999999999999 58899999999999876
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHH-HHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~ 235 (306)
...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+ ..+.......
T Consensus 337 ~~~~~~--------~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 408 (576)
T 2acx_A 337 PEGQTI--------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY 408 (576)
T ss_dssp CTTCCE--------ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC
T ss_pred ccCccc--------cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC
Confidence 443221 2457899999999999999999999999999999999999999875433222222 2222222222
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHHHHHHhHh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRLFHDLFS 278 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~l~~~~~ 278 (306)
+ ..+++++.+||.+||+.||.+|| +++++++ +.+++
T Consensus 409 p-----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~--HpfF~ 449 (576)
T 2acx_A 409 S-----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE--HPLFK 449 (576)
T ss_dssp C-----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT--SGGGT
T ss_pred C-----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh--Chhhc
Confidence 2 56789999999999999999999 6788876 45554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=309.62 Aligned_cols=262 Identities=18% Similarity=0.252 Sum_probs=203.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCC---CceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
..+|++.+.||+|+||.||+|++..+ ...+++|.+...... ..+.+|+.+++.+.|++.+..+..+...+...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 45799999999999999999987543 335889988764432 347789999999987555555555556667889
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++|++ +++|.+++......+++..++.++.|++.||.|||+.|++||||||+||++ +.++.+||+|||.+.....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence 999999 669999997656668999999999999999999999999999999999999 5889999999999976543
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||......... ...........
T Consensus 181 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~- 253 (298)
T 3f66_A 181 KEYYS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQGRRLLQ- 253 (298)
T ss_dssp GGGCB---C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHHHTTCCCCC-
T ss_pred cchhc---cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHhcCCCCCC-
Confidence 22111 111224466788999999999999999999999999999999 56677654433222 22222221111
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...+++.+.++|.+||+.||.+|||+.++++.|+.++...
T Consensus 254 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 254 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1456889999999999999999999999999999998743
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=319.67 Aligned_cols=264 Identities=22% Similarity=0.240 Sum_probs=197.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-hhhHHHHHHHHHHhCCCCCCcceeecee----CceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~~~~ 79 (306)
-.++|++.+.||+|+||.||+|++. ++.||+|++...... ....+|+.++..+.| +++..+..++.. ....+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKH-ENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCC-CCchhhcceeccCCCCCceEE
Confidence 4578999999999999999999874 789999998643222 234457777777776 445444444333 33479
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CccccCCCCCceeeccCCCcceEEEE
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR----------GFLHRDIKPDNFLMGLGRKANQVYII 148 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----------~i~H~dlkp~Nilv~~~~~~~~~kl~ 148 (306)
+++||+ +++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEc
Confidence 999999 7799999875 4599999999999999999999999 99999999999999 588999999
Q ss_pred eeccccccCCCCCCccccccCCccccccccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh--
Q 021855 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-- 221 (306)
Q Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~-- 221 (306)
|||++.......... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+......
T Consensus 174 DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 174 DFGLALKFEAGKSAG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CCTTCEEECTTSCCC-----CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred cCCcccccccccCcc-----ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 999997765433221 11245789999999999874 456789999999999999999999976432111
Q ss_pred ----------HHHH-HHHhhcccccchHHH--hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 222 ----------KQKY-DKICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 222 ----------~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
.... ............+.. ....++.+.++|.+||+.||++|||+.++++.|+.+.+..+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~~ 321 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTN 321 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1111 111111111111111 11224569999999999999999999999999999876543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=311.27 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=198.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
...++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++......
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCcE
Confidence 345789999999999999999999999999999998875322 2346789999999876 5666666666677889
Q ss_pred EEEEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 79 VLVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
++++|++ +++|.+++.. ....+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEecccee
Confidence 9999999 6699988864 24458999999999999999999999999999999999999 578999999999987
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
........ .....++..|+|||++.+..++.++||||||+++|+|++|..||.+.... .............+
T Consensus 185 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 185 FFSSKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYP 256 (310)
T ss_dssp ---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHHTTCSC
T ss_pred eecCCCcc-------ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhhcccCC
Confidence 65433221 12446789999999999999999999999999999999999999764321 11222222222222
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
.. ....+++++.++|.+||+.||++|||+.++++.|+.+.....-+
T Consensus 257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 11 11456889999999999999999999999999999997755544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=321.07 Aligned_cols=261 Identities=20% Similarity=0.291 Sum_probs=207.8
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+.+..++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++......
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCC-CCEEEEeEEEEECCEE
Confidence 567889999999999999999999999999999999998765332 346788888888865 6666666667778889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
+++|||+ +++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||++ +.++.++|+|||++...
T Consensus 107 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHH
T ss_pred EEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccc
Confidence 9999999 6799999876 34699999999999999999999996 99999999999999 57899999999998654
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH----------
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD---------- 226 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~---------- 226 (306)
..... ....+++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.
T Consensus 183 ~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 183 IDSMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp HHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred ccccc---------cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 32221 14568999999999999999999999999999999999999998754432221111
Q ss_pred -----------------------------HHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 227 -----------------------------KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 227 -----------------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.......... ....+++++.++|.+||+.||++|||+.++++ +.++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~ 328 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL---PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV--HAFI 328 (360)
T ss_dssp --------------------CCCHHHHHHHHHHSCCCCC---CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHH
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCC---CcccccHHHHHHHHHHhhcChhhCCCHHHHhh--ChHh
Confidence 1111110000 11345788999999999999999999999988 6666
Q ss_pred hhcC
Q 021855 278 SREG 281 (306)
Q Consensus 278 ~~~~ 281 (306)
+...
T Consensus 329 ~~~~ 332 (360)
T 3eqc_A 329 KRSD 332 (360)
T ss_dssp HHHH
T ss_pred hcch
Confidence 5433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=330.97 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=207.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+..++|++.+.||+|+||.||+|+++.+|+.||+|++... .....+.+|..++..+.| +++..+...+......
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC-CCEeeEEEEEeeCCEE
Confidence 4557899999999999999999999999999999987532 333557889999999865 6666666667777889
Q ss_pred EEEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 79 VLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
|++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.+|.+||+|||++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence 9999999 789998886532 359999999999999999999999999999999999999 589999999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh-hHHHHHHHhhccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKICEKKV 233 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~ 233 (306)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .......+.....
T Consensus 338 ~~~~~~~~-------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~ 410 (543)
T 3c4z_A 338 ELKAGQTK-------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410 (543)
T ss_dssp ECCTTCCC-------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred eccCCCcc-------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence 76543321 124578999999999999999999999999999999999999998754322 2233344444444
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCCh-----HHHHH
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY-----GFLKR 271 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~-----~~l~~ 271 (306)
..+ ..+++.+.++|.+||+.||.+||++ +++++
T Consensus 411 ~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 TYP-----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCC-----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCC-----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 443 5678999999999999999999964 66765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=322.20 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=199.2
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeece-----eCce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~ 77 (306)
.....+|++.+.||+|+||.||+|++..+++ +|+|.+..... ...+|+.+++.+.|.+.+.....+.. ....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4556789999999999999999999887766 77776654332 23479999999987444443333322 2223
Q ss_pred eEEEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 78 NVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
.+++|||+.+++...+.. ....+++..++.++.||+.||.|||+.||+||||||+|||++ ..++.+||+|||++.
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcc
Confidence 789999998887765542 245699999999999999999999999999999999999993 268999999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
........ ....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.+......
T Consensus 191 ~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 191 ILIAGEPN--------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp ECCTTCCC--------CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cccCCCCC--------cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 76443321 245679999999999775 489999999999999999999999998765544333333221110
Q ss_pred --------------------ccc-hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 234 --------------------STP-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 234 --------------------~~~-~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+ ...+...+++++.+||.+||+.||.+|||+.++++ +.+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~ 327 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC--HPFFDE 327 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGST
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc--Chhhhh
Confidence 001 11223457889999999999999999999999987 667653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=315.06 Aligned_cols=269 Identities=20% Similarity=0.235 Sum_probs=205.7
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee-----
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD----- 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~----- 74 (306)
..++++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+.| +++..+..+...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH-ENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCSTT
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcC-CCcCCeeeeecccccCc
Confidence 35678999999999999999999999999999999998654332 346789999999976 444444433322
Q ss_pred CceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
....++++|++.++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 86 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred cceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccccc
Confidence 356899999999999988875 469999999999999999999999999999999999999 588999999999998
Q ss_pred ccCCCCCCcccc---ccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 155 KYRDPTTNRHIP---YRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 155 ~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
...........+ ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 765332211100 001124568999999998764 6789999999999999999999999988654433332222211
Q ss_pred cc------------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 231 KK------------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 231 ~~------------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.. .........+.+++.+.++|.+||+.||++|||+.++++ +.++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 311 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE--HPYLQT 311 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc--Cccccc
Confidence 11 111223334577899999999999999999999999988 667653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=324.33 Aligned_cols=260 Identities=23% Similarity=0.252 Sum_probs=199.5
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeece-----eCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~~ 79 (306)
...+|++.+.||+|+||.||+|++..+++.||+|.+..... ...+|+.+++.+.|.+.+.....+.. +....+
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 34579999999999999999999999999999998865433 34579999999987544443333322 122467
Q ss_pred EEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 80 LVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
+++||+.+++.+.+.. ....+++..++.++.||+.||.|||+.||+||||||+|||+. .+.+.+||+|||+++..
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhc
Confidence 9999998888877653 245699999999999999999999999999999999999994 24568899999999865
Q ss_pred CCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc-
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS- 234 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~- 234 (306)
...... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.+.......
T Consensus 208 ~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 208 VRGEPN--------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CTTCCC--------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccCCCc--------eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 433221 245789999999999775 6899999999999999999999999886654433333222111100
Q ss_pred -------------c-------chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 -------------T-------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 -------------~-------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
. ....+....++++.+||.+||+.||.+|||+.++++ +.++.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~--hp~f~ 341 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--HSFFD 341 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC--CHhhc
Confidence 0 011122456889999999999999999999999987 56654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=317.46 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=205.3
Q ss_pred CCceeEeeeecccCccEEEEEEEc---CCCceEEEEEccCC------CCchhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
.++|++.+.||+|+||.||+|++. .+++.||+|++... .....+.+|+.++..+.+++++..+..++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 378999999999999999999984 58899999987642 233456779999999987788888877778888
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 999999999 7799998876 3469999999999999999999999999999999999999 5889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHH-HHHHhhcc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK-YDKICEKK 232 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~ 232 (306)
....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||........... ........
T Consensus 209 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 209 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282 (355)
T ss_dssp CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred cccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence 5432221 11245789999999999864 478999999999999999999999976443322222 22333333
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHHHHHHhH
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRLFHDLF 277 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~~l~~~~ 277 (306)
...+ ..+++.+.++|.+||+.||.+|| |++++++ +.++
T Consensus 283 ~~~~-----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~--h~~f 325 (355)
T 1vzo_A 283 PPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE--HLFF 325 (355)
T ss_dssp CCCC-----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT--SGGG
T ss_pred CCCC-----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc--Ccch
Confidence 3332 56688999999999999999999 8888877 4444
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=309.11 Aligned_cols=258 Identities=21% Similarity=0.310 Sum_probs=202.6
Q ss_pred cCCceeEee-eecccCccEEEEEEE--cCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 5 IGVKYKLGR-KIGSGSFGEIFLASH--VDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 5 ~~~~y~i~~-~lg~g~~~~v~~~~~--~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
..++|++.+ .||+|+||.||+|.+ ..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++ ....
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEE-CCCC
Confidence 456899998 999999999999954 56778999999875533 2457789999999976 5555554444 5567
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCcceee
Confidence 89999999 6899998876 4569999999999999999999999999999999999999 47899999999999876
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.........+ ......
T Consensus 168 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~ 239 (291)
T 1xbb_A 168 RADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML----EKGERM 239 (291)
T ss_dssp CTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCC
T ss_pred ccCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCC
Confidence 5433211 01123345688999999998889999999999999999999 99999876543222222 111111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
. ....+++.+.++|.+||+.||.+|||+.++++.|+.++.+
T Consensus 240 ~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 240 G---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp C---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 1256789999999999999999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=320.72 Aligned_cols=257 Identities=19% Similarity=0.235 Sum_probs=190.9
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeC-----
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~----- 75 (306)
+.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+.|+ ++..+..++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK-NIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCT-TBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCC-CccceEEeecccccccc
Confidence 457899999999999999999999999999999998764332 3467899999999764 444443333222
Q ss_pred -ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 -~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...+++||++.++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 175 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC--
T ss_pred ccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeeccc
Confidence 3689999999989888875 358999999999999999999999999999999999999 588999999999997
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-- 232 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-- 232 (306)
....... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 176 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 176 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred ccccccc--------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 6543221 124578999999999999999999999999999999999999998765433222221111000
Q ss_pred -----------------ccc---chH------------HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 233 -----------------VST---PIE------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 233 -----------------~~~---~~~------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
... ... ......++.+.+||.+||+.||++|||++++++ +.++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~ 323 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--HPYIN 323 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC--Ccchh
Confidence 000 000 000112567999999999999999999999988 66665
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=317.55 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=199.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCce---
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED--- 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~--- 77 (306)
+.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+.|++.+..+..+ .....
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF-TPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE-CSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhe-eccCCccc
Confidence 568999999999999999999999999999999998765433 3467899999999875544444433 33322
Q ss_pred ---eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 78 ---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 78 ---~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
.++++|++.++|.+.+ ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 119 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 119 FYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR 192 (371)
T ss_dssp CCCCEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC-
T ss_pred ceeEEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCccc
Confidence 3999999998887776 3459999999999999999999999999999999999999 588999999999997
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc--
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK-- 231 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-- 231 (306)
....... ...+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 193 ~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 193 HADAEMT----------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccCcC----------CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 6543322 4567999999999987 67899999999999999999999999876544333322221111
Q ss_pred ---------------------ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 232 ---------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 232 ---------------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..........+.+++.+.+||.+||+.||.+|||+.++++ +.+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~ 328 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT--HPFFE 328 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGT
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc--Ccccc
Confidence 1111122333567899999999999999999999999988 66665
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.16 Aligned_cols=264 Identities=17% Similarity=0.241 Sum_probs=196.3
Q ss_pred CceeEeeeecccCccEEEEEEEcCC---CceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
..|++.+.||+|+||.||+|++..+ +..||+|.+...... ..+.+|+.+++.+.|++.+..+..+.......++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 3588999999999999999987533 246899988754332 3577899999999775544444444555667899
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
++||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++......
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccccccc
Confidence 99999 779999998655668999999999999999999999999999999999999 58899999999999765432
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
..... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...+...... ....... ...
T Consensus 246 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~~~~~-~~~- 317 (373)
T 3c1x_A 246 EFDSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRR-LLQ- 317 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHHTTCC-CCC-
T ss_pred ccccc---cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHHcCCC-CCC-
Confidence 21110 01123456788999999999999999999999999999999 778887654432222 2222211 111
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
...+++.+.++|.+||+.||++|||+.++++.|++++....-.
T Consensus 318 --p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 318 --PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 1456889999999999999999999999999999998755433
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=314.96 Aligned_cols=261 Identities=18% Similarity=0.191 Sum_probs=188.2
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeC------ceeE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG------EDNV 79 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~------~~~~ 79 (306)
++|++.+.||+|+||.||+|++..+++.||+|++.... ......+++..+..+.|++.+..+..+.... ...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 67999999999999999999999999999999876543 3345667777788887644444333332211 2378
Q ss_pred EEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH--HcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 80 LVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
++|||+.+++...+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++ +.++.+||+|||++.
T Consensus 103 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTCB
T ss_pred EEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCce
Confidence 9999998888766553 2445889999999999999999999 99999999999999994 238899999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
........ ....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.+......
T Consensus 181 ~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 181 KLSPSEPN--------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCCTTSCC--------CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ecCCCCCc--------ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 66543321 2456799999999997655 89999999999999999999999988665443333332221111
Q ss_pred cc--------------------chHHH----hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 234 ST--------------------PIEVL----CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 234 ~~--------------------~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.. +.... ....++++.+||.+||+.||.+|||+.++++ +.++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~ 320 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC--HPYFDE 320 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT--SGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc--Cccccc
Confidence 00 00000 1125678999999999999999999999988 666653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=310.26 Aligned_cols=263 Identities=19% Similarity=0.254 Sum_probs=206.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEc-CCCceEEEEEccCC----CCchhhHHHHHHHHHHh--CCCCCCcceeece----
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSG----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGV---- 73 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~-~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~---- 73 (306)
.+++|++.+.||+|+||.||+|++. .+++.||+|++... .....+.+|+.+++.+. .|+++..+..++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4688999999999999999999985 67889999987532 22345778898888885 4566666654443
Q ss_pred -eCceeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeec
Q 021855 74 -DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (306)
Q Consensus 74 -~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg 151 (306)
.....++++|++.++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecCc
Confidence 456789999999999999987643 348999999999999999999999999999999999999 588999999999
Q ss_pred cccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc
Q 021855 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
.+........ .....++..|+|||++.+..++.++|||||||++|+|++|..||.+.........+......
T Consensus 166 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 166 LARIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp SCCCCCGGGG--------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ccccccCCCC--------ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9875432211 12456789999999999999999999999999999999999999876554333333221111
Q ss_pred c-------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 232 K-------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 232 ~-------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
. ...+.......+++.+.++|.+||+.||.+|||+.++++ +.++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~~ 303 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--HPYFQDL 303 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTTC
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc--Ccccccc
Confidence 0 011122333567889999999999999999999999987 6666533
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=329.62 Aligned_cols=261 Identities=21% Similarity=0.376 Sum_probs=208.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+|+.+++.+.|+ ++..+..+.. ....+++|
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD-KLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCT-TBCCEEEEEC-SSSCEEEE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCC-CEeeEEEEEe-CCccEEEE
Confidence 45678999999999999999999985 46789999987643 345688999999999774 4545544443 55789999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCc
Confidence 999 789999987432 358899999999999999999999999999999999999 588999999999998654321
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+. .....+.+
T Consensus 339 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~----~~~~~~~~- 407 (454)
T 1qcf_A 339 YT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE----RGYRMPRP- 407 (454)
T ss_dssp HH------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----HTCCCCCC-
T ss_pred ee------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----cCCCCCCC-
Confidence 10 1123345778999999998899999999999999999999 999998865543322222 22222221
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
..+|+.+.++|.+||+.||++|||+++|++.|+.++......
T Consensus 408 --~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 408 --ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred --CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 567899999999999999999999999999999988654433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=309.16 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=183.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|++|.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++......+++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH-PSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCC-TTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCC-CCeEeEEEEEccCCeEEEE
Confidence 5799999999999999999999999999999987532 223557789999988876 6666666666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|++ +++|.+++......+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||.+.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCCC
Confidence 9999 679999888655679999999999999999999999999999999999999 588999999999997654332
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. .....+++.|+|||++.+..++.++|||||||++|+|++|..||...... .............+
T Consensus 167 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~---- 232 (278)
T 3cok_A 167 EK-------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK---NTLNKVVLADYEMP---- 232 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCCCCC----
T ss_pred Cc-------ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH---HHHHHHhhcccCCc----
Confidence 21 12456889999999999988999999999999999999999999864432 11222222222222
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+++++.++|.+||+.||++|||+.++++ +.++.
T Consensus 233 -~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~ 267 (278)
T 3cok_A 233 -SFLSIEAKDLIHQLLRRNPADRLSLSSVLD--HPFMS 267 (278)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--STTTC
T ss_pred -cccCHHHHHHHHHHcccCHhhCCCHHHHhc--Ccccc
Confidence 456889999999999999999999999977 44443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=317.35 Aligned_cols=264 Identities=24% Similarity=0.317 Sum_probs=203.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-------CCchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++.....
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH-PNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC-CCcceeehhhccCCe
Confidence 457899999999999999999999999999999987532 233567889999999975 666667667777888
Q ss_pred eEEEEecc-CCCHHHHHHHh---------------------------------------cCCCCHHHHHHHHHHHHHHHH
Q 021855 78 NVLVLDLL-GPSLEDLFVYC---------------------------------------RRKFSLKTVLMLADQMIARIE 117 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~~L~ 117 (306)
.+++|||+ +++|.+++... ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999 88998887410 011357788899999999999
Q ss_pred HHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccC--CCCCchhh
Q 021855 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDD 195 (306)
Q Consensus 118 ~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sD 195 (306)
|||+.||+||||||+||+++. +..+.+||+|||++........... .......+|+.|+|||++.+ ..++.++|
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEY---YGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCcccc---ccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999941 1233899999999986543222110 11225568999999999975 67899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 196 iwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
||||||++|+|++|..||.+.... .............+.+ ....+++.+.++|.+||+.||.+|||+.++++ +.
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~--hp 332 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDA---DTISQVLNKKLCFENP-NYNVLSPLARDLLSNLLNRNVDERFDAMRALQ--HP 332 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCTTSG-GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH--SH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHhcccccCCc-ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc--Ch
Confidence 999999999999999999876543 3333333333333222 22457899999999999999999999999988 66
Q ss_pred hHhh
Q 021855 276 LFSR 279 (306)
Q Consensus 276 ~~~~ 279 (306)
++++
T Consensus 333 ~~~~ 336 (345)
T 3hko_A 333 WISQ 336 (345)
T ss_dssp HHHT
T ss_pred hhcc
Confidence 6654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=314.77 Aligned_cols=255 Identities=25% Similarity=0.317 Sum_probs=209.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
...++|.+.+.||+|+||.||++++..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++......
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCeE
Confidence 35678999999999999999999999999999999876442 12346778999998866 5666666667777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++....
T Consensus 117 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecc
Confidence 9999999 6789888776 4579999999999999999999999999999999999999 578999999999998764
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.......+
T Consensus 193 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~- 261 (335)
T 2owb_A 193 YDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIKKNEYSIP- 261 (335)
T ss_dssp STTCC-------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCC-
T ss_pred cCccc-------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHhcCCCCCC-
Confidence 33221 12456899999999999989999999999999999999999999875433 22333333333333
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
..+++.+.++|.+||+.||++|||+.++++ +.++...
T Consensus 262 ----~~~~~~~~~li~~~l~~dp~~Rps~~ell~--~~~~~~~ 298 (335)
T 2owb_A 262 ----KHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTSG 298 (335)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHTS
T ss_pred ----ccCCHHHHHHHHHHccCChhHCcCHHHHhc--CccccCC
Confidence 456889999999999999999999999988 6666543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=306.45 Aligned_cols=253 Identities=20% Similarity=0.259 Sum_probs=204.9
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeece--------
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-------- 73 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-------- 73 (306)
+..++++|++.+.||+|++|.||+|++..+++.||+|.+.... ..+.+|+.++..+.|.+.+..+..+..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567889999999999999999999999899999999887543 467889999999987544443332221
Q ss_pred -------eCceeEEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcce
Q 021855 74 -------DGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (306)
Q Consensus 74 -------~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~ 144 (306)
.....++++||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---cCCCC
Confidence 244579999999 56999998754 3468999999999999999999999999999999999999 47899
Q ss_pred EEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHH
Q 021855 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224 (306)
Q Consensus 145 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 224 (306)
++|+|||++......... ....+++.|+|||++.+..++.++|||||||++|+|++|..||.... ..
T Consensus 161 ~kl~Dfg~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~ 227 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKR--------TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KF 227 (284)
T ss_dssp EEECCCTTCEESSCCSCC--------CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HH
T ss_pred EEECcchhheeccccccc--------cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HH
Confidence 999999999876543321 24468999999999999999999999999999999999999885422 11
Q ss_pred HHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
........ ....+++.+.++|.+||+.||.+|||+.++++.|..+.+.
T Consensus 228 ~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 228 FTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11211111 1145678899999999999999999999999999987653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=310.40 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=199.7
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeecee--CceeEEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GEDNVLVL 82 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~~lv~ 82 (306)
..++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+|+.+++.+.+++++..+..++.. ....++++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 357899999999999999999999999999999998743 346688999999999977777777666555 56789999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcc-eEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~-~~kl~Dfg~~~~~~~~~ 160 (306)
|++ +++|.+++. .+++..+..++.||+.||.|||+.||+||||||+|||++ .++ .++|+|||++.......
T Consensus 113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID---HEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc---CCCCEEEEEeCCCceEcCCCC
Confidence 999 678877763 488999999999999999999999999999999999994 444 89999999997654433
Q ss_pred CCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhh-hhHHHHHHHhh--------
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICE-------- 230 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~-------- 230 (306)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+.....
T Consensus 186 ~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 186 EY--------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CC--------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred cc--------ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence 21 24567889999999987 56899999999999999999999999543211 11111111000
Q ss_pred --cccccc-------------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 231 --KKVSTP-------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 231 --~~~~~~-------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...... .......+++++.++|.+||+.||.+|||++++++ +.++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~--hp~f~ 324 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--HPYFY 324 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SGGGT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CccHh
Confidence 000000 00011236889999999999999999999999987 55554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=307.47 Aligned_cols=262 Identities=20% Similarity=0.291 Sum_probs=206.9
Q ss_pred ccCCceeEee-eecccCccEEEEEEEc--CCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 4 IIGVKYKLGR-KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~-~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+..++|.+.+ .||+|+||.||+|.+. .++..||+|++..... ...+.+|+.+++.+.| +++..+..++ ....
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVC-QAEA 83 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEE-ESSS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEe-cCCC
Confidence 3456788877 9999999999999864 4678899999876543 2347789999999976 5555554444 4556
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++|++ +++|.+++......+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceeee
Confidence 89999999 669999887655669999999999999999999999999999999999999 47899999999999876
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......... ..+.... ..
T Consensus 161 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~i~~~~-~~ 232 (287)
T 1u59_A 161 GADDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGK-RM 232 (287)
T ss_dssp TTCSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HHHHTTC-CC
T ss_pred ccCccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHhcCC-cC
Confidence 4432211 11123456788999999988889999999999999999998 99999875543222 2222211 11
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
. ....+++.+.++|.+||+.||.+|||+.++++.|+.++.+.+
T Consensus 233 ~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 233 E---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp C---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred C---CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1 125678999999999999999999999999999999976443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=326.18 Aligned_cols=261 Identities=22% Similarity=0.351 Sum_probs=204.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|+||.||+|.+.. +..||+|++..... ...+.+|+.+++.+.|+ ++..+..+... ...+++|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE-KLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCT-TBCCEEEEECS-SSCEEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCC-CEeeEEEEEcC-CceEEEe
Confidence 456789999999999999999999865 46699999886543 35688999999999874 44444444433 5689999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCc
Confidence 999 78999998753 3458999999999999999999999999999999999999 588999999999997654322
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+ ......+.+
T Consensus 335 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~~~~~~~~- 403 (452)
T 1fmk_A 335 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----ERGYRMPCP- 403 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCCCC-
T ss_pred ee------cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCCC-
Confidence 11 1123456778999999998899999999999999999999 99999886554322222 222222211
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
..+|+.+.++|.+||+.||++|||+++|++.|+.++......
T Consensus 404 --~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 404 --PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred --CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 567889999999999999999999999999999998755443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=309.57 Aligned_cols=252 Identities=17% Similarity=0.296 Sum_probs=198.5
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
-..++|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++......+++
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH-PYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCC-TTBCCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCC-CCEeeeeeeeeeCCeEEEE
Confidence 35678999999999999999999999999999999876543 33567889999999876 5666666666667789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|++ +++|.+++......+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||++.......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccccccc
Confidence 9999 678888887666779999999999999999999999999999999999999 478999999999875422111
Q ss_pred CCccccccCCccccccccccCcccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTH-----LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
. ......++..|+|||++ .+..++.++|||||||++|+|++|..||...+.... ...........
T Consensus 172 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~ 241 (302)
T 2j7t_A 172 Q-------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIAKSDPPT 241 (302)
T ss_dssp H-------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSCCCC
T ss_pred c-------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHHHhccCCcc
Confidence 0 11244688999999998 366789999999999999999999999987654322 22222222211
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
. .....+++.+.++|.+||+.||.+|||+.++++
T Consensus 242 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 L--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 112566889999999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=316.36 Aligned_cols=266 Identities=16% Similarity=0.217 Sum_probs=206.7
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
..++|++.+.||+|+||.||+|++. +++.||+|.+...... ..+.+|+.+++.+.| +++..+..++......++++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRH-PHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCC-TTBCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEE
Confidence 4578999999999999999999964 6889999987755432 457789999988876 56666666667778899999
Q ss_pred ecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 83 DLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 999 779988876432 248899999999999999999999999999999999999 5889999999999976443
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH----HHhhcccc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD----KICEKKVS 234 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~----~~~~~~~~ 234 (306)
..... ......++..|+|||++.+..++.++|||||||++|+|++|..||.+........... ........
T Consensus 192 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 192 LDQTH-----LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp SSCCC-----CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred ccccc-----cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 22111 1124568999999999998899999999999999999999999997644322111111 00000000
Q ss_pred -----cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 235 -----TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 235 -----~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
..........++.+.+++.+||+.||++|||+.++++.|+.+++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 0111122344678999999999999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=308.50 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=200.6
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhC-CCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQG-GSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~~~ 78 (306)
+.+++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+|+.++..+.+ ++++..+..++......
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 46788999999999999999999975 5889999988755433 456789999999986 67777777777778889
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++++|+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||++ +++.+||+|||++.....
T Consensus 104 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~----~~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 104 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTEEEECCCSSSCC---
T ss_pred EEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE----ECCeEEEeeccccccccC
Confidence 99999889999999886 4578999999999999999999999999999999999999 358999999999976543
Q ss_pred CCCCccccccCCccccccccccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (306)
..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ......
T Consensus 179 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~ 251 (313)
T 3cek_A 179 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHA 251 (313)
T ss_dssp ----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHH
T ss_pred ccccc-----cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--HHHHHH
Confidence 32211 1124468999999999876 46888999999999999999999999764322 122223
Q ss_pred HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.......... ....++.+.++|.+||+.||.+|||+.++++ +.++.
T Consensus 252 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~~~ 297 (313)
T 3cek_A 252 IIDPNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQ 297 (313)
T ss_dssp HHCTTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred HHhcccccCC---cccchHHHHHHHHHHccCCcccCcCHHHHhc--Ccccc
Confidence 3222222211 1445788999999999999999999999987 56665
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=306.00 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=207.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC----CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
.+.++|++.+.||+|++|.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++......+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccC-CCccEEEEEEeCCCeEE
Confidence 4567999999999999999999999999999999987533 234567889999999966 56666666667778899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+++|++ +++|.+.+.. ...+++..++.++.||+.||.|||+.|++||||||+||+++..+.++.+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999 7899888775 34699999999999999999999999999999999999996434456899999999876544
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.... ....++..|+|||++.+. ++.++||||||+++|+|++|..||.+.+.. .....+.......+.+
T Consensus 177 ~~~~--------~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 177 NTKM--------KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETGKYAFDLP 244 (287)
T ss_dssp CSSC--------SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCCSG
T ss_pred CCcc--------ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCCch
Confidence 3221 244688999999998764 899999999999999999999999876543 2233333333332222
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
....+++++.++|.+||+.||.+|||+.++++ ..++++
T Consensus 245 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~~~~ 282 (287)
T 2wei_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQK 282 (287)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHH
T ss_pred -hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc--CHHHhc
Confidence 12567889999999999999999999999987 455543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.79 Aligned_cols=274 Identities=18% Similarity=0.210 Sum_probs=193.7
Q ss_pred ccCCceeE-eeeecccCccEEEEEEEc--CCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeec-eeCceeE
Q 021855 4 IIGVKYKL-GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNV 79 (306)
Q Consensus 4 ~~~~~y~i-~~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~~~ 79 (306)
.+.+.|++ ++.||+|+||.||+|+++ .+++.||+|++........+.+|+.+++.+.|++.+..+..+. ......+
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 45567887 568999999999999976 5788999999988777778899999999998754444443332 3466789
Q ss_pred EEEeccCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC-CCcceEEEEee
Q 021855 80 LVLDLLGPSLEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDF 150 (306)
Q Consensus 80 lv~e~~~~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~-~~~~~~kl~Df 150 (306)
+++||++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+... +..+.+||+||
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 999999999998876422 148999999999999999999999999999999999999533 36789999999
Q ss_pred ccccccCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhh------hHH
Q 021855 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------KKQ 223 (306)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~------~~~ 223 (306)
|++......... ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+..... ...
T Consensus 177 g~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 177 GFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp TCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred CCceecCCCCcc----cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999876443211 1112355789999999999875 48999999999999999999999997543210 011
Q ss_pred HHHHHhhcccccc---------------------------------hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHH
Q 021855 224 KYDKICEKKVSTP---------------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (306)
Q Consensus 224 ~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~ 270 (306)
.+..+........ ........++.+.+||.+||+.||.+|||+++++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1111111000000 0000112267889999999999999999999998
Q ss_pred HHHHHhHhhcCCC
Q 021855 271 RLFHDLFSREGYD 283 (306)
Q Consensus 271 ~~l~~~~~~~~~~ 283 (306)
+ +.++......
T Consensus 333 ~--hp~f~~~~~~ 343 (405)
T 3rgf_A 333 Q--DPYFLEDPLP 343 (405)
T ss_dssp T--SGGGTSSSCC
T ss_pred c--ChhhccCCCC
Confidence 8 8888755443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=308.00 Aligned_cols=256 Identities=26% Similarity=0.318 Sum_probs=202.1
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
|..-+.++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++.....
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNI 79 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTE
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCC-CCceeeeeEEEcCCE
Confidence 344456789999999999999999999999999999998764322 2457789999988866 566666666777888
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.|++||||+|+||++ +.++.++|+|||.+...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCcccc
Confidence 99999999 6689888764 4468999999999999999999999999999999999999 47899999999998765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
....... ......++..|+|||++.+..+ +.++|||||||++|+|++|..||........ .+..........
T Consensus 156 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~ 228 (276)
T 2yex_A 156 RYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYL 228 (276)
T ss_dssp EETTEEC-----CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTTCTTS
T ss_pred CCCcchh-----cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhccccc
Confidence 4322110 1124568999999999988775 7899999999999999999999987543221 122221111111
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
+ ....+++.+.++|.+||+.||++|||+.++++
T Consensus 229 ~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 N---PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp T---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1 12567889999999999999999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=305.80 Aligned_cols=250 Identities=18% Similarity=0.198 Sum_probs=201.8
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
|...+.++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+|+..+..+..|+++..+..++....
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 345567899999999999999999999999999999998875432 2346778888888866678888877778888
Q ss_pred eeEEEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC------------
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR------------ 140 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~------------ 140 (306)
..++++||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999 779999987532 5689999999999999999999999999999999999995221
Q ss_pred ----CcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 021855 141 ----KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQG 215 (306)
Q Consensus 141 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~ 215 (306)
....++|+|||.+....... ...++..|+|||++.+. .+++++|||||||++|+|++|..|+..
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 44589999999997754432 33578999999999876 567899999999999999999887765
Q ss_pred chhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
... ...+.....+ .....+++.+.++|.+||+.||++|||+.++++
T Consensus 234 ~~~------~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 234 GDQ------WHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp SHH------HHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhH------HHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 322 2222222221 122567899999999999999999999999977
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=324.96 Aligned_cols=250 Identities=16% Similarity=0.130 Sum_probs=186.4
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhC-CCCCCc-ceee------ce
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQG-GSGIPN-IKWY------GV 73 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~-~~~~~~-~~~~------~~ 73 (306)
..|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.++..+.+ |+++.. +..+ ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999998875532 235667766777762 344332 2111 11
Q ss_pred eC-----------------ceeEEEEeccCCCHHHHHHHhcCCCCHHHH------HHHHHHHHHHHHHHHHcCccccCCC
Q 021855 74 DG-----------------EDNVLVLDLLGPSLEDLFVYCRRKFSLKTV------LMLADQMIARIEYVHSRGFLHRDIK 130 (306)
Q Consensus 74 ~~-----------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~------~~~~~qi~~~L~~LH~~~i~H~dlk 130 (306)
.. ...+++|||+.++|.+++...+..++...+ ..++.||+.||.|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 11 347999999999999999875445555555 6778999999999999999999999
Q ss_pred CCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHh
Q 021855 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLR 208 (306)
Q Consensus 131 p~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t 208 (306)
|+|||+ +.++.+||+|||++........ ...+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 222 p~NIll---~~~~~~kL~DFG~a~~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFI---MPDGRLMLGDVSALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEE---CTTSCEEECCGGGEEETTCEEE----------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---CCCCCEEEEecceeeecCCCcc----------CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999 5889999999999986543211 3456699999999987 679999999999999999999
Q ss_pred CCCCCCCchhhhhHHHHHH---HhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 209 GSLPWQGLKAATKKQKYDK---ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 209 g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
|..||.+....... .+.. ......... ...+..+++.+.++|.+||+.||++|||+.++++
T Consensus 289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLA-FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCC-CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCccccc-chhhhhhhhccccccc-hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999875432111 0100 000000111 1112567899999999999999999999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=305.79 Aligned_cols=254 Identities=22% Similarity=0.268 Sum_probs=198.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeece---eCce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV---DGED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~---~~~~ 77 (306)
.+..|++.+.||+|+||.||+|.+..++..||+|.+...... ..+.+|+.+++.+.|++.+..+..+.. ....
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 456799999999999999999999999999999987654322 346789999999876444443333322 2456
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
.++++||+ +++|.+++.. ...+++..++.++.||+.||.|||+.| ++||||||+||+++ +.++.++|+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence 89999999 7799999876 356999999999999999999999999 99999999999994 368899999999996
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
....... ....+++.|+|||++.+ .++.++|||||||++|+|++|..||...... ............+
T Consensus 181 ~~~~~~~---------~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 181 LKRASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVKP 248 (290)
T ss_dssp GCCTTSB---------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCCC
T ss_pred ccccccc---------ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHHHHhccCCc
Confidence 5433221 24568999999998875 5899999999999999999999999764332 1222222222211
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.......++.+.++|.+||+.||.+|||+.++++ +.+++
T Consensus 249 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~f~ 287 (290)
T 1t4h_A 249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQ 287 (290)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC
T ss_pred ---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh--Ccccc
Confidence 1223556789999999999999999999999987 55543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=310.09 Aligned_cols=257 Identities=19% Similarity=0.312 Sum_probs=199.9
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-CCchhhHHHHHHHHHHhCCCCCCcceeecee------Cc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLYEAKVYKILQGGSGIPNIKWYGVD------GE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~------~~ 76 (306)
...++|++.+.||+|++|.||+|++..+++.||+|++... .....+.+|+.++..+.+|+++..+..++.. ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3578999999999999999999999999999999988654 3345688899999999666777766555443 46
Q ss_pred eeEEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
..++++||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCce
Confidence 789999999 569999987642 458999999999999999999999999999999999999 488999999999987
Q ss_pred ccCCCCCCccccccCCccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 229 (306)
........ .....++..|+|||++. +..++.++|||||||++|+|++|..||........ ...+.
T Consensus 178 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~ 247 (326)
T 2x7f_A 178 QLDRTVGR-------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIP 247 (326)
T ss_dssp --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHH
T ss_pred ecCcCccc-------cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhh
Confidence 65432211 12456899999999997 55689999999999999999999999987554322 22222
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
....+.. ....+++.+.++|.+||+.||.+|||+.++++ +.++.
T Consensus 248 ~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--hp~~~ 291 (326)
T 2x7f_A 248 RNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK--HPFIR 291 (326)
T ss_dssp HSCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT--SHHHH
T ss_pred cCccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh--ChHHh
Confidence 2221111 12556889999999999999999999999987 56665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=315.53 Aligned_cols=270 Identities=22% Similarity=0.314 Sum_probs=199.5
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHh-CCCCCCcceeeceeC----ce
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSGIPNIKWYGVDG----ED 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~----~~ 77 (306)
+.+.++|++.+.||+|+||.||+|++. ++.||+|++.... ......|..++..+. .|+++..+..++... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 456789999999999999999999874 8899999886432 233445555554442 456666665554444 67
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCceeeccCCCcceEEEE
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYII 148 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------~i~H~dlkp~Nilv~~~~~~~~~kl~ 148 (306)
.+++|||+ +++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEE
Confidence 89999999 7799999864 4699999999999999999999998 99999999999999 588999999
Q ss_pred eeccccccCCCCCCccccccCCccccccccccCcccccCCCCCch------hhHHHHHHHHHHHHhC----------CCC
Q 021855 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRR------DDLESLGYVLLYFLRG----------SLP 212 (306)
Q Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~------sDiwslG~il~~l~tg----------~~p 212 (306)
|||++............ ......||+.|+|||++.+...+.. +|||||||++|+|++| ..|
T Consensus 185 Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp CCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred eCCCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999765443322111 1124578999999999988776554 9999999999999999 777
Q ss_pred CCCchhhhh-HHHHHHHh-hcccc--cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 213 WQGLKAATK-KQKYDKIC-EKKVS--TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 213 f~~~~~~~~-~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
|........ ........ ..... .+.......+++.+.++|.+||+.||.+|||+.++++.|+.+.+..+.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 336 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTCC
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcccC
Confidence 765322211 11111111 11111 1111112345778999999999999999999999999999999876654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=312.66 Aligned_cols=265 Identities=22% Similarity=0.278 Sum_probs=205.5
Q ss_pred cccCCce-eEeeeecccCccEEEEEEE----cCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 3 RIIGVKY-KLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 3 ~~~~~~y-~i~~~lg~g~~~~v~~~~~----~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
.+++++| ++.+.||+|+||.||++.+ ..+++.||+|++...... ..+.+|+.+++.+.| +++..+..++..
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 104 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EHIIKYKGCCED 104 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCC-cchhhEEEEEec
Confidence 4567777 9999999999999988764 357889999998865432 347889999999986 555555444443
Q ss_pred --CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeec
Q 021855 75 --GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (306)
Q Consensus 75 --~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg 151 (306)
....++++||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg 179 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFG 179 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGG
T ss_pred CCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcc
Confidence 46789999999 7799998864 358999999999999999999999999999999999999 588999999999
Q ss_pred cccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh-----------
Q 021855 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT----------- 220 (306)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~----------- 220 (306)
++.......... .......++..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 180 ~a~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 255 (318)
T 3lxp_A 180 LAKAVPEGHEYY----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255 (318)
T ss_dssp GCEECCTTCSEE----EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred cccccccccccc----ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence 998765433211 11224457888999999999889999999999999999999999997643211
Q ss_pred hHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...............+ ....+++.+.++|.+||+.||.+|||+.++++.|+.+.++.
T Consensus 256 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 256 TVLRLTELLERGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 0111122222222222 12567899999999999999999999999999999997643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=305.04 Aligned_cols=259 Identities=21% Similarity=0.354 Sum_probs=205.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|++|.||+|++. ++..||+|.+.... ....+.+|+.+++.+.| +++..+..+.. ....++++
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCC-cCcceEEEEEc-CCCcEEEE
Confidence 45689999999999999999999975 46789999887554 34567889999999976 44544544433 44689999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|++ +++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||.+.......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCcc
Confidence 999 789999886432 258999999999999999999999999999999999999 588999999999998754432
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+...... ..... ......
T Consensus 164 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~-~~~~~~--- 230 (279)
T 1qpc_A 164 YT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLE-RGYRMV--- 230 (279)
T ss_dssp EE------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHH-TTCCCC---
T ss_pred cc------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHHHh-cccCCC---
Confidence 11 1123456778999999998889999999999999999999 9999987554322 22221 111111
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
....+++.+.++|.+||+.||++|||+.++++.|++++....
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 125668899999999999999999999999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=313.82 Aligned_cols=254 Identities=25% Similarity=0.315 Sum_probs=197.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----------CchhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
.+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.| +++..+..++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCC-TTBCCEEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCC-CCCceEeeEEc
Confidence 45678999999999999999999999999999999876432 12347789999999976 45555544444
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
.. ..++++||+ +++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++..+.++.+||+|||+
T Consensus 86 ~~-~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 86 AE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp SS-SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred CC-ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 33 489999999 6799888765 45699999999999999999999999999999999999996333455699999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 229 (306)
+........ .....++..|+|||++. ...++.++|||||||++|+|++|..||........ ....+.
T Consensus 164 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~ 233 (322)
T 2ycf_A 164 SKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 233 (322)
T ss_dssp CEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH
T ss_pred ceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH
Confidence 976543211 12446899999999974 55689999999999999999999999976443211 112222
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..... ..+.....+++.+.++|.+||+.||++|||+.++++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCccc-cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 22222 223344677899999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=307.88 Aligned_cols=260 Identities=21% Similarity=0.317 Sum_probs=194.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcC---CCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeC-
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG- 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~- 75 (306)
+..++|++.+.||+|+||.||+|++.. +++.||+|++...... ..+.+|+.+++.+.|++.+..+..+....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 456789999999999999999998764 5568999998765433 34778999999998654444443332222
Q ss_pred ---ceeEEEEecc-CCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEE
Q 021855 76 ---EDNVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146 (306)
Q Consensus 76 ---~~~~lv~e~~-~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~k 146 (306)
...++++|++ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEE
Confidence 1359999999 77999988532 2458999999999999999999999999999999999999 4789999
Q ss_pred EEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHH
Q 021855 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKY 225 (306)
Q Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~ 225 (306)
|+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 188 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--- 259 (313)
T 3brb_A 188 VADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY--- 259 (313)
T ss_dssp ECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---
T ss_pred EeecCcceeccccccc-----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---
Confidence 9999999765433211 11124456788999999999999999999999999999999 89999875543222
Q ss_pred HHHhhcc-cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 226 DKICEKK-VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 226 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
....... ...+ ..+++.+.++|.+||+.||.+|||+.++++.|+.++++
T Consensus 260 ~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 260 DYLLHGHRLKQP-----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHTTCCCCCB-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCC-----ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2222221 1222 56788999999999999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=311.86 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=204.7
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--------CchhhHHHHHHHHHHhC-CCCCCcceeec
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQG-GSGIPNIKWYG 72 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~~-~~~~~~~~~~~ 72 (306)
+..+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.+ ++++..+..++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3567899999999999999999999999999999999876432 23457789999999985 67777777777
Q ss_pred eeCceeEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEee
Q 021855 73 VDGEDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (306)
Q Consensus 73 ~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Df 150 (306)
......++++|++. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++ .+++.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeC
Confidence 77888999999994 799998876 45799999999999999999999999999999999999993 26789999999
Q ss_pred ccccccCCCCCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh
Q 021855 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 229 (306)
|++........ ....++..|+|||++.+..+ +.++|||||||++|+|++|..||..... ..
T Consensus 195 g~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~~ 256 (320)
T 3a99_A 195 GSGALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------II 256 (320)
T ss_dssp TTCEECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH
T ss_pred ccccccccccc---------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------hh
Confidence 99987554322 24568999999999987665 7889999999999999999999976432 11
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
......+ ..+++.+.++|.+||+.||.+|||++++++ ..++
T Consensus 257 ~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--hp~~ 297 (320)
T 3a99_A 257 RGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWM 297 (320)
T ss_dssp HCCCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGG
T ss_pred ccccccc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc--CHhh
Confidence 2222222 567889999999999999999999999977 4444
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=334.69 Aligned_cols=271 Identities=19% Similarity=0.257 Sum_probs=209.2
Q ss_pred CCceeEee-eecccCccEEEEEEEc--CCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 6 GVKYKLGR-KIGSGSFGEIFLASHV--DTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 6 ~~~y~i~~-~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
..++.+.+ .||+|+||.||+|.+. .++..||+|++.... ....+.+|+.+++.+.| +++..+..++.. ...+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCC-TTBCCEEEEEES-SSEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEecc-CCeE
Confidence 34555666 8999999999999875 356679999987643 33568899999999976 555555444443 5689
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+||||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC-
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCcccccC
Confidence 999999 789999987655669999999999999999999999999999999999999 4889999999999986543
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
..... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..... ..+.. ....+.
T Consensus 489 ~~~~~----~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~~i~~-~~~~~~ 560 (613)
T 2ozo_A 489 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQ-GKRMEC 560 (613)
T ss_dssp -----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---HHHHT-TCCCCC
T ss_pred CCcee----eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHc-CCCCCC
Confidence 22111 11113345678999999998899999999999999999998 99999886554322 22222 212221
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCcccccee
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTI 292 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~ 292 (306)
...+++.+.++|.+||+.||++|||+.+|++.|+.++...+...+.+..+++
T Consensus 561 ---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s~lev 612 (613)
T 2ozo_A 561 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALEV 612 (613)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSSSCSC
T ss_pred ---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCccceec
Confidence 1567899999999999999999999999999999998877777666655544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=311.63 Aligned_cols=255 Identities=19% Similarity=0.220 Sum_probs=191.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeecee-------
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD------- 74 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~------- 74 (306)
+-++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.|++.+..+..+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 34689999999999999999999999999999998874432 24578899999999764444433332211
Q ss_pred -------------------------------------------------CceeEEEEecc-CCCHHHHHHHhcC--CCCH
Q 021855 75 -------------------------------------------------GEDNVLVLDLL-GPSLEDLFVYCRR--KFSL 102 (306)
Q Consensus 75 -------------------------------------------------~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~ 102 (306)
....+++|||+ +++|.+++..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 12379999999 7799999875332 2456
Q ss_pred HHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc-----cccCCccccccc
Q 021855 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-----PYRENKNLTGTA 177 (306)
Q Consensus 103 ~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 177 (306)
..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++............ .+.......+|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 6789999999999999999999999999999999 47899999999999876554321110 011223457899
Q ss_pred cccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhc
Q 021855 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQS 257 (306)
Q Consensus 178 ~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 257 (306)
.|+|||++.+..++.++|||||||++|+|++|..|+... ............ +......++.+.++|.+||+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVRNLKF----PLLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHHTTCC----CHHHHHHCHHHHHHHHHHHC
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhhccCC----CcccccCChhHHHHHHHHcc
Confidence 999999999999999999999999999999987775421 112222222211 11224446788999999999
Q ss_pred CCCCCCCChHHHHH
Q 021855 258 LTFDQRPDYGFLKR 271 (306)
Q Consensus 258 ~dP~~Rps~~~l~~ 271 (306)
.||.+|||+.++++
T Consensus 312 ~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 312 PSPTERPEATDIIE 325 (332)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CCCCcCCCHHHHhh
Confidence 99999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.01 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=206.2
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
....|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+|+.++..+.| +++..+..++......+++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEE
Confidence 45679999999999999999999999999999998875432 3557889999999866 5666666666677889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+||+ +++|.+++. ...+++..+..++.||+.||.|||+.|++||||+|+||++ +.++.++|+|||.+.......
T Consensus 99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCccc
Confidence 9999 668888876 3569999999999999999999999999999999999999 588999999999997654432
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. .....++..|+|||++.+..++.++|||||||++|+|++|..||........ ...+...... ..
T Consensus 174 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~----~~ 239 (303)
T 3a7i_A 174 IK-------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LFLIPKNNPP----TL 239 (303)
T ss_dssp CC-------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSCCC----CC
T ss_pred cc-------cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HHHhhcCCCC----CC
Confidence 21 1245688999999999999999999999999999999999999987544322 2222221111 12
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
...+++.+.++|.+||+.||.+|||+.++++ +.++..
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~ 276 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK--HKFILR 276 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT--CHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhh--Chhhhc
Confidence 2567889999999999999999999999988 455543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=314.64 Aligned_cols=259 Identities=16% Similarity=0.191 Sum_probs=201.3
Q ss_pred ccCCceeEeeeecccCccEEEEE-----EEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhC--CCCCCcceeeceeCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG--GSGIPNIKWYGVDGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~--~~~~~~~~~~~~~~~ 76 (306)
+.+++|++.+.||+|+||.||+| .+..+++.||+|++... ....+..|..++..+.+ ++++..+..++....
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 45678999999999999999999 46678999999998754 34567788888888873 344555556666777
Q ss_pred eeEEEEecc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc--------CCCcc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL--------GRKAN 143 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~--------~~~~~ 143 (306)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++. .+.++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 899999999 78999998752 456999999999999999999999999999999999999952 11179
Q ss_pred eEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHH
Q 021855 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223 (306)
Q Consensus 144 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 223 (306)
.+||+|||++.......... ......||..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGT-----IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTE-----EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred CEEEeeCchhhhhhccCCCc-----eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 99999999997543222111 11255789999999999999999999999999999999999999965432110
Q ss_pred HHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCC-ChHHHHHHHHHhHhhc
Q 021855 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSRE 280 (306)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~~~~ 280 (306)
.. ...... ...++.+.+++..||+.+|.+|+ +++++.+.|+.++.+.
T Consensus 294 ~~----~~~~~~------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 KP----EGLFRR------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EE----CSCCTT------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ee----chhccc------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00 001111 12356788999999999999995 8999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=302.88 Aligned_cols=251 Identities=10% Similarity=0.129 Sum_probs=200.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeC--ce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG--ED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--~~ 77 (306)
+.-++|++.+.||+|+||.||+|++ +++.||+|++...... ..+.+|+.+++.+.| +++..+..++... ..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH-PNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSC-TTEECEEEEECTTTSSS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CchhheEEEEccCCCCC
Confidence 4567899999999999999999998 4788999998765432 346778888888866 5555554444443 67
Q ss_pred eEEEEecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
.++++||+ +++|.+++..... .+++..++.++.||+.||.|||+.| ++||||||+||++ +.++.++|+|||.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVK 160 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSC
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccce
Confidence 89999999 6799999976433 4899999999999999999999999 9999999999999 57889999998887
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR---RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
...... ...+|+.|+|||++.+..++. ++|||||||++|+|++|..||.+.+.... ......
T Consensus 161 ~~~~~~------------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~ 225 (271)
T 3kmu_A 161 FSFQSP------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---GMKVAL 225 (271)
T ss_dssp CTTSCT------------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---HHHHHH
T ss_pred eeeccc------------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---HHHHHh
Confidence 543221 346789999999998776544 89999999999999999999987654322 222222
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...... ....+++.+.++|.+||+.||++|||+.++++.|+.+.+
T Consensus 226 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 EGLRPT---IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp SCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 222222 125678999999999999999999999999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.38 Aligned_cols=266 Identities=21% Similarity=0.248 Sum_probs=205.6
Q ss_pred cccCCceeEeeeecccCccEEEEEE----EcCCCceEEEEEccCCCCc--hhhHHHHHHHHHHhCCCCCCcceeece--e
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGV--D 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~----~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~~~~~--~ 74 (306)
.+..++|++.+.||+|++|.||+|+ +..+++.||+|++...... ..+.+|+.+++.+.|. ++..+..+.. .
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD-NIVKYKGVCYSAG 115 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCT-TBCCEEEEECC--
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEEecC
Confidence 4567789999999999999999998 4568999999998764332 3578899999999764 4444433322 2
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
....++++|++ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcch
Confidence 34689999999 779999998765669999999999999999999999999999999999999 47899999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhh------------
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK------------ 221 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~------------ 221 (306)
........... ......++..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 193 ~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 193 KVLPQDKEYYK----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp EECCSSCSEEE----CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred hhccccccccc----cccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 87654332110 11234567789999999988899999999999999999999999875321110
Q ss_pred HHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
...+...+......+ ....+++.+.++|.+||+.||++|||+.++++.|+.+.++
T Consensus 269 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 269 VFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 001111222111111 1256789999999999999999999999999999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=304.67 Aligned_cols=257 Identities=18% Similarity=0.299 Sum_probs=202.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC------CCchhhHHHHHHHHHHhCCCCCCcceeec--eeCc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYG--VDGE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~--~~~~ 76 (306)
+.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.+++.+.| +++..+..++ ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH-KNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCC
Confidence 457899999999999999999999999999999987642 233567889999999976 4454444433 3455
Q ss_pred eeEEEEeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++||+.+++.+++... ...+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEA 158 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccccc
Confidence 78999999987788877653 3458999999999999999999999999999999999999 4789999999999986
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
........ ......++..|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.. .....+.....
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENIGKGSY 230 (305)
T ss_dssp CCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCC
T ss_pred cCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHHhcCCC
Confidence 54322211 112456899999999998754 378999999999999999999999875433 23333333333
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
..+ ..+++.+.++|.+||+.||.+|||+.++++ +.++...
T Consensus 231 ~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~ 270 (305)
T 2wtk_C 231 AIP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ--HSWFRKK 270 (305)
T ss_dssp CCC-----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH--SHHHHSC
T ss_pred CCC-----CccCHHHHHHHHHHccCChhhCCCHHHHhc--CcccccC
Confidence 333 567889999999999999999999999987 5666543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=327.85 Aligned_cols=239 Identities=14% Similarity=0.120 Sum_probs=182.2
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-----CchhhHHHHHHHHHHh--CCCCCCcce-------ee
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ--GGSGIPNIK-------WY 71 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~--~~~~~~~~~-------~~ 71 (306)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++..+. .|+++..+. .+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999998899999999876331 2245678886555554 234433322 11
Q ss_pred ceeCc-----------------eeEEEEeccCCCHHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHcCcccc
Q 021855 72 GVDGE-----------------DNVLVLDLLGPSLEDLFVYCRRKFS-------LKTVLMLADQMIARIEYVHSRGFLHR 127 (306)
Q Consensus 72 ~~~~~-----------------~~~lv~e~~~~~l~~~~~~~~~~~~-------~~~~~~~~~qi~~~L~~LH~~~i~H~ 127 (306)
....+ ..+++|||++|+|.+++.... .++ +..++.++.||+.||.|||+.||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 11111 378999999999999987632 233 47888899999999999999999999
Q ss_pred CCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCC-----------CCCchhhH
Q 021855 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----------EQSRRDDL 196 (306)
Q Consensus 128 dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDi 196 (306)
||||+|||+ +.++.+||+|||++....... ....| +.|+|||++.+. .++.++||
T Consensus 231 Dikp~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 231 YLRPVDIVL---DQRGGVFLTGFEHLVRDGARV----------VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp CCCGGGEEE---CTTCCEEECCGGGCEETTCEE----------ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred CCCHHHEEE---cCCCCEEEEechhheecCCcc----------cCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999 478999999999998533211 14456 899999999987 89999999
Q ss_pred HHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 197 ESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 197 wslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
|||||++|+|++|..||.+....... ..+. .. ...+++++.++|.+||+.||++|||+.++++
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~---~~~~----~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGS---EWIF----RS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCS---GGGG----SS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCcccccccch---hhhh----hh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999999999765432211 1111 11 1566889999999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.00 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=197.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeC-----
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~----- 75 (306)
+.++|.+.+.||+|+||.||+|++..+|+.||+|++...... ..+.+|+.+++.+.|++.+..+..+....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 457899999999999999999999999999999998765433 34678999999998754444444333222
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++|++.++|.+++. ..+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC
T ss_pred eeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeecccccC
Confidence 2359999999988877663 358999999999999999999999999999999999999 5889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-- 232 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-- 232 (306)
..... ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.+.....
T Consensus 176 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 176 ADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245 (353)
T ss_dssp ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred CCCCc----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 43321 14467899999999987 678999999999999999999999998765443322222211110
Q ss_pred ---------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 233 ---------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 233 ---------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...........+++.+.++|.+||+.||++|||+.++++ +.++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~f~ 310 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT--HPFFE 310 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGT
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc--Ccchh
Confidence 011112223466889999999999999999999999987 66664
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.57 Aligned_cols=264 Identities=25% Similarity=0.322 Sum_probs=198.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhC----------CCCCCcceeec
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQG----------GSGIPNIKWYG 72 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~----------~~~~~~~~~~~ 72 (306)
+..++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++..+.+ ++++..+..++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 456799999999999999999999999999999999875432 3456789999998874 24555554443
Q ss_pred eeC----ceeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccC---CCcc
Q 021855 73 VDG----EDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLG---RKAN 143 (306)
Q Consensus 73 ~~~----~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~---~~~~ 143 (306)
... ...++++|+++++|.+++.... ..+++..+..++.||+.||.|||+. ||+||||||+|||++.. +..+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred hccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 322 2689999999999999987643 4599999999999999999999998 99999999999999421 2455
Q ss_pred eEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh---
Q 021855 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT--- 220 (306)
Q Consensus 144 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~--- 220 (306)
.+||+|||++........ ...+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.....
T Consensus 176 ~~kl~Dfg~a~~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHYT----------NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EEEECCCTTCEETTBCCC----------SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred eEEEcccccccccCCCCC----------CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 899999999976544322 4467999999999999999999999999999999999999998643211
Q ss_pred hHHHHHHHhhcccccchH-------------------------------------HHhhcCchHHHHHHHhhhcCCCCCC
Q 021855 221 KKQKYDKICEKKVSTPIE-------------------------------------VLCKSHPAEFASYFHYCQSLTFDQR 263 (306)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~li~~cl~~dP~~R 263 (306)
....+..+.......+.. .....+++.+.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111111111111010000 0112346789999999999999999
Q ss_pred CChHHHHHHHHHhHhh
Q 021855 264 PDYGFLKRLFHDLFSR 279 (306)
Q Consensus 264 ps~~~l~~~l~~~~~~ 279 (306)
||+.++++ +.++..
T Consensus 326 pt~~ell~--hp~f~~ 339 (373)
T 1q8y_A 326 ADAGGLVN--HPWLKD 339 (373)
T ss_dssp BCHHHHHT--CGGGTT
T ss_pred CCHHHHhh--Chhhhc
Confidence 99999988 666654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=307.05 Aligned_cols=266 Identities=18% Similarity=0.231 Sum_probs=198.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeece---eCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGV---DGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~---~~~~~ 78 (306)
+.+++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.|++.+..+..+.. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 45689999999999999999999999999999999875432 23457789999999877544444433321 23467
Q ss_pred EEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 79 VLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
++++||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||.+.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcch
Confidence 8999999 66999988753 4569999999999999999999999999999999999999 588999999999886
Q ss_pred ccCCCCCCcc--ccccCCccccccccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHh
Q 021855 155 KYRDPTTNRH--IPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (306)
Q Consensus 155 ~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 229 (306)
.......... ..........++..|+|||++.+.. ++.++|||||||++|+|++|..||........ ......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~ 260 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAV 260 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHHh
Confidence 5432111000 0000001234688999999998664 68899999999999999999999965322111 111112
Q ss_pred hcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
......+. ...+++.+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus 261 ~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 261 QNQLSIPQ---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HCC--CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hccCCCCc---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 22222221 1456889999999999999999999999999998774
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=314.71 Aligned_cols=261 Identities=16% Similarity=0.213 Sum_probs=200.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
...++|++.+.||+|+||.||+|++ .+++.||+|++..... ...+.+|+.+++.+.| +++..+..++......++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC-TTBCCCCEEECCSSCCEE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC-CCccceEEEEecCCceEE
Confidence 4678999999999999999999985 4688999998875432 2357889999988876 556666666667778899
Q ss_pred EEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc---CccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 81 VLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
++||+ +++|.+++.... ..+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.++|+|||++
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA 181 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCccc
Confidence 99999 779999887532 2489999999999999999999999 99999999999999 58899999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhH-HHHHHHhhcc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDKICEKK 232 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~ 232 (306)
.......... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||......... ..........
T Consensus 182 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 182 KLMDYKDTHV------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp EECCSSSSCE------ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cccCcccccc------cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 8764333221 12445899999999999888999999999999999999999999632211100 0000000000
Q ss_pred ccc----------chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 233 VST----------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 233 ~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
... .........++.+.+++.+||+.||.+|||+.++++.|+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 000 0011112335789999999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=304.64 Aligned_cols=261 Identities=21% Similarity=0.263 Sum_probs=196.2
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcC-CCc--eEEEEEccCCC-----CchhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-TNE--IVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~-~~~--~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
.+..++|++.+.||+|++|.||+|++.. +++ .||+|++.... ....+.+|+.+++.+.| +++..+..+...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~ 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLT 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEcc
Confidence 3456899999999999999999998653 333 68999876542 12457789999999976 555555444443
Q ss_pred CceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
. ..++++|++ +++|.+++......+++..++.++.||+.||.|||+.|++|+||||+||++ +.++.++|+|||++
T Consensus 93 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 93 P-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLM 168 (291)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTC
T ss_pred C-CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEcccccc
Confidence 3 488999999 789999988766679999999999999999999999999999999999999 47899999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
........... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.. .....+....
T Consensus 169 ~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~ 241 (291)
T 1u46_A 169 RALPQNDDHYV----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKIDKEG 241 (291)
T ss_dssp EECCC-CCEEE----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTSC
T ss_pred ccccccccchh----hhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHHHccC
Confidence 87654332111 1123456778999999998889999999999999999999 99999876543 2233332222
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+. ...+++.+.++|.+||+.||.+|||+.++++.|+++..
T Consensus 242 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 ERLPR---PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCC---CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 22221 25678999999999999999999999999999988754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=301.94 Aligned_cols=249 Identities=22% Similarity=0.258 Sum_probs=197.6
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeec--eeCceeE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYG--VDGEDNV 79 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~--~~~~~~~ 79 (306)
.++|++.+.||+|++|.||+|++..+++.||+|.+...... ..+.+|+.+++.+.| +++..+..++ ......+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-PNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCC-CCCCeEEEEEecCCCceEE
Confidence 46899999999999999999999999999999988754432 347789999999976 4555554333 3456789
Q ss_pred EEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCceeeccCCCcceEEEEee
Q 021855 80 LVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDF 150 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dlkp~Nilv~~~~~~~~~kl~Df 150 (306)
+++||+ +++|.+++.... ..+++..++.++.||+.||.|||+.| ++||||||+||++ +.++.++|+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecC
Confidence 999999 669999987532 34899999999999999999999999 9999999999999 58899999999
Q ss_pred ccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
|.+......... .....++..|+|||++.+..++.++|||||||++|+|++|..||...+... ....+..
T Consensus 161 g~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~~ 230 (279)
T 2w5a_A 161 GLARILNHDTSF-------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIRE 230 (279)
T ss_dssp CHHHHC---CHH-------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred chheeecccccc-------ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHHhh
Confidence 999765432211 113467899999999999999999999999999999999999998765432 2222222
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 272 (306)
..... ....+++.+.++|.+||+.||.+|||+.+|++.
T Consensus 231 ~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 231 GKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp TCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccccc----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 22211 124678899999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=327.86 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=207.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|+||.||+|++.. +..||+|++..... ...+.+|+.+++.+.|.+ +..+..+... ...+++|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK-LVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTT-BCCEEEEECS-SSCEEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCC-EeeEEEEEee-ccceEee
Confidence 456789999999999999999999865 46699999886543 356889999999998744 4444444433 5689999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCc
Confidence 999 77999998753 3458999999999999999999999999999999999999 578999999999997654221
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+ ......+.+
T Consensus 418 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i----~~~~~~~~~- 486 (535)
T 2h8h_A 418 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----ERGYRMPCP- 486 (535)
T ss_dssp H------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH----HTTCCCCCC-
T ss_pred e------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCCC-
Confidence 1 01123346778999999998899999999999999999999 99999876544322222 222222211
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
..+++.+.+||.+||+.||++|||+++|++.|+.++.....
T Consensus 487 --~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 487 --PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred --CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 56788999999999999999999999999999998865443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=311.80 Aligned_cols=270 Identities=24% Similarity=0.300 Sum_probs=203.5
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHH-hCCCCCCcceeeceeCc----e
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSGIPNIKWYGVDGE----D 77 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~----~ 77 (306)
+.+.++|++.+.||+|+||.||+|++ +++.||+|++... ....+.+|..++..+ ..|+++..+..++.... .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 34668999999999999999999987 5899999998643 234567788888873 23456655554444443 7
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCccccCCCCCceeeccCCCcceEEEE
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH--------SRGFLHRDIKPDNFLMGLGRKANQVYII 148 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--------~~~i~H~dlkp~Nilv~~~~~~~~~kl~ 148 (306)
.++++||+ +++|.+++.. ..+++..++.++.|++.||.||| +.||+||||||+|||+ +.++.+||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~ 189 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 189 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEEC
T ss_pred eEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEE
Confidence 89999999 6699999874 46899999999999999999999 8999999999999999 578999999
Q ss_pred eeccccccCCCCCCccccccCCccccccccccCcccccCCC------CCchhhHHHHHHHHHHHHhC----------CCC
Q 021855 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRG----------SLP 212 (306)
Q Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~sDiwslG~il~~l~tg----------~~p 212 (306)
|||++............ ......+++.|+|||++.+.. ++.++|||||||++|+|++| ..|
T Consensus 190 Dfg~~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp CCTTCEEEETTTTEEEE---CCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred ECCCceecccccccccc---ccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999766543321100 112457899999999998763 34789999999999999999 789
Q ss_pred CCCchhhh--hHHHHHHHhhcccccchHH--HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 213 WQGLKAAT--KKQKYDKICEKKVSTPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 213 f~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
|....... .................+. ....+++.+.++|.+||+.||++|||+.++++.|+.+.++.+.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~~ 341 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 341 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC--
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcCC
Confidence 87643221 1112222222222222111 11234567999999999999999999999999999999877653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=304.07 Aligned_cols=256 Identities=20% Similarity=0.317 Sum_probs=184.6
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchh---hHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
-++|++.+.||+|+||.||+|++..+++.||+|++........ ...|...+.....|+++..+..++......++++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 3578999999999999999999999999999999876544322 2333333333334577777777777788899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|++++.+..+.......+++..++.++.||+.||.|||+. |++||||||+||++ +.++.+||+|||++........
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCcc
Confidence 9997777777766566799999999999999999999996 99999999999999 5889999999999876543322
Q ss_pred CccccccCCccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
. ....++..|+|||++. +..++.++|||||||++|+|++|..||...... ...+...........
T Consensus 181 ~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 181 K--------DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQEEPPLL 250 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHHSCCCCC
T ss_pred c--------cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHhccCCCCC
Confidence 1 2446889999999995 456889999999999999999999999763321 222333333322211
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
. ....+++++.++|.+||+.||.+|||++++++ +.+++
T Consensus 251 ~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~ 288 (318)
T 2dyl_A 251 P--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE--HSFIK 288 (318)
T ss_dssp C--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHH
T ss_pred C--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh--CHHHH
Confidence 1 11356889999999999999999999999987 45554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=307.29 Aligned_cols=255 Identities=19% Similarity=0.288 Sum_probs=179.8
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch---hhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+..++|++.+.||+|+||.||+|.+..+++.||+|++....... .+..|...+.+...|+++..+..++......++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 45688999999999999999999999999999999987654322 344455533333455777777777777788999
Q ss_pred EEeccCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 81 VLDLLGPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 81 v~e~~~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
++|++.++|.+++.. ....+++..+..++.|++.||.|||+. ||+||||||+||++ +.++.+||+|||++..
T Consensus 99 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC
T ss_pred EEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCcee
Confidence 999998898888764 245689999999999999999999999 99999999999999 4889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTH----LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
....... ....++..|+|||++ .+..++.++|||||||++|+|++|..||...... ..........
T Consensus 176 ~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~ 245 (327)
T 3aln_A 176 LVDSIAK--------TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKG 245 (327)
T ss_dssp --------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCS
T ss_pred ccccccc--------ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcC
Confidence 5433221 134688999999998 4566899999999999999999999999864321 1112222222
Q ss_pred ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
............+++.+.++|.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 2111111122457889999999999999999999999977
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=300.27 Aligned_cols=258 Identities=24% Similarity=0.294 Sum_probs=198.2
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC------CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
|...+.||+|++|.||+|++ +++.||+|.+.... ....+.+|+.+++.+.| +++..+..++......++++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH-ENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC-CCeEEEEEEEecCCceEEEE
Confidence 34458999999999999986 67889999876432 12457789999999976 66666666666777899999
Q ss_pred ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 83 DLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 83 e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
|++ +++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence 999 88999988743 3458999999999999999999999999999999999999 58899999999998765433
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccc---
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP--- 236 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 236 (306)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|..||...........+...........
T Consensus 187 ~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 187 AQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp SSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred cccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 2211 1124568999999998875 588999999999999999999999987543322222222111111100
Q ss_pred ----hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 237 ----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 237 ----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
........++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 011112345779999999999999999999999999998753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=329.37 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=204.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCC---CceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+..++|++.+.||+|+||.||+|++..+ +..||+|.+...... ..+.+|+.+++.+.| +++..+..++. +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVIT-ENP 464 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SSS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEe-cCc
Confidence 4457899999999999999999998643 457999987654332 457789999999977 44545544443 456
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.+++|||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCeec
Confidence 89999999 789999998755579999999999999999999999999999999999999 47899999999999865
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....... ..+.... ..
T Consensus 542 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i~~~~-~~ 611 (656)
T 2j0j_A 542 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGE-RL 611 (656)
T ss_dssp CC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHHTC-CC
T ss_pred CCCcce------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHcCC-CC
Confidence 433221 1123456778999999998899999999999999999997 99999876544322 2222221 11
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
+ ....+++.+.++|.+||+.||++|||+.+|++.|+++++.+
T Consensus 612 ~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 P---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1 12567899999999999999999999999999999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=302.58 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=194.3
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--------CchhhHHHHHHHHHHh---CCCCCCcceee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQ---GGSGIPNIKWY 71 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~---~~~~~~~~~~~ 71 (306)
..+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++..+. .|+++..+..+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 456789999999999999999999999999999999986543 2234667999999995 45667777666
Q ss_pred ceeCceeEEEEec-c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEe
Q 021855 72 GVDGEDNVLVLDL-L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 72 ~~~~~~~~lv~e~-~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
+......++++|+ + +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++ ..++.++|+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEE
Confidence 6677788999998 4 7899999876 45699999999999999999999999999999999999993 2688999999
Q ss_pred eccccccCCCCCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 021855 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 228 (306)
||++........ ....++..|+|||++.+..+ +.++|||||||++|+|++|..||..... .
T Consensus 184 fg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~ 245 (312)
T 2iwi_A 184 FGSGALLHDEPY---------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------I 245 (312)
T ss_dssp CSSCEECCSSCB---------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H
T ss_pred cchhhhcccCcc---------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------H
Confidence 999987554322 24568899999999887665 4589999999999999999999976321 1
Q ss_pred hhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.......+ ..+++.+.++|.+||+.||++|||+.++++ +.++.
T Consensus 246 ~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--~~~~~ 288 (312)
T 2iwi_A 246 LEAELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILL--DPWMQ 288 (312)
T ss_dssp HHTCCCCC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH--STTTC
T ss_pred hhhccCCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhc
Confidence 12222222 556889999999999999999999999987 45543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=298.92 Aligned_cols=249 Identities=20% Similarity=0.243 Sum_probs=194.3
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CCCH
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSL 89 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l 89 (306)
..||+|+||.||+|++..+++.||+|.+..... ...+.+|+.+++.+.| +++..+..++......++++|++ +++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCC-CCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 399999999999999999999999998765432 3557889999998876 55666666667778899999999 7899
Q ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccccc
Q 021855 90 EDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (306)
Q Consensus 90 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (306)
.+++..... .+++..++.++.||+.||.|||+.|++|+||||+||+++ ..++.++|+|||.+.........
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~----- 179 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINPC----- 179 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC---------
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCCc-----
Confidence 999876433 366888999999999999999999999999999999994 23889999999999765432211
Q ss_pred cCCccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCc
Q 021855 168 RENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (306)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (306)
.....++..|+|||++.+.. ++.++||||||+++|+|++|..||..................... ....++
T Consensus 180 --~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 252 (295)
T 2clq_A 180 --TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE-----IPESMS 252 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC-----CCTTSC
T ss_pred --ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc-----ccccCC
Confidence 12456899999999997654 889999999999999999999999764332211111111111111 225678
Q ss_pred hHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 246 AEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 246 ~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+.+.++|.+||+.||++|||+.++++ +.++.
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~ 283 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLV--DEFLK 283 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHT--SGGGC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc--Chhhh
Confidence 89999999999999999999999977 55554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=306.41 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=185.4
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
+..++|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+..++......++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH-PNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCC-TTBCCEEEEEESSSCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCC-CCEeeEEEEEeecCCcEE
Confidence 45789999999999999999999998899999999876532 23456778888888765 566666666667778999
Q ss_pred EEecc-CCCHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 81 VLDLL-GPSLEDLFVYC-------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
++||+ +++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||.
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccc
Confidence 99999 78999988642 3458999999999999999999999999999999999999 5889999999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
+........... ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||......... ......
T Consensus 168 ~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~ 242 (303)
T 2vwi_A 168 SAFLATGGDITR--NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQN 242 (303)
T ss_dssp HHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHTS
T ss_pred hheeccCCCccc--hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhcc
Confidence 876543221110 001124568999999999876 46899999999999999999999999875443221 112222
Q ss_pred ccccc-----hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 232 KVSTP-----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 232 ~~~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..... .......+++.+.++|.+||+.||.+|||+.++++ +.++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~~~ 292 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR--HKFFQ 292 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT--STTC-
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh--Chhhh
Confidence 11111 11122456889999999999999999999999987 44443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=307.33 Aligned_cols=272 Identities=17% Similarity=0.232 Sum_probs=197.5
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
.+..++|++.+.||+|++|.||+|++.. .+++|++.... ....+.+|+.+++.+.| +++..+..++......
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH-ENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCC-TTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCCce
Confidence 3556899999999999999999998853 48999876432 23456788889988876 5555565566677789
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++++|++ +++|.+++......+++..++.++.||+.||.|||+.|++||||||+||++ +++.++|+|||++....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~----~~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE----C--CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE----eCCCEEEeecCCccccc
Confidence 9999999 689999987655569999999999999999999999999999999999999 36799999999986543
Q ss_pred CCCCCccccccCCccccccccccCcccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG---------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 228 (306)
....... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||....... .....
T Consensus 181 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~ 255 (319)
T 2y4i_B 181 VLQAGRR--EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---IIWQM 255 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---HHHHH
T ss_pred ccccccc--ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHh
Confidence 2211110 011224468899999999875 357899999999999999999999998755432 22222
Q ss_pred hhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccc
Q 021855 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290 (306)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 290 (306)
.....+.. ....+++.+.++|.+||+.||.+|||+.++++.|+.+..+......-...|
T Consensus 256 ~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~ 314 (319)
T 2y4i_B 256 GTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314 (319)
T ss_dssp HTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred ccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence 22221111 113568899999999999999999999999999999987665544444444
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=309.69 Aligned_cols=271 Identities=17% Similarity=0.220 Sum_probs=190.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHH--HHhCCCCCCccee-----eceeCc
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK--ILQGGSGIPNIKW-----YGVDGE 76 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~--~l~~~~~~~~~~~-----~~~~~~ 76 (306)
+.-++|++.+.||+|+||.||+|++ +++.||+|++.... ...+..|..+.. .+.| +++..+.. ......
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h-~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEH-DNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccC-cchhhheecccccccCCCc
Confidence 4567899999999999999999977 68899999886432 233344444432 3444 44444432 222344
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CccccCCCCCceeeccCCCcceEE
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---------GFLHRDIKPDNFLMGLGRKANQVY 146 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---------~i~H~dlkp~Nilv~~~~~~~~~k 146 (306)
..+++|||+ +++|.+++.. ...++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEE
Confidence 678999999 7899999874 3468899999999999999999999 99999999999999 4789999
Q ss_pred EEeeccccccCCCCCCcc-ccccCCccccccccccCcccccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCchh
Q 021855 147 IIDFGLAKKYRDPTTNRH-IPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (306)
Q Consensus 147 l~Dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~ 218 (306)
|+|||++........... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654322110 00111224568999999999987 3566789999999999999999777644221
Q ss_pred hhhH--------------HHHHHHh-hcccccchHHHh---hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 219 ATKK--------------QKYDKIC-EKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 219 ~~~~--------------~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
.... ....... ........+... ..+++.+.++|.+||+.||++|||+.++++.|+.++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1110 0000111 011111111100 113457999999999999999999999999999999755
Q ss_pred CCC
Q 021855 281 GYD 283 (306)
Q Consensus 281 ~~~ 283 (306)
.-+
T Consensus 321 ~~~ 323 (336)
T 3g2f_A 321 ERN 323 (336)
T ss_dssp CC-
T ss_pred Hhc
Confidence 444
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=327.59 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=196.1
Q ss_pred eeecccCccEEEEEEE--cCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSGSFGEIFLASH--VDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~--~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+.||+|+||.||+|.+ ..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++. ....+++|||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCC-TTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe-cCCEEEEEEccC
Confidence 4899999999999955 45678899998875432 2468889999999986 55555544443 44588999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..........
T Consensus 453 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~-- 526 (635)
T 4fl3_A 453 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYY-- 526 (635)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccCcccc--
Confidence 7899999875 5569999999999999999999999999999999999999 488999999999998765432211
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. ....... ...+
T Consensus 527 --~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~----~~~~~~~---p~~~ 597 (635)
T 4fl3_A 527 --KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE----KGERMGC---PAGC 597 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----TTCCCCC---CTTC
T ss_pred --ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----cCCCCCC---CCCC
Confidence 11123346778999999999999999999999999999998 999998866543222222 2222221 1567
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
|+++.++|.+||+.||++|||+.+|++.|++++.+
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999998753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=298.23 Aligned_cols=258 Identities=19% Similarity=0.224 Sum_probs=189.3
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeec-----------
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYG----------- 72 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~----------- 72 (306)
+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.|++.+..+..+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4578999999999999999999999999999999886432 2245778999999987644444333221
Q ss_pred -eeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEee
Q 021855 73 -VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (306)
Q Consensus 73 -~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Df 150 (306)
......++++|++ +++|.+++......+++..++.++.||+.||.|||++|++||||||+||++ +.++.++|+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeC
Confidence 1245679999999 679999998655568899999999999999999999999999999999999 58899999999
Q ss_pred ccccccCCCCCCcc-------ccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhH
Q 021855 151 GLAKKYRDPTTNRH-------IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222 (306)
Q Consensus 151 g~~~~~~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~ 222 (306)
|.+........... ..........++..|+|||++.+. .++.++|||||||++|+|++ ||...... .
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--~ 235 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--V 235 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--H
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--H
Confidence 99976543211000 000112245688999999999865 68999999999999999998 66542221 1
Q ss_pred HHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.............+ +......++.+.++|.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKKLRSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHSTTCCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccccccccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 22222222222222 2233556778999999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=294.37 Aligned_cols=249 Identities=20% Similarity=0.201 Sum_probs=189.4
Q ss_pred CCceeEe-eeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeecee----CceeEE
Q 021855 6 GVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVL 80 (306)
Q Consensus 6 ~~~y~i~-~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~~~~l 80 (306)
-++|.+. +.||+|+||.||+|++..+++.||+|++.. .....+|+.++.++.+|+++..+..++.. ....++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 3456666 889999999999999999999999999864 35677899888777677777777555443 567899
Q ss_pred EEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 81 VLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++..+.++.++|+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 99999 679999988643 359999999999999999999999999999999999999633337899999999985421
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH-HHhhcccccch
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD-KICEKKVSTPI 237 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~ 237 (306)
+..++.++|||||||++|+|++|..||............. .........+
T Consensus 172 ----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 222 (299)
T 3m2w_A 172 ----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP- 222 (299)
T ss_dssp ----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC-
T ss_pred ----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC-
Confidence 1346779999999999999999999997754322111111 1111111122
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCcccc
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFD 289 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~ 289 (306)
......+++++.++|.+||+.||.+|||+.++++ +.++.+.......++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--hp~~~~~~~~~~~~~~ 272 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQSTKVPQTPLH 272 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHTGGGSCCCBCS
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc--ChhhcccccCCCCCCc
Confidence 2223567899999999999999999999999988 7777655555454443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=307.36 Aligned_cols=257 Identities=16% Similarity=0.240 Sum_probs=202.1
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-------------------hhhHHHHHHHHHHhCCC
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------------------PQLLYEAKVYKILQGGS 63 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~~e~~~l~~l~~~~ 63 (306)
.+..++|++.+.||+|++|.||+|++ +++.||+|++...... ..+.+|+.++..+.| +
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ 103 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN-E 103 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC-T
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC-C
Confidence 44568999999999999999999998 8999999987632110 668889999999976 5
Q ss_pred CCCcceeeceeCceeEEEEecc-CCCHHHH------HHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCce
Q 021855 64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDL------FVYC-RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNF 134 (306)
Q Consensus 64 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~------~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Ni 134 (306)
++..+..++......+++|||+ +++|.++ +... ...+++..++.++.||+.||.|||+ .|++||||+|+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 5666666666778899999999 5699887 4432 3468999999999999999999999 9999999999999
Q ss_pred eeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCC-CCCc-hhhHHHHHHHHHHHHhCCCC
Q 021855 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSR-RDDLESLGYVLLYFLRGSLP 212 (306)
Q Consensus 135 lv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~sDiwslG~il~~l~tg~~p 212 (306)
++ +.++.++|+|||.+........ ....++..|+|||++.+. .++. ++|||||||++|+|++|..|
T Consensus 184 l~---~~~~~~kl~dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 184 LM---DKNGRVKLSDFGESEYMVDKKI---------KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp EE---CTTSCEEECCCTTCEECBTTEE---------CSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred EE---cCCCcEEEeccccccccccccc---------cCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 99 5889999999999976543311 245688999999999887 5665 99999999999999999999
Q ss_pred CCCchhhhhHHHHHHHhhcccccch--------------HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 213 WQGLKAATKKQKYDKICEKKVSTPI--------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
|...... ......+.......+. ......+++.+.++|.+||+.||.+|||+.++++ +.++.
T Consensus 252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~--hp~f~ 327 (348)
T 2pml_X 252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK--HEWLA 327 (348)
T ss_dssp SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGT
T ss_pred CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc--Ccccc
Confidence 9875431 2223333333222221 1111457889999999999999999999999987 55554
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=312.98 Aligned_cols=255 Identities=18% Similarity=0.168 Sum_probs=189.0
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~ 85 (306)
..+|.+.+.||+|+||.|+. +...+++.||||++.... .....+|+.+++.+..|+++..+...+.+....+++||++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 45799999999999999664 334578999999886543 3457789999999966677777777777888899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC--CcceEEEEeeccccccCCCCCCc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~--~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+++|.+++.......+...++.++.||+.||.|||+.||+||||||+|||++..+ ....++|+|||++..........
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 180 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence 9999999886554566666788999999999999999999999999999995332 34468899999998765432210
Q ss_pred cccccCCccccccccccCccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 164 HIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.......||+.|+|||++. ...++.++|||||||++|+|++ |..||....... ...... ........
T Consensus 181 ----~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~~~-~~~~~~~~ 251 (432)
T 3p23_A 181 ----SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILLG-ACSLDCLH 251 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHHTT-CCCCTTSC
T ss_pred ----eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHHhc-cCCccccC
Confidence 1123457899999999998 4567889999999999999999 999996543221 111111 11111000
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.....+..+.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 01223556889999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=310.41 Aligned_cols=260 Identities=21% Similarity=0.190 Sum_probs=190.6
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
.+.+++.|.+.+.||+|+||+||.+. ..+|+.||+|++.... ...+.+|+.++..+.+|+++..+...+......+++
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 45678889999999999999998653 4579999999876532 345678999999886667787777777788889999
Q ss_pred EeccCCCHHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC----------CCcceE
Q 021855 82 LDLLGPSLEDLFVYCRRK------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----------RKANQV 145 (306)
Q Consensus 82 ~e~~~~~l~~~~~~~~~~------~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~----------~~~~~~ 145 (306)
+|+++++|.+++...... .++..++.++.||+.||.|||+.||+||||||+|||++.. +..+.+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 999999999998753211 1222356799999999999999999999999999999522 235689
Q ss_pred EEEeeccccccCCCCCCccccccCCccccccccccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 021855 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (306)
Q Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~t-g~~pf~~~~ 217 (306)
||+|||++........... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||....
T Consensus 168 kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999987654322110 01124578999999999976 568999999999999999999 999997643
Q ss_pred hhhhHHHHHHHhhcccccc--hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 218 AATKKQKYDKICEKKVSTP--IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
... . .+.......+ .......+++++.++|.+||+.||.+|||+.++++
T Consensus 245 ~~~--~---~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRE--S---NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THH--H---HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhH--H---HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 321 1 1222221111 01011234678999999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=289.30 Aligned_cols=235 Identities=12% Similarity=0.076 Sum_probs=187.1
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+++++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+..+..+.| +++..+..++...+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK-PGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCC-CCcceeeEEEEECCcE
Confidence 7889999999999999999999999999999999998866443 457888888888866 5666677777778889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+++|||+ +++|.+++.. ......+..++.||+.||.|||+.||+||||||+|||+ +.++.++|++++
T Consensus 107 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA------ 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC------
T ss_pred EEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc------
Confidence 9999999 6799998853 34666788899999999999999999999999999999 478888887432
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
|++ .++.++|||||||++|+|++|..||.+.+.........+..... ..+.
T Consensus 175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~ 225 (286)
T 3uqc_A 175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ-PIEP 225 (286)
T ss_dssp ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSC-BCCH
T ss_pred ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccC-CCCh
Confidence 122 36789999999999999999999998755432111111111111 2223
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcC
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~ 281 (306)
......+++.+.++|.+||+.||.+| |+.++++.|+.+.....
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 34456789999999999999999999 99999999999876443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=309.99 Aligned_cols=239 Identities=15% Similarity=0.135 Sum_probs=183.5
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcce------------
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIK------------ 69 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~------------ 69 (306)
..|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.++..+.|..++..+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458899999999999999999999999999998873322 345778888888776633211100
Q ss_pred ---------eece-----eCceeEEEEeccCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC
Q 021855 70 ---------WYGV-----DGEDNVLVLDLLGPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129 (306)
Q Consensus 70 ---------~~~~-----~~~~~~lv~e~~~~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl 129 (306)
.... .....+++++.++++|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 0011 12346888898999999998532 234778889999999999999999999999999
Q ss_pred CCCceeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccc----------cCCCCCchhhHHHH
Q 021855 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH----------LGIEQSRRDDLESL 199 (306)
Q Consensus 130 kp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~sDiwsl 199 (306)
||+|||+ +.++.+||+|||++....... ....| +.|+|||++ .+..++.++|||||
T Consensus 238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~~----------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVL---DQRGGVFLTGFEHLVRDGASA----------VSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTEEE----------CCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccceEEE---ecCCeEEEEeccceeecCCcc----------ccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999 588899999999987644321 14456 899999999 55568899999999
Q ss_pred HHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 200 GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 200 G~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
||++|+|++|+.||........ ...+.. . +..+|+.+.++|.+||+.||.+|||+.++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~---~~~~~~----~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG---SEWIFR----S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC---SGGGGS----S-----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhhh---HHHHHh----h-----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999999987543221 111111 1 1456889999999999999999999777644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=312.76 Aligned_cols=264 Identities=17% Similarity=0.212 Sum_probs=194.4
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeece------eCc
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV------DGE 76 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~------~~~ 76 (306)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.+++.+.|+ ++..+..+.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~Hp-nIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP-NVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBT-TBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCC-CCCceeeeecccccccCCC
Confidence 4789999999999999999999999999999998875433 23477899999999774 4444433322 256
Q ss_pred eeEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
..++++||+ +++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||+++.......++|+|||.+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 779999999 8899999875332 5889999999999999999999999999999999999963334456999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHH----------
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ---------- 223 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~---------- 223 (306)
......... ....++..|+|||++.+..++.++|||||||++|+|++|..||.+........
T Consensus 172 ~~~~~~~~~--------~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 172 KELDQGELC--------TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CBTTSCCCC--------CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred ccccccccc--------ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 876543321 24578999999999999999999999999999999999999997532111000
Q ss_pred -HHHHHhhcccc-----cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHH-----HHHHHHHhHh
Q 021855 224 -KYDKICEKKVS-----TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF-----LKRLFHDLFS 278 (306)
Q Consensus 224 -~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~-----l~~~l~~~~~ 278 (306)
.......+... .........+++.+.++|.+||+.||++|||+.+ ..+.++.++.
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00000000000 0011122446788999999999999999999988 4566666664
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=314.50 Aligned_cols=243 Identities=16% Similarity=0.210 Sum_probs=189.4
Q ss_pred CcccCCceeEeeeecccCccEEEEEEEcC-CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 2 ~~~~~~~y~i~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+.++.++|++.+.||+|+||.||+|++.. +++.||+|++...... ..+.+|+.++..+.| ++++.+..++.....
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH-PSIVQIFNFVEHTDR 153 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEEECT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCC-CCcCeEeeeEeecCC
Confidence 35678999999999999999999999975 7899999988754332 346788889998876 555555544443333
Q ss_pred -----eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeec
Q 021855 78 -----NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (306)
Q Consensus 78 -----~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg 151 (306)
.|+||||+ +++|.+.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++ . +.+||+|||
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG 226 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLG 226 (681)
T ss_dssp TSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCT
T ss_pred CCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEecc
Confidence 69999999 678877654 2699999999999999999999999999999999999994 3 489999999
Q ss_pred cccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc
Q 021855 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
++...... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.....
T Consensus 227 ~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------- 283 (681)
T 2pzi_A 227 AVSRINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------- 283 (681)
T ss_dssp TCEETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------
T ss_pred cchhcccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------
Confidence 99865443 1456899999999987654 889999999999999999999987632110
Q ss_pred ccccchHHHhhcCchHHHHHHHhhhcCCCCCCC-ChHHHHHHHHHhHh
Q 021855 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFS 278 (306)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~~ 278 (306)
.....+. ...++.+.++|.+||+.||.+|| +++++.+.|..++.
T Consensus 284 -~~~~~~~--~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 -LPEDDPV--LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -CCTTCHH--HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -ccccccc--cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000010 12357899999999999999999 67778777776653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=286.83 Aligned_cols=239 Identities=21% Similarity=0.158 Sum_probs=179.9
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----------hhhHHHHHHHHHHh--------CCCCCC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------PQLLYEAKVYKILQ--------GGSGIP 66 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~e~~~l~~l~--------~~~~~~ 66 (306)
..++|++.+.||+|+||.||+|++ +++.||+|++...... ..+.+|+.+++.+. .|+++.
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999998 7899999988754321 56788999999997 344443
Q ss_pred cceee-----------------ce-------------eCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 021855 67 NIKWY-----------------GV-------------DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115 (306)
Q Consensus 67 ~~~~~-----------------~~-------------~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~ 115 (306)
.+... +. .....++||||+ +|++.+.+. ...+++..++.++.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHH
Confidence 33211 11 267899999998 665655553 3568999999999999999
Q ss_pred HHHHH-HcCccccCCCCCceeeccCCCcc--------------------eEEEEeeccccccCCCCCCccccccCCcccc
Q 021855 116 IEYVH-SRGFLHRDIKPDNFLMGLGRKAN--------------------QVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174 (306)
Q Consensus 116 L~~LH-~~~i~H~dlkp~Nilv~~~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (306)
|.||| ++||+||||||+|||++ .++ .+||+|||+|+..... ...
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~---~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~ 238 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLK---KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVV 238 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEE---ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEE
T ss_pred HHHHHHhCCEeECCCCHHHEEEe---ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEE
Confidence 99999 99999999999999995 444 8999999999865431 347
Q ss_pred ccccccCcccccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCchhhhhHHHHHHHhhc--ccccchHHHhhcCchHHHHH
Q 021855 175 GTARYASCNTHLGIEQSRRDDLESLGYV-LLYFLRGSLPWQGLKAATKKQKYDKICEK--KVSTPIEVLCKSHPAEFASY 251 (306)
Q Consensus 175 ~~~~y~aPE~~~~~~~~~~sDiwslG~i-l~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l 251 (306)
||+.|+|||++.+.. +.++||||+|++ .+++++|..||.+.... .......... ....+.......+++++.+|
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhhhhhhccCcccchhhhhhcCHHHHHH
Confidence 899999999999876 899999998777 77888999999652210 0111121111 11111122335678899999
Q ss_pred HHhhhcCCCCCCCChHHHH
Q 021855 252 FHYCQSLTFDQRPDYGFLK 270 (306)
Q Consensus 252 i~~cl~~dP~~Rps~~~l~ 270 (306)
|.+||++| |+++++
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999987 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=253.47 Aligned_cols=184 Identities=16% Similarity=0.113 Sum_probs=129.0
Q ss_pred eecccCccEEEEEEEcCCCceEEEEEccCCCC------------chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 14 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
....|+.+.+..++...+|+.+++|++..... ..++.+|+.+++++.++++++.+..++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34566666666666667899999998865421 235788999999998889999999999999999999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ |++|.+.+.. .+++++. .++.||+.||.|+|++||+||||||+|||+ +.+|.+||+|||+++......
T Consensus 321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCC
Confidence 9999 8899999976 4567764 478999999999999999999999999999 588999999999998765443
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p 212 (306)
.. ....+||+.|+|||++.+. +..++|+||+|++++.+.++..+
T Consensus 394 ~~-------~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SW-------PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC-------SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cc-------ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 31 2356899999999999864 56789999999998876655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=214.56 Aligned_cols=187 Identities=19% Similarity=0.178 Sum_probs=137.6
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----------hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
-.+.||+|+||.||+|.. .++.+++|........ ..+.+|+.+++++.| +++.....++......++
T Consensus 340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKD-FGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGG-GTCCCCCEEEEETTTTEE
T ss_pred CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCC-CCcCceEEEEEeCCccEE
Confidence 356899999999999954 5778899875543221 236889999999977 555544555556777899
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
+|||+ +++|.+++.. +..++.||+.||.|||++||+||||||+|||++ . .+||+|||+++.....
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCH
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCc
Confidence 99999 6899888763 567999999999999999999999999999994 4 9999999999876543
Q ss_pred CCCccccccCCccccccccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQ 214 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~ 214 (306)
.......+.......||+.|+|||++.. ..|+..+|+||..+-..+-..++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2111000001135679999999999986 457788999999988888888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=182.18 Aligned_cols=131 Identities=21% Similarity=0.322 Sum_probs=102.7
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--------------------chhhHHHHHHHHHHhCCCCCC
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------------------HPQLLYEAKVYKILQGGSGIP 66 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--------------------~~~~~~e~~~l~~l~~~~~~~ 66 (306)
..|.+.+.||+|++|.||+|++ .+|+.||+|++..... ...+.+|+.+++.+.+ +.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 3456679999999999999999 8899999998864321 2346789999999982 33
Q ss_pred cceeeceeCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceE
Q 021855 67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (306)
Q Consensus 67 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~ 145 (306)
....+ .....+++|||+ +++|.+ +. . .....++.|++.||.|||+.||+||||||+|||+ + ++.+
T Consensus 166 v~~~~--~~~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~v 231 (282)
T 1zar_A 166 VPKVY--AWEGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGI 231 (282)
T ss_dssp SCCEE--EEETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEE
T ss_pred cCeEE--eccceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcE
Confidence 22322 224579999999 668877 31 1 2345699999999999999999999999999999 5 8999
Q ss_pred EEEeeccccc
Q 021855 146 YIIDFGLAKK 155 (306)
Q Consensus 146 kl~Dfg~~~~ 155 (306)
+|+|||++..
T Consensus 232 kl~DFG~a~~ 241 (282)
T 1zar_A 232 WIIDFPQSVE 241 (282)
T ss_dssp EECCCTTCEE
T ss_pred EEEECCCCeE
Confidence 9999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=161.83 Aligned_cols=136 Identities=22% Similarity=0.281 Sum_probs=104.7
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCce--EEEEEccCCCCc--------------------------hhhHHHHHHHHHH
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTKH--------------------------PQLLYEAKVYKIL 59 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~--vaiK~~~~~~~~--------------------------~~~~~e~~~l~~l 59 (306)
-|++.+.||+|++|.||+|.+..+|+. ||+|++...... ..+.+|..++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778888 999986543110 1467899999999
Q ss_pred hCCC-CCCcceeeceeCceeEEEEeccC--C----CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCC
Q 021855 60 QGGS-GIPNIKWYGVDGEDNVLVLDLLG--P----SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKP 131 (306)
Q Consensus 60 ~~~~-~~~~~~~~~~~~~~~~lv~e~~~--~----~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dlkp 131 (306)
.+.. .++.+... ...+++|||++ | +|.+.... .++..+..++.|++.||.+|| +.||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8753 23333222 35789999994 3 56555321 234567789999999999999 99999999999
Q ss_pred CceeeccCCCcceEEEEeecccccc
Q 021855 132 DNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 132 ~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.|||++ . .++|+|||+|...
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEET
T ss_pred HHEEEc---C--cEEEEECcccccC
Confidence 999994 3 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5e-17 Score=142.15 Aligned_cols=134 Identities=22% Similarity=0.313 Sum_probs=94.9
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----------------Cch--------hhHHHHHHHHHHhCCC
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------------KHP--------QLLYEAKVYKILQGGS 63 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----------------~~~--------~~~~e~~~l~~l~~~~ 63 (306)
-|++...||.|++|.||+|.+. +|+.||||++.... ... ...+|...+.++.+ .
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~-~ 173 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE-E 173 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH-T
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh-c
Confidence 3899999999999999999974 68999999865321 000 12346677777754 3
Q ss_pred CCCcceeeceeCceeEEEEeccC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc
Q 021855 64 GIPNIKWYGVDGEDNVLVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (306)
Q Consensus 64 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~ 142 (306)
+++....+.. ...+++|||++ .+|..+. +.+....++.||+.+|.+||+.||+||||||.|||++ ++
T Consensus 174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~---~d 241 (397)
T 4gyi_A 174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR---EE 241 (397)
T ss_dssp TCSCCCEEEE--ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---EE
T ss_pred CCCCCeeeec--cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe---CC
Confidence 3333322222 23479999994 4553321 1123456789999999999999999999999999995 33
Q ss_pred c----------eEEEEeeccccc
Q 021855 143 N----------QVYIIDFGLAKK 155 (306)
Q Consensus 143 ~----------~~kl~Dfg~~~~ 155 (306)
+ .+.++||+-+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 3 488999998765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=9.4e-12 Score=104.16 Aligned_cols=137 Identities=17% Similarity=0.194 Sum_probs=104.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC--CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
..|++...++.|+.+.||++.. .++.+++|+.... .....+.+|..+++.+..+..++.+..++...+..+++||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 3589999999899999999974 3678999987642 23346888999999997656677777777777889999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------------------------------ 121 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~------------------------------------------ 121 (306)
+ |.++.+.+. +......++.+++.+|..||+
T Consensus 92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9 556655421 112234677899999999998
Q ss_pred -----------------cCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 122 -----------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 122 -----------------~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
..++|||++|.||++. +...+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4589999999999993 44455699998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=1.1e-10 Score=97.19 Aligned_cols=133 Identities=17% Similarity=0.106 Sum_probs=93.1
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCC-CCcceeeceeCceeEEEEeccC
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLG 86 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~~~~~~~~~~~~lv~e~~~ 86 (306)
.|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|..+++.+.++.. ++.+..++...+..+++||++.
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 466655444566689999964 45677999987654 33567889999999987633 5555555656667899999994
Q ss_pred C-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 021855 87 P-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG------------------------------------------ 123 (306)
Q Consensus 87 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~------------------------------------------ 123 (306)
| ++ + . . ..+. ..++.+++..|..||+..
T Consensus 99 G~~l-~-~---~-~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 99 GQDL-L-S---S-HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp SEET-T-T---S-CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred Cccc-C-c---C-cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 4 55 3 1 1 1222 245667777777777643
Q ss_pred ----------------ccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 124 ----------------FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 124 ----------------i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
++|||++|.||+++ +++.+.|+||+.+.
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999993 45556699999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=2.6e-09 Score=93.41 Aligned_cols=138 Identities=14% Similarity=0.191 Sum_probs=97.2
Q ss_pred eEeeeecccCccEEEEEEEcCCCceEEEEEcc--CCC---CchhhHHHHHHHHHHhCCC-CCCcceeeceeC---ceeEE
Q 021855 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGT---KHPQLLYEAKVYKILQGGS-GIPNIKWYGVDG---EDNVL 80 (306)
Q Consensus 10 ~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~--~~~---~~~~~~~e~~~l~~l~~~~-~~~~~~~~~~~~---~~~~l 80 (306)
.-.+.++.|.++.||++... +..+++|+.. ... ....+.+|..+++.+.... .++.+..+..+. +..++
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678899999999999753 4678888765 322 2346788999999998632 255555444443 34789
Q ss_pred EEeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 021855 81 VLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-------------------------------------- 121 (306)
Q Consensus 81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-------------------------------------- 121 (306)
+||++.| .+.+. ....++......++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999954 44321 12246788888899999999999997
Q ss_pred --------------------cCccccCCCCCceeeccCCCc--ceEEEEeeccccc
Q 021855 122 --------------------RGFLHRDIKPDNFLMGLGRKA--NQVYIIDFGLAKK 155 (306)
Q Consensus 122 --------------------~~i~H~dlkp~Nilv~~~~~~--~~~kl~Dfg~~~~ 155 (306)
..++|||++|.||++. .+ ..+.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CCCCcEEEEECcccccc
Confidence 3589999999999994 33 3468999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=5.1e-10 Score=95.67 Aligned_cols=190 Identities=15% Similarity=0.169 Sum_probs=115.5
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCC--CcceeeceeCc---eeEEEEeccC
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI--PNIKWYGVDGE---DNVLVLDLLG 86 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~--~~~~~~~~~~~---~~~lv~e~~~ 86 (306)
.+.++.|..+.||.+. ..+++|+.........+.+|..++..+.....+ +.+...+.... ..|++|+++.
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568899999999863 458889865443345678899999988654333 33333332222 3478899994
Q ss_pred -CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 021855 87 -PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-------------------------------------------- 121 (306)
Q Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-------------------------------------------- 121 (306)
.++..... ..++.+....++.+++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 45544322 246777777888888888888885
Q ss_pred --------------cCccccCCCCCceeeccCCC--cceEEEEeeccccccCCCCCCccccccC--Cc-cc-c-ccccc-
Q 021855 122 --------------RGFLHRDIKPDNFLMGLGRK--ANQVYIIDFGLAKKYRDPTTNRHIPYRE--NK-NL-T-GTARY- 179 (306)
Q Consensus 122 --------------~~i~H~dlkp~Nilv~~~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--~~-~~-~-~~~~y- 179 (306)
..++|+|++|.||+++ . ...+.|+||+.+................ .. .. . --..|
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~---~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFD---TEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEE---TTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEe---CCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1369999999999994 4 4567899999876432110000000000 00 00 0 00001
Q ss_pred -cC-cccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 021855 180 -AS-CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214 (306)
Q Consensus 180 -~a-PE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~ 214 (306)
.. |+.... .....+.|++|.+++.+.+|..+|.
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 111100 1123689999999999999988874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=1.2e-06 Score=73.07 Aligned_cols=132 Identities=16% Similarity=0.142 Sum_probs=91.1
Q ss_pred eecccCcc-EEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccCC-CHHH
Q 021855 14 KIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP-SLED 91 (306)
Q Consensus 14 ~lg~g~~~-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 91 (306)
.+..|..+ .||+......+..+++|+.... ....+.+|...++.+...-.+|.+..++.+.+..+++|+++.| ++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 34445544 6898877666778899975533 2345778999999987654566677777777889999999944 5555
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------------
Q 021855 92 LFVYCRRKFSLKTVLMLADQMIARIEYVHS-------------------------------------------------- 121 (306)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-------------------------------------------------- 121 (306)
..... ......++.+++..|..||+
T Consensus 110 ~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 110 VLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred cccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 44321 12223455667777777774
Q ss_pred --------cCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 122 --------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 122 --------~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
..++|+|+.+.|||+. ..+.+-|+||+.+.
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred hcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 1269999999999993 55556699999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.2e-06 Score=74.67 Aligned_cols=136 Identities=21% Similarity=0.231 Sum_probs=86.0
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCC--CCcceeece-eCceeEEEEeccCC-
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG--IPNIKWYGV-DGEDNVLVLDLLGP- 87 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~--~~~~~~~~~-~~~~~~lv~e~~~~- 87 (306)
.+.++.|....||.. +..+++|+.........+.+|..++..+.++.. ++....++. ..+..+++|+++.|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788888899988 456888985433233467889999999986422 444444442 34457899999944
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------------
Q 021855 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------------------------------------------- 122 (306)
Q Consensus 88 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--------------------------------------------- 122 (306)
++.+... ..++......++.+++..|..||+.
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 5544211 1234444444555555555555531
Q ss_pred ---------------CccccCCCCCceeeccCCCcce-EEEEeeccccc
Q 021855 123 ---------------GFLHRDIKPDNFLMGLGRKANQ-VYIIDFGLAKK 155 (306)
Q Consensus 123 ---------------~i~H~dlkp~Nilv~~~~~~~~-~kl~Dfg~~~~ 155 (306)
.++|+|+.|.||+++..+.++. ..|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999952112355 47999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=6.7e-06 Score=72.69 Aligned_cols=75 Identities=16% Similarity=0.181 Sum_probs=49.0
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCCC---------CchhhHHHHHHHHHHhCC--CCCCcceeeceeCceeE
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~e~~~l~~l~~~--~~~~~~~~~~~~~~~~~ 79 (306)
-.+.+|.|..+.||+++...+++.+++|...... .......|..++..+... ..+|.+.. .+....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~--~d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE--EcCCccE
Confidence 3678999999999999765567789999754321 223457799999888653 23444433 3445578
Q ss_pred EEEeccCC
Q 021855 80 LVLDLLGP 87 (306)
Q Consensus 80 lv~e~~~~ 87 (306)
++||++.+
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999954
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=5.4e-06 Score=72.14 Aligned_cols=78 Identities=10% Similarity=0.272 Sum_probs=51.1
Q ss_pred eEeeee-cccCccEEEEEEEc--C----CCceEEEEEccCCC-----CchhhHHHHHHHHHHhCC--CCCCcceeeceeC
Q 021855 10 KLGRKI-GSGSFGEIFLASHV--D----TNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGG--SGIPNIKWYGVDG 75 (306)
Q Consensus 10 ~i~~~l-g~g~~~~v~~~~~~--~----~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~--~~~~~~~~~~~~~ 75 (306)
...+.| +.|..+.+|+.... . ++..+++|+..... ....+.+|..+++.+... -.++.+..+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345777 88888999988643 0 15678899765432 234678899999988764 2345554444333
Q ss_pred ---ceeEEEEeccCC
Q 021855 76 ---EDNVLVLDLLGP 87 (306)
Q Consensus 76 ---~~~~lv~e~~~~ 87 (306)
+..+++||++.|
T Consensus 103 ~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 DVLGTPFFLMDYVEG 117 (357)
T ss_dssp TTTSSCEEEEECCCC
T ss_pred CccCCceEEEEecCC
Confidence 346899999943
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.06 E-value=0.00013 Score=58.01 Aligned_cols=142 Identities=12% Similarity=0.101 Sum_probs=90.2
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCcc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (306)
..+|.+++...+++++++++|.++.|.+.+|.-.-. +.-..+=..|..|++ ..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C-------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc----------
Confidence 347899999889999999999999999999876622 121122334577777 4677776653 1110
Q ss_pred ccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
.....+.+||... ...+.+.-|||||+++|.-+--..|=.. + ..+
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e--------------------E-----~eL 142 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE--------------------E-----REL 142 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE--------------------E-----ECC
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc--------------------c-----hhh
Confidence 1123455777753 2345788999999999998754333211 1 445
Q ss_pred chHHHHHHHhhhcC-------------------------CCCCCCChHHHHHHHHHh
Q 021855 245 PAEFASYFHYCQSL-------------------------TFDQRPDYGFLKRLFHDL 276 (306)
Q Consensus 245 ~~~~~~li~~cl~~-------------------------dP~~Rps~~~l~~~l~~~ 276 (306)
|+++..||..|..- .+..|+++++|++.=+.-
T Consensus 143 S~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 143 SPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH 199 (229)
T ss_dssp CHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence 77888888888755 346788998888765533
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.88 E-value=0.00025 Score=60.93 Aligned_cols=72 Identities=15% Similarity=0.134 Sum_probs=40.5
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCC-CCCCccee------eceeCceeEEEEec
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG-SGIPNIKW------YGVDGEDNVLVLDL 84 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~~~------~~~~~~~~~lv~e~ 84 (306)
.+.|+.|..+.||++... +..+++|+.... ......|..++..|... ..++.+.. +....+..++++++
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 445666678899998753 345889988752 23444566777766532 12233321 11245567899999
Q ss_pred cCC
Q 021855 85 LGP 87 (306)
Q Consensus 85 ~~~ 87 (306)
+.|
T Consensus 113 i~G 115 (346)
T 2q83_A 113 IEG 115 (346)
T ss_dssp CCC
T ss_pred ecC
Confidence 944
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00024 Score=60.13 Aligned_cols=68 Identities=19% Similarity=0.164 Sum_probs=45.4
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-CC
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP 87 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~-~~ 87 (306)
.+.|+.|....+|++ ..+++|+...... .....+|..+++.+......|.+... +....+++++|+ +|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 678888999999998 4578898765321 22346788888888765544555443 333457889998 55
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00063 Score=57.12 Aligned_cols=79 Identities=16% Similarity=0.112 Sum_probs=56.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
..|.+..-.+.+|.|..+.||+++. .+|+.+++|+...... ...+..|...++.|.....++....+..+ ..+++
T Consensus 12 l~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~~lv 88 (288)
T 3f7w_A 12 LTGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--DRTLA 88 (288)
T ss_dssp HHCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--TTEEE
T ss_pred hcCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--CceEE
Confidence 4566777789999999999999974 4688899998654332 23567899999999765444444333333 34788
Q ss_pred Eecc
Q 021855 82 LDLL 85 (306)
Q Consensus 82 ~e~~ 85 (306)
||+.
T Consensus 89 ~e~l 92 (288)
T 3f7w_A 89 MEWV 92 (288)
T ss_dssp EECC
T ss_pred EEee
Confidence 8887
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00035 Score=62.13 Aligned_cols=73 Identities=12% Similarity=0.302 Sum_probs=43.1
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccC------CC---CchhhHHHHHHHHHHh--CCCCCCcceeeceeCceeE
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENS------GT---KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~------~~---~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~~ 79 (306)
-.+.+|.|..+.||++.. +++.+++|.... .. .......|..++..+. .+..+|.+..++ ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467789999999999964 467799993221 11 1122233444443332 223344444433 56679
Q ss_pred EEEecc-CC
Q 021855 80 LVLDLL-GP 87 (306)
Q Consensus 80 lv~e~~-~~ 87 (306)
++||++ .+
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00039 Score=59.18 Aligned_cols=74 Identities=24% Similarity=0.296 Sum_probs=54.6
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCC--CCCCcceeeceeCceeEEEEeccCC
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVLVLDLLGP 87 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~--~~~~~~~~~~~~~~~~~lv~e~~~~ 87 (306)
-.+.++.|....+|+... ++..+++|+.... ....+..|...++.|... ..+|.+..++...+..+++||++.+
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 457789999999999974 4667889976543 234577899999988753 4456666666666788999999943
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0023 Score=54.39 Aligned_cols=139 Identities=17% Similarity=0.203 Sum_probs=75.7
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCC-CCcceee------ceeCceeEEEEe
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWY------GVDGEDNVLVLD 83 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~~~~------~~~~~~~~lv~e 83 (306)
-.+.|+.|....+|++... +..+++|+.........+..|..++..+..... ++.+... ....+..+++++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred EeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 3566777888899998753 336889988764344566778888888875322 3333211 112345688999
Q ss_pred ccCCC-H-----H------HH---HHHhcCCC--------CHHHHHH---------------HHHHHHHHHHHHHH----
Q 021855 84 LLGPS-L-----E------DL---FVYCRRKF--------SLKTVLM---------------LADQMIARIEYVHS---- 121 (306)
Q Consensus 84 ~~~~~-l-----~------~~---~~~~~~~~--------~~~~~~~---------------~~~qi~~~L~~LH~---- 121 (306)
++.|. + . .. +......+ ....... +...+...+..+.+
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 98442 1 1 01 11111111 1110000 00123444555553
Q ss_pred ---cCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 122 ---RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 122 ---~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
.+++|+|+.+.||++. .++.+.++||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 3689999999999993 44455799998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0011 Score=57.96 Aligned_cols=139 Identities=17% Similarity=0.171 Sum_probs=77.7
Q ss_pred eeeecccCccEEEEEEEcC-------CCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 12 GRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.+.+..|-...+|++.... +++.+++|+..... ......+|..+++.|......+.+...+.+ .+++|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 4567668888999987642 34678999864322 234566899999999876666666544432 28899
Q ss_pred ccCC-CHH--------------HHHHHh-c------CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 021855 84 LLGP-SLE--------------DLFVYC-R------RKFS--LKTVLMLADQMIA-------------------RIEYVH 120 (306)
Q Consensus 84 ~~~~-~l~--------------~~~~~~-~------~~~~--~~~~~~~~~qi~~-------------------~L~~LH 120 (306)
|+.| ++. ..+... . .... ...+..+..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9833 211 111111 0 1111 3444445443322 233333
Q ss_pred ----H----cCccccCCCCCceeeccC-CCcceEEEEeecccc
Q 021855 121 ----S----RGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAK 154 (306)
Q Consensus 121 ----~----~~i~H~dlkp~Nilv~~~-~~~~~~kl~Dfg~~~ 154 (306)
. ..++|+|+.+.||++... +..+.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 258999999999999521 113688999998774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0033 Score=53.79 Aligned_cols=75 Identities=9% Similarity=-0.029 Sum_probs=37.6
Q ss_pred eeeecccCccE-EEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCC-CCcceeeceeCceeEEEEeccCC-C
Q 021855 12 GRKIGSGSFGE-IFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLGP-S 88 (306)
Q Consensus 12 ~~~lg~g~~~~-v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~~~~~~~~~~~~lv~e~~~~-~ 88 (306)
.+.|+.|+... +|+... .++..+++|...... ......|..++..+..... ++.+..+.. ...++++|++++ +
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 44565555554 667653 225667777644332 1455678888888875432 444444322 223788998854 4
Q ss_pred HH
Q 021855 89 LE 90 (306)
Q Consensus 89 l~ 90 (306)
+.
T Consensus 99 l~ 100 (333)
T 3csv_A 99 FT 100 (333)
T ss_dssp HH
T ss_pred hH
Confidence 43
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0099 Score=52.87 Aligned_cols=73 Identities=12% Similarity=0.108 Sum_probs=48.6
Q ss_pred EeeeecccCccEEEEEEEcC-------CCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 11 LGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
-.+.|+.|....+|++.... +++.+++|+.........+..|..++..|......+.+...+. + .++++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 35677788889999997642 2567899988443221566789999998876555555543332 1 27888
Q ss_pred ccCC
Q 021855 84 LLGP 87 (306)
Q Consensus 84 ~~~~ 87 (306)
|+.|
T Consensus 153 ~l~G 156 (429)
T 1nw1_A 153 YIPS 156 (429)
T ss_dssp CCCE
T ss_pred EeCC
Confidence 8843
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0051 Score=53.49 Aligned_cols=72 Identities=17% Similarity=0.084 Sum_probs=42.4
Q ss_pred eeeecccCccEEEEEEEcC--------CCceEEEEEccCCCCc-hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 12 GRKIGSGSFGEIFLASHVD--------TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~--------~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.+.++.|....+|++.... .++.+++|+....... .....|..++..+......+.+.... . .++++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 5667778888999987542 1267889986543211 12467888888887654444443322 2 36789
Q ss_pred eccCC
Q 021855 83 DLLGP 87 (306)
Q Consensus 83 e~~~~ 87 (306)
+++.|
T Consensus 114 e~i~G 118 (369)
T 3c5i_A 114 EWLYG 118 (369)
T ss_dssp ECCCS
T ss_pred EEecC
Confidence 99844
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.034 Score=47.16 Aligned_cols=73 Identities=11% Similarity=0.018 Sum_probs=44.9
Q ss_pred eeecccCccEEEEEEEcCCCceEEEEEccCC-CCchhhHHHHHHHHHHhCCCC-CCcceee-----ceeCceeEEEEecc
Q 021855 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLYEAKVYKILQGGSG-IPNIKWY-----GVDGEDNVLVLDLL 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~~~~~-~~~~~~~-----~~~~~~~~lv~e~~ 85 (306)
..++ |....||.+.. .+|+.+++|..... ........|..++..+..... ++.+... ...++..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4565 78889998753 34567899988744 233456678888888865321 2222221 11234567899998
Q ss_pred CC
Q 021855 86 GP 87 (306)
Q Consensus 86 ~~ 87 (306)
.|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.062 Score=48.10 Aligned_cols=72 Identities=11% Similarity=0.020 Sum_probs=46.0
Q ss_pred EeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEeccC
Q 021855 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG 86 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~~ 86 (306)
-.+.|+.|....+|++.....+..+++|+...... .....+|..++..|......+.+...+. . ..+++|+.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 35678788888999998754347888998754321 1223589999999987655555544432 2 25889883
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.99 E-value=0.087 Score=45.09 Aligned_cols=30 Identities=33% Similarity=0.578 Sum_probs=25.5
Q ss_pred CccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 123 ~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
.++|+|+.+.||+++ .++.+.++||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG---NEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEEC---GGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEe---CCCeEEEEECCCCee
Confidence 589999999999993 567899999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.38 E-value=0.12 Score=45.74 Aligned_cols=72 Identities=18% Similarity=0.137 Sum_probs=47.6
Q ss_pred eeeecccCccEEEEEEEcCC-------CceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 12 GRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~-------~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.+.+..|-...+|++..... ++.+++|+...... ..+..+|..+++.+......+.+...+ . .+++++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 55666788889999986421 57789998654322 223468999999988655555554322 2 368899
Q ss_pred ccCC
Q 021855 84 LLGP 87 (306)
Q Consensus 84 ~~~~ 87 (306)
|+.|
T Consensus 151 fI~G 154 (424)
T 3mes_A 151 FIDG 154 (424)
T ss_dssp CCCS
T ss_pred EeCC
Confidence 9844
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.22 E-value=0.08 Score=46.48 Aligned_cols=31 Identities=29% Similarity=0.547 Sum_probs=24.9
Q ss_pred ccccCCCCCceeeccC---CCcceEEEEeecccc
Q 021855 124 FLHRDIKPDNFLMGLG---RKANQVYIIDFGLAK 154 (306)
Q Consensus 124 i~H~dlkp~Nilv~~~---~~~~~~kl~Dfg~~~ 154 (306)
++|+|+.+.|||+... ++...+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999421 356789999998774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 306 | ||||
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-89 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-88 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-32 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-31 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-31 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-30 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-29 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-27 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-26 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-26 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-25 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-25 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-25 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-25 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-24 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-24 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-23 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-23 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-22 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-21 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-21 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-20 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-20 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-19 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-17 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 266 bits (681), Expect = 2e-89
Identities = 205/299 (68%), Positives = 258/299 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+ ++
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 264 bits (675), Expect = 2e-88
Identities = 166/292 (56%), Positives = 212/292 (72%), Gaps = 2/292 (0%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
++GV YK+GR+IG GSFG IF +++ N+ VA+K E + PQL E + YK+L G +
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 61
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
GIPN+ ++G +G NVLV+DLLGPSLEDL C RKFS+KTV M A QM+AR++ +H +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 124 FLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
++RDIKPDNFL+G + AN +Y++DFG+ K YRDP T +HIPYRE KNL+GTARY S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQGLKAAT KQKY++I EKK STP+ LC
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293
P EF Y HY ++L FD PDY +L+ LF + R D FDW +L
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-33
Identities = 47/259 (18%), Positives = 98/259 (37%), Gaps = 16/259 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
KY + +G G FG + + + K ++ GT + E + I + I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
++ E+ V++ + + G + + + + + ++ Q+ ++++HS
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
H DI+P+N + R+++ + II+FG A++ + R + Y + H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245
S D+ SLG ++ L G P+ T +Q + I + + E K
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYTFDEEAF-KEIS 231
Query: 246 AEFASYFHYCQSLTFDQRP 264
E + R
Sbjct: 232 IEAMDFVDRLLVKERKSRM 250
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 6e-33
Identities = 53/287 (18%), Positives = 105/287 (36%), Gaps = 26/287 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
++ ++G+G+ G +F SH + ++A K+ E Q++ E +V
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS--- 63
Query: 65 IPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I +YG + + ++ + D + + + + ++ +I + Y+
Sbjct: 64 -PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 122 R-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+ +HRD+KP N L+ ++ + DFG++ + D N + GT Y
Sbjct: 123 KHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYM 170
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S G S + D+ S+G L+ G P A + + E +
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDY---GFLKRLFHDLFSREGYDF 284
+ + + DY +L +FS E DF
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 122 bits (306), Expect = 7e-33
Identities = 44/260 (16%), Positives = 94/260 (36%), Gaps = 17/260 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++G+G+FG + + T A K + + E + +L+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTL 85
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
N+ D + V++ + + G L + K S + Q+ + ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+H D+KP+N + +++N++ +IDFGL + + TGTA +A+
Sbjct: 146 VHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPEV 196
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244
G D+ S+G + L G P+ G + + +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRNVKSCDWNMDDSAF-SGI 252
Query: 245 PAEFASYFHYCQSLTFDQRP 264
+ + + R
Sbjct: 253 SEDGKDFIRKLLLADPNTRM 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 121 bits (304), Expect = 1e-32
Identities = 54/260 (20%), Positives = 90/260 (34%), Gaps = 17/260 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++GSG+FG + T + K + E + L +
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKL 88
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
N+ D + VL+L+ L G L D K S V+ Q ++++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+H DIKP+N + +KA+ V IIDFGLA K + T TA +A+
Sbjct: 149 VHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEFAAPEI 199
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244
D+ ++G + L G P+ G + + + S
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWEFDEDAF-SSV 255
Query: 245 PAEFASYFHYCQSLTFDQRP 264
E + +R
Sbjct: 256 SPEAKDFIKNLLQKEPRKRL 275
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 4e-32
Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 26/262 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+++GR +G G FG ++LA + I+A+K+ QL E ++ L+
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 65
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + Y D L+L+ + KF + ++ + Y HS+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
+HRDIKP+N L+G A ++ I DFG + H P L GT Y
Sbjct: 126 RVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDYLPP 173
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
G + DL SLG + FL G P++ T ++ Y +I + + P V
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFPDFV--- 227
Query: 243 SHPAEFASYFHYCQSLTFDQRP 264
QRP
Sbjct: 228 --TEGARDLISRLLKHNPSQRP 247
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-31
Identities = 51/284 (17%), Positives = 105/284 (36%), Gaps = 32/284 (11%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+++ ++G G+FG+++ A + +T+ + A K+ S + + E + P
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH----P 69
Query: 67 NI-KWYGVDGEDN--VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
NI K +N ++++ G +++ + + R + + ++ Q + + Y+H
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS- 181
+HRD+K N L + + DFG++ K R + GT + +
Sbjct: 130 KIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAP 179
Query: 182 ----CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
C T + D+ SLG L+ P L + KI + + P
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE--PPT 234
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
+ F + C D R L + H + +
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFVTVDS 276
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (293), Expect = 1e-31
Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 27/268 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
+ +G++IGSGSFG ++ VAVK+ N PQ E V + +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-- 63
Query: 64 GIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
NI + G + +V G SL KF + ++ +A Q ++Y+H
Sbjct: 64 --VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
++ +HRD+K +N + + V I DFGLA + + + L+G+ +
Sbjct: 122 AKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILWM 173
Query: 181 S---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ S + D+ + G VL + G LP+ + + Q + +S +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDL 231
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPD 265
+ + P C D+RP
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPL 259
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 4e-31
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 19/238 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+K G+ +G GSF + LA + T+ A+KI K P + E V L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + D E L L ++ F ++++ +EY+H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+G +HRD+KP+N L+ + + I DFG AK + + GTA+Y S
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
+ DL +LG ++ + G P++ + + KI + + P +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYDFPEKF 233
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 6e-30
Identities = 67/248 (27%), Positives = 101/248 (40%), Gaps = 21/248 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
+ L + +G G++GE+ LA + T E VAVKI + + + E + K+L
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH--- 62
Query: 65 IPNI-KWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
N+ K+YG E N+ L L+ + Q++A + Y+H
Sbjct: 63 -ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
G HRDIKP+N L+ + + + I DFGLA +R R + + GT Y +
Sbjct: 122 IGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVA 173
Query: 182 CNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
E + D+ S G VL L G LPW + Q+Y EKK
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLNPWKK 231
Query: 241 CKSHPAEF 248
S P
Sbjct: 232 IDSAPLAL 239
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 112 bits (281), Expect = 6e-30
Identities = 56/269 (20%), Positives = 100/269 (37%), Gaps = 27/269 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+Y+LG +G G E+ LA + + VAVK+ + + + EA+ L
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH- 66
Query: 63 SGIPNI-KWYGVDGEDN------VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
P I Y + +V++ + V+ + K + +
Sbjct: 67 ---PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
+ + H G +HRD+KP N ++ N V ++DFG+A+ D + + + G
Sbjct: 124 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QTAAVIG 176
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
TA+Y S G R D+ SLG VL L G P+ G + + +
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG---DSPVSVAYQHVREDP-I 232
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
P + A+ + + + R
Sbjct: 233 PPSARHEGLSADLDAVVLKALAKNPENRY 261
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (283), Expect = 7e-30
Identities = 55/284 (19%), Positives = 97/284 (34%), Gaps = 37/284 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+ R+IG GSFG ++ A V +E+VA+K + S K ++ E + + L+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN ++ G LV++ S DL ++ + + + + Y+
Sbjct: 75 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS +HRD+K N L+ + V + DFG A + GT +
Sbjct: 132 HSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANS-----------FVGTPYW 177
Query: 180 AS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
+ + + D+ SLG + P + I + +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPAL 234
Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
F ++ C RP L + H RE
Sbjct: 235 QSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRE 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 2e-29
Identities = 54/277 (19%), Positives = 112/277 (40%), Gaps = 27/277 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
KL ++G+G FGE+++ + + + VAVK ++ L EA + K LQ
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH----Q 68
Query: 67 NI-KWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ + Y V ++ + ++ + + G ++ L K ++ +L +A Q+ + ++ R
Sbjct: 69 RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
++HRD++ N L+ I DFGLA+ D + ++ +
Sbjct: 129 NYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTAP 179
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
+ + D+ S G +L + G +P+ G ++ + V
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNLERGYRMVRP 232
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
+ P E C + RP + +L+ + D F+
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-29
Identities = 47/237 (19%), Positives = 95/237 (40%), Gaps = 25/237 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+ + +G G+FG++ L T A+KI + + + E++V + +
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH- 64
Query: 63 SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
P + + L + + +LF + R+ F+ + ++++ +EY+
Sbjct: 65 ---PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HSR ++RDIK +N ++ K + I DFGL K+ GT Y
Sbjct: 122 HSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPEY 171
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
+ + R D LG V+ + G LP+ ++ ++ I +++ P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEIRFP 225
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 2e-29
Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 22/227 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
+Y++G +GSG FG ++ V N VA+K ++ E + K +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 60 QGG-SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIE 117
G SG+ + + + VL+L+ P + R + Q++ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
+ H+ G LHRDIK +N L + ++ +IDFG +D + GT
Sbjct: 125 HCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT---------DFDGTR 173
Query: 178 RYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
Y+ R + SLG +L + G +P++ + + Q
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 4e-29
Identities = 64/289 (22%), Positives = 99/289 (34%), Gaps = 27/289 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQG-- 61
KY+ KIG G+FGE+F A H T + VA+K L E K+ ++L+
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 62 -----GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
Y LV D L L KF+L + + ++ +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y+H LHRD+K N L+ + + + DFGLA+ + ++ Y N T
Sbjct: 131 YYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVVT 184
Query: 177 ARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
Y LG DL G ++ S QG T++ + I + S
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGSI 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
EV + + L + RL + D
Sbjct: 242 TPEVW------PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 110 bits (275), Expect = 4e-29
Identities = 47/269 (17%), Positives = 84/269 (31%), Gaps = 22/269 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------ENSGTKHPQLLYEAKVY 56
Y+ +G G + H T + AVKI E L E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 57 KILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
+ + G I +K LV DL+ L D ++ + S K + ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRALLEV 122
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
I +H +HRD+KP+N L+ + + DFG + + R + +
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
+ + H G + D+ S G ++ L GS P+ + I
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNYQF 234
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ + +R
Sbjct: 235 GSPEW-DDYSDTVKDLVSRFLVVQPQKRY 262
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-29
Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 22/245 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA++ K ++ E V + + I
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNI 79
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
N + G++ +V++ L G SL D+ + + + + +E++HS
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRDIK DN L+ V + DFG + + R + GT + +
Sbjct: 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPEV 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG------LKAATKKQKYDKICEKKVSTPIE 238
+ D+ SLG + + + G P+ L + +K+S
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 239 VLCKS 243
Sbjct: 248 DFLNR 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-28
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 20/234 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+ L + +G GSFG++FLA TN+ A+K ++ + ++L P
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 67 NI-KWYGVDGEDNVLVLDL---LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ + L + G L + KF L A ++I ++++HS+
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYH-IQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
G ++RD+K DN L+ K + I DFG+ K+ + GT Y +
Sbjct: 123 GIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIAP 172
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
LG + + D S G +L L G P+ G +++ + I P
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIRMDNPFYP 223
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-28
Identities = 51/268 (19%), Positives = 89/268 (33%), Gaps = 19/268 (7%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
II + +G G G++ + T E A+K+ P+ E +++
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCP 65
Query: 64 GIPNIKWYGVDGEDN----VLVLDLL-GPSLEDLFV-YCRRKFSLKTVLMLADQMIARIE 117
I I + ++V++ L G L + F+ + + + I+
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+HS HRD+KP+N L R + + DFG AK+ + Y T
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TP 177
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL-KAATKKQKYDKICEKKVSTP 236
Y + + + D+ SLG ++ L G P+ A +I + P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP 264
E QR
Sbjct: 238 NP-EWSEVSEEVKMLIRNLLKTEPTQRM 264
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (271), Expect = 4e-28
Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 16/278 (5%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
Y+L RK+G G + E+F A ++ NE V VKI K ++ E K+ + L+GG I
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIIT 94
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
+ D L + D + + + +++ ++Y HS G +HR
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-LTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP N + + + ++ +ID+GLA+ Y + + +
Sbjct: 154 DVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLVD 203
Query: 188 IEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246
+ D+ SLG +L + P+ + +I + + + +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
E F+ +R + H + S E DF
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLV-SPEALDF 298
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (268), Expect = 8e-28
Identities = 51/261 (19%), Positives = 100/261 (38%), Gaps = 18/261 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
Y +G+G+F E+ LA T ++VA+K + K + E V ++
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPN 68
Query: 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + G L++ L+ G L D + + ++ + L Q++ ++Y+H G
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFD-RIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
+HRD+KP+N L + +++ I DFGL+K + GT Y +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGYVAPE 179
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
S+ D S+G + L G P+ + +++I + +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYEFDSPYW-DD 235
Query: 244 HPAEFASYFHYCQSLTFDQRP 264
+ + ++R
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRF 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-27
Identities = 64/277 (23%), Positives = 119/277 (42%), Gaps = 27/277 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIP 66
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----E 72
Query: 67 NI-KWYGVDGEDNVLVL--DLLGPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSR 122
+ + Y V E+ + ++ + SL D K+ L ++ +A Q+ + + YV
Sbjct: 73 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
++HRD++ N L+G + + DFGLA+ D Y + ++ +
Sbjct: 133 NYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAP 183
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
L + + D+ S G +L +G +P+ G+ ++ D++ E+ P C
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC 239
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
P C ++RP + +L+ D F+
Sbjct: 240 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 2e-27
Identities = 55/273 (20%), Positives = 95/273 (34%), Gaps = 33/273 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
Y++ IG+GS+G +I+ K + + L+ E + + L+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HP 63
Query: 64 GIPNIKWYGVDGEDNV--LVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARIE 117
I +D + +V++ G L + ++ + VL + Q+ ++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 118 YVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
H R LHRD+KP N + V + DFGLA+ T+ K
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KA 173
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
GT Y S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGK 230
Query: 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
E +L RP
Sbjct: 231 FRRIPYRY----SDELNEIITRMLNLKDYHRPS 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (265), Expect = 6e-27
Identities = 54/239 (22%), Positives = 91/239 (38%), Gaps = 20/239 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
+ + R IG G FGE++ DT ++ A+K L E + ++ G
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 64 --GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
I + + + +LDL+ + FS + A ++I +E++H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
R ++RD+KP N L+ + V I D GLA + + + GT Y +
Sbjct: 126 RFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMA 173
Query: 182 CNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
G+ D SLG +L LRG P++ K K + V P
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-26
Identities = 63/295 (21%), Positives = 108/295 (36%), Gaps = 39/295 (13%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R V Y + IG+GSFG ++ A D+ E+VA+K + E ++ + L
Sbjct: 15 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDH 72
Query: 62 GSGIPNIKWYGVDGEDN-----VLVLDLLGPS-LEDLFVYCRRK--FSLKTVLMLADQMI 113
+ + ++ GE LVLD + + Y R K + V + Q+
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRE 169
+ Y+HS G HRDIKP N L + + DFG AK+ + YR
Sbjct: 133 RSLAYIHSFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
+ + G Y + D+ S G VL L G + G + + +I
Sbjct: 191 PELIFGATDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEII 236
Query: 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
+ + E + + +P F ++ + ++F E
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPW---------TKVFRPRTPPEAIAL 282
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-26
Identities = 49/266 (18%), Positives = 94/266 (35%), Gaps = 26/266 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
K +IG GSF ++ +T VA + + ++ + EA++ K LQ +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 65 IPNIKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + + VLV +L+ ++ + +K + Q++ ++++H+
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 122 RG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
R +HRD+K DN + V I D GLA R K + GT +
Sbjct: 131 RTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAVIGTPEF 179
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
+ + + D+ + G +L P+ Q Y ++ +
Sbjct: 180 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPASFD- 235
Query: 240 LCKSHPAEFASYFHYCQSLTFDQRPD 265
K E C D+R
Sbjct: 236 --KVAIPEVKEIIEGCIRQNKDERYS 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (260), Expect = 2e-26
Identities = 57/297 (19%), Positives = 114/297 (38%), Gaps = 32/297 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
++ + +G+GSFG + L H ++ A+KI + L E ++ + +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-F 100
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ +++ D + +V++ + + +FS A Q++ EY+HS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
++RD+KP+N L+ + + DFG AK+ + T GT +
Sbjct: 161 DLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWTLC----------GTPEALAP 207
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
L ++ D +LG ++ G P+ Q Y+KI KV P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVSGKVRFPSHF--- 261
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
++ L D +G LK +D+ + + + DW + ++ +
Sbjct: 262 --SSDLKDLLRNL--LQVDLTKRFGNLKNGVNDIKNHK---WFATTDWIAIYQRKVE 311
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-26
Identities = 63/274 (22%), Positives = 98/274 (35%), Gaps = 30/274 (10%)
Query: 4 IIGVK-YKLGRKIGSGSFGEIFLASHVDTN---EIVAVKI-----ENSGTKHPQLLYEAK 54
+IG K +L K+G GSFG + + VAVK + + E
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 55 VYKILQGGSGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQ 111
L N+ + YGV + +V +L SL D + F L T+ A Q
Sbjct: 64 AMHSLDH----RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+ S+ F+HRD+ N L+ + V I DFGL + + Y +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQE 172
Query: 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICE 230
+ + + + S D G L G PW GL Q KI +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDK 229
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ P C P + + C + + RP
Sbjct: 230 EGERLPRPEDC---PQDIYNVMVQCWAHKPEDRP 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (256), Expect = 4e-26
Identities = 49/233 (21%), Positives = 91/233 (39%), Gaps = 22/233 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
+++ R +G+GSFG + L A+K+ + E + I+
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 64
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + D + +++D + + ++F A ++ +EY+HS+
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
++RD+KP+N L+ K + I DFG AK D T L GT Y +
Sbjct: 125 IIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYIAPE 171
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
++ D S G ++ L G P+ + + Y+KI ++ P
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELRFP 221
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-25
Identities = 57/274 (20%), Positives = 114/274 (41%), Gaps = 27/274 (9%)
Query: 13 RKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIP 66
+++GSG+FG + + + VAVKI + P +LL EA V + L P
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN----P 68
Query: 67 NI-KWYGV-DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I + G+ + E +LV+++ + ++ R K ++ L Q+ ++Y+ F
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRD+ N L+ + I DFGL+K R Y+ + ++ +
Sbjct: 129 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPEC 181
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
+ S + D+ S G ++ G P++G+K + +K +++ P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GERMGCPAGC---- 235
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
P E + C + + RP + ++ + +
Sbjct: 236 -PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-25
Identities = 54/274 (19%), Positives = 106/274 (38%), Gaps = 27/274 (9%)
Query: 13 RKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPN 67
++G G+FG + + + VA+K+ GT+ +++ EA++ L P
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70
Query: 68 I-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I + GV + + LV+++ G L V R + + V L Q+ ++Y+ + F
Sbjct: 71 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRD+ N L+ + I DFGL+K + ++ +
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
+ S R D+ S G + L G P++ + + I + K
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGKRMECPPEC--- 237
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
P E + C ++ RPD+ +++ +
Sbjct: 238 -PPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (249), Expect = 3e-25
Identities = 55/277 (19%), Positives = 108/277 (38%), Gaps = 25/277 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
+ K+G G +GE++ + VAVK ++ + + L EA V K ++ P
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----P 73
Query: 67 NI-KWYGVDGEDNVLVLDL----LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
N+ + GV + + G L+ L R++ S +L +A Q+ + +EY+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+ F+HRD+ N L+G + + V + DFGL++ T H + ++ +
Sbjct: 134 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTA 184
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
+ + S + D+ + G +L + + ++ EK C
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP---GIDLSQVYELLEKDYRMERPEGC 241
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
P + C RP + + + F +F
Sbjct: 242 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-25
Identities = 53/289 (18%), Positives = 99/289 (34%), Gaps = 46/289 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEI-----VAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ G+ +GSG+FG++ A+ ++ VAVK+ + ++ L+ E K+ L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFS----------------- 101
I N+ L+ + L + R KFS
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 102 -----LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
+ +L A Q+ +E++ + +HRD+ N L+ V I DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDI 214
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQG 215
+ Y N ++ + + + + D+ S G +L G P+ G
Sbjct: 215 MSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ + K+ + E C + +RP
Sbjct: 270 I---PVDANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRP 312
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.3 bits (247), Expect = 4e-25
Identities = 57/280 (20%), Positives = 99/280 (35%), Gaps = 33/280 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+ KL + IG G FG++ L + VAVK + L EA V L+ N
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH----SN 61
Query: 68 I-KWYGVDGEDN---VLVLDLL-GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + GV E+ +V + + SL D L R +L + + +EY+
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
F+HRD+ N L+ + N + DFGL K+ ++ +
Sbjct: 122 NNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWTA 168
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
+ S + D+ S G +L G +P+ + K ++ + +
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPDGC 225
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
P C L RP + L+ + + E
Sbjct: 226 ----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 6e-25
Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 30/283 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+ +LGR IG G FG++ ++ VA+K S + + L EA +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 62 GSGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
P+I K GV E+ V ++++L L + L ++++ A Q+ + Y
Sbjct: 68 ----PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ S+ F+HRDI N L+ + V + DFGL++ D T Y + +
Sbjct: 124 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDST------YYKASKGKLPIK 174
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ + + + D+ G + L G P+QG+ K + + + +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGER 227
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
+ + P S C + +RP + LK + E
Sbjct: 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 1e-24
Identities = 53/269 (19%), Positives = 95/269 (35%), Gaps = 28/269 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y G ++GSG F + T A K G + E + K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
Q PN+ + V + D +L+L+L+ F+ + + + Q++ +
Sbjct: 71 QH----PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 117 EYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
Y+HS H D+KP+N ++ ++ IIDFGLA K ++I G
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FG 178
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
T + + D+ S+G + L G+ P+ G TK++ +
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLANVSAVNYEF 235
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
E + A + +R
Sbjct: 236 EDEYF-SNTSALAKDFIRRLLVKDPKKRM 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 1e-24
Identities = 53/285 (18%), Positives = 101/285 (35%), Gaps = 30/285 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGG 62
+Y+ +IG G++G++F A + + VA+K + E V + L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL--------GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
++ + V L L +T+ + Q++
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++++HS +HRD+KP N L+ + Q+ + DFGLA+ Y +
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV--------V 176
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
T Y + L + DL S+G + R ++G ++ + KI +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKIL-DVIG 232
Query: 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
P E A FH + ++ + L DL +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD--IDELGKDLLLK 275
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 97.9 bits (243), Expect = 2e-24
Identities = 45/272 (16%), Positives = 98/272 (36%), Gaps = 21/272 (7%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKI---ENSGTKHPQLLYEAKV 55
+ I K+ + IG+G FGE+ + VA+K + + L EA +
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
+ +++ +++ + + SL+ +F++ ++ + + A
Sbjct: 81 MGQFDH-PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++Y+ ++HRD+ N L+ + DFGL++ D T++ Y
Sbjct: 140 GMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGK 194
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKV 233
R+ + + + D+ S G V+ + G P+ + T + + I +
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDYR 251
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
P P+ C + RP
Sbjct: 252 LPPPM----DCPSALHQLMLDCWQKDRNHRPK 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 2e-24
Identities = 59/291 (20%), Positives = 94/291 (32%), Gaps = 33/291 (11%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+G +Y IG G++G + A VA+K T + L E K+ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 62 GSGIPNI-KWYGV-------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
NI + +D LV L+G L L + S + Q++
Sbjct: 66 ----ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQIL 119
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
++Y+HS LHRD+KP N L+ + I DFGLA+ +
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
A N ++ D+ S+G +L L + G + + I
Sbjct: 177 WYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGILG 230
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
S E L L + RLF + + D
Sbjct: 231 SPSQEDL------NCIINLKARNYLLSLPHKNKVPWNRLFPNA-DSKALDL 274
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-24
Identities = 51/265 (19%), Positives = 95/265 (35%), Gaps = 24/265 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQG 61
+K + +GSG+FG ++ + E V + + S + ++L EA V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + + ++ + L D + + +L Q+ + Y+
Sbjct: 71 -PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
R +HRD+ N L+ V I DFGLAK H + ++ +
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMA 181
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
+ L + + D+ S G + + GS P+ G+ A + I EK P +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSILEKGERLPQPPI 237
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPD 265
C + C + D RP
Sbjct: 238 C---TIDVYMIMVKCWMIDADSRPK 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 96.1 bits (238), Expect = 8e-24
Identities = 62/281 (22%), Positives = 105/281 (37%), Gaps = 29/281 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
KY KIG G++G ++ A + + E A+K + + E + K L+ S
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-S 60
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + + VLV + L L+ L C T Q++ I Y H R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH-----IPYRENKNLTGTAR 178
LHRD+KP N L+ + ++ I DFGLA+ + P + YR L G+ +
Sbjct: 121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y S D+ S+G + + G+ + G ++ + +I + + TP
Sbjct: 178 Y-----------STTIDIWSVGCIFAEMVNGTPLFPG---VSEADQLMRIF-RILGTPNS 222
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
+ ++ L DL S+
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 1e-23
Identities = 49/248 (19%), Positives = 106/248 (42%), Gaps = 23/248 (9%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKI------ENSGTKHPQLLYE 52
E++ ++L + +G+G++G++FL + DT ++ A+K+ E
Sbjct: 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78
Query: 53 AKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
+V + ++ + + + L+LD + + R +F+ V + ++
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
+ +E++H G ++RDIK +N L+ V + DFGL+K++ T R +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC---- 191
Query: 173 LTGTARYASCNTHLGIEQ--SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
GT Y + + G + + D SLG ++ L G+ P+ +K +I
Sbjct: 192 --GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV---DGEKNSQAEISR 246
Query: 231 KKVSTPIE 238
+ + +
Sbjct: 247 RILKSEPP 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 1e-23
Identities = 49/263 (18%), Positives = 99/263 (37%), Gaps = 27/263 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+++G+G FG + VA+K I+ + + EAKV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH----EK 60
Query: 68 I-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ + YGV ++ + + L + R +F + +L + + +EY+ S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
FLHRD+ N L+ V + DFGL++ D Y + R++
Sbjct: 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPE 171
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
+ + S + D+ + G ++ G +P++ T + + I + +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGLRLYRPHLA-- 226
Query: 243 SHPAEFASYFHYCQSLTFDQRPD 265
+ + + C D+RP
Sbjct: 227 --SEKVYTIMYSCWHEKADERPT 247
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.9 bits (237), Expect = 3e-23
Identities = 64/310 (20%), Positives = 106/310 (34%), Gaps = 37/310 (11%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQ 60
E +Y L RK+G G F ++LA + N VA+K + E K+ + +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 61 ----------GGSGIPNIKWYGVDGEDNVLVLDLLG-----PSLEDLFVYCRRKFSLKTV 105
G + I + + N + + ++ L + Y R L V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 106 LMLADQMIARIEYV-HSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKKYRDPTT 161
++ Q++ ++Y+ G +H DIKP+N LM Q+ I D G A Y + T
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
N T Y S LG D+ S ++ + G ++ + +
Sbjct: 188 NSI----------QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237
Query: 222 KQKYD---KICEKKVSTPIEVLCKSHPAEF----ASYFHYCQSLTFDQRPDYGFLKRLFH 274
+ D +I E P +L L F D K F
Sbjct: 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297
Query: 275 DLFSREGYDF 284
++E DF
Sbjct: 298 KDEAKEISDF 307
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 3e-23
Identities = 50/284 (17%), Positives = 92/284 (32%), Gaps = 39/284 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ G+ +G+G+FG++ A D VAVK+ T+ L+ E KV L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL-----------------FVYCRRKFS 101
I N+ G +++ + L +
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
L+ +L + Q+ + ++ S+ +HRD+ N L+ I DFGLA+ ++ +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSN 200
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
Y N ++ + + + D+ S G L
Sbjct: 201 -----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPV 253
Query: 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
K+ K+ ++ PAE C +RP
Sbjct: 254 DSKFYKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLKRPT 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.9 bits (235), Expect = 4e-23
Identities = 56/301 (18%), Positives = 98/301 (32%), Gaps = 51/301 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ R IG G+FG +F A + +VAVK+ E S EA +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL-----------------------FVY 95
+ + + G+ L+ + + L +
Sbjct: 74 DNPNIVKLL-GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 96 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
S L +A Q+ A + Y+ R F+HRD+ N L+G + V I DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRN 189
Query: 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
Y+ + N R+ + + D+ + G VL L
Sbjct: 190 IYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-- 242
Query: 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG----FLKR 271
++ + + + E + P E + C S RP + L+R
Sbjct: 243 YYGMAHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
Query: 272 L 272
+
Sbjct: 299 M 299
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (233), Expect = 5e-23
Identities = 59/282 (20%), Positives = 101/282 (35%), Gaps = 27/282 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
KY+ KIG G++G +F A + +T+EIVA+K ++ L E + K L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HK 61
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + + LV + L+ F C + V Q++ + + HSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
LHRD+KP N L+ + ++ + +FGLA+ + P T Y +
Sbjct: 122 VLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYS-------AEVVTLWYRPPD 171
Query: 184 THLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
G + S D+ S G + P + +I + E
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEE---- 225
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
++ S + P L + L + G D
Sbjct: 226 ----QWPSMTKLPDYKPYPMYPATTSLVNVVPKL-NATGRDL 262
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 8e-23
Identities = 60/291 (20%), Positives = 105/291 (36%), Gaps = 43/291 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
+Y+ +GSG++G + A T VAVK S + E ++ K ++
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-- 76
Query: 64 GIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
N+ + D LV L+G L ++ +K + V L Q++
Sbjct: 77 --ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQILR 132
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++Y+HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVA--------- 180
Query: 175 GTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
T Y + L ++ D+ S+G ++ L G + G + I
Sbjct: 181 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVG 236
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
+ E+L K +Y + Q P F + D
Sbjct: 237 TPGAELLKKISSESARNYIQ-----SLTQMPKMNFANVFIG--ANPLAVDL 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 1e-22
Identities = 55/261 (21%), Positives = 103/261 (39%), Gaps = 38/261 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
Y+ + +GSG++G + A T VA+K S + E ++ K ++
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH-- 76
Query: 64 GIPNI-KWYGVDGEDN--------VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
N+ V D LV+ +G L L K + L QM+
Sbjct: 77 --ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGEDRIQFLVYQMLK 132
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR--HIPYRENKN 172
+ Y+H+ G +HRD+KP N + + ++ I+DFGLA++ T YR +
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 189
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
+ RY ++ D+ S+G ++ + G ++G + + +I +
Sbjct: 190 ILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKG---SDHLDQLKEIMKVT 235
Query: 233 VSTPIEVLCKSHPAEFASYFH 253
+ P E + + E +Y
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMK 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 2e-22
Identities = 53/277 (19%), Positives = 95/277 (34%), Gaps = 19/277 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
++ KIG G++G ++ A + T E+VA+K + + E + K L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HP 61
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + LV + L L+ L + Q++ + + HS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
LHRD+KP N L+ + + DFGLA+ + P + A
Sbjct: 122 RVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPE 172
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
S D+ SLG + + + G ++ + +I + + TP EV+
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIF-RTLGTPDEVVWP 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
+ + + D L L S+
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.7 bits (227), Expect = 2e-22
Identities = 45/213 (21%), Positives = 85/213 (39%), Gaps = 20/213 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
++IGSG FG + L ++ ++ VA+K I + EA+V L P
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSH----PK 61
Query: 68 I-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ + YGV + LV + + L D R F+ +T+L + + + Y+
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
+HRD+ N L+ + + + DFG+ + D + ++AS
Sbjct: 122 VIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPE 172
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQG 215
S + D+ S G ++ G +P++
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 8e-22
Identities = 56/278 (20%), Positives = 91/278 (32%), Gaps = 30/278 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQGGSGI 65
+G G F ++ A +TN+IVA+K E + L E K+ + L
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH---- 59
Query: 66 PNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
PNI G + LV D + LE + + + + +EY+H
Sbjct: 60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
LHRD+KP+N L+ + + + DFGLAK + P + T Y +
Sbjct: 120 WILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYT-------HQVVTRWYRAP 169
Query: 183 NTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
G D+ ++G +L L G + + +I E + E
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQWP 226
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
F + DL
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSA--AGDDLLDLIQG 262
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 8e-22
Identities = 56/290 (19%), Positives = 113/290 (38%), Gaps = 30/290 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
+Y+ + IGSG+ G + A + VA+K + T + E + K + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 64 -----GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
+ + + +D LV++L+ +L + + + + L QM+ I++
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKH 134
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+HS G +HRD+KP N ++ + + I+DFGLA+ T
Sbjct: 135 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY--------VVTRY 183
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y + LG+ D+ S+G ++ +R + + G +++K+ E+ + E
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGTPCPE 240
Query: 239 VLCKSHPA--EFASYFHYCQSLTFDQRPDYGFLK--RLFHDLFSREGYDF 284
+ K P + LTF + + L + + D
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 1e-21
Identities = 44/280 (15%), Positives = 98/280 (35%), Gaps = 30/280 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNE----IVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+ IG+G FGE++ ++ VA+K + + L EA +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 62 GSGIPNI-KWYGVDGEDNVLVLDL---LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
NI + GV + +++ +L+ +FS+ ++ + + A ++
Sbjct: 69 ----HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+ + ++HRD+ N L+ + DFGL++ D +
Sbjct: 125 YLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPI 177
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK-KVSTP 236
R+ + + + D+ S G V+ + + + I + ++ TP
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGFRLPTP 235
Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
++ P+ C +RP + + + L
Sbjct: 236 MDC-----PSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 3e-21
Identities = 49/279 (17%), Positives = 85/279 (30%), Gaps = 40/279 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
K IG G+FG++ A + I S H E +V L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDL---------------FVYCRRKFSLKTVLM 107
I N+ L ++ +L D S + +L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
A + ++Y+ + F+HRD+ N L+G + I DFGL++
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG-- 186
Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYD 226
R+ + + + D+ S G +L + G P+ G+ T + Y+
Sbjct: 187 ------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYE 237
Query: 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
K+ + E C +RP
Sbjct: 238 KLPQGYRLEKPLNC----DDEVYDLMRQCWREKPYERPS 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 3e-20
Identities = 49/282 (17%), Positives = 101/282 (35%), Gaps = 23/282 (8%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKHP---QLLYEAKVYKILQ 60
+ IG G FG ++ + +D + AVK N T Q L E + K
Sbjct: 27 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 61 GGSGIPNIKWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
+ ++ + E + +VL + L + ++K ++ Q+ +++
Sbjct: 87 H-PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ S+ F+HRD+ N ++ + V + DFGLA+ D + +
Sbjct: 146 LASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVK 199
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ + + + + + D+ S G +L + RG+ P+ + + + +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYLLQGRRLLQP 256
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
E P C + RP + L +FS
Sbjct: 257 EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 3e-20
Identities = 52/285 (18%), Positives = 103/285 (36%), Gaps = 42/285 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVKI---ENSGTKHPQLLYEAKVYK 57
+ LG+ +G G+FG++ LA + ++ VAVK+ + + L+ E ++ K
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 58 ILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFS 101
++ I N+ ++++ +L + R + S
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 190
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAAT 220
+ N ++ + + + D+ S G +L G P+ G+
Sbjct: 191 YKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---P 242
Query: 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
++ + + E E C QRP
Sbjct: 243 VEELFKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPT 283
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 1e-19
Identities = 72/311 (23%), Positives = 105/311 (33%), Gaps = 45/311 (14%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
I L IG G FGE++ E VAVKI +S + EA++Y+ +
Sbjct: 1 IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS-REERSWFREAEIYQTVMLRH- 56
Query: 65 IPNI-KWYGVDGEDNV------LVLDLL-GPSLED------LFVYCRRKFSLKTVLMLAD 110
NI + D +DN LV D SL D + V K +L T LA
Sbjct: 57 -ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAH 115
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
+ + HRD+K N L+ K I D GLA ++ T I
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP--- 169
Query: 171 KNLTGTARY------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG--------- 215
+ GT RY E +R D+ ++G V R
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229
Query: 216 ---LKAATKKQKYDKICEKKVSTPIEVLCKSHPA--EFASYFHYCQSLTFDQRPDYGFLK 270
+ ++ +CE+K+ I +S A A C R +K
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 271 RLFHDLFSREG 281
+ L +EG
Sbjct: 290 KTLSQLSQQEG 300
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 2e-19
Identities = 58/295 (19%), Positives = 104/295 (35%), Gaps = 40/295 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62
+ KLG+ +G G+FG++ A T VAVK+ G H + KIL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 63 SGIPNIK--WYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FSL 102
N+ L++ + +L Y R K +L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I DFGLA+
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD- 189
Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATK 221
Y + ++ + T + + D+ S G +L + P+ G+K
Sbjct: 190 ----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-- 243
Query: 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
+++ + ++ E C QRP + L +L
Sbjct: 244 -EEFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 2e-19
Identities = 55/301 (18%), Positives = 106/301 (35%), Gaps = 39/301 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
K + R++G GSFG ++ + VA+K S + + L EA V K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR---------KFSLKTVLMLA 109
+ + G+ +++++L+ L+ R SL ++ +A
Sbjct: 81 N-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
++ + Y+++ F+HRD+ N ++ + V I DFG+ + + YR+
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRK 191
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKI 228
R+ S + + D+ S G VL P+QGL + +Q +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFV 248
Query: 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG----FLKRLFHDLFSREGYDF 284
E + + P C RP + +K F + +
Sbjct: 249 MEGGLLDKPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 304
Query: 285 D 285
Sbjct: 305 S 305
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.0 bits (186), Expect = 3e-17
Identities = 28/183 (15%), Positives = 61/183 (33%), Gaps = 32/183 (17%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------KHPQLLYEAKV- 55
+G+ +G G +F + VK G A
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 56 ----YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
++ LQ G+ K Y + N +++ E + + ++ + D
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWE--GNAVLM-------ELIDAKELYRVRVENPDEVLDM 111
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
++ + + RG +H D+ N L+ ++IIDF + + + + R+ +
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWREIL-ERDVR 166
Query: 172 NLT 174
N+
Sbjct: 167 NII 169
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 306 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.13 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.23 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.08 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-61 Score=413.83 Aligned_cols=297 Identities=69% Similarity=1.235 Sum_probs=259.7
Q ss_pred CCcccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 1 ~~~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
|+-.+|++|++.+.||+|+||.||+|++..+|+.||+|++........+..|+.+++.+.|+++++.+..++......++
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 67788999999999999999999999999999999999988777777899999999999999999998888888899999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+||++++++...+......+++..+..++.|++.||.|||++||+||||||+|||+...+.+..++|+|||+|+......
T Consensus 81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99999999998888767789999999999999999999999999999999999998655667789999999999877665
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.....++.......||+.|+|||++.+..+++++|||||||++|||++|..||...........+.+........+.+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 55444455556778999999999999999999999999999999999999999887665555555555555555666666
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceecchhh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQ 297 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 297 (306)
...+|+++.++|.+||+.||++||++.+|.+.|+.++.+.+++.+.+|||+.++...
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~~ 297 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGA 297 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGTC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCCC
Confidence 788999999999999999999999999999999999999999999999999987654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7e-60 Score=402.97 Aligned_cols=291 Identities=57% Similarity=0.996 Sum_probs=257.9
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++++++|++++.||+|+||.||+|++..+|+.||+|++........+.+|+.+++.+.++++++.+..++......+++|
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 47899999999999999999999999999999999998877777788999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC--CCcceEEEEeeccccccCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~--~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|+++++|.+++......++...+..++.|++.||.|||++||+||||||+|||++.. ...+.++|+|||+|+......
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 999999999988766779999999999999999999999999999999999999632 236789999999998876655
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.....+........||+.|+|||++.+..+++++|||||||++|+|++|..||.+...........++.......+...+
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 54444445556778999999999999999999999999999999999999999876655555555555555555566667
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCccccceec
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 293 (306)
+..+|+++.+++..||+.+|++||+++.+.+.|++++++.+...+.+|||+.+
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 78899999999999999999999999999999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=375.89 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=212.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
.=++|++.+.||+|+||.||+|+++.+++.||+|++.. ......+.+|+.+++.+.| +++..+..++.+....+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRVY 82 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCC-CCCCeEEEEEEECCEEE
Confidence 34689999999999999999999999999999998752 3344567889999999976 66667777777888999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++|||+ +|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 83 ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCC
T ss_pred EEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCC
Confidence 999999 7899998876 4569999999999999999999999999999999999999 5789999999999976544
Q ss_pred CCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
... ....||+.|+|||++.+..+++++|||||||++|+|++|+.||.+.+.. ..+..+.......+
T Consensus 159 ~~~---------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~p-- 224 (263)
T d2j4za1 159 SRR---------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISRVEFTFP-- 224 (263)
T ss_dssp CCC---------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCCCCC--
T ss_pred Ccc---------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC--
Confidence 322 2557999999999999999999999999999999999999999875543 34444444444443
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+|+++.++|.+||+.||++|||++++++ +.++..
T Consensus 225 ---~~~s~~~~~li~~~L~~dp~~R~t~~eil~--hp~~~~ 260 (263)
T d2j4za1 225 ---DFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITA 260 (263)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--CHHHHH
T ss_pred ---ccCCHHHHHHHHHHccCCHhHCcCHHHHHc--CcCcCC
Confidence 567899999999999999999999999987 555543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-56 Score=378.04 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=208.8
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC--CCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
.++|++.+.||+|+||.||+|+++.+|+.||+|++... .....+.+|+.+++.+.| +++..+..++......+++||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCC-CCEeeEeEEEEECCEEEEEEE
Confidence 35899999999999999999999999999999987643 334568899999999987 566666666777888999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|.........
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeecccccc
Confidence 99 7899887764 469999999999999999999999999999999999999 47899999999999876543321
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.... ...+........ ....
T Consensus 173 -------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~~~~~--~~~~ 240 (293)
T d1yhwa1 173 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLIATNGTPEL--QNPE 240 (293)
T ss_dssp -------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHHCSCCC--SSGG
T ss_pred -------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH---HHHHHhCCCCCC--CCcc
Confidence 1355799999999999999999999999999999999999999987554322 222222221111 1125
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.+|+++.++|.+||+.||++|||++|+++ +.+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~--Hp~~~ 274 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLK 274 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT--CGGGG
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhC
Confidence 67899999999999999999999999977 56664
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-56 Score=376.66 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=208.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
...++|++++.||+|+||.||+|+++.+++.||+|++.. ......+.+|+.+++++.| +++..+..++.+....
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCS-TTBCCEEEEEECSSEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCC-CCeeEEEEEEEECCEE
Confidence 345689999999999999999999999999999998753 2334568899999999977 5666676777788889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
|++|||+ +|+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||+ ++++.+||+|||+|+...
T Consensus 84 ~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecc
Confidence 9999999 7799988776 4579999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+.++.......+
T Consensus 160 ~~~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~~p- 230 (288)
T d1uu3a_ 160 PESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQKIIKLEYDFP- 230 (288)
T ss_dssp ---------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTTCCCCC-
T ss_pred cCCccc-----ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHHHHHHcCCCCCC-
Confidence 432211 112457999999999999999999999999999999999999999875443 44455555554444
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..+++++.+||.+||+.||++|||++|+++
T Consensus 231 ----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 ----EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 567899999999999999999999999765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-55 Score=378.47 Aligned_cols=259 Identities=21% Similarity=0.283 Sum_probs=202.5
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
+.++|++.+.||+|+||.||+|+++.+++.||+|++.... ....+.+|+.+++.+.| +++..+..++.+....|++
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH-PNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEE
Confidence 4577999999999999999999999999999999886542 23456789999999976 6666777777788899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+|.......
T Consensus 86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999 7899999875 5579999999999999999999999999999999999999765678999999999997654332
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. ....||+.|+|||++.+..+++++|||||||++|+|++|..||.+.... .....+.......+.+ .
T Consensus 165 ~~--------~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~-~ 232 (307)
T d1a06a_ 165 VL--------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQILKAEYEFDSP-Y 232 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHTTCCCCCTT-T
T ss_pred ee--------eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHhccCCCCCCc-c
Confidence 21 2567999999999999999999999999999999999999999875443 3344444444433322 2
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
...+|+++.+||.+||++||++|||++|+++ +.++..
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~ 269 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIAG 269 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTTS
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhCC
Confidence 3567899999999999999999999999988 566653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-56 Score=373.88 Aligned_cols=255 Identities=26% Similarity=0.321 Sum_probs=204.9
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC---CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
-++|++.+.||+|+||.||+|+++.+|+.||+|++.... ....+.+|+.+++++.| +++..+..++.+....+++|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCC-CCEeeEeeeeccCceeEEEE
Confidence 468999999999999999999999999999999876542 23468899999999976 56666777777888999999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+ +|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+|........
T Consensus 83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCCc
Confidence 999 7799988864 4579999999999999999999999999999999999999 4789999999999987543322
Q ss_pred CccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... +........... .
T Consensus 159 ~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~~~~~~~~~~~---~ 228 (271)
T d1nvra_ 159 ER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYLN---P 228 (271)
T ss_dssp EC-----CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HHHHHTTCTTST---T
T ss_pred cc-----cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HHHHhcCCCCCC---c
Confidence 11 1235679999999999998876 67899999999999999999999765433222 222222211111 1
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
...+|+++.+||.+||+.||++|||++++++ +.++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hpwf 263 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKK--DRWY 263 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhh
Confidence 2567899999999999999999999999976 4444
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=374.99 Aligned_cols=253 Identities=17% Similarity=0.302 Sum_probs=207.8
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
+.|++.+.||+|+||.||+|+++.+++.||+|++..... ...+.+|+.+++++.| +++..+..++.+....++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCeEEEEEec
Confidence 569999999999999999999999999999999875433 3568899999999986 6666676677788899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +|+|.+++.....++++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|........
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc--
Confidence 9 789998877666779999999999999999999999999999999999999 4789999999999875432211
Q ss_pred cccccCCccccccccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 164 HIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
......||+.|+|||++. +..|+.++|||||||++|+|++|..||.+.+.. ..+.++.....+..
T Consensus 166 -----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~~~~~~~-- 235 (288)
T d2jfla1 166 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAKSEPPTL-- 235 (288)
T ss_dssp -----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHHSCCCCC--
T ss_pred -----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCCCC--
Confidence 112457899999999984 456899999999999999999999999876544 33334443332221
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.....+|+++.+||.+||+.||++|||++|+++ +.++
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~--hp~~ 272 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFV 272 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGG
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhc--Cccc
Confidence 112567899999999999999999999999976 3444
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-55 Score=369.79 Aligned_cols=261 Identities=19% Similarity=0.278 Sum_probs=212.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|+||.||+|+++.+++.||+|++..+.. ...+.+|+.++++++| +++..+..++......+++|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCC-CCEecCCccEeeCCeeEEEe
Confidence 345689999999999999999999999999999999876543 3568899999999976 66666666667778899999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCC
Confidence 999 78999888753 3458999999999999999999999999999999999999 588999999999998654433
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. ......+++.|+|||++.+..++.++|||||||++|||++|..||...... ..+.+.+......+.
T Consensus 170 ~~------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---~~~~~~i~~~~~~~~--- 237 (287)
T d1opja_ 170 YT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYRMER--- 237 (287)
T ss_dssp SE------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHTTCCCCC---
T ss_pred ce------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH---HHHHHHHhcCCCCCC---
Confidence 22 112446788999999999999999999999999999999977666442222 222233333333222
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...+|+.+.+||.+||+.||++|||+++|++.|+.++++.
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 2567899999999999999999999999999999887644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=369.05 Aligned_cols=259 Identities=19% Similarity=0.247 Sum_probs=213.3
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--------CchhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
-+.++|++++.||+|+||.||+|+++.+|+.||+|++.... ....+.+|+.+++++.| +++..+..++.+.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~ 85 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENK 85 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC
Confidence 35788999999999999999999999999999999876332 12457889999999976 6666777777788
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCC-CcceEEEEeeccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLA 153 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~-~~~~~kl~Dfg~~ 153 (306)
...+++|||+ +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+...+ ....+||+|||++
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 8999999999 7899999876 45799999999999999999999999999999999999995221 2336999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (306)
........ .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.....
T Consensus 165 ~~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~ 233 (293)
T d1jksa_ 165 HKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVNY 233 (293)
T ss_dssp EECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTTCC
T ss_pred hhcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCC
Confidence 87654322 12557899999999999999999999999999999999999999876543 33344444443
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..+ ......+|+.+.+||.+||+.||++|||++++++ +.+++
T Consensus 234 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 275 (293)
T d1jksa_ 234 EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIK 275 (293)
T ss_dssp CCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTC
T ss_pred CCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 333 3334678999999999999999999999999987 55654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=381.37 Aligned_cols=261 Identities=20% Similarity=0.300 Sum_probs=206.1
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC---chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
++.+++|++.+.||+|+||.||+|+++.+|+.||+|++..... ...+.+|+.+++.++| +++..+..++.+....+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCC-TTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEE
Confidence 4678899999999999999999999999999999999875432 2457889999999976 56666766777888899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+|....
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccC
Confidence 999999 6799998876 4569999999999999999999997 599999999999999 588999999999998654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc----
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV---- 233 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---- 233 (306)
.... ....||+.|+|||++.+..|++++||||+||++|||++|+.||.+.+................
T Consensus 157 ~~~~---------~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
T d1s9ja_ 157 DSMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227 (322)
T ss_dssp HHTC------------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred CCcc---------ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence 3222 256899999999999999999999999999999999999999977543221111100000000
Q ss_pred -------------------cc-------------chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 234 -------------------ST-------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 234 -------------------~~-------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.. +.......+|+++.++|.+||+.||.+|||++|+++ +.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~--Hpf~~~ 303 (322)
T d1s9ja_ 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV--HAFIKR 303 (322)
T ss_dssp ------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHH
T ss_pred cccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh--CHhhCc
Confidence 00 000000234778999999999999999999999988 566654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-54 Score=377.31 Aligned_cols=257 Identities=18% Similarity=0.264 Sum_probs=214.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
++|++.+.||+|+||.||+|+++.+|+.||+|++..... ...+.+|+.+++++.| +++..+..++.+....+++|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEEc
Confidence 579999999999999999999999999999999875433 2347789999999976 6666776777788899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. +.++.+||+|||+|.........
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~- 182 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSV- 182 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSCE-
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheeccccccc-
Confidence 9 78999988655567999999999999999999999999999999999999942 24689999999999876543321
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+ ......
T Consensus 183 -------~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~ 251 (350)
T d1koaa2 183 -------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDWNMD-DSAFSG 251 (350)
T ss_dssp -------EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCSC-CGGGGG
T ss_pred -------ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-cccccC
Confidence 2567899999999999999999999999999999999999999876543 34444444443333 223367
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+|+++.+||.+||+.||++|||++++++ +.++..
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~--hp~~~~ 285 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTP 285 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHH--STTTSC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCC
Confidence 7899999999999999999999999988 555543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=364.16 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=199.3
Q ss_pred CcccCCce-eEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeece---
Q 021855 2 ERIIGVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV--- 73 (306)
Q Consensus 2 ~~~~~~~y-~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~--- 73 (306)
+...+++| ++.+.||+|+||.||+|++..+++.||+|.+..... ...+.+|+.+++++.|++.+..+..+..
T Consensus 3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence 34456677 788899999999999999999999999998765432 2347789999999987444443333322
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeccCCCcceEEEEee
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDF 150 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~Nilv~~~~~~~~~kl~Df 150 (306)
.....+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ++++.+||+||
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DF 159 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL 159 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCT
T ss_pred cCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeec
Confidence 245679999999 7899998876 457999999999999999999999998 99999999999995 35789999999
Q ss_pred ccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
|+|........ ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... ......+..
T Consensus 160 Gla~~~~~~~~---------~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i~~ 227 (270)
T d1t4ha_ 160 GLATLKRASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTS 227 (270)
T ss_dssp TGGGGCCTTSB---------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTT
T ss_pred CcceeccCCcc---------CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHHHHc
Confidence 99975433221 25679999999999876 5999999999999999999999999764322 222333332
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...+. .+....++++.++|.+||++||++|||++|+++
T Consensus 228 ~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 GVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TCCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCc---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 22221 223567889999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-54 Score=359.94 Aligned_cols=257 Identities=18% Similarity=0.281 Sum_probs=200.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
-..+|++.+.||+|+||.||+|++. +++.||||++.... ....+.+|+.++++++| +++..+..++......+++||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCC-CCcccccceeccCCceEEEEE
Confidence 3578999999999999999999976 56789999987543 34568999999999976 666666666667778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++........
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC-----------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCce
Confidence 99 889999887656678999999999999999999999999999999999999 58999999999999765443322
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (306)
......||..|+|||++.+..++.++|||||||++|||+| |..||...+.. ..+..+.. ....+.+
T Consensus 158 ------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~~-~~~~~~p--- 224 (263)
T d1sm2a_ 158 ------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIST-GFRLYKP--- 224 (263)
T ss_dssp -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHHH-TCCCCCC---
T ss_pred ------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHHh-cCCCCCc---
Confidence 1124568899999999999999999999999999999999 56666554432 22222222 2222222
Q ss_pred hcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 242 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+++++.++|.+||+.||++|||+++|++.|+++.+.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 45688999999999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=365.34 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=203.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~ 79 (306)
+-.++|++.+.||+|+||.||+|++. ..||+|++..... ...+.+|+.++.+++| +++..+..+. .....+
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~-~~~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-VNILLFMGYS-TAPQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCC-TTBCCEEEEE-CSSSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeeeeEEE-eccEEE
Confidence 45678999999999999999999863 3599999874432 2457789999999976 4555555544 345689
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
++|||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC---
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeeccc
Confidence 999999 689999987656679999999999999999999999999999999999999 5889999999999976543
Q ss_pred CCCCccccccCCccccccccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.+.... ............
T Consensus 157 ~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~p 229 (276)
T d1uwha_ 157 WSGSH-----QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMVGRGYLSP 229 (276)
T ss_dssp --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHHTSCCC
T ss_pred cCCcc-----cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHHhcCCCCC
Confidence 22211 12355789999999998753 489999999999999999999999987554322 222222333333
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
........+|+++.+||.+||+.||++|||+.+|++.|+.+.+
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3344456789999999999999999999999999999998875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=374.08 Aligned_cols=269 Identities=19% Similarity=0.163 Sum_probs=210.5
Q ss_pred cCCceeEee-eecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeecee----CceeE
Q 021855 5 IGVKYKLGR-KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNV 79 (306)
Q Consensus 5 ~~~~y~i~~-~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~~~~ 79 (306)
+-++|++.. .||+|+||.||+|++..+++.||+|++.. .....+|+.++.++.+|+++..+..++.+ ....|
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 346798875 69999999999999999999999999864 35678899988877666777776554432 46689
Q ss_pred EEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 80 LVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
++|||| +|+|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+|+...
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 999999 789999987543 459999999999999999999999999999999999999755567889999999998765
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHH-HHHhhcccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKVSTP 236 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~ 236 (306)
..... ....||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+.......+ ..+.......+
T Consensus 166 ~~~~~--------~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 166 SHNSL--------TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp CCCCC--------CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred CCCcc--------ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 43322 2557899999999999999999999999999999999999999875543322222 22222222222
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCCCCcc
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFV 287 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~~~~~ 287 (306)
. .....+|+++.+||.+||+.||++|||+.++++ +.++.+.......|
T Consensus 238 ~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~~~~~~~~~ 285 (335)
T d2ozaa1 238 N-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQSTKVPQTP 285 (335)
T ss_dssp T-THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SHHHHTTTSSCCCE
T ss_pred C-cccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHhhCCCCCCCCC
Confidence 2 223567899999999999999999999999987 56665444333333
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-54 Score=367.18 Aligned_cols=263 Identities=18% Similarity=0.289 Sum_probs=201.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCc---eEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+..++|++.+.||+|+||.||+|+++.+++ .||+|.+...... ..+.+|+.++++++| +++..+..++.....
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNVIHLEGVVTKSTP 101 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeCCE
Confidence 445789999999999999999999986664 5888887654333 357889999999976 666666666677788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.+++|||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 99999999 789998887656679999999999999999999999999999999999999 58999999999999866
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
........ ........+|+.|+|||++.+..++.++|||||||++|||+| |..||.+.+... ....+.. ....
T Consensus 179 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~~-~~~~ 252 (299)
T d1jpaa_ 179 EDDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQ-DYRL 252 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT-TCCC
T ss_pred cCCCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-CCCC
Confidence 54322111 011123457889999999999999999999999999999998 899998765542 2222222 2222
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+. ...+|+.+.+||.+||+.||++|||+.+|++.|++++++
T Consensus 253 ~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 253 PP---PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CC---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 21 156789999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=364.06 Aligned_cols=248 Identities=22% Similarity=0.273 Sum_probs=192.4
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeece--eCceeE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNV 79 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~~ 79 (306)
.++|++.+.||+|+||.||+|+++.+|+.||+|.+...... ..+.+|+.+++++.|+ ++..+..++. .....+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP-NIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCT-TBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCC-CEeeEEEEEEeCCCCEEE
Confidence 46899999999999999999999999999999998765433 3477899999999874 4444443332 345679
Q ss_pred EEEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCceeeccCCCcceEEEEee
Q 021855 80 LVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDF 150 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~-----i~H~dlkp~Nilv~~~~~~~~~kl~Df 150 (306)
++|||+ +|+|.+++.. ....+++..++.++.||+.||.|||+.| |+||||||+|||+ +.++.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence 999999 7899998864 2456999999999999999999999976 9999999999999 58899999999
Q ss_pred ccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh
Q 021855 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (306)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 230 (306)
|+|+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+..
T Consensus 159 G~a~~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~~ 228 (269)
T d2java1 159 GLARILNHDTSF-------AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIRE 228 (269)
T ss_dssp HHHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred cceeecccCCCc-------cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHHc
Confidence 999876543321 12567899999999999999999999999999999999999999876543 33333333
Q ss_pred cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
..... ....+|+++.+||.+||+.||++|||++|+++
T Consensus 229 ~~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 33322 12567899999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-54 Score=368.13 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=203.8
Q ss_pred ceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 8 ~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
.|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++++.| +++..+..++.+....+++|
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEECCEEEEEE
Confidence 599999999999999999999999999999988765432 347789999999976 66666666677788999999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|||.+.+.+.+.....++++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|......
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB---
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCCC---
Confidence 999554444444446679999999999999999999999999999999999999 48899999999999764332
Q ss_pred ccccccCCccccccccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+.. ..+.++.....+...+
T Consensus 169 --------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~- 236 (309)
T d1u5ra_ 169 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPALQS- 236 (309)
T ss_dssp --------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCCCCCSC-
T ss_pred --------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCCC-
Confidence 24578999999999864 35899999999999999999999999875443 3344444444333222
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+|+.+.+||.+||+.||.+|||++++++ +.++.+
T Consensus 237 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--Hp~~~~ 272 (309)
T d1u5ra_ 237 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 272 (309)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred --CCCCHHHHHHHHHHCcCChhHCcCHHHHHh--CHHhcC
Confidence 567899999999999999999999999987 455543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-54 Score=375.93 Aligned_cols=257 Identities=23% Similarity=0.232 Sum_probs=212.7
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC--chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEe
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e 83 (306)
-++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.+++++.| +++..+..++.++...+++||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEE
Confidence 3679999999999999999999999999999999876532 2346789999999976 666667677778889999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|.+.+.....++++..++.++.||+.||.|||++||+||||||+|||++. ..++.+||+|||+|.........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCCce
Confidence 99 78998887765567999999999999999999999999999999999999931 25789999999999876543321
Q ss_pred ccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+ .....
T Consensus 186 --------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~ 253 (352)
T d1koba_ 186 --------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRCDWEFD-EDAFS 253 (352)
T ss_dssp --------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHCCCCCC-SSTTT
T ss_pred --------eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-ccccc
Confidence 2557899999999999999999999999999999999999999876543 33444444443332 22235
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.+|+++.+||.+||++||.+|||++++++ +.+++
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~--Hp~~~ 287 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLK 287 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhC
Confidence 77999999999999999999999999987 45554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=368.16 Aligned_cols=246 Identities=21% Similarity=0.297 Sum_probs=210.9
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
=++|++++.||+|+||.||+|+++.+|+.||+|++.. ......+.+|+.+++.+.| +++..+...+.+....|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC-CCEEEEEeeecccccccc
Confidence 3579999999999999999999999999999998763 2334567889999999875 677777777788889999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.+|.+||+|||+|+.....
T Consensus 83 v~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCT
T ss_pred ceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccC
Confidence 99999 7899888876 4579999999999999999999999999999999999999 58899999999999865443
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.. ..+..+.......+
T Consensus 159 ~~~-------~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~i~~~~~~~p--- 225 (337)
T d1o6la_ 159 GAT-------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEEIRFP--- 225 (337)
T ss_dssp TCC-------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC---
T ss_pred Ccc-------cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHHHHhcCCCCCC---
Confidence 321 12568999999999999999999999999999999999999999886543 44555555555555
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
..+|+++.+||.+||++||.+|++ ++++++
T Consensus 226 --~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 667999999999999999999995 778876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-53 Score=359.01 Aligned_cols=251 Identities=19% Similarity=0.172 Sum_probs=211.3
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----------hhhHHHHHHHHHHhCCCCCCcceeece
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~~~~~~~~~~ 73 (306)
+.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++++..|+++..+..++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 457999999999999999999999999999999988754321 246789999999987788888878888
Q ss_pred eCceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecc
Q 021855 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (306)
Q Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~ 152 (306)
+....|++|||+ +++|.+++.. .+++++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 156 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchh
Confidence 889999999999 7899999976 4579999999999999999999999999999999999999 5899999999999
Q ss_pred ccccCCCCCCccccccCCccccccccccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH
Q 021855 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (306)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 226 (306)
+......... ....||..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.. ....
T Consensus 157 a~~~~~~~~~--------~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~~~~ 225 (277)
T d1phka_ 157 SCQLDPGEKL--------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR 225 (277)
T ss_dssp CEECCTTCCB--------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH
T ss_pred eeEccCCCce--------eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---HHHH
Confidence 9876543221 25678999999999863 34688999999999999999999999986543 3344
Q ss_pred HHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
.+.......+.+ ...++|+++.++|.+||++||++|||++++++
T Consensus 226 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 444444433322 22578999999999999999999999999976
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=365.73 Aligned_cols=257 Identities=18% Similarity=0.240 Sum_probs=214.7
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
-++|++++.||+|+||.||+|+++.+++.||+|++...... ..+.+|+.+++.+.| +++..+..++.+....|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEEec
Confidence 46799999999999999999999999999999998765433 346789999999987 6666676777788899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
| +++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||++. +....+||+|||++........
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~-- 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCCc--
Confidence 9 67999998765557999999999999999999999999999999999999941 2456899999999987544321
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
.....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+.. ....
T Consensus 160 ------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~-~~~~ 229 (321)
T d1tkia_ 160 ------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEYTFDEE-AFKE 229 (321)
T ss_dssp ------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCCHH-HHTT
T ss_pred ------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCChh-hccC
Confidence 12557899999999999999999999999999999999999999886543 4455555555554433 3357
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+|+++.+||.+||+.||++|||++|+++ +.++.
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~ 262 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLK 262 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhc
Confidence 8999999999999999999999999987 45654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-53 Score=363.48 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=207.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++++.||+|+||.||+|+++.+|+.||+|++.. ......+.+|+.+++.+.| +++..+..++.+....+++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccC-cChhheeeeEeeCCeeeeE
Confidence 579999999999999999999999999999998753 2334567889999999977 6666777777788899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ ++++..++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSCB
T ss_pred eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEecccc
Confidence 9999 6777777665 5678999999999999999999999999999999999999 588999999999998765432
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
. ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ....++.......+
T Consensus 159 ~----------~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~~~~~p---- 221 (316)
T d1fota_ 159 Y----------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKILNAELRFP---- 221 (316)
T ss_dssp C----------CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHCCCCCC----
T ss_pred c----------cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHHHHHcCCCCCC----
Confidence 2 567999999999999999999999999999999999999999875543 44455555555444
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
+.+|+++.++|.+||+.||.+|+ |++++++
T Consensus 222 -~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 56789999999999999999996 8999977
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=367.13 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=207.9
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCc-----eEEEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~-----~vaiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
.++|++.+.||+|+||.||+|++..+++ .||+|.+... .....+.+|+.++.++.+|+++..+..++.....
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3689999999999999999999876543 6899987543 3345688899999999777888888777778888
Q ss_pred eEEEEecc-CCCHHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCce
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 134 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Ni 134 (306)
.+++|||+ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 99999999 889999987532 2478899999999999999999999999999999999
Q ss_pred eeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 021855 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 213 (306)
Q Consensus 135 lv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf 213 (306)
|+ +.++.+||+|||+|+......... ......+|+.|+|||++.+..+++++|||||||++|||+| |..||
T Consensus 196 ll---~~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 196 LV---THGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp EE---ETTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred cc---ccCCeEEEeeccccccccCCCcee-----eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99 588999999999997655433221 1124567999999999999999999999999999999998 89999
Q ss_pred CCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHH
Q 021855 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (306)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~ 274 (306)
.+.+.. ..+.+++......+.+ ..+|+++.+||.+||+.||++|||+++|++.|.
T Consensus 268 ~~~~~~---~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVD---ANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCS---HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHH---HHHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 875443 2333444444333322 567899999999999999999999999999885
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-53 Score=368.25 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=207.8
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++++.||+|+||.||+|+++.+|+.||+|++.. ......+.+|+.+++.+.| +++..+...+......+++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCC-CcEeecccccccccccccc
Confidence 679999999999999999999999999999998753 2333567889999999876 5666666667778889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
+|++ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 120 ~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSCB
T ss_pred cccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeeccccc
Confidence 9999 7888888876 4579999999999999999999999999999999999999 588999999999998765432
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+.++.......+
T Consensus 196 ----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~~~~~p---- 258 (350)
T d1rdqe_ 196 ----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIVSGKVRFP---- 258 (350)
T ss_dssp ----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC----
T ss_pred ----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHHHHhcCCCCCC----
Confidence 2567999999999999999999999999999999999999999875443 44555555555554
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCC-----ChHHHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~~l~~ 271 (306)
..+|+++.++|.+||+.||.+|+ |++++++
T Consensus 259 -~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 56789999999999999999995 8999877
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=354.83 Aligned_cols=252 Identities=18% Similarity=0.299 Sum_probs=209.1
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
.++|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+|+.++.+++| +++..+..++.+....+++|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~H-pnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCceEEEEEc
Confidence 478999999999999999999985 67889999887543 45678999999999976 5566666666677789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +|++.+++......+++..+..++.||++||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC-
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCce-
Confidence 9 788888877666679999999999999999999999999999999999999 58899999999999765543322
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhh
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (306)
......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.... ...+.. ....+.+ .
T Consensus 157 -----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~---~~~i~~-~~~~~~p---~ 224 (258)
T d1k2pa_ 157 -----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---AEHIAQ-GLRLYRP---H 224 (258)
T ss_dssp -----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHHHT-TCCCCCC---T
T ss_pred -----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH---HHHHHh-CCCCCCc---c
Confidence 1124568899999999999999999999999999999998 8999988765432 223322 2222222 5
Q ss_pred cCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 243 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
..++.+.++|.+||+.||++|||+++|++.|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 668899999999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.6e-53 Score=357.15 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=203.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc-----hhhHHHHHHHHHHhCCCCCCcceeeceeC---
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDG--- 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--- 75 (306)
.++++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+.+|+.+++.+.|++.+..+..+....
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 4678999999999999999999999999999999998754332 24678999999988755554444443322
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...|++|||+ +++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++++|||.+.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCE
T ss_pred ceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhhh
Confidence 3478999999 6788887765 4579999999999999999999999999999999999999 488999999999987
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
......... .......||+.|+|||++.+..+++++|||||||++|+|+||..||.+.+.. ....+.......
T Consensus 160 ~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 160 AIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHVREDPI 232 (277)
T ss_dssp ECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCCC
T ss_pred hhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH---HHHHHHHhcCCC
Confidence 654332211 1223567899999999999999999999999999999999999999875543 333344443333
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCC-ChHHHHHHHHHhH
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLF 277 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~~l~~~l~~~~ 277 (306)
.+ ......+|+++.++|.+||++||++|| |++++++.|..+.
T Consensus 233 ~~-~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PP-SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CG-GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CC-chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 22 233467899999999999999999999 8999999888764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.6e-53 Score=368.87 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=202.5
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCC-----CCchhhHHHHHHHHHHh--CCCCCCcceeeceeCceeE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNV 79 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~~ 79 (306)
++|++.+.||+|+||.||+|+++.+|+.||+|++... .....+.+|..++..+. +|+++..+..++......|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999999999999999987532 23334566666666655 3567777777777888899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCC
Q 021855 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (306)
Q Consensus 80 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~ 158 (306)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence 999999 7899998876 4568999999999999999999999999999999999999 5889999999999987654
Q ss_pred CCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccch
Q 021855 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (306)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (306)
... ....||+.|+|||++.+ ..+++++|||||||++|+|++|+.||.+.+..................+
T Consensus 160 ~~~---------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 229 (364)
T d1omwa3 160 KKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP- 229 (364)
T ss_dssp SCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCC-
T ss_pred Ccc---------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCC-
Confidence 332 25579999999999975 5689999999999999999999999987654433333333333333222
Q ss_pred HHHhhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHH
Q 021855 238 EVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (306)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~ 271 (306)
..+|+++.+||.+||++||++||| ++++++
T Consensus 230 ----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 ----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 567999999999999999999998 688876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=363.19 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=206.6
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccC-----CCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv 81 (306)
++|++.+.||+|+||+||+|+++.+++.||+|++.. ......+..|..++.+..+|+++..+...+.+....|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 469999999999999999999999999999998863 233345677777776555567788887778888899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
|||+ +|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 9999 7899998876 4569999999999999999999999999999999999999 588999999999998654433
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
.. .....||+.|+|||++.+..+++++|||||||++|+|++|+.||.+.+.. ..+.++....+..+
T Consensus 158 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~p---- 223 (320)
T d1xjda_ 158 AK-------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNPFYP---- 223 (320)
T ss_dssp CC-------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC----
T ss_pred cc-------ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC----
Confidence 21 12557899999999999999999999999999999999999999886543 34444444444443
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChH-HHHH
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYG-FLKR 271 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~-~l~~ 271 (306)
..+|+++.+||.+||++||++|||+. ++++
T Consensus 224 -~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 -RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 56789999999999999999999985 6765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=357.16 Aligned_cols=258 Identities=21% Similarity=0.341 Sum_probs=204.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC-CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+..++|++.+.||+|+||.||+|+++ +++.||||++.... ....+.+|+.++.+++| +++..+..+.. ....+++|
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~-~~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLVRLYAVVT-QEPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCC-CCEeEEEeeec-cCCeEEEE
Confidence 44578999999999999999999975 57789999987543 34568999999999976 45555544443 34679999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +|+|.+++... ..++++..+..++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+|+......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCc
Confidence 999 78998876532 2358999999999999999999999999999999999999 589999999999998765432
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-WQGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......+++.|+|||++.+..++.++|||||||++|||+||..| |...+.. .....+ ......+.+
T Consensus 164 ~~------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~i-~~~~~~~~p- 232 (272)
T d1qpca_ 164 YT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNL-ERGYRMVRP- 232 (272)
T ss_dssp EE------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH-HTTCCCCCC-
T ss_pred cc------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHHH-HhcCCCCCc-
Confidence 21 12245688999999999988999999999999999999996554 4443332 222222 222222222
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
..+|+++.+||.+||+.||++|||+++|++.|++++...
T Consensus 233 --~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 233 --DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 567899999999999999999999999999999998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=356.50 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=201.1
Q ss_pred cCCceeEeeeecccCccEEEEEEEcC-----CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeec-eeC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYG-VDG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~ 75 (306)
..++|++.+.||+|+||.||+|++.. +++.||+|++...... ..+.+|...+.++.||+++....... ...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 34789999999999999999999754 4468999998754432 34677888898898888777665443 445
Q ss_pred ceeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccC
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~ 139 (306)
...+++|||+ +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--- 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--- 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE---
Confidence 5789999999 899999987532 248899999999999999999999999999999999999
Q ss_pred CCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCchh
Q 021855 140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKA 218 (306)
Q Consensus 140 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg-~~pf~~~~~ 218 (306)
++++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||++| ..||.+...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp CGGGCEEECC------CCSCTTSC-----CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCCCcEEEccCcchhhcccccccc-----ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 588999999999997654433221 22355789999999999999999999999999999999996 567876443
Q ss_pred hhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
. ..+...+........+ ..+++++.++|.+||+.||++|||+++++++|+++++.+
T Consensus 243 ~---~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 243 D---EEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp S---HHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H---HHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 2 2222222332222222 567899999999999999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=353.31 Aligned_cols=262 Identities=16% Similarity=0.222 Sum_probs=201.4
Q ss_pred cccCCceeEeeeecccCccEEEEEEEcCCC----ceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 3 ~~~~~~y~i~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
.+-...|++.+.||+|+||.||+|.++.++ ..||||.+...... ..+.+|+.++.+++| +++..+..++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCC-CCEeeeeEEEecC
Confidence 455678999999999999999999987554 46999988754432 347889999999976 5666666666677
Q ss_pred ceeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
...++++|++ ++++.+.+......+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhh
Confidence 7899999999 667777777666679999999999999999999999999999999999999 589999999999998
Q ss_pred ccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC-CchhhhhHHHHHHHhhccc
Q 021855 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ-GLKAATKKQKYDKICEKKV 233 (306)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~-~~~~~~~~~~~~~~~~~~~ 233 (306)
.......... ......||+.|+|||++.+..++.++|||||||++|||++|..||. ..+.. ... +.+....
T Consensus 159 ~~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~---~~~-~~i~~~~ 230 (283)
T d1mqba_ 159 VLEDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVM-KAINDGF 230 (283)
T ss_dssp -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH-HHHHTTC
T ss_pred cccCCCccce----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH---HHH-HHHhccC
Confidence 6544322111 1124467899999999999999999999999999999999655554 33322 222 2233333
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+.+ ..+|+.+.+||.+||+.||++|||+.+|++.|+.+++.
T Consensus 231 ~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 RLPTP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCC---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCc---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 33322 55789999999999999999999999999999998863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=354.94 Aligned_cols=256 Identities=20% Similarity=0.286 Sum_probs=204.7
Q ss_pred CceeEeee-ecccCccEEEEEEEcC--CCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEE
Q 021855 7 VKYKLGRK-IGSGSFGEIFLASHVD--TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 7 ~~y~i~~~-lg~g~~~~v~~~~~~~--~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~l 80 (306)
++|.+.+. ||+|+||.||+|.++. ++..||||++...... ..+.+|+.++.+++| +++..+..++. .+..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~-~~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQ-AEALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEE-SSSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCC-CCEeeEeeeec-cCeEEE
Confidence 56888885 9999999999998764 4557999998755433 357889999999976 45555554443 346899
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCC
Q 021855 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (306)
Q Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~ 159 (306)
||||+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhccccc
Confidence 99999 679999877656679999999999999999999999999999999999999 48899999999999876543
Q ss_pred CCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchH
Q 021855 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (306)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (306)
.... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.... ...+..+ ...+.
T Consensus 163 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~~i~~~-~~~~~- 233 (285)
T d1u59a_ 163 DSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQG-KRMEC- 233 (285)
T ss_dssp SCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHHHHTT-CCCCC-
T ss_pred cccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HHHHHcC-CCCCC-
Confidence 3221 11224568899999999999899999999999999999998 9999987654322 2222222 22221
Q ss_pred HHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
++.+|+++.+||.+||+.||++|||+.+|.+.|+..+.
T Consensus 234 --p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp --CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 25678999999999999999999999999999998764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=354.84 Aligned_cols=241 Identities=23% Similarity=0.339 Sum_probs=200.8
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--------CchhhHHHHHHHHHHhC-CCCCCcceeeceeC
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQG-GSGIPNIKWYGVDG 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~ 75 (306)
++++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+|+.+++.+.+ |+++..+..++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 5789999999999999999999999999999999876431 12346789999999974 57777787778888
Q ss_pred ceeEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccc
Q 021855 76 EDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (306)
Q Consensus 76 ~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~ 153 (306)
...+++||++. +++.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .+.+.+||+|||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence 89999999993 466666665 55799999999999999999999999999999999999994 24689999999999
Q ss_pred cccCCCCCCccccccCCccccccccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc
Q 021855 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (306)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (306)
........ ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+... +....
T Consensus 159 ~~~~~~~~---------~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i~~~~ 220 (273)
T d1xwsa_ 159 ALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIRGQ 220 (273)
T ss_dssp EECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HHHCC
T ss_pred eecccccc---------cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------Hhhcc
Confidence 76543221 25678999999999987765 6789999999999999999999986421 22233
Q ss_pred cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHH
Q 021855 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (306)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 271 (306)
...+ ..+|+++.++|.+||+.||++|||++|+++
T Consensus 221 ~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 VFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCC-----CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 3333 567999999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=352.60 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=198.4
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCC---ceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~---~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
+..++|++.+.||+|+||.||+|++..++ ..||+|.+...... ..+.+|+.++++++| +++..+..++. ...
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVIT-ENP 81 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEC-SSS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe-cCe
Confidence 34578999999999999999999986543 46888887654332 357889999999976 55555555443 457
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.+++|||+ +|++.+++.....++++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence 89999999 788888877666679999999999999999999999999999999999999 58899999999999865
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhccccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (306)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.... ...+.... ..
T Consensus 159 ~~~~~~------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~~~~-~~ 228 (273)
T d1mp8a_ 159 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGE-RL 228 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTC-CC
T ss_pred cCCcce------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHHHHcCC-CC
Confidence 433221 1124567899999999999999999999999999999998 8999987655432 22322222 11
Q ss_pred chHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
+ ...++|+.+.+||.+||+.||++|||+.+|++.|+++++++
T Consensus 229 ~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 229 P---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1 22677999999999999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=352.14 Aligned_cols=249 Identities=21% Similarity=0.320 Sum_probs=195.9
Q ss_pred eeecccCccEEEEEEEc--CCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEecc-
Q 021855 13 RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (306)
Q Consensus 13 ~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~~- 85 (306)
+.||+|+||.||+|.+. .+++.||+|++...... ..+.+|+.++++++| +++..+..++. ....++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~g~~~-~~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICE-AESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCC-CCCceEEEEec-cCCEEEEEEcCC
Confidence 46999999999999864 45678999998654332 357889999999976 55555544443 34578999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCccc
Q 021855 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (306)
Q Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (306)
+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..........
T Consensus 91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~- 165 (277)
T d1xbba_ 91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYK- 165 (277)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEE-
T ss_pred CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhccccccccc-
Confidence 7899998875 5579999999999999999999999999999999999999 4889999999999987654333211
Q ss_pred cccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHHhhcC
Q 021855 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (306)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (306)
......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..... ..+.. ....+.+ ..+
T Consensus 166 ---~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~---~~i~~-~~~~~~p---~~~ 235 (277)
T d1xbba_ 166 ---AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---AMLEK-GERMGCP---AGC 235 (277)
T ss_dssp ---C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHT-TCCCCCC---TTC
T ss_pred ---cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH---HHHHc-CCCCCCC---ccc
Confidence 1224568899999999999999999999999999999998 89999886554222 22222 2222222 567
Q ss_pred chHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 245 ~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
|+++.+||.+||+.||++|||+.+|.+.|+.++.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 8999999999999999999999999999988763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-52 Score=354.10 Aligned_cols=257 Identities=20% Similarity=0.231 Sum_probs=204.3
Q ss_pred eEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-------chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 10 ~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+.++.||+|+||+||+|+++.+|+.||+|++..... ...+.+|+.+++.++| +++..+..++......++||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTCCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCC-CCEeEEEeeeccCCceeehh
Confidence 356899999999999999999999999998764322 2457889999999987 55666666677778899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
||+.+.+...+......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCccc
Confidence 999777666666546679999999999999999999999999999999999999 58899999999999765543321
Q ss_pred ccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhccc--------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-------- 233 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-------- 233 (306)
.....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.+......
T Consensus 157 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 157 -------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp -------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred -------ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 1245789999999998755 579999999999999999999999988666544444433322111
Q ss_pred ------------ccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 234 ------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 234 ------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
..+........++++.+||.+||+.||++|||++|+++ +.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~--Hp~f~~ 285 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSN 285 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC--CHhhCC
Confidence 11223334567889999999999999999999999987 677753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=350.84 Aligned_cols=261 Identities=20% Similarity=0.243 Sum_probs=209.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+|+.+++++.| +++..+..++.+....|++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-p~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEEeccccccccceeEEE
Confidence 58999999999999999999999999999999886443 24567889999999876 66667777778888999999
Q ss_pred eccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 83 DLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 83 e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
||+++++.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.|.....+..
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc
Confidence 99988877766543 4569999999999999999999999999999999999999 5889999999999987654332
Q ss_pred CccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc--------
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-------- 232 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------- 232 (306)
. .....+|+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+.......+.......
T Consensus 158 ~-------~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 T-------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp C-------TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-------ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 1 22557899999999987766 5889999999999999999999998765543333222211111
Q ss_pred -------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 233 -------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 233 -------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...........+++++.+||.+||+.||++|||++|+++ +.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~--H~ff~~~ 289 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDV 289 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTTC
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC--CHhhccC
Confidence 111123334567889999999999999999999999988 6676543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=348.13 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=198.6
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeec-eeCceeEEEEe
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVLD 83 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~~~lv~e 83 (306)
--++|++.+.||+|+||.||+|++ +|..||+|++..+...+.+.+|+.++++++| +++..+..++ ......++|+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCC-TTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEecCCcEEEEEe
Confidence 346799999999999999999998 4778999999888778889999999999976 5555555444 34456899999
Q ss_pred cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCC
Q 021855 84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~ 161 (306)
|+ +|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD 158 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCCc
Confidence 99 889999986533 348999999999999999999999999999999999999 5899999999999976543222
Q ss_pred CccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccchHHH
Q 021855 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (306)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (306)
...++..|+|||++.+..+++++|||||||++|||+| |+.||...+.... ...+.. ....+ .
T Consensus 159 ----------~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i~~-~~~~~---~ 221 (262)
T d1byga_ 159 ----------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEK-GYKMD---A 221 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTT-TCCCC---C
T ss_pred ----------cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHc-CCCCC---C
Confidence 3456889999999999999999999999999999998 7888877554422 222222 22222 2
Q ss_pred hhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 241 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+++.+.+||.+||+.||.+|||+.+|++.|+.+-.
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 25678999999999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=354.43 Aligned_cols=256 Identities=21% Similarity=0.293 Sum_probs=200.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCc----eEEEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
..+|++++.||+|+||.||+|++..+|+ .||+|.+... .....+.+|+.++++++| +++..+..++..+. .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~-~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTST-V 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCC-TTBCCEEEEEESSS-E
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCC-e
Confidence 3469999999999999999999987776 5788876543 234568899999999976 55656655555544 4
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
+++++++ +++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceecc
Confidence 5555665 899999888767789999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccccc
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (306)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+.+...... .+......+
T Consensus 163 ~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~----~i~~~~~~~ 233 (317)
T d1xkka_ 163 AEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGERLP 233 (317)
T ss_dssp TTCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH----HHHHTCCCC
T ss_pred cccccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcCCCCC
Confidence 433321 1124467999999999999999999999999999999998 899998765443222 222222222
Q ss_pred hHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.+ ..+|+.+.+||.+||+.||++|||+.+|++.|..+.+
T Consensus 234 ~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 234 QP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 22 5668999999999999999999999999999988764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=349.69 Aligned_cols=261 Identities=20% Similarity=0.258 Sum_probs=202.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCC-CceEEEEEccCC----CCchhhHHHHHHHHHHh--CCCCCCcceeece----
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSG----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGV---- 73 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~-~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~---- 73 (306)
.+++|++++.||+|+||.||+|++..+ ++.||+|++... .....+.+|+.+++.+. +|+++..+...+.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 357899999999999999999999765 567999987532 23345778999888885 4566655543332
Q ss_pred -eCceeEEEEeccCCCHHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeec
Q 021855 74 -DGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (306)
Q Consensus 74 -~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg 151 (306)
.....++++|++.+.+..+.. .....+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence 335679999999776665544 334569999999999999999999999999999999999999 588999999999
Q ss_pred cccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc
Q 021855 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (306)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (306)
.+....... ......||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 162 ~~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 162 LARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp SCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhcccc--------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 987543222 123567899999999999999999999999999999999999999886655443333332211
Q ss_pred c-------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 232 K-------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 232 ~-------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
. ...+.......+++.+.+||.+||++||++|||++|+++ +.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~--Hpff~ 297 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--HPYFQ 297 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGT
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--Chhhc
Confidence 1 111122333567888999999999999999999999977 55553
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=347.29 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=199.2
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
+-.++|++++.||+|+||.||+|++..+ +.||+|++..... ...+.+|+.++.+++|++ +..+..++. +...+++|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK-LVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTT-BCCEEEEEC-SSSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCC-EeEEEEEEe-cCCeEEEE
Confidence 3457899999999999999999998755 5699999875543 356899999999998755 445544443 34578999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCC
Q 021855 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (306)
Q Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~ 160 (306)
||+ +|+|..++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCC
Confidence 999 77888777643 3469999999999999999999999999999999999999 588999999999997654332
Q ss_pred CCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCchhhhhHHHHHHHhhcccccchHH
Q 021855 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW-QGLKAATKKQKYDKICEKKVSTPIEV 239 (306)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (306)
.. ......+|+.|+|||++....++.++|||||||++|||++|..|| ...... ..+..+. .....+.
T Consensus 168 ~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~---~~~~~i~-~~~~~~~-- 235 (285)
T d1fmka3 168 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVE-RGYRMPC-- 235 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH-TTCCCCC--
T ss_pred ce------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHH-hcCCCCC--
Confidence 21 112456899999999999999999999999999999999966555 443322 2222222 2222222
Q ss_pred HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
...+|+++.++|.+||+.||++|||+++|++.|++++...
T Consensus 236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 2567899999999999999999999999999999988643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-51 Score=354.70 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=199.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeecee-----C
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVD-----G 75 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~ 75 (306)
+.++|++++.||+|+||.||+|+++.+|+.||+|++...... ..+.+|+.+++.+.|++.+.....+... .
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 678999999999999999999999999999999998765433 3467899999999875555444443322 2
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...+++|||++.+|..+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|||.|..
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceec
Confidence 35799999998888887764 469999999999999999999999999999999999999 5899999999999987
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc---
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--- 231 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--- 231 (306)
.....+ ...+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..............
T Consensus 171 ~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 171 ADSEMT----------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCSSCC----------SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCCccc----------cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 654332 55789999999998875 4689999999999999999999999876544333222221111
Q ss_pred --------------------ccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 232 --------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 232 --------------------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.............++.+.+||.+||+.||++|||++++++ +.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~--Hp~f~~ 306 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA--HPYFES 306 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTT
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc--ChhhCc
Confidence 0111122233566889999999999999999999999988 566543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-51 Score=347.11 Aligned_cols=260 Identities=20% Similarity=0.312 Sum_probs=208.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCC-------ceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN-------EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~-------~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 74 (306)
--++|++++.||+|+||.||+|++..++ ..||+|++..+... ..+.+|...+.++.+|+++..+..++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 4578999999999999999999876554 47999998765543 3467788899999777888888777777
Q ss_pred CceeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc
Q 021855 75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (306)
Q Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~ 138 (306)
....+++|||+ +|+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl-- 168 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-- 168 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee--
Confidence 88899999999 889999986432 348999999999999999999999999999999999999
Q ss_pred CCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 021855 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (306)
Q Consensus 139 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~ 217 (306)
+.++.+||+|||.+.......... ......+++.|+|||++.++.|++++|||||||++|||++ |..||.+.+
T Consensus 169 -~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 169 -TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp -CTTCCEEECSTTCCCCGGGCCTTC-----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -cCCCCeEeccchhhcccccccccc-----ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 588999999999998765443321 2235678899999999999999999999999999999998 788998755
Q ss_pred hhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
... .+. .+......+. ...+|+.+.+||.+||+.||++|||+.+|++.|++++..
T Consensus 243 ~~~---~~~-~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 243 VEE---LFK-LLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHH---HHH-HHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH---HHH-HHHcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 432 222 2222322222 256789999999999999999999999999999999764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=346.26 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=196.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEcC-CC--ceEEEEEccCCCC-----chhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVD-TN--EIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~-~~--~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
-.++|++.+.||+|+||.||+|++.. ++ ..||+|++..... ...+.+|+.++++++| +++..+..++.+ .
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLT-P 83 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS-S
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEee-c
Confidence 35679999999999999999998653 33 4689998765322 2457899999999976 666666555544 4
Q ss_pred eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
..++++||+ ++++.+.+......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRA 160 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEE
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhh
Confidence 678999999 788888877666679999999999999999999999999999999999999 4788999999999987
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
......... ......++..|+|||++.+..++.++|||||||++|||+| |..||.+.+.. .....+......
T Consensus 161 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i~~~~~~ 233 (273)
T d1u46a_ 161 LPQNDDHYV----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKIDKEGER 233 (273)
T ss_dssp CCC-CCEEE----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTSCCC
T ss_pred cccCCCcce----ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHHHhCCCC
Confidence 655433211 1224457788999999999999999999999999999998 89999886554 333444444333
Q ss_pred cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHH
Q 021855 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (306)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~ 275 (306)
.+.+ ..+|+.+.+||.+||+.||++|||+.+|.+.|++
T Consensus 234 ~~~~---~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 LPRP---EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 3322 5678999999999999999999999999988875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-50 Score=347.45 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=204.6
Q ss_pred CCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
.++|++.+.||+|+||.||+|+++ .+++.||||++...... ..+.+|+.+++++.| +++..+..++.....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCC-CCcccceeeeccCCc
Confidence 467999999999999999999875 35678999998765433 358899999999977 455555555566778
Q ss_pred eEEEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 133 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~N 133 (306)
.++++|++ +++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 99999999 889999886421 237888999999999999999999999999999999
Q ss_pred eeeccCCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CC
Q 021855 134 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS-LP 212 (306)
Q Consensus 134 ilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~-~p 212 (306)
||+ +.++.+||+|||+|+......... ......+++.|+|||++.+..+++++|||||||++|||++|. .|
T Consensus 171 ILl---d~~~~~Kl~DFGls~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 171 CLV---GENMVVKIADFGLSRNIYSADYYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp EEE---CGGGCEEECCCSCHHHHTGGGCBC---------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEE---CCCCcEEEccchhheeccCCcccc-----ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999 588999999999997654332211 123556889999999999999999999999999999999985 67
Q ss_pred CCCchhhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
|.+.+... ....+..... .+ ....+|+++.+||.+||+.||++||||.+|++.|+++.
T Consensus 243 ~~~~~~~e---~~~~v~~~~~-~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEE---VIYYVRDGNI-LA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHH---HHHHHHTTCC-CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHH---HHHHHHcCCC-CC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 87765442 2333333222 11 12567899999999999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-50 Score=344.44 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=203.5
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC----chhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++.+.||+|+||.||+|+++ +|+.||+|++..... ...+.+|+.+++++.| +++..+...+...+..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEeeeeecccCCceeEEE
Confidence 58999999999999999999985 789999999865432 3468899999999976 66666777777888999999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
+++++++...+....+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+.....+...
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCccc
Confidence 999888877776656779999999999999999999999999999999999999 58899999999999876543321
Q ss_pred ccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc---------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------- 232 (306)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 157 -------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 157 -------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 1245688999999999765 46999999999999999999999998765543333322221111
Q ss_pred ------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 233 ------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 233 ------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
...+.......+++.+.++|++||++||++|||+.|+++ +.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~--Hp~f~ 285 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE--HAYFK 285 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGG
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 001112233556888999999999999999999999976 45443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=348.23 Aligned_cols=261 Identities=18% Similarity=0.203 Sum_probs=209.7
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcCCCce--EEEEEccCC---CCchhhHHHHHHHHHHhCCCCCCcceeeceeCcee
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~--vaiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 78 (306)
+--++|++.+.||+|+||.||+|+++.++.. ||||.+... .....+.+|+.++.++.+|+++..+..++..+...
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 3346899999999999999999999888764 677766432 23456899999999986668888887778888899
Q ss_pred EEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc
Q 021855 79 VLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~ 142 (306)
++||||+ +|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCC
Confidence 9999999 89999988642 2468999999999999999999999999999999999999 588
Q ss_pred ceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCchhhhh
Q 021855 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS-LPWQGLKAATK 221 (306)
Q Consensus 143 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~-~pf~~~~~~~~ 221 (306)
+.+||+|||+++........ ....+|..|+|||.+.+..++.++|||||||++|||++|. .||.+.+..
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~--------~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-- 233 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKK--------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-- 233 (309)
T ss_dssp GCEEECCTTCEESSCEECCC------------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred CceEEccccccccccccccc--------cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--
Confidence 99999999999764433221 2446889999999999999999999999999999999965 567765443
Q ss_pred HHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCC
Q 021855 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282 (306)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~ 282 (306)
.....+..+ ...+ ....+++++.+||.+||+.||++|||+.+|++.|+.++++...
T Consensus 234 -~~~~~i~~~-~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 234 -ELYEKLPQG-YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp -HHHHHGGGT-CCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -HHHHHHHhc-CCCC---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 233333322 1222 1256789999999999999999999999999999999976543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=343.74 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=213.4
Q ss_pred cCCceeEeeeecccCccEEEEEEEc-----CCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCc
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 76 (306)
-.++|++.+.||+|+||.||+|++. .+++.||+|++...... ..+.+|+.++..+.+|+++..+..++....
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 4578999999999999999999863 46678999998765433 347789999999987788888888777888
Q ss_pred eeEEEEecc-CCCHHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeecc
Q 021855 77 DNVLVLDLL-GPSLEDLFVYCR-----------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (306)
Q Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~-----------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~ 138 (306)
..+++|||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||++
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~-- 178 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-- 178 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc--
Confidence 899999999 789998886532 258899999999999999999999999999999999999
Q ss_pred CCCcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 021855 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (306)
Q Consensus 139 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~ 217 (306)
+.++.++++|||.++......... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||...+
T Consensus 179 -~~~~~~ki~DfG~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 179 -THGRITKICDFGLARDIKNDSNYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp -ETTTEEEECCCGGGSCTTSCTTSE-----ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -cccCcccccccchheeccCCCcce-----EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 588999999999998765433221 2235678999999999999999999999999999999999 566665544
Q ss_pred hhhhHHHHHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
.. ..+.+++........+ ..+|+.+.+||.+||+.||.+|||+.+|++.|++++..
T Consensus 253 ~~---~~~~~~i~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 253 VD---SKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SS---HHHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---HHHHHHHhcCCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 32 2333333433333322 45689999999999999999999999999999998865
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=347.10 Aligned_cols=263 Identities=21% Similarity=0.241 Sum_probs=200.9
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeecee----Cce
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD----GED 77 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~----~~~ 77 (306)
++.+|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++++.|++.+.....+... ...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 458999999999999999999999999999999998754432 3567899999999876555444443322 234
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
.++++++++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeecc
Confidence 677777779999999874 469999999999999999999999999999999999999 588999999999997654
Q ss_pred CCCCCccccccCCccccccccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhh------
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------ 230 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~------ 230 (306)
....... ......+|+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+.............
T Consensus 161 ~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 161 PDHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp GGGCBCC----TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCCccce----eeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 3322111 1235578999999999855 4578999999999999999999999987554333222211110
Q ss_pred -----------------cccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 231 -----------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 231 -----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.....+.....+.+++++.+||.+||++||.+|||++++++ +.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~--hpf~~ 299 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLE 299 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGT
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhc
Confidence 11112223344567889999999999999999999999988 45544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=343.22 Aligned_cols=264 Identities=23% Similarity=0.273 Sum_probs=202.1
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC----CchhhHHHHHHHHHHhCCCCCCcceeec-------eeC
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYG-------VDG 75 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~-------~~~ 75 (306)
++|++.+.||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.++|++.+.....+. ..+
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999999999999999876442 2345789999999998755555444332 224
Q ss_pred ceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccc
Q 021855 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (306)
Q Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~ 155 (306)
...++++|++.+.+..........+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceeee
Confidence 5689999999888877766656679999999999999999999999999999999999999 5889999999999976
Q ss_pred cCCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc
Q 021855 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (306)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (306)
......... .......||+.|+|||++.+. .+++++||||+||++|+|++|+.||.+.+.......+.+.......
T Consensus 167 ~~~~~~~~~---~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CCC-----C---CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccccccc---ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 654332211 122355789999999999866 5899999999999999999999999876655444444443322211
Q ss_pred cc----------------------h-HH-HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 TP----------------------I-EV-LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 ~~----------------------~-~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.. . +. .....++.+.+||.+||++||++|||++|+++ +.++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~--Hpff~ 309 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFW 309 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc--Chhhc
Confidence 10 0 00 01123667889999999999999999999987 77775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=339.46 Aligned_cols=257 Identities=18% Similarity=0.224 Sum_probs=199.1
Q ss_pred EeeeecccCccEEEEEEEcCCC---ceEEEEEccCCCCc---hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 11 LGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 11 i~~~lg~g~~~~v~~~~~~~~~---~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
+.+.||+|+||+||+|++..++ ..||+|.++..... ..+.+|+.++.+++|++.+..+..+...+...+++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3678999999999999986543 35899988643332 45889999999998744444444444456688999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCCc
Q 021855 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (306)
Q Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (306)
+ +++|.+++......+++..+..++.|++.||.|||+.+|+||||||+|||+ ++++.+||+|||+++.........
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccccc
Confidence 9 788888887656668899999999999999999999999999999999999 588999999999998765433221
Q ss_pred cccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccccchHHHhhc
Q 021855 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (306)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (306)
. .......+|..|+|||++.+..++.++|||||||++|||++|..||...... ......+..+. .... ...
T Consensus 188 ~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~g~-~~~~---p~~ 258 (311)
T d1r0pa_ 188 V---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGR-RLLQ---PEY 258 (311)
T ss_dssp T---TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTC-CCCC---CTT
T ss_pred c---eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCC-CCCC---ccc
Confidence 1 1222456889999999999999999999999999999999988887653322 12222222222 2221 256
Q ss_pred CchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhh
Q 021855 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (306)
Q Consensus 244 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~ 279 (306)
+++++.+||.+||+.||++|||+.+|++.|+.+++.
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 688999999999999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=344.57 Aligned_cols=258 Identities=23% Similarity=0.258 Sum_probs=198.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeece-----eCceeEE
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDNVL 80 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~~l 80 (306)
..+|+..+.||+|+||+||+|++..+|+.||+|++..... ...+|+.++++++|.+.+.....+.. +..+.++
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4479999999999999999999999999999999876533 34579999999987554444433321 3345789
Q ss_pred EEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCc-ceEEEEeecccccc
Q 021855 81 VLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDFGLAKKY 156 (306)
Q Consensus 81 v~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~-~~~kl~Dfg~~~~~ 156 (306)
+|||+++++.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||+. .+ ..+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~---~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe---cCCCceeEecccchhhc
Confidence 999998877665542 345699999999999999999999999999999999999994 44 58999999999866
Q ss_pred CCCCCCccccccCCccccccccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcccc-
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS- 234 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~- 234 (306)
...... ....|+..|+|||++.+. .++.++||||+||++|||++|+.||...+.......+.+.......
T Consensus 174 ~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 174 VRGEPN--------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CTTSCC--------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCCccc--------ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 443321 255789999999988765 5899999999999999999999999876554433333222211100
Q ss_pred --------------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 --------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 --------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
..........++++.+||.+||++||++|||+.|+++ +.+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~ 307 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--HSFFD 307 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhc
Confidence 0011122456888999999999999999999999987 45543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=340.21 Aligned_cols=254 Identities=21% Similarity=0.335 Sum_probs=207.2
Q ss_pred CceeEeeeecccCccEEEEEEE---cCCCceEEEEEccCC------CCchhhHHHHHHHHHHhCCCCCCcceeeceeCce
Q 021855 7 VKYKLGRKIGSGSFGEIFLASH---VDTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~---~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 77 (306)
++|++++.||+|+||.||+|++ +.+|+.||+|++... .....+.+|+.+++++.|++++..+...+.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999987 357899999987632 2345678899999999999899888888888889
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 78 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
.++++||+ +++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhh
Confidence 99999999 7899988876 4468899999999999999999999999999999999999 57899999999999765
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH-hhccc
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI-CEKKV 233 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~ 233 (306)
...... ......+++.|++||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+.+. .....
T Consensus 180 ~~~~~~------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 180 VADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253 (322)
T ss_dssp CGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC
T ss_pred cccccc------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC
Confidence 433222 123567899999999997654 688999999999999999999999876554444443332 22222
Q ss_pred ccchHHHhhcCchHHHHHHHhhhcCCCCCCCC-----hHHHHHHHHHhH
Q 021855 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKRLFHDLF 277 (306)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~~l~~~l~~~~ 277 (306)
+.+ ..+|+++.++|.+||++||++||| ++|+++ +.++
T Consensus 254 ~~~-----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~--Hpff 295 (322)
T d1vzoa_ 254 PYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE--HLFF 295 (322)
T ss_dssp CCC-----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT--SGGG
T ss_pred CCc-----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc--CHhh
Confidence 222 567899999999999999999995 677765 4444
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-48 Score=336.72 Aligned_cols=255 Identities=20% Similarity=0.293 Sum_probs=198.3
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeece--eCceeEEEEe
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVLVLD 83 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~~lv~e 83 (306)
.++|++++.||+|+||+||+|+++.+|+.||+|++... ....+.+|+.++..+.+|+++..+..++. .....+++||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 46799999999999999999999999999999998754 34567899999999987788877765554 3456899999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
|+ +++|..+ .+.+++..+..++.||+.||.|||++||+||||||+|||++ .+++.+||+|||+|.........
T Consensus 113 ~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 113 HVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp CCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCCC
T ss_pred ecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCcc
Confidence 99 5666544 34699999999999999999999999999999999999995 24557999999999876543321
Q ss_pred ccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhh-hHHHHHHHhhcc--------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKICEKK-------- 232 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~-------- 232 (306)
....+|+.|+|||++.+.. ++.++||||+||++|+|++|..||....... ....+.......
T Consensus 187 --------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 187 --------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp --------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred --------cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 2557899999999988764 7999999999999999999999997643221 111111111100
Q ss_pred --cc-------------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhH
Q 021855 233 --VS-------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (306)
Q Consensus 233 --~~-------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~ 277 (306)
.. .........+++++.+||++||++||.+|||++|+++ +.++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~--Hp~F 322 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--HPYF 322 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGG
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc--Cccc
Confidence 00 0001112346788999999999999999999999987 5454
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=340.35 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=199.5
Q ss_pred CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeec-----eeCc
Q 021855 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYG-----VDGE 76 (306)
Q Consensus 6 ~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~ 76 (306)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.+.|++.+.....+. .+..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999999999999999998765433 24678999999998755554444332 1233
Q ss_pred eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeecccccc
Q 021855 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (306)
Q Consensus 77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~ 156 (306)
..++++++++++|.+++. .+++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|||.+...
T Consensus 97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhccc
Confidence 456666666999999885 4569999999999999999999999999999999999999 58899999999998754
Q ss_pred CCCCCCccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhcc---
Q 021855 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--- 232 (306)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--- 232 (306)
.... ....|+..|+|||+..+.. ++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 172 ~~~~----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 172 DDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp TGGG----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred Cccc----------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 3322 2567899999999877765 6899999999999999999999998765543333332221111
Q ss_pred --------------------cccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhc
Q 021855 233 --------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (306)
Q Consensus 233 --------------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~ 280 (306)
............++.+.+||.+||+.||++|||++|+++ +.++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~--Hp~f~~~ 307 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQY 307 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc--CHhhCCC
Confidence 111122233467889999999999999999999999988 6777543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=336.12 Aligned_cols=259 Identities=20% Similarity=0.287 Sum_probs=207.0
Q ss_pred ccCCceeEeeeecccCccEEEEEEEcC-----CCceEEEEEccCCCCch---hhHHHHHHHHHHhCCCCCCcceeeceeC
Q 021855 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (306)
Q Consensus 4 ~~~~~y~i~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~---~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 75 (306)
+.-++|++.+.||+|+||.||+|.+.. ++..||||++....... .+.+|+.+++++.| +++..+...+..+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQG 95 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCC-CCEeeeeeEEecC
Confidence 445889999999999999999998752 35789999987544332 37889999999986 4555555566677
Q ss_pred ceeEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceE
Q 021855 76 EDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (306)
Q Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~ 145 (306)
...++++||+ +|+|.+++.... ..++...+..++.|++.||.|||+++|+||||||+|||+ +.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 7899999999 889998876432 246889999999999999999999999999999999999 589999
Q ss_pred EEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCchhhhhHHH
Q 021855 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQK 224 (306)
Q Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg-~~pf~~~~~~~~~~~ 224 (306)
||+|||+++......... ......+++.|+|||.+.+..++.++|||||||++|||+|| ..||.+.+.. ..
T Consensus 173 Kl~DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~ 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QV 244 (308)
T ss_dssp EECCTTCCCGGGGGGCEE-----GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HH
T ss_pred EEeecccceeccCCccee-----eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence 999999997654433211 12344688999999999999999999999999999999998 5778775543 33
Q ss_pred HHHHhhcccccchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
+..+..... .+. ...+|+.+.++|.+||+.||++|||+.+|++.|+..++
T Consensus 245 ~~~i~~~~~-~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 LRFVMEGGL-LDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHTTCC-CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHhCCC-CCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 333333222 211 15678899999999999999999999999999987754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=336.98 Aligned_cols=267 Identities=24% Similarity=0.260 Sum_probs=195.0
Q ss_pred cCCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHH--HHHhCCCCCCcceeecee-C---cee
Q 021855 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY--KILQGGSGIPNIKWYGVD-G---EDN 78 (306)
Q Consensus 5 ~~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l--~~l~~~~~~~~~~~~~~~-~---~~~ 78 (306)
++..|.+.+.||+|+||.||+|++ +|+.||||++..... ....+|.+++ ..++| +++..+..++.. . ...
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~H-pnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCC-CcCcceEEEEEeCCCcceEE
Confidence 467899999999999999999987 688999998865432 3344454443 34455 555455444332 2 357
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCccccCCCCCceeeccCCCcceEEEEe
Q 021855 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS--------RGFLHRDIKPDNFLMGLGRKANQVYIID 149 (306)
Q Consensus 79 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--------~~i~H~dlkp~Nilv~~~~~~~~~kl~D 149 (306)
+++|||+ +|+|.+++.. .++++..++.++.|++.||.|||+ +||+||||||+|||+ +.++.+||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~D 151 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEe
Confidence 9999999 8899999975 468999999999999999999996 599999999999999 5889999999
Q ss_pred eccccccCCCCCCccccccCCccccccccccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCchhh----
Q 021855 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRGSLPWQGLKAA---- 219 (306)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~sDiwslG~il~~l~tg~~pf~~~~~~---- 219 (306)
||++............ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||......
T Consensus 152 FGl~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEECC-------CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred cCccccccCCCcceec---cccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 9999876543322111 122557899999999987653 567899999999999999998887432211
Q ss_pred --------hhHHHHHHHhhcccccchHH--HhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHhhcCCC
Q 021855 220 --------TKKQKYDKICEKKVSTPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD 283 (306)
Q Consensus 220 --------~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~~~~~~ 283 (306)
..............+...+. .....+..+.+|+.+||+.||++|||+.||++.|+++.++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 01111112222222222111 11223456899999999999999999999999999999887754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=328.83 Aligned_cols=259 Identities=22% Similarity=0.286 Sum_probs=201.4
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCc----hhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEE
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~ 82 (306)
++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.+.| +++..+..++......++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCc-CCEEeeccccccccceeEEe
Confidence 5899999999999999999999999999999998654332 356789999999877 55656667777888899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccCCCCCC
Q 021855 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (306)
Q Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (306)
+++.+.....+....+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||.+.........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCcc
Confidence 999655555555556679999999999999999999999999999999999999 47889999999999876544332
Q ss_pred ccccccCCccccccccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCch-hhhhHHHHHHHhhcccc------
Q 021855 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLK-AATKKQKYDKICEKKVS------ 234 (306)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~-~~~~~~~~~~~~~~~~~------ 234 (306)
.....++..|+|||++.+.. ++.++|||||||++|+|++|..||.... .......+.........
T Consensus 158 -------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 158 -------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred -------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh
Confidence 12445678899999988766 6899999999999999999999975432 22222222222111100
Q ss_pred ---------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 235 ---------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 235 ---------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
.........+++.+.+||.+||++||.+|||++|+++ +.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~--Hp~f~ 287 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFS 287 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGS
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc--Chhhc
Confidence 0112223456788999999999999999999999977 55553
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=335.64 Aligned_cols=256 Identities=20% Similarity=0.237 Sum_probs=191.0
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCCch----hhHHHHHHHHHHhCCCCCCcceeece-----eCce
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGV-----DGED 77 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~ 77 (306)
++|++.+.||+|+||+||+|+++.+|+.||||++....... .+.+|+.+++.++|++.+.....+.. ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999999999999999987654432 46789999999976444443433322 3367
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEEeeccccccC
Q 021855 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (306)
Q Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~~~~ 157 (306)
.|++|||+.+++.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++++|||.+....
T Consensus 97 ~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhccc
Confidence 8999999988877765 3468999999999999999999999999999999999999 478999999999987654
Q ss_pred CCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHhhc------
Q 021855 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK------ 231 (306)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~------ 231 (306)
.... .....+|+.|+|||++.+..+++++||||+||++|+|++|+.||.+.+.......+......
T Consensus 171 ~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 171 TSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc--------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 4332 12557899999999999999999999999999999999999999876544333322211111
Q ss_pred -------------ccc---------------cchHHHhhcCchHHHHHHHhhhcCCCCCCCChHHHHHHHHHhHh
Q 021855 232 -------------KVS---------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 232 -------------~~~---------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~l~~~~~ 278 (306)
... ..........++++.+||++||+.||++|||++|+++ +.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~--Hpw~~ 315 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--HPYIN 315 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTG
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--CcccC
Confidence 000 0000011223677999999999999999999999988 56665
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-43 Score=306.94 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=187.1
Q ss_pred Cccc-CCceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCC----------CCCcce
Q 021855 2 ERII-GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS----------GIPNIK 69 (306)
Q Consensus 2 ~~~~-~~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~----------~~~~~~ 69 (306)
++++ +++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+|+.+++.+.|.+ ++..+.
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 4444 4679999999999999999999999999999999886532 245678999998887643 333333
Q ss_pred eec--eeCceeEEEEecc--CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeccCC---
Q 021855 70 WYG--VDGEDNVLVLDLL--GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR--- 140 (306)
Q Consensus 70 ~~~--~~~~~~~lv~e~~--~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~Nilv~~~~--- 140 (306)
.++ ......+++++++ .++....... ....+++..++.++.||+.||.|||+ .||+||||||+|||+...+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 222 2334455555555 4444443332 23458999999999999999999998 8999999999999994211
Q ss_pred CcceEEEEeeccccccCCCCCCccccccCCccccccccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCchhhh
Q 021855 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (306)
Q Consensus 141 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 220 (306)
....++++|||.+........ ...+|+.|+|||++.+..++.++||||+||++++|++|+.||.......
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~~----------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHYT----------NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp TEEEEEECCCTTCEETTBCCC----------SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred ccceeeEeecccccccccccc----------cccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 113589999999876543322 5578999999999999999999999999999999999999997543211
Q ss_pred h------HHHHHHHhhcc---------------------------cccchH-------HHhhcCchHHHHHHHhhhcCCC
Q 021855 221 K------KQKYDKICEKK---------------------------VSTPIE-------VLCKSHPAEFASYFHYCQSLTF 260 (306)
Q Consensus 221 ~------~~~~~~~~~~~---------------------------~~~~~~-------~~~~~~~~~~~~li~~cl~~dP 260 (306)
. ........... ...+.. ......++.+.+||.+||++||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 1 01111111000 000000 0012336779999999999999
Q ss_pred CCCCChHHHHHHHHHhHh
Q 021855 261 DQRPDYGFLKRLFHDLFS 278 (306)
Q Consensus 261 ~~Rps~~~l~~~l~~~~~ 278 (306)
.+|||++|+++ +.+++
T Consensus 317 ~~Rpta~e~L~--Hp~f~ 332 (362)
T d1q8ya_ 317 RKRADAGGLVN--HPWLK 332 (362)
T ss_dssp TTCBCHHHHHT--CGGGT
T ss_pred hHCcCHHHHhc--CcccC
Confidence 99999999987 66664
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=9.9e-24 Score=167.24 Aligned_cols=132 Identities=19% Similarity=0.331 Sum_probs=95.3
Q ss_pred eeEeeeecccCccEEEEEEEcCCCceEEEEEccCCCC------------c--------hhhHHHHHHHHHHhCCCCCCcc
Q 021855 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------H--------PQLLYEAKVYKILQGGSGIPNI 68 (306)
Q Consensus 9 y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~------------~--------~~~~~e~~~l~~l~~~~~~~~~ 68 (306)
+.+++.||+|+||.||+|++. +|+.||+|++..... . ....+|...+.++.+.+ ++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA-VPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS-SCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC-cceE
Confidence 468999999999999999874 689999998653211 0 11234566677776533 3332
Q ss_pred eeeceeCceeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeccCCCcceEEEE
Q 021855 69 KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (306)
Q Consensus 69 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~Nilv~~~~~~~~~kl~ 148 (306)
..+ . ..+++||++++... ..++...+..++.|++.+|.|||++||+||||||+|||++ +..++|+
T Consensus 80 ~~~--~--~~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li 144 (191)
T d1zara2 80 YAW--E--GNAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII 144 (191)
T ss_dssp EEE--E--TTEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred EEe--c--CCEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence 222 1 24799999965432 1244455677899999999999999999999999999993 4558999
Q ss_pred eeccccccC
Q 021855 149 DFGLAKKYR 157 (306)
Q Consensus 149 Dfg~~~~~~ 157 (306)
|||.|....
T Consensus 145 DFG~a~~~~ 153 (191)
T d1zara2 145 DFPQSVEVG 153 (191)
T ss_dssp CCTTCEETT
T ss_pred ECCCcccCC
Confidence 999987654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=1.1e-06 Score=70.97 Aligned_cols=137 Identities=17% Similarity=0.183 Sum_probs=88.9
Q ss_pred CceeEeeeecccCccEEEEEEEcCCCceEEEEEccCCC--CchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 7 ~~y~i~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
..|++.+..+.++.+.||+.. ..++.+++|+..... ......+|...+..+...-.+|.+..++...+..+++|++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 356666665544557899885 356667888765432 2334678888888887655567776666677788999999
Q ss_pred cCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 021855 85 LGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------------------------------ 121 (306)
Q Consensus 85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~------------------------------------------ 121 (306)
..| ++.+.... ... ...++.+++..+..||+
T Consensus 92 l~G~~~~~~~~~---~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 92 ADGVLCSEEYED---EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHTTT---CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred cccccccccccc---ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 955 44333211 111 22234555555555653
Q ss_pred -----------------cCccccCCCCCceeeccCCCcceEEEEeecccc
Q 021855 122 -----------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (306)
Q Consensus 122 -----------------~~i~H~dlkp~Nilv~~~~~~~~~kl~Dfg~~~ 154 (306)
..++|+|+.|.|||+ ++++..-|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceee---cCCceEEEeechhcc
Confidence 127999999999999 344555699998774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.13 E-value=8.5e-06 Score=69.82 Aligned_cols=74 Identities=16% Similarity=0.192 Sum_probs=46.9
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccC------C---CCchhhHHHHHHHHHHhCCC--CCCcceeeceeCceeEE
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENS------G---TKHPQLLYEAKVYKILQGGS--GIPNIKWYGVDGEDNVL 80 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~------~---~~~~~~~~e~~~l~~l~~~~--~~~~~~~~~~~~~~~~l 80 (306)
.+.||.|....||++....+++.+++|.... + ........|...+..+.... .+|.+ +..+....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v--~~~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRV--FYSDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCE--EEEETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceE--EEEcCCCCEE
Confidence 5678999999999998777788899995321 1 11223456888888776432 23333 3445667789
Q ss_pred EEeccCC
Q 021855 81 VLDLLGP 87 (306)
Q Consensus 81 v~e~~~~ 87 (306)
+||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999843
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=2.9e-05 Score=61.94 Aligned_cols=72 Identities=18% Similarity=0.106 Sum_probs=48.0
Q ss_pred eecccCc-cEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCCCC-CCcceeeceeCceeEEEEeccCC
Q 021855 14 KIGSGSF-GEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLGP 87 (306)
Q Consensus 14 ~lg~g~~-~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~~~~~~~~~~~~lv~e~~~~ 87 (306)
.+..|.. +.||+... ..+..+++|..... ....+..|...++.+..... +|.+.....+.+..+++|+++.|
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 3444543 57898874 34566788875543 34567889999988876433 45555555666778999999843
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.25 E-value=0.00062 Score=57.87 Aligned_cols=72 Identities=13% Similarity=0.123 Sum_probs=50.4
Q ss_pred eeeecccCccEEEEEEEcC-------CCceEEEEEccCCCCchhhHHHHHHHHHHhCCCCCCcceeeceeCceeEEEEec
Q 021855 12 GRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~~lv~e~ 84 (306)
++.|+.|-.-.+|++.... ..+.|++++...........+|..+++.+......|.+..++.+ .++++|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4677778888999998643 24567888776444445567799999999877766777665532 578888
Q ss_pred cCC
Q 021855 85 LGP 87 (306)
Q Consensus 85 ~~~ 87 (306)
..|
T Consensus 123 i~g 125 (395)
T d1nw1a_ 123 IPS 125 (395)
T ss_dssp CCE
T ss_pred ecc
Confidence 743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.23 E-value=0.0025 Score=52.01 Aligned_cols=49 Identities=12% Similarity=0.148 Sum_probs=30.1
Q ss_pred eeeecccCccEEEEEEEcCCCceEEEEEccCCCCchhhHHHHHHHHHHhCC
Q 021855 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62 (306)
Q Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~ 62 (306)
.+.|..|--.+.|++... +..+++|+............|..++..|...
T Consensus 23 ~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~ 71 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAK 71 (316)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHT
T ss_pred eecCCCCcccCeEEEEEC--CCcEEEEEcCCCCCHHHHHHHHHHHHhhhhc
Confidence 445556666788998753 3458899987655555666788888887753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.08 E-value=0.0031 Score=51.85 Aligned_cols=68 Identities=13% Similarity=0.048 Sum_probs=43.0
Q ss_pred cCccEEEEEEEcCCCceEEEEEccCCCC-chhhHHHHHHHHHHhCCCCCCcc-------eeeceeCceeEEEEeccCC
Q 021855 18 GSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNI-------KWYGVDGEDNVLVLDLLGP 87 (306)
Q Consensus 18 g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~-------~~~~~~~~~~~lv~e~~~~ 87 (306)
+....||.++. .+|+.+++|+...... ..++..|...+..|.... ++.. ......+...+.++++..|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~g-ipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcC-CCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 44568999974 5688899998776533 355777888888887532 2211 1222344556778888743
|